rearrangement	amino_acid	frame_type	rearrangement_type	templates	reads	frequency	productive_frequency	cdr3_length	v_family	v_gene	v_allele	d_family	d_gene	d_allele	j_family	j_gene	j_allele	v_deletions	d5_deletions	d3_deletions	j_deletions	n2_insertions	n1_insertions	v_index	n1_index	n2_index	d_index	j_index	v_family_ties	v_gene_ties	v_allele_ties	d_family_ties	d_gene_ties	d_allele_ties	j_family_ties	j_gene_ties	j_allele_ties	sequence_tags	v_shm_count	v_shm_indexes	antibody	bio_identity	v_resolved	d_resolved	j_resolved	sample_name	species	locus	product_subtype	kit_pool	sku	test_name	sample_catalog_tags	sample_rich_tags	sample_rich_tags_json	kit_control	total_templates	productive_templates	outofframe_templates	stop_templates	dj_templates	total_rearrangements	productive_rearrangements	outofframe_rearrangements	stop_rearrangements	dj_rearrangements	total_reads	total_productive_reads	total_outofframe_reads	total_stop_reads	total_dj_reads	productive_clonality	productive_entropy	sample_clonality	sample_entropy	sample_amount_ng	sample_cells_mass_estimate	fraction_productive_of_cells_mass_estimate	sample_cells	fraction_productive_of_cells	max_productive_frequency	max_frequency	counting_method	primer_set	sequence_result_status	release_date	upload_date	sample_tags	fraction_productive	order_name	kit_id	total_t_cells	total_templates_agg
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTGGAAGGACAGGGTGATAGAGCTTTCTTTGGACAA	CASSLEGQGDRAFF	In	VDJ	1	49	7.26382201560684E-5	8.808545367603968E-5	42	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	1	3	10	4	6	18	32	44	36	50														CASSLEGQGDRAFF+TCRBV07-06+TCRBJ01-01	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTGACTAGTCAGAACTACGAGCAGTACTTCGGGCCG	CASSLTSQNYEQYF	In	VDJ	1	54	8.005028343729987E-5	9.707376527563557E-5	42	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	2	8	3	0	6	18	-1	38	32	44						01,02								CASSLTSQNYEQYF+TCRBV07-06+TCRBJ02-07	TCRBV07-06*01	TCRBD02-01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCATGTATCGCTGTGCCAGCACCTCTGATCCGGGACAGGGTAGGGGCTACACCTTCGGTTCG	CASTSDPGQGRGYTF	In	VDJ	1	55	8.153269609354617E-5	9.887142759555474E-5	45	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	0	3	8	10	4	18	28	47	38	51														CASTSDPGQGRGYTF+TCRBV07-06+TCRBJ01-02	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCCCAGGGGGCTGAACACTGAAGCTTTCTTTGGACAA	CASSPRGLNTEAFF	In	VDJ	1	66	9.783923531225541E-5	1.1864571311466569E-4	42	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	0	0	2	0	18	30	-1	32	40														CASSPRGLNTEAFF+TCRBV07-06+TCRBJ01-01	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTCGACAAACGTTGGTGGCGAGCAGTACTTCGGGCCG	CASSSTNVGGEQYF	In	VDJ	1	73	1.0821612390597947E-4	1.3122934935409992E-4	42	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	2	6	6	1	11	18	31	36	32	47														CASSSTNVGGEQYF+TCRBV07-06+TCRBJ02-07	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCCCATTGGGGCAGGGAAATTGGGAAACACCATATATTTTGGAGAG	CASSPIGAGKLGNTIYF	In	VDJ	1	93	1.3786437703090535E-4	1.6718259575248346E-4	51	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	4	3	4	10	6	18	30	45	40	51														CASSPIGAGKLGNTIYF+TCRBV07-06+TCRBJ01-03	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCAGCTTGGGTGAATCTCGAAGCCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	123	1.8233675671829416E-4		49	TCRBV07	TCRBV07-06	01				TCRBJ01	TCRBJ01-02	01	5	0	9	4	5	13	18	30	38	35	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-06+TCRBJ01-02	TCRBV07-06*01		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCCAAACCGGGACTGCCAACACTGAAGCTTTCTTTGGACAA	CASSQTGTANTEAFF	In	VDJ	1	52	7.708545812480728E-5	9.34784406357972E-5	45	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	0	10	2	6	3	19	31	43	37	46						01,02								CASSQTGTANTEAFF+TCRBV07-05+TCRBJ01-01	TCRBV07-05*01	TCRBD02-01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTAGGTCGGGGAAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLGRGSSYNEQFF	In	VDJ	1	70	1.0376888593724057E-4	1.258363623943424E-4	48	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	8	3	0	2	3	19	35	42	37	45														CASSLGRGSSYNEQFF+TCRBV07-05+TCRBJ02-01	TCRBV07-05*01	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTTTCTGAGAAGGGTTGGAATCAGCCCCAGCATTTTGGTGAT	CASSFSEKGWNQPQHF	In	VDJ	1	75	1.1118094921847204E-4	1.348246739939383E-4	48	TCRBV07	TCRBV07-05	01				TCRBJ01	TCRBJ01-05	01	2	5	3	4	8	4	19	33	45	41	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFSEKGWNQPQHF+TCRBV07-05+TCRBJ01-05	TCRBV07-05*01		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGATACGGGACAGTTACCCATTCAGTACTTCGGCGCC		Out	VDJ	1	84	1.245226631246887E-4		40	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	8	0	5	9	7	5	19	27	41	34	46														X+TCRBV07-05+TCRBJ02-04	TCRBV07-05*01	TCRBD01-01*01	TCRBJ02-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTGGATCTGGGGAGTGGAAACACCATATATTTTGGAGAG	CASSLDLGSGNTIYF	In	VDJ	1	146	2.1643224781195893E-4	2.6245869870819983E-4	45	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	2	9	2	3	7	0	19	33	-1	40	45														CASSLDLGSGNTIYF+TCRBV07-05+TCRBJ01-03	TCRBV07-05*01	TCRBD02-01*02	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGTTGAGAATTCACCCCTCCACTTTGGGAAC	CASSEVENSPLHF	In	VDJ	1	56	8.301510874979246E-5	1.0066908991547392E-4	39	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	1	11	2	7	2	0	23	39	-1	41	44														CASSEVENSPLHF+TCRBV06-01+TCRBJ01-06	TCRBV06-01*01	TCRBD02-01*02	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGGCCGGGACAGATCGAATTCACCCCTCCACTTTGGGAAC	CASSEGRDRSNSPLHF	In	VDJ	1	59	8.746234671853134E-5	1.0606207687523144E-4	48	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	1	0	5	7	3	4	23	39	49	42	53														CASSEGRDRSNSPLHF+TCRBV06-01+TCRBJ01-06	TCRBV06-01*01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGGATTCGGGGAGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSEGFGESNQPQHF	In	VDJ	1	62	9.190958468727023E-5	1.1145506383498898E-4	48	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	1	8	3	1	4	2	23	39	48	43	50						01,02								CASSEGFGESNQPQHF+TCRBV06-01+TCRBJ01-05	TCRBV06-01*01	TCRBD02-01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCTTTAGGACAGGCTGAAGCTTTCTTTGGACAA	CASSEALGQAEAFF	In	VDJ	1	64	9.487440999976282E-5	1.1505038847482733E-4	42	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	1	4	6	4	0	23	40	-1	44	51														CASSEALGQAEAFF+TCRBV06-01+TCRBJ01-01	TCRBV06-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCGTGGACCAACAATGAGCAGTTCTTCGGGCCA	CASSEAWTNNEQFF	In	VDJ	1	68	1.0080406062474798E-4	1.2224103775450404E-4	42	TCRBV06	TCRBV06-01	01				TCRBJ02	TCRBJ02-01	01	0	1	7	5	2	2	23	40	46	42	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEAWTNNEQFF+TCRBV06-01+TCRBJ02-01	TCRBV06-01*01		TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCGCGGGGGGCGGGCTCCTACGAGCAGTACTTCGGGCCG	CASSEARGAGSYEQYF	In	VDJ	1	77	1.1414577453096463E-4	1.3841999863377664E-4	48	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	7	1	0	0	4	23	-1	48	40	52														CASSEARGAGSYEQYF+TCRBV06-01+TCRBJ02-07	TCRBV06-01*01	TCRBD02-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGGACAGAACTATGGCTACACCTTCGGTTCG	CASSEGQNYGYTF	In	VDJ	1	88	1.3045231374967387E-4	1.581942841528876E-4	39	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	2	5	2	0	0	23	-1	-1	39	44														CASSEGQNYGYTF+TCRBV06-01+TCRBJ01-02	TCRBV06-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCTAGAGAGGTCAATGAGCAGTTCTTCGGGCCA	CASSEAREVNEQFF	In	VDJ	1	95	1.4082920234339793E-4	1.7077792039232181E-4	42	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	11	1	6	4	1	23	40	48	44	49														CASSEAREVNEQFF+TCRBV06-01+TCRBJ02-01	TCRBV06-01*01	TCRBD02-01*02	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGGACGATATCGAGGCACCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSEGRYRGTSGANVLTF	In	VDJ	1	96	1.4231161499964423E-4	1.72575582712241E-4	57	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	1	11	1	0	9	3	23	39	52	48	55														CASSEGRYRGTSGANVLTF+TCRBV06-01+TCRBJ02-06	TCRBV06-01*01	TCRBD02-01*02	TCRBJ02-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCAGTCCCGGGGAGAAACGAGCAGTACTTCGGGCCG	CASSEAVPGRNEQYF	In	VDJ	1	98	1.452764403121368E-4	1.7617090735207936E-4	45	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	8	3	5	5	4	23	40	50	45	54						01,02								CASSEAVPGRNEQYF+TCRBV06-01+TCRBJ02-07	TCRBV06-01*01	TCRBD02-01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGGGGGACAAGGGATAGCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	103	1.5268850359336829E-4		53	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	0	6	0	1	8	23	39	46	40	54														X+TCRBV06-01+TCRBJ01-03	TCRBV06-01*01	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGTTGGGGGCCACACCATATATTTTGGAGAG	CASSEVGGHTIYF	In	VDJ	1	106	1.5713574156210716E-4	1.9055220591143276E-4	39	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	6	0	8	2	1	23	39	47	41	48														CASSEVGGHTIYF+TCRBV06-01+TCRBJ01-03	TCRBV06-01*01	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGGCGAGGCCGCTAACTATGGCTACACCTTCGGTTCG	CASSEGEAANYGYTF	In	VDJ	1	123	1.8233675671829416E-4	2.211124653500588E-4	45	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	1	11	1	0	2	3	23	39	45	41	48														CASSEGEAANYGYTF+TCRBV06-01+TCRBJ01-02	TCRBV06-01*01	TCRBD02-01*02	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCGGACAGATCCTACGAGCAGTACTTCGGGCCG	CASSEADRSYEQYF	In	VDJ	1	124	1.8381916937454046E-4	2.2291012766997796E-4	42	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	1	5	1	0	1	23	-1	46	40	47														CASSEADRSYEQYF+TCRBV06-01+TCRBJ02-07	TCRBV06-01*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGTTTGGGTCTCGAACACTGAAGCTTTCTTTGGACAA	CASSEVWVSNTEAFF	In	VDJ	1	126	1.8678399468703303E-4	2.265054523098163E-4	45	TCRBV06	TCRBV06-01	01				TCRBJ01	TCRBJ01-01	01	1	0	9	1	3	4	23	39	45	42	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEVWVSNTEAFF+TCRBV06-01+TCRBJ01-01	TCRBV06-01*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGTAGGGGGGTCCAATCAGCCCCAGCATTTTGGTGAT	CASSEVGGSNQPQHF	In	VDJ	1	129	1.912312326557719E-4	2.3189843926957383E-4	45	TCRBV06	TCRBV06-01	01				TCRBJ01	TCRBJ01-05	01	1	5	1	3	1	3	23	39	46	40	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEVGGSNQPQHF+TCRBV06-01+TCRBJ01-05	TCRBV06-01*01		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGGTACAGGAGTTGAAAAACTGTTTTTTGGCAGT	CASSEGTGVEKLFF	In	VDJ	1	130	1.9271364531201821E-4	2.3369610158949304E-4	42	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	3	4	7	2	3	23	39	46	41	49														CASSEGTGVEKLFF+TCRBV06-01+TCRBJ01-04	TCRBV06-01*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCCGGAATGATGAGCACCTATAGCAATCAACCCCAGCATTTTGGTGAT	CASSEAGMMSTYSNQPQHF	In	VDJ	1	138	2.0457294656198857E-4	2.4807740014884643E-4	57	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	0	5	7	10	18	6	23	40	62	58	68						01,02								CASSEAGMMSTYSNQPQHF+TCRBV06-01+TCRBJ01-05	TCRBV06-01*01	TCRBD02-01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGAGGGTGTAGCCGAAGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	150	2.2236189843694408E-4		53	TCRBV06	TCRBV06-01	01				TCRBJ02	TCRBJ02-01	01	1	5	3	0	0	11	23	-1	43	39	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-01+TCRBJ02-01	TCRBV06-01*01		TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGAGGTGGGGGGCGGGCAGCCCCAGCATTTTGGTGAT	CASSEEVGGGQPQHF	In	VDJ	2	313	4.6399516140509E-4	5.626683061347024E-4	45	TCRBV06	TCRBV06-01	01				TCRBJ01	TCRBJ01-05	01	1	6	0	7	5	3	23	39	50	44	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEEVGGGQPQHF+TCRBV06-01+TCRBJ01-05	TCRBV06-01*01		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGGAGGGACCCAATACGAGCAGTACTTCGGGCCG	CASSEGGTQYEQYF	In	VDJ	4	627	9.294727354664263E-4	0.001127134274589324	42	TCRBV06	TCRBV06-01	01				TCRBJ02	TCRBJ02-07	01	1	0	7	4	2	4	23	39	46	41	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEGGTQYEQYF+TCRBV06-01+TCRBJ02-07	TCRBV06-01*01		TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCGCCGAGAGGCGGGGGTTCCAGATACGCAGTATTTTGGCCCA		Out	VDJ	4	652	9.665330518725837E-4		52	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	7	2	4	8	3	23	40	55	48	58														X+TCRBV06-01+TCRBJ02-03	TCRBV06-01*01	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGGGTGACAGCCCATATGGCTACACCTTCGGTTCG		Out	VDJ	11	1909	0.002829925760774175		43	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	2	5	5	3	4	23	39	47	42	51														X+TCRBV06-01+TCRBJ01-02	TCRBV06-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGGCCAGACAGGAGCTACGAGCAGTACTTCGGGCCG	CASRPDRSYEQYF	In	VDJ	1	128	1.8974881999952564E-4	2.3010077694965466E-4	39	TCRBV07	TCRBV07-04	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	4	3	4	2	22	33	43	37	45														CASRPDRSYEQYF+TCRBV07-04+TCRBJ02-07	TCRBV07-04*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCGTTATTAGGGTGTTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	45	6.670856953108322E-5		40	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-06	01	3	5	3	9	7	2	26	37	48	44	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	X+TCRBV30-01+TCRBJ01-06	TCRBV30-01*01		TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGCCCTCCGGGACAGGGGGCCAAGGATTTCTTTGGACAA	CACPPGQGAKDFF	In	VDJ	1	46	6.819098218732952E-5	8.269246671628214E-5	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	0	13	6	6	26	34	52	40	58													Vb 20	CACPPGQGAKDFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTCCCCCCGGGACGGGAAAACTATGGCTACACCTTCGGTTCG	CAWSVPPGRENYGYTF	In	VDJ	1	47	6.967339484357581E-5	8.449012903620132E-5	48	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-02	01	0	0	7	2	6	5	26	40	51	46	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVPPGRENYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*02		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGATCCCCGTACAGGGTTTATGGGCTTTCTTTGGACAA	CAWIPVQGLWAFF	In	VDJ	1	48	7.115580749982211E-5	8.62877913561205E-5	39	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	3	11	7	7	26	36	49	43	56			unresolved										Vb 20	CAWIPVQGLWAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACAGGGTAATCAGCCCCAGCATTTTGGTGAT	CAWSVQGNQPQHF	In	VDJ	1	50	7.41206328123147E-5	8.988311599595886E-5	39	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	3	3	4	0	1	26	-1	46	40	47													Vb 20	CAWSVQGNQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGATGGGACAGGTATTTTGAACATTCAGTACTTCGGCGCC	CAWSDGTGILNIQYF	In	VDJ	1	52	7.708545812480728E-5	9.34784406357972E-5	45	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	1	0	4	7	2	7	26	39	49	41	56													Vb 20	CAWSDGTGILNIQYF+TCRBV30-01+TCRBJ02-04	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCTACAGGGGCCAAGAAGTACTTCGGGCCG	CAWSPTGAKKYF	In	VDJ	1	54	8.005028343729987E-5	9.707376527563557E-5	36	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	3	2	11	3	6	26	38	48	41	54													Vb 20	CAWSPTGAKKYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTTCAAACAGGGCGAAGCTTTCTTTGGACAA	CAWSFKQGEAFF	In	VDJ	1	55	8.153269609354617E-5	9.887142759555474E-5	36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	3	8	5	1	26	38	49	43	50			unresolved										Vb 20	CAWSFKQGEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGACCTCCCCGGGGAAACTGAAGCTTTCTTTGGACAA	CAWDLPGETEAFF	In	VDJ	1	56	8.301510874979246E-5	1.0066908991547392E-4	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	8	3	5	8	2	26	35	48	43	50			unresolved										Vb 20	CAWDLPGETEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD02-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGGCCGACTAGCGGCAAGAGACCCAGTACTTCGGGCCA	CAWRAD*RQETQYF	Stop	VDJ	1	58	8.597993406228505E-5		42	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	2	5	2	4	0	26	37	-1	41	50			unresolved			01,02							Vb 20	CAWRAD*RQETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*02	TCRBD02-01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCGGGGGACCTGTTAGAAGCTTTCTTTGGACAA	CAWSPGDLLEAFF	In	VDJ	1	60	8.894475937477764E-5	1.0785973919515063E-4	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	2	8	2	8	1	8	26	38	45	39	53													Vb 20	CAWSPGDLLEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD02-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGAACAGGGTTGGGGCTACACCTTCGGTTCG	CAWSEQGWGYTF	In	VDJ	1	60	8.894475937477764E-5	1.0785973919515063E-4	36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	3	3	8	1	4	26	39	46	40	50													Vb 20	CAWSEQGWGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGTGACTCTGGCTTCTATCTCTGTGCCTGGATGCAGGGTCCAAAGGGGCGCCGGCGAGATATGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	62	9.190958468727023E-5		59	TCRBV30	TCRBV30-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	4	3	3	2	23	22	32	39	34	62			01,02										Vb 20	X+TCRBV30-01+TCRBJ01-03	TCRBV30-01	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCGTAAGGGGGTACACTGAAGCTTTCTTTGGACAA	CAVRGYTEAFF	In	VDJ	1	63	9.339199734351652E-5	1.1325272615490816E-4	33	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	5	1	3	3	1	26	32	41	35	42			unresolved										Vb 20	CAVRGYTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTTAAAGGGGTACACTGAAGCTTTCTTTGGACAA	CALKGYTEAFF	In	VDJ	1	64	9.487440999976282E-5	1.1505038847482733E-4	33	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	5	2	3	3	1	26	33	41	36	42													Vb 20	CALKGYTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCGCAGACAGGGGGACGGGGGCAATCAGCCCCAGCATTTTGGTGAT	CAWSRRQGDGGNQPQHF	In	VDJ	1	65	9.635682265600911E-5	1.1684805079474652E-4	51	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	2	1	2	4	6	26	38	51	42	57			unresolved										Vb 20	CAWSRRQGDGGNQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGGGACGGCCTGCACACTGAAGCTTTCTTTGGACAA	CAWGDGLHTEAFF	In	VDJ	1	65	9.635682265600911E-5	1.1684805079474652E-4	39	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-01	01	5	0	7	3	1	7	26	35	41	36	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWGDGLHTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGGGGATCCGGGGAGCTGTTTTTTGGAGAA	CAWSGGSGELFF	In	VDJ	1	66	9.783923531225541E-5	1.1864571311466569E-4	36	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-02	01	1	0	8	6	1	1	26	39	44	40	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSGGSGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01		TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGCTGAGGCCCCATCACCCCTCCACTTTGGGAAC	CAWSAEAPSPLHF	In	VDJ	1	67	9.93216479685017E-5	1.2044337543458487E-4	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	1	11	1	10	2	5	26	39	45	41	50													Vb 20	CAWSAEAPSPLHF+TCRBV30-01+TCRBJ01-06	TCRBV30-01*01	TCRBD02-01*02	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAAGGGGGGGCCGAATGAGCAGTTCTTCGGGCCA	CAWKGGPNEQFF	In	VDJ	1	68	1.0080406062474798E-4	1.2224103775450404E-4	36	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	9	0	7	1	3	26	36	44	37	47			unresolved										Vb 20	CAWKGGPNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*02	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTAACTTCGAGGGTGTTAAGGGCTACACCTTCGGTTCG	CAWSNFEGVKGYTF	In	VDJ	1	69	1.0228647328099429E-4	1.2403870007442322E-4	42	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	2	11	0	8	6	7	26	38	49	44	56													Vb 20	CAWSNFEGVKGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD02-01*02	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCCAGCGGGGGGGCTGGAGATACGCAGTATTTTGGCCCA	CAWSPSGGAGDTQYF	In	VDJ	1	69	1.0228647328099429E-4	1.2403870007442322E-4	45	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	6	0	5	3	4	26	38	51	41	55			unresolved										Vb 20	CAWSPSGGAGDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTATACGGGACAGGGCTTACAATGAGCAGTTCTTCGGGCCA	CAWSIRDRAYNEQFF	In	VDJ	1	70	1.0376888593724057E-4	1.258363623943424E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	0	3	4	4	2	26	38	51	42	53			unresolved										Vb 20	CAWSIRDRAYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACAACCATCCTACGAGCAGTACTTCGGGCCG	CAWSVQPSYEQYF	In	VDJ	1	70	1.0376888593724057E-4	1.258363623943424E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	3	6	1	0	4	26	-1	43	40	47			unresolved										Vb 20	CAWSVQPSYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACGGGGTGAGCAGTACTTCGGGCCG	CAWSVRGEQYF	In	VDJ	1	73	1.0821612390597947E-4	1.3122934935409992E-4	33	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	8	3	7	1	1	26	40	46	41	47													Vb 20	CAWSVRGEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTACGGGACAGGGGGCGGAAGGCTACACCTTCGGTTCG	CAWSTGQGAEGYTF	In	VDJ	1	74	1.0969853656222575E-4	1.3302701167401912E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	0	0	8	2	4	26	38	52	40	56													Vb 20	CAWSTGQGAEGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAAATACAGGGAAAAAGGGACCCAGTACTTCGGGCCA	CAWKYREKGTQYF	In	VDJ	1	78	1.1562818718721093E-4	1.4021766095369582E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	3	3	7	3	7	26	36	45	39	52													Vb 20	CAWKYREKGTQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCATAATTCACCCCTCCACTTTGGGAAC	CAWSHNSPLHF	In	VJ	1	80	1.1859301249970352E-4	1.4381298559353417E-4	33	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-06	01	2	0	0	5	0	1	26	-1	38	-1	39													Vb 20	CAWSHNSPLHF+TCRBV30-01+TCRBJ01-06	TCRBV30-01*02		TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCGCCGGTTCCTCTGTGAGGGAGGGGGAAAAACTGTTTTTTGGCAGT	CAAGSSVREGEKLFF	In	VDJ	1	80	1.1859301249970352E-4	1.4381298559353417E-4	45	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	8	9	0	8	16	1	26	32	55	48	56													Vb 20	CAAGSSVREGEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*01	TCRBD02-01*02	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTCGACAGGGATCGGGAACACTGAAGCTTTCTTTGGACAA	CASTGIGNTEAFF	In	VDJ	1	81	1.2007542515594981E-4	1.4561064791345334E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	2	3	1	1	5	26	33	41	34	46													Vb 20	CASTGIGNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCGGGACAGGGGACACTGAAGCTTTCTTTGGACAA	CAWSGTGDTEAFF	In	VDJ	1	83	1.230402504684424E-4	1.492059725532917E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	2	3	1	0	26	37	-1	38	48													Vb 20	CAWSGTGDTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACGTCTAACTATGGCTACACCTTCGGTTCG	CAWTSNYGYTF	In	VDJ	1	85	1.26005075780935E-4	1.5280129719313007E-4	33	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	4	8	6	0	0	1	26	-1	38	36	39						01,02							Vb 20	CAWTSNYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD02-01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGCAAGGACAGCCAAACACTGAAGCTTTCTTTGGACAA	CAWRQGQPNTEAFF	In	VDJ	1	87	1.2896990109342757E-4	1.5639662183296842E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	1	5	2	4	3	26	37	47	41	50													Vb 20	CAWRQGQPNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGCCGGGGAGCGCACAGATACGCAGTATTTTGGCCCA	CAWSAGERTDTQYF	In	VDJ	1	87	1.2896990109342757E-4	1.5639662183296842E-4	42	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	8	3	1	1	3	26	39	45	40	48						01,02							Vb 20	CAWSAGERTDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD02-01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCAGAGGAACGAGCAGTACTTCGGGCCG	CAWSQRNEQYF	In	VDJ	1	89	1.3193472640592017E-4	1.5999194647280677E-4	33	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	11	1	5	2	1	26	38	44	40	45													Vb 20	CAWSQRNEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*02	TCRBD02-01*02	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCGTAACACTGAAGCTTTCTTTGGACAA	CAWSRNTEAFF	In	VDJ	1	90	1.3341713906216645E-4	1.6178960879272594E-4	33	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	2	8	6	2	0	1	26	-1	40	38	41			unresolved			01,02							Vb 20	CAWSRNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD02-01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACCTAGGACCCAGGGGGAGGGTTGAAGCTTTCTTTGGACAA		Out	VDJ	1	90	1.3341713906216645E-4		49	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-01	01	0	4	1	7	10	5	26	40	57	50	62			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	X+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCGAGGTGGGAGGGTTCGGCTTTCTTTGGACAA	CAWSPRWEGSAFF	In	VDJ	1	91	1.3489955171841275E-4	1.6358727111264511E-4	39	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	9	0	11	7	4	26	38	52	45	56			unresolved										Vb 20	CAWSPRWEGSAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD02-01*02	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTATCCGCCACCGGGGAGCTGTTTTTTGGAGAA	CAWSVSATGELFF	In	VDJ	1	92	1.3638196437465905E-4	1.653849334325643E-4	39	TCRBV30	TCRBV30-01	02				TCRBJ02	TCRBJ02-02	01	0	10	0	4	4	0	26	40	-1	44	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVSATGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*02		TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
YCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGCCCTACCGAGGGACTAGCGGGGGGGAAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	94	1.3934678968715162E-4		56	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	0	0	0	9	1	25	34	59	43	60			unresolved										Vb 20	X+TCRBV30-01+TCRBJ02-03	TCRBV30-01*02	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTCAAGACAGGGACCGGGTCAGCCCCAGCATTTTGGTGAT	CASRQGPGQPQHF	In	VDJ	1	94	1.3934678968715162E-4	1.6898025807240264E-4	39	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	2	3	6	3	6	26	33	43	36	49													Vb 20	CASRQGPGQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTATGGGGGATAGGAGTTGCTGAAGCTTTCTTTGGACAA	CAWSVWGIGVAEAFF	In	VDJ	1	94	1.3934678968715162E-4	1.6898025807240264E-4	45	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-01	01	0	6	1	6	2	10	26	40	47	42	57			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVWGIGVAEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGGACGGCGGGGTACAATTCACCCCTCCACTTTGGGAAC	CAWGTAGYNSPLHF	In	VDJ	1	94	1.3934678968715162E-4	1.6898025807240264E-4	42	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	5	7	3	7	6	3	26	35	47	41	50			unresolved										Vb 20	CAWGTAGYNSPLHF+TCRBV30-01+TCRBJ01-06	TCRBV30-01*01	TCRBD02-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACCCAGGGTTTGGGATCACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	95	1.4082920234339793E-4		47	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	4	3	2	2	9	26	36	43	38	52													Vb 20	X+TCRBV30-01+TCRBJ01-04	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACCAAAGGTAGGCACACTGAAGCTTTCTTTGGACAA	CAWTKGRHTEAFF	In	VDJ	1	96	1.4231161499964423E-4	1.72575582712241E-4	39	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-01	01	4	5	4	3	4	5	26	36	43	40	48			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWTKGRHTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGAACCAACTCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	96	1.4231161499964423E-4		37	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	1	3	10	4	5	0	26	39	-1	44	47						01,02							Vb 20	X+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD02-01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCCGCTGGGGACCTCGAAAACATTCAGTACTTCGGCGCC	CAWSPAGDLENIQYF	In	VDJ	1	98	1.452764403121368E-4	1.7617090735207936E-4	45	TCRBV30	TCRBV30-01	02				TCRBJ02	TCRBJ02-04	01	2	0	7	5	7	4	26	38	50	45	54			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSPAGDLENIQYF+TCRBV30-01+TCRBJ02-04	TCRBV30-01*02		TCRBJ02-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCCATTACGTAGGCTACACCTTCGGTTCG	CAWSHYVGYTF	In	VDJ	1	101	1.4972367828087568E-4	1.815638943118369E-4	33	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-02	01	3	3	7	8	5	3	26	37	44	42	47			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSHYVGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*02		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTACAGGGGGCTGACTTACGAGCAGTACTTCGGGCCG	CAWSYRGLTYEQYF	In	VDJ	1	104	1.5417091624961456E-4	1.869568812715944E-4	42	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	3	0	4	1	5	26	38	48	39	53			unresolved										Vb 20	CAWSYRGLTYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTCCGTCAGGACAGGAAAGATGTTAAATGAGCAGTTCTTCGGGCCA	CASVRTGKMLNEQFF	In	VDJ	1	105	1.5565332890586086E-4	1.887545435915136E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	1	4	7	6	10	26	33	46	39	56			unresolved										Vb 20	CASVRTGKMLNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAAGAAAGGGGCGGGAGAAAAACTGTTTTTTGGCAGT	CAWKKGAGEKLFF	In	VDJ	1	105	1.5565332890586086E-4	1.887545435915136E-4	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	4	7	3	8	8	0	26	36	-1	44	50													Vb 20	CAWKKGAGEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*01	TCRBD02-01*02	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGTCAGGGTAGGGAGCAGTACTTCGGGCCG	CAWSGQGREQYF	In	VDJ	1	105	1.5565332890586086E-4	1.887545435915136E-4	36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	4	3	7	2	4	26	39	46	41	50													Vb 20	CAWSGQGREQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGATCTCCTATTAAAACTGTTTTTTGGCAGT		Out	VDJ	1	106	1.5713574156210716E-4		35	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	3	4	9	10	6	2	26	37	46	43	48						01,02							Vb 20	X+TCRBV30-01+TCRBJ01-04	TCRBV30-01*02	TCRBD02-01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGACTTCAGGGGGATGGCTTTCTTTGGACAA	CAWDFRGMAFF	In	VDJ	1	107	1.5861815421835347E-4	1.9234986823135194E-4	33	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	1	11	5	3	26	35	47	40	50													Vb 20	CAWDFRGMAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTATCGGGACGGTTGGGAATGAGCAGTTCTTCGGGCCA	CAWSIGTVGNEQFF	In	VDJ	1	108	1.6010056687459974E-4	1.9414753055127114E-4	42	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-01	01	2	0	7	7	3	7	26	38	46	41	53			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSIGTVGNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01		TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGTGAGGGAGCGGGGGGCGAGGCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	112	1.6603021749958492E-4		49	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	6	1	4	7	5	26	35	51	42	56													Vb 20	X+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCAGCCGGGGGAAGTTGGAGCCCCAGCATTTTGGTGAT	CAWSSRGKLEPQHF	In	VDJ	1	114	1.6899504281207752E-4	2.049335044707862E-4	42	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	3	8	2	8	4	7	26	37	47	41	54			unresolved										Vb 20	CAWSSRGKLEPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD02-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGCGGAAGGATTGAACACTGAAGCTTTCTTTGGACAA	CAWAEGLNTEAFF	In	VDJ	1	114	1.6899504281207752E-4	2.049335044707862E-4	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	7	5	0	0	6	26	-1	39	35	45						01,02							Vb 20	CAWAEGLNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD02-01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGTTGGGCTCCGGGAGGCTACACCTTCGGTTCG	CACWAPGGYTF	In	VDJ	1	114	1.6899504281207752E-4	2.049335044707862E-4	33	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	6	8	3	8	8	0	26	34	-1	42	47			unresolved										Vb 20	CACWAPGGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD02-01*02	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCGGGGACCCTTGCGGATGCAACTAATGAAAAACTGTTTTTTGGCAGT	CAGTLADATNEKLFF	In	VDJ	1	115	1.704774554683238E-4	2.0673116679070536E-4	45	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-04	01	9	0	7	0	1	11	26	31	37	32	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAGTLADATNEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*02		TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGCGACCGGGACAGGGATTCCCAATGAGCAGTTCTTCGGGCCA	CAWATGTGIPNEQFF	In	VDJ	1	115	1.704774554683238E-4	2.0673116679070536E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	3	6	6	5	26	35	50	41	55													Vb 20	CAWATGTGIPNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGCGCCGCACTATGGGCGGCTACACCTTCGGTTCG	CAWRRRTMGGYTF	In	VDJ	1	116	1.719598681245701E-4	2.0852882911062454E-4	39	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-02	01	3	8	0	8	12	0	26	37	-1	49	53			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWRRRTMGGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*02		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAACCGGGCGGTTGGAAACACCATATATTTTGGAGAG	CAWNRAVGNTIYF	In	VDJ	1	122	1.8085434406204785E-4	2.193148030301396E-4	39	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-03	01	4	8	0	3	3	3	26	36	43	39	46			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWNRAVGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01		TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCTGGTAGCGGGGTCTTACGAGCAGTACTTCGGGCCG	CAWSLVAGSYEQYF	In	VDJ	1	127	1.8826640734327934E-4	2.2830311462973549E-4	42	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	2	5	3	4	4	3	26	38	50	42	53			unresolved										Vb 20	CAWSLVAGSYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*02	TCRBD02-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACCGTTGGGGGCAGGGCTAATTCACCCCTCCACTTTGGGAAC	CAWTVGGRANSPLHF	In	VDJ	1	128	1.8974881999952564E-4	2.3010077694965466E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	6	0	6	5	5	26	36	47	41	52			unresolved										Vb 20	CAWTVGGRANSPLHF+TCRBV30-01+TCRBJ01-06	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGGGGACACGGGGCCCCGGGGAGCTGTTTTTTGGAGAA	CAWRGTRGPGELFF	In	VDJ	1	130	1.9271364531201821E-4	2.3369610158949304E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	0	6	6	1	7	26	37	44	38	51													Vb 20	CAWRGTRGPGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGGACGGGGGGTCGGCAGACCCAGTACTTCGGGCCA	CAWSGTGGRQTQYF	In	VDJ	1	130	1.9271364531201821E-4	2.3369610158949304E-4	42	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	8	1	6	3	5	26	39	49	42	54			unresolved										Vb 20	CAWSGTGGRQTQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTATGACAGGCCCTCCTACGAGCAGTACTTCGGGCCG	CAYDRPSYEQYF	In	VDJ	1	133	1.971608832807571E-4	2.3908908854925056E-4	36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	2	4	0	2	2	26	33	41	35	43			unresolved										Vb 20	CAYDRPSYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTGTGGGGAAGCGACACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	133	1.971608832807571E-4		43	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-01	01	2	0	8	5	4	6	26	38	46	42	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	X+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01		TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCGGTGGAGACTAGCGGGAGGGAGACCCAGTACTTCGGGCCA	CAVETSGRETQYF	In	VDJ	1	135	2.001257085932497E-4	2.426844131890889E-4	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	9	2	1	5	6	0	26	31	-1	37	50			unresolved										Vb 20	CAVETSGRETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCTACAGGGGATCGGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	137	2.0309053390574227E-4		43	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	2	3	2	5	26	38	47	40	52			unresolved										Vb 20	X+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAGGAGGGAGCGACGAGCAGTACTTCGGGCCG	CAWSVGGSDEQYF	In	VDJ	1	139	2.0605535921823487E-4	2.498750624687656E-4	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	10	0	5	1	4	26	40	47	41	51													Vb 20	CAWSVGGSDEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTTGAGATCGAGTGGAAACACCATATATTTTGGAGAG	CALRSSGNTIYF	In	VDJ	1	145	2.1494983515571263E-4	2.6066103638828066E-4	36	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	3	11	2	3	3	0	26	37	-1	40	43			unresolved										Vb 20	CALRSSGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01	TCRBD02-01*02	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTATGGCGTGGATGGCTACACCTTCGGTTCG	CAWSYGVDGYTF	In	VDJ	1	146	2.1643224781195893E-4	2.6245869870819983E-4	36	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-02	01	2	9	0	6	3	4	26	38	44	41	48			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSYGVDGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCCCCATGGACAGGGATACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	150	2.2236189843694408E-4		47	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	1	3	3	6	2	26	37	51	43	53													Vb 20	X+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGCAGGGGGGTTCGACATTCAGTACTTCGGCGCC	CAWAGGFDIQYF	In	VDJ	1	152	2.253267237494367E-4	2.7324467262771493E-4	36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	4	1	8	1	5	26	35	43	36	48													Vb 20	CAWAGGFDIQYF+TCRBV30-01+TCRBJ02-04	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGAGAACAGGGGAGGAAAGTATGGCTACACCTTCGGTTCG	CAWENRGGKYGYTF	In	VDJ	1	154	2.2829154906192926E-4	2.768399972675533E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	2	5	4	7	26	35	46	39	53			unresolved										Vb 20	CAWENRGGKYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTTTACTCGCCGGGCACAGATACGCAGTATTTTGGCCCA	CAWSVYSPGTDTQYF	In	VDJ	1	155	2.2977396171817557E-4	2.7863765958747246E-4	45	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	3	10	1	2	6	26	40	45	42	51						01,02							Vb 20	CAWSVYSPGTDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD02-01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGAGGAAAGGGCAGGGGATATCGAACACTGAAGCTTTCTTTGGACAA	CAWRRKGQGISNTEAFF	In	VDJ	1	157	2.3273878703066814E-4	2.822329842273108E-4	51	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	2	1	10	5	26	37	53	47	58			unresolved										Vb 20	CAWRRKGQGISNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGATTGTAAAGGCAGCGAGTATGAACACTGAAGCTTTCTTTGGACAA	CAWIVKAASMNTEAFF	In	VDJ	1	162	2.4015085031189962E-4	2.912212958269067E-4	48	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	6	6	0	6	4	26	40	50	46	54			unresolved			01,02							Vb 20	CAWIVKAASMNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD02-01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAATGAGGAACAGGTCGGGGAAAAACTGTTTTTTGGCAGT	CAWNEEQVGEKLFF	In	VDJ	1	163	2.4163326296814592E-4	2.9301895814682586E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	3	4	8	7	5	26	36	48	43	53													Vb 20	CAWNEEQVGEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACAGGGGACCTCTAACTATGGCTACACCTTCGGTTCG	CAWSVQGTSNYGYTF	In	VDJ	1	167	2.475629135931311E-4	3.0020960742650255E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	3	2	0	0	4	26	-1	47	40	51													Vb 20	CAWSVQGTSNYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGCGAGCAGGGGCCTTACAATGAGCAGTTCTTCGGGCCA	CACEQGPYNEQFF	In	VDJ	1	173	2.5645738953060886E-4	3.1099558134601766E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	4	2	4	4	3	26	34	44	38	47													Vb 20	CACEQGPYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGAGGGGAACAATTGGGTTCACCCCTCCACTTTGGGAAC	CAWRGEQLGSPLHF	In	VDJ	1	173	2.5645738953060886E-4	3.1099558134601766E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	5	2	9	0	10	26	-1	42	37	52			unresolved										Vb 20	CAWRGEQLGSPLHF+TCRBV30-01+TCRBJ01-06	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGAGATCCAGGGGTATACGAGCAGTACTTCGGGCCG	CAWRDPGVYEQYF	In	VDJ	1	179	2.653518654680866E-4	3.217815552655327E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	2	4	5	2	26	37	48	42	50			unresolved										Vb 20	CAWRDPGVYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAATCCGCAGGGCTACGAGCAGTACTTCGGGCCG	CAWNPQGYEQYF	In	VDJ	1	180	2.668342781243329E-4	3.235792175854519E-4	36	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	4	3	3	5	0	26	36	-1	41	46													Vb 20	CAWNPQGYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTAAACGGACTTTCGGCGAGCAGTACTTCGGGCCG	CAWSKRTFGEQYF	In	VDJ	1	181	2.683166907805792E-4	3.2537687990537105E-4	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	1	10	6	4	5	26	38	47	42	52						01,02							Vb 20	CAWSKRTFGEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCAGGGGTCCGGGAACACTGAAGCTTTCTTTGGACAA	CAWSQGSGNTEAFF	In	VDJ	1	184	2.727639287493181E-4	3.307698668651286E-4	42	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	2	1	0	5	26	-1	44	38	49			unresolved										Vb 20	CAWSQGSGNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTCCAGGACAGGGTGGCAGCCCCAGCATTTTGGTGAT	CAWSSRTGWQPQHF	In	VDJ	1	185	2.7424634140556437E-4	3.3256752918504775E-4	42	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	1	3	7	4	3	26	38	50	42	53			unresolved										Vb 20	CAWSSRTGWQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGCAGGGGGAGGCAGGGATGAAGCTTTCTTTGGACAA	CAWSAGGGRDEAFF	In	VDJ	1	185	2.7424634140556437E-4	3.3256752918504775E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	4	1	7	0	9	26	-1	46	39	55													Vb 20	CAWSAGGGRDEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACGGGACTAGCGGGAGCCCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	187	2.77211166718057E-4		46	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	0	2	2	1	2	26	36	51	37	53													Vb 20	X+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAACTCCGGGACAGGCGCTGGCTACACCTTCGGTTCG	CAWNSGTGAGYTF	In	VDJ	1	189	2.801759920305496E-4	3.3975817846472445E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	4	7	5	3	26	36	49	41	52			unresolved										Vb 20	CAWNSGTGAGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCGGCCGGGGAGCCTATAATTCACCCCTCCACTTTGGGAAC	CAGRGAYNSPLHF	In	VDJ	1	194	2.87588055311781E-4	3.487464900643204E-4	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	8	8	3	2	3	2	26	32	40	35	42			unresolved			01,02							Vb 20	CAGRGAYNSPLHF+TCRBV30-01+TCRBJ01-06	TCRBV30-01*01	TCRBD02-01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCTCTCAGTTCGTGAAAAACTGTTTTTTGGCAGT	CAWSLSVREKLFF	In	VDJ	1	196	2.905528806242736E-4	3.5234181470415873E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	4	5	7	4	4	26	38	45	42	49													Vb 20	CAWSLSVREKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTTTACAGGGGGCTATGGCTACACCTTCGGTTCG	CAWSFTGGYGYTF	In	VDJ	1	198	2.935177059367662E-4	3.559371393439971E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	3	1	4	3	0	26	38	-1	41	49													Vb 20	CAWSFTGGYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCTTACCTGGACAGGGAGCTAACTATGGCTACACCTTCGGTTCG	CAWSLPGQGANYGYTF	In	VDJ	1	219	3.2464837171793836E-4	3.936880480622998E-4	48	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	3	0	7	2	26	37	52	44	54			unresolved										Vb 20	CAWSLPGQGANYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTATTTGTGTCGAGGGACAGACCCTACGAGCAGTACTTCGGGCCG	CAWSVFVSRDRPYEQYF	In	VDJ	1	226	3.3502526031166244E-4	4.06271684301734E-4	51	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	5	2	11	2	26	40	58	51	60													Vb 20	CAWSVFVSRDRPYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGTCTGGGGGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	226	3.3502526031166244E-4		37	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-01	01	5	6	1	1	4	0	26	35	-1	39	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	X+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAACGGAGGGCAGGAGGGCCAGCCCCAGCATTTTGGTGAT	CAWNGGQEGQPQHF	In	VDJ	1	227	3.365076729679087E-4	4.080693466216532E-4	42	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	4	10	0	7	2	9	26	36	44	38	53			unresolved										Vb 20	CAWNGGQEGQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*02	TCRBD02-01*02	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGGTGGCCTAGGGAAGGCTACACCTTCGGTTCG	CAWSGWPREGYTF	In	VDJ	1	229	3.394724982804013E-4	4.1166467126149155E-4	39	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-02	01	1	0	8	8	9	1	26	39	52	48	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSGWPREGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTGGGACAGGGGTACACCGGGGAGCTGTTTTTTGGAGAA	CAWSVGQGYTGELFF	In	VDJ	1	236	3.4984938687412535E-4	4.2424830750092577E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	0	2	3	0	1	26	-1	50	40	51													Vb 20	CAWSVGQGYTGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCTCGCCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CAWSLASGANVLTF	In	VDJ	1	239	3.542966248428643E-4	4.2964129446068335E-4	42	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-06	01	2	10	0	0	3	0	26	38	-1	41	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSLASGANVLTF+TCRBV30-01+TCRBJ02-06	TCRBV30-01*01		TCRBJ02-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCCACGCGGTTTTAGGGGACACTGAAGCTTTCTTTGGACAA	CAHAVLGDTEAFF	In	VDJ	1	247	3.661559260928346E-4	4.4402259302003675E-4	39	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	5	2	3	11	0	26	32	-1	43	48													Vb 20	CAHAVLGDTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGAGACAGGGGTCAATGAGCAGTTCTTCGGGCCA	CAWSETGVNEQFF	In	VDJ	1	254	3.7653281468655867E-4	4.5660622925947097E-4	39	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	2	2	6	1	1	26	39	48	40	49			unresolved										Vb 20	CAWSETGVNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCTTAGGAAAGGGAGCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	260	3.8542729062403643E-4		49	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	2	9	2	0	10	0	26	38	-1	48	53													Vb 20	X+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01	TCRBD02-01*02	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGCAGGCATGAACACTGAAGCTTTCTTTGGACAA	CAWSAGMNTEAFF	In	VDJ	2	284	4.210051943739475E-4	5.105360988570463E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	4	4	0	0	2	26	-1	43	39	45			unresolved										Vb 20	CAWSAGMNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGGCTTTAGGGCAGGACTATGGCTACACCTTCGGTTCG	CAWRALGQDYGYTF	In	VDJ	2	350	5.188444296862029E-4	6.29181811971712E-4	42	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-02	01	3	4	4	3	10	0	26	37	-1	47	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWRALGQDYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAAGGCCTAGCTGGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	375	5.559047460923603E-4		41	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	4	7	5	5	2	26	40	50	45	52			unresolved			01,02							Vb 20	X+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01	TCRBD02-01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGAGATGGAAACACCATATATTTTGGAGAG	CAWGDGNTIYF	In	VDJ	3	486	7.204525509356989E-4	8.736638874807201E-4	33	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	5	10	2	3	0	1	26	-1	39	35	40			unresolved										Vb 20	CAWGDGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01	TCRBD02-01*02	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCATACGACTCAGGGCCCCTATGGCTACACCTTCGGTTCG	CAWSHTTQGPYGYTF	In	VDJ	3	588	8.716586418728208E-4	0.0010570254441124762	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	3	4	9	3	26	38	52	47	55			unresolved										Vb 20	CAWSHTTQGPYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGAGGGGGACGGGACCCGAACATTCACCCCTCCACTTTGGGAAC	CAWRRGTGPEHSPLHF	In	VDJ	4	748	0.001108844666872228	0.0013446514152995444	48	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	5	1	8	1	13	26	37	44	38	57			unresolved										Vb 20	CAWRRGTGPEHSPLHF+TCRBV30-01+TCRBJ01-06	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGATTAGAACACGCTATACGTATTGGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	4	769	0.0011399753326534002		52	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-05	01	4	3	6	2	5	14	26	36	44	41	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	X+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGACTAGCGGGGTGGGCCGGGGAGCTGTTTTTTGGAGAA	CAWSGLAGWAGELFF	In	VDJ	9	1504	0.002229548634994426	0.0027036841291584422	45	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	1	2	3	6	0	4	26	-1	50	39	54			unresolved										Vb 20	CAWSGLAGWAGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTATACAGGGGAACACTGAAGCTTTCTTTGGACAA	CAWSIQGNTEAFF	In	VDJ	20	3553	0.005267012167643082	0.006387094222672836	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	3	1	2	0	26	38	-1	40	46			unresolved										Vb 20	CAWSIQGNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCAAGAGGACTAGCTTGGCGATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	46	6.819098218732952E-5		44	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	1	7	8	4	6	23	35	47	39	53			01,02			01,02							Vb 1	X+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCAGGGACAGGGTTGGCCTACGAGCAGTACTTCGGGCCG	CASSPGTGLAYEQYF	In	VDJ	1	50	7.41206328123147E-5	8.988311599595886E-5	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	3	2	3	4	23	35	47	38	51			01,02										Vb 1	CASSPGTGLAYEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCTACAGGGGGCAAATTCACCCCTCCACTTTGGGAAC	CASSLQGANSPLHF	In	VDJ	1	50	7.41206328123147E-5	8.988311599595886E-5	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	3	0	7	2	1	23	35	46	37	47			01,02										Vb 1	CASSLQGANSPLHF+TCRBV09-01+TCRBJ01-06	TCRBV09-01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCACCCATCCGACGGAGGGTGTTGATGAGCAGTTCTTCGGGCCA	CASSTHPTEGVDEQFF	In	VDJ	1	52	7.708545812480728E-5	9.34784406357972E-5	48	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	10	0	8	11	5	23	35	52	46	57			01,02										Vb 1	CASSTHPTEGVDEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01*02	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCAGGGGCACGGGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	53	7.856787078105358E-5		38	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	4	2	8	0	5	23	-1	41	35	46			01,02										Vb 1	X+TCRBV09-01+TCRBJ01-04	TCRBV09-01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGATGACTCCAGGGACTTGGATACGCAGTATTTTGGCCCA	CASSDDSRDLDTQYF	In	VDJ	1	53	7.856787078105358E-5	9.527610295571638E-5	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	0	10	6	11	2	23	34	51	45	53			01,02			01,02							Vb 1	CASSDDSRDLDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD02-01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCTACAGGGGGCCAACTGAAGCTTTCTTTGGACAA	CASSYRGPTEAFF	In	VDJ	1	54	8.005028343729987E-5	9.707376527563557E-5	39	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	0	5	1	2	23	35	45	36	47			01,02										Vb 1	CASSYRGPTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCTTACACGACAGGGAGGAGTACGAGCAGTACTTCGGGCCG	CASSLHDREEYEQYF	In	VDJ	1	54	8.005028343729987E-5	9.707376527563557E-5	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	2	3	4	6	5	23	35	48	41	53			01,02										Vb 1	CASSLHDREEYEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAAGAAGGAGACGGTAAGTCATGAGTGAAAGACCTATGGCTACACCTTCGGTTCG	CASKKETVSHE*KTYGYTF	Stop	VDJ	1	56	8.301510874979246E-5		57	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	6	10	2	4	4	23	23	33	41	37	64			01,02										Vb 1	CASKKETVSHE*KTYGYTF+TCRBV09-01+TCRBJ01-02	TCRBV09-01	TCRBD02-01*02	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGCTGACGGGGAGCTGTTTTTTGGAGAA	CASSVADGELFF	In	VDJ	1	58	8.597993406228505E-5	1.0426441455531227E-4	36	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-02	01	0	2	8	7	2	0	23	39	-1	41	43			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVADGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01		TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTCAACTAGGCCGACGGCCCCAAGAGACCCAGTACTTCGGGCCA	CASSQLGRRPQETQYF	In	VDJ	1	58	8.597993406228505E-5	1.0426441455531227E-4	48	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	3	8	1	3	10	23	34	42	37	52			01,02			01,02							Vb 1	CASSQLGRRPQETQYF+TCRBV09-01+TCRBJ02-05	TCRBV09-01	TCRBD02-01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCCGGGACAGTCCCCACAGATACGCAGTATTTTGGCCCA	CASSAGTVPTDTQYF	In	VDJ	1	59	8.746234671853134E-5	1.0606207687523144E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	0	5	2	2	4	23	36	45	38	49			01,02										Vb 1	CASSAGTVPTDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTCCAGGGTGGCTATGGCTACACCTTCGGTTCG	CASSVQGGYGYTF	In	VDJ	1	60	8.894475937477764E-5	1.0785973919515063E-4	39	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	3	4	1	3	23	37	43	38	46			01,02										Vb 1	CASSVQGGYGYTF+TCRBV09-01+TCRBJ01-02	TCRBV09-01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCAAAGACTAGCGGCAAACGAGCAGTTCTTCGGGCCA	CASSQRLAANEQFF	In	VDJ	1	61	9.042717203102393E-5	1.096574015150698E-4	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	2	5	10	4	5	23	35	48	39	53			01,02			01,02							Vb 1	CASSQRLAANEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCTCGACTAAAAGCACCACAGATACGCAGTATTTTGGCCCA	CASSSTKSTTDTQYF	In	VDJ	1	62	9.190958468727023E-5	1.1145506383498898E-4	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	2	9	2	2	7	23	35	42	37	49			01,02			01,02							Vb 1	CASSSTKSTTDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD02-01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGGGGTGGAACAGAGCAGTACTTCGGGCCG	CASSVGGGTEQYF	In	VDJ	1	63	9.339199734351652E-5	1.1325272615490816E-4	39	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-07	01	0	6	2	7	0	7	23	-1	43	39	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVGGGTEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01		TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGTTCGGGGGGAAGTTACACTGAAGCTTTCTTTGGACAA	CASSVGSGGSYTEAFF	In	VDJ	1	65	9.635682265600911E-5	1.1684805079474652E-4	48	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	0	8	1	3	3	5	23	39	49	42	54			01,02										Vb 1	CASSVGSGGSYTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD02-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCACGGAACAGGGTTGGTGAAAAACTGTTTTTTGGCAGT	CASSPRNRVGEKLFF	In	VDJ	1	67	9.93216479685017E-5	1.2044337543458487E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	3	3	7	7	4	23	35	48	42	52			01,02										Vb 1	CASSPRNRVGEKLFF+TCRBV09-01+TCRBJ01-04	TCRBV09-01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCGGATTGCGGCCCCCACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	68	1.0080406062474798E-4		37	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	10	7	5	5	5	5	23	29	38	34	43			01,02			01,02							Vb 1	X+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGATTCGGACAGGGGATTCTTGAAAAACTGTTTTTTGGCAGT	CASRFGQGILEKLFF	In	VDJ	1	78	1.1562818718721093E-4	1.4021766095369582E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	1	2	7	4	5	23	34	47	38	52			01,02										Vb 1	CASRFGQGILEKLFF+TCRBV09-01+TCRBJ01-04	TCRBV09-01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCTCCTGGGGACATCAATCAGCCCCAGCATTTTGGTGAT	CASSPPGDINQPQHF	In	VDJ	1	79	1.1711059984345722E-4	1.42015323273615E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	0	6	3	7	1	23	35	48	42	49			01,02										Vb 1	CASSPPGDINQPQHF+TCRBV09-01+TCRBJ01-05	TCRBV09-01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCACTATACAAGGCGAGTACACCGGGGAGCTGTTTTTTGGAGAA	CASSTIQGEYTGELFF	In	VDJ	1	81	1.2007542515594981E-4	1.4561064791345334E-4	48	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	3	9	3	0	12	23	-1	39	35	51			01,02			01,02							Vb 1	CASSTIQGEYTGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01	TCRBD02-01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGAGGCGGGGACTTCCTACAATGAGCAGTTCTTCGGGCCA	CASSEAGTSYNEQFF	In	VDJ	1	83	1.230402504684424E-4	1.492059725532917E-4	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	10	1	7	0	23	34	-1	41	47			01,02			01,02							Vb 1	CASSEAGTSYNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGGAGTCCTGACGGGGGTCAATGAGCAGTTCTTCGGGCCA	CASSGVLTGVNEQFF	In	VDJ	1	85	1.26005075780935E-4	1.5280129719313007E-4	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	8	2	6	9	1	23	36	51	45	52			01,02										Vb 1	CASSGVLTGVNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCGGGGAGGGACAGGGTTGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	86	1.274874884371813E-4		50	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	0	3	2	7	2	23	35	51	42	53			01,02										Vb 1	X+TCRBV09-01+TCRBJ01-05	TCRBV09-01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCCATTAGCGGGGCCGGGCTAGATACGCAGTATTTTGGCCCA	CASSAISGAGLDTQYF	In	VDJ	1	88	1.3045231374967387E-4	1.581942841528876E-4	48	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	5	3	5	4	7	23	36	48	40	55			01,02										Vb 1	CASSAISGAGLDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGCAGGGGAGCTCCGTGAGCAGTTCTTCGGGCCA	CASSAGELREQFF	In	VDJ	1	91	1.3489955171841275E-4	1.6358727111264511E-4	39	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	4	2	9	2	7	23	34	42	36	49			01,02										Vb 1	CASSAGELREQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGTTTGACTGTTAAAAGGAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	94	1.3934678968715162E-4		47	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	5	2	10	5	5	9	23	34	43	39	52			01,02			01,02							Vb 1	X+TCRBV09-01+TCRBJ01-04	TCRBV09-01	TCRBD02-01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTCGGACAACCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSVGQPNTGELFF	In	VDJ	1	95	1.4082920234339793E-4	1.7077792039232181E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	1	6	0	1	2	23	37	43	38	45			01,02										Vb 1	CASSVGQPNTGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCAGGACACCAGAACACTGAAGCTTTCTTTGGACAA	CASSPGHQNTEAFF	In	VDJ	1	98	1.452764403121368E-4	1.7617090735207936E-4	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	6	1	3	3	23	35	43	38	46			01,02										Vb 1	CASSPGHQNTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCAGAAGGGCAGCTCCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	104	1.5417091624961456E-4		49	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-03	01	4	5	3	0	5	6	23	35	44	40	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	X+TCRBV09-01+TCRBJ01-03	TCRBV09-01		TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGACGTGGCAGATACGCAGTATTTTGGCCCA	CASSVDVADTQYF	In	VDJ	1	106	1.5713574156210716E-4	1.9055220591143276E-4	39	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-03	01	0	0	10	4	4	0	23	39	-1	43	45			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVDVADTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01		TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGAACAGGTGGGCAATCAGCCCCAGCATTTTGGTGAT	CASSEQVGNQPQHF	In	VDJ	1	106	1.5713574156210716E-4	1.9055220591143276E-4	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	3	4	2	3	3	23	34	42	37	45			01,02										Vb 1	CASSEQVGNQPQHF+TCRBV09-01+TCRBJ01-05	TCRBV09-01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCGTAGTGGAGGGTGAATGAGCAGTACTTCGGGCCG		Out	VDJ	1	115	1.704774554683238E-4		41	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	10	0	7	6	5	23	35	47	41	52			01,02										Vb 1	X+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD02-01*02	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGACAGGAACACTGAAGCTTTCTTTGGACAA	CASSVDRNTEAFF	In	VDJ	1	120	1.7788951874955528E-4	2.1571947839030126E-4	39	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	3	5	1	0	0	23	-1	-1	39	43			01,02										Vb 1	CASSVDRNTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCCCCGGGAGGTCAAGAGACCCAGTACTTCGGGCCA	CASSPPGGQETQYF	In	VDJ	1	122	1.8085434406204785E-4	2.193148030301396E-4	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	8	1	2	4	1	23	35	46	39	47			01,02										Vb 1	CASSPPGGQETQYF+TCRBV09-01+TCRBJ02-05	TCRBV09-01	TCRBD02-01*02	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCTTGGGCGGGTACGGGACTGAAGCTTTCTTTGGACAA	CASSLGGYGTEAFF	In	VDJ	1	125	1.8530158203078673E-4	2.2470778998989714E-4	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	7	4	5	4	6	23	35	44	39	50			01,02			01,02							Vb 1	CASSLGGYGTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD02-01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCTCGGACAGGGCCCTCTAATGAAAAACTGTTTTTTGGCAGT	CASSPRTGPSNEKLFF	In	VDJ	1	126	1.8678399468703303E-4	2.265054523098163E-4	48	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	1	3	3	4	4	23	35	47	39	51			01,02										Vb 1	CASSPRTGPSNEKLFF+TCRBV09-01+TCRBJ01-04	TCRBV09-01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCGGAAGGACTGACTCCTACAATGAGCAGTTCTTCGGGCCA	CASGRTDSYNEQFF	In	VDJ	1	126	1.8678399468703303E-4	2.265054523098163E-4	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	1	10	0	4	2	23	32	41	36	43			01,02			01,02							Vb 1	CASGRTDSYNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGAATTTGGGAGGTCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSEFGRSTNEKLFF	In	VDJ	1	135	2.001257085932497E-4	2.426844131890889E-4	48	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	5	9	1	0	7	1	23	34	47	41	48			01,02										Vb 1	CASSEFGRSTNEKLFF+TCRBV09-01+TCRBJ01-04	TCRBV09-01	TCRBD02-01*02	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAACGGGACTAGACTACGAGCAGTACTTCGGGCCG	CASSVTGLDYEQYF	In	VDJ	1	136	2.0160812124949597E-4	2.444820755090081E-4	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	0	8	3	2	1	23	38	48	40	49			01,02			01,02							Vb 1	CASSVTGLDYEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD02-01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGAGAATCAAGACGAGCAGTACTTCGGGCCG	CASSVENQDEQYF	In	VDJ	1	138	2.0457294656198857E-4	2.4807740014884643E-4	39	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-07	01	0	2	8	5	1	6	23	39	42	40	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVENQDEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01		TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGAAACGAACACTGAAGCTTTCTTTGGACAA	CASSVETNTEAFF	In	VDJ	1	143	2.1198500984322003E-4	2.570657117484423E-4	39	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-01	01	0	3	7	1	2	0	23	39	-1	41	43			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVETNTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCGTAAGGATCCCGACCTGGGAGCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	148	2.193970731244515E-4		50	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	7	9	2	2	16	0	23	32	-1	48	53			01,02										Vb 1	X+TCRBV09-01+TCRBJ01-03	TCRBV09-01	TCRBD02-01*02	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCATGGGACCCCCAGGAAACGAGCAGTACTTCGGGCCG	CASMGPPGNEQYF	In	VDJ	1	209	3.0982424515547545E-4	3.75711424863108E-4	39	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-07	01	6	0	7	5	1	9	23	33	39	34	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASMGPPGNEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01		TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAACCCGGACAGAAGGAGACTAATGAAAAACTGTTTTTTGGCAGT	CASSQPGQKETNEKLFF	In	VDJ	1	51	7.560304546856099E-5	9.168077831587803E-5	51	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	1	5	2	3	6	29	44	53	47	59													Vb 16	CASSQPGQKETNEKLFF+TCRBV14-01+TCRBJ01-04	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGACAGGCTGGGTATTCACCCCTCCACTTTGGGAAC	CASSQGQAGYSPLHF	In	VDJ	1	51	7.560304546856099E-5	9.168077831587803E-5	45	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	1	2	4	8	0	6	29	-1	51	45	57													Vb 16	CASSQGQAGYSPLHF+TCRBV14-01+TCRBJ01-06	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCTAACAGGGGCGGGGGAAAAACTGTTTTTTGGCAGT	CASSLTGAGEKLFF	In	VDJ	1	56	8.301510874979246E-5	1.0066908991547392E-4	42	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	3	2	8	2	5	29	42	51	44	56													Vb 16	CASSLTGAGEKLFF+TCRBV14-01+TCRBJ01-04	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCGGCCCATAGTAAATCTGGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	56	8.301510874979246E-5		52	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-02	01	5	1	8	4	16	5	29	41	60	57	65				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	X+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAGCTTCCGAACACTGAAGCTTTCTTTGGACAA	CASSQLPNTEAFF	In	VDJ	1	57	8.449752140603876E-5	1.024667522353931E-4	39	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-01	01	3	10	0	1	0	4	29	-1	45	43	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQLPNTEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TATTTCTGTGCCAGCAGCCAAGTTTCCATACAAATCCTCGGTGGGGTGGATGGAAACACCATATATTTTGGAGAG	CASSQVSIQILGGVDGNTIYF	In	VDJ	1	59	8.746234671853134E-5	1.0606207687523144E-4	63	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-03	01	1	6	2	3	20	4	6	22	46	42	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQVSIQILGGVDGNTIYF+TCRBV14-01+TCRBJ01-03	TCRBV14-01*01		TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAAGTATATCAGCTAATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	60	8.894475937477764E-5		43	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-06	01	7	4	5	5	7	3	29	39	49	46	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	X+TCRBV14-01+TCRBJ01-06	TCRBV14-01*01		TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATCTGGCCTCCTACGAGCAGTACTTCGGGCCG	CASSQDLASYEQYF	In	VDJ	1	65	9.635682265600911E-5	1.1684805079474652E-4	42	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	9	0	0	3	0	29	46	-1	49	52													Vb 16	CASSQDLASYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAACAGGGGAACACTGAAGCTTTCTTTGGACAA	CASSQQGNTEAFF	In	VDJ	1	76	1.1266336187471834E-4	1.3662233631385747E-4	39	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	3	1	0	0	29	-1	-1	44	49													Vb 16	CASSQQGNTEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGTGGGGCCGTCGAGCAGTACTTCGGGCCG	CASSGAVEQYF	In	VDJ	1	81	1.2007542515594981E-4	1.4561064791345334E-4	33	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	7	0	6	1	3	29	40	46	41	49													Vb 16	CASSGAVEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCCCGCGTCCATCCGAGGCGGCTACACCTTCGGTTCG	CASSPASIRGGYTF	In	VDJ	1	83	1.230402504684424E-4	1.492059725532917E-4	42	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	4	11	1	8	12	1	29	42	58	54	59													Vb 16	CASSPASIRGGYTF+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01	TCRBD02-01*02	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAAAACCAAGAGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	87	1.2896990109342757E-4		43	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-01	01	2	2	8	1	7	0	29	44	-1	51	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	X+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCTTCTGGGACAATTCTATGGCTACACCTTCGGTTCG	CASSLLGQFYGYTF	In	VDJ	1	90	1.3341713906216645E-4	1.6178960879272594E-4	42	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	6	4	4	3	29	42	52	46	55													Vb 16	CASSLLGQFYGYTF+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGACAAAACAGGGGGAGTTTGGAACGAGCAGTACTTCGGGCCG		Out	VDJ	1	99	1.467588529683831E-4		46	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	3	1	5	1	8	29	44	53	45	61													Vb 16	X+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGAAGCCCAGGGCACAGATACGCAGTATTTTGGCCCA	CASSQEAQGTDTQYF	In	VDJ	1	99	1.467588529683831E-4	1.7796856967199854E-4	45	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	4	4	1	4	0	29	46	-1	50	54													Vb 16	CASSQEAQGTDTQYF+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCGCGGACTAGCGGGGAAACTTGCAGGGGCAGTATTTTGGCCCA		Out	VDJ	1	99	1.467588529683831E-4		49	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	1	3	11	2	12	29	42	56	44	68													Vb 16	X+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGGACATCTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	110	1.6306539218709234E-4		43	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	1	6	0	0	2	29	-1	50	45	52													Vb 16	X+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGAGGGTCCGGGTCGCCCTAATGAAAAACTGTTTTTTGGCAGT	CASSQEGPGRPNEKLFF	In	VDJ	1	113	1.6751263015583122E-4	2.03135842150867E-4	51	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	0	8	4	3	5	5	29	46	55	51	60						01,02							Vb 16	CASSQEGPGRPNEKLFF+TCRBV14-01+TCRBJ01-04	TCRBV14-01*01	TCRBD02-01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGTGCCCGGGACTGAAGCTTTCTTTGGACAA	CASSQVPGTEAFF	In	VDJ	1	113	1.6751263015583122E-4	2.03135842150867E-4	39	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	8	4	5	4	0	29	45	-1	49	53						01,02							Vb 16	CASSQVPGTEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD02-01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCTATGCCAAGGAAGTGAGGCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	116	1.719598681245701E-4		47	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	4	11	1	4	14	0	29	42	-1	56	60													Vb 16	X+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01	TCRBD02-01*02	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGAGGACAACTCTATGGCTACACCTTCGGTTCG	CASSQGGQLYGYTF	In	VDJ	1	127	1.8826640734327934E-4	2.2830311462973549E-4	42	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	1	6	4	2	3	29	45	52	47	55													Vb 16	CASSQGGQLYGYTF+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATTCGCCCGGGGTTGGCTATGGCTACACCTTCGGTTCG	CASSQDSPGVGYGYTF	In	VDJ	1	128	1.8974881999952564E-4	2.3010077694965466E-4	48	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	0	8	3	4	6	4	29	46	57	52	61													Vb 16	CASSQDSPGVGYGYTF+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01	TCRBD02-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCCTCCCGCCGACTAGCTAGGATCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	132	1.9567847062451082E-4		50	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	2	7	7	8	6	29	42	57	50	63						01,02							Vb 16	X+TCRBV14-01+TCRBJ02-02	TCRBV14-01*01	TCRBD02-01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGTCGGACTAGCGGGGGAGCAGATACGCAGTATTTTGGCCCA	CASSRTSGGADTQYF	In	VDJ	1	144	2.1346742249946633E-4	2.588633740683615E-4	45	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	1	2	4	2	2	29	40	55	42	57													Vb 16	CASSRTSGGADTQYF+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCTTGGTAGGGTACCTCGGGTGGATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	149	2.208794857806978E-4		43	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-05	01	12	5	3	5	5	12	29	34	43	39	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	X+TCRBV14-01+TCRBJ01-05	TCRBV14-01*01		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGGGCAGCCGCCTATGGCTACACCTTCGGTTCG	CASSQGAAAYGYTF	In	VDJ	1	151	2.2384431109319039E-4	2.7144701030779576E-4	42	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	8	0	4	0	6	29	-1	49	45	55													Vb 16	CASSQGAAAYGYTF+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGGGAGTATCAGCCCCAGCATTTTGGTGAT	CASSQGEYQPQHF	In	VDJ	1	164	2.431156756243922E-4	2.9481662046674503E-4	39	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	1	9	2	5	0	1	29	-1	50	45	51													Vb 16	CASSQGEYQPQHF+TCRBV14-01+TCRBJ01-05	TCRBV14-01*01	TCRBD02-01*02	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGCCCAGGGTTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	165	2.445980882806385E-4		43	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	4	3	1	2	1	29	45	52	47	53													Vb 16	X+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCACTTGAGGCCTGGCAGTACTTCGGGCCG		Out	VDJ	1	167	2.475629135931311E-4		35	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	11	1	9	3	4	29	43	50	46	54													Vb 16	X+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGTGGTCAGTTACGAGCAGTACTTCGGGCCG	CASSQVVSYEQYF	In	VDJ	1	177	2.62387040155594E-4	3.1818623062569436E-4	39	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	4	5	4	4	1	29	45	52	49	53													Vb 16	CASSQVVSYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGAGTTTGGGACAGGGAAAACTTTCTTTGGACAA	CASSQEFGTGKTFF	In	VDJ	1	178	2.6386945281184034E-4	3.1998389294561353E-4	42	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	0	3	12	4	4	29	46	59	50	63													Vb 16	CASSQEFGTGKTFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGTCCTGGACGGGGTCACGCAGTATTTTGGCCCA	CASSQVLDGVTQYF	In	VDJ	1	179	2.653518654680866E-4	3.217815552655327E-4	42	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	8	3	9	7	2	29	45	57	52	59													Vb 16	CASSQVLDGVTQYF+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCTTGGGGGGGACACTGAAGCTTTCTTTGGACAA	CASSLGGDTEAFF	In	VDJ	1	180	2.668342781243329E-4	3.235792175854519E-4	39	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	4	9	0	3	2	0	29	42	-1	44	51													Vb 16	CASSLGGDTEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD02-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGAAGAAAAGGGGCTACGGCTACACCTTCGGTTCG		Out	VDJ	1	182	2.697991034368255E-4		43	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	5	2	8	5	4	29	46	56	51	60													Vb 16	X+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGCGCCCTCCTTGACCCAGTACTTCGGGCCA	CASSQAPSLTQYF	In	VDJ	1	183	2.712815160930718E-4	3.289722045452094E-4	39	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-05	01	1	10	0	7	1	7	29	45	48	46	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQAPSLTQYF+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01		TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCGAGCGGCCACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	185	2.7424634140556437E-4		38	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	6	5	2	1	3	29	41	47	42	50						01,02							Vb 16	X+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCTAAGGGGGGGTTCTTCTGAAGCTTTCTTTGGACAA	CASSLRGGSSEAFF	In	VDJ	1	208	3.083418324992291E-4	3.739137625431888E-4	42	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	4	9	0	6	3	5	29	42	52	45	57													Vb 16	CASSLRGGSSEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD02-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGTCGGGGGCCACAATGAGCAGTTCTTCGGGCCA	CASSQVGGHNEQFF	In	VDJ	1	209	3.0982424515547545E-4	3.75711424863108E-4	42	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-01	01	1	6	0	5	2	1	29	45	53	47	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQVGGHNEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01		TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATAAGATGACGTCGGGGAACACTGAAGCTTTCTTTGGACAA	CASSQDKMTSGNTEAFF	In	VDJ	1	211	3.1278907046796805E-4	3.7930674950294635E-4	51	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	8	4	1	11	0	29	46	-1	57	61						01,02							Vb 16	CASSQDKMTSGNTEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD02-01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAGCTTTGGGGCCGGGGAGCGGGAAACACCATATATTTTGGAGAG	CASSQLWGRGAGNTIYF	In	VDJ	1	214	3.1723630843670693E-4	3.846997364627039E-4	51	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-03	01	3	7	0	4	5	9	29	43	53	48	62				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQLWGRGAGNTIYF+TCRBV14-01+TCRBJ01-03	TCRBV14-01*01		TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCAACAGGGGAGGGAACGGCTACACCTTCGGTTCG	CASSNRGGNGYTF	In	VDJ	1	220	3.261307843741847E-4	3.95485710382219E-4	39	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-02	01	5	3	2	8	1	7	29	41	49	42	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSNRGGNGYTF+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGGCGTTATAATTCACCCCTCCACTTTGGGAAC	CASSQGRYNSPLHF	In	VDJ	1	225	3.3354284765541617E-4	4.0447402198181485E-4	42	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-06	01	1	9	0	4	0	2	29	-1	48	45	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQGRYNSPLHF+TCRBV14-01+TCRBJ01-06	TCRBV14-01*01		TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGTGGCAGGGGTCCCCGGGGAGCTGTTTTTTGGAGAA	CASSQVAGVPGELFF	In	VDJ	1	227	3.365076729679087E-4	4.080693466216532E-4	45	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	4	2	6	3	3	29	45	54	48	57													Vb 16	CASSQVAGVPGELFF+TCRBV14-01+TCRBJ02-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATGGGTTATAGCGGGGGACTCGGCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	230	3.409549109366476E-4		55	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	5	2	6	7	6	26	43	59	50	65													Vb 16	X+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCCGATCAGGGTTCGTAGCGGGGGACACACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	230	3.409549109366476E-4		56	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	5	2	5	13	4	25	38	60	51	64													Vb 16	X+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATTGTAGCGGGGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	237	3.513317995303717E-4		53	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	5	2	0	3	2	28	45	57	48	59													Vb 16	X+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGAAGATTGTGTGGACCGCTGTTTGAAGCTTTCTTTGGACAA		Out	VDJ	2	380	5.633168093735917E-4		50	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-01	01	0	1	7	7	9	7	29	46	59	55	66				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	X+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATAAACACAGGGTCGAAAACTGTTTTTTGGCAGT		Out	VDJ	3	474	7.026635990607434E-4		44	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	3	3	10	5	3	29	46	57	51	60													Vb 16	X+TCRBV14-01+TCRBJ01-04	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCGGGGACTTCGGAAGGAGGTGAAAAACTGTTTTTTGGCAGT		Out	VDJ	3	484	7.174877256232063E-4		46	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	5	0	10	7	1	11	29	41	48	42	59						01,02							Vb 16	X+TCRBV14-01+TCRBJ01-04	TCRBV14-01*01	TCRBD02-01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATAGACCGGGATGAGCAGTTCTTCGGGCCA		Out	VDJ	4	651	9.650506392163374E-4		40	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	8	4	8	5	0	29	46	-1	51	55						01,02							Vb 16	X+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCATCCGAACACTGAAGCTTTCTTTGGACAA	CASSHPNTEAFF	In	VDJ	1	44	6.522615687483693E-5	7.90971420764438E-5	36	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	6	1	0	3	24	-1	38	36	41														CASSHPNTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTGGGACAGGGGGCAACTATGGCTACACCTTCGGTTCG	CASSGTGGNYGYTF	In	VDJ	1	44	6.522615687483693E-5	7.90971420764438E-5	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	0	2	1	0	24	35	-1	36	48														CASSGTGGNYGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGAAGGGGGAACAGATACGCAGTATTTTGGCCCA	CASSVEGGTDTQYF	In	VDJ	1	47	6.967339484357581E-5	8.449012903620132E-5	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	5	1	3	5	1	24	36	47	41	48														CASSVEGGTDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGCTACAGGGGAAGAGACCCAGTACTTCGGGCCA	CASSVATGEETQYF	In	VDJ	1	48	7.115580749982211E-5	8.62877913561205E-5	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	3	2	3	6	0	24	36	-1	42	49														CASSVATGEETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTCCTCGGCGGGGTTCTACGAGCAGTACTTCGGGCCG	CASSSSAGFYEQYF	In	VDJ	1	48	7.115580749982211E-5	8.62877913561205E-5	42	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	7	3	3	6	2	24	36	48	42	50														CASSSSAGFYEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCATGGGGCAGGGGCCGCTGCCCCCACATAACTATGGCTACACCTTCGGTTCG	CASMGQGPLPPHNYGYTF	In	VDJ	1	50	7.41206328123147E-5	8.988311599595886E-5	54	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	10	4	2	1	8	14	24	31	45	39	59														CASMGQGPLPPHNYGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGATTTAACGGTCAACTATGGCTACACCTTCGGTTCG	CASSVDLTVNYGYTF	In	VDJ	1	52	7.708545812480728E-5	9.34784406357972E-5	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	5	8	2	1	11	24	36	40	37	51						01,02								CASSVDLTVNYGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTTACAGGGGCCGGAGCACTGAAGCTTTCTTTGGACAA	CASSYRGRSTEAFF	In	VDJ	1	52	7.708545812480728E-5	9.34784406357972E-5	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	2	4	2	6	24	35	44	37	50														CASSYRGRSTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTACCCTTGGAACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSTLGTNTGELFF	In	VDJ	1	53	7.856787078105358E-5	9.527610295571638E-5	45	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-02	01	6	1	8	0	7	1	24	35	45	42	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSTLGTNTGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01		TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCCTGGGGGTCACCGGGAGAAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	54	8.005028343729987E-5		47	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	8	2	7	13	1	24	36	55	49	56														X+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGAACGGGATCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	55	8.153269609354617E-5		37	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	8	3	3	3	1	24	36	44	39	45														X+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGTATCCGGGACAGGGTGGACACTGAAGCTTTCTTTGGACAA	CASIRDRVDTEAFF	In	VDJ	1	55	8.153269609354617E-5	9.887142759555474E-5	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	10	0	3	3	6	3	24	31	46	37	49														CASIRDRVDTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTGCACGGCTTAGGGACGAGCAGTACTTCGGGCCG	CASSARLRDEQYF	In	VDJ	1	56	8.301510874979246E-5	1.0066908991547392E-4	39	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-07	01	6	5	3	5	10	0	24	35	-1	45	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSARLRDEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01		TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTAGGCCGATCAGGGACGACGGGCGAGCAGTACTTCGGGCCG	CASSLGRSGTTGEQYF	In	VDJ	1	58	8.597993406228505E-5	1.0426441455531227E-4	48	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-07	01	5	0	7	6	12	6	24	36	53	48	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGRSGTTGEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01		TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCCGGGACAGGGTCCTCTGGCTACACCTTCGGTTCG	CASSPGTGSSGYTF	In	VDJ	1	59	8.746234671853134E-5	1.0606207687523144E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	3	7	3	5	24	36	48	39	53														CASSPGTGSSGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGGATACAGGGAAATACGCAGTATTTTGGCCCA	CASRIQGNTQYF	In	VDJ	1	60	8.894475937477764E-5	1.0785973919515063E-4	36	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	3	3	7	3	2	24	35	44	38	46														CASRIQGNTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGCGACAGGATTCTCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	61	9.042717203102393E-5		41	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	4	3	2	5	24	36	44	38	49														X+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCAGAAGGTAGCGAGGCCGGGGAGCTGTTTTTTGGAGAA	CASSPEGSEAGELFF	In	VDJ	1	64	9.487440999976282E-5	1.1505038847482733E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	5	6	6	8	3	24	36	49	44	52						01,02								CASSPEGSEAGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGGAGGACTAGCGGGGGGTAGCGCCTACAATGAGCAGTTCTTCGGGCCA	CASSGGLAGGSAYNEQFF	In	VDJ	1	64	9.487440999976282E-5	1.1505038847482733E-4	54	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	1	1	2	3	5	24	36	53	39	58														CASSGGLAGGSAYNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCATGGGGGTGAACACTGAAGCTTTCTTTGGACAA	CASMGVNTEAFF	In	VDJ	1	64	9.487440999976282E-5	1.1505038847482733E-4	36	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-01	01	10	6	1	0	4	0	24	31	-1	35	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASMGVNTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAACAGCGTGACTAGCGGGGGAGCAGATACGCAGTATTTTGGCCCA	CANSVTSGGADTQYF	In	VDJ	1	65	9.635682265600911E-5	1.1684805079474652E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	2	2	4	2	2	24	36	50	38	52														CANSVTSGGADTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGAAACGGAGTGACTGAAGCTTTCTTTGGACAA	CASRNGVTEAFF	In	VDJ	1	65	9.635682265600911E-5	1.1684805079474652E-4	36	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	10	2	5	4	2	24	35	43	39	45														CASRNGVTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCACAGGGCAAAACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	67	9.93216479685017E-5		37	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	10	3	3	2	2	5	24	31	39	33	44														X+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCGGAACGGACTATGGTGGCTACACCTTCGGTTCG	CASGTDYGGYTF	In	VDJ	1	67	9.93216479685017E-5	1.2044337543458487E-4	36	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	10	1	9	7	7	3	24	31	44	38	47						01,02								CASGTDYGGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGCTAGCGGGGGGGACTATGATACGCAGTATTTTGGCCCA	CASSASGGDYDTQYF	In	VDJ	1	68	1.0080406062474798E-4	1.2224103775450404E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	4	0	6	1	5	24	36	49	37	54														CASSASGGDYDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTGAATCCCCGGGACAGGGGGATGGCTACACCTTCGGTTCG	CASSESPGQGDGYTF	In	VDJ	1	68	1.0080406062474798E-4	1.2224103775450404E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	1	6	9	0	24	35	-1	44	55														CASSESPGQGDGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCGGCCGGGACAAAGGAAAAACTGTTTTTTGGCAGT	CASSPAGTKEKLFF	In	VDJ	1	69	1.0228647328099429E-4	1.2403870007442322E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	0	6	8	6	3	24	36	48	42	51														CASSPAGTKEKLFF+TCRBV21-or09_02+TCRBJ01-04	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGCCGGGACAGGCGACATGAACACTGAAGCTTTCTTTGGACAA	CASSAGTGDMNTEAFF	In	VDJ	1	69	1.0228647328099429E-4	1.2403870007442322E-4	48	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	4	0	3	5	24	36	47	39	52														CASSAGTGDMNTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCGCTGGACAGTTTGGCCTACGAGCAGTACTTCGGGCCG	CASSPLDSLAYEQYF	In	VDJ	1	70	1.0376888593724057E-4	1.258363623943424E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	5	2	5	5	24	36	47	41	52														CASSPLDSLAYEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTATCAGGGGATGGCTACACCTTCGGTTCG	CASSLSGDGYTF	In	VDJ	1	70	1.0376888593724057E-4	1.258363623943424E-4	36	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	2	6	4	0	24	36	-1	40	46														CASSLSGDGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTTTCCGGGGGGGCCGCAGATACGCAGTATTTTGGCCCA	CASSVSGGAADTQYF	In	VDJ	1	71	1.0525129859348688E-4	1.2763402471426157E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	8	0	4	5	3	24	36	49	41	52														CASSVSGGAADTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTATCTGCGGAAACCGGGGAGCTGTTTTTTGGAGAA	CASSVSAETGELFF	In	VDJ	1	72	1.0673371124973316E-4	1.2943168703418074E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	7	5	5	6	2	24	36	46	42	48						01,02								CASSVSAETGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAAAGGGACTAGCGGTTTCAGATACGCAGTATTTTGGCCCA	CASSVKGLAVSDTQYF	In	VDJ	1	73	1.0821612390597947E-4	1.3122934935409992E-4	48	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	0	5	4	5	3	24	36	52	41	55						01,02								CASSVKGLAVSDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAGGGGGGCTTAGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	75	1.1118094921847204E-4		46	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-01	01	4	6	0	0	1	4	24	37	44	38	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01		TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCATGGGGGGGTACCAAGAGACCCAGTACTTCGGGCCA	CASSMGGYQETQYF	In	VDJ	1	75	1.1118094921847204E-4	1.348246739939383E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	9	0	0	1	1	24	37	45	38	46														CASSMGGYQETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGTAGCGGGCCTTTACAATGAGCAGTTCTTCGGGCCA	CASSVVAGLYNEQFF	In	VDJ	1	75	1.1118094921847204E-4	1.348246739939383E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	5	4	4	4	4	24	36	47	40	51						01,02								CASSVVAGLYNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGGAGGACAGGGACTGTCCGGGGAGCTATTTTTTGGAGAA	CASSVGGQGLSGELFF	In	VDJ	1	76	1.1266336187471834E-4	1.3662233631385747E-4	48	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	1	3	17	6	16	24	36	50	42	66														CASSVGGQGLSGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTATTTGAGGGCACTGAAGCTTTCTTTGGACAA	CASSVFEGTEAFF	In	VDJ	1	76	1.1266336187471834E-4	1.3662233631385747E-4	39	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	11	0	4	6	0	24	36	-1	42	47														CASSVFEGTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGCTGAAGATTGGGGCACAGATACGCAGTATTTTGGCCCA	CASSAEDWGTDTQYF	In	VDJ	1	78	1.1562818718721093E-4	1.4021766095369582E-4	45	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-03	01	5	0	9	1	10	0	24	36	-1	46	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSAEDWGTDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01		TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTAGGACGGATCAATTCACCCCTCCACTTTGGGAAC	CASSLGRINSPLHF	In	VDJ	1	79	1.1711059984345722E-4	1.42015323273615E-4	42	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-06	01	5	1	7	7	3	5	24	36	43	39	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGRINSPLHF+TCRBV21-or09_02+TCRBJ01-06	TCRBV21-or09_02*01		TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTACCAGCAGCGTAGTCCTCGGAGTGAGCTACGAGCAGTACTTCGGGCCG	CTSSVVLGVSYEQYF	In	VDJ	1	81	1.2007542515594981E-4	1.4561064791345334E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	10	2	3	9	4	24	36	49	45	53														CTSSVVLGVSYEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGCTACCCCGTACAATGAGCAGTTCTTCGGGCCA	CASSVATPYNEQFF	In	VDJ	1	81	1.2007542515594981E-4	1.4561064791345334E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	5	7	4	1	7	24	36	41	37	48						01,02								CASSVATPYNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTAGAAGGGAATAACTATGGCTACACCTTCGGTTCG	CASSLEGNNYGYTF	In	VDJ	1	81	1.2007542515594981E-4	1.4561064791345334E-4	42	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-02	01	5	0	8	1	6	1	24	36	46	42	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLEGNNYGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTTTAGGGAACACTGAAGCTTTCTTTGGACAA	CASSLGNTEAFF	In	VDJ	1	82	1.215578378121961E-4	1.4740831023337252E-4	36	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-01	01	6	5	4	1	3	0	24	35	-1	38	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGNTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCACGCACGGGGGTTTGATGCATGAGTGAAAGACCTATGGCTACACCTTCGGTTCG	CASTHGGLMHE*KTYGYTF	Stop	VDJ	1	84	1.245226631246887E-4		57	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	10	8	2	4	7	21	24	31	44	38	65														CASTHGGLMHE*KTYGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCTAGGGCGGGGCTAGACTTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSPRAGLDLAKNIQYF	In	VDJ	1	84	1.245226631246887E-4	1.5100363487321086E-4	54	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	5	7	3	0	6	8	24	36	48	42	56														CASSPRAGLDLAKNIQYF+TCRBV21-or09_02+TCRBJ02-04	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTGGTGGAGTGGGCCACTGAAGCTTTCTTTGGACAA	CASSLVEWATEAFF	In	VDJ	1	84	1.245226631246887E-4	1.5100363487321086E-4	42	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-01	01	5	8	0	4	10	0	24	36	-1	46	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVEWATEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCTACGGGACGGGGATCGCGGGGAAACACCATATATTTTGGAGAG	CASSPTGRGSRGNTIYF	In	VDJ	1	86	1.274874884371813E-4	1.5459895951304924E-4	51	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-03	01	5	0	7	4	5	11	24	36	46	41	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPTGRGSRGNTIYF+TCRBV21-or09_02+TCRBJ01-03	TCRBV21-or09_02*01		TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCCCGGGACTCCTTCACTGAAGCTTTCTTTGGACAA	CASSPRDSFTEAFF	In	VDJ	1	88	1.3045231374967387E-4	1.581942841528876E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	0	10	4	4	4	24	36	46	40	50						01,02								CASSPRDSFTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGTCAGCCTGAACACTGAAGCTTTCTTTGGACAA	CASSVVSLNTEAFF	In	VDJ	1	90	1.3341713906216645E-4	1.6178960879272594E-4	42	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-01	01	5	4	5	0	5	2	24	36	44	41	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVVSLNTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTCCCTCCAGTTGGCGGGGGGTAAAGACCCAGTACTTCGGGCCA	CASSPSSWRGVKTQYF	In	VDJ	1	91	1.3489955171841275E-4	1.6358727111264511E-4	48	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	7	1	6	12	3	24	35	55	47	58														CASSPSSWRGVKTQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGGAGGACAGGGCGTCCCAATTCACCCCTCCACTTTGGGAAC	CASRRTGRPNSPLHF	In	VDJ	1	92	1.3638196437465905E-4	1.653849334325643E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	1	3	7	2	6	24	35	45	37	51														CASRRTGRPNSPLHF+TCRBV21-or09_02+TCRBJ01-06	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGAAAGGGGGACAGGGCAATCACCCCTCCACTTTGGGAAC	CASSERGTGQSPLHF	In	VDJ	1	94	1.3934678968715162E-4	1.6898025807240264E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	0	3	10	6	3	24	36	51	42	54														CASSERGTGQSPLHF+TCRBV21-or09_02+TCRBJ01-06	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTAGGGGCAGCAGGGTACACTGAAGCTTTCTTTGGACAA	CASSLGAAGYTEAFF	In	VDJ	1	95	1.4082920234339793E-4	1.7077792039232181E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	3	3	10	1	24	36	51	46	52														CASSLGAAGYTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCACATCTATAATGCCTGAGTGAAAGACCTATGGCTACACCTTCGGTTCG	CASSTSIMPE*KTYGYTF	Stop	VDJ	1	99	1.467588529683831E-4		54	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-02	01	4	2	7	4	22	0	24	37	-1	59	62				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSTSIMPE*KTYGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGAAGGGCCCTACAATGAGCAGTTCTTCGGGCCA	CASSEGPYNEQFF	In	VDJ	1	100	1.482412656246294E-4	1.7976623199191771E-4	39	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	9	0	2	0	0	24	-1	-1	40	43														CASSEGPYNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAACGTAGATGGTCTCGCCGGGGAGCTGTTTTTTGGAGAA	CASNVDGLAGELFF	In	VDJ	1	101	1.4972367828087568E-4	1.815638943118369E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	10	5	8	6	6	9	24	31	40	37	49						01,02								CASNVDGLAGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCACAGGGGATGGGGAAAAACTGTTTTTTGGCAGT	CASTGDGEKLFF	In	VDJ	1	103	1.5268850359336829E-4	1.8515921895167524E-4	36	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	10	3	2	8	2	5	24	31	40	33	45														CASTGDGEKLFF+TCRBV21-or09_02+TCRBJ01-04	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGCTAAGAAGGAGGGATACGCAGTATTTTGGCCCA		Out	VDJ	1	103	1.5268850359336829E-4		43	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	10	1	6	11	0	24	36	-1	47	52														X+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTCAGCGGGGCGTCTGAAGCTTTCTTTGGACAA	CASSVSGASEAFF	In	VDJ	1	108	1.6010056687459974E-4	1.9414753055127114E-4	39	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	6	3	6	3	3	24	36	46	39	49														CASSVSGASEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGGGAGGGGGAACACTGAAGCTTTCTTTGGACAA	CASSVGRGNTEAFF	In	VDJ	1	109	1.6158297953084604E-4	1.9594519287119031E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	9	0	1	3	1	24	36	46	39	47														CASSVGRGNTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGACCTAGCGGGTGCGACAGATACGCAGTATTTTGGCCCA	CASSVDLAGATDTQYF	In	VDJ	1	115	1.704774554683238E-4	2.0673116679070536E-4	48	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	4	4	3	6	4	24	36	50	42	54						01,02								CASSVDLAGATDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGGGACAGTCACCGGGGAGCTGTTTTTTGGAGAA	CASSGTVTGELFF	In	VDJ	1	126	1.8678399468703303E-4	2.265054523098163E-4	39	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	5	4	0	1	24	-1	43	36	44														CASSGTVTGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGGCGGCCGTGGAACCGGGGAGCTGTTTTTTGGAGAA	CASSVGGRGTGELFF	In	VDJ	1	127	1.8826640734327934E-4	2.2830311462973549E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	7	5	5	4	7	24	36	44	40	51						01,02								CASSVGGRGTGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGATAGGACAAGGTCTGGAAACACCATATATTTTGGAGAG	CASSDRTRSGNTIYF	In	VDJ	1	131	1.9419605796826452E-4	2.354937639094122E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	1	6	1	4	3	24	36	45	40	48														CASSDRTRSGNTIYF+TCRBV21-or09_02+TCRBJ01-03	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGGTACAACAGATAATTCACCCCTCCACTTTGGGAAC	CASSGTTDNSPLHF	In	VDJ	1	131	1.9419605796826452E-4	2.354937639094122E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	3	5	5	6	0	24	36	-1	42	46														CASSGTTDNSPLHF+TCRBV21-or09_02+TCRBJ01-06	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTAGGGAGGAGGACAGGGGGCACTGAAGCTTTCTTTGGACAA	CASSLGRRTGGTEAFF	In	VDJ	1	134	1.986432959370034E-4	2.4088675086916974E-4	48	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	1	4	10	0	24	36	-1	46	56														CASSLGRRTGGTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCATGTCCCGCTCTGGAAACACCATATATTTTGGAGAG	CASSMSRSGNTIYF	In	VDJ	1	135	2.001257085932497E-4	2.426844131890889E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	4	8	6	0	5	0	24	37	-1	42	44						01,02								CASSMSRSGNTIYF+TCRBV21-or09_02+TCRBJ01-03	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGCCCCAGGGGAACGAGGCTACACCTTCGGTTCG	CASSAPGERGYTF	In	VDJ	1	137	2.0309053390574227E-4	2.4627973782892726E-4	39	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	2	8	4	5	24	36	46	40	51														CASSAPGERGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAACCTAGCGGGGGGGTTTTCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	141	2.0902018453072745E-4		50	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	10	4	0	0	5	4	24	31	48	36	52														X+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGGGGGGATCACCGGGGAGCTGTTTTTTGGAGAA	CASSGGITGELFF	In	VDJ	1	141	2.0902018453072745E-4	2.5347038710860396E-4	39	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	9	1	4	0	2	24	-1	42	36	44														CASSGGITGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGCGTCCTCCGGGACAGGGGGCGAAAAACTGTTTTTTGGCAGT	CASSASSGTGGEKLFF	In	VDJ	1	142	2.1050259718697375E-4	2.5526804942852313E-4	48	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	0	0	8	9	0	24	36	-1	45	57														CASSASSGTGGEKLFF+TCRBV21-or09_02+TCRBJ01-04	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGGCGGAGCCCCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSVGGAPNTGELFF	In	VDJ	1	142	2.1050259718697375E-4	2.5526804942852313E-4	48	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	7	5	0	4	5	24	36	44	40	49						01,02								CASSVGGAPNTGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCCCAAGGGACAGGAAATTCACCCCTCCACTTTGGGAAC	CASSPQGTGNSPLHF	In	VDJ	1	143	2.1198500984322003E-4	2.570657117484423E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	0	4	7	6	1	24	36	50	42	51														CASSPQGTGNSPLHF+TCRBV21-or09_02+TCRBJ01-06	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCTTATTATGGAGACACTGAAGCTTTCTTTGGACAA	CASSPYYGDTEAFF	In	VDJ	1	145	2.1494983515571263E-4	2.6066103638828066E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	10	2	3	9	0	24	36	-1	45	49														CASSPYYGDTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCACGGAGACAGGAATACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	148	2.193970731244515E-4		43	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	10	2	4	3	7	3	24	31	44	38	47														X+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGCGGGGGATGGAAACACCATATATTTTGGAGAG	CASSVAGDGNTIYF	In	VDJ	1	148	2.193970731244515E-4	2.6605402334803824E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	5	5	2	3	1	1	24	36	46	37	47														CASSVAGDGNTIYF+TCRBV21-or09_02+TCRBJ01-03	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGCCTACAGGGACCGAAATGAAAAACTGTTTTTTGGCAGT	CASSAYRDRNEKLFF	In	VDJ	1	149	2.208794857806978E-4	2.678516856679574E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	3	3	5	4	5	24	36	46	40	51														CASSAYRDRNEKLFF+TCRBV21-or09_02+TCRBJ01-04	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAAAGCGCTAAGGGAACAGGAGTGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	166	2.460805009368848E-4		56	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	3	4	1	9	3	24	41	55	50	58														X+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGGGGGACAGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSVGGQGNTGELFF	In	VDJ	1	175	2.5942221484310146E-4	3.14590905985856E-4	48	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	3	1	5	0	24	36	-1	41	50														CASSVGGQGNTGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCGACCGGGACAGGGGAGGAAAAACTGTTTTTTGGCAGT	CASSPTGTGEEKLFF	In	VDJ	1	179	2.653518654680866E-4	3.217815552655327E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	0	2	8	6	2	24	36	52	42	54														CASSPTGTGEEKLFF+TCRBV21-or09_02+TCRBJ01-04	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCTGGGACAGGGGCTGGAAACACCATATATTTTGGAGAG	CASSPGTGAGNTIYF	In	VDJ	1	180	2.668342781243329E-4	3.235792175854519E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	0	2	2	3	0	24	36	-1	39	49														CASSPGTGAGNTIYF+TCRBV21-or09_02+TCRBJ01-03	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCGGGGATCTCCTCTATGGCTACACCTTCGGTTCG	CASGDLLYGYTF	In	VDJ	1	186	2.757287540618107E-4	3.3436519150496693E-4	36	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	10	7	3	4	0	7	24	-1	37	31	44														CASGDLLYGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTTAGCGGGGGGGCCGGCAATGAGCAGTTCTTCGGGCCA	CASSFSGGAGNEQFF	In	VDJ	1	200	2.964825312492588E-4	3.5953246398383543E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	5	0	6	2	4	24	36	49	38	53														CASSFSGGAGNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGAGGGGGACCCCCACGAAAATGGACTGTTTTTTGGCAGT	CASSVEGDPHENGLFF	In	VDJ	1	221	3.2761319703043096E-4	3.9728337270213815E-4	48	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	5	1	13	4	16	24	36	46	40	62														CASSVEGDPHENGLFF+TCRBV21-or09_02+TCRBJ01-04	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTCGGGACGGTCTCCTATAATTCACCCCTCCACTTTGGGAAC	CASSVGTVSYNSPLHF	In	VDJ	1	226	3.3502526031166244E-4	4.06271684301734E-4	48	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-06	01	5	0	7	0	3	3	24	36	44	39	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVGTVSYNSPLHF+TCRBV21-or09_02+TCRBJ01-06	TCRBV21-or09_02*01		TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGACGCCTTGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSVDALNTGELFF	In	VDJ	1	237	3.513317995303717E-4	4.2604596982084495E-4	45	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-02	01	5	2	7	1	3	5	24	36	42	39	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVDALNTGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01		TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTCATAGCGGGGGGGCCTCAGATACGCAGTATTTTGGCCCA	CASSHSGGASDTQYF	In	VDJ	1	251	3.720855767178198E-4	4.5121324229971345E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	5	0	4	3	3	24	35	49	38	52														CASSHSGGASDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAACAGCGACGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASNSDGNTGELFF	In	VDJ	2	270	4.002514171864994E-4	4.853688263781778E-4	42	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-02	01	10	3	5	1	3	6	24	31	38	34	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASNSDGNTGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01		TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGGAGACCGGGACAGGTTGTCTGAAGCTTTCTTTGGACAA	CASSGDRDRLSEAFF	In	VDJ	2	272	4.0321624249899194E-4	4.889641510180162E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	4	6	7	4	24	36	51	43	55														CASSGDRDRLSEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCGGCAGCGTGGGGAACACTGAAGCTTTCTTTGGACAA	CAGSVGNTEAFF	In	VDJ	2	300	4.4472379687388817E-4	5.392986959757532E-4	36	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	11	6	6	1	3	4	24	30	37	33	41						01,02								CAGSVGNTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGGTGTTAGCGGTACCCAAGGGGAGACCCAGTACTTCGGGCCA	CASSVGVSGTQGETQYF	In	VDJ	2	318	4.714072246863215E-4	5.716566177342983E-4	51	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	5	5	5	8	10	24	36	50	44	60						01,02								CASSVGVSGTQGETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTTTCTTACAGGTTGCGACACCCCTCCACTTTGGGAAC	CASSFLQVATPLHF	In	VDJ	3	526	7.797490571855506E-4	9.455703802774872E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	3	4	11	6	6	24	35	46	41	52														CASSFLQVATPLHF+TCRBV21-or09_02+TCRBJ01-06	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCTAGCCAACCCTGGGGACTCAGGGAGGTTACAATGAGCAGTTCTTCGGGCCA	CAS*PTLGTQGGYNEQFF	Stop	VDJ	3	617	9.146486089039634E-4		54	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	10	0	10	4	14	9	24	31	51	45	60						01,02								CAS*PTLGTQGGYNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCCATGGCCTATAATTCACCCCTCCACTTTGGGAAC	CASSPMAYNSPLHF	In	VDJ	5	881	0.001306005550152985	0.001583740503848795	42	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-06	01	5	0	10	2	5	0	24	36	-1	41	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPMAYNSPLHF+TCRBV21-or09_02+TCRBJ01-06	TCRBV21-or09_02*01		TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTGTCGGTCAGGGGACAGGGGTAGGATCCTACAATGAGCAGTTCTTCGGGCCA	CASSVGQGTGVGSYNEQFF	In	VDJ	16	2840	0.004210051943739475	0.005105360988570463	57	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	2	1	10	5	24	35	55	45	60														CASSVGQGTGVGSYNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGGTCTAGCGGGATACAATGAGCAGTTCTTCGGGCCA	CASSVGLAGYNEQFF	In	VDJ	57	10057	0.014908624083868978	0.018079089951427166	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	4	3	4	6	0	24	36	-1	42	51														CASSVGLAGYNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCACCTGACAGGCGCTCCCTATGGCTACACCTTCGGTTCG		Out	VDJ	119	20970	0.031086193401484784		44	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	4	4	3	6	24	37	46	40	52														X+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCTCATGATAGGGATTATGAACACTGAAGCTTTCTTTGGACAA	CASSLMIGIMNTEAFF	In	VDJ	1	44	6.522615687483693E-5	7.90971420764438E-5	48	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-01	01	4	0	8	0	9	3	19	31	44	40	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLMIGIMNTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCACCGGGACGACGGGACAAATAATGGAGACCCAGTACTTCGGGCCA	CASTGTTGQIMETQYF	In	VDJ	1	45	6.670856953108322E-5	8.089480439636297E-5	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	0	6	5	10	7	19	29	45	39	52													Vb 5.1	CASTGTTGQIMETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTAGCCGGGGTCTCGGGAGGAAACACCATATATTTTGGAGAG	CASSLAGVSGGNTIYF	In	VDJ	1	46	6.819098218732952E-5	8.269246671628214E-5	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	2	8	3	4	3	8	19	33	41	36	49						01,02							Vb 5.1	CASSLAGVSGGNTIYF+TCRBV05-01+TCRBJ01-03	TCRBV05-01*01	TCRBD02-01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTCGGGCAGGGGGGAGAAAAACTGTTTTTTGGCAGT	CASSFGQGGEKLFF	In	VDJ	1	47	6.967339484357581E-5	8.449012903620132E-5	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	4	1	8	4	2	19	33	44	37	46													Vb 5.1	CASSFGQGGEKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGTTTAACTAGCGGGAGGGCTGTGAATGAGCAGTTCTTCGGGCCA	CASSLTSGRAVNEQFF	In	VDJ	1	49	7.26382201560684E-5	8.808545367603968E-5	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	3	0	7	4	5	19	30	47	34	52													Vb 5.1	CASSLTSGRAVNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTGGTGGGGCAGGGAGTCCTACAATGAGCAGTTCTTCGGGCCA	CASSWWGRESYNEQFF	In	VDJ	1	51	7.560304546856099E-5	9.168077831587803E-5	48	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-01	01	3	4	3	1	7	2	19	32	44	39	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSWWGRESYNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01		TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCACCCCCCGAAGGCACTCAAGAGCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	52	7.708545812480728E-5		50	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-02	01	6	5	4	4	8	10	19	29	40	37	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	X+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01		TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCATCCTCGAGGGGGGGAATTCACCCCTCCACTTTGGGAAC	CASSILEGGNSPLHF	In	VDJ	1	52	7.708545812480728E-5	9.34784406357972E-5	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	4	9	0	7	8	0	19	31	-1	39	46													Vb 5.1	CASSILEGGNSPLHF+TCRBV05-01+TCRBJ01-06	TCRBV05-01*01	TCRBD02-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCCGGCAGGGGGCTTGGAAACACCATATATTTTGGAGAG	CASSPGRGLGNTIYF	In	VDJ	1	54	8.005028343729987E-5	9.707376527563557E-5	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	4	0	3	5	1	19	31	44	36	45													Vb 5.1	CASSPGRGLGNTIYF+TCRBV05-01+TCRBJ01-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCCGGGGGCGGGGTAGACACTGAAGCTTTCTTTGGACAA	CASSPGGGVDTEAFF	In	VDJ	1	54	8.005028343729987E-5	9.707376527563557E-5	45	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-01	01	4	6	0	3	3	7	19	31	40	34	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSPGGGVDTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCGTTTATATCGGGGTGCCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSRLYRGASYNEQFF	In	VDJ	1	54	8.005028343729987E-5	9.707376527563557E-5	51	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	8	3	0	9	3	19	31	45	40	48													Vb 5.1	CASSRLYRGASYNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCACGTACCGGGGCCATTAGGGAAATAGAAAAACTGTTTTTTGGCAGT	CASSSRTGAIREIEKLFF	In	VDJ	1	55	8.153269609354617E-5	9.887142759555474E-5	54	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-04	01	3	7	0	8	8	13	19	32	45	40	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSSRTGAIREIEKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01		TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTAAATACAAGACAGGGGAGATATAATTCACCCCTCCACTTTGGGAAC	CASSLNTRQGRYNSPLHF	In	VDJ	1	55	8.153269609354617E-5	9.887142759555474E-5	54	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	2	2	2	4	8	3	19	33	49	41	52													Vb 5.1	CASSLNTRQGRYNSPLHF+TCRBV05-01+TCRBJ01-06	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGCCGGGGGCAGGGTCATTACACGAGCAGTACTTCGGGCCG	CASSLPGAGSLHEQYF	In	VDJ	1	55	8.153269609354617E-5	9.887142759555474E-5	48	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-07	01	1	6	0	5	2	11	19	34	42	36	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLPGAGSLHEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01		TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCTCAGGGGAGCAATTCACCCCTCCACTTTGGGAAC	CASSPQGSNSPLHF	In	VDJ	1	56	8.301510874979246E-5	1.0066908991547392E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	4	2	7	3	3	19	31	40	34	43													Vb 5.1	CASSPQGSNSPLHF+TCRBV05-01+TCRBJ01-06	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGTATGCAGGGGGAGTTATGGCTACACCTTCGGTTCG		Out	VDJ	1	56	8.301510874979246E-5		44	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	4	1	5	4	3	19	34	45	38	48													Vb 5.1	X+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCTAGGACAGGGGGCGAGGGAAGCTTTCTTTGGACAA	CASSLGQGAREAFF	In	VDJ	1	61	9.042717203102393E-5	1.096574015150698E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	0	8	3	4	19	31	45	34	49													Vb 5.1	CASSLGQGAREAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCTGGCTCAGGACAGGGGTCTTATAATGAAAAACTGTTTTTTGGCAGT	CASSSGSGQGSYNEKLFF	In	VDJ	1	61	9.042717203102393E-5	1.096574015150698E-4	54	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	1	2	4	8	5	19	32	49	40	54													Vb 5.1	CASSSGSGQGSYNEKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCTGGACAGGGGGCTGCACGACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	62	9.190958468727023E-5		46	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	3	0	5	0	6	19	-1	44	35	50													Vb 5.1	X+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGTTACCAGCGGGGGGAAATGAGCAGTTCTTCGGGCCA	CASSLLPAGGNEQFF	In	VDJ	1	62	9.190958468727023E-5	1.1145506383498898E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	6	1	7	5	1	19	34	48	39	49													Vb 5.1	CASSLLPAGGNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCCCCCCGAGTCATACCTCCAAACTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	62	9.190958468727023E-5		52	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	7	11	2	0	5	13	19	28	36	33	49													Vb 5.1	X+TCRBV05-01+TCRBJ01-03	TCRBV05-01*01	TCRBD02-01*02	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGACGTGACAGGGGAAAACACCATATATTTTGGAGAG	CASSLDVTGENTIYF	In	VDJ	1	63	9.339199734351652E-5	1.1325272615490816E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	2	2	6	4	1	19	35	47	39	48													Vb 5.1	CASSLDVTGENTIYF+TCRBV05-01+TCRBJ01-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGACCTTCGGGCGCGGCATTTTGCTGAGCAGTTCTTCGGGCCA	CASSLDLRARHFAEQFF	In	VDJ	1	64	9.487440999976282E-5	1.1505038847482733E-4	51	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-01	01	0	8	0	9	6	12	19	35	45	41	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLDLRARHFAEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01		TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGAGGGGGGGCGGAGACCCAGTACTTCGGGCCA	CASSLGGGAETQYF	In	VDJ	1	67	9.93216479685017E-5	1.2044337543458487E-4	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	9	0	5	2	2	19	35	44	37	46													Vb 5.1	CASSLGGGAETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCAAGACAGGGGTGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSKTGVNTGELFF	In	VDJ	1	70	1.0376888593724057E-4	1.258363623943424E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	2	2	1	2	1	19	31	41	33	42													Vb 5.1	CASSKTGVNTGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGACCTGGTAGATAATTCACCCCTCCACTTTGGGAAC	CASSLDLVDNSPLHF	In	VDJ	1	72	1.0673371124973316E-4	1.2943168703418074E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	0	5	8	5	6	0	19	35	-1	41	44						01,02							Vb 5.1	CASSLDLVDNSPLHF+TCRBV05-01+TCRBJ01-06	TCRBV05-01*01	TCRBD02-01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGAACCCAGCGGGGCAGCAAGATACGCAGTATTTTGGCCCA	CASSLNPAGQQDTQYF	In	VDJ	1	76	1.1266336187471834E-4	1.3662233631385747E-4	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	6	3	5	5	5	19	34	46	39	51													Vb 5.1	CASSLNPAGQQDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGTCCGACAAATTCCCAAGAGACCCAGTACTTCGGGCCA	CASSPTNSQETQYF	In	VDJ	1	76	1.1266336187471834E-4	1.3662233631385747E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	2	6	1	3	5	19	30	37	33	42													Vb 5.1	CASSPTNSQETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCGGAGGGGGGTGAAAACACTGAAGCTTTCTTTGGACAA	CASSPEGGENTEAFF	In	VDJ	1	81	1.2007542515594981E-4	1.4561064791345334E-4	45	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-01	01	4	5	1	2	4	5	19	31	41	35	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSPEGGENTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGGGACCAATCGGGACTAGCAGAAGATACGCAGTATTTTGGCCCA	CASRDQSGLAEDTQYF	In	VDJ	1	83	1.230402504684424E-4	1.492059725532917E-4	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	0	7	5	9	3	19	30	48	39	51						01,02							Vb 5.1	CASRDQSGLAEDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGGGGGACAGGATCAGTCTCTGGAAACACCATATATTTTGGAGAG	CASRGTGSVSGNTIYF	In	VDJ	1	85	1.26005075780935E-4	1.5280129719313007E-4	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	0	4	0	1	6	19	30	39	31	45													Vb 5.1	CASRGTGSVSGNTIYF+TCRBV05-01+TCRBJ01-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCGGTGGTCTCCCAGGGTCAGATACGCAGTATTTTGGCCCA	CASSGGLPGSDTQYF	In	VDJ	1	96	1.4231161499964423E-4	1.72575582712241E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	4	3	4	10	1	19	31	46	41	47													Vb 5.1	CASSGGLPGSDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGCCCCAGGGAGTGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSLAPGSGTGELFF	In	VDJ	1	106	1.5713574156210716E-4	1.9055220591143276E-4	48	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-02	01	0	4	3	4	3	5	19	35	43	38	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLAPGSGTGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01		TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGAAGCGGGCTTGGGGAACACTGAAGCTTTCTTTGGACAA	CASSLEAGLGNTEAFF	In	VDJ	1	109	1.6158297953084604E-4	1.9594519287119031E-4	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	6	4	1	1	6	19	35	42	36	48						01,02							Vb 5.1	CASSLEAGLGNTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD02-01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGACTCAGGGGGGCGCAGAGACCCAGTACTTCGGGCCA	CASSLTQGGAETQYF	In	VDJ	1	137	2.0309053390574227E-4	2.4627973782892726E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	4	1	4	3	4	19	34	44	37	48													Vb 5.1	CASSLTQGGAETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTCTCCCTTGAAGGAAACGAGCAGTACTTCGGGCCG	CASSFSLEGNEQYF	In	VDJ	1	145	2.1494983515571263E-4	2.6066103638828066E-4	42	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-07	01	2	1	8	5	10	1	19	33	46	43	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSFSLEGNEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01		TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGATACTAGCGGGGGCCGAGGGGAGCAGTTCTTCGGGCCA	CASSLDTSGGRGEQFF	In	VDJ	1	149	2.208794857806978E-4	2.678516856679574E-4	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	3	2	10	2	7	19	35	48	37	55													Vb 5.1	CASSLDTSGGRGEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCGGACTCCAGGGGATTTACAATGAGCAGTTCTTCGGGCCA	CASGLQGIYNEQFF	In	VDJ	1	226	3.3502526031166244E-4	4.06271684301734E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	4	2	4	6	3	19	28	40	34	43													Vb 5.1	CASGLQGIYNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGAACAGAGCACAGATACGCAGTATTTTGGCCCA	CASSLEQSTDTQYF	In	VDJ	1	260	3.8542729062403643E-4	4.673922031789861E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	3	5	0	1	0	19	35	-1	36	40													Vb 5.1	CASSLEQSTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCACTGGGGGACAGGGCGGGAACACTGAAGCTTTCTTTGGACAA	CASTGGQGGNTEAFF	In	VDJ	2	313	4.6399516140509E-4	5.626683061347024E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	3	1	4	3	19	29	42	33	45													Vb 5.1	CASTGGQGGNTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTTGACCACACCATATCCTACGAGCAGTACTTCGGGCCG	CASSFDHTISYEQYF	In	VDJ	2	401	5.944474751547639E-4	7.2086259028759E-4	45	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-07	01	2	2	7	1	1	9	19	33	37	34	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSFDHTISYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01		TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCTTGGACAGGGAAACACTGAAGCTTTCTTTGGACAA	CASSLGQGNTEAFF	In	VDJ	7	1297	0.0019226892151514433	0.002331568028935173	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	3	2	3	1	19	31	42	34	43													Vb 5.1	CASSLGQGNTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGTTACCCTCTCAAGTACCGGGGAGCTGTTTTTTGGAGAA	CASSLVTLSSTGELFF	In	VDJ	8	1341	0.0019879153720262803	0.0024106651710116165	48	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-02	01	0	3	7	5	2	10	19	35	39	37	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLVTLSSTGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01		TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GAGGGACTCAGCCGTGTATCTCTACAGTAGTGAGTATGGACAGAGTGTCGTCGACATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	60	8.894475937477764E-5		50	TCRBV17	TCRBV17-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	1	5	5	7	12	22	30	43	37	55														X+TCRBV17-01+TCRBJ01-05	TCRBV17-01*01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATACGGCAGGGGGTTATCCAATGGCTACACCTTCGGTTCG	CASSLYGRGLSNGYTF	In	VDJ	1	44	6.522615687483693E-5	7.90971420764438E-5	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	4	1	6	4	7	25	41	52	45	59													Vb 3	CASSLYGRGLSNGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTGCGGGGGCGGACGAGCAGTACTTCGGGCCG	CASSFAGADEQYF	In	VDJ	1	44	6.522615687483693E-5	7.90971420764438E-5	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	7	2	5	1	3	25	39	47	40	50													Vb 3	CASSFAGADEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAATTCAATGGACAGAAAATCAGCCCCAGCATTTTGGTGAT	CASSLIQWTENQPQHF	In	VDJ	1	45	6.670856953108322E-5	8.089480439636297E-5	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	1	5	4	7	2	25	40	53	47	55													Vb 3	CASSLIQWTENQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCGGACTTTTACTCTACGAGCAGTACTTCGGGCCG	CASSSGLLLYEQYF	In	VDJ	1	46	6.819098218732952E-5	8.269246671628214E-5	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	1	10	3	2	6	25	38	45	40	51						01,02							Vb 3	CASSSGLLLYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGTACCTCTGTGCCAGCACCCCCCTTAGGACAGAAGGTATGAACACAGGTATGAACACTGAAGCTTTCTTTGGACAA	CASTPLRTEGMNTGMNTEAFF	In	VDJ	1	46	6.819098218732952E-5	8.269246671628214E-5	63	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	1	5	0	9	18	8	18	33	27	51													Vb 3	CASTPLRTEGMNTGMNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTACCCGACAGGGGCTTCCTTTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSYPTGASFSNQPQHF	In	VDJ	1	50	7.41206328123147E-5	8.988311599595886E-5	54	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	2	2	0	4	7	25	38	50	42	57													Vb 3	CASSYPTGASFSNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCGGGCGGCAGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CASSSGGSSYNSPLHF	In	VDJ	1	50	7.41206328123147E-5	8.988311599595886E-5	48	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-06	01	4	8	0	0	1	5	25	38	43	39	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSSGGSSYNSPLHF+TCRBV28-01+TCRBJ01-06	TCRBV28-01*01		TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCACGACTCGTCCGGGGAGCTGTTTTTTGGAGAA	CASSHDSSGELFF	In	VDJ	1	51	7.560304546856099E-5	9.168077831587803E-5	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	2	10	6	3	3	25	37	44	40	47						01,02							Vb 3	CASSHDSSGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTGGGACAGGATCCGCTCTGGAAACACCATATATTTTGGAGAG	CASSWDRIRSGNTIYF	In	VDJ	1	52	7.708545812480728E-5	9.34784406357972E-5	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	0	4	0	0	5	25	-1	46	38	51													Vb 3	CASSWDRIRSGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTATCCCGAACACTGAAGCTTTCTTTGGACAA	CASSFIPNTEAFF	In	VDJ	1	52	7.708545812480728E-5	9.34784406357972E-5	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	5	9	1	0	4	25	-1	41	39	45						01,02							Vb 3	CASSFIPNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTCGGGAGGACGAAGAACTAGATGATACGCAGTATTTTGGCCCA	CASSFREDEELDDTQYF	In	VDJ	1	52	7.708545812480728E-5	9.34784406357972E-5	51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	8	1	6	1	14	25	39	47	40	61													Vb 3	CASSFREDEELDDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGTGAACTTCAGGGGCGGGCCTACGAGCAGTACTTCGGGCCG	CASELQGRAYEQYF	In	VDJ	1	53	7.856787078105358E-5	9.527610295571638E-5	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	9	4	2	2	7	4	25	33	46	40	50													Vb 3	CASELQGRAYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTGGCTCATGGACTATGGCTACACCTTCGGTTCG	CASSWLMDYGYTF	In	VDJ	1	54	8.005028343729987E-5	9.707376527563557E-5	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	9	0	3	0	6	25	-1	41	38	47													Vb 3	CASSWLMDYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTCCCGGGACGGTGGGGTCAGATACGCAGTATTTTGGCCCA	CASSFPGTVGSDTQYF	In	VDJ	1	55	8.153269609354617E-5	9.887142759555474E-5	48	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-03	01	3	0	7	4	4	8	25	39	48	43	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSFPGTVGSDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01		TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTACCAGCAGCTTACCCAGGGGAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	56	8.301510874979246E-5		44	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	4	2	0	2	0	25	40	-1	42	48													Vb 3	X+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCGACAGGGGATTCACTGAAGCTTTCTTTGGACAA	CASSDRGFTEAFF	In	VDJ	1	57	8.449752140603876E-5	1.024667522353931E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	2	4	1	3	25	36	45	37	48													Vb 3	CASSDRGFTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGACCGGATTTGGGGTACAGTTCACCCCTCCACTTTGGGAAC	CASRPDLGYSSPLHF	In	VDJ	1	58	8.597993406228505E-5	1.0426441455531227E-4	45	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-06	01	6	3	5	9	14	0	25	36	-1	50	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASRPDLGYSSPLHF+TCRBV28-01+TCRBJ01-06	TCRBV28-01*01		TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCAGGGGGGGTGTCCGGCTACACCTTCGGTTCG	CASSPGGVSGYTF	In	VDJ	1	60	8.894475937477764E-5	1.0785973919515063E-4	39	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-02	01	6	4	1	8	2	7	25	36	45	38	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSPGGVSGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACTAATACTCGGGGGTGGCTACACCTTCGGTTCG	CASSLLILGGGYTF	In	VDJ	1	60	8.894475937477764E-5	1.0785973919515063E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	2	8	2	7	8	0	25	40	-1	48	54													Vb 3	CASSLLILGGGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCTGAGCCTAGGAGATCACCCCTCCACTTTGGGAAC	CASSPEPRRSPLHF	In	VDJ	1	61	9.042717203102393E-5	1.096574015150698E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	6	4	8	10	8	4	25	36	48	44	52						01,02							Vb 3	CASSPEPRRSPLHF+TCRBV28-01+TCRBJ01-06	TCRBV28-01*01	TCRBD02-01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCTCGGACAGGTGTCTACGAGCAGTACTTCGGGCCG	CASSSRTGVYEQYF	In	VDJ	1	61	9.042717203102393E-5	1.096574015150698E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	1	4	3	3	3	25	38	48	41	51													Vb 3	CASSSRTGVYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAACGGGGCCAACCAATGAGCAGTTCTTCGGGCCA	CASSLTGPTNEQFF	In	VDJ	1	62	9.190958468727023E-5	1.1145506383498898E-4	42	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-01	01	2	7	0	6	2	4	25	40	47	42	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLTGPTNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01		TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCGGACCGTCGAAAACGAGCAGTACTTCGGGCCG	CASSRTVENEQYF	In	VDJ	1	64	9.487440999976282E-5	1.1505038847482733E-4	39	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	6	1	7	5	2	8	25	36	42	38	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSRTVENEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCCATAGCCCTCTCTCTGGAAACACCATATATTTTGGAGAG	CASSPHSPLSGNTIYF	In	VDJ	1	64	9.487440999976282E-5	1.1505038847482733E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	5	5	7	0	5	5	25	37	46	42	51						01,02							Vb 3	CASSPHSPLSGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD02-01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCGCCGGGGGTGGAGGCAATCAGCCCCAGCATTTTGGTGAT	CASSSAGGGGNQPQHF	In	VDJ	1	64	9.487440999976282E-5	1.1505038847482733E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	4	8	2	2	4	5	25	38	48	42	53													Vb 3	CASSSAGGGGNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACGCCACCGCGTGGAGCCCAGCATTTTGGTGAT	CASTPPRGAQHF	In	VDJ	1	66	9.783923531225541E-5	1.1864571311466569E-4	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	7	10	2	11	11	0	25	35	-1	46	50													Vb 3	CASTPPRGAQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGACTACAGGGGCGATCCTACGAGCAGTACTTCGGGCCG	CASRLQGRSYEQYF	In	VDJ	1	67	9.93216479685017E-5	1.2044337543458487E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	3	2	1	3	3	25	36	46	39	49													Vb 3	CASRLQGRSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTAGCTCGACGGGGAGCTCCTACGAGCAGTACTTCGGGCCG	CASSSSTGSSYEQYF	In	VDJ	1	67	9.93216479685017E-5	1.2044337543458487E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	8	3	0	7	2	25	37	49	44	51						01,02							Vb 3	CASSSSTGSSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGGAGCAGGGGAAAATTCACCCCTCCACTTTGGGAAC	CASSGAGENSPLHF	In	VDJ	1	67	9.93216479685017E-5	1.2044337543458487E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	4	2	7	4	2	25	37	47	41	49													Vb 3	CASSGAGENSPLHF+TCRBV28-01+TCRBJ01-06	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATTAGAGGGAGCCACAGATACGCAGTATTTTGGCCCA	CASSLLEGATDTQYF	In	VDJ	1	67	9.93216479685017E-5	1.2044337543458487E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	9	2	2	4	1	25	41	50	45	51													Vb 3	CASSLLEGATDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGACAGACGTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASRQTYSNQPQHF	In	VDJ	1	68	1.0080406062474798E-4	1.2224103775450404E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	3	5	0	0	5	25	-1	40	36	45													Vb 3	CASRQTYSNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGCGGCCCATCCCAACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	68	1.0080406062474798E-4		43	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	7	5	2	0	10	25	-1	41	37	51						01,02							Vb 3	X+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATCAATGAACTATAATTCACCCCTCCACTTTGGGAAC	CASSLSMNYNSPLHF	In	VDJ	1	68	1.0080406062474798E-4	1.2224103775450404E-4	45	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-06	01	1	2	8	3	4	1	25	41	47	45	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLSMNYNSPLHF+TCRBV28-01+TCRBJ01-06	TCRBV28-01*01		TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCACAGGGCTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSSQGYSNQPQHF	In	VDJ	1	69	1.0228647328099429E-4	1.2403870007442322E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	3	3	0	1	3	25	38	45	39	48													Vb 3	CASSSQGYSNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCCCGGGACAGGTTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	70	1.0376888593724057E-4		40	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	4	4	5	1	25	36	49	41	50													Vb 3	X+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCGCCGGGGCTGGGGACACCATATATTTTGGAGAG	CASSPAGAGDTIYF	In	VDJ	1	70	1.0376888593724057E-4	1.258363623943424E-4	42	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-03	01	5	7	0	8	6	5	25	37	48	43	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSPAGAGDTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01		TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCGACCGTGGGGGGTCAGCCCCAGCATTTTGGTGAT	CASSPTVGGQPQHF	In	VDJ	1	70	1.0376888593724057E-4	1.258363623943424E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	5	9	1	6	8	0	25	37	-1	45	51													Vb 3	CASSPTVGGQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACTCGACAGGGAGGGCAATGAGCAGTTCTTCGGGCCA	CASSLLDREGNEQFF	In	VDJ	1	70	1.0376888593724057E-4	1.258363623943424E-4	45	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-01	01	2	2	3	6	3	4	25	40	50	43	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLLDREGNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01		TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGGCGGGCAGGGCTGGGAGACCCAGTACTTCGGGCCA	CASSLGGQGWETQYF	In	VDJ	1	70	1.0376888593724057E-4	1.258363623943424E-4	45	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-05	01	2	4	3	5	6	4	25	40	51	46	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLGGQGWETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01		TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCTCCTGGACTAGCGGGGTGGGAGACCCAGTACTTCGGGCCA	CASSPPGLAGWETQYF	In	VDJ	1	71	1.0525129859348688E-4	1.2763402471426157E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	1	3	5	6	3	25	37	55	43	58													Vb 3	CASSPPGLAGWETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCACAGGGGGGGAACACTGAAGCTTTCTTTGGACAA	CASSSQGGNTEAFF	In	VDJ	1	71	1.0525129859348688E-4	1.2763402471426157E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	1	1	1	1	25	38	47	39	48													Vb 3	CASSSQGGNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCCGGAGGGGAATGCAGTATTTTGGCCCA	CASSFRRGMQYF	In	VDJ	1	71	1.0525129859348688E-4	1.2763402471426157E-4	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	10	0	11	2	4	25	39	47	41	51													Vb 3	CASSFRRGMQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCACCGAGGTATGGGGGGTGACTAATTCACCCCTCCACTTTGGGAAC	CASSSTEVWGVTNSPLHF	In	VDJ	1	72	1.0673371124973316E-4	1.2943168703418074E-4	54	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	4	9	1	6	12	4	25	38	56	50	60													Vb 3	CASSSTEVWGVTNSPLHF+TCRBV28-01+TCRBJ01-06	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTATTCGGACAGGGGCAAGTGGCTACACCTTCGGTTCG	CASSIRTGASGYTF	In	VDJ	1	73	1.0821612390597947E-4	1.3122934935409992E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	2	7	4	4	25	37	50	41	54													Vb 3	CASSIRTGASGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCAGGGCTGAACACTGAAGCTTTCTTTGGACAA	CASSPGLNTEAFF	In	VDJ	1	73	1.0821612390597947E-4	1.3122934935409992E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	3	0	1	1	25	37	43	38	44													Vb 3	CASSPGLNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGGGGGGGAAACAGCCCCAGCATTTTGGTGAT	CASSLGGKQPQHF	In	VDJ	1	73	1.0821612390597947E-4	1.3122934935409992E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	3	9	0	7	0	3	25	-1	46	39	49													Vb 3	CASSLGGKQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATTAGGGGGGGTCAGACATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLLGGVRHSNQPQHF	In	VDJ	1	74	1.0969853656222575E-4	1.3302701167401912E-4	54	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	1	9	0	0	2	7	25	41	50	43	57													Vb 3	CASSLLGGVRHSNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCTTGGGGAGACCGCGGCGATACGCAGTATTTTGGCCCA	CASSPWGDRGDTQYF	In	VDJ	1	75	1.1118094921847204E-4	1.348246739939383E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	9	2	6	6	8	25	36	47	42	55													Vb 3	CASSPWGDRGDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCGTTAGGGGCACCTACGAGCAGTACTTCGGGCCG	CASSVRGTYEQYF	In	VDJ	1	75	1.1118094921847204E-4	1.348246739939383E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	5	2	2	4	2	25	36	45	40	47													Vb 3	CASSVRGTYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCCTGGCCGACTTCTCTGGAAACACCATATATTTTGGAGAG	CASLADFSGNTIYF	In	VDJ	1	76	1.1266336187471834E-4	1.3662233631385747E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	8	2	10	0	6	1	25	34	44	40	45						01,02							Vb 3	CASLADFSGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD02-01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGAAGCAGGGGTCAGCCCCAGCATTTTGGTGAT	CASRSRGQPQHF	In	VDJ	1	77	1.1414577453096463E-4	1.3841999863377664E-4	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	4	2	6	3	0	25	36	-1	39	45													Vb 3	CASRSRGQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTACGCTCAGGGATTGGACTAATGAAAAACTGTTTTTTGGCAGT	CASSTLRDWTNEKLFF	In	VDJ	1	77	1.1414577453096463E-4	1.3841999863377664E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	4	3	2	5	5	25	37	47	42	52													Vb 3	CASSTLRDWTNEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCGACAGGGCGACCCTACAATGAGCAGTTCTTCGGGCCA	CASSPTGRPYNEQFF	In	VDJ	1	77	1.1414577453096463E-4	1.3841999863377664E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	2	3	2	2	4	25	37	46	39	50													Vb 3	CASSPTGRPYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCGGGGGAATAGCCTGAATCAGCCCCAGCATTTTGGTGAT	CASSRGNSLNQPQHF	In	VDJ	1	77	1.1414577453096463E-4	1.3841999863377664E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	5	8	2	4	0	9	25	-1	43	37	52													Vb 3	CASSRGNSLNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGCCGATAGGGTCGGAAATCAGCCCCAGCATTTTGGTGAT	CASSADRVGNQPQHF	In	VDJ	1	78	1.1562818718721093E-4	1.4021766095369582E-4	45	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-05	01	5	5	3	4	6	5	25	37	47	43	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSADRVGNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACAGGGCTACTCTGGAAACACCATATATTTTGGAGAG	CASSLQGYSGNTIYF	In	VDJ	1	78	1.1562818718721093E-4	1.4021766095369582E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	4	3	0	0	3	25	-1	45	40	48													Vb 3	CASSLQGYSGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCGAGGCCCCCGGGGCCAACGTCCTGACTTTCGGGGCC	CASTEAPGANVLTF	In	VDJ	1	80	1.1859301249970352E-4	1.4381298559353417E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	7	11	1	4	2	5	25	35	41	37	46													Vb 3	CASTEAPGANVLTF+TCRBV28-01+TCRBJ02-06	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTATCAACGGGGGGGTCTACAATGAGCAGTTCTTCGGGCCA	CASSINGGVYNEQFF	In	VDJ	1	81	1.2007542515594981E-4	1.4561064791345334E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	8	0	3	5	1	25	37	50	42	51													Vb 3	CASSINGGVYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTACGGGACAGGGGGACCAAGAGACCCAGTACTTCGGGCCA	CASSTGQGDQETQYF	In	VDJ	1	82	1.215578378121961E-4	1.4740831023337252E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	1	0	2	0	25	37	-1	39	50													Vb 3	CASSTGQGDQETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGTAGTTTAGGGACAGGGGAAGGCTCACCCCTCCACTTTGGGAAC	CASSLGTGEGSPLHF	In	VDJ	1	83	1.230402504684424E-4	1.492059725532917E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	2	0	2	10	0	5	25	-1	50	40	55													Vb 3	CASSLGTGEGSPLHF+TCRBV28-01+TCRBJ01-06	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCGGCCGGGACAGAGTCAATCAGCCCCAGCATTTTGGTGAT	CAGRDRVNQPQHF	In	VDJ	1	84	1.245226631246887E-4	1.5100363487321086E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	11	0	5	3	4	3	25	31	42	35	45													Vb 3	CAGRDRVNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCAAAGTTTATGCAGGAGGTCAGCCCCAGTATTTTGGTGAT	CASSKVYAGGQPQYF	In	VDJ	1	85	1.26005075780935E-4	1.5280129719313007E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	6	10	1	17	13	11	25	36	54	49	65													Vb 3	CASSKVYAGGQPQYF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAACGACAGGGACAATTCACCCCTCCACTTTGGGAAC	CASNDRDNSPLHF	In	VDJ	1	89	1.3193472640592017E-4	1.5999194647280677E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	7	2	3	7	2	2	25	35	44	37	46													Vb 3	CASNDRDNSPLHF+TCRBV28-01+TCRBJ01-06	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCAGACAGGGATATAGTTCTTCGGGCCA		Out	VDJ	1	89	1.3193472640592017E-4		34	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	2	3	14	2	4	25	38	47	40	51													Vb 3	X+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAATGACAGGCAACACTGAAGCTTTCTTTGGACAA	CASSLMTGNTEAFF	In	VDJ	1	89	1.3193472640592017E-4	1.5999194647280677E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	2	4	2	2	1	25	40	48	42	49													Vb 3	CASSLMTGNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCCGGACCCGAAAAGCTAACTATGGCTACACCTTCGGTTCG	CASRTRKANYGYTF	In	VDJ	1	89	1.3193472640592017E-4	1.5999194647280677E-4	42	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-02	01	8	1	7	0	1	8	25	34	39	35	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASRTRKANYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGACCTATGGTCCTACAGGGAACTACTGAAGCTTTCTTTGGACAA	CASRPMVLQGTTEAFF	In	VDJ	1	90	1.3341713906216645E-4	1.6178960879272594E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	3	5	12	4	25	36	54	48	58													Vb 3	CASRPMVLQGTTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCCGGACTAGCGGGGGGGCGGAGGAGACCCAGTACTTCGGGCCA	CASSSRTSGGAEETQYF	In	VDJ	1	90	1.3341713906216645E-4	1.6178960879272594E-4	51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	1	0	5	3	5	25	38	56	41	61													Vb 3	CASSSRTSGGAEETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAAGCGGGGRGACCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	90	1.3341713906216645E-4		44	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	6	3	0	0	2	25	-1	47	40	49													Vb 3	X+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGTGACCGGGACAGGTATCAATACAATGAGCAGTTCTTCGGGCCA	CASDRDRYQYNEQFF	In	VDJ	1	90	1.3341713906216645E-4	1.6178960879272594E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	9	0	4	4	5	6	25	33	46	38	52													Vb 3	CASDRDRYQYNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCAAGGGCGGGGGCTATGGCTACACCTTCGGTTCG	CASSKGGGYGYTF	In	VDJ	1	91	1.3489955171841275E-4	1.6358727111264511E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	6	7	2	4	5	0	25	36	-1	41	48													Vb 3	CASSKGGGYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCACGGACAGGGAAGGTGATCACCCCTCCACTTTGGGAAC	CASSHGQGR*SPLHF	Stop	VDJ	1	94	1.3934678968715162E-4		45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	1	3	10	3	7	25	37	48	40	55													Vb 3	CASSHGQGR*SPLHF+TCRBV28-01+TCRBJ01-06	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATATTTGACAGGGTATGGCTACACCTTCGGTTCG	CASSLYLTGYGYTF	In	VDJ	1	94	1.3934678968715162E-4	1.6898025807240264E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	2	3	5	4	0	25	41	-1	45	52													Vb 3	CASSLYLTGYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCTGGGACTTTCGGGGAGCTGTTTTTTGGAGAA	CASSSGTFGELFF	In	VDJ	1	95	1.4082920234339793E-4	1.7077792039232181E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	0	10	7	2	2	25	38	46	40	48						01,02							Vb 3	CASSSGTFGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCTAGCACCCTTTGGGGGGGACCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASTLWGGPNTGELFF	In	VDJ	1	97	1.437940276558905E-4	1.743732450321602E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	7	9	0	0	6	2	25	35	48	41	50													Vb 3	CASTLWGGPNTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGACCGAGAAGACAGGGAGGGGGGAAAAACTGTTTTTTGGCAGT	CASRTEKTGRGEKLFF	In	VDJ	1	98	1.452764403121368E-4	1.7617090735207936E-4	48	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-04	01	6	2	3	8	9	6	25	36	52	45	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASRTEKTGRGEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01		TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCTCCCCCGGGCAGGGGGCTATCAGCCCCAGCATTTTGGTGAT	CASSLPRAGGYQPQHF	In	VDJ	1	99	1.467588529683831E-4	1.7796856967199854E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	4	0	5	10	1	25	37	55	47	56													Vb 3	CASSLPRAGGYQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGTTGCAGGGAAACAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	99	1.467588529683831E-4		41	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	3	7	4	3	25	39	48	43	51													Vb 3	X+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGGTGGGTGGTAGTTAGCCCCAGCATTTTGGTGAT	CASSLVGGS*PQHF	Stop	VDJ	1	101	1.4972367828087568E-4		42	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-05	01	3	0	9	8	3	8	25	39	45	42	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLVGGS*PQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCCTACAGCTCTGGAAACACCATATATTTTGGAGAG	CASSPYSSGNTIYF	In	VDJ	1	103	1.5268850359336829E-4	1.8515921895167524E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	3	5	0	5	0	25	36	-1	41	45													Vb 3	CASSPYSSGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAATCCCCAGCATGAACACTGAAGCTTTCTTTGGACAA	CASSLIPSMNTEAFF	In	VDJ	1	103	1.5268850359336829E-4	1.8515921895167524E-4	45	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	2	4	5	0	5	2	25	40	48	45	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLIPSMNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCGTGGGACAGGGCCTACGAGCAGTACTTCGGGCCG	CASSPWDRAYEQYF	In	VDJ	1	107	1.5861815421835347E-4	1.9234986823135194E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	3	2	4	0	25	37	-1	41	50													Vb 3	CASSPWDRAYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCGGACAGGGGACCCACAATGAGCAGTTCTTCGGGCCA	CASSSGQGTHNEQFF	In	VDJ	1	107	1.5861815421835347E-4	1.9234986823135194E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	1	2	5	2	4	25	38	49	40	53													Vb 3	CASSSGQGTHNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCCCGGGACAGGTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	108	1.6010056687459974E-4		43	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	4	1	3	0	25	39	-1	42	50													Vb 3	X+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGGCGGGGAGGGGGCCCTACGAGCAGTACTTCGGGCCG	CASSLAGRGPYEQYF	In	VDJ	1	108	1.6010056687459974E-4	1.9414753055127114E-4	45	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	3	5	0	2	7	0	25	39	-1	46	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLAGRGPYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCATAGACAGGGATTACACTGAAGCTTTCTTTGGACAA	CASTIDRDYTEAFF	In	VDJ	1	109	1.6158297953084604E-4	1.9594519287119031E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	2	3	3	5	3	25	35	47	40	50													Vb 3	CASTIDRDYTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACAGGGGCCGAATGAGCAGTTCTTCGGGCCA	CASSLQGPNEQFF	In	VDJ	1	110	1.6306539218709234E-4	1.977428551911095E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	4	2	7	0	3	25	-1	46	40	49													Vb 3	CASSLQGPNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGGCGGGGGATCGGGGCTACACCTTCGGTTCG	CASSLAGDRGYTF	In	VDJ	1	110	1.6306539218709234E-4	1.977428551911095E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	3	7	2	8	1	5	25	39	47	40	52													Vb 3	CASSLAGDRGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCAAGCACAGATACGCAGTATTTTGGCCCA	CASSPSTDTQYF	In	VDJ	1	111	1.6454780484333862E-4	1.9954051751102866E-4	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	4	6	0	1	0	25	37	-1	38	40													Vb 3	CASSPSTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGAGTGACGGCCGAACAGATACGCAGTATTTTGGCCCA	CASSLSDGRTDTQYF	In	VDJ	1	111	1.6454780484333862E-4	1.9954051751102866E-4	45	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-03	01	3	2	7	3	4	6	25	39	46	43	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLSDGRTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01		TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCGGGCCCGTTCTAGAATCCACTTTGGGAAC	CASSRARSRIHF	In	VDJ	1	112	1.6603021749958492E-4	2.0133817983094784E-4	36	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-06	01	5	8	0	17	1	11	25	37	42	38	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSRARSRIHF+TCRBV28-01+TCRBJ01-06	TCRBV28-01*01		TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCGAACCGGGTTGGGGGGGTAAGACTGAAGCTTTCTTTGGACAA	CASSEPGWGGKTEAFF	In	VDJ	1	113	1.6751263015583122E-4	2.03135842150867E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	6	9	0	5	11	4	25	36	54	47	58													Vb 3	CASSEPGWGGKTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGACAGGGTATAGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CASSLTGYSSYNSPLHF	In	VDJ	1	114	1.6899504281207752E-4	2.049335044707862E-4	51	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	2	3	0	0	5	25	-1	46	39	51													Vb 3	CASSLTGYSSYNSPLHF+TCRBV28-01+TCRBJ01-06	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAAGCGACAGAACACTGAAGCTTTCTTTGGACAA	CASKRQNTEAFF	In	VDJ	1	117	1.734422807808164E-4	2.103264914305437E-4	36	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	7	2	6	1	3	0	25	35	-1	38	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASKRQNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCATACATTGACAGGGGTCGGAGAAAAACTGTTTTTTGGCAGT	CASSHTLTGVGEKLFF	In	VDJ	1	117	1.734422807808164E-4	2.103264914305437E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	2	2	8	8	5	25	37	53	45	58													Vb 3	CASSHTLTGVGEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCACCCTGGCCCCCCGAGCAGTACTTCGGGCCG	CASSPPWPPEQYF	In	VDJ	1	117	1.734422807808164E-4	2.103264914305437E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	9	0	6	7	4	25	37	47	44	51													Vb 3	CASSPPWPPEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCACCGGGACTTTTAGGTTCACCCCTCCACTTTGGGAAC	CASSSPGLLGSPLHF	In	VDJ	1	118	1.7492469343706268E-4	2.1212415375046289E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	4	0	10	9	4	6	25	38	48	42	54						01,02							Vb 3	CASSSPGLLGSPLHF+TCRBV28-01+TCRBJ01-06	TCRBV28-01*01	TCRBD02-01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATCGGGGTCAGGAGGAGAAAAACTGTTTTTTGGCAGT	CASSLSGSGGEKLFF	In	VDJ	1	122	1.8085434406204785E-4	2.193148030301396E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	1	8	3	8	0	9	25	-1	46	41	55						01,02							Vb 3	CASSLSGSGGEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD02-01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCATCGGAGACAGGGGGCGGAAGTATGGCTACACCTTCGGTTCG	CAIGDRGRKYGYTF	In	VDJ	1	123	1.8233675671829416E-4	2.211124653500588E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	10	2	0	5	5	5	25	32	47	37	52													Vb 3	CAIGDRGRKYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACCCGGGACAACGACTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	124	1.8381916937454046E-4		50	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	0	6	0	3	4	25	40	49	43	53													Vb 3	X+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAAAGGCCTCGAGGAACACTGAAGCTTTCTTTGGACAA	CASSLKASRNTEAFF	In	VDJ	1	126	1.8678399468703303E-4	2.265054523098163E-4	45	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	2	5	4	1	1	7	25	40	44	41	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLKASRNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGACCGGGACAGGGAAGGTATGGCTACACCTTCGGTTCG	CASRPGQGRYGYTF	In	VDJ	1	127	1.8826640734327934E-4	2.2830311462973549E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	3	5	3	4	25	36	48	39	52													Vb 3	CASRPGQGRYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCTGAGCAGGGGGGTATGGGTGCTGAAGCTTTCTTTGGACAA	CAEQGGMGAEAFF	In	VDJ	1	127	1.8826640734327934E-4	2.2830311462973549E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	12	4	1	6	4	9	25	30	41	34	50													Vb 3	CAEQGGMGAEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCGCCCCTGACAGGTCGAACACTGAAGCTTTCTTTGGACAA	CASTAPDRSNTEAFF	In	VDJ	1	129	1.912312326557719E-4	2.3189843926957383E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	2	4	1	8	2	25	35	49	43	51													Vb 3	CASTAPDRSNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTACCGGGACAGGGGTCTACGAGCAGTACTTCGGGCCG	CASSTGTGVYEQYF	In	VDJ	1	129	1.912312326557719E-4	2.3189843926957383E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	2	3	3	1	25	37	50	40	51													Vb 3	CASSTGTGVYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCTTGCGACACACAAACACTGAAGCTTTCTTTGGACAA	CASTLRHTNTEAFF	In	VDJ	1	130	1.9271364531201821E-4	2.3369610158949304E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	2	6	2	6	4	25	35	45	41	49													Vb 3	CASTLRHTNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGCGACAGGGGGCGCCGACACCGGGGAGCTGTTTTTTGGAGAA	CASSATGGADTGELFF	In	VDJ	1	134	1.986432959370034E-4	2.4088675086916974E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	2	0	3	2	4	25	37	49	39	53													Vb 3	CASSATGGADTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCGCTGGTCTAGCCAAAAACATTCAGTACTTCGGCGCC	CASAGLAKNIQYF	In	VDJ	1	134	1.986432959370034E-4	2.4088675086916974E-4	39	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-04	01	8	0	10	0	3	3	25	34	39	37	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASAGLAKNIQYF+TCRBV28-01+TCRBJ02-04	TCRBV28-01*01		TCRBJ02-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTACAAGGGTTACTGAAGCTTTCTTTGGACAA	CASSTRVTEAFF	In	VDJ	1	138	2.0457294656198857E-4	2.4807740014884643E-4	36	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	5	5	3	5	3	2	25	37	44	40	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSTRVTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGGGGCAGGGCAATTCACCCCTCCACTTTGGGAAC	CASSLGQGNSPLHF	In	VDJ	1	138	2.0457294656198857E-4	2.4807740014884643E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	4	3	7	4	1	25	39	48	43	49													Vb 3	CASSLGQGNSPLHF+TCRBV28-01+TCRBJ01-06	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCTGTAGGGGAACTAACTAATGAAAAACTGTTTTTTGGCAGT	CASSSVGELTNEKLFF	In	VDJ	1	143	2.1198500984322003E-4	2.570657117484423E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	5	2	1	4	4	25	38	47	42	51													Vb 3	CASSSVGELTNEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCTTAGGGGAGGTGAGGAAGGAGCCCCAGCATTTTGGTGAT	CASSLGEVRKEPQHF	In	VDJ	1	144	2.1346742249946633E-4	2.588633740683615E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	2	9	1	8	1	9	25	40	47	41	56													Vb 3	CASSLGEVRKEPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATTAAGACAGTCGAGCACTGAAGCTTTCTTTGGACAA	CASSLLRQSSTEAFF	In	VDJ	1	144	2.1346742249946633E-4	2.588633740683615E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	2	5	4	3	5	25	41	49	44	54													Vb 3	CASSLLRQSSTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCGGGGCTTTAATTCACCCCTCCACTTTGGGAAC	CASSRGFNSPLHF	In	VDJ	1	145	2.1494983515571263E-4	2.6066103638828066E-4	39	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-06	01	6	7	0	6	2	2	25	36	43	38	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSRGFNSPLHF+TCRBV28-01+TCRBJ01-06	TCRBV28-01*01		TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCGCCTTACTAGCGGGGTCGGATGAGCAGTTCTTCGGGCCA	CASALLAGSDEQFF	In	VDJ	1	147	2.179146604682052E-4	2.6425636102811906E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	8	3	3	8	5	4	25	34	49	39	53													Vb 3	CASALLAGSDEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCAACCCCAATACATCAGACACCCCTCCACTTTGGGAAC	CASSPTPIHQTPLHF	In	VDJ	1	150	2.2236189843694408E-4	2.696493479878766E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	3	6	11	11	5	25	37	51	48	56													Vb 3	CASSPTPIHQTPLHF+TCRBV28-01+TCRBJ01-06	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCAGGACTAGCGGGGAACACGGAGACCCAGTACTTCGGGCCA	CASSSGLAGNTETQYF	In	VDJ	1	155	2.2977396171817557E-4	2.7863765958747246E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	1	3	5	2	6	25	38	52	40	58													Vb 3	CASSSGLAGNTETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTATGGGGGAACATCAGCCCCAGCATTTTGGTGAT	CASSFMGEHQPQHF	In	VDJ	1	156	2.3125637437442187E-4	2.8043532190739163E-4	42	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-05	01	3	6	1	5	3	3	25	39	47	42	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSFMGEHQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGTAGGATAGGGCTAGCGGGGGTTTCGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	161	2.3866843765565332E-4		59	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	4	2	1	11	4	22	36	57	47	61													Vb 3	X+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCTAGCAGTTTAGGCAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLGSNQPQHF	In	VDJ	1	168	2.490453262493774E-4	3.0200726974642173E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	9	0	1	0	0	25	-1	-1	40	43													Vb 3	CASSLGSNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCTCACAGGGCCTTAAGGTAATGAAAAACTGTTTTTTGGCAGT	CASSLTGP*GNEKLFF	Stop	VDJ	1	170	2.5201015156187E-4		48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	3	3	4	3	8	25	37	46	40	54													Vb 3	CASSLTGP*GNEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCCGGGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSPGGTGELFF	In	VDJ	1	172	2.549749768743626E-4	3.091979190260985E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	6	8	2	4	3	0	25	36	-1	39	45													Vb 3	CASSPGGTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCCAACTAGCGACTTCCTACGAGCAGTACTTCGGGCCG	CASTQLATSYEQYF	In	VDJ	1	176	2.6090462749934774E-4	3.163885683057752E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	3	6	1	4	3	25	35	46	39	49						01,02							Vb 3	CASTQLATSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAAGTCGGTCCGAGCGGGAGACCCAGTACTTCGGGCCA	CASSLSRSERETQYF	In	VDJ	1	180	2.668342781243329E-4	3.235792175854519E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	6	5	5	10	0	25	40	-1	50	55						01,02							Vb 3	CASSLSRSERETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAATCCCCCCGGACAGGGCCTCATTCCTCAATCAGCCCCAGCATTTTGGTGAT	CASSLIPPDRASFLNQPQHF	In	VDJ	1	182	2.697991034368255E-4	3.2717454222529023E-4	60	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	1	3	3	8	10	21	36	52	44	62													Vb 3	CASSLIPPDRASFLNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGAAGAAGGGGGCGCACAGATACGCAGTATTTTGGCCCA	CASRRRGRTDTQYF	In	VDJ	1	185	2.7424634140556437E-4	3.3256752918504775E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	5	0	1	4	0	25	36	-1	40	47													Vb 3	CASRRRGRTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCCCTGTTGGGTACGCAGTATTTTGGCCCA	CASSPLLGTQYF	In	VDJ	1	193	2.8610564265553473E-4	3.469488277444012E-4	36	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-03	01	6	0	9	8	9	0	25	36	-1	45	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSPLLGTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01		TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCGGGGAAACTAATGAAAAACTGTTTTTTGGCAGT	CASSFGETNEKLFF	In	VDJ	1	193	2.8610564265553473E-4	3.469488277444012E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	3	8	3	1	0	1	25	-1	44	39	45													Vb 3	CASSFGETNEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTACCGGGACAGGGGGCTCCGAAAAACTGTTTTTTGGCAGT	CASSTGTGGSEKLFF	In	VDJ	1	194	2.87588055311781E-4	3.487464900643204E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	0	0	8	3	3	25	37	52	40	55													Vb 3	CASSTGTGGSEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATATGGGGGCAGGGGGCAGCCCCAGCATTTTGGTGAT	CASSLYGGRGQPQHF	In	VDJ	1	194	2.87588055311781E-4	3.487464900643204E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	4	1	7	7	0	25	41	-1	48	55													Vb 3	CASSLYGGRGQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGGATAACTATGGCTACACCTTCGGTTCG	CASSLDNYGYTF	In	VDJ	1	195	2.8907046796802733E-4	3.5054415238423956E-4	36	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-02	01	3	1	8	1	0	0	25	-1	-1	39	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLDNYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAAAGAACACTGAAGCTTTCTTTGGACAA	CASSLKNTEAFF	In	VJ	1	213	3.157538957804606E-4	3.829020741427847E-4	36	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	2	0	0	1	0	2	25	-1	40	-1	42													Vb 3	CASSLKNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCCCCGCCGGGACAGGGCTTACTGAAGCTTTCTTTGGACAA	CASSSPAGTGLTEAFF	In	VDJ	1	222	3.2909560968667724E-4	3.990810350220573E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	3	5	8	3	25	38	55	46	58													Vb 3	CASSSPAGTGLTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCATTGACAGGAACACTGAAGCTTTCTTTGGACAA	CASIDRNTEAFF	In	VDJ	1	228	3.3799008562415505E-4	4.098670089415724E-4	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	2	5	1	2	0	25	35	-1	37	42													Vb 3	CASIDRNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCCCCCAAGTGCCTGAAGCTTTCTTTGGACAA	CASSPPQVPEAFF	In	VDJ	1	236	3.4984938687412535E-4	4.2424830750092577E-4	39	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	5	4	6	6	6	5	25	37	45	43	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSPPQVPEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCTAGCAGCCAAGCGGGAGCGGGGGGAGGCACTGAAGCTTTCTTTGGACAA	CASSQAGAGGGTEAFF	In	VDJ	1	240	3.5577903749911056E-4	4.314389567806025E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	6	6	1	4	9	3	25	36	54	45	57													Vb 3	CASSQAGAGGGTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCTTCAGGGGCCCTCGGGGAAAAACTGTTTTTTGGCAGT	CASSPSGALGEKLFF	In	VDJ	1	257	3.8098005265529755E-4	4.619992162192285E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	4	2	8	4	8	25	37	47	41	55													Vb 3	CASSPSGALGEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCTTGATTCAGCTGAACACTGAAGCTTTCTTTGGACAA	CASTLIQLNTEAFF	In	VDJ	1	259	3.8394487796779015E-4	4.6559454085906684E-4	42	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	7	4	5	0	8	1	25	35	46	43	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASTLIQLNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCCCTTCTAGGGGCTATAACTATGGCTACACCTTCGGTTCG	CASSSPSRGYNYGYTF	In	VDJ	2	276	4.0914589312397715E-4	4.961548002976929E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	5	2	1	8	3	25	38	51	46	54													Vb 3	CASSSPSRGYNYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGTCGGACACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASRSDTNTGELFF	In	VDJ	2	293	4.3434690828016414E-4	5.267150597363188E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	1	6	0	3	0	25	36	-1	39	44													Vb 3	CASRSDTNTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCACCCTCCGAGGGGCAGACACTGAAGCTTTCTTTGGACAA	CATLRGADTEAFF	In	VDJ	2	324	4.8030170062379925E-4	5.824425916538134E-4	39	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	10	5	2	3	7	3	25	32	44	39	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CATLRGADTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAAGGGGATGGGGACTGAAGCTTTCTTTGGACAA	CASKGMGTEAFF	In	VDJ	2	341	5.055027157799863E-4	6.130028510924394E-4	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	5	2	5	0	6	25	-1	40	35	46													Vb 3	CASKGMGTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCTCCAGGACTAGCGGGGGGGCAGAAGAGACCCAGTACTTCGGGCCA	CASSSRTSGGAEETQYF	In	VDJ	2	406	6.018595384359954E-4	7.298509018871859E-4	51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	1	0	3	5	3	25	36	56	41	59													Vb 3	CASSSRTSGGAEETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTAGTCCGGGACAGGGAAATGAAAAACTGTTTTTTGGCAGT	CASSSPGQGNEKLFF	In	VDJ	2	417	6.181660776547046E-4	7.496251874062968E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	0	3	5	5	1	25	37	51	42	52													Vb 3	CASSSPGQGNEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTCGGGGGGGTGGCAATCAGCCCCAGCATTTTGGTGAT	CASSFRGGGNQPQHF	In	VDJ	3	490	7.263822015606841E-4	8.808545367603968E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	3	8	0	2	1	2	25	39	48	40	50													Vb 3	CASSFRGGGNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCGGGAGACTACGAGCAGTACTTCGGGCCG	CASSSGDYEQYF	In	VDJ	3	506	7.501008040606248E-4	9.096171338791036E-4	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	8	2	3	0	1	25	-1	44	38	45													Vb 3	CASSSGDYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATCCGGGACCTCTGGAAACACCATATATTTTGGAGAG	CASSLSGTSGNTIYF	In	VDJ	3	547	8.108797229667228E-4	9.833212889957899E-4	45	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-03	01	1	0	7	0	2	0	25	41	-1	43	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLSGTSGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01		TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGCAGACGCAGATACGCAGTATTTTGGCCCA	CASSLADADTQYF	In	VDJ	3	590	8.746234671853135E-4	0.0010606207687523146	39	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-03	01	2	2	7	4	3	1	25	40	46	43	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLADADTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01		TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCGTACGGGGAACCTACGAGCAGTACTTCGGGCCG	CASSVRGTYEQYF	In	VDJ	4	629	9.324375607789189E-4	0.0011307295992291624	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	8	3	2	4	2	25	36	45	40	47													Vb 3	CASSVRGTYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCCCGGGCCGTGGGGGTTCTAACACTGAAGCTTTCTTTGGACAA	CASSSPGRGGSNTEAFF	In	VDJ	5	828	0.0012274376793719314	0.0014884644008930786	51	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	4	6	1	2	11	4	25	38	54	49	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSSPGRGGSNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCGGCAACTAGCGGGAATAAATACGCAGTATTTTGGCCCA	CASSRQLAGINTQYF	In	VDJ	1	48	7.115580749982211E-5	8.62877913561205E-5	45	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	3	3	7	4	4	23	36	50	40	54														CASSRQLAGINTQYF+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01	TCRBD02-01*02	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCGGGGACTAGCGTGGGGGAGAGGCACAGATACGCAGTATTTTGGCCCA	CASSRGLAWGRGTDTQYF	In	VDJ	1	51	7.560304546856099E-5	9.168077831587803E-5	54	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	0	6	1	1	10	23	36	47	37	57						01,02								CASSRGLAWGRGTDTQYF+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01	TCRBD02-01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGTCACCTAGCGGGGGGGTATGATACGCAGTATTTTGGCCCA	CASSHLAGGYDTQYF	In	VDJ	1	52	7.708545812480728E-5	9.34784406357972E-5	45	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	4	0	6	4	3	23	34	50	38	53														CASSHLAGGYDTQYF+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGTCGGGGACAGCACCTACGAGCAGTACTTCGGGCCG	CASSQVGDSTYEQYF	In	VDJ	1	53	7.856787078105358E-5	9.527610295571638E-5	45	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	0	5	2	3	2	23	39	49	42	51														CASSQVGDSTYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAACCAAGTCCGGGGGAATACTGAAGCTTTCTTTGGACAA	CASNQVRGNTEAFF	In	VDJ	1	60	8.894475937477764E-5	1.0785973919515063E-4	42	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	1	8	2	5	2	3	23	39	47	41	50														CASNQVRGNTEAFF+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01	TCRBD02-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGTCGTCGCGGGCGCAGACTATGGCTACACCTTCGGTTCG	CASSQVVAGADYGYTF	In	VDJ	1	63	9.339199734351652E-5	1.1325272615490816E-4	48	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	1	7	4	3	5	5	23	39	49	44	54						01,02								CASSQVVAGADYGYTF+TCRBV01-01+TCRBJ01-02	TCRBV01-01*01	TCRBD02-01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCCGTCAGGGGGATCCCGCCAGAATCAGCCCCAGCATTTTGGTGAT	CASSPSGGSRQNQPQHF	In	VDJ	1	66	9.783923531225541E-5	1.1864571311466569E-4	51	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	4	1	4	3	10	23	36	46	39	56														CASSPSGGSRQNQPQHF+TCRBV01-01+TCRBJ01-05	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATAGTACGCGGATGAACACTGAAGCTTTCTTTGGACAA	CASSQDSTRMNTEAFF	In	VDJ	1	69	1.0228647328099429E-4	1.2403870007442322E-4	48	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	7	5	0	6	1	23	40	50	46	51						01,02								CASSQDSTRMNTEAFF+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01	TCRBD02-01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGGAGCACAGGGGGCCTACGAGCAGTACTTCGGGCCG	CASSQGAQGAYEQYF	In	VDJ	1	70	1.0376888593724057E-4	1.258363623943424E-4	45	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	3	1	2	4	0	23	39	-1	43	51														CASSQGAQGAYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGTTCTAGCGGGGACAGGGGAGCTGTTTTTTGGAGAA	CASSQVLAGTGELFF	In	VDJ	1	72	1.0673371124973316E-4	1.2943168703418074E-4	45	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	1	4	3	8	2	3	23	39	50	41	53														CASSQVLAGTGELFF+TCRBV01-01+TCRBJ02-02	TCRBV01-01*01	TCRBD02-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCCCACGAAGAAACCCAGCAATCAGCCCCAGCATTTTGGTGAT	CASSPTKKPSNQPQHF	In	VDJ	1	75	1.1118094921847204E-4	1.348246739939383E-4	48	TCRBV01	TCRBV01-01	01				TCRBJ01	TCRBJ01-05	01	4	2	8	1	4	8	23	36	42	40	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPTKKPSNQPQHF+TCRBV01-01+TCRBJ01-05	TCRBV01-01*01		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAACCAAAAAGGGCGAAGCTCCTCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	80	1.1859301249970352E-4		53	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-01	01	2	5	3	0	2	10	23	38	44	40	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01		TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCACGGATGGGGCCAAGGGTACGAGCAGTACTTCGGGCCG	CASSHGWGQGYEQYF	In	VDJ	1	82	1.215578378121961E-4	1.4740831023337252E-4	45	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	7	0	4	5	6	23	37	47	42	53														CASSHGWGQGYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCCCCGAGAGGGGGGCAATCAGCCCCAGCATTTTGGTGAT	CASSPREGGNQPQHF	In	VDJ	1	82	1.215578378121961E-4	1.4740831023337252E-4	45	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	5	1	2	6	0	23	36	-1	42	48														CASSPREGGNQPQHF+TCRBV01-01+TCRBJ01-05	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGTAGGGTACGATGAGCAGTTCTTCGGGCCA	CASSQVGYDEQFF	In	VDJ	1	90	1.3341713906216645E-4	1.6178960879272594E-4	39	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-01	01	1	5	3	8	1	4	23	39	44	40	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQVGYDEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01		TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCGCTTGCACTGAACCGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	94	1.3934678968715162E-4		50	TCRBV01	TCRBV01-01	01				TCRBJ01	TCRBJ01-02	01	4	2	7	4	18	0	23	36	-1	54	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV01-01+TCRBJ01-02	TCRBV01-01*01		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAACGTTGGGGCCTTTACACAGATACGCAGTATTTTGGCCCA	CASSQRWGLYTDTQYF	In	VDJ	1	95	1.4082920234339793E-4	1.7077792039232181E-4	48	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	7	0	2	4	5	23	38	47	42	52														CASSQRWGLYTDTQYF+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCCAAGATCGAATCCTTCGCAGGGAGCTTTCTTTGGACAA	CASSPRSNPSQGAFF	In	VDJ	1	96	1.4231161499964423E-4	1.72575582712241E-4	45	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	3	10	17	0	23	36	-1	53	58														CASSPRSNPSQGAFF+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCAAGATCGGGCCTCCCATCTTGACACCGGGGAGCTGTTTTTTGGAGAA	CTSSQDRASHLDTGELFF	In	VDJ	1	115	1.704774554683238E-4	2.0673116679070536E-4	54	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-02	01	0	8	0	3	2	11	23	40	46	42	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CTSSQDRASHLDTGELFF+TCRBV01-01+TCRBJ02-02	TCRBV01-01*01		TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATCGCGGCAGGGGAAACACCATATATTTTGGAGAG	CASSQDRGRGNTIYF	In	VDJ	1	122	1.8085434406204785E-4	2.193148030301396E-4	45	TCRBV01	TCRBV01-01	01				TCRBJ01	TCRBJ01-03	01	0	4	4	4	6	0	23	40	-1	46	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDRGRGNTIYF+TCRBV01-01+TCRBJ01-03	TCRBV01-01*01		TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCTCCTTCGCGGGGGGACAAATGAGCAGTTCTTCGGGCCA	CASSLLRGGTNEQFF	In	VDJ	1	144	2.1346742249946633E-4	2.588633740683615E-4	45	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	7	1	7	6	3	23	36	50	42	53														CASSLLRGGTNEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGGACCCGGGACAGGGAGGCCTACGAGCAGTACTTCGGGCCG	CASRTRDREAYEQYF	In	VDJ	1	148	2.193970731244515E-4	2.6605402334803824E-4	45	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	3	2	5	3	23	34	48	39	51														CASRTRDREAYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCGTGCGGGCCTTAAATGAAAAACTGTTTTTTGGCAGT	CASSVRALNEKLFF	In	VDJ	1	176	2.6090462749934774E-4	3.163885683057752E-4	42	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	5	7	4	5	2	5	23	35	42	37	47						01,02								CASSVRALNEKLFF+TCRBV01-01+TCRBJ01-04	TCRBV01-01*01	TCRBD02-01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATACCCGAGACAGGGAATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	184	2.727639287493181E-4		53	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	2	3	0	7	2	23	40	54	47	56														X+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATGAGTTCCGTAACCCCCTGTTTTTTGGCAGT	CASSQDEFRNPLFF	In	VDJ	1	209	3.0982424515547545E-4	3.75711424863108E-4	42	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	0	11	2	14	1	12	23	40	44	41	56														CASSQDEFRNPLFF+TCRBV01-01+TCRBJ01-04	TCRBV01-01*01	TCRBD02-01*02	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATGATAGGGACAGGATCATCTCTGGAAACACCATATATTTTGGAGAG	CASSQDDRDRIISGNTIYF	In	VDJ	2	273	4.0469865515523827E-4	4.907618133379353E-4	57	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	0	4	0	5	5	23	40	53	45	58														CASSQDDRDRIISGNTIYF+TCRBV01-01+TCRBJ01-03	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCCCCGTGGGGGCTCGGCCGAAAAACTGTTTTTTGGCAGT	CASSPRGGSAEKLFF	In	VDJ	2	273	4.0469865515523827E-4	4.907618133379353E-4	45	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	6	0	8	5	6	23	36	47	41	53														CASSPRGGSAEKLFF+TCRBV01-01+TCRBJ01-04	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGTTTACCGGGGGGACCGAACACTGAAGCTTTCTTTGGACAA	CASLPGGPNTEAFF	In	VDJ	1	44	6.522615687483693E-5	7.90971420764438E-5	42	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	8	8	1	1	4	3	18	27	38	31	41														CASLPGGPNTEAFF+TCRBV12-02+TCRBJ01-01	TCRBV12-02*01	TCRBD02-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCCCCCAAGCCCTAGCGGGGGGGGTTAATGAGCAGTTCTTCGGGCCA	CASRPQALAGGVNEQFF	In	VDJ	1	49	7.26382201560684E-5	8.808545367603968E-5	51	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	4	0	7	9	3	18	30	51	39	54														CASRPQALAGGVNEQFF+TCRBV12-02+TCRBJ02-01	TCRBV12-02*01	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCTTATAGAACAGACGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	49	7.26382201560684E-5		44	TCRBV12	TCRBV12-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	5	1	4	2	18	33	41	37	43														X+TCRBV12-02+TCRBJ01-01	TCRBV12-02*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCTTTCCCCTAGCGGGGGGTGCCTACGAGCAGTACTTCGGGCCG	CASRFPLAGGAYEQYF	In	VDJ	1	71	1.0525129859348688E-4	1.2763402471426157E-4	48	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	4	1	2	4	2	18	32	47	36	49														CASRFPLAGGAYEQYF+TCRBV12-02+TCRBJ02-07	TCRBV12-02*01	TCRBD02-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCCCACATAGTCGCAGGGCCAACACTGAAGCTTTCTTTGGACAA	CASRPHSRRANTEAFF	In	VDJ	1	78	1.1562818718721093E-4	1.4021766095369582E-4	48	TCRBV12	TCRBV12-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	3	2	11	2	18	30	46	41	48														CASRPHSRRANTEAFF+TCRBV12-02+TCRBJ01-01	TCRBV12-02*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGTGGTTCATCAGGGAACACAGATACGCAGTATTTTGGCCCA	CASGSSGNTDTQYF	In	VDJ	1	78	1.1562818718721093E-4	1.4021766095369582E-4	42	TCRBV12	TCRBV12-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	8	4	3	2	7	2	18	27	39	34	41														CASGSSGNTDTQYF+TCRBV12-02+TCRBJ02-03	TCRBV12-02*01	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGTAGACGGGCCAGCTAAATTATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	87	1.2896990109342757E-4		47	TCRBV12	TCRBV12-02	01				TCRBJ01	TCRBJ01-06	01	8	8	0	4	4	9	18	27	35	31	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-02+TCRBJ01-06	TCRBV12-02*01		TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGTAAGCTAGCGGGGAGGCCTAATGAGCAGTTCTTCGGGCCA	CASKLAGRPNEQFF	In	VDJ	1	197	2.9203529328051994E-4	3.541394770240779E-4	42	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	8	4	3	7	3	6	18	27	39	30	45														CASKLAGRPNEQFF+TCRBV12-02+TCRBJ02-01	TCRBV12-02*01	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCTCCTCTCTAGCGGGGGGGCGAGAGACCCAGTACTTCGGGCCA	CASRSSLAGGRETQYF	In	VDJ	2	322	4.7733687531130664E-4	5.78847267013975E-4	48	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	4	0	4	5	2	18	31	48	36	50														CASRSSLAGGRETQYF+TCRBV12-02+TCRBJ02-05	TCRBV12-02*01	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCTACCTGGGACAGCAAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	2	336	4.980906524987548E-4		44	TCRBV12	TCRBV12-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	4	0	5	4	4	2	18	31	42	35	44														X+TCRBV12-02+TCRBJ02-04	TCRBV12-02*01	TCRBD01-01*01	TCRBJ02-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTTAGGAGTGAACACTGAAGCTTTCTTTGGACAA	CASSLGVNTEAFF	In	VDJ	1	55	8.153269609354617E-5	9.887142759555474E-5	39	TCRBV07	TCRBV07-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	10	2	0	2	0	22	35	-1	37	41														CASSLGVNTEAFF+TCRBV07-01+TCRBJ01-01	TCRBV07-01*01	TCRBD02-01*02	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTCCGGACGGGAGAACACTGAAGTTTTCTTTGGACAA	CASSSGRENTEVFF	In	VDJ	1	58	8.597993406228505E-5	1.0426441455531227E-4	42	TCRBV07	TCRBV07-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	8	2	13	4	11	22	36	46	40	57														CASSSGRENTEVFF+TCRBV07-01+TCRBJ01-01	TCRBV07-01*01	TCRBD02-01*02	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTTAGTCGGAGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	78	1.1562818718721093E-4		40	TCRBV07	TCRBV07-01	01				TCRBJ01	TCRBJ01-01	01	4	1	8	1	5	0	22	35	-1	40	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-01+TCRBJ01-01	TCRBV07-01*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCGCGGCATTCGTGGGCAGACATATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	96	1.4231161499964423E-4		56	TCRBV07	TCRBV07-01	01				TCRBJ01	TCRBJ01-05	01	5	2	6	0	16	2	22	34	54	50	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-01+TCRBJ01-05	TCRBV07-01*01		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCCCACTAGCGACCGGGGAGCTGTTTTTTGGAGAA	CASSPLATGELFF	In	VDJ	1	127	1.8826640734327934E-4	2.2830311462973549E-4	39	TCRBV07	TCRBV07-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	3	6	5	2	0	22	34	-1	36	43						01,02								CASSPLATGELFF+TCRBV07-01+TCRBJ02-02	TCRBV07-01*01	TCRBD02-01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTTACGAGGGAACACTGAAGCTTTCTTTGGACAA	CASSLRGNTEAFF	In	VDJ	1	142	2.1050259718697375E-4	2.5526804942852313E-4	39	TCRBV07	TCRBV07-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	11	1	1	3	0	22	35	-1	38	42														CASSLRGNTEAFF+TCRBV07-01+TCRBJ01-01	TCRBV07-01*01	TCRBD02-01*02	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGCGGAGACCTCTCTGGAAACACCATATATTTTGGAGAG	CASSGDLSGNTIYF	In	VDJ	1	45	6.670856953108322E-5	8.089480439636297E-5	42	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	6	10	2	0	1	4	23	34	39	35	43													Vb 12	CASSGDLSGNTIYF+TCRBV10-02+TCRBJ01-03	TCRBV10-02*01	TCRBD02-01*02	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGCTTCAGACACCGGGGAGCTGTTTTTTGGAGAA	CASSASDTGELFF	In	VDJ	1	46	6.819098218732952E-5	8.269246671628214E-5	39	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	4	5	3	3	0	23	36	-1	39	42													Vb 12	CASSASDTGELFF+TCRBV10-02+TCRBJ02-02	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTCCAGGGGGCGCAGAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	52	7.708545812480728E-5		43	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	0	2	1	4	23	35	44	36	48													Vb 12	X+TCRBV10-02+TCRBJ01-02	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCGTGGCAGGGGGCTTACGAGCAGTACTTCGGGCCG	CASSESWQGAYEQYF	In	VDJ	1	52	7.708545812480728E-5	9.34784406357972E-5	45	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	0	4	4	1	23	40	52	44	53													Vb 12	CASSESWQGAYEQYF+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCCTGGGACTAGCGGGGGGGAATGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	53	7.856787078105358E-5		47	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	8	0	0	5	2	5	23	32	50	34	55													Vb 12	X+TCRBV10-02+TCRBJ02-05	TCRBV10-02*01	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAATCGCCGGGACTAGCGGGGGGGTTCGGATTACTACGAGCAGTACTTCGGGCCG	CASNRRD*RGGSDYYEQYF	Stop	VDJ	1	54	8.005028343729987E-5		57	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	7	0	0	3	6	9	23	33	55	39	64													Vb 12	CASNRRD*RGGSDYYEQYF+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01	TCRBD02-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGGGGTCTTGTGAGGTAGGGATCGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	55	8.153269609354617E-5		50	TCRBV10	TCRBV10-02	01				TCRBJ01	TCRBJ01-03	01	6	0	8	4	15	2	23	34	53	49	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	X+TCRBV10-02+TCRBJ01-03	TCRBV10-02*01		TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGGGGACAGGGGAGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASRGQGRNTGELFF	In	VDJ	1	58	8.597993406228505E-5	1.0426441455531227E-4	45	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	0	2	1	0	2	23	-1	44	34	46													Vb 12	CASRGQGRNTGELFF+TCRBV10-02+TCRBJ02-02	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGAAGCGGGGGGAAGAGACCCAGTACTTCGGGCCA	CASSEKRGEETQYF	In	VDJ	1	58	8.597993406228505E-5	1.0426441455531227E-4	42	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	6	1	3	1	0	23	38	-1	39	48													Vb 12	CASSEKRGEETQYF+TCRBV10-02+TCRBJ02-05	TCRBV10-02*01	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTTCCCTTAGTGGCGAGCAGTACTTCGGGCCG	CASSSLSGEQYF	In	VDJ	1	62	9.190958468727023E-5	1.1145506383498898E-4	36	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	5	8	6	5	3	23	35	43	40	46						01,02							Vb 12	CASSSLSGEQYF+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01	TCRBD02-01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGACTCCGCCGGGACCGCAGAAGCTTTCTTTGGACAA	CASSDSAGTAEAFF	In	VDJ	1	71	1.0525129859348688E-4	1.2763402471426157E-4	42	TCRBV10	TCRBV10-02	01				TCRBJ01	TCRBJ01-01	01	3	0	7	8	7	4	23	37	49	44	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSDSAGTAEAFF+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGTGGGGACAGGGGTCGCTGAAGCTTTCTTTGGACAA	CASSVGTGVAEAFF	In	VDJ	1	73	1.0821612390597947E-4	1.3122934935409992E-4	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	2	6	2	3	23	36	48	38	51													Vb 12	CASSVGTGVAEAFF+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGCCGCTTAGGAGGGTCGGCTGAAGCTTTCTTTGGACAA	CASSRLGGSAEAFF	In	VDJ	1	80	1.1859301249970352E-4	1.4381298559353417E-4	42	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	10	0	6	7	4	23	34	47	41	51													Vb 12	CASSRLGGSAEAFF+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01	TCRBD02-01*02	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCACCGAGAGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CATESSYNSPLHF	In	VDJ	1	86	1.274874884371813E-4	1.5459895951304924E-4	39	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	10	11	2	0	2	2	23	30	35	32	37													Vb 12	CATESSYNSPLHF+TCRBV10-02+TCRBJ01-06	TCRBV10-02*01	TCRBD02-01*02	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGGGACGGTTTCTATGGCTACACCTTCGGTTCG	CASRDGFYGYTF	In	VDJ	1	86	1.274874884371813E-4	1.5459895951304924E-4	36	TCRBV10	TCRBV10-02	01				TCRBJ01	TCRBJ01-02	01	6	1	7	4	0	5	23	-1	38	34	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASRDGFYGYTF+TCRBV10-02+TCRBJ01-02	TCRBV10-02*01		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTTTCACGGGACGCTACAACTCGGATCACCCCTCCACTTTGGGAAC		Out	VDJ	1	90	1.3341713906216645E-4		50	TCRBV10	TCRBV10-02	01				TCRBJ01	TCRBJ01-06	01	5	0	7	10	5	13	23	35	45	40	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	X+TCRBV10-02+TCRBJ01-06	TCRBV10-02*01		TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGCGTAGCAGGTCCAACCACAGATACGCAGTATTTTGGCCCA	CASSVAGPTTDTQYF	In	VDJ	1	95	1.4082920234339793E-4	1.7077792039232181E-4	45	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-03	01	6	4	4	2	5	6	23	34	43	39	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSVAGPTTDTQYF+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01		TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTCGGGACAAATCTAACTATGGCTACACCTTCGGTTCG	CASSRDKSNYGYTF	In	VDJ	1	95	1.4082920234339793E-4	1.7077792039232181E-4	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	6	0	1	3	23	35	42	36	45													Vb 12	CASSRDKSNYGYTF+TCRBV10-02+TCRBJ01-02	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCACGGGGTTTACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASTGFTNTGELFF	In	VDJ	1	103	1.5268850359336829E-4	1.8515921895167524E-4	42	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	7	8	3	0	0	4	23	-1	38	33	42													Vb 12	CASTGFTNTGELFF+TCRBV10-02+TCRBJ02-02	TCRBV10-02*01	TCRBD02-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGAGGATCTAGCACAGATACGCAGTATTTTGGCCCA	CASRGSSTDTQYF	In	VDJ	1	116	1.719598681245701E-4	2.0852882911062454E-4	39	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-03	01	6	1	8	0	1	3	23	34	38	35	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASRGSSTDTQYF+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01		TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCCGAAGTAAACATTCAGTACTTCGGCGCC	CASSESEVNIQYF	In	VDJ	1	121	1.7937193140580158E-4	2.1751714071022044E-4	39	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-04	01	0	2	8	6	1	3	23	40	43	41	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSESEVNIQYF+TCRBV10-02+TCRBJ02-04	TCRBV10-02*01		TCRBJ02-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCACTTTAAACCAGGGGTTCGGCACTGAAGCTTTCTTTGGACAA	CASTLNQGFGTEAFF	In	VDJ	1	213	3.157538957804606E-4	3.829020741427847E-4	45	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	4	2	4	8	5	23	33	47	41	52													Vb 12	CASTLNQGFGTEAFF+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGGGGAGAGGCGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CASSGERRSYNSPLHF	In	VDJ	2	282	4.180403690614549E-4	5.069407742172079E-4	48	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	4	9	2	0	0	5	23	-1	41	36	46													Vb 12	CASSGERRSYNSPLHF+TCRBV10-02+TCRBJ01-06	TCRBV10-02*01	TCRBD02-01*02	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCAGTTTCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	3	475	7.041460117169897E-4		41	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-03	01	0	5	5	2	0	3	23	-1	42	40	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	X+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01		TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCACCCCGGACCGACTACACAATGAAAAACTGTTTTTTGGCAGT	CASTPDRLHNEKLFF	In	VDJ	4	672	9.961813049975095E-4	0.001208029078985687	45	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	7	2	9	5	9	3	23	33	47	42	50						01,02							Vb 12	CASTPDRLHNEKLFF+TCRBV10-02+TCRBJ01-04	TCRBV10-02*01	TCRBD02-01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGAAGGAAACAGGACCCCTACAATGAGCAGTTCTTCGGGCCA	CASRRKQDPYNEQFF	In	VDJ	4	732	0.0010851260643722873	0.0013158888181808376	45	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	3	4	2	6	3	23	34	45	40	48													Vb 12	CASRRKQDPYNEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGAGGACAGAGAGGACTGAAGCTTTCTTTGGACAA	CASSERTERTEAFF	In	VDJ	5	939	0.00139198548421527	0.0016880049184041072	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	1	5	5	1	5	23	38	45	39	50													Vb 12	CASSERTERTEAFF+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCGAGGCAGGGAAATGAAAAACTGTTTTTTGGCAGT	CAISESRQGNEKLFF	In	VDJ	1	57	8.449752140603876E-5	1.024667522353931E-4	45	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	4	3	5	4	1	23	40	49	44	50													Vb 12	CAISESRQGNEKLFF+TCRBV10-03+TCRBJ01-04	TCRBV10-03*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGGTCAGGGGGCGCGACAATGAGCAGTTCTTCGGGCCA	CAISEVRGRDNEQFF	In	VDJ	1	59	8.746234671853134E-5	1.0606207687523144E-4	45	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	4	0	5	2	3	23	38	48	40	51													Vb 12	CAISEVRGRDNEQFF+TCRBV10-03+TCRBJ02-01	TCRBV10-03*01	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCCCGGACAGCAAATTCTCCCTACGAGCAGTACTTCGGGCCG	CAISESRTANSPYEQYF	In	VDJ	1	90	1.3341713906216645E-4	1.6178960879272594E-4	51	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	1	5	2	2	9	23	40	48	42	57													Vb 12	CAISESRTANSPYEQYF+TCRBV10-03+TCRBJ02-07	TCRBV10-03*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCGGGGAACTATGGCTACACCTTCGGTTCG	CAISESGNYGYTF	In	VDJ	1	106	1.5713574156210716E-4	1.9055220591143276E-4	39	TCRBV10	TCRBV10-03	01				TCRBJ01	TCRBJ01-02	01	0	6	2	2	0	0	23	-1	-1	40	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CAISESGNYGYTF+TCRBV10-03+TCRBJ01-02	TCRBV10-03*01		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGGTTCGGTTCCCCACTGAAGCTTTCTTTGGACAA	CAISEVRFPTEAFF	In	VDJ	1	109	1.6158297953084604E-4	1.9594519287119031E-4	42	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	2	8	5	4	3	5	23	38	44	41	49						01,02							Vb 12	CAISEVRFPTEAFF+TCRBV10-03+TCRBJ01-01	TCRBV10-03*01	TCRBD02-01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCGAGGGGACACAATGAGCAGTTCTTCGGGCCA	CAISESRGHNEQFF	In	VDJ	1	128	1.8974881999952564E-4	2.3010077694965466E-4	42	TCRBV10	TCRBV10-03	01				TCRBJ02	TCRBJ02-01	01	0	0	7	5	3	0	23	40	-1	43	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CAISESRGHNEQFF+TCRBV10-03+TCRBJ02-01	TCRBV10-03*01		TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCAAGGGGATTGGCTAATGAAAAACTGTTTTTTGGCAGT	CAISESRGLANEKLFF	In	VDJ	1	158	2.3422119968691444E-4	2.8403064654723E-4	48	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	5	2	3	1	5	23	40	46	41	51													Vb 12	CAISESRGLANEKLFF+TCRBV10-03+TCRBJ01-04	TCRBV10-03*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCAGGGGGAGAGCAGTTCTTCGGGCCA	CAISESGGEQFF	In	VDJ	11	1907	0.0028269609354616824	0.0034281420440858707	36	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	5	1	10	0	1	23	-1	46	40	47													Vb 12	CAISESGGEQFF+TCRBV10-03+TCRBJ02-01	TCRBV10-03*01	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGCGGGACCGTTGAACACTGAAGCTTTCTTTGGACAA	CASSIAGPLNTEAFF	In	VDJ	1	44	6.522615687483693E-5	7.90971420764438E-5	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	1	0	7	0	1	3	27	43	49	44	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIAGPLNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTATAGGTAAGGGTTCCACTGAAGCTTTCTTTGGACAA	CASIGKGSTEAFF	In	VDJ	1	48	7.115580749982211E-5	8.62877913561205E-5	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	7	5	3	4	6	3	27	37	47	43	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASIGKGSTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAACCACGGCGGGAACACTGAAGCTTTCTTTGGACAA	CASNHGGNTEAFF	In	VDJ	1	49	7.26382201560684E-5	8.808545367603968E-5	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	7	7	5	1	6	0	27	37	-1	43	47			01,02			01,02							Vb 17	CASNHGGNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACGGGCACGAGAACTGAAGCTTTCTTTGGACAA	CASTGTRTEAFF	In	VDJ	1	51	7.560304546856099E-5	9.168077831587803E-5	36	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	7	8	0	5	1	6	27	37	42	38	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASTGTRTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCCCAGGCTTTACAGGGGATGGCTACACCTTCGGTTCG	CASPGFTGDGYTF	In	VDJ	1	53	7.856787078105358E-5	9.527610295571638E-5	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	9	3	2	6	10	0	27	35	-1	45	52			01,02										Vb 17	CASPGFTGDGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAAGACAGGGTCACTAGCGGGGGGCAGAAACAATGAGCAGTTCTTCGGGCCA	CASSKTGSLAGGRNNEQFF	In	VDJ	1	54	8.005028343729987E-5	9.707376527563557E-5	57	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	3	1	5	10	5	24	37	59	47	64			01,02										Vb 17	CASSKTGSLAGGRNNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTGGGGCAAGGGACTGAAGCTTTCTTTGGACAA	CASSLGQGTEAFF	In	VDJ	1	54	8.005028343729987E-5	9.707376527563557E-5	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	7	0	5	2	5	27	39	46	41	51			01,02										Vb 17	CASSLGQGTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCACGGGACGGAATTATTCACCCCTCCACTTTGGGAAC	CASSTTGRNYSPLHF	In	VDJ	1	56	8.301510874979246E-5	1.0066908991547392E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-06	01	4	0	7	8	4	6	27	40	49	44	55			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSTTGRNYSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01		TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCCCTTAGTTCGAGCAGCAATCAGCCCCAGCATTTTGGTGAT	CASSSLSSSSNQPQHF	In	VDJ	1	56	8.301510874979246E-5	1.0066908991547392E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	5	5	8	1	5	7	27	39	47	44	54			01,02			01,02							Vb 17	CASSSLSSSSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACGACTAGCGGGGGCTACAATGAGCAGTTCTTCGGGCCA	CASSTTSGGYNEQFF	In	VDJ	1	57	8.449752140603876E-5	1.024667522353931E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	2	2	3	1	0	27	40	-1	41	53			01,02										Vb 17	CASSTTSGGYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGCGGGGGTCCCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSIGGGPSYNEQFF	In	VDJ	1	57	8.449752140603876E-5	1.024667522353931E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	7	2	0	0	3	27	-1	50	43	53			01,02										Vb 17	CASSIGGGPSYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTTGTTTTCGGGGTGAAGAGACCCAGTACTTCGGGCCA	CASCFRGEETQYF	In	VDJ	1	57	8.449752140603876E-5	1.024667522353931E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	8	8	3	3	6	2	27	36	47	42	49			01,02										Vb 17	CASCFRGEETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCCTACTAGCGGGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CATLLAGSSYNEQFF	In	VDJ	1	59	8.746234671853134E-5	1.0606207687523144E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	10	3	3	0	4	2	27	34	48	38	50			01,02										Vb 17	CATLLAGSSYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGCGTTGGCAGCTACACCTTCGGTTCG	CASSIGVGSYTF	In	VDJ	1	59	8.746234671853134E-5	1.0606207687523144E-4	36	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	1	9	0	9	5	1	27	43	51	48	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIGVGSYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAATCTCGAACGACAGCCCCAGCATTTTGGTGAT	CASNLERQPQHF	In	VDJ	1	60	8.894475937477764E-5	1.0785973919515063E-4	36	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	7	2	8	7	5	4	27	37	44	42	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASNLERQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGGGCGGCGGGAGAGCAGTTCTTCGGGCCA	CASSRAAGEQFF	In	VDJ	1	60	8.894475937477764E-5	1.0785973919515063E-4	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	7	3	10	5	0	27	40	-1	45	51			01,02										Vb 17	CASSRAAGEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGTGGGGCTAACTATGGCTACACCTTCGGTTCG	CASSIGGANYGYTF	In	VDJ	1	60	8.894475937477764E-5	1.0785973919515063E-4	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	3	6	2	0	4	0	27	41	-1	45	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIGGANYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCAATCGGGGGGACTGTTTGAAGCTTTCTTTGGACAA	CASQSGGLFEAFF	In	VDJ	1	60	8.894475937477764E-5	1.0785973919515063E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	8	8	1	7	4	6	27	36	47	40	53			01,02										Vb 17	CASQSGGLFEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCAGCAACAGGAGTTACGACTGAAGCTTTCTTTGGACAA	CASSAATGVTTEAFF	In	VDJ	1	61	9.042717203102393E-5	1.096574015150698E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	4	5	6	7	27	39	50	45	57			01,02										Vb 17	CASSAATGVTTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAATGATCGCCGAGGGGGATACAATGAGCAGTTCTTCGGGCCA	CASSNDRRGGYNEQFF	In	VDJ	1	62	9.190958468727023E-5	1.1145506383498898E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	5	1	4	10	1	27	40	56	50	57			01,02										Vb 17	CASSNDRRGGYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCCCACAGGGGTACTAGGTAATGAAAAACTGTTTTTTGGCAGT	CASSPTGVLGNEKLFF	In	VDJ	1	65	9.635682265600911E-5	1.1684805079474652E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	3	2	4	4	7	27	38	49	42	56			01,02										Vb 17	CASSPTGVLGNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTCTGGGGGGATCGCGACAATGAGCAGTTCTTCGGGCCA	CASSFWGDRDNEQFF	In	VDJ	1	66	9.783923531225541E-5	1.1864571311466569E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	9	1	5	4	6	27	39	49	43	55			01,02										Vb 17	CASSFWGDRDNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAAGACAGGGGCGCGGGCCTACGAGCAGTACTTCGGGCCG	CASSKTGARAYEQYF	In	VDJ	1	68	1.0080406062474798E-4	1.2224103775450404E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	2	2	2	1	6	27	40	49	41	55			01,02										Vb 17	CASSKTGARAYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCAAAACTTTGGAGGGAAGGGGCTATGGCTACACCTTCGGTTCG	CASKTLEGRGYGYTF	In	VDJ	1	69	1.0228647328099429E-4	1.2403870007442322E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	9	10	0	4	9	6	27	35	50	44	56			01,02										Vb 17	CASKTLEGRGYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01*02	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCACAGGGAAATGGGGACACCCCTCCACTTTGGGAAC	CASSHREMGTPLHF	In	VDJ	1	69	1.0228647328099429E-4	1.2403870007442322E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	3	3	11	2	9	27	38	46	40	55			01,02										Vb 17	CASSHREMGTPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAAAGGGTGACACCGGGGAGCTGTTTTTTGGAGAA	CASSIKGDTGELFF	In	VDJ	1	71	1.0525129859348688E-4	1.2763402471426157E-4	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-02	01	2	5	3	3	1	2	27	42	47	43	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIKGDTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01		TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGGACAGGATGAAACTATGGCTACACCTTCGGTTCG	CASSGTG*NYGYTF	Stop	VDJ	1	72	1.0673371124973316E-4		42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	4	2	0	4	27	-1	47	39	51			01,02										Vb 17	CASSGTG*NYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCACTCATTGGTCTGGCAATCAGCCCCAGCATTTTGGTGAT	CASSTHWSGNQPQHF	In	VDJ	1	73	1.0821612390597947E-4	1.3122934935409992E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	6	3	10	2	1	10	27	38	42	39	52			01,02			01,02							Vb 17	CASSTHWSGNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCCCGGGGGAGGGAAATATGGCTACACCTTCGGTTCG	CASSIPGGGKYGYTF	In	VDJ	1	73	1.0821612390597947E-4	1.3122934935409992E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	3	9	0	5	6	3	27	41	54	47	57			01,02										Vb 17	CASSIPGGGKYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01*02	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTGGGGACAGATACGCAGTATTTTGGCCCA	CASSLGTDTQYF	In	VDJ	1	73	1.0821612390597947E-4	1.3122934935409992E-4	36	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	5	6	2	3	2	0	27	39	-1	41	45			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSLGTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCCTGGGGGGAAGCTTTCTTTGGACAA	CASSSWGEAFF	In	VDJ	1	74	1.0969853656222575E-4	1.3302701167401912E-4	33	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	5	6	1	8	4	0	27	39	-1	43	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSSWGEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAAGAGGGCTAGCGGGGACCACAGATACGCAGTATTTTGGCCCA	CASSIRGLAGTTDTQYF	In	VDJ	1	75	1.1118094921847204E-4	1.348246739939383E-4	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	4	3	2	6	2	27	42	57	48	59			01,02										Vb 17	CASSIRGLAGTTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCCCCCCTGACAGGACTCCGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	75	1.1118094921847204E-4		43	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	11	2	4	0	6	6	27	33	45	39	51			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGAAACAGGAGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASRNRRNTGELFF	In	VDJ	1	76	1.1266336187471834E-4	1.3662233631385747E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	3	4	1	2	2	27	38	45	40	47			01,02										Vb 17	CASRNRRNTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGAGGAGTGGGGACCGGGGAGCTGTTTTTTGGAGAA	CASSIGGVGTGELFF	In	VDJ	1	76	1.1266336187471834E-4	1.3662233631385747E-4	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-02	01	1	6	2	5	7	0	27	43	-1	50	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIGGVGTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01		TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTTCGGACTACGAGGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	76	1.1266336187471834E-4		50	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	1	9	1	3	5	27	43	52	46	57			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACAGCTAACTATGGCTACACCTTCGGTTCG	CASSTANYGYTF	In	VDJ	1	77	1.1414577453096463E-4	1.3841999863377664E-4	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	4	5	0	0	0	27	-1	-1	40	43			01,02										Vb 17	CASSTANYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGAGGCCAGGGGTGAACACTGAAGCTTTCTTTGGACAA	CASSMRPGVNTEAFF	In	VDJ	1	77	1.1414577453096463E-4	1.3841999863377664E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	2	0	5	0	27	41	-1	46	52			01,02										Vb 17	CASSMRPGVNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGCTGGGCGGAACACTGAAGCTTTCTTTGGACAA	CASSMAGRNTEAFF	In	VDJ	1	79	1.1711059984345722E-4	1.42015323273615E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	8	0	1	4	1	27	41	49	45	50			01,02										Vb 17	CASSMAGRNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTATCGGTTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASIGYSNQPQHF	In	VDJ	1	83	1.230402504684424E-4	1.492059725532917E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	7	8	5	0	1	3	27	37	41	38	44			01,02			01,02							Vb 17	CASIGYSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCACGGGGGGACCTTACAATGAGCAGTTCTTCGGGCCA	CASSTGGPYNEQFF	In	VDJ	1	85	1.26005075780935E-4	1.5280129719313007E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	8	1	4	2	4	27	38	47	40	51			01,02										Vb 17	CASSTGGPYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGCACCGGGACCGCGCGGCCAAAAACATTCAGTACTTCGGCGCC	CASSMHRDRAAKNIQYF	In	VDJ	1	87	1.2896990109342757E-4	1.5639662183296842E-4	51	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-04	01	3	0	7	1	5	6	27	41	51	46	57			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSMHRDRAAKNIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01		TCRBJ02-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGATTCCGGGTCTGGTTACTACGAGCAGTACTTCGGGCCG	CASSDSGSGYYEQYF	In	VDJ	1	89	1.3193472640592017E-4	1.5999194647280677E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	8	4	3	5	8	27	39	48	44	56			01,02			01,02							Vb 17	CASSDSGSGYYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGAGGCCCGCTCGGGGACCGGGGAGCTGTTTTTTGGAGAA	CASSEARSGTGELFF	In	VDJ	1	90	1.3341713906216645E-4	1.6178960879272594E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	8	3	5	10	0	27	39	-1	49	54			01,02										Vb 17	CASSEARSGTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGACACGGGGGGGCGGACAGATACGCAGTATTTTGGCCCA	CASDTGGRTDTQYF	In	VDJ	1	90	1.3341713906216645E-4	1.6178960879272594E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	8	8	0	3	4	3	27	36	48	40	51			01,02										Vb 17	CASDTGGRTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGACTACATACGGGACTAGCGGAGAAAGATACGCAGTATTTTGGCCCA	CASRLHTGLAEKDTQYF	In	VDJ	1	92	1.3638196437465905E-4	1.653849334325643E-4	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	0	5	5	9	4	27	38	58	47	62			01,02			01,02							Vb 17	CASRLHTGLAEKDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCTAGGGAACACTGAAGCTTTCTTTGGACAA	CASSILGNTEAFF	In	VDJ	1	92	1.3638196437465905E-4	1.653849334325643E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	4	8	1	1	1	27	41	46	42	47			01,02			01,02							Vb 17	CASSILGNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCACCGACTGACAGTAGAGCTTTCTTTGGACAA	CASSPPTDSRAFF	In	VDJ	1	92	1.3638196437465905E-4	1.653849334325643E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	5	10	9	3	27	39	53	48	56			01,02										Vb 17	CASSPPTDSRAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGGACCCGGGACAGGGGAAGGATGGCTACACCTTCGGTTCG	CASRDPGQGKDGYTF	In	VDJ	1	93	1.3786437703090535E-4	1.6718259575248346E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	2	6	6	4	27	38	54	44	58			01,02										Vb 17	CASRDPGQGKDGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGGGAATACTCTTATACCGGGGAGCTGTTTTTTGGAGAA	CASSREYSYTGELFF	In	VDJ	1	93	1.3786437703090535E-4	1.6718259575248346E-4	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-02	01	4	0	8	5	0	10	27	-1	44	40	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSREYSYTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01		TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGAGAGGGGCTCGACTGAAGCTTTCTTTGGACAA	CASSIERGSTEAFF	In	VDJ	1	95	1.4082920234339793E-4	1.7077792039232181E-4	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	0	5	2	5	1	4	27	44	50	45	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIERGSTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAATCCTGCAGGGGGATATGGCTACACCTTCGGTTCG	CASNPAGGYGYTF	In	VDJ	1	97	1.437940276558905E-4	1.743732450321602E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	4	1	5	6	1	27	37	50	43	51			01,02										Vb 17	CASNPAGGYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGCCGGGACAGTACACTGAAGCTTTCTTTGGACAA	CASRPGQYTEAFF	In	VDJ	1	97	1.437940276558905E-4	1.743732450321602E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	5	3	3	1	27	38	48	41	49			01,02										Vb 17	CASRPGQYTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATATCGCGGACAGGGCACAATGAGCAGTTCTTCGGGCCA	CASSISRTGHNEQFF	In	VDJ	1	97	1.437940276558905E-4	1.743732450321602E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	1	3	5	4	1	27	42	54	46	55			01,02										Vb 17	CASSISRTGHNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATATTAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VJ	1	97	1.437940276558905E-4		38	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	2	0	0	0	0	1	27	-1	42	-1	43			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCGGGGGGACAGGGAGATGAAAAACTGTTTTTTGGCAGT	CASSPGGQGDEKLFF	In	VDJ	1	97	1.437940276558905E-4	1.743732450321602E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	0	3	6	5	2	27	39	53	44	55			01,02										Vb 17	CASSPGGQGDEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGAGGGACAGCAAGTTCTTACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	99	1.467588529683831E-4		52	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	0	5	2	2	10	27	43	52	45	62			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGGACAGGTGGCAACGAGCAGTACTTCGGGCCG	CASSIGTGGNEQYF	In	VDJ	1	99	1.467588529683831E-4	1.7796856967199854E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	4	5	1	5	27	41	50	42	55			01,02										Vb 17	CASSIGTGGNEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCGCGACAGAAGCAATCAGCCCCAGCATTTTGGTGAT	CASSRDRSNQPQHF	In	VDJ	1	100	1.482412656246294E-4	1.7976623199191771E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	2	5	1	4	1	27	38	47	42	48			01,02										Vb 17	CASSRDRSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTCGGGCAAAATTCACCCCTCCACTTTGGGAAC	CASSIVGQNSPLHF	In	VDJ	1	100	1.482412656246294E-4	1.7976623199191771E-4	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-06	01	1	8	0	7	2	2	27	43	49	45	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIVGQNSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01		TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGGGGAGGGTCCTAGCAATCAGCCCCAGCATTTTGGTGAT	CASGEGPSNQPQHF	In	VDJ	1	100	1.482412656246294E-4	1.7976623199191771E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	8	9	0	0	1	3	27	36	44	37	47			01,02										Vb 17	CASGEGPSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*02	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTAAATCTAGGTCAGCCCCAGCATTTTGGTGAT	CASSIVNLGQPQHF	In	VDJ	1	102	1.5120609093712198E-4	1.8336155663175606E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	1	4	8	6	5	1	27	43	52	48	53			01,02			01,02							Vb 17	CASSIVNLGQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCTCAAGCAGAACACTGTACACTGAAGCTTTCTTTGGACAA	CASSRTLYTEAFF	In	VDJ	1	102	1.5120609093712198E-4	1.8336155663175606E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	11	3	6	3	9	4	27	33	45	42	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSRTLYTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGAAACCGGGACTAGCGGCTTACAATGAGCAGTTCTTCGGGCCA	CASSIGKPGLAAYNEQFF	In	VDJ	1	104	1.5417091624961456E-4	1.869568812715944E-4	54	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	0	5	4	7	2	27	43	61	50	63			01,02			01,02							Vb 17	CASSIGKPGLAAYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCAGGCAGGGTCGTCCAGATACGCAGTATTTTGGCCCA	CASSIRQGRPDTQYF	In	VDJ	1	104	1.5417091624961456E-4	1.869568812715944E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	4	3	4	4	5	27	41	50	45	55			01,02										Vb 17	CASSIRQGRPDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCAAGCGGGGGGACAGATACGCAGTATTTTGGCCCA	CASSPSGGTDTQYF	In	VDJ	1	104	1.5417091624961456E-4	1.869568812715944E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	6	1	3	3	0	27	39	-1	42	51			01,02										Vb 17	CASSPSGGTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTCACAGGGCACTATGGCTACACCTTCGGTTCG	CASSLTGHYGYTF	In	VDJ	1	104	1.5417091624961456E-4	1.869568812715944E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	3	3	3	1	27	39	48	42	49			01,02										Vb 17	CASSLTGHYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCATGACAGGAGGAAAAGCAATCAGCCCCAGCATTTTGGTGAT	CASHDRRKSNQPQHF	In	VDJ	1	105	1.5565332890586086E-4	1.887545435915136E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	2	4	1	3	6	27	36	45	39	51			01,02										Vb 17	CASHDRRKSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAAACAAATAGGACGGGGGACGGGAAACTATGGCTACACCTTCGGTTCG	CASSKQIGRGTGNYGYTF	In	VDJ	1	108	1.6010056687459974E-4	1.9414753055127114E-4	54	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	4	8	2	2	11	6	27	40	57	51	63			01,02										Vb 17	CASSKQIGRGTGNYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTTGGGGTGACACTGAAGCTTTCTTTGGACAA	CASSIWGDTEAFF	In	VDJ	1	112	1.6603021749958492E-4	2.0133817983094784E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	3	6	2	3	2	2	27	41	47	43	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIWGDTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGTTCCAGCTACACCTTCGGTTCG	CASSIGSSYTF	In	VDJ	1	113	1.6751263015583122E-4	2.03135842150867E-4	33	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	4	6	9	4	0	27	43	-1	47	49			01,02										Vb 17	CASSIGSSYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCAACAGGGATCGTACCACTGAAGCTTTCTTTGGACAA	CASNRDRTTEAFF	In	VDJ	1	114	1.6899504281207752E-4	2.049335044707862E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	9	3	3	4	2	7	27	35	43	37	50			01,02										Vb 17	CASNRDRTTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCGCAACAGGGACGCTACACCTTCGGTTCG	CASSPQQGRYTF	In	VDJ	1	114	1.6899504281207752E-4	2.049335044707862E-4	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	3	9	5	2	27	39	50	44	52			01,02										Vb 17	CASSPQQGRYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCCGGACCGCACAATCAGCCCCAGCATTTTGGTGAT	CASSSGPHNQPQHF	In	VDJ	1	114	1.6899504281207752E-4	2.049335044707862E-4	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	5	1	7	3	3	4	27	39	46	42	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSSGPHNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCCCCGACAGGGCGGGAAAAACTGTTTTTTGGCAGT	CASSSPTGREKLFF	In	VDJ	1	115	1.704774554683238E-4	2.0673116679070536E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	2	3	8	5	3	27	39	51	44	54			01,02										Vb 17	CASSSPTGREKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGGGTGGGGCATTGGGGGCAATGAGCAGTTCTTCGGGCCA	CASSIGWGIGGNEQFF	In	VDJ	1	116	1.719598681245701E-4	2.0852882911062454E-4	48	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	3	6	1	6	13	0	27	41	-1	54	59			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIGWGIGGNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGAGGGCAGGGAGTAGGGCTGAAGCTTTCTTTGGACAA	CASSMRAGSRAEAFF	In	VDJ	1	117	1.734422807808164E-4	2.103264914305437E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	3	4	3	6	5	7	27	41	51	46	58			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSMRAGSRAEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGTCGGGACAGGGGTCAGTGAGCAGTTCTTCGGGCCA	CASSVGTGVSEQFF	In	VDJ	1	117	1.734422807808164E-4	2.103264914305437E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	2	9	3	4	27	39	52	42	56			01,02										Vb 17	CASSVGTGVSEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTCGGGGACGGCAATCAGCCCCAGCATTTTGGTGAT	CASSIVGDGNQPQHF	In	VDJ	1	118	1.7492469343706268E-4	2.1212415375046289E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	1	0	7	2	3	1	27	43	51	46	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIVGDGNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTCGATTTGACTGAAGCTTTCTTTGGACAA	CASSLDLTEAFF	In	VDJ	1	119	1.7640710609330898E-4	2.139218160703821E-4	36	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	5	2	8	5	3	4	27	39	44	42	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSLDLTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGTGGCTCAGGGCACTGAAGCTTTCTTTGGACAA	CASSIVAQGTEAFF	In	VDJ	1	120	1.7788951874955528E-4	2.1571947839030126E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	3	4	7	0	27	41	-1	48	53			01,02										Vb 17	CASSIVAQGTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAAGCCGATCCTACGAGCAGTACTTCGGGCCG	CASSISRSYEQYF	In	VDJ	1	122	1.8085434406204785E-4	2.193148030301396E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	6	7	1	0	3	27	-1	45	42	48			01,02			01,02							Vb 17	CASSISRSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAAACCCGGGGAATCAGCCCCAGCATTTTGGTGAT	CASSINPGNQPQHF	In	VDJ	1	124	1.8381916937454046E-4	2.2291012766997796E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	2	8	3	4	4	0	27	42	-1	46	51			01,02										Vb 17	CASSINPGNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCAGGAAAGGCCCCAGCATTTTGGTGAT	CASSIQERPQHF	In	VDJ	1	126	1.8678399468703303E-4	2.265054523098163E-4	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	4	9	1	4	27	41	46	42	50			01,02										Vb 17	CASSIQERPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGTACGGGGCCTTCGGGAAAACAGATACGCAGTATTTTGGCCCA	CASRYGAFGKTDTQYF	In	VDJ	1	127	1.8826640734327934E-4	2.2830311462973549E-4	48	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	6	7	0	3	4	10	27	38	47	42	57			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASRYGAFGKTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCCCGGGGCCCCTACGCAGTATTTTGGCCCA	CASSIPGAPTQYF	In	VDJ	1	127	1.8826640734327934E-4	2.2830311462973549E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	3	7	0	8	4	3	27	41	50	45	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIPGAPTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTTCGGCAGGGGGGTATCAGCCCCAGCATTTTGGTGAT	CASSISAGGYQPQHF	In	VDJ	1	127	1.8826640734327934E-4	2.2830311462973549E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	1	5	5	2	27	41	53	46	55			01,02										Vb 17	CASSISAGGYQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTCCATAATCAGCCCCAGCATTTTGGTGAT	CASSFHNQPQHF	In	VDJ	1	127	1.8826640734327934E-4	2.2830311462973549E-4	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	4	6	4	3	1	27	39	44	42	45			01,02										Vb 17	CASSFHNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGATCTTCGAAGGCTGGGGACCCAGTACTTCGGGCCA	CASSIDLRRLGTQYF	In	VDJ	1	128	1.8974881999952564E-4	2.3010077694965466E-4	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	0	0	9	7	12	0	27	44	-1	56	59			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIDLRRLGTQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCGACGACAACCCTAGGGGAAAAACTGTTTTTTGGCAGT	CASSPTTTLGEKLFF	In	VDJ	1	128	1.8974881999952564E-4	2.3010077694965466E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-04	01	5	2	6	8	5	9	27	39	48	44	57			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSPTTTLGEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01		TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTATCGAACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSYRTNTGELFF	In	VDJ	1	128	1.8974881999952564E-4	2.3010077694965466E-4	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-02	01	5	2	8	0	4	1	27	39	45	43	46			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSYRTNTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01		TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGAAGCGCGACAGGGAGAGGAAATTCACCCCTCCACTTTGGGAAC	CASRSATGRGNSPLHF	In	VDJ	1	133	1.971608832807571E-4	2.3908908854925056E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	2	3	7	6	6	27	38	51	44	57			01,02										Vb 17	CASRSATGRGNSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACGTAGGGACTAGCGGGGTGACGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	133	1.971608832807571E-4		49	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	4	0	3	7	4	3	27	40	57	44	60			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGCACTCGGTGAAGCTTTCTTTGGACAA	CASSIALGEAFF	In	VDJ	1	135	2.001257085932497E-4	2.426844131890889E-4	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	3	10	7	1	3	27	43	47	44	50			01,02			01,02							Vb 17	CASSIALGEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATACAGGGCTACGAGCAGTACTTCGGGCCG	CASSIQGYEQYF	In	VDJ	1	136	2.0160812124949597E-4	2.444820755090081E-4	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	3	3	0	0	27	-1	-1	42	47			01,02										Vb 17	CASSIQGYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGTTTAGCGGGGGGTCTCCTACGAGCAGTACTTCGGGCCG	CASSIV*RGVSYEQYF	Stop	VDJ	1	136	2.0160812124949597E-4		48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	5	1	0	4	1	27	41	55	45	56			01,02										Vb 17	CASSIV*RGVSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCAACGACAGGTTTAATGAAAAACTGTTTTTTGGCAGT	CASNDRFNEKLFF	In	VDJ	1	137	2.0309053390574227E-4	2.4627973782892726E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	9	2	4	4	4	2	27	35	45	39	47			01,02										Vb 17	CASNDRFNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCTTGCAGGGGCCTGCACTCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	137	2.0309053390574227E-4		50	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	4	2	3	5	8	27	39	50	44	58			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGAGGAACGGGACAGGGGGCTGAAGCTTTCTTTGGACAA	CASSIGGTGQGAEAFF	In	VDJ	1	138	2.0457294656198857E-4	2.4807740014884643E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	0	1	6	7	0	27	43	-1	50	61			01,02										Vb 17	CASSIGGTGQGAEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGAGGGCAGTGGGATATGGCTACACCTTCGGTTCG	CASSMRAVGYGYTF	In	VDJ	1	141	2.0902018453072745E-4	2.5347038710860396E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	3	11	0	5	0	8	27	-1	46	41	54			01,02										Vb 17	CASSMRAVGYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01*02	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTTTCAACCAGGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSFSTRSNQPQHF	In	VDJ	1	143	2.1198500984322003E-4	2.570657117484423E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	4	4	1	8	0	27	39	-1	47	51			01,02										Vb 17	CASSFSTRSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCTCAGGGGGCAAAAGAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	144	2.1346742249946633E-4		43	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	4	0	3	2	5	27	38	48	40	53			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCCGTTTAGGGGAACTTACGACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	144	2.1346742249946633E-4		41	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	11	5	2	3	5	8	27	33	43	38	51			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGACGACAGGGCTTAACAATGAGCAGTTCTTCGGGCCA	CASSMTTGLNNEQFF	In	VDJ	1	145	2.1494983515571263E-4	2.6066103638828066E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	2	3	5	3	4	27	41	51	44	55			01,02										Vb 17	CASSMTTGLNNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATATTGGCTAAGGGGAAGCTGTTTTTTGGAGAA	CASSILAKGKLFF	In	VDJ	1	148	2.193970731244515E-4	2.6605402334803824E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	5	2	12	7	1	27	42	54	49	55			01,02										Vb 17	CASSILAKGKLFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGGGACAGGGCTCACAGATACGCAGTATTTTGGCCCA	CASSIGTGLTDTQYF	In	VDJ	1	148	2.193970731244515E-4	2.6605402334803824E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	0	3	2	1	2	27	41	51	42	53			01,02										Vb 17	CASSIGTGLTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGATCTGAGGGGAAACACTGAAGCTTTCTTTGGACAA	CASSIDLRGNTEAFF	In	VDJ	1	150	2.2236189843694408E-4	2.696493479878766E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	0	5	2	2	4	1	27	44	53	48	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIDLRGNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTGGGGGACAGGGGGCCAAGAGACCCAGTACTTCGGGCCA	CASSWGTGGQETQYF	In	VDJ	1	151	2.2384431109319039E-4	2.7144701030779576E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	1	1	3	0	27	39	-1	42	53			01,02										Vb 17	CASSWGTGGQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGGAGTAAACACTGAAGCTTTCTTTGGACAA	CASSIGVNTEAFF	In	VDJ	1	152	2.253267237494367E-4	2.7324467262771493E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	10	2	2	1	2	27	41	46	42	48			01,02										Vb 17	CASSIGVNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*02	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCTCCGAAGGGCAACACTGAAGCTTTCTTTGGACAA	CAPKGNTEAFF	In	VDJ	1	152	2.253267237494367E-4	2.7324467262771493E-4	33	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	12	5	3	2	5	1	27	32	41	37	42			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CAPKGNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTTAGGTTCCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	152	2.253267237494367E-4		32	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-03	01	14	5	4	0	1	3	27	30	34	31	37			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ01-03	TCRBV19-01		TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGCCGAGGGGAGGACTTCCCTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	153	2.26809136405683E-4		55	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	9	1	0	6	8	26	40	52	46	60			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCGTACCAGGGGGAACTATGGCTACACCTTCGGTTCG	CASSRTRGNYGYTF	In	VDJ	1	155	2.2977396171817557E-4	2.7863765958747246E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	4	1	2	6	0	27	38	-1	44	51			01,02										Vb 17	CASSRTRGNYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGACCGGGACAGTGAAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	155	2.2977396171817557E-4		41	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	8	0	5	7	4	3	27	36	47	40	50			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGGGACTAGCGGGAGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	159	2.3570361234316075E-4		46	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	0	3	1	0	0	27	-1	-1	38	51			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*02	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTCGAAGGGGCGTGAATGAAAAACTGTTTTTTGGCAGT	CASSIRRGVNEKLFF	In	VDJ	1	161	2.3866843765565332E-4	2.894236335069875E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	5	2	5	4	4	27	41	50	45	54			01,02										Vb 17	CASSIRRGVNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCGGCCGAGCAGGGCTCACCGGGGAGCTGTTTTTTGGAGAA	CATGRAGLTGELFF	In	VDJ	1	162	2.4015085031189962E-4	2.912212958269067E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	10	4	3	4	9	2	27	34	48	43	50			01,02										Vb 17	CATGRAGLTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATATCGCGGTTCCCCACTGAAGCTTTCTTTGGACAA	CASSISRFPTEAFF	In	VDJ	1	162	2.4015085031189962E-4	2.912212958269067E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	2	7	5	4	2	5	27	42	48	44	53			01,02			01,02							Vb 17	CASSISRFPTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGTACTAGCGACTGGGGAGCTGTTTTTTGGAGAA	CASSMVLATGELFF	In	VDJ	1	163	2.4163326296814592E-4	2.9301895814682586E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	3	6	8	3	3	27	41	51	44	54			01,02			01,02							Vb 17	CASSMVLATGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGTAACAGGGGGCGACGGGGAGCTGTTTTTTGGAGAA	CASSVTGGDGELFF	In	VDJ	1	165	2.445980882806385E-4	2.966142827866642E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	3	0	7	3	2	27	39	51	42	53			01,02										Vb 17	CASSVTGGDGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCCGGGACAGCAATTCACCCCTCCACTTTGGGAAC	CASRDSNSPLHF	In	VDJ	1	167	2.475629135931311E-4	3.0020960742650255E-4	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	9	0	5	7	2	1	27	35	44	37	45			01,02										Vb 17	CASRDSNSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGACAGTCCAATGAGCAGTTCTTCGGGCCA	CASSRQSNEQFF	In	VDJ	1	167	2.475629135931311E-4	3.0020960742650255E-4	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	2	5	6	0	2	27	-1	45	40	47			01,02										Vb 17	CASSRQSNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACAAACCTGGGACTGTTCTACGAGCAGTACTTCGGGCCG	CASSTNLGLFYEQYF	In	VDJ	1	170	2.5201015156187E-4	3.0560259438626013E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	0	10	3	7	3	27	40	53	47	56			01,02			01,02							Vb 17	CASSTNLGLFYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGACAGGGGGCTGTGGCTACACCTTCGGTTCG		Out	VDJ	1	171	2.5349256421811626E-4		38	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	0	7	0	2	27	-1	50	40	52			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCTCACCGGGACTAGCTTCAGATACGCAGTATTTTGGCCCA	CASSSPGLASDTQYF	In	VDJ	1	172	2.549749768743626E-4	3.091979190260985E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	0	7	4	6	2	27	38	53	44	55			01,02			01,02							Vb 17	CASSSPGLASDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCGACAGGGGGCCGGGCTACACCTTCGGTTCG	CASSPDRGPGYTF	In	VDJ	1	173	2.5645738953060886E-4	3.1099558134601766E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	0	8	3	2	27	39	52	42	54			01,02										Vb 17	CASSPDRGPGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCTATTCAACCGGGACAGGGATATACCATATATTTTGGAGAG		Out	VDJ	1	174	2.5793980218685513E-4		43	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	9	0	3	10	10	4	27	35	54	45	58			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGGACTTACACCGGGGAGCTGTTTTTTGGAGAA	CASSGTYTGELFF	In	VDJ	1	175	2.5942221484310146E-4	3.14590905985856E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	0	10	3	0	1	27	-1	45	39	46			01,02			01,02							Vb 17	CASSGTYTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCCAGGGTCACTGAAGCTTTCTTTGGACAA	CASSARVTEAFF	In	VDJ	1	181	2.683166907805792E-4	3.2537687990537105E-4	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	3	4	2	1	27	39	46	41	47			01,02										Vb 17	CASSARVTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGCTCAATAGTCGGACACACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	181	2.683166907805792E-4		44	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	1	6	2	11	2	27	36	52	47	54			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAAGGCCGGAGGTCAGCCCCAGCATTTTGGTGAT	CASSKAGGQPQHF	In	VDJ	1	182	2.697991034368255E-4	3.2717454222529023E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	4	10	1	6	5	0	27	40	-1	45	50			01,02										Vb 17	CASSKAGGQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*02	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAAGGGTTAATGAGCAGTTCTTCGGGCCA	CASSIRVNEQFF	In	VDJ	1	183	2.712815160930718E-4	3.289722045452094E-4	36	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	2	5	3	7	0	2	27	-1	46	42	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIRVNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCAACAGGGCCCGTAATCAGCCCCAGCATTTTGGTGAT	CASSINRARNQPQHF	In	VDJ	1	183	2.712815160930718E-4	3.289722045452094E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	3	3	4	2	5	27	41	49	43	54			01,02										Vb 17	CASSINRARNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGATGGGCGGGCAGGACGGCAACGAGCAGTACTTCGGGCCG	CASRMGGQDGNEQYF	In	VDJ	1	185	2.7424634140556437E-4	3.3256752918504775E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	7	4	5	5	10	27	38	48	43	58			01,02			01,02							Vb 17	CASRMGGQDGNEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGGGCGAGAGCACTGAAGCTTTCTTTGGACAA	CASSIGGESTEAFF	In	VDJ	1	185	2.7424634140556437E-4	3.3256752918504775E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	7	0	4	0	5	27	-1	48	43	53			01,02										Vb 17	CASSIGGESTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAACAGGGGTGGGAACGAGCAGTACTTCGGGCCG	CASSNRGGNEQYF	In	VDJ	1	187	2.77211166718057E-4	3.361628538248861E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	3	2	5	0	5	27	-1	47	40	52			01,02										Vb 17	CASSNRGGNEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCGAGACACCTTTCGGACCTATGGCTACACCTTCGGTTCG	CASSIRDTFRTYGYTF	In	VDJ	1	191	2.8314081734304213E-4	3.433535031045628E-4	48	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	3	1	7	4	14	0	27	41	-1	55	59			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIRDTFRTYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGGGTGGGCCTACGAGCAGTACTTCGGGCCG	CASSIGWAYEQYF	In	VDJ	1	191	2.8314081734304213E-4	3.433535031045628E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	3	0	9	2	1	4	27	41	45	42	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIGWAYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCCCGGGCGCCTCTCTGGAAACACCATATATTTTGGAGAG	CASPGRLSGNTIYF	In	VDJ	1	192	2.8462322999928846E-4	3.45151165424482E-4	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-03	01	8	8	0	0	3	4	27	36	43	39	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASPGRLSGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01		TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCGGACGGGACAGATATCAGCCCCAGCATTTTGGTGAT	CASGRDRYQPQHF	In	VDJ	1	193	2.8610564265553473E-4	3.469488277444012E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	9	0	5	5	5	2	27	35	47	40	49			01,02										Vb 17	CASGRDRYQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTAACTCAGGGGAGCACTGAAGCTTTCTTTGGACAA	CASSLTQGSTEAFF	In	VDJ	1	193	2.8610564265553473E-4	3.469488277444012E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	2	4	6	2	27	39	51	45	53			01,02										Vb 17	CASSLTQGSTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAACGATAGGGTTGGCAGATACGCAGTATTTTGGCCCA	CASSITIGLADTQYF	In	VDJ	1	194	2.87588055311781E-4	3.487464900643204E-4	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	2	5	3	4	5	4	27	42	51	47	55			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSITIGLADTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGAGGGTCAATGAGCAGTTCTTCGGGCCA	CASSMRVNEQFF	In	VDJ	1	194	2.87588055311781E-4	3.487464900643204E-4	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	11	0	6	0	1	27	-1	46	41	47			01,02										Vb 17	CASSMRVNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCCCGGACTGGGAAAATGGGCCAGTACTTCGGGCCA		Out	VDJ	1	196	2.905528806242736E-4		44	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	1	10	10	4	11	27	41	50	45	61			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCTTGACAGGGGGTTACTACGAGCAGTACTTCGGGCCG	CASSLTGGYYEQYF	In	VDJ	1	197	2.9203529328051994E-4	3.541394770240779E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	1	3	3	3	27	38	50	41	53			01,02										Vb 17	CASSLTGGYYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTCGCGGGATAGCGGGGGAGTCAGATACGCAGTATTTTGGCCCA	CASSIRGIAGESDTQYF	In	VDJ	1	201	2.979649439055051E-4	3.613301263037546E-4	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	5	2	4	8	3	27	41	58	49	61			01,02										Vb 17	CASSIRGIAGESDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGTAGCGGGGGGGCCCGGGAGCAGTTCTTCGGGCCA	CASSGSGGAREQFF	In	VDJ	1	201	2.979649439055051E-4	3.613301263037546E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	5	0	10	2	5	27	39	52	41	57			01,02										Vb 17	CASSGSGGAREQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCGGGAGGGGCAGGTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	204	3.0241218187424397E-4		43	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	8	0	1	1	5	27	38	47	39	52			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACTTATCAGGGTGGCTCTGGAAACACCATATATTTTGGAGAG	CASSTYQGGSGNTIYF	In	VDJ	1	204	3.0241218187424397E-4	3.6672311326351213E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	4	3	0	5	3	27	40	50	45	53			01,02										Vb 17	CASSTYQGGSGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTCGGGGGAACAGGGGGCACGAACAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	204	3.0241218187424397E-4		50	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	3	0	7	9	5	27	39	57	48	62			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCCCACGGGCTGGGGGCGAAAAACTGAAGCTTTCTTTGGACAA	CASTPTGWGRKTEAFF	In	VDJ	1	210	3.113066578117217E-4	3.775090871830272E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	6	0	5	12	5	27	37	55	49	60			01,02										Vb 17	CASTPTGWGRKTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCCGGGACGCTCTGAACACTGAAGCTTTCTTTGGACAA	CASRDALNTEAFF	In	VDJ	1	213	3.157538957804606E-4	3.829020741427847E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	9	0	7	0	2	4	27	35	42	37	46			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASRDALNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGGAAGGAGGGATCCTCGGGGGGGGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	214	3.1723630843670693E-4		47	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	9	8	0	4	14	1	27	35	57	49	58			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCAACCCTGGGGGAACGGTCCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	214	3.1723630843670693E-4		52	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-03	01	6	6	1	0	7	7	27	38	50	45	57			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ01-03	TCRBV19-01		TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTTTGAGAAGCAGGGAAGCTCCTATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	215	3.187187210929532E-4		50	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	8	4	3	0	8	3	27	36	49	44	52			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTTTTAGGGGATGGCTACACCTTCGGTTCG	CASSIVLGDGYTF	In	VDJ	1	216	3.202011337491995E-4	3.882950611025423E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	5	2	6	4	0	27	43	-1	47	52			01,02										Vb 17	CASSIVLGDGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCAGGGCCCTAAGTGAAAAACTGTTTTTTGGCAGT	CATRALSEKLFF	In	VDJ	1	217	3.216835464054458E-4	3.9009272342246145E-4	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	10	4	3	7	1	7	27	34	40	35	47			01,02										Vb 17	CATRALSEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGATACGGGTACGGATGAAAAACTGTTTTTTGGCAGT	CASSIDTGTDEKLFF	In	VDJ	1	218	3.231659590616921E-4	3.9189038574238063E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	0	8	4	6	2	5	27	44	50	46	55			01,02			01,02							Vb 17	CASSIDTGTDEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD02-01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTGGGGGGAGCTGAAGCTTTCTTTGGACAA	CASSIVGGAEAFF	In	VDJ	1	220	3.261307843741847E-4	3.95485710382219E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	1	9	1	6	1	2	27	43	50	44	52			01,02										Vb 17	CASSIVGGAEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGGGCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	222	3.2909560968667724E-4		34	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	3	6	2	6	0	0	27	-1	-1	41	45			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTTCGGGGAGGACTGAAGCTTTCTTTGGACAA	CASSISGRTEAFF	In	VDJ	1	224	3.3206043499916984E-4	4.026763596618957E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	9	1	5	4	0	27	41	-1	45	51			01,02										Vb 17	CASSISGRTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*02	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCTCGACAGGGGCAGATTCACCCCTCCACTTTGGGAAC	CASSISTGADSPLHF	In	VDJ	1	226	3.3502526031166244E-4	4.06271684301734E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	2	2	8	3	3	27	41	52	44	55			01,02										Vb 17	CASSISTGADSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTAACAGGGACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLTGTNTGELFF	In	VDJ	1	226	3.3502526031166244E-4	4.06271684301734E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	3	3	0	3	1	27	39	48	42	49			01,02										Vb 17	CASSLTGTNTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGGACCTCTACTCTGGAAACACCATATATTTTGGAGAG	CASRDLYSGNTIYF	In	VDJ	1	229	3.394724982804013E-4	4.1166467126149155E-4	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-03	01	6	1	7	0	0	5	27	-1	42	38	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASRDLYSGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01		TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGACCGATTTTCTGGAAACACCATATATTTTGGAGAG	CASSIDRFSGNTIYF	In	VDJ	1	236	3.4984938687412535E-4	4.2424830750092577E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-03	01	0	2	8	1	2	3	27	44	48	46	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIDRFSGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01		TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCGAAGGGACAGGGAGGGCACTGAAGCTTTCTTTGGACAA	CASRRDREGTEAFF	In	VDJ	1	242	3.5874386281160316E-4	4.350342814204409E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	0	3	4	4	4	27	36	49	40	53			01,02										Vb 17	CASRRDREGTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTGACAGGGGGGTTCACTGAAGCTTTCTTTGGACAA	CASSLTGGFTEAFF	In	VDJ	1	243	3.6022627546784943E-4	4.3683194374036005E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	1	4	2	3	27	39	50	41	53			01,02										Vb 17	CASSLTGGFTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCCGGATAGAATGGCTGGCTACACCTTCGGTTCG	CASTPDRMAGYTF	In	VDJ	1	246	3.646735134365883E-4	4.422249307001176E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	7	1	8	7	4	9	27	37	44	41	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASTPDRMAGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAAGGCCGCAGAACACTGAAGCTTTCTTTGGACAA	CASSIRPQNTEAFF	In	VDJ	1	255	3.7801522734280495E-4	4.5840389157939015E-4	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	2	5	4	1	0	5	27	-1	45	42	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIRPQNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACTGCGACCAGGAGTGGAAACACCATATATTTTGGAGAG	CATATRSGNTIYF	In	VDJ	1	256	3.794976399990513E-4	4.602015538993093E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-03	01	10	4	4	3	7	2	27	34	45	41	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CATATRSGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01		TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGCGGGCAGGGGCTACAATGAGCAGTTCTTCGGGCCA	CASAGRGYNEQFF	In	VDJ	1	257	3.8098005265529755E-4	4.619992162192285E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	8	4	2	3	5	0	27	36	-1	41	47			01,02										Vb 17	CASAGRGYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGACTAGCGGGCCCTTCAGAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	264	3.9135694124902163E-4		56	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	1	2	4	0	0	8	25	-1	51	41	59			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD02-01	TCRBJ02-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGAGCAGGAGCACAGATACGCAGTATTTTGGCCCA	CASSMSRSTDTQYF	In	VDJ	2	266	3.943217665615142E-4	4.781781770985011E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	4	4	0	3	0	27	41	-1	44	48			01,02										Vb 17	CASSMSRSTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTTGGGGGGAACAGGGAAGCAATCAGCCCCAGCATTTTGGTGAT	CASSIWGEQGSNQPQHF	In	VDJ	2	271	4.0173382984274566E-4	4.87166488698097E-4	51	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	3	3	3	1	9	1	27	41	56	50	57			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIWGEQGSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGACAGGGGGTACGAGCAGTACTTCGGGCCG	CASSMDRGYEQYF	In	VDJ	2	274	4.0618106781148454E-4	4.925594756578545E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	1	1	4	0	0	27	-1	-1	41	51			01,02										Vb 17	CASSMDRGYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACTTCCAACAGGGACTACAATGAGCAGTTCTTCGGGCCA	CATSNRDYNEQFF	In	VDJ	2	275	4.076634804677308E-4	4.943571379777737E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	10	3	3	3	6	1	27	34	46	40	47			01,02										Vb 17	CATSNRDYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCTCGGGCGCAGGCCTATTGAACACTGAAGCTTTCTTTGGACAA	CASTSGAGLLNTEAFF	In	VDJ	2	297	4.402765589051493E-4	5.339057090159956E-4	48	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	7	4	4	0	9	5	27	37	50	46	55			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASTSGAGLLNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGATCAGCGAGGGGGCAACACAGATACGCAGTATTTTGGCCCA	CASSIDQRGGNTDTQYF	In	VDJ	2	303	4.4917103484262705E-4	5.446916829355107E-4	51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	5	0	2	6	2	27	44	57	50	59			01,02										Vb 17	CASSIDQRGGNTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGCCGGGACGGGGGAACACTGAAGCTTTCTTTGGACAA	CASSMPGRGNTEAFF	In	VDJ	2	306	4.53618272811366E-4	5.500846698952682E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	3	0	7	1	3	4	27	41	49	44	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSMPGRGNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCAAGAGGGAGGTGGGAAACACCATATATTTTGGAGAG	CASTKREVGNTIYF	In	VDJ	2	314	4.654775740613363E-4	5.644659684546216E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	7	9	1	4	6	2	27	37	49	43	51			01,02										Vb 17	CASTKREVGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD02-01*02	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCATCAGGAATTCACCCCTCCACTTTGGGAAC	CASSPIRNSPLHF	In	VDJ	2	321	4.7585446265506037E-4	5.770496046940558E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	4	4	7	5	0	27	39	-1	44	48			01,02										Vb 17	CASSPIRNSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAATGTGGACAGGGGTTTCACCCCTCCACTTTGGGAAC	CASSIMWTGVSPLHF	In	VDJ	2	326	4.8326652593629185E-4	5.860379162936517E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	2	1	2	9	4	1	27	42	55	46	56			01,02										Vb 17	CASSIMWTGVSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGTTAGGACCYAGGGGGTTCAGCAATCAGCCCCAGCATTTTGGTGAT	CASSMLGPRGFSNQPQHF	In	VDJ	2	329	4.8771376390503073E-4	5.914309032534092E-4	54	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	5	1	1	10	3	27	41	57	51	60			01,02										Vb 17	CASSMLGPRGFSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCGGGGACAGGGAAGGGACGAGCAGTACTTCGGGCCG	CASSRGQGRDEQYF	In	VDJ	2	331	4.906785892175233E-4	5.950262278932476E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	3	5	2	5	27	39	50	41	55			01,02										Vb 17	CASSRGQGRDEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTTCCCTTACTGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSLTATNEKLFF	In	VDJ	2	339	5.025378904674936E-4	6.094075264526011E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	8	3	10	0	6	1	27	36	45	42	46			01,02			01,02							Vb 17	CASSLTATNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD02-01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAAAGGGCAGGGGCGAGAGTCAGCCCCAGCATTTTGGTGAT	CASSIKGRGESQPQHF	In	VDJ	2	345	5.114323664049714E-4	6.201935003721161E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	4	2	6	5	6	27	42	53	47	59			01,02										Vb 17	CASSIKGRGESQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACTCCGACATTTGGCGGCAATCAGCCCCAGCATTTTGGTGAT	CASTPTFGGNQPQHF	In	VDJ	2	346	5.129147790612177E-4	6.219911626920353E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	2	6	2	4	7	27	37	45	41	52			01,02										Vb 17	CASTPTFGGNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCCCCCCTCGGGGGCTATGGCTACACCTTCGGTTCG	CASSAPLGGYGYTF	In	VDJ	2	349	5.173620170299566E-4	6.273841496517928E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	5	8	2	4	8	0	27	39	-1	47	53			01,02										Vb 17	CASSAPLGGYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACGCGGGCGGGGGCGTCGACTGAAGCTTTCTTTGGACAA	CASSTRAGASTEAFF	In	VDJ	2	381	5.64799222029838E-4	6.849093438892064E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	4	7	2	5	5	5	27	40	52	45	57			01,02										Vb 17	CASSTRAGASTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGACAGCGAACTCTATAATTCACCCCTCCACTTTGGGAAC	CASSIDSELYNSPLHF	In	VDJ	2	393	5.825881739047935E-4	7.064812917282366E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	0	6	6	3	1	4	27	44	49	45	53			01,02			01,02							Vb 17	CASSIDSELYNSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD02-01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCACGACAGAGGGAGGCTACACCTTCGGTTCG		Out	VDJ	2	430	6.374374421859064E-4		38	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	5	2	5	8	4	5	27	39	48	43	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGATCACTAGTAAAGAACCTACGAGCAGTACTTCGGGCCG	CASSIDH**RTYEQYF	Stop	VDJ	2	437	6.478143307796305E-4		48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	3	8	2	2	7	27	44	51	46	58			01,02			01,02							Vb 17	CASSIDH**RTYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGGACAGGGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSGTGGTGELFF	In	VDJ	3	503	7.456535660918859E-4	9.042241469193461E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	1	4	0	0	27	-1	-1	39	50			01,02										Vb 17	CASSGTGGTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACTCGCACCGGGACAGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CATRTGTANTGELFF	In	VDJ	3	507	7.51583216716871E-4	9.114147961990228E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	10	0	5	0	8	0	27	34	-1	42	49			01,02										Vb 17	CATRTGTANTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCCCCGGGGCTGTAACCACAGGGGAGCAGTTCTTCGGGCCA	CASSTPGAVTTGEQFF	In	VDJ	3	512	7.589952799981026E-4	9.204031077986186E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	3	3	10	17	0	27	40	-1	57	63			01,02										Vb 17	CASSTPGAVTTGEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCTGGTCCGACAGGAGAACTGGAAACACCATATATTTTGGAGAG	CASSIWSDRRTGNTIYF	In	VDJ	3	515	7.634425179668414E-4	9.257960947583762E-4	51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	2	4	2	7	4	27	41	54	48	58			01,02										Vb 17	CASSIWSDRRTGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCCCAAGAGTTATGGCTACACCTTCGGTTCG		Out	VDJ	3	521	7.723369939043192E-4		32	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	10	11	2	5	6	1	27	34	43	40	44			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01*02	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCAGGGGGTTGAACACTGAAGCTTTCTTTGGACAA	CASSRGLNTEAFF	In	VDJ	3	544	8.064324849979839E-4	9.779283020360323E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	1	0	0	1	27	-1	45	38	46			01,02										Vb 17	CASSRGLNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGACAGGGGTAACCGGGGAGCTGTTTTTTGGAGAA	CASRTGVTGELFF	In	VDJ	3	583	8.642465785915894E-4	0.0010480371325128802	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	2	2	5	0	2	27	-1	46	38	48			01,02										Vb 17	CASRTGVTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCAGACTAGCGGGGGGTCAAGAGACCCAGTACTTCGGGCCA	CASSPRLAGGQETQYF	In	VDJ	3	584	8.657289912478357E-4	0.0010498347948327993	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	2	1	2	4	1	27	39	56	43	57			01,02										Vb 17	CASSPRLAGGQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGCGGAGCGAGACCGATTTGGCAGTTCTTCGGGCCA	CASSIGGARPIWQFF	In	VDJ	3	601	8.909300064040227E-4	0.0010803950542714255	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	6	6	12	4	11	27	43	51	47	62			01,02			01,02							Vb 17	CASSIGGARPIWQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGATCCCAACAGGGTTGGACTAGCATATAATGAGCAGTTCTTCGGGCCA	CASSIDPNRVGLAYNEQFF	In	VDJ	3	605	8.968596570290079E-4	0.0010875857035511022	57	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	1	7	7	13	4	24	41	62	54	66			01,02			01,02							Vb 17	CASSIDPNRVGLAYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTCAGCCTTACAATGAGCAGTTCTTCGGGCCA	CASSIQPYNEQFF	In	VDJ	3	605	8.968596570290079E-4	0.0010875857035511022	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	3	4	5	4	1	3	27	41	45	42	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIQPYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAAGAGGGGGCAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	3	607	8.998244823415004E-4		41	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	5	0	1	3	0	27	37	-1	40	47			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCTGACAGGGGCGCGAGGATTGAGCACTGAAGCTTTCTTTGGACAA	CASSLTGARGLSTEAFF	In	VDJ	4	633	9.383672114039041E-4	0.001137920248508839	51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	2	4	3	13	27	38	49	41	62			01,02										Vb 17	CASSLTGARGLSTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCAGGGAAGTACACTGAAGCTTTCTTTGGACAA	CASSPGKYTEAFF	In	VDJ	4	639	9.472616873413819E-4	0.0011487062224283542	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	3	3	1	4	27	39	45	40	49			01,02										Vb 17	CASSPGKYTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGGACTAGCGGGGTTGATGAGCAGTTCTTCGGGCCA	CASSGTSGVDEQFF	In	VDJ	4	642	9.517089253101207E-4	0.0011540992093881117	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	0	3	8	0	3	27	-1	52	39	55			01,02										Vb 17	CASSGTSGVDEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCTACGGGGGTTTGGACACTGAAGCTTTCTTTGGACAA	CASSYGGLDTEAFF	In	VDJ	4	766	0.0011355280946846612	0.0013770093370580896	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	6	8	2	3	3	5	27	38	47	41	52			01,02										Vb 17	CASSYGGLDTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGCGGGACAGTCTACGAGCAGTACTTCGGGCCG	CASSIGGTVYEQYF	In	VDJ	4	776	0.001150352221247124	0.0013949859602572815	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	5	3	4	1	27	41	52	45	53			01,02										Vb 17	CASSIGGTVYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAATGCTGCTGGAAACACCATATATTTTGGAGAG	CASSNAAGNTIYF	In	VDJ	5	818	0.0012126135528094685	0.0014704877776938869	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-03	01	4	10	0	2	2	2	27	40	44	42	46			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSNAAGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01		TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGGGGGCGCAACACCGGGGAGCTGTTTTTTGGAGAA	CASSIGGRNTGELFF	In	VDJ	5	848	0.0012570859324968573	0.001524417647291462	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	3	8	1	2	0	3	27	-1	48	41	51			01,02										Vb 17	CASSIGGRNTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGAAACAGGGGGCTATGAACACTGAAGCTTTCTTTGGACAA	CASRKQGAMNTEAFF	In	VDJ	6	1092	0.001618794620620953	0.0019630472533517414	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	0	0	3	2	27	38	50	41	52			01,02										Vb 17	CASRKQGAMNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCATCGGACAGGGGCAGCCCCAGCATTTTGGTGAT	CASSTIGQGQPQHF	In	VDJ	10	1713	0.0025393728801499016	0.0030793955540215504	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	1	2	7	5	0	27	40	-1	45	54			01,02										Vb 17	CASSTIGQGQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGGACTGACGATTAGGGATGGCTACACCTTCGGTTCG	CASSGLTIRDGYTF	In	VDJ	1	45	6.670856953108322E-5	8.089480439636297E-5	42	TCRBV25	TCRBV25-01	01				TCRBJ01	TCRBJ01-02	01	4	5	3	6	11	0	23	36	-1	47	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CASSGLTIRDGYTF+TCRBV25-01+TCRBJ01-02	TCRBV25-01*01		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGGGACAGAAAATTCACCCCTCCACTTTGGGAAC	CASSGTENSPLHF	In	VDJ	1	49	7.26382201560684E-5	8.808545367603968E-5	39	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	1	5	7	0	2	23	-1	42	36	44													Vb 11	CASSGTENSPLHF+TCRBV25-01+TCRBJ01-06	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCACCCTACCCGGGGAGCGTATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	50	7.41206328123147E-5		47	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	7	8	3	4	7	4	23	33	45	40	49						01,02							Vb 11	X+TCRBV25-01+TCRBJ01-06	TCRBV25-01*01	TCRBD02-01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAGGGGCAGGGGAGCACTGAAGCTTTCTTTGGACAA	CASSEGQGSTEAFF	In	VDJ	1	50	7.41206328123147E-5	8.988311599595886E-5	42	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	2	4	4	2	23	37	47	41	49													Vb 11	CASSEGQGSTEAFF+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGGAACCTAGCGGTTCCACACAGATACGCAGTATTTTGGCCCA	CASSGT*RFHTDTQYF	Stop	VDJ	1	53	7.856787078105358E-5		48	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	4	5	2	4	5	23	36	47	40	52						01,02							Vb 11	CASSGT*RFHTDTQYF+TCRBV25-01+TCRBJ02-03	TCRBV25-01*01	TCRBD02-01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAGGAGTGGCCCCAGAACACTGAAGCTTTCTTTGGACAA	CASSEEWPQNTEAFF	In	VDJ	1	66	9.783923531225541E-5	1.1864571311466569E-4	45	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	10	2	1	0	8	23	-1	41	37	49													Vb 11	CASSEEWPQNTEAFF+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01	TCRBD02-01*02	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGCGAGGACAGGGGGTTTAGAGCCTACAATGAGCAGTTCTTCGGGCCA	CASSEDRGFRAYNEQFF	In	VDJ	1	74	1.0969853656222575E-4	1.3302701167401912E-4	51	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	1	1	2	3	7	23	34	47	37	54													Vb 11	CASSEDRGFRAYNEQFF+TCRBV25-01+TCRBJ02-01	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTCGAACGGGCCTCAGAAAGGGATTGTTCTTCGGGCCA	CASSRTGLRKGLFF	In	VDJ	1	76	1.1266336187471834E-4	1.3662233631385747E-4	42	TCRBV25	TCRBV25-01	01				TCRBJ02	TCRBJ02-01	01	5	0	8	15	17	2	23	35	56	52	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CASSRTGLRKGLFF+TCRBV25-01+TCRBJ02-01	TCRBV25-01*01		TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTCCTCCCCGGACAGGGAAGAACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	80	1.1859301249970352E-4		46	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	3	5	7	4	23	35	50	42	54													Vb 11	X+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAGATCGGAGGGAACTATGGCTACACCTTCGGTTCG	CASSEIGGNYGYTF	In	VDJ	1	84	1.245226631246887E-4	1.5100363487321086E-4	42	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	3	10	0	2	4	0	23	37	-1	41	47													Vb 11	CASSEIGGNYGYTF+TCRBV25-01+TCRBJ01-02	TCRBV25-01*01	TCRBD02-01*02	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAATACCCCGCGGAGCTCCTATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	95	1.4082920234339793E-4		52	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	0	7	5	0	4	2	23	40	48	44	50						01,02							Vb 11	X+TCRBV25-01+TCRBJ01-06	TCRBV25-01*01	TCRBD02-01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGCAGGGGCCACCATGAACACTGAAGCTTTCTTTGGACAA	CASSAGATMNTEAFF	In	VDJ	1	111	1.6454780484333862E-4	1.9954051751102866E-4	45	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	2	0	0	6	23	-1	42	36	48													Vb 11	CASSAGATMNTEAFF+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGTAGCAGGGACAGATACGCAGTATTTTGGCCCA	CASSVAGTDTQYF	In	VDJ	1	145	2.1494983515571263E-4	2.6066103638828066E-4	39	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	4	3	3	3	0	23	36	-1	39	44													Vb 11	CASSVAGTDTQYF+TCRBV25-01+TCRBJ02-03	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAATTCAGGGGACGCACAGATACGCAGTATTTTGGCCCA	CASSEFRGRTDTQYF	In	VDJ	1	161	2.3866843765565332E-4	2.894236335069875E-4	45	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	4	2	1	1	2	23	39	46	40	48													Vb 11	CASSEFRGRTDTQYF+TCRBV25-01+TCRBJ02-03	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCACATACCTCTCAGTACCTCTGTGCTAGCAGTGATTCGTCCGGGACAGATACGCAGTATTTTGGCCCA	CASSDSSGTDTQYF	In	VDJ	1	161	2.3866843765565332E-4	2.894236335069875E-4	42	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	8	4	3	6	0	23	37	-1	43	47						01,02							Vb 11	CASSDSSGTDTQYF+TCRBV25-01+TCRBJ02-03	TCRBV25-01*01	TCRBD02-01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAACGGGTCAACGGGACAGGGTGTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	213	3.157538957804606E-4		46	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	0	3	4	10	2	23	33	52	43	54													Vb 11	X+TCRBV25-01+TCRBJ02-07	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGCCGGGGGGGGCTCAATCAGCCCCAGCATTTTGGTGAT	CASSRGGLNQPQHF	In	VDJ	1	215	3.187187210929532E-4	3.864973987826231E-4	42	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	6	8	0	3	1	3	23	34	43	35	46													Vb 11	CASSRGGLNQPQHF+TCRBV25-01+TCRBJ01-05	TCRBV25-01*01	TCRBD02-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGACCCCGGGACAGCAAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	239	3.542966248428643E-4		43	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	0	5	7	5	2	23	34	46	39	48													Vb 11	X+TCRBV25-01+TCRBJ01-06	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGGACCCGGGACAGGGACCCCTCTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	2	298	4.417589715613956E-4		53	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	3	0	5	6	23	36	50	41	56													Vb 11	X+TCRBV25-01+TCRBJ01-02	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAAAGCAGGGACACTGAAGCTTTCTTTGGACAA	CASSESRDTEAFF	In	VDJ	2	395	5.855529992172861E-4	7.10076616368075E-4	39	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	3	3	2	0	23	38	-1	40	45													Vb 11	CASSESRDTEAFF+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAAGACCCCCGGGGAAACATTCAGTACTTCGGCGCC	CASSEDPRGNIQYF	In	VDJ	7	1294	0.0019182419771827043	0.002326175041975415	42	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	2	8	3	6	6	0	23	38	-1	44	49													Vb 11	CASSEDPRGNIQYF+TCRBV25-01+TCRBJ02-04	TCRBV25-01*01	TCRBD02-01*01	TCRBJ02-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCAGTTTATCGTCGGGACAGGTGAATGATGGCTACACCTTCGGTTCG	CASSLSSGQVNDGYTF	In	VDJ	1	45	6.670856953108322E-5	8.089480439636297E-5	48	TCRBV27	TCRBV27-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	0	4	6	3	6	33	50	61	53	67													Vb 14	CASSLSSGQVNDGYTF+TCRBV27-01+TCRBJ01-02	TCRBV27-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTTTCGCCAGGGGACCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	47	6.967339484357581E-5		40	TCRBV27	TCRBV27-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	2	7	3	2	23	37	46	40	48													Vb 14	X+TCRBV27-01+TCRBJ01-05	TCRBV27-01*01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGACGTCAGGGACAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	74	1.0969853656222575E-4		44	TCRBV27	TCRBV27-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	4	3	0	4	1	23	34	43	38	44													Vb 14	X+TCRBV27-01+TCRBJ01-04	TCRBV27-01*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAATCGCTGACAGGGACTAGCGCCTACAATGAGCAGTTCTTCGGGCCA	CSVESLTGTSAYNEQFF	In	VDJ	1	45	6.670856953108322E-5	8.089480439636297E-5	51	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	0	6	2	9	0	25	37	-1	46	56						01,02							Vb 4	CSVESLTGTSAYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCGGGACAGGAGGGGACTGAAGCTTTCTTTGGACAA	CSVAGQEGTEAFF	In	VDJ	1	46	6.819098218732952E-5	8.269246671628214E-5	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	4	5	1	5	25	35	44	36	49													Vb 4	CSVAGQEGTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCTAGTCTTGGGACAGGGAATATTTACACTGAAGCTTTCTTTGGACAA	CSASLGTGNIYTEAFF	In	VDJ	1	47	6.967339484357581E-5	8.449012903620132E-5	48	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	0	3	3	8	7	25	32	49	40	56													Vb 4	CSASLGTGNIYTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCTCCGGGACGGCCCAATCAGCCCCAGCATTTTGGTGAT	CSVAPGRPNQPQHF	In	VDJ	1	47	6.967339484357581E-5	8.449012903620132E-5	42	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-05	01	4	0	7	3	4	4	25	35	44	39	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVAPGRPNQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCGCCTCAGGTAGCAATCAGCCCCAGCATTTTGGTGAT	CSAASGSNQPQHF	In	VDJ	1	50	7.41206328123147E-5	8.988311599595886E-5	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	4	4	0	6	0	25	32	-1	38	42													Vb 4	CSAASGSNQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCGGCAGGGTTCTGGAAACACCATATATTTTGGAGAG	CSVRQGSGNTIYF	In	VDJ	1	50	7.41206328123147E-5	8.988311599595886E-5	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	4	3	1	3	1	25	34	42	37	43													Vb 4	CSVRQGSGNTIYF+TCRBV29-01+TCRBJ01-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGAGGGGGGGCCGGTGGCAATCAGCCCCAGCATTTTGGTGAT	CSVGGGAGGNQPQHF	In	VDJ	1	50	7.41206328123147E-5	8.988311599595886E-5	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	4	9	0	2	2	6	25	35	44	37	50													Vb 4	CSVGGGAGGNQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD02-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCAAAAGGGGGGGGGCCCATGAGCAGTTCTTCGGGCCA	CSAKRGGAHEQFF	In	VDJ	1	51	7.560304546856099E-5	9.168077831587803E-5	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	7	9	0	8	6	5	25	32	45	38	50													Vb 4	CSAKRGGAHEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCAAGGCACCCACTCCTATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	51	7.560304546856099E-5		46	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-06	01	4	5	4	0	2	6	25	35	40	37	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	X+TCRBV29-01+TCRBJ01-06	TCRBV29-01*01		TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGACGGCCAGGGCGTCTCCTACGAGCAGTACTTCGGGCCG	CSVDGQGVSYEQYF	In	VDJ	1	53	7.856787078105358E-5	9.527610295571638E-5	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	3	0	4	3	25	36	45	40	48													Vb 4	CSVDGQGVSYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATCTCCAGGGCACCCAGCATTTTGGTGAT	CSVEDLQGTQHF	In	VDJ	1	57	8.449752140603876E-5	1.024667522353931E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	4	3	11	4	2	25	39	48	43	50													Vb 4	CSVEDLQGTQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCCAAGACAGGGGGCCTGGCTACACCTTCGGTTCG	CSVQDRGPGYTF	In	VDJ	1	58	8.597993406228505E-5	1.0426441455531227E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	0	7	4	1	25	33	47	37	48													Vb 4	CSVQDRGPGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATAAGGGCGGCACTGAAGCTTTCTTTGGACAA	CSVEDKGGTEAFF	In	VDJ	1	58	8.597993406228505E-5	1.0426441455531227E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-01	01	0	5	3	4	2	3	25	39	45	41	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVEDKGGTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGTTCCCAGGAGTCCTCCTACGAGCAGTACTTCGGGCCG	CSGSQESSYEQYF	In	VDJ	1	59	8.746234671853134E-5	1.0606207687523144E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-07	01	7	4	4	0	5	4	25	32	41	37	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSGSQESSYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01		TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGGCCGGGACAGGGGACTATGGCTACACCTTCGGTTCG	CSVAGTGDYGYTF	In	VDJ	1	59	8.746234671853134E-5	1.0606207687523144E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	2	3	4	0	25	33	-1	37	47													Vb 4	CSVAGTGDYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGCACAGGGCGGGGACACTGAAGCTTTCTTTGGACAA	CSVEAQGGDTEAFF	In	VDJ	1	60	8.894475937477764E-5	1.0785973919515063E-4	42	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-01	01	1	3	3	3	1	5	25	38	45	39	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVEAQGGDTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAATGGGCTTCCCAACCCTATGGCTACACCTTCGGTTCG	CSVEWASQPYGYTF	In	VDJ	1	62	9.190958468727023E-5	1.1145506383498898E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	8	0	4	1	9	25	37	42	38	51													Vb 4	CSVEWASQPYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCAGGGGGGGGCAAGAGACCCAGTACTTCGGGCCA	CSARGGQETQYF	In	VDJ	1	63	9.339199734351652E-5	1.1325272615490816E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-05	01	7	4	1	2	1	3	25	32	40	33	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSARGGQETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01		TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCCCCTCGGGGGCGACCAATTGAAAAACTGTTTTTTGGCAGT	CSVAPRGRPIEKLFF	In	VDJ	1	65	9.635682265600911E-5	1.1684805079474652E-4	45	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-04	01	4	6	0	7	6	7	25	35	47	41	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVAPRGRPIEKLFF+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01		TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGGCCTTTGCCGGGGGCTAGATACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	65	9.635682265600911E-5		43	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-03	01	9	6	0	3	9	5	25	30	45	39	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	X+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01		TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGATAAACCGGGACAGGGAAAGAGAGACCCAGTACTTCGGGCCA	CSVINRDRERETQYF	In	VDJ	1	66	9.783923531225541E-5	1.1864571311466569E-4	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	0	3	4	8	4	25	33	50	41	54													Vb 4	CSVINRDRERETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGAAGTTATGGGACTAGCAGGAGAGCCGAGCAGTACTTCGGGCCG		Out	VDJ	1	67	9.93216479685017E-5		50	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	0	7	6	6	8	25	39	54	45	62						01,02							Vb 4	X+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGAGCGCCTAGCGGGGGCCTACAATGAGCAGTTCTTCGGGCCA	CSERLAGAYNEQFF	In	VDJ	1	69	1.0228647328099429E-4	1.2403870007442322E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	7	4	2	2	5	0	25	32	-1	37	47													Vb 4	CSERLAGAYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGACAGGACAGGATAATGAAGCTTTCTTTGGACAA	CSVGTGQDNEAFF	In	VDJ	1	69	1.0228647328099429E-4	1.2403870007442322E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	4	7	0	9	25	-1	42	35	51													Vb 4	CSVGTGQDNEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGAATTCACCGCTAACTATGGCTACACCTTCGGTTCG	CSEFTANYGYTF	In	VDJ	1	74	1.0969853656222575E-4	1.3302701167401912E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-02	01	7	3	7	0	5	2	25	32	39	37	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSEFTANYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTAAGGGGAAGGGACAGGGGAACACTGAAGCTTTCTTTGGACAA	CSVKGKGQGNTEAFF	In	VDJ	1	74	1.0969853656222575E-4	1.3302701167401912E-4	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	3	1	8	0	25	34	-1	42	51													Vb 4	CSVKGKGQGNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATCCGAAGACAGGGCCCGGGGAGCTGTTTTTTGGAGAA	CSVEDPKTGPGELFF	In	VDJ	1	77	1.1414577453096463E-4	1.3841999863377664E-4	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	2	3	6	6	1	25	39	52	45	53													Vb 4	CSVEDPKTGPGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATGGCATCTACTATGGCTACACCTTCGGTTCG	CSVEDGIYYGYTF	In	VDJ	1	77	1.1414577453096463E-4	1.3841999863377664E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	9	0	3	1	4	25	39	43	40	47													Vb 4	CSVEDGIYYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTAAGCAGGGGGGGCACAGATACGCAGTATTTTGGCCCA	CSVSRGGTDTQYF	In	VDJ	1	78	1.1562818718721093E-4	1.4021766095369582E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	4	1	1	3	1	25	33	43	36	44													Vb 4	CSVSRGGTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTAACAGGGGTGGCACAAATACGCAGTATTTTGGCCCA	CSVNRGGTNTQYF	In	VDJ	1	82	1.215578378121961E-4	1.4740831023337252E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	3	2	7	1	8	25	34	42	35	50													Vb 4	CSVNRGGTNTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCCTTCACCGGGACTTAAGAGGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	83	1.230402504684424E-4		40	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	8	0	10	8	7	6	25	31	44	38	50						01,02							Vb 4	X+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01	TCRBD02-01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCGGGAGGACTGGACAGTCGAGGTACACTGAAGCTTTCTTTGGACAA	CSAGRTGQSRYTEAFF	In	VDJ	1	84	1.245226631246887E-4	1.5100363487321086E-4	48	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	7	8	1	3	1	16	25	32	40	33	56													Vb 4	CSAGRTGQSRYTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAACGGGACTAAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	84	1.245226631246887E-4		38	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	2	0	9	2	1	0	25	37	-1	38	45						01,02							Vb 4	X+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD02-01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTTTCCAGACAGGGGCGGGCACTGAAGCTTTCTTTGGACAA	CSVFQTGAGTEAFF	In	VDJ	1	84	1.245226631246887E-4	1.5100363487321086E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	2	4	5	4	25	34	47	39	51													Vb 4	CSVFQTGAGTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGCTGACAGGGTATAACTATGGCTACACCTTCGGTTCG	CSVLTGYNYGYTF	In	VDJ	1	88	1.3045231374967387E-4	1.581942841528876E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	3	1	3	2	25	33	43	36	45													Vb 4	CSVLTGYNYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCGGGACTAGCGGGGGGACAGATACGCAGTATTTTGGCCCA	CSVGTSGGTDTQYF	In	VDJ	1	90	1.3341713906216645E-4	1.6178960879272594E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	0	1	3	1	0	25	33	-1	34	49													Vb 4	CSVGTSGGTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGAGGGGGGGACAATGAGCAGTTCTTCGGGCCA	CSVGGGDNEQFF	In	VDJ	1	92	1.3638196437465905E-4	1.653849334325643E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	9	0	5	2	0	25	35	-1	37	44													Vb 4	CSVGGGDNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTAAGACAGGGGGGACTGAAGCTTTCTTTGGACAA	CSVKTGGTEAFF	In	VDJ	1	93	1.3786437703090535E-4	1.6718259575248346E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	1	5	2	1	25	34	45	36	46													Vb 4	CSVKTGGTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGATGTGGGGGGTCCCTACGAGCAGTACTTCGGGCCG	CSVDVGGPYEQYF	In	VDJ	1	93	1.3786437703090535E-4	1.6718259575248346E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	9	1	2	3	2	25	36	45	39	47													Vb 4	CSVDVGGPYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGATTTTGGACACGGCGTAGATGAAAAACTGTTTTTTGGCAGT	CSVDFGHGVDEKLFF	In	VDJ	1	94	1.3934678968715162E-4	1.6898025807240264E-4	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	1	6	6	4	8	25	36	45	40	53													Vb 4	CSVDFGHGVDEKLFF+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGTCAGCCCTTCACAATGAGCAGTTCTTCGGGCCA	CSVESALHNEQFF	In	VDJ	1	95	1.4082920234339793E-4	1.7077792039232181E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-01	01	3	4	5	5	2	6	25	36	41	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVESALHNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01		TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCGAGGGGCAGGAGTTTAACAGATACGCAGTATTTTGGCCCA	CSVARGRSLTDTQYF	In	VDJ	1	95	1.4082920234339793E-4	1.7077792039232181E-4	45	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-03	01	4	5	2	3	2	10	25	35	42	37	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVARGRSLTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01		TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGTGCGGGGGGGGCCGGGAGAGCAGTACTTCGGGCCG	CSVEVRGGPGEQYF	In	VDJ	1	97	1.437940276558905E-4	1.743732450321602E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	1	7	0	7	1	7	25	38	48	39	55													Vb 4	CSVEVRGGPGEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCTGTGTTGGGGTCCACTGAAGCTTTCTTTGGACAA	CSAVLGSTEAFF	In	VDJ	1	98	1.452764403121368E-4	1.7617090735207936E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-01	01	7	6	2	4	7	2	25	32	43	39	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSAVLGSTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTAATACAGGGGAGCAATCAGCCCCAGCATTTTGGTGAT	CSVIQGSNQPQHF	In	VDJ	1	99	1.467588529683831E-4	1.7796856967199854E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	3	2	1	3	0	25	33	-1	36	43													Vb 4	CSVIQGSNQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAATACCCGGCAGACTTGAACACTGAAGCTTTCTTTGGACAA	CSVEYPADLNTEAFF	In	VDJ	1	100	1.482412656246294E-4	1.7976623199191771E-4	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	2	2	10	0	9	0	25	37	-1	46	50						01,02							Vb 4	CSVEYPADLNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCTGCTGGGGGGACACAAACACCGGGGAGCTGTTTTTTGGAGAA	CSCWGDTNTGELFF	In	VDJ	1	100	1.482412656246294E-4	1.7976623199191771E-4	42	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-02	01	8	0	6	2	7	2	25	31	44	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSCWGDTNTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01		TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCCTAAAGTACACCGGGGAGCTGTTTTTTGGAGAA	CSALKYTGELFF	In	VDJ	1	101	1.4972367828087568E-4	1.815638943118369E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	7	4	9	3	2	4	25	32	37	34	41						01,02							Vb 4	CSALKYTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD02-01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGGGACAGGGGGCTCAGGGCTACACCTTCGGTTCG	CSVEGQGAQGYTF	In	VDJ	1	103	1.5268850359336829E-4	1.8515921895167524E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	0	8	0	4	25	-1	48	36	52													Vb 4	CSVEGQGAQGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTACCGGACAGGGGTTATGGCTACACCTTCGGTTCG	CSVVPDRGYGYTF	In	VDJ	1	103	1.5268850359336829E-4	1.8515921895167524E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	2	5	4	1	25	35	48	39	49													Vb 4	CSVVPDRGYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGCCAGGGGGCGAGTACTGAAGCTTTCTTTGGACAA	CSVGQGASTEAFF	In	VDJ	1	104	1.5417091624961456E-4	1.869568812715944E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	0	5	2	4	25	35	45	37	49													Vb 4	CSVGQGASTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTAATACAGGGGGACTCCTACGAGCAGTACTTCGGGCCG	CSVIQGDSYEQYF	In	VDJ	1	105	1.5565332890586086E-4	1.887545435915136E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	3	1	0	3	1	25	33	44	36	45													Vb 4	CSVIQGDSYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCGGACAGGTTAGGAACGAGCAGTACTTCGGGCCG	CSAGQVRNEQYF	In	VDJ	1	107	1.5861815421835347E-4	1.9234986823135194E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	1	4	5	2	6	25	32	41	34	47													Vb 4	CSAGQVRNEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGAGACAGGGAAAACTGGGGATCTGAAGCTTTCTTTGGACAA	CSGDRENWGSEAFF	In	VDJ	1	109	1.6158297953084604E-4	1.9594519287119031E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	2	3	6	2	12	25	32	41	34	53													Vb 4	CSGDRENWGSEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCTACAGGGCCGCGCGAAGCAATGAGCAGTTCTTCGGGCCA	CSVYRAARSNEQFF	In	VDJ	1	111	1.6454780484333862E-4	1.9954051751102866E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	3	3	6	2	10	25	33	41	35	51													Vb 4	CSVYRAARSNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTTCTCGGGACTAGCGGGAATGAGCAGTTCTTCGGGCCA	CSVVLGTSGNEQFF	In	VDJ	1	113	1.6751263015583122E-4	2.03135842150867E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	0	4	7	5	0	25	35	-1	40	52						01,02							Vb 4	CSVVLGTSGNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCGAACAGACTAGCGGGGGGGCAGATACGCAGTATTTTGGCCCA	CSVEQTSGGADTQYF	In	VDJ	1	117	1.734422807808164E-4	2.103264914305437E-4	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	2	0	4	2	0	25	37	-1	39	53													Vb 4	CSVEQTSGGADTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTAGTAGCGGGGGGTCCCTTTCCTACAATGAGCAGTTCTTCGGGCCA	CSVSSGGSLSYNEQFF	In	VDJ	1	118	1.7492469343706268E-4	2.1212415375046289E-4	48	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	5	1	1	2	6	25	34	46	36	52													Vb 4	CSVSSGGSLSYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGACTAGCGGGGGACGATACGCAGTATTTTGGCCCA	CSVGLAGDDTQYF	In	VDJ	1	126	1.8678399468703303E-4	2.265054523098163E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	2	2	6	0	2	25	-1	47	35	49													Vb 4	CSVGLAGDDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCTCATTACTAGCACAGATACGCAGTATTTTGGCCCA	CSVLITSTDTQYF	In	VDJ	1	127	1.8826640734327934E-4	2.2830311462973549E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	3	10	0	6	0	25	34	-1	40	43						01,02							Vb 4	CSVLITSTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAACCTCCGGGACAGGGAGTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	129	1.912312326557719E-4		46	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	0	3	1	5	2	25	37	51	42	53													Vb 4	X+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCGCGTTTAACACGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	132	1.9567847062451082E-4		37	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-05	01	6	3	6	5	8	3	25	33	44	41	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	X+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01		TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGGTGATACTAGCGGTCCAAATGGTGTTCTTCGGGCCA	CSVVILAVQMVFF	In	VDJ	1	138	2.0457294656198857E-4	2.4807740014884643E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	3	5	15	6	10	25	33	47	39	57						01,02							Vb 4	CSVVILAVQMVFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTTGACGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CSVVDANTGELFF	In	VDJ	1	138	2.0457294656198857E-4	2.4807740014884643E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-02	01	4	2	7	0	2	1	25	35	40	37	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVVDANTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01		TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCGGGGGCAGGGCAATGGGAACTGAAGCTTTCTTTGGACAA	CSVGGRAMGTEAFF	In	VDJ	1	146	2.1643224781195893E-4	2.6245869870819983E-4	42	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-01	01	6	6	0	5	1	12	25	33	40	34	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVGGRAMGTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCGGACAGGGGAACACTGAAGCTTTCTTTGGACAA	CSVGQGNTEAFF	In	VDJ	1	151	2.2384431109319039E-4	2.7144701030779576E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	3	1	1	0	25	33	-1	34	42													Vb 4	CSVGQGNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGGGCGGGAATTCACCCCTCCACTTTGGGAAC	CSVGGGNSPLHF	In	VDJ	1	156	2.3125637437442187E-4	2.8043532190739163E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-06	01	4	7	0	7	0	3	25	-1	40	35	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVGGGNSPLHF+TCRBV29-01+TCRBJ01-06	TCRBV29-01*01		TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTATCACGAGGGAACGGGGAGCTGTTTTTTGGAGAA	CSVSRGNGELFF	In	VDJ	1	163	2.4163326296814592E-4	2.9301895814682586E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	11	0	7	5	2	25	33	43	38	45													Vb 4	CSVSRGNGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGACCGGGACAGGGAACACTGAAGCTTTCTTTGGACAA	CSVTGTGNTEAFF	In	VDJ	1	168	2.490453262493774E-4	3.0200726974642173E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	4	1	4	0	25	33	-1	37	45													Vb 4	CSVTGTGNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGGGCGGACAGCTGGACTACACAGATACGCAGTATTTTGGCCCA	CSVGGQLDYTDTQYF	In	VDJ	1	172	2.549749768743626E-4	3.091979190260985E-4	45	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-03	01	6	1	5	2	4	8	25	33	43	37	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVGGQLDYTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01		TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTTGGACAGGGTTGAACACTGAAGCTTTCTTTGGACAA	CSVWTGLNTEAFF	In	VDJ	1	173	2.5645738953060886E-4	3.1099558134601766E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	3	0	1	1	25	34	43	35	44													Vb 4	CSVWTGLNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTAAGACAGGGGGCGATTCCTACGAGCAGTACTTCGGGCCG	CSVKTGGDSYEQYF	In	VDJ	1	180	2.668342781243329E-4	3.235792175854519E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	0	1	2	3	25	34	46	36	49													Vb 4	CSVKTGGDSYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCCCGGGACCAACGAACACCGGGGAGCTGTTTTTTGGAGAA	CSVPGPTNTGELFF	In	VDJ	1	189	2.801759920305496E-4	3.3975817846472445E-4	42	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-02	01	6	0	7	0	3	3	25	33	41	36	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVPGPTNTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01		TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTACCCAGGCCAGGGACTGAAGCTTTCTTTGGACAA	CSVVPRPGTEAFF	In	VDJ	1	190	2.8165840468679585E-4	3.4155584078464363E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	3	5	9	0	25	35	-1	44	49													Vb 4	CSVVPRPGTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGCACACAGGGGGGGAATGAAAAACTGTTTTTTGGCAGT	CSGTQGGNEKLFF	In	VDJ	1	207	3.0685941984298285E-4	3.7211610022326965E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	7	3	1	5	4	2	25	32	44	36	46													Vb 4	CSGTQGGNEKLFF+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCTACCGGGACAGAGGTGAAAAACTGTTTTTTGGCAGT	CSYRDRGEKLFF	In	VDJ	1	221	3.2761319703043096E-4	3.9728337270213815E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	8	0	5	7	4	3	25	31	42	35	45													Vb 4	CSYRDRGEKLFF+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGACGGACAGGGAATGAAAAACTGTTTTTTGGCAGT	CSVGRTGNEKLFF	In	VDJ	1	236	3.4984938687412535E-4	4.2424830750092577E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	1	3	5	3	0	25	35	-1	38	46													Vb 4	CSVGRTGNEKLFF+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCCCGGGCCGAACACTGAAGCTTTCTTTGGACAA	CSVPGPNTEAFF	In	VDJ	1	256	3.794976399990513E-4	4.602015538993093E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-01	01	5	8	0	1	3	1	25	34	41	37	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVPGPNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTTGGACTAGCGGGGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	286	4.2397001968644005E-4		44	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	1	3	1	2	0	25	35	-1	37	49													Vb 4	X+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGTTTCTTACAGGGGGCGCCGCCTACAATGAGCAGTTCTTCGGGCCA	CSVEFLTGGAAYNEQFF	In	VDJ	2	330	4.89196176561277E-4	5.932285655733284E-4	51	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	3	0	2	7	4	25	36	52	43	56													Vb 4	CSVEFLTGGAAYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGACGTGAGAGCTAACTATGGCTACACCTTCGGTTCG	CSVDVRANYGYTF	In	VDJ	3	504	7.471359787481321E-4	9.060218092392652E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	3	11	2	0	3	2	25	36	42	39	44													Vb 4	CSVDVRANYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGATGTAGTCTAGCGGGGGGCATGGGAAGAAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	4	731	0.001083643651716041		55	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	4	1	3	6	10	25	36	53	42	63													Vb 4	X+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGCTAGCGGGGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	11	1865	0.0027646996038993383		40	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	4	3	0	2	0	25	35	-1	37	46													Vb 4	X+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATAACAAGTATGGCTACACCTTCGGTTCG	CSVEDNKYGYTF	In	VDJ	26	4587	0.00679982685420175	0.008245877061469266	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	3	6	5	2	2	25	39	44	41	46													Vb 4	CSVEDNKYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGTAAGTGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSVSGTGELFF	In	VDJ	1	47	6.967339484357581E-5	8.449012903620132E-5	39	TCRBV02	TCRBV02-01	01				TCRBJ02	TCRBJ02-02	01	4	0	10	4	5	0	23	36	-1	41	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASSVSGTGELFF+TCRBV02-01+TCRBJ02-02	TCRBV02-01*01		TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCGTCCGGGAGGGAAGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	47	6.967339484357581E-5		37	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	8	8	0	8	3	2	23	32	43	35	45													Vb 22	X+TCRBV02-01+TCRBJ01-04	TCRBV02-01*01	TCRBD02-01*02	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTCCCAGGGACTATGGCTACACCTTCGGTTCG	CASSPRDYGYTF	In	VDJ	1	49	7.26382201560684E-5	8.808545367603968E-5	36	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	3	3	2	0	23	35	-1	37	42													Vb 22	CASSPRDYGYTF+TCRBV02-01+TCRBJ01-02	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGGGGGAGGGGCGGAAGACAATGGCTACACCTTCGGTTCG	CASSGGGAEDNGYTF	In	VDJ	1	62	9.190958468727023E-5	1.1145506383498898E-4	45	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	4	9	0	6	1	10	23	36	44	37	54													Vb 22	CASSGGGAEDNGYTF+TCRBV02-01+TCRBJ01-02	TCRBV02-01*01	TCRBD02-01*02	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAAAGGGGACGGGGCCAACGTCCTGACTTTCGGGGCC	CASKGDGANVLTF	In	VDJ	1	67	9.93216479685017E-5	1.2044337543458487E-4	39	TCRBV02	TCRBV02-01	01				TCRBJ02	TCRBJ02-06	01	7	0	7	4	3	0	23	33	-1	36	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASKGDGANVLTF+TCRBV02-01+TCRBJ02-06	TCRBV02-01*01		TCRBJ02-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGGAGTGTATCGAACACTGAAGCTTTCTTTGGACAA	CASRSVSNTEAFF	In	VDJ	1	81	1.2007542515594981E-4	1.4561064791345334E-4	39	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	11	2	1	0	6	23	-1	37	34	43													Vb 22	CASRSVSNTEAFF+TCRBV02-01+TCRBJ01-01	TCRBV02-01*01	TCRBD02-01*02	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGGTTTACAGGGCAATCAGCCCCAGCATTTTGGTGAT	CASSGLQGNQPQHF	In	VDJ	1	86	1.274874884371813E-4	1.5459895951304924E-4	42	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	3	4	2	4	0	23	36	-1	40	45													Vb 22	CASSGLQGNQPQHF+TCRBV02-01+TCRBJ01-05	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCATGGGCGGGACAGTTATCAATCAGCCCCAGCATTTTGGTGAT	CASMGGTVINQPQHF	In	VDJ	1	89	1.3193472640592017E-4	1.5999194647280677E-4	45	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	0	5	3	5	4	23	33	45	38	49													Vb 22	CASMGGTVINQPQHF+TCRBV02-01+TCRBJ01-05	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCCGGGGGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASRGGTGELFF	In	VDJ	1	105	1.5565332890586086E-4	1.887545435915136E-4	36	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	8	8	0	4	0	0	23	-1	-1	32	40													Vb 22	CASRGGTGELFF+TCRBV02-01+TCRBJ02-02	TCRBV02-01*01	TCRBD02-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGCTTCGGGACAGACCTATATGGCTACACCTTCGGTTCG	CASSFGTDLYGYTF	In	VDJ	1	124	1.8381916937454046E-4	2.2291012766997796E-4	42	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	5	5	4	5	23	34	45	38	50													Vb 22	CASSFGTDLYGYTF+TCRBV02-01+TCRBJ01-02	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGTTGGAGGGCTAGCGGGGGATGAGCAGTTCTTCGGGCCA	CASSVGGLAGDEQFF	In	VDJ	1	124	1.8381916937454046E-4	2.2291012766997796E-4	45	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	4	2	8	8	0	23	36	-1	44	54													Vb 22	CASSVGGLAGDEQFF+TCRBV02-01+TCRBJ02-01	TCRBV02-01*01	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTCCAGGGGGCGGAAGGGTTGAGACCCAGTACTTCGGGCCA	CASSPGGGRVETQYF	In	VDJ	1	142	2.1050259718697375E-4	2.5526804942852313E-4	45	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	4	0	5	1	9	23	35	44	36	53													Vb 22	CASSPGGGRVETQYF+TCRBV02-01+TCRBJ02-05	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAAGCGGGGATCCGGGACGGCTACGAGCAGTACTTCGGGCCG	CASSEAGIRDGYEQYF	In	VDJ	1	149	2.208794857806978E-4	2.678516856679574E-4	48	TCRBV02	TCRBV02-01	01				TCRBJ02	TCRBJ02-07	01	0	0	7	3	8	2	23	40	53	48	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASSEAGIRDGYEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01		TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTAGGATAGGGAACACTGAAGCTTTCTTTGGACAA	CASSRIGNTEAFF	In	VDJ	1	193	2.8610564265553473E-4	3.469488277444012E-4	39	TCRBV02	TCRBV02-01	01				TCRBJ01	TCRBJ01-01	01	5	1	8	1	1	4	23	35	39	36	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASSRIGNTEAFF+TCRBV02-01+TCRBJ01-01	TCRBV02-01*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTCCCCAAGGGGGGAGGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSPQGGRSNQPQHF	In	VDJ	1	220	3.261307843741847E-4	3.95485710382219E-4	48	TCRBV02	TCRBV02-01	01				TCRBJ01	TCRBJ01-05	01	5	5	1	1	5	4	23	35	46	40	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASSPQGGRSNQPQHF+TCRBV02-01+TCRBJ01-05	TCRBV02-01*01		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAACGAACAAGTACAGGGGTATCAGCCCCAGCATTTTGGTGAT	CASNEQVQGYQPQHF	In	VDJ	1	45	6.670856953108322E-5	8.089480439636297E-5	45	TCRBV06	TCRBV06-04		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	3	2	5	10	1	28	38	55	48	56			01,02											CASNEQVQGYQPQHF+TCRBV06-04+TCRBJ01-05	TCRBV06-04	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCGCACGGATCGGGAATGAGCAGTTCTTCGGGCCA	CAARIGNEQFF	In	VDJ	1	50	7.41206328123147E-5	8.988311599595886E-5	33	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	11	8	4	7	8	0	26	32	-1	40	44						01,02								CAARIGNEQFF+TCRBV06-07+TCRBJ02-01	TCRBV06-07*01	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCTTAATGCACAGGGCCGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	54	8.005028343729987E-5		43	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	3	3	1	7	2	26	35	48	42	50														X+TCRBV06-07+TCRBJ01-01	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGGGGGGTTTACGAGCAGTACTTCGGGCCG	CASRGVYEQYF	In	VDJ	1	60	8.894475937477764E-5	1.0785973919515063E-4	33	TCRBV06	TCRBV06-07	01				TCRBJ02	TCRBJ02-07	01	6	6	1	4	0	2	26	-1	42	37	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRGVYEQYF+TCRBV06-07+TCRBJ02-07	TCRBV06-07*01		TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGAGAAGCTGAAAAACTGTTTTTTGGCAGT	CASREAEKLFF	In	VDJ	1	66	9.783923531225541E-5	1.1864571311466569E-4	33	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	6	6	7	7	3	0	26	37	-1	40	43						01,02								CASREAEKLFF+TCRBV06-07+TCRBJ01-04	TCRBV06-07*01	TCRBD02-01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAATGAAGGACGGGATAATTCACCCCTCCACTTTGGGAAC	CASNEGRDNSPLHF	In	VDJ	1	70	1.0376888593724057E-4	1.258363623943424E-4	42	TCRBV06	TCRBV06-07	01				TCRBJ01	TCRBJ01-06	01	7	1	7	5	5	3	26	36	45	41	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASNEGRDNSPLHF+TCRBV06-07+TCRBJ01-06	TCRBV06-07*01		TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTGACCTCTCCTTCACCTCAGGGAACTATGGCTACACCTTCGGTTCG	CASSDLSFTSGNYGYTF	In	VDJ	1	76	1.1266336187471834E-4	1.3662233631385747E-4	51	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	3	2	16	0	26	38	-1	54	59														CASSDLSFTSGNYGYTF+TCRBV06-07+TCRBJ01-02	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACTCGACGGGCAGGGGAATTAAGAGGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	78	1.1562818718721093E-4		58	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	4	2	2	6	9	23	40	52	46	61														X+TCRBV06-07+TCRBJ01-05	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACCCCTCTCTCGGGGAACTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	102	1.5120609093712198E-4		49	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	2	8	3	0	8	2	26	41	54	49	56														X+TCRBV06-07+TCRBJ02-07	TCRBV06-07*01	TCRBD02-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGAAAGGGGGGGCCCGGTATAGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	151	2.2384431109319039E-4		43	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	9	9	0	5	3	10	26	34	44	37	54														X+TCRBV06-07+TCRBJ02-05	TCRBV06-07*01	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTCAGCCTGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	161	2.3866843765565332E-4		34	TCRBV06	TCRBV06-07	01				TCRBJ02	TCRBJ02-02	01	4	4	5	8	0	3	26	-1	42	39	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-07+TCRBJ02-02	TCRBV06-07*01		TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTTCGGCGGGGAGCTGTTTTTTGGAGAA	CASSFGGELFF	In	VDJ	2	329	4.8771376390503073E-4	5.914309032534092E-4	33	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	8	5	7	1	0	26	39	-1	40	43						01,02								CASSFGGELFF+TCRBV06-07+TCRBJ02-02	TCRBV06-07*01	TCRBD02-01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCGGCATTTCCTACGAGCAGTACTTCGGGCCG	CASGISYEQYF	In	VDJ	5	951	0.0014097744360902255	0.0017095768662431375	33	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	9	0	1	0	3	26	-1	38	35	41														CASGISYEQYF+TCRBV06-07+TCRBJ02-07	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTACTGGACAGGAACGTTATAATAAGTGGCCCCAGCATTTTGGTGAT	CASSTGQERYNKWPQHF	In	VDJ	7	1285	0.0019049002632764878	0.0023099960810961427	51	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	1	4	9	3	16	26	38	48	41	64														CASSTGQERYNKWPQHF+TCRBV06-07+TCRBJ01-05	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGCCTACTGGGACAGGGAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	18	3244	0.004808946656862978		44	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	0	3	7	6	0	26	37	-1	43	52														X+TCRBV06-07+TCRBJ01-06	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCCCCATATCCGGGACAGGGGACGAAAAACTGTTTTTTGGCAGT	CASSPISGTGDEKLFF	In	VDJ	1	74	1.0969853656222575E-4	1.3302701167401912E-4	48	TCRBV16	TCRBV16-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	0	2	8	8	2	29	42	60	50	62			01,02											CASSPISGTGDEKLFF+TCRBV16-01+TCRBJ01-04	TCRBV16-01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCGCTACCGGACAGGGGGCCTCGGGCTTTTATGGCTACACCTTCGGTTCG	CASSATGQGASGFYGYTF	In	VDJ	1	79	1.1711059984345722E-4	1.42015323273615E-4	54	TCRBV16	TCRBV16-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	0	5	6	10	27	39	56	45	66			01,02											CASSATGQGASGFYGYTF+TCRBV16-01+TCRBJ01-02	TCRBV16-01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCCGGAGGGACCCATCCGGCAATCAGCCCCAGCATTTTGGTGAT	CASSRRDPSGNQPQHF	In	VDJ	1	89	1.3193472640592017E-4	1.5999194647280677E-4	48	TCRBV16	TCRBV16-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	4	10	0	2	0	9	29	-1	48	42	57			01,02											CASSRRDPSGNQPQHF+TCRBV16-01+TCRBJ01-05	TCRBV16-01	TCRBD02-01*02	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCCAGGACAGGAACAATCAGCCCCAGCATTTTGGTGAT	CASSQDRNNQPQHF	In	VDJ	1	183	2.712815160930718E-4	3.289722045452094E-4	42	TCRBV16	TCRBV16-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	1	4	3	0	2	29	-1	50	43	52			01,02											CASSQDRNNQPQHF+TCRBV16-01+TCRBJ01-05	TCRBV16-01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GCCACGTTTGGTGGTCAGGAGACACAGCACGTATTTCTGTGCCAGCAGCACCTGACAGGCGCTCCCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	46	6.819098218732952E-5		44	TCRBV21	TCRBV21-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	4	4	3	6	37	50	59	53	65														X+TCRBV21-01+TCRBJ01-02	TCRBV21-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GCCACGTTTGGTGGTCAGGGACACAGCACGGTATTTCTGTGCCAGCAGCACCTGACAGGCGCTCCCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	94	1.3934678968715162E-4		44	TCRBV21	TCRBV21-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	4	4	3	6	37	50	59	53	65														X+TCRBV21-01+TCRBJ01-02	TCRBV21-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCACGTTTGGTGKYMRGRRRMACAGCACGGTATTTCTGTGCCAGCAGCTTAGAACTAGCGGGTAACAATGAGCAGTTCTTCGGGCCA	CASSLELAGNNEQFF	In	VDJ	1	44	6.522615687483693E-5	7.90971420764438E-5	45	TCRBV21	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	3	4	5	5	2	24	36	50	41	52		TCRBV21-01,TCRBV21-or09_02				01,02								CASSLELAGNNEQFF+TCRBV21-X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGACTCGGCYGTGTATCTCTGTGCCAGCACCTACAGGGGTAGCAATCAGCCCCAGCATTTTGGTGAT	CASTYRGSNQPQHF	In	VDJ	1	45	6.670856953108322E-5	8.089480439636297E-5	42	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	3	2	0	5	0	19	27	-1	32	39		TCRBV07-02,TCRBV07-05												CASTYRGSNQPQHF+TCRBV07-X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
SGACTCRGCYRTGTATCKCTGTGCCAGAAGCAGGATGTGGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	46	6.819098218732952E-5		40	TCRBV07	unresolved					TCRBJ01	TCRBJ01-01	01	5	1	8	1	1	5	19	31	35	32	40		TCRBV07-05,TCRBV07-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-X+TCRBJ01-01	unresolved		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTGACAGGGATAATTCACCCCTCCACTTTGGGAAC	CASSDRDNSPLHF	In	VDJ	1	46	6.819098218732952E-5	8.269246671628214E-5	39	TCRBV06	unresolved		unresolved			TCRBJ01	TCRBJ01-06	01	2	5	3	5	0	0	28	-1	-1	43	47		TCRBV06-04,TCRBV06-08		TCRBD01,TCRBD02										CASSDRDNSPLHF+TCRBV06-X+TCRBJ01-06	unresolved	unresolved	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGACTCGGCYRTGTATCKCTGTGCCAGCAGCGGTCTGGGGGACTACTATGGCTATATCTTCGGTTCG	CASSGLGDYYGYIF	In	VDJ	1	47	6.967339484357581E-5	8.449012903620132E-5	42	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	0	9	16	7	12	18	30	44	37	56		TCRBV07-05,TCRBV07-06				01,02								CASSGLGDYYGYIF+TCRBV07-X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCGCAGCGTCTTGAGGGGCAAATGAATACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	47	6.967339484357581E-5		52	TCRBV11	unresolved					TCRBJ01	TCRBJ01-01	01	5	5	2	5	11	9	18	30	46	41	55		TCRBV11-01,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-X+TCRBJ01-01	unresolved		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTGACAGCACAAATGAAAAACTGTTTTTTGGCAGT	CASSDSTNEKLFF	In	VDJ	1	49	7.26382201560684E-5	8.808545367603968E-5	39	TCRBV06	unresolved		unresolved			TCRBJ01	TCRBJ01-04	01	5	2	5	5	0	4	23	-1	40	35	44		TCRBV06-04,TCRBV06-08		TCRBD01,TCRBD02										CASSDSTNEKLFF+TCRBV06-X+TCRBJ01-04	unresolved	unresolved	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGGGGACTYRGCTGTGTATCTCTGTGCCAGCAGCTTACCCACAGGGGTGCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	49	7.26382201560684E-5		43	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	3	2	4	5	2	22	35	47	40	49		TCRBV07-01,TCRBV07-04												X+TCRBV07-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTACCCTCTAGCGGGGGGCCACCGGGGAGCTGTTTTTTGGAGAA	CASSTL*RGATGELFF	Stop	VDJ	1	50	7.41206328123147E-5		48	TCRBV10	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	4	1	4	5	1	26	38	54	43	55		TCRBV10-01,TCRBV10-02												CASSTL*RGATGELFF+TCRBV10-X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGCCCGAGGACTGGGGCCTACGAGCAGTACTTCGGGCCG	CASSPRTGAYEQYF	In	VDJ	1	51	7.560304546856099E-5	9.168077831587803E-5	42	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	1	10	2	5	4	26	37	47	42	51		TCRBV06-07,TCRBV06-08				01,02								CASSPRTGAYEQYF+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGYWCCCTCTCAGACWTCTGTKTACTTCTGTGCCAGCAGTGAAGCAGCGGGGGGGCCAAATGAGCAGTTCTTCGGGCCA	CASSEAAGGPNEQFF	In	VDJ	1	51	7.560304546856099E-5	9.168077831587803E-5	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	6	0	7	5	3	26	38	53	43	56		TCRBV06-04,TCRBV06-07												CASSEAAGGPNEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGGACTCSGCCGTGTATCTCTGTGCCAGCAGTTCAACAGGGTTAAGTCCCCAGCATTTTGGTGAT	CASSSTGLSPQHF	In	VDJ	1	53	7.856787078105358E-5	9.527610295571638E-5	39	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	3	3	10	4	6	18	29	39	33	45		TCRBV07-02,TCRBV07-08												CASSSTGLSPQHF+TCRBV07-X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCCCGGAGGGGTTCACCGGGGAGCTGTTTTTTGGAGAA	CASSPEGFTGELFF	In	VDJ	1	53	7.856787078105358E-5	9.527610295571638E-5	42	TCRBV11	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	10	0	4	2	3	18	30	38	32	41		TCRBV11-01,TCRBV11-03												CASSPEGFTGELFF+TCRBV11-X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGTCGGACAGAATAATTCACCCCTCCACTTTGGGAAC	CASSVGQNNSPLHF	In	VDJ	1	54	8.005028343729987E-5	9.707376527563557E-5	42	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	1	5	5	2	1	26	39	47	41	48		TCRBV10-01,TCRBV10-02												CASSVGQNNSPLHF+TCRBV10-X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCCCCCGGACAGGTGCTCTCCAAGAGACCCAGTACTTCGGGCCA	CASSPRTGALQETQYF	In	VDJ	1	56	8.301510874979246E-5	1.0066908991547392E-4	48	TCRBV11	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	1	4	1	4	6	18	30	41	34	47		TCRBV11-01,TCRBV11-03												CASSPRTGALQETQYF+TCRBV11-X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGACTCGGCYRTGTATCKCTGTGCCAGCAGAATCCAGCCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	57	8.449752140603876E-5		41	TCRBV07	unresolved					TCRBJ01	TCRBJ01-03	01	6	4	5	0	4	1	18	29	36	33	37		TCRBV07-05,TCRBV07-06		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-X+TCRBJ01-03	unresolved		TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAAAGGGAGTAGCGGACTCTACGAGCAGTACTTCGGGCCG	CASKGSSGLYEQYF	In	VDJ	1	60	8.894475937477764E-5	1.0785973919515063E-4	42	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	5	5	3	7	3	23	33	46	40	49		TCRBV06-07,TCRBV06-08				01,02								CASKGSSGLYEQYF+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGAGAGGGACAGTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASREGQYSNQPQHF	In	VDJ	1	60	8.894475937477764E-5	1.0785973919515063E-4	45	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	0	5	0	3	2	23	34	44	37	46		TCRBV06-07,TCRBV06-08												CASREGQYSNQPQHF+TCRBV06-X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGAAAGGGGGACAGGGGGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	62	9.190958468727023E-5		43	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	1	3	5	0	26	37	-1	42	53		TCRBV06-07,TCRBV06-08												X+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGGGGACTYRGCTGTGTATCTCTGTGCCAGCAGCAGATTGGCAGCTCACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	62	9.190958468727023E-5		53	TCRBV07	unresolved					TCRBJ02	TCRBJ02-06	01	5	3	6	5	13	5	22	34	50	47	55		TCRBV07-01,TCRBV07-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-X+TCRBJ02-06	unresolved		TCRBJ02-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGGGGACTYRGCTGTGTATCTCTGTGCCAGCAGCCCAGGGTGGGAAGAGACCCAGTACTTCGGGCCA	CASSPGWEETQYF	In	VDJ	1	62	9.190958468727023E-5	1.1145506383498898E-4	39	TCRBV07	unresolved		unresolved			TCRBJ02	TCRBJ02-05	01	1	0	9	3	3	0	22	38	-1	41	44		TCRBV07-01,TCRBV07-04		TCRBD01,TCRBD02										CASSPGWEETQYF+TCRBV07-X+TCRBJ02-05	unresolved	unresolved	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAAGCCCCGGGGGGCGGTATTCAGTTCTTCGGGCCA	CASSEAPGGGIQFF	In	VDJ	1	63	9.339199734351652E-5	1.1325272615490816E-4	42	TCRBV10	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	8	1	13	5	7	26	40	52	45	59		TCRBV10-01,TCRBV10-02												CASSEAPGGGIQFF+TCRBV10-X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCTTAAGGACAGGGAACTATGGCTACACCTTCGGTTCG	CASSLRTGNYGYTF	In	VDJ	1	63	9.339199734351652E-5	1.1325272615490816E-4	42	TCRBV11	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	1	3	2	1	0	19	34	-1	35	43		TCRBV11-01,TCRBV11-03												CASSLRTGNYGYTF+TCRBV11-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTGAGCTAGCAAGCACAGATACGCAGTATTTTGGCCCA	CASSELASTDTQYF	In	VDJ	1	63	9.339199734351652E-5	1.1325272615490816E-4	42	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	4	7	0	1	1	28	42	48	43	49		TCRBV06-04,TCRBV06-08				01,02								CASSELASTDTQYF+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGGGGCAGGGCAAAGCTTTCTTTGGACAA	CASSEGQGKAFF	In	VDJ	1	64	9.487440999976282E-5	1.1505038847482733E-4	36	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	3	9	3	2	23	38	46	41	48		TCRBV10-01,TCRBV10-02												CASSEGQGKAFF+TCRBV10-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCACCCGGCCGGGACAGGGCCTTACCGGGGAGCTGTTTTTTGGAGAA	CASTRPGQGLTGELFF	In	VDJ	1	68	1.0080406062474798E-4	1.2224103775450404E-4	48	TCRBV12	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	12	0	3	5	12	4	26	31	52	43	56		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASTRPGQGLTGELFF+TCRBV12-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCAGTTGGACAGGGCACCAATCAGCCCCAGCATTTTGGTGAT	CAVGQGTNQPQHF	In	VDJ	1	69	1.0228647328099429E-4	1.2403870007442322E-4	39	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	12	1	3	3	4	3	23	28	40	32	43		TCRBV06-07,TCRBV06-08												CAVGQGTNQPQHF+TCRBV06-X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGGGGACTYGGCYRTGTATCKCTGTGCCAGCAGCTTAACAATAACTTGAGACTATCGGATACGCAGTATTTTGGCCCA		Out	VDJ	1	71	1.0525129859348688E-4		50	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	2	9	6	12	3	18	33	50	45	53		TCRBV07-01,TCRBV07-06				01,02								X+TCRBV07-X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTGGGGACGACGATGAGCAGTTCTTCGGGCCA	CASSGDDDEQFF	In	VDJ	1	72	1.0673371124973316E-4	1.2943168703418074E-4	36	TCRBV06	unresolved					TCRBJ02	TCRBJ02-01	01	5	0	7	8	1	4	23	35	41	36	45		TCRBV06-04,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGDDDEQFF+TCRBV06-X+TCRBJ02-01	unresolved		TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCTTTTTTGGGCGACTCGGGGACAAAAACATTCAGTACTTCGGCGCC	CASFFGRLGDKNIQYF	In	VDJ	1	75	1.1118094921847204E-4	1.348246739939383E-4	48	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	8	8	3	3	14	1	23	32	51	46	52		TCRBV06-07,TCRBV06-08												CASFFGRLGDKNIQYF+TCRBV06-X+TCRBJ02-04	unresolved	TCRBD02-01*01	TCRBJ02-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCACCACCCTGGGACTAGCGGGGGACACCACAGATACGCAGTATTTTGGCCCA	CATTLGLAGDTTDTQYF	In	VDJ	1	77	1.1414577453096463E-4	1.3841999863377664E-4	51	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	10	0	2	2	7	4	26	33	54	40	58		TCRBV06-07,TCRBV06-08												CATTLGLAGDTTDTQYF+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGACTCGGCYRTGTATCKCTGTGCCAGCAGCTTAGGAGGGTTTATCTACGAGCAGTACTTCGGGCCG	CASSLGGFIYEQYF	In	VDJ	1	78	1.1562818718721093E-4	1.4021766095369582E-4	42	TCRBV07	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	11	0	3	0	5	19	-1	40	35	45		TCRBV07-05,TCRBV07-06												CASSLGGFIYEQYF+TCRBV07-X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTAGCCGACAGGGTTGGAACGAGCAGTACTTCGGGCCG	CASSSRQGWNEQYF	In	VDJ	1	79	1.1711059984345722E-4	1.42015323273615E-4	42	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	3	5	4	5	26	38	49	42	54		TCRBV06-07,TCRBV06-08												CASSSRQGWNEQYF+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACTCGCAGTCTGGAAACACCATATATTTTGGAGAG	CASSYSQSGNTIYF	In	VDJ	1	81	1.2007542515594981E-4	1.4561064791345334E-4	42	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	4	5	1	1	0	23	40	-1	41	44		TCRBV06-07,TCRBV06-08												CASSYSQSGNTIYF+TCRBV06-X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGGGGACTYGGCYGTGTATCTCTGTGCCAGCAGTCAGGAGCTGAACACTGAAGCTTTCTTTGGACAA	CASSQELNTEAFF	In	VDJ	1	81	1.2007542515594981E-4	1.4561064791345334E-4	39	TCRBV07	unresolved					TCRBJ01	TCRBJ01-01	01	6	4	4	0	1	3	18	29	34	30	37		TCRBV07-01,TCRBV07-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQELNTEAFF+TCRBV07-X+TCRBJ01-01	unresolved		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCACTGTCCACCCCAACACCGGGGAGCTGTTTTTTGGAGAA	CASTVHPNTGELFF	In	VDJ	1	85	1.26005075780935E-4	1.5280129719313007E-4	42	TCRBV06	unresolved					TCRBJ02	TCRBJ02-02	01	7	3	7	2	6	3	23	33	41	39	44		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTVHPNTGELFF+TCRBV06-X+TCRBJ02-02	unresolved		TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGGGGACTYGGCYGTGTATCTCTGTGCCAGCAGTTTTACTAGCGGCAATGAGCAGTTCTTCGGGCCA	CASSFTSGNEQFF	In	VDJ	1	88	1.3045231374967387E-4	1.581942841528876E-4	39	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	3	5	6	4	0	18	29	-1	33	41		TCRBV07-01,TCRBV07-02				01,02								CASSFTSGNEQFF+TCRBV07-X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGTCGGGACCCGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	89	1.3193472640592017E-4		46	TCRBV10	unresolved					TCRBJ02	TCRBJ02-02	01	0	0	7	0	0	1	23	-1	45	40	46		TCRBV10-01,TCRBV10-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV10-X+TCRBJ02-02	unresolved		TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCRTGTATCKCTGTGCCAGCAGCCCAAGGGCTGGGCAGGGAGGCGGGGAGCTGTTTTTTGGAGAA	CASSPRAGQGGGELFF	In	VDJ	1	91	1.3489955171841275E-4	1.6358727111264511E-4	48	TCRBV07	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	9	1	7	14	0	18	30	-1	44	50		TCRBV07-02,TCRBV07-06												CASSPRAGQGGGELFF+TCRBV07-X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGACGAACACTGAAGCTTTCTTTGGACAA	CASSETNTEAFF	In	VDJ	1	92	1.3638196437465905E-4	1.653849334325643E-4	36	TCRBV10	unresolved					TCRBJ01	TCRBJ01-01	01	2	3	7	1	0	0	26	-1	-1	41	43		TCRBV10-01,TCRBV10-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSETNTEAFF+TCRBV10-X+TCRBJ01-01	unresolved		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCRGCCATGTATCGCTGTGCCAGCAGCTTAGAACAGGACAGGTATCCCCCTGGTGAGCAGTTCTTCGGGCCA	CASSLEQDRYPPGEQFF	In	VDJ	1	96	1.4231161499964423E-4	1.72575582712241E-4	51	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	1	4	9	4	11	18	34	45	38	56		TCRBV07-06,TCRBV07-07												CASSLEQDRYPPGEQFF+TCRBV07-X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCATTATCGGGACATCCTACGAGCAGTACTTCGGGCCG	CASIIGTSYEQYF	In	VDJ	1	99	1.467588529683831E-4	1.7796856967199854E-4	39	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	0	6	1	5	0	23	33	-1	38	44		TCRBV10-01,TCRBV10-02												CASIIGTSYEQYF+TCRBV10-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGTCAGGGGAGCTCCTATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	101	1.4972367828087568E-4		49	TCRBV10	unresolved					TCRBJ01	TCRBJ01-06	01	0	5	2	0	0	2	26	-1	48	43	50		TCRBV10-01,TCRBV10-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV10-X+TCRBJ01-06	unresolved		TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCACCTGTGAGGGGAGAATAAACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	101	1.4972367828087568E-4		40	TCRBV10	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	9	2	5	0	5	23	-1	43	38	48		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACGGGGGAATAGGGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSYGGIGSNQPQHF	In	VDJ	1	104	1.5417091624961456E-4	1.869568812715944E-4	48	TCRBV06	unresolved					TCRBJ01	TCRBJ01-05	01	2	6	1	1	0	7	23	-1	43	38	50		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYGGIGSNQPQHF+TCRBV06-X+TCRBJ01-05	unresolved		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGGACAGGGATACAGGCTACACCTTCGGTTCG	CASSEDRDTGYTF	In	VDJ	1	105	1.5565332890586086E-4	1.887545435915136E-4	39	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	2	3	8	0	5	26	-1	48	41	53		TCRBV10-01,TCRBV10-02												CASSEDRDTGYTF+TCRBV10-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGACTTTCCCGGGATTAAGACCGGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	107	1.5861815421835347E-4		49	TCRBV10	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	3	8	3	8	6	9	23	37	48	43	57		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ01-04	unresolved	TCRBD02-01*02	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTCACGACAGTTTTCAGCCCCAGCATTTTGGTGAT	CASSHDSFQPQHF	In	VDJ	1	109	1.6158297953084604E-4	1.9594519287119031E-4	39	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	2	5	6	3	3	23	35	43	38	46		TCRBV06-07,TCRBV06-08												CASSHDSFQPQHF+TCRBV06-X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCCTAAGGGAGCGGGGGCCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	113	1.6751263015583122E-4		41	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	8	6	2	6	7	1	23	32	47	39	48		TCRBV06-07,TCRBV06-08												X+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGGGGGGGTGCTCAATATTAATTCACCCCTCCACTTTGGGAAC	CASSGGVLNINSPLHF	In	VDJ	1	123	1.8233675671829416E-4	2.211124653500588E-4	48	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	5	9	0	6	0	10	23	-1	42	35	52		TCRBV06-07,TCRBV06-08												CASSGGVLNINSPLHF+TCRBV06-X+TCRBJ01-06	unresolved	TCRBD02-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGGGGACTYGGCYGTGTATCTCTGTGCCAGCAGCTTAGGACAGGGTTCACCCCTCCACTTTGGGAAC	CASSLGQGSPLHF	In	VDJ	1	125	1.8530158203078673E-4	2.2470778998989714E-4	39	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	1	2	3	9	0	0	18	-1	-1	34	41		TCRBV07-01,TCRBV07-02												CASSLGQGSPLHF+TCRBV07-X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGGACGTCCCGGGACAGGGACTCCTACGAGCAGTATTTCGGGCCG		Out	VDJ	1	126	1.8678399468703303E-4		50	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	3	16	8	17	26	39	56	47	73		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGACAGGGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	126	1.8678399468703303E-4		38	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	4	2	0	0	23	-1	-1	37	41		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAGACATCTGTRTATTTCTGCGCCAGCAGCCCCCAGGGACAGCAATAATAACCGACCAAGCTACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	128	1.8974881999952564E-4		61	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	5	3	6	20	20	31	44	37	64		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACGACAGGGTCTATGGCTACACCTTCGGTTCG	CASSYDRVYGYTF	In	VDJ	1	137	2.0309053390574227E-4	2.4627973782892726E-4	39	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	2	3	4	0	1	23	-1	45	38	46		TCRBV06-07,TCRBV06-08												CASSYDRVYGYTF+TCRBV06-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCTTGTTGTGGGGTTTGGGTGAAAAACTGTTTTTTGGCAGT	CASSLLWGLGEKLFF	In	VDJ	1	137	2.0309053390574227E-4	2.4627973782892726E-4	45	TCRBV11	unresolved					TCRBJ01	TCRBJ01-04	01	3	6	2	7	5	6	18	32	41	37	47		TCRBV11-01,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLLWGLGEKLFF+TCRBV11-X+TCRBJ01-04	unresolved		TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCCAAGTGGGGGGCCTCTCCTACGAGCAGTACTTCGGGCCG	CASQVGGLSYEQYF	In	VDJ	1	140	2.0753777187448115E-4	2.516727247886848E-4	42	TCRBV06	unresolved					TCRBJ02	TCRBJ02-07	01	8	6	0	0	6	2	26	35	47	41	49		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASQVGGLSYEQYF+TCRBV06-X+TCRBJ02-07	unresolved		TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAAGGACGGTCTGAAGCTTTCTTTGGACAA	CASSEGRSEAFF	In	VDJ	1	145	2.1494983515571263E-4	2.6066103638828066E-4	36	TCRBV10	unresolved					TCRBJ01	TCRBJ01-01	01	3	1	7	6	1	3	23	37	42	38	45		TCRBV10-01,TCRBV10-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEGRSEAFF+TCRBV10-X+TCRBJ01-01	unresolved		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGACCTAGCGGGGCCATACGAGCAGTACTTCGGGCCG	CASSDLAGPYEQYF	In	VDJ	1	146	2.1643224781195893E-4	2.6245869870819983E-4	42	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	4	3	4	3	3	23	35	47	38	50		TCRBV06-07,TCRBV06-08												CASSDLAGPYEQYF+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGATTCGGGCGAAAAACTGTTTTTTGGCAGT	CASSDSGEKLFF	In	VDJ	1	160	2.3718602499940705E-4	2.8762597118706833E-4	36	TCRBV10	unresolved					TCRBJ01	TCRBJ01-04	01	3	8	0	8	3	0	23	37	-1	40	44		TCRBV10-01,TCRBV10-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDSGEKLFF+TCRBV10-X+TCRBJ01-04	unresolved		TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGGSGACTCRGCTGTGTATCTCTGTGCCAGCAGCTTACAGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLQGNTGELFF	In	VDJ	1	160	2.3718602499940705E-4	2.8762597118706833E-4	42	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	4	3	1	0	0	22	-1	-1	37	42		TCRBV07-04,TCRBV07-05												CASSLQGNTGELFF+TCRBV07-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGTGACAGCGGCGGGGGGCGATGCACAGATACGCAGTATTTTGGCCCA	CASDSGGGRCTDTQYF	In	VDJ	1	161	2.3866843765565332E-4	2.894236335069875E-4	48	TCRBV10	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	9	7	1	1	8	4	23	31	47	39	51		TCRBV10-01,TCRBV10-02												CASDSGGGRCTDTQYF+TCRBV10-X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGAAGAGGATAGCCGCTTAACTCATGAAAAACTGTTTTTTGGCAGT	CASSEEDSRLTHEKLFF	In	VDJ	1	167	2.475629135931311E-4	3.0020960742650255E-4	51	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	5	5	7	6	8	10	26	38	50	46	60		TCRBV06-01,TCRBV06-07				01,02								CASSEEDSRLTHEKLFF+TCRBV06-X+TCRBJ01-04	unresolved	TCRBD02-01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGGSGACTCRGCTGTGTATCTCTGTGCCAGCAGCCCATAGGACAGCGCCCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	180	2.668342781243329E-4		47	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	1	5	2	5	4	22	34	45	39	49		TCRBV07-04,TCRBV07-05												X+TCRBV07-X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGCAACCAGGGTTCCCGCACAGATACGCAGTATTTTGGCCCA	CASSNQGSRTDTQYF	In	VDJ	1	181	2.683166907805792E-4	3.2537687990537105E-4	45	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	4	3	1	4	5	23	34	43	38	48		TCRBV06-07,TCRBV06-08												CASSNQGSRTDTQYF+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGAAGGGACAGGGTTTGAAAAACTGTTTTTTGGCAGT	CASSEGTGFEKLFF	In	VDJ	1	210	3.113066578117217E-4	3.775090871830272E-4	42	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	1	3	7	0	2	23	-1	47	39	49		TCRBV06-01,TCRBV06-07												CASSEGTGFEKLFF+TCRBV06-X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCACCCTGAGTTGGGGGGTAACTAATGAAAAACTGTTTTTTGGCAGT	CASTLSWGVTNEKLFF	In	VDJ	1	232	3.439197362491402E-4	4.170576582212491E-4	48	TCRBV10	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	7	9	1	1	9	1	26	36	51	45	52		TCRBV10-01,TCRBV10-02												CASTLSWGVTNEKLFF+TCRBV10-X+TCRBJ01-04	unresolved	TCRBD02-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCACCCCATGGGACACCGGTGAATCCACGAGCAGTACTTCGGGCCG		Out	VDJ	2	275	4.076634804677308E-4		47	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	0	6	5	6	11	23	33	45	39	56		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCGGGGGCAGATCAGATACTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	291	4.3138208296767154E-4		41	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	6	0	3	0	10	26	-1	41	35	51		TCRBV06-07,TCRBV06-08												X+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGGACTCSGCCGTGTATCTCTGTGCTGGGGAGAGGAGCTCTGGAAACACCATATATTTTGGAGAG	CAGERSSGNTIYF	In	VDJ	3	446	6.611560446858471E-4	8.01757394683953E-4	39	TCRBV07	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	12	9	2	0	2	5	18	23	30	25	35		TCRBV07-02,TCRBV07-08												CAGERSSGNTIYF+TCRBV07-X+TCRBJ01-03	unresolved	TCRBD02-01*02	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAAAGGACTAGCGGGGGGGCCTTTGCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	3	585	8.67211403904082E-4		55	TCRBV10	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	1	0	2	2	6	23	37	54	39	60		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGCGGGCGACTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	10	1808	0.0026802020824932995		41	TCRBV10	unresolved					TCRBJ02	TCRBJ02-07	01	2	8	0	0	1	2	23	38	43	39	45		TCRBV10-01,TCRBV10-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV10-X+TCRBJ02-07	unresolved		TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGGGCCCCTCATACGGGACACCATATATTTTGGAGAG	CASSQGPLIRDTIYF	In	VDJ	1	44	6.522615687483693E-5	7.90971420764438E-5	45	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	1	8	4	8	11	0	23	39	-1	50	54						01,02							Vb 7.1	CASSQGPLIRDTIYF+TCRBV04-01+TCRBJ01-03	TCRBV04-01*01	TCRBD02-01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAGACCGGGACAGGGTACCAGCCCCAGCATTTTGGTGAT	CASSQTGTGYQPQHF	In	VDJ	1	44	6.522615687483693E-5	7.90971420764438E-5	45	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	0	3	7	4	3	23	37	50	41	53													Vb 7.1	CASSQTGTGYQPQHF+TCRBV04-01+TCRBJ01-05	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCACATTAGCGGGGGGGGAAATGAGCAGTTCTTCGGGCCA	CASSHISGGGNEQFF	In	VDJ	1	46	6.819098218732952E-5	8.269246671628214E-5	45	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	5	0	7	3	2	23	37	51	40	53													Vb 7.1	CASSHISGGGNEQFF+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGGGGTTCAGAGAACAGGGATGGAAACACCATATATTTTGGAGAG	CASRGSENRDGNTIYF	In	VDJ	1	55	8.153269609354617E-5	9.887142759555474E-5	48	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	3	3	3	11	1	23	34	51	45	52													Vb 7.1	CASRGSENRDGNTIYF+TCRBV04-01+TCRBJ01-03	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCAAGTGGGGTTCTGGCCCCAGCATTTTGGTGAT	XASSQVGFWPQHF	In	VDJ	1	62	9.190958468727023E-5	1.1145506383498898E-4	39	TCRBV04	TCRBV04-01	01				TCRBJ01	TCRBJ01-05	01	1	6	2	9	1	5	22	38	43	39	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	XASSQVGFWPQHF+TCRBV04-01+TCRBJ01-05	TCRBV04-01*01		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCACCGGGAACGAACCGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	70	1.0376888593724057E-4		49	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	5	8	3	4	2	14	23	35	42	37	56													Vb 7.1	X+TCRBV04-01+TCRBJ01-02	TCRBV04-01*01	TCRBD02-01*02	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCAAGAGGGACTAGCGGGGGGTGCGAGAACCGGGGAGCTGTTTTTTGGAGAA	YASSQEGLAGGARTGELFF	In	VDJ	1	72	1.0673371124973316E-4	1.2943168703418074E-4	57	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	0	1	5	0	7	22	-1	54	39	61													Vb 7.1	YASSQEGLAGGARTGELFF+TCRBV04-01+TCRBJ02-02	TCRBV04-01*01	TCRBD02-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCAAGTTCACGGCTCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	72	1.0673371124973316E-4		41	TCRBV04	TCRBV04-01	01				TCRBJ02	TCRBJ02-07	01	1	9	0	3	5	1	22	38	46	43	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	X+TCRBV04-01+TCRBJ02-07	TCRBV04-01*01		TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGATAGGGGGGTTTTAATCTATGGCTACACCTTCGGTTCG	CASSQDRGVLIYGYTF	In	VDJ	1	73	1.0821612390597947E-4	1.3122934935409992E-4	48	TCRBV04	TCRBV04-01	01				TCRBJ01	TCRBJ01-02	01	0	5	1	4	1	8	23	40	47	41	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSQDRGVLIYGYTF+TCRBV04-01+TCRBJ01-02	TCRBV04-01*01		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCAAGATCCGGAGGGCTACGAGCAGTACTTCGGGCCG	YASSQDPEGYEQYF	In	VDJ	1	73	1.0821612390597947E-4	1.3122934935409992E-4	42	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	10	0	3	3	0	22	39	-1	42	48													Vb 7.1	YASSQDPEGYEQYF+TCRBV04-01+TCRBJ02-07	TCRBV04-01*01	TCRBD02-01*02	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCAAGTCCTAGACAGGGCGCACGAGCAGTACTTCGGGCCG	YASSQVLDRAHEQYF	In	VDJ	1	78	1.1562818718721093E-4	1.4021766095369582E-4	45	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	2	3	5	5	3	22	38	50	43	53													Vb 7.1	YASSQVLDRAHEQYF+TCRBV04-01+TCRBJ02-07	TCRBV04-01*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGTCGGACTAGCCTCGACGAGCAGTTCTTCGGGCCA	CASSRTSLDEQFF	In	VDJ	1	80	1.1859301249970352E-4	1.4381298559353417E-4	39	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	1	7	10	2	6	23	34	44	36	50						01,02							Vb 7.1	CASSRTSLDEQFF+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCCCCGGTGGCCGGGTGAAGCTTTCTTTGGACAA	CASSPRWPGEAFF	In	VDJ	1	85	1.26005075780935E-4	1.5280129719313007E-4	39	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	8	4	7	9	0	23	36	-1	45	49						01,02							Vb 7.1	CASSPRWPGEAFF+TCRBV04-01+TCRBJ01-01	TCRBV04-01*01	TCRBD02-01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAACACCGAACACTGAAGCTTTCTTTGGACAA	CASSQTPNTEAFF	In	VDJ	1	88	1.3045231374967387E-4	1.581942841528876E-4	39	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	6	1	0	2	23	-1	41	38	43													Vb 7.1	CASSQTPNTEAFF+TCRBV04-01+TCRBJ01-01	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCTCACCATTTGTGACGGCCATGAACACTGAAGCTTTCTTTGGACAA	CASSSPFVTAMNTEAFF	In	VDJ	1	93	1.3786437703090535E-4	1.6718259575248346E-4	51	TCRBV04	TCRBV04-01	01				TCRBJ01	TCRBJ01-01	01	5	2	7	0	11	5	23	35	49	46	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSSPFVTAMNTEAFF+TCRBV04-01+TCRBJ01-01	TCRBV04-01*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCGAATCGGGAAGAATCAGCCCCAGCATTTTGGTGAT	CASSRIGKNQPQHF	In	VDJ	1	97	1.437940276558905E-4	1.743732450321602E-4	42	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	4	8	3	4	4	2	23	36	45	40	47													Vb 7.1	CASSRIGKNQPQHF+TCRBV04-01+TCRBJ01-05	TCRBV04-01*01	TCRBD02-01*02	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCACCCGGGACTAGCGGGACAAGAGACCCAGTACTTCGGGCCA	CASSHPGLAGQETQYF	In	VDJ	1	99	1.467588529683831E-4	1.7796856967199854E-4	48	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	0	3	2	3	0	23	37	-1	40	53													Vb 7.1	CASSHPGLAGQETQYF+TCRBV04-01+TCRBJ02-05	TCRBV04-01*01	TCRBD02-01*02	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAGGGGGAGGATCAGCCCCAGCATTTTGGTGAT	CASSQGEDQPQHF	In	VDJ	1	100	1.482412656246294E-4	1.7976623199191771E-4	39	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	3	9	1	5	2	0	23	37	-1	39	45													Vb 7.1	CASSQGEDQPQHF+TCRBV04-01+TCRBJ01-05	TCRBV04-01*01	TCRBD02-01*02	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCTCCAACCAGGCGGGACAAACTAATGAAAAACTGTTTTTTGGCAGT	CASSNQAGQTNEKLFF	In	VDJ	1	104	1.5417091624961456E-4	1.869568812715944E-4	48	TCRBV04	TCRBV04-01	01				TCRBJ01	TCRBJ01-04	01	8	0	6	1	11	0	23	32	-1	43	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSNQAGQTNEKLFF+TCRBV04-01+TCRBJ01-04	TCRBV04-01*01		TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCCCACGGCAGGGTCCACTGAAGCTTTCTTTGGACAA	CASSPTAGSTEAFF	In	VDJ	1	109	1.6158297953084604E-4	1.9594519287119031E-4	42	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	3	4	6	2	23	36	47	42	49													Vb 7.1	CASSPTAGSTEAFF+TCRBV04-01+TCRBJ01-01	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGTCCCGCGGACAGGGGGTAGCACCGGGGAGCTGTTTTTTGGAGAA	CASSQVPRTGGSTGELFF	In	VDJ	1	111	1.6454780484333862E-4	1.9954051751102866E-4	54	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	1	1	4	6	3	23	39	55	45	58													Vb 7.1	CASSQVPRTGGSTGELFF+TCRBV04-01+TCRBJ02-02	TCRBV04-01*01	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGATAGAGTCACTAGCCTAACTAGCACAGATACGCAGTATTTTGGCCCA	CASSQDRVTSLTSTDTQYF	In	VDJ	1	135	2.001257085932497E-4	2.426844131890889E-4	57	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	3	7	0	7	6	23	40	53	47	59						01,02							Vb 7.1	CASSQDRVTSLTSTDTQYF+TCRBV04-01+TCRBJ02-03	TCRBV04-01*01	TCRBD02-01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGGGAGCTCCTCTGGAAACACCATATATTTTGGAGAG	CASSQGSSSGNTIYF	In	VDJ	1	147	2.179146604682052E-4	2.6425636102811906E-4	45	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	1	10	2	0	0	3	23	-1	43	39	46													Vb 7.1	CASSQGSSSGNTIYF+TCRBV04-01+TCRBJ01-03	TCRBV04-01*01	TCRBD02-01*02	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGGTTGGCAGTCTAATGAAAAACTGTTTTTTGGCAGT	CASSQGWQSNEKLFF	In	VDJ	1	148	2.193970731244515E-4	2.6605402334803824E-4	45	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	4	5	3	5	1	23	39	47	44	48													Vb 7.1	CASSQGWQSNEKLFF+TCRBV04-01+TCRBJ01-04	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCTCTGAAAACAGGGGAGGAACTGAAGCTTTCTTTGGACAA	CASSSENRGGTEAFF	In	VDJ	1	150	2.2236189843694408E-4	2.696493479878766E-4	45	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	2	5	7	4	23	35	49	42	53													Vb 7.1	CASSSENRGGTEAFF+TCRBV04-01+TCRBJ01-01	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGACGACCGGACCACCAGGGCCCTCCACTTTGGGAAC	CASSQDDRTTRALHF	In	VDJ	1	161	2.3866843765565332E-4	2.894236335069875E-4	45	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	4	3	14	12	0	23	40	-1	52	57													Vb 7.1	CASSQDDRTTRALHF+TCRBV04-01+TCRBJ01-06	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCAAGATGGGGCAGCTACTGAAGCTTTCTTTGGACAA	XASSQDGAATEAFF	In	VDJ	1	167	2.475629135931311E-4	3.0020960742650255E-4	42	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	7	0	5	1	4	23	40	46	41	50													Vb 7.1	XASSQDGAATEAFF+TCRBV04-01+TCRBJ01-01	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGTGCCCGGCGGGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSQVPGGGTGELFF	In	VDJ	1	193	2.8610564265553473E-4	3.469488277444012E-4	48	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	1	7	2	4	6	0	23	39	-1	45	52													Vb 7.1	CASSQVPGGGTGELFF+TCRBV04-01+TCRBJ02-02	TCRBV04-01*01	TCRBD02-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCAACACGGAACTAATGAAAAACTGTTTTTTGGCAGT	XASSQHGTNEKLFF	In	VDJ	1	202	2.9944735656175136E-4	3.631277886236738E-4	42	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	2	8	5	1	2	0	22	37	-1	39	42						01,02							Vb 7.1	XASSQHGTNEKLFF+TCRBV04-01+TCRBJ01-04	TCRBV04-01*01	TCRBD02-01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGGAAAGGACACCCAGAATGAAAAACTGTTTTTTGGCAGT	CASSQGKDTQNEKLFF	In	VDJ	1	205	3.0389459453049024E-4	3.685207755834313E-4	48	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	1	6	5	4	5	23	39	48	43	53													Vb 7.1	CASSQGKDTQNEKLFF+TCRBV04-01+TCRBJ01-04	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGGAGCCCGACGGTCGGGAAAAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	3	475	7.041460117169897E-4		53	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	1	8	3	2	12	2	23	39	56	51	58													Vb 7.1	X+TCRBV04-01+TCRBJ01-01	TCRBV04-01*01	TCRBD02-01*02	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GCCTATATTTCTGTGCCAGCAGCTCTCGGGACTAGCGGGAGAATTTTGGACGCGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	47	6.967339484357581E-5		64	TCRBV12	TCRBV12-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	0	2	0	3	11	11	24	41	27	52														X+TCRBV12-01+TCRBJ02-02	TCRBV12-01*01	TCRBD02-01*02	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGCACCATACCCGGGAGCAAAAGGCTGTTGGTGGCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	90	1.3341713906216645E-4		59	TCRBV12	TCRBV12-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	7	8	2	3	7	17	22	32	45	39	62														X+TCRBV12-01+TCRBJ02-04	TCRBV12-01*01	TCRBD02-01*02	TCRBJ02-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGCAGCTTACGACAGGGGGCGATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	99	1.467588529683831E-4		44	TCRBV12	TCRBV12-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	2	0	8	2	1	22	36	48	38	49														X+TCRBV12-01+TCRBJ01-06	TCRBV12-01*01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGCAGCCCTAGCGGGACGTCCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	101	1.4972367828087568E-4		46	TCRBV12	TCRBV12-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	4	3	2	1	4	22	34	44	35	48														X+TCRBV12-01+TCRBJ02-01	TCRBV12-01*01	TCRBD02-01*02	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGCAGCTTTCCAAACAGGGGTTAAGTCGCTCGGGCCG		Out	VDJ	1	132	1.9567847062451082E-4		37	TCRBV12	TCRBV12-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	3	2	17	4	9	22	37	48	41	57														X+TCRBV12-01+TCRBJ02-07	TCRBV12-01*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGCAGCTCCGGACCTAGCGGGGGGGACACAGATACGCAGTATTTTGGCCCA	CASSSGPSGGDTDTQYF	In	VDJ	1	202	2.9944735656175136E-4	3.631277886236738E-4	51	TCRBV12	TCRBV12-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	4	0	2	6	1	22	35	53	41	54														CASSSGPSGGDTDTQYF+TCRBV12-01+TCRBJ02-03	TCRBV12-01*01	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATACTGGTGGGAACACTGAAGCTTTCTTTGGACAA	CATSRDTGGNTEAFF	In	VDJ	1	52	7.708545812480728E-5	9.34784406357972E-5	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	3	10	1	1	5	18	35	39	36	44						01,02								CATSRDTGGNTEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01	TCRBD02-01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACGCAGCCATGTACCTGTGTGCCACCAGTTACAGTTTGGGGAACACTGAAGCTTTCTTTGGACAA	CATSYSLGNTEAFF	In	VDJ	1	60	8.894475937477764E-5	1.0785973919515063E-4	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	5	1	2	6	18	29	35	31	41														CATSYSLGNTEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGCCCTGGGGGTCACAGATACGCAGTATTTTGGCCCA	CATSRALGVTDTQYF	In	VDJ	1	65	9.635682265600911E-5	1.1684805079474652E-4	45	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-03	01	1	6	1	2	4	1	18	34	43	38	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRALGVTDTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01		TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGTCGACAGACCTACAATGAGCAGTTCTTCGGGCCA	CATSSRQTYNEQFF	In	VDJ	1	77	1.1414577453096463E-4	1.3841999863377664E-4	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	2	5	2	2	1	18	32	39	34	40														CATSSRQTYNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGCACGAGGGTCCTCCTACGAGCAGTACTTCGGGCCG	CATSRARGSSYEQYF	In	VDJ	1	85	1.26005075780935E-4	1.5280129719313007E-4	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	11	0	0	3	2	18	34	42	37	44														CATSRARGSSYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGGTGGGAATTCGAACTATGGCTACACCTTCGGTTCG	CATSRGGNSNYGYTF	In	VDJ	1	85	1.26005075780935E-4	1.5280129719313007E-4	45	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-02	01	1	0	8	2	2	5	18	34	40	36	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRGGNSNYGYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGGGGATTGGGGCTGGGCTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	105	1.5565332890586086E-4		49	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	7	0	0	6	4	18	32	43	38	47														X+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCTAGGTTACAATGAGCAGTTCTTCGGGCCA	CATSRDLGYNEQFF	In	VDJ	1	106	1.5713574156210716E-4	1.9055220591143276E-4	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	4	8	4	1	2	18	35	40	36	42						01,02								CATSRDLGYNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCTACTCGACAATGAGCAGTTCTTCGGGCCA	CATSRDLLDNEQFF	In	VDJ	1	113	1.6751263015583122E-4	2.03135842150867E-4	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	3	10	5	3	2	18	35	41	38	43						01,02								CATSRDLLDNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGCTTAGCGGGGTCGCAAGAGACCCAGTACTTCGGGCCA	CATSSLAGSQETQYF	In	VDJ	1	114	1.6899504281207752E-4	2.049335044707862E-4	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	5	3	2	2	3	18	32	42	34	45														CATSSLAGSQETQYF+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATATGGACAGGGACTATGGCTACACCTTCGGTTCG	CATSRDMDRDYGYTF	In	VDJ	1	116	1.719598681245701E-4	2.0852882911062454E-4	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	1	3	3	3	0	18	35	-1	38	46														CATSRDMDRDYGYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATGAGCTCGATTCTGGCTACACCTTCGGTTCG	CATSRDELDSGYTF	In	VDJ	1	117	1.734422807808164E-4	2.103264914305437E-4	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	0	6	7	7	2	7	18	35	40	37	47						01,02								CATSRDELDSGYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01	TCRBD02-01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCATTACGTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	119	1.7640710609330898E-4		44	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-04	01	0	3	7	4	5	1	18	35	42	40	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01		TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCGAATGGGACAGGGGGGGCTATGGCTACACCTTCGGTTCG	CATSEWDRGGYGYTF	In	VDJ	1	123	1.8233675671829416E-4	2.211124653500588E-4	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	1	4	4	2	18	30	45	34	47														CATSEWDRGGYGYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCACCCGCGAGACAGGGAGGAGCTACACCTTCGGTTCG	CATSTRETGRSYTF	In	VDJ	1	128	1.8974881999952564E-4	2.3010077694965466E-4	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	3	9	7	4	18	31	45	38	49														CATSTRETGRSYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATGAGAGCCAGGCTATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	128	1.8974881999952564E-4		53	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	4	4	0	7	3	18	35	46	42	49														X+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCGGTACAGGGGGCATTCAGCCCCAGCATTTTGGTGAT	CATSGTGGIQPQHF	In	VDJ	1	132	1.9567847062451082E-4	2.3729142622933139E-4	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	3	0	6	3	2	18	30	42	33	44														CATSGTGGIQPQHF+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATAGGGGACACTATGGCTACACCTTCGGTTCG	CATSRDRGHYGYTF	In	VDJ	1	138	2.0457294656198857E-4	2.4807740014884643E-4	42	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-02	01	0	0	7	3	3	0	18	35	-1	38	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRDRGHYGYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCTTGCACAGGGTCCGGTATGGCTACACCTTCGGTTCG	CATSLHRVRYGYTF	In	VDJ	1	142	2.1050259718697375E-4	2.5526804942852313E-4	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	3	5	4	5	18	30	40	34	45														CATSLHRVRYGYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGAGATGGGCGGGACTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	145	2.1494983515571263E-4		47	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	7	3	0	5	0	18	35	-1	40	46														X+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGGGCCCGAGACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	151	2.2384431109319039E-4		44	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-03	01	1	9	0	2	0	6	18	-1	37	34	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01		TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCTAGACAGGGGTGGTACGAGGGATTCAGTACTTCGGCGCC	CATS*TGVVRGIQYF	Stop	VDJ	1	157	2.3273878703066814E-4		45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	2	2	10	2	11	18	30	40	32	51														CATS*TGVVRGIQYF+TCRBV15-01+TCRBJ02-04	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACGCAGCCATGTACCTGTGTGCCACCTCCAGAGCGGGGGGCTACAATGAGCAGTTCTTCGGGCCA	CATSRAGGYNEQFF	In	VDJ	1	163	2.4163326296814592E-4	2.9301895814682586E-4	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	8	1	3	0	0	18	-1	-1	34	41														CATSRAGGYNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATGGAGTTGGTTCTAGCACAGATACGCAGTATTTTGGCCCA	CATSRDGVGSSTDTQYF	In	VDJ	1	166	2.460805009368848E-4	2.984119451065834E-4	51	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	10	2	0	1	8	18	35	40	36	48														CATSRDGVGSSTDTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGACAGTTGGTACGAAAAACTGTTTTTTGGCAGT	CATSRDSWYEKLFF	In	VDJ	1	169	2.5052773890562365E-4	3.038049320663409E-4	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	4	5	8	0	7	18	-1	38	35	45														CATSRDSWYEKLFF+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCGTAGGACAGCGCCTTAAGACCTCCCCTTTGAACACTGAAGCTTTCTTTGGACAA	CATSVGQRLKTSPLNTEAFF	In	VDJ	1	170	2.5201015156187E-4	3.0560259438626013E-4	60	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	5	0	3	19	18	30	39	33	58														CATSVGQRLKTSPLNTEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATGACCGAGCGGGGGGCGCAATTTTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	183	2.712815160930718E-4		62	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	6	1	0	6	9	18	35	50	41	59														X+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACGCAGCCATGTACCTGTGTGCCACCATTTTCAGGACTGGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CATIFRTGSYNSPLHF	In	VDJ	1	186	2.757287540618107E-4	3.3436519150496693E-4	48	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	7	1	10	0	6	2	18	28	39	34	41						01,02								CATIFRTGSYNSPLHF+TCRBV15-01+TCRBJ01-06	TCRBV15-01*01	TCRBD02-01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGACGGCCTAGCAATCAGCCCCAGCATTTTGGTGAT	CATSRRPSNQPQHF	In	VDJ	1	187	2.77211166718057E-4	3.361628538248861E-4	42	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-05	01	2	9	0	0	1	1	18	33	37	34	38				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRRPSNQPQHF+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGGAGGGGAGAGGCCCGATACGCAGTATTTTGGCCCA	CATSRGGERPDTQYF	In	VDJ	1	206	3.0537700718673657E-4	3.703184379033505E-4	45	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-03	01	1	5	2	6	1	8	18	34	40	35	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRGGERPDTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01		TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATTGAAGGGACAGGGGAGGGGAGATTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	246	3.646735134365883E-4		59	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	0	2	4	5	9	18	35	50	40	59														X+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGACCGCTAGCGGGGGAAGAGACCCAGTACTTCGGGCCA	CATSRPLAGEETQYF	In	VDJ	1	257	3.8098005265529755E-4	4.619992162192285E-4	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	4	2	3	3	0	18	33	-1	36	46														CATSRPLAGEETQYF+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCCGACGGGAACGGACCTACGAGCAGTACTTCGGGCCG	CATSRRERTYEQYF	In	VDJ	1	260	3.8542729062403643E-4	4.673922031789861E-4	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	8	3	2	3	5	18	30	38	33	43														CATSRRERTYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGGTCGCAGACAGGGATCTTCTATGGYTACACCTTCGGTTCG	CATSRSQTGIFYGYTF	In	VDJ	2	303	4.4917103484262705E-4	5.446916829355107E-4	48	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	3	4	6	5	18	32	45	38	50														CATSRSQTGIFYGYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGTCGTGGACAGGGGGGTGTGACTGAAAAACTGTTTTTTGGCAGT	CATSSRGQGGVTEKLFF	In	VDJ	2	342	5.069851284362325E-4	6.148005134123586E-4	51	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	1	1	7	4	7	18	32	46	36	53														CATSSRGQGGVTEKLFF+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCGGAGGACAGGGGTCCTACGAGCAGTACTTCGGGCCG	CATSGGQGSYEQYF	In	VDJ	2	369	5.470102701548825E-4	6.633373960501763E-4	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	2	2	1	0	0	18	-1	-1	34	42														CATSGGQGSYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGGCCTAGGCTCTTCGGGTGAAAAACTGTTTTTTGGCAGT	CATSRGLGSSGEKLFF	In	VDJ	2	404	5.988947131235027E-4	7.262555772473476E-4	48	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	1	4	8	7	2	10	18	34	40	36	50						01,02								CATSRGLGSSGEKLFF+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01	TCRBD02-01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCCCGCGACAGGGAACTAATGAAAAACTGTTTTTTGGCAGT	CATSPRQGTNEKLFF	In	VDJ	2	405	6.003771257797491E-4	7.280532395672667E-4	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	2	3	1	4	0	18	30	-1	34	41														CATSPRQGTNEKLFF+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGGACTAGCGGGGGGGCAGATACGCAGTATTTTGGCCCA	CATSRTSGGADTQYF	In	VDJ	3	465	6.893218851545267E-4	8.359129787624173E-4	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	2	0	4	0	0	18	-1	-1	32	46														CATSRTSGGADTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGCCGGGGGGCGGTGAAAAACTGTTTTTTGGCAGT	CASRPGGGEKLFF	In	VDJ	1	44	6.522615687483693E-5	7.90971420764438E-5	39	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	6	8	1	7	2	3	26	37	46	39	49		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRPGGGEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD02-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGGGACTAGCGGGGGTCCCGGGACCCAGTACTTCGGGCCA	CASSLGTSGGPGTQYF	In	VDJ	1	44	6.522615687483693E-5	7.90971420764438E-5	48	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	1	2	7	0	6	26	-1	55	42	61		TCRBV12-03,TCRBV12-04												CASSLGTSGGPGTQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACGAGGGGAGCGAGAGACCCAGTACTTCGGGCCA	CSARRGERETQYF	In	VDJ	1	44	6.522615687483693E-5	7.90971420764438E-5	39	TCRBV20						TCRBJ02	TCRBJ02-05	01	2	5	2	4	2	4	26	38	45	40	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARRGERETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTTGGAGGTGGAGGCGAATCAGCCCCAGCATTTTGGTGAT	CSARDLEVEANQPQHF	In	VDJ	1	44	6.522615687483693E-5	7.90971420764438E-5	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	0	10	1	4	3	8	26	40	48	43	56		TCRBV20-01,TCRBV20-or09_02												CSARDLEVEANQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01*02	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGCCCCGGGAGTGAACACTGAAGCTTTCTTTGGACAA	CSARAPGVNTEAFF	In	VDJ	1	44	6.522615687483693E-5	7.90971420764438E-5	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	8	2	0	5	0	26	37	-1	42	48		TCRBV20-01,TCRBV20-or09_02												CSARAPGVNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*02	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCCCGGTCCTTATACAATGAGCAGTTCTTCGGGCCA	CSASRSLYNEQFF	In	VDJ	1	44	6.522615687483693E-5	7.90971420764438E-5	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	8	5	4	3	6	26	35	41	38	47		TCRBV20-01,TCRBV20-or09_02				01,02								CSASRSLYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATCCGCGCTTAACAGGGGGCGGTGGCTACACCTTCGGTTCG	CASSQDPRLTGGGGYTF	In	VDJ	1	44	6.522615687483693E-5	7.90971420764438E-5	51				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	3	0	7	10	2	18	35	54	45	56	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQDPRLTGGGGYTF+X+TCRBJ01-02		TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGCCACGGTAAAAATGGACTATGGCTACACCTTCGGTTCG	CASSATVKMDYGYTF	In	VDJ	1	45	6.670856953108322E-5	8.089480439636297E-5	45	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	6	8	5	3	5	9	26	37	45	42	54		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASSATVKMDYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD02-01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGCGGAGGACGGAGAACACTGAAGCTTTCTTTGGACAA	CSARRTENTEAFF	In	VDJ	1	45	6.670856953108322E-5	8.089480439636297E-5	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	10	1	1	2	5	26	34	41	36	46		TCRBV20-01,TCRBV20-or09_02												CSARRTENTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*02	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCTGCGGAGTAACTATGGCTACACCTTCGGTTCG	CSASLRSNYGYTF	In	VDJ	1	45	6.670856953108322E-5	8.089480439636297E-5	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	3	7	5	1	3	2	26	37	44	40	46		TCRBV20-01,TCRBV20-or09_02				01,02								CSASLRSNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGCACCCGGGACAGGGGGCTCTGGAAACACCATATATTTTGGAGAG	CSAAPGTGGSGNTIYF	In	VDJ	1	45	6.670856953108322E-5	8.089480439636297E-5	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	0	1	0	6	0	26	35	-1	41	52		TCRBV20-01,TCRBV20-or09_02												CSAAPGTGGSGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTTGGGACGGAGGACCAAACTATGGCTACACCTTCGGTTCG	CSWDGGPNYGYTF	In	VDJ	1	45	6.670856953108322E-5	8.089480439636297E-5	39	TCRBV20						TCRBJ01	TCRBJ01-02	01	8	0	7	2	1	9	26	32	38	33	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSWDGGPNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCRTGTATCTCTGTGCCAGCAGCACGCTACAGGGGTCTCAGGGCTACACCTTCGGTTCG	CASSTLQGSQGYTF	In	VDJ	1	45	6.670856953108322E-5	8.089480439636297E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	2	8	5	6	19	31	43	36	49	TCRBV07,TCRBV11													CASSTLQGSQGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGACCCCACAGGTACCCAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	45	6.670856953108322E-5		49	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	4	2	9	5	24	36	50	45	55	TCRBV09,TCRBV21													X+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGACCAACGGGAGAGAACACTGAAGCTTTCTTTGGACAA	CASRPTGENTEAFF	In	VDJ	1	46	6.819098218732952E-5	8.269246671628214E-5	42	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	8	2	1	5	1	26	37	48	42	49		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRPTGENTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01*02	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCAGACTCAGGACAGGGATGGGAGACCCAGTACTTCGGGCCA	CSAPDSGQGWETQYF	In	VDJ	1	46	6.819098218732952E-5	8.269246671628214E-5	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	1	3	5	10	4	26	34	52	44	56		TCRBV20-01,TCRBV20-or09_02												CSAPDSGQGWETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGGAGACTAGCGGAGAAACTTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	46	6.819098218732952E-5		46	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	2	5	4	4	7	26	34	47	38	54		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAGCCAGGGTAATGAAAAACTGTTTTTTGGCAGT	CSARDSQGNEKLFF	In	VDJ	1	46	6.819098218732952E-5	8.269246671628214E-5	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	4	3	4	4	0	26	40	-1	44	49		TCRBV20-01,TCRBV20-or09_02												CSARDSQGNEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGAGAGTAATCAGCCCCAGCATTTTGGTGAT	CSASESNQPQHF	In	VDJ	1	46	6.819098218732952E-5	8.269246671628214E-5	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	3	11	2	4	1	3	26	37	41	38	44		TCRBV20-01,TCRBV20-or09_02												CSASESNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01*02	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCCCAAGACAGCTCTTACGAGCAGTACTTCGGGCCG	CASSSQDSSYEQYF	In	VDJ	1	46	6.819098218732952E-5	8.269246671628214E-5	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	5	4	6	4	24	36	47	42	51		TCRBV24-01,TCRBV24-or09_02												CASSSQDSSYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCCGGGAGTGGCCCAGACAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	46	6.819098218732952E-5		46	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	8	2	2	0	10	18	-1	36	30	46	TCRBV07,TCRBV11													X+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCTCCCACAACAGGGACCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	46	6.819098218732952E-5		46	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	3	3	0	8	0	18	30	-1	38	44	TCRBV07,TCRBV11													X+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGCTCCTTGGGACAGGGAATTCACCCCTCCACTTTGGGAAC	CASRLLGTGNSPLHF	In	VDJ	1	47	6.967339484357581E-5	8.449012903620132E-5	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	0	3	7	7	0	26	37	-1	44	53		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRLLGTGNSPLHF+TCRBV12-X+TCRBJ01-06	TCRBV12	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCAGGGGTCTATAATTCACCCCTCCACTTTGGGAAC	CASSSGVYNSPLHF	In	VDJ	1	47	6.967339484357581E-5	8.449012903620132E-5	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	4	2	3	0	1	26	-1	45	39	46		TCRBV12-03,TCRBV12-04												CASSSGVYNSPLHF+TCRBV12-X+TCRBJ01-06	TCRBV12	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGRSGACTYGGCYSTGTATCTCTGTGCCAGCAGCTTAGAGGCTAATCAGCCCCAGCATTTTGGTGAT	CASSLEANQPQHF	In	VDJ	1	47	6.967339484357581E-5	8.449012903620132E-5	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	2	11	1	4	1	2	20	34	39	35	41	TCRBV05,TCRBV07													CASSLEANQPQHF+X+TCRBJ01-05	unresolved	TCRBD02-01*02	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCAGCCAGGGTAGAATGGCTACACCTTCGGTTCG	CSARDQPG*NGYTF	Stop	VDJ	1	47	6.967339484357581E-5		42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	3	6	5	4	26	40	50	45	54		TCRBV20-01,TCRBV20-or09_02												CSARDQPG*NGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCGAACCCAATCCGGGACAGGGATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	47	6.967339484357581E-5		52	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	0	3	5	12	0	22	33	-1	45	54		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ01-06	TCRBV12	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
SGACTCGGCYRTGTATCTCTGTGCCAGCAGCTTAGTAGGGGGCGCGGTACTAGCGGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSLVGGAVLAGGTDTQYF	In	VDJ	1	47	6.967339484357581E-5	8.449012903620132E-5	60	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	3	2	1	13	0	19	35	-1	48	59	TCRBV07,TCRBV11													CASSLVGGAVLAGGTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTCCGAGGGACACACTCCTACGAGCAGTACTTCGGGCCG	CASSFRGTHSYEQYF	In	VDJ	1	47	6.967339484357581E-5	8.449012903620132E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	0	6	0	4	2	19	33	43	37	45	TCRBV05,TCRBV11													CASSFRGTHSYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCCACGTTTGGTGGGGACTCGGCCTCTATCTCTGTGCCAGCAGCCAGCAGCTTGGGACAGTAAACACTGAAGCTTTCTTTGGACAA	CASSQQLGTVNTEAFF	In	VDJ	1	48	7.115580749982211E-5	8.62877913561205E-5	48	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	5	2	9	2	33	45	61	54	63		TCRBV05-06,TCRBV05-07												CASSQQLGTVNTEAFF+TCRBV05-X+TCRBJ01-01	TCRBV05	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGTTGGGGTAACTATGGCTACACCTTCGGTTCG	CASSQGWGNYGYTF	In	VDJ	1	48	7.115580749982211E-5	8.62877913561205E-5	42	TCRBV03						TCRBJ01	TCRBJ01-02	01	1	6	2	1	3	0	26	42	-1	45	49		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGWGNYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGAGAGGGACAGGGGGATTCACCCCTCCACTTTGGGAAC	CASSREGQGDSPLHF	In	VDJ	1	48	7.115580749982211E-5	8.62877913561205E-5	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	0	1	8	0	0	26	-1	-1	43	54		TCRBV03-01,TCRBV03-02												CASSREGQGDSPLHF+TCRBV03-X+TCRBJ01-06	TCRBV03	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGACCCTGACAGGGGGTATGAAAAACTGTTTTTTGGCAGT	CASSQDPDRGYEKLFF	In	VDJ	1	48	7.115580749982211E-5	8.62877913561205E-5	48				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	2	1	6	4	1	18	35	48	39	49	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQDPDRGYEKLFF+X+TCRBJ01-04		TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGGGGGGGAAAGAGACCCAGTACTTCGGGCCA	CASSLGGKETQYF	In	VDJ	1	49	7.26382201560684E-5	8.808545367603968E-5	39	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	9	0	3	0	1	26	-1	47	40	48		TCRBV12-03,TCRBV12-04												CASSLGGKETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCACCCGGGACAGACAAGAGACCCAGTACTTCGGGCCA	CATRDRQETQYF	In	VDJ	1	49	7.26382201560684E-5	8.808545367603968E-5	36	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	10	0	5	2	3	1	26	33	43	36	44		TCRBV03-01,TCRBV03-02												CATRDRQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCAGGACCGTGGATACGCAGTATTTTGGCCCA	CASSPRTVDTQYF	In	VDJ	1	49	7.26382201560684E-5	8.808545367603968E-5	39	TCRBV03						TCRBJ02	TCRBJ02-03	01	4	1	7	6	3	4	26	39	46	42	50		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPRTVDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTTAGACAGGGGGAATAATGAGCAGTTCTTCGGGCCA	CSARDLDRGNNEQFF	In	VDJ	1	49	7.26382201560684E-5	8.808545367603968E-5	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	2	1	7	4	3	26	40	53	44	56		TCRBV20-01,TCRBV20-or09_02												CSARDLDRGNNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGCAGCCCAGGGGAGCCCTGGAGACCCAGTACTTCGGGCCA	CATSDLQPRGALETQYF	In	VDJ	1	49	7.26382201560684E-5	8.808545367603968E-5	51	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	4	2	5	5	7	24	42	53	47	60		TCRBV24-01,TCRBV24-or09_02												CATSDLQPRGALETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCACCCCAGCCGGGGCTGAAGCTTTCTTTGGACAA	CASTPAGAEAFF	In	VDJ	1	49	7.26382201560684E-5	8.808545367603968E-5	36	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	7	8	3	6	7	0	23	33	-1	40	45	TCRBV06,TCRBV10													CASTPAGAEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATCGGACAGCGTCTGGCTACACCTTCGGTTCG	CASSQDRTASGYTF	In	VDJ	1	49	7.26382201560684E-5	8.808545367603968E-5	42				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	1	5	7	2	4	18	35	43	37	47	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQDRTASGYTF+X+TCRBJ01-02		TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCACATCTCTCGGGGACCCCAGCACAGATACGCAGTATTTTGGCCCA	CASTSLGDPSTDTQYF	In	VDJ	1	49	7.26382201560684E-5	8.808545367603968E-5	48	unresolved						TCRBJ02	TCRBJ02-03	01	7	0	7	0	9	3	19	29	43	38	46	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTSLGDPSTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
SGACTCGGCYSTSTATCTCTGTGCCAGCAGCTTGGATGGGACCTACTATGGCTACACCTTCGGTTCG	CASSLDGTYYGYTF	In	VDJ	1	49	7.26382201560684E-5	8.808545367603968E-5	42	unresolved						TCRBJ01	TCRBJ01-02	01	0	0	7	3	2	2	19	35	42	37	44	TCRBV05,TCRBV07			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDGTYYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCACCGGGACAGGCTACGAGCAGTACTTCGGGCCG	CASTGTGYEQYF	In	VDJ	1	49	7.26382201560684E-5	8.808545367603968E-5	36	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	10	0	4	3	5	0	24	31	-1	36	44	TCRBV02,TCRBV21													CASTGTGYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGTGAAGCGTTAGGACGGTCACTCTTCGGGCCA	CASSEALGRSLF	In	VDJ	1	49	7.26382201560684E-5	8.808545367603968E-5	36	unresolved						TCRBJ02	TCRBJ02-01	01	6	1	7	17	10	6	24	35	49	45	55	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEALGRSLF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCGAGGTAGAGACCCAGTACTTCGGGCCA	CASSFEVETQYF	In	VDJ	1	50	7.41206328123147E-5	8.988311599595886E-5	36	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	11	1	4	1	1	26	40	45	41	46		TCRBV12-03,TCRBV12-04												CASSFEVETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01*02	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTAGGGAGGCTTCGATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	50	7.41206328123147E-5		46	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	1	9	1	5	2	5	26	42	50	44	55		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD02-01*02	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAGAGGCGGGTACGAGCAGTACTTCGGGCCG	CSARGGYEQYF	In	VDJ	1	50	7.41206328123147E-5	8.988311599595886E-5	33	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	7	4	4	0	0	26	-1	-1	39	44		TCRBV20-01,TCRBV20-or09_02				01,02								CSARGGYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGTTTTTCCGAGCGAGGGGTTCTCCGAGCAGTACTTCGGGCCG	CSASVFPSEGFSEQYF	In	VDJ	1	50	7.41206328123147E-5	8.988311599595886E-5	48	TCRBV20						TCRBJ02	TCRBJ02-07	01	3	5	2	6	14	5	26	37	56	51	61		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASVFPSEGFSEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGGGGACAGACGGGGAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	50	7.41206328123147E-5		44	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	0	5	7	2	6	26	37	46	39	52		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCCCAAACAGGGCCCTACCCTCTGGAAACACCATATATTTTGGAGAG	CASPNRALPSGNTIYF	In	VDJ	1	50	7.41206328123147E-5	8.988311599595886E-5	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	8	3	3	0	4	7	23	32	42	36	49	TCRBV06,TCRBV10													CASPNRALPSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGACAGGGGAATAAACACTGAAGCTTTCTTTGGACAA	CASSQDRGINTEAFF	In	VDJ	1	50	7.41206328123147E-5	8.988311599595886E-5	45				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	2	2	0	4	18	-1	41	35	45	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQDRGINTEAFF+X+TCRBJ01-01		TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGGAAGTTGGGGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSGSWGSGANVLTF	In	VDJ	1	50	7.41206328123147E-5	8.988311599595886E-5	48	unresolved						TCRBJ02	TCRBJ02-06	01	5	6	2	0	8	0	23	34	-1	42	46	TCRBV02,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGSWGSGANVLTF+X+TCRBJ02-06	unresolved		TCRBJ02-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTGCTACAGGGGGGAATAGGACGCAGTATTTTGGCCCA	CASSATGGNRTQYF	In	VDJ	1	51	7.560304546856099E-5	9.168077831587803E-5	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	3	1	9	3	7	26	38	49	41	56		TCRBV12-03,TCRBV12-04												CASSATGGNRTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGGAAGATCAAGAGACCCAGTACTTCGGGCCA	CASSLEDQETQYF	In	VDJ	1	51	7.560304546856099E-5	9.168077831587803E-5	39	TCRBV12						TCRBJ02	TCRBJ02-05	01	3	1	8	2	0	4	26	-1	43	40	47		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLEDQETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12		TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCTTGAGGAACACTGAAGCTTTCTTTGGACAA	CASSPLRNTEAFF	In	VDJ	1	51	7.560304546856099E-5	9.168077831587803E-5	39	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	11	2	1	4	0	26	39	-1	43	46		TCRBV03-01,TCRBV03-02												CASSPLRNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01*02	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTTATGACGGACGATCGGGCTACACCTTCGGTTCG	CASSYDGRSGYTF	In	VDJ	1	51	7.560304546856099E-5	9.168077831587803E-5	39	TCRBV03						TCRBJ01	TCRBJ01-02	01	6	1	7	8	7	5	26	37	48	44	53		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYDGRSGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCCTGCTAGCGGGGGGGCCAATGAGCAGTTCTTCGGGCCA	CSASPASGGANEQFF	In	VDJ	1	51	7.560304546856099E-5	9.168077831587803E-5	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	4	0	6	5	1	26	37	54	42	55		TCRBV20-01,TCRBV20-or09_02												CSASPASGGANEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCCTCTCAGCACCGGGGAGCTGTTTTTTGGAGAA	CSASPLSTGELFF	In	VDJ	1	51	7.560304546856099E-5	9.168077831587803E-5	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	4	5	4	6	0	26	37	-1	43	46		TCRBV20-01,TCRBV20-or09_02												CSASPLSTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGAATCCAGCGGGGCCTACAATGAGCAGTTCTTCGGGCCA	CASSESSGAYNEQFF	In	VDJ	1	51	7.560304546856099E-5	9.168077831587803E-5	45	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	6	3	2	6	0	22	34	-1	40	47		TCRBV12-03,TCRBV12-04												CASSESSGAYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCTCCTTCGGTCTCGAACACTGAAGCTTTCTTTGGACAA	CASSSPSVSNTEAFF	In	VDJ	1	51	7.560304546856099E-5	9.168077831587803E-5	45	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	8	5	1	7	4	24	36	46	43	50		TCRBV24-01,TCRBV24-or09_02				01,02								CASSSPSVSNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD02-01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAACGGGGGGCTCCACTGAAGCTTTCTTTGGACAA	CASSLTGGSTEAFF	In	VDJ	1	51	7.560304546856099E-5	9.168077831587803E-5	42	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	6	8	1	4	4	3	24	36	47	40	50		TCRBV24-01,TCRBV24-or09_02												CASSLTGGSTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD02-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTCAGGAAAGCGTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	51	7.560304546856099E-5		40	TCRBV24						TCRBJ01	TCRBJ01-05	01	6	4	4	6	2	6	24	36	42	38	48		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ01-05	TCRBV24		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGTAGGGCGAGGGCCCGGCGAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	51	7.560304546856099E-5		40	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	9	11	0	8	6	7	23	31	42	37	49	TCRBV06,TCRBV10													X+X+TCRBJ01-05	unresolved	TCRBD02-01*02	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCAGAGGGAGGGGCCAAGAGACCCAGTACTTCGGGCCA	CASSRGRGQETQYF	In	VDJ	1	51	7.560304546856099E-5	9.168077831587803E-5	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	9	0	1	3	1	18	30	40	33	41	TCRBV07,TCRBV11													CASSRGRGQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCCAAGACCCACTAGCAAGTTCGAGCAGTTCTTCGGGCCA		Out	VDJ	1	51	7.560304546856099E-5		44				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	3	7	10	3	6	18	35	44	38	50	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03				01,02								X+X+TCRBJ02-01		TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTCCTAGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSFLGGTDTQYF	In	VDJ	1	51	7.560304546856099E-5	9.168077831587803E-5	42	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	5	2	1	3	0	19	33	-1	36	41		TCRBV05-06,TCRBV05-07												CASSFLGGTDTQYF+TCRBV05-X+TCRBJ02-03	TCRBV05	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTCTCAAGACCTATGGCTACACCTTCGGTTCG	CASSLKTYGYTF	In	VDJ	1	51	7.560304546856099E-5	9.168077831587803E-5	36	unresolved						TCRBJ01	TCRBJ01-02	01	5	2	7	4	5	0	23	35	-1	40	43	TCRBV02,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLKTYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGTAGACCAACCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSVDQPGANVLTF	In	VDJ	1	52	7.708545812480728E-5	9.34784406357972E-5	45	TCRBV12						TCRBJ02	TCRBJ02-06	01	6	2	7	2	4	4	26	37	44	41	48		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVDQPGANVLTF+TCRBV12-X+TCRBJ02-06	TCRBV12		TCRBJ02-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCCTTCAGCCAGCCCCAGCATTTTGGTGAT	CASSSFSQPQHF	In	VDJ	1	52	7.708545812480728E-5	9.34784406357972E-5	36	TCRBV12						TCRBJ01	TCRBJ01-05	01	4	4	5	7	4	1	26	39	46	43	47		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSFSQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCGACCCTGGGGGCGGGGGGTAATTCACCCCTCCACTTTGGGAAC	CASSSTLGAGGNSPLHF	In	VDJ	1	52	7.708545812480728E-5	9.34784406357972E-5	51	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	4	7	1	6	11	0	26	39	-1	50	58		TCRBV12-03,TCRBV12-04												CASSSTLGAGGNSPLHF+TCRBV12-X+TCRBJ01-06	TCRBV12	TCRBD02-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCGAAGAGGCGGGCAGTTCTTCGGGCCA	CASSQDRRGGQFF	In	VDJ	1	52	7.708545812480728E-5	9.34784406357972E-5	39	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	7	5	12	8	0	26	43	-1	51	55		TCRBV03-01,TCRBV03-02				01,02								CASSQDRRGGQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAACGCACCGGGACAGGGTGATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	52	7.708545812480728E-5		49	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	3	0	7	3	26	36	52	43	55		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCGATAGCGGTTCTAGCACAGATACGCAGTATTTTGGCCCA	CSATDSGSSTDTQYF	In	VDJ	1	52	7.708545812480728E-5	9.34784406357972E-5	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	5	5	0	4	4	26	36	46	40	50		TCRBV20-01,TCRBV20-or09_02				01,02								CSATDSGSSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAGCAATATTATAAGAAGTATTTTGGCCCA		Out	VDJ	1	52	7.708545812480728E-5		38	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	5	7	13	0	12	26	-1	44	40	56		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGTTACAGTTTAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	52	7.708545812480728E-5		44	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	3	5	0	3	2	26	39	46	42	48		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGACACAGGTCCCACTGAAGCTTTCTTTGGACAA	CSADTGPTEAFF	In	VDJ	1	52	7.708545812480728E-5	9.34784406357972E-5	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	4	4	3	3	26	35	43	38	46		TCRBV20-01,TCRBV20-or09_02												CSADTGPTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGAACAGGCCCATCAAGCTCCTACGAGCAGTACTTCGGGCCG	CASRTGPSSSYEQYF	In	VDJ	1	52	7.708545812480728E-5	9.34784406357972E-5	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	3	4	0	1	9	22	33	39	34	48		TCRBV12-03,TCRBV12-04												CASRTGPSSSYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCCCCTCAGGGGGGTCTAACTATGACTACACCTTCGGTTCG	CASSPSGGSNYDYTF	In	VDJ	1	52	7.708545812480728E-5	9.34784406357972E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	1	10	4	12	18	30	41	34	53	TCRBV07,TCRBV11													CASSPSGGSNYDYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGCCCTTTGGCGGGGGGCGGTAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	52	7.708545812480728E-5		53				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	7	1	4	8	4	18	35	51	43	55	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												X+X+TCRBJ02-05		TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGGCCATAGCGGGGGGCCTTCAAGAGACCCAGTACTTCGGGCCA	CASSLAAIAGGLQETQYF	In	VDJ	1	52	7.708545812480728E-5	9.34784406357972E-5	54				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	5	1	2	5	4	18	35	50	40	54	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLAAIAGGLQETQYF+X+TCRBJ02-05		TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCAGGGAGCTCTGGAAACACCATATATTTTGGAGAG	CASSQAGSSGNTIYF	In	VDJ	1	53	7.856787078105358E-5	9.527610295571638E-5	45	TCRBV03						TCRBJ01	TCRBJ01-03	01	1	4	3	0	0	2	26	-1	47	42	49		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQAGSSGNTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03		TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTCTAACAGGGCTGCACCGGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	53	7.856787078105358E-5		49	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	3	3	3	4	9	26	39	49	43	58		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAGGACAGGGGAACACTGAAGCTTTCTTTGGACAA	CASSLGQGNTEAFF	In	VDJ	1	53	7.856787078105358E-5	9.527610295571638E-5	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	3	1	3	0	24	36	-1	39	47		TCRBV24-01,TCRBV24-or09_02												CASSLGQGNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTCTGGGGTTTTAGGCACAGATACGCAGTATTTTGGCCCA	CASSSGVLGTDTQYF	In	VDJ	1	53	7.856787078105358E-5	9.527610295571638E-5	45	unresolved						TCRBJ02	TCRBJ02-03	01	4	6	2	1	2	6	18	31	37	33	43	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSGVLGTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACKCRGCCMTSTAYCTSTGTGCCAGCAGCGGCCGACTAGCGGGGGGGCCGACAGATACGCAGTATTTTGGCCCA	CASSGRLAGGPTDTQYF	In	VDJ	1	53	7.856787078105358E-5	9.527610295571638E-5	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	2	0	3	4	3	19	31	49	35	52	TCRBV05,TCRBV15													CASSGRLAGGPTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGGTAGCGGAGACCAAGAGACCCAGTACTTCGGGCCA	CASSLGSGDQETQYF	In	VDJ	1	54	8.005028343729987E-5	9.707376527563557E-5	45	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	5	5	0	1	2	26	42	49	43	51		TCRBV12-03,TCRBV12-04				01,02								CASSLGSGDQETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCTTTGACCCCAGGGCTGAAGCTTTCTTTGGACAA	XASSFDPRAEAFF	In	VDJ	1	54	8.005028343729987E-5	9.707376527563557E-5	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	3	6	8	0	23	35	-1	43	48	TCRBV01,TCRBV07													XASSFDPRAEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CTMSCTCYCAGACWTCTGTKTACTTCTGTGCCAGCAGGAGGGCAGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	54	8.005028343729987E-5		35	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	11	0	3	0	3	24	-1	40	35	43	TCRBV06,TCRBV10													X+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATTTGGGTGACGCCTACGAGCAGTACTTCGGGCCG	CASSQDLGDAYEQYF	In	VDJ	1	54	8.005028343729987E-5	9.707376527563557E-5	45	TCRBV03						TCRBJ02	TCRBJ02-07	01	0	0	9	2	3	5	26	43	49	46	54		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDLGDAYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCAAGCGGGGCCAAAACACAGATACGCAGTATTTTGGCCCA	CSATKRGQNTDTQYF	In	VDJ	1	54	8.005028343729987E-5	9.707376527563557E-5	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	6	3	2	3	6	26	36	46	39	52		TCRBV20-01,TCRBV20-or09_02												CSATKRGQNTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCGGCGATTCGGACAGAAATTTTGAAAAACTGTTTTTTGGCAGT	CASSGDSDRNFEKLFF	In	VDJ	1	54	8.005028343729987E-5	9.707376527563557E-5	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	1	5	7	9	6	22	33	48	42	54		TCRBV12-03,TCRBV12-04												CASSGDSDRNFEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGCCCGAGGACTAGCGGGTTCCTACGAGCAGTACTTCGGGCCG	CATSARGLAGSYEQYF	In	VDJ	1	54	8.005028343729987E-5	9.707376527563557E-5	48	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	1	4	1	5	1	24	37	53	42	54		TCRBV24-01,TCRBV24-or09_02				01,02								CATSARGLAGSYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCRTGTATSKCTGTGCTAGCAGCCTAGGACTAGCGGGGGGATCAGATACGCAGTATTTTGGCCCA	CASSLGLAGGSDTQYF	In	VDJ	1	54	8.005028343729987E-5	9.707376527563557E-5	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	2	1	4	0	2	18	-1	47	34	49	TCRBV07,TCRBV11													CASSLGLAGGSDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCAGACAGGGGAACTATGGCTACACCTTCGGTTCG	CASSRQGNYGYTF	In	VDJ	1	54	8.005028343729987E-5	9.707376527563557E-5	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	2	2	0	0	24	-1	-1	37	45	TCRBV09,TCRBV21													CASSRQGNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGCCGCGACAGGATCTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	54	8.005028343729987E-5		43	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	4	0	3	2	24	36	45	39	47	TCRBV02,TCRBV21													X+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTATCCCGGGACAGGCCAACTATGGCTACACCTTCGGTTCG	CASSIPGQANYGYTF	In	VDJ	1	55	8.153269609354617E-5	9.887142759555474E-5	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	4	2	5	2	26	38	51	43	53		TCRBV12-03,TCRBV12-04												CASSIPGQANYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCCCGCGGGGATAGGACTGAAGCTTTCTTTGGACAA	CASSSRGDRTEAFF	In	VDJ	1	55	8.153269609354617E-5	9.887142759555474E-5	42	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	4	7	3	5	3	5	26	39	48	42	53		TCRBV12-03,TCRBV12-04												CASSSRGDRTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCTCAGGGGCGGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSSQGRSNQPQHF	In	VDJ	1	55	8.153269609354617E-5	9.887142759555474E-5	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	4	2	1	2	3	26	39	47	41	50		TCRBV12-03,TCRBV12-04												CASSSQGRSNQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACCGGGACTCGCCCAAAGCAGATACGCAGTATTTTGGCCCA	CSARDRDSPKADTQYF	In	VDJ	1	55	8.153269609354617E-5	9.887142759555474E-5	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	0	10	4	2	9	26	40	48	42	57		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDRDSPKADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAGTGAAGGGGGAGTGGCTGAAGCTTTCTTTGGACAA	CASSEGGVAEAFF	In	VDJ	1	55	8.153269609354617E-5	9.887142759555474E-5	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	5	1	6	2	5	22	34	42	36	47	TCRBV12,TCRBV21													CASSEGGVAEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCCCACAGGTTAACACTGAAGCTTTCTTTGGACAA	CASSPQVNTEAFF	In	VDJ	1	55	8.153269609354617E-5	9.887142759555474E-5	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	4	2	2	2	24	36	43	38	45	TCRBV09,TCRBV21													CASSPQVNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGGCTGGGCAGGTACAACTAATGAAAAACTGTTTTTTGGCAGT	CASSVGWAGTTNEKLFF	In	VDJ	1	55	8.153269609354617E-5	9.887142759555474E-5	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	4	4	0	6	2	23	39	49	45	51	TCRBV09,TCRBV21													CASSVGWAGTTNEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCTGACTACCGAGCGGTTTCTGGGCAGTTCTTCGGGCCA	CASSPDYRAVSGQFF	In	VDJ	1	56	8.301510874979246E-5	1.0066908991547392E-4	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	2	9	12	2	15	26	39	46	41	61		TCRBV03-01,TCRBV03-02				01,02								CASSPDYRAVSGQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGCCCAGACTATAAACACTGAAGCTTTCTTTGGACAA	CASSAQTINTEAFF	In	VDJ	1	56	8.301510874979246E-5	1.0066908991547392E-4	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	2	9	2	5	2	26	38	48	43	50		TCRBV03-01,TCRBV03-02				01,02								CASSAQTINTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAGTAGGCTCCAGGACAGAGGCTAGTATTTCTGAAGCTTTCTTTGGACAA	CSAVGSRTEASISEAFF	In	VDJ	1	56	8.301510874979246E-5	1.0066908991547392E-4	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	5	6	11	12	26	34	51	45	63		TCRBV20-01,TCRBV20-or09_02												CSAVGSRTEASISEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAAAGGGCCGATTTTGGACACTGAAGCTTTCTTTGGACAA	CSAKGPILDTEAFF	In	VDJ	1	56	8.301510874979246E-5	1.0066908991547392E-4	42	TCRBV20						TCRBJ01	TCRBJ01-01	01	6	5	3	3	3	10	26	34	41	37	51		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAKGPILDTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGAAGACAGGAGTCAGCGGCGGAAGACGAATGAGCAGTTCTTCGGGCCA	CSAEDRSQRRKTNEQFF	In	VDJ	1	56	8.301510874979246E-5	1.0066908991547392E-4	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	2	4	7	4	18	26	34	44	38	62		TCRBV20-01,TCRBV20-or09_02												CSAEDRSQRRKTNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGCGACTTCCTAGCGGGGGGTTCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	56	8.301510874979246E-5		50	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	4	1	3	9	2	26	35	55	44	57		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGTAGCGGTGAACACCTACGAGCAGTACTTCGGGCCG	CSAVAVNTYEQYF	In	VDJ	1	56	8.301510874979246E-5	1.0066908991547392E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	5	5	2	1	6	26	35	42	36	48		TCRBV20-01,TCRBV20-or09_02				01,02								CSAVAVNTYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTAAGGTAAGCTCCTATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	56	8.301510874979246E-5		43	TCRBV20						TCRBJ01	TCRBJ01-06	01	5	5	4	0	2	4	26	35	40	37	44		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-06	TCRBV20		TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCTGGGACTAGCGGGACCATTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	56	8.301510874979246E-5		49	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	0	3	4	3	4	24	38	54	41	58		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*02	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTGTAATACAGGGGGCTGTAGATGGCTACACCTTCGGTTCG	CASSVIQGAVDGYTF	In	VDJ	1	56	8.301510874979246E-5	1.0066908991547392E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	0	6	4	5	24	37	50	41	55		TCRBV24-01,TCRBV24-or09_02												CASSVIQGAVDGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCAGGAGACWCRGCMSKGTATKTCTGTGCCAGCAGCTTAACCACCTGTTAGGAGAAGAGCAGTACTTCGGGCCG		Out	VDJ	1	56	8.301510874979246E-5		44	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	10	2	7	11	2	18	33	48	44	50	TCRBV11,TCRBV21													X+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAATGGACAGGGTAATCTATGGTTACACCTTCGGTTCG		Out	VDJ	1	57	8.449752140603876E-5		40	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	3	11	2	11	26	36	46	38	57		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTCCAGCGGGGGGTCCCTTCGGGAGACCCAGTACTTCGGGCCA	CSASSSGGSLRETQYF	In	VDJ	1	57	8.449752140603876E-5	1.024667522353931E-4	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	6	1	5	4	9	26	37	50	41	59		TCRBV20-01,TCRBV20-or09_02												CSASSSGGSLRETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCAAACCCCAGCCTACAAGCAGTACTTCGGGCCG	CASSQTPAYKQYF	In	VDJ	1	57	8.449752140603876E-5	1.024667522353931E-4	39	TCRBV24						TCRBJ02	TCRBJ02-07	01	6	3	6	8	13	0	24	36	-1	49	52		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQTPAYKQYF+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCATCAGTGAGATCAACGGGACAGGGACGAGCAGTACTTCGGGCCG		Out	VDJ	1	57	8.449752140603876E-5		44	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	3	5	7	0	24	38	-1	45	54		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCACCTTAGCGGGGGGGAGCGAGACCCAGTACTTCGGGCCA	CASSTLAGGSETQYF	In	VDJ	1	57	8.449752140603876E-5	1.024667522353931E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	5	0	5	4	3	18	30	45	34	48	TCRBV07,TCRBV11													CASSTLAGGSETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGGGGGACTAGTAGTATCCGGGGAGCTGTTTTTTGGAGAA	CASSGGLVVSGELFF	In	VDJ	1	57	8.449752140603876E-5	1.024667522353931E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	0	8	6	2	6	24	36	46	38	52	TCRBV09,TCRBV21					01,02								CASSGGLVVSGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAGTGAATGGGGGGACAGGGTGAGTGAGCAGTTCTTCGGGCCA	CASSEWGDRVSEQFF	In	VDJ	1	57	8.449752140603876E-5	1.024667522353931E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	3	9	8	4	24	35	52	43	56	TCRBV12,TCRBV21													CASSEWGDRVSEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGGGGACAGGGCGGCTTTAGAAACACCATATATTTTGGAGAG	CASRGQGGFRNTIYF	In	VDJ	1	57	8.449752140603876E-5	1.024667522353931E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	0	3	5	0	8	23	-1	43	34	51	TCRBV09,TCRBV21													CASRGQGGFRNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCCTCAGCGGGGGGTGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	57	8.449752140603876E-5		40	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	7	6	1	3	3	2	23	32	44	35	46	TCRBV09,TCRBV21													X+X+TCRBJ01-01	unresolved	TCRBD02-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTTTCCCGGGACAGGATACTACGAGCAGTACTTCGGGCCG	CASSFPGTGYYEQYF	In	VDJ	1	58	8.597993406228505E-5	1.0426441455531227E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	4	3	7	3	26	37	52	44	55		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSFPGTGYYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGAGACTATGGCTACACCTTCGGTTCG	CASSQGDYGYTF	In	VDJ	1	58	8.597993406228505E-5	1.0426441455531227E-4	36	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	1	11	2	3	0	0	26	-1	-1	42	45		TCRBV03-01,TCRBV03-02												CASSQGDYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD02-01*02	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGAACATTGGGGTGGGGAAACACCATATATTTTGGAGAG	CSAGTLGWGNTIYF	In	VDJ	1	58	8.597993406228505E-5	1.0426441455531227E-4	42	TCRBV20						TCRBJ01	TCRBJ01-03	01	5	6	2	4	8	3	26	35	47	43	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAGTLGWGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20		TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGGGGGGACCCCTATGGCTACACCTTCGGTTCG	CSAGGDPYGYTF	In	VDJ	1	58	8.597993406228505E-5	1.0426441455531227E-4	36	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	5	9	0	4	0	4	26	-1	42	35	46		TCRBV20-01,TCRBV20-or09_02												CSAGGDPYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAGCCCTACAGGGGGCGAGTATAATTCACCCCTCCACTTTGGGAAC	CAISPTGGEYNSPLHF	In	VDJ	1	58	8.597993406228505E-5	1.0426441455531227E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	3	0	4	4	3	23	34	47	38	50	TCRBV06,TCRBV10													CAISPTGGEYNSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTAGTATCCGGTGAAAATGAAAAACTGTTTTTTGGCAGT	CASSLVSGENEKLFF	In	VDJ	1	58	8.597993406228505E-5	1.0426441455531227E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	1	8	5	5	4	4	18	34	41	38	45	TCRBV07,TCRBV11					01,02								CASSLVSGENEKLFF+X+TCRBJ01-04	unresolved	TCRBD02-01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGGCCCTAGCGGCCTCCAAGAGACCCAGTACTTCGGGCCA	CASSVGPSGLQETQYF	In	VDJ	1	58	8.597993406228505E-5	1.0426441455531227E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	4	5	1	3	3	23	39	49	42	52	TCRBV09,TCRBV21					01,02								CASSVGPSGLQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGACAGGGGAAAGATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	59	8.746234671853134E-5		40	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	2	2	6	0	4	26	-1	45	37	49		TCRBV12-03,TCRBV12-04,TCRBV12-05												X+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCGACTGAGGGCCAACGTCCTGACTTTCGGGGCC	CASSRLRANVLTF	In	VDJ	1	59	8.746234671853134E-5	1.0606207687523144E-4	39	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	5	2	10	5	1	2	26	38	43	39	45		TCRBV12-03,TCRBV12-04				01,02								CASSRLRANVLTF+TCRBV12-X+TCRBJ02-06	TCRBV12	TCRBD02-01	TCRBJ02-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCTAGCAGCCAAGGGACTAGCGAGGATACGCAGTATTTTGGCCCA	XASSQGTSEDTQYF	In	VDJ	1	59	8.746234671853134E-5	1.0606207687523144E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	1	6	6	0	2	23	-1	48	39	50	TCRBV01,TCRBV17					01,02								XASSQGTSEDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAGGAAAGACAGGGAAGTCGGGGAGCTGTTTTTTGGAGAA	CAIRKDREVGELFF	In	VDJ	1	59	8.746234671853134E-5	1.0606207687523144E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	2	3	7	4	4	24	35	46	39	50	TCRBV06,TCRBV10													CAIRKDREVGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAGACTTACAATGAGCAGTTCTTCGGGCCA	CSAKTYNEQFF	In	VDJ	1	59	8.746234671853134E-5	1.0606207687523144E-4	33	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	2	10	4	1	0	26	36	-1	37	41		TCRBV20-01,TCRBV20-or09_02				01,02								CSAKTYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAGTGTAGAATCCAGGGGCGTTGGCTACACCTTCGGTTCG	CASSVESRGVGYTF	In	VDJ	1	59	8.746234671853134E-5	1.0606207687523144E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	4	2	7	4	3	22	38	48	42	51	TCRBV12,TCRBV21													CASSVESRGVGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGAACAGGGGGCACTGAAGCTTTCTTTGGACAA	CASRTGGTEAFF	In	VDJ	1	59	8.746234671853134E-5	1.0606207687523144E-4	36	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	3	1	4	1	0	24	35	-1	36	44	TCRBV24,TCRBV27													CASRTGGTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGCGGACAGGGATCCTCCTACGAGCAGTACTTCGGGCCG	CASSGQGSSYEQYF	In	VDJ	1	59	8.746234671853134E-5	1.0606207687523144E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	1	3	0	1	3	24	35	44	36	47	TCRBV24,TCRBV27													CASSGQGSSYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTATTGTCCCGGTTACTGAAGCTTTCTTTGGACAA	CASSIVPVTEAFF	In	VDJ	1	59	8.746234671853134E-5	1.0606207687523144E-4	39	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	8	5	5	7	2	24	36	46	43	48		TCRBV24-01,TCRBV24-or09_02				01,02								CASSIVPVTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD02-01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGGGGACTCAGCYWTGTATYKCTGTGCCAGCAGCCCCCCGGGGAAAAACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	59	8.746234671853134E-5		43	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	8	3	2	4	5	19	31	40	35	45	TCRBV07,TCRBV09													X+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGTTATCACCTACTTTCGCAGTATTTTGGCCCA	CASSYHLLSQYF	In	VDJ	1	60	8.894475937477764E-5	1.0785973919515063E-4	36	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	3	10	10	7	2	26	39	49	46	51	TCRBV12,TCRBV21					01,02								CASSYHLLSQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGRKGACTCKGCYSTGTATYTCTGTGCCAGCAGCTTAGAAGTCAACTATGGCTACACCTTCGGTTCG	CASSLEVNYGYTF	In	VDJ	1	60	8.894475937477764E-5	1.0785973919515063E-4	39	unresolved			unresolved			TCRBJ01	TCRBJ01-02	01	2	2	8	2	1	4	20	34	37	35	41	TCRBV03,TCRBV05			TCRBD01,TCRBD02										CASSLEVNYGYTF+X+TCRBJ01-02	unresolved	unresolved	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCCGACAGGGGTAAGGCTTTCTTTGGACAA	CSAPDRGKAFF	In	VDJ	1	60	8.894475937477764E-5	1.0785973919515063E-4	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	2	11	4	4	26	34	46	38	50		TCRBV20-01,TCRBV20-or09_02												CSAPDRGKAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGCTGCACACAGATACGCAGTATTTTGGCCCA	CSALHTDTQYF	In	VDJ	1	60	8.894475937477764E-5	1.0785973919515063E-4	33	TCRBV20						TCRBJ02	TCRBJ02-03	01	6	4	6	2	4	0	26	34	-1	38	40		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSALHTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTTGTGCGCCGGGAAAACTGTTTTTTGGCAGT		Out	VDJ	1	60	8.894475937477764E-5		38	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	1	8	4	10	8	0	26	39	-1	47	51		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD02-01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCAGAGGGGTCCCGCCGGATACGCAGTATTTTGGCCCA	CSASRGVPPDTQYF	In	VDJ	1	60	8.894475937477764E-5	1.0785973919515063E-4	42	TCRBV20						TCRBJ02	TCRBJ02-03	01	3	5	2	6	3	8	26	37	45	40	53		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASRGVPPDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTAATTTACAGGGTCTAATCAGCCCCAGCATTTTGGTGAT	CSA*FTGSNQPQHF	Stop	VDJ	1	60	8.894475937477764E-5		42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	3	3	4	6	3	26	35	47	41	50		TCRBV20-01,TCRBV20-or09_02												CSA*FTGSNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTAAGACTAGCGGGGGGCGTCGTGGCACCGGGGAGCTGTTTTTTGGAGAA	CATSKTSGGRRGTGELFF	In	VDJ	1	60	8.894475937477764E-5	1.0785973919515063E-4	54	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	6	2	1	4	2	8	24	36	51	38	59		TCRBV24-01,TCRBV24-or09_02												CATSKTSGGRRGTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCAGCACAGGGTGGGATTGGCGAAAAACTGTTTTTTGGCAGT	CASSSAQGGIGEKLFF	In	VDJ	1	60	8.894475937477764E-5	1.0785973919515063E-4	48				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	3	3	8	0	10	18	-1	41	35	51	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSSAQGGIGEKLFF+X+TCRBJ01-04		TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTCCCAAACGGGACAGAACACCTACGAGCAGTACTTCGGGCCG	CASSSQTGQNTYEQYF	In	VDJ	1	60	8.894475937477764E-5	1.0785973919515063E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	5	2	7	4	18	31	45	38	49	TCRBV07,TCRBV11													CASSSQTGQNTYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTAGTGGCAGAATCCTTTTATGGCTACACCTTCGGTTCG	CASSLVAESFYGYTF	In	VDJ	1	60	8.894475937477764E-5	1.0785973919515063E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	4	5	5	3	8	18	34	40	37	48	TCRBV07,TCRBV11													CASSLVAESFYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCSRGGGACTYRGCTGTGTATYTYTGTGCCAGCAGCTCTGGGCAGGGGCCTTATGGCTACACCTTCGGTTCG	CASSSGQGPYGYTF	In	VDJ	1	61	9.042717203102393E-5	1.096574015150698E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	4	2	5	7	3	26	37	50	44	53	TCRBV07,TCRBV12													CASSSGQGPYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGTGGAGGAGGGGGATCGGGAAAACTGTTTTTTGGCAGT	CASSGGGGSGKLFF	In	VDJ	1	61	9.042717203102393E-5	1.096574015150698E-4	42	unresolved						TCRBJ01	TCRBJ01-04	01	5	5	1	10	5	6	26	38	49	43	55	TCRBV12,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGGGGSGKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTATCTTTCACAGATACGCAGTATTTTGGCCCA	CASSLSFTDTQYF	In	VDJ	1	61	9.042717203102393E-5	1.096574015150698E-4	39	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	4	10	2	1	2	26	41	44	42	46		TCRBV12-03,TCRBV12-04				01,02								CASSLSFTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTTTACGCGGACTAGCGGGGGACCAAGAGACCCAGTACTTCGGGCCA	CASSLRGLAGDQETQYF	In	VDJ	1	61	9.042717203102393E-5	1.096574015150698E-4	51	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	1	2	0	7	0	26	37	-1	44	57		TCRBV03-01,TCRBV03-02												CASSLRGLAGDQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGTTCGGTAGCAGGGGGCTAGGAAACACCATATATTTTGGAGAG	CSARGFGSRGLGNTIYF	In	VDJ	1	61	9.042717203102393E-5	1.096574015150698E-4	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	4	0	4	10	2	26	39	57	49	59		TCRBV20-01,TCRBV20-or09_02												CSARGFGSRGLGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGGACTAGTGGCCCTTCTGGTACGCAGTATTTTGGCCCA	CSAGTSGPSGTQYF	In	VDJ	1	61	9.042717203102393E-5	1.096574015150698E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	0	8	8	0	12	26	-1	43	35	55		TCRBV20-01,TCRBV20-or09_02				01,02								CSAGTSGPSGTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGCTACTCAGGGGGCTTGGGTGAAAAACTGTTTTTTGGCAGT	CASSYSGGLGEKLFF	In	VDJ	1	61	9.042717203102393E-5	1.096574015150698E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	4	0	7	5	5	23	34	47	39	52	TCRBV24,TCRBV27													CASSYSGGLGEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTATCAGGCTTCTATGGCTACACCTTCGGTTCG	CASSLSGFYGYTF	In	VDJ	1	61	9.042717203102393E-5	1.096574015150698E-4	39	unresolved			unresolved			TCRBJ01	TCRBJ01-02	01	0	5	4	4	0	3	23	-1	43	40	46	TCRBV24,TCRBV27			TCRBD01,TCRBD02										CASSLSGFYGYTF+X+TCRBJ01-02	unresolved	unresolved	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGCGCAGGAGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	61	9.042717203102393E-5		44	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	4	1	2	1	24	42	48	44	49		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTTGCCGACTAGACTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	61	9.042717203102393E-5		44	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	2	8	3	4	1	24	41	51	45	52		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCCAACAGGGGGAAGGGGCTACACCTTCGGTTCG	CASSPTGGRGYTF	In	VDJ	1	61	9.042717203102393E-5	1.096574015150698E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	3	1	8	4	4	24	35	47	39	51		TCRBV24-01,TCRBV24-or09_02												CASSPTGGRGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCTACTCCACACAGGGCTGAGCACTGAAGCTTTCTTTGGACAA	CASSLLHTGLSTEAFF	In	VDJ	1	61	9.042717203102393E-5	1.096574015150698E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	3	4	9	5	24	36	51	45	56		TCRBV24-01,TCRBV24-or09_02												CASSLLHTGLSTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCTTCTGTCGTAAACAGTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	61	9.042717203102393E-5		46				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	3	5	1	9	0	18	32	-1	41	45	TCRBV05,TCRBV11	TCRBV05-03,TCRBV11-03												X+X+TCRBJ01-02		TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GCCACGTTTGGTGGTCAGGAGACMAGCACGGTATTTCTGTGCCAGCAGCACCTGACAGGCGCTCCCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	61	9.042717203102393E-5		44	TCRBV21			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	4	4	3	6	37	50	59	53	65		TCRBV21-or09_02,TCRBV21-01												X+TCRBV21-X+TCRBJ01-02	TCRBV21	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTGGGTGACAGGGAGGCTTTCTTTGGACAA		Out	VDJ	1	62	9.190958468727023E-5		34	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	3	11	4	2	26	38	49	42	51		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCCCTAGCGGGGGGGTGGGATACGCAGTATTTTGGCCCA	CASSSLAGGWDTQYF	In	VDJ	1	62	9.190958468727023E-5	1.1145506383498898E-4	45	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	4	0	6	2	3	26	39	53	41	56		TCRBV12-03,TCRBV12-04												CASSSLAGGWDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTGGGTCTTATCAGCCCCAGCATTTTGGTGAT	CASSFGSYQPQHF	In	VDJ	1	62	9.190958468727023E-5	1.1145506383498898E-4	39	TCRBV12						TCRBJ01	TCRBJ01-05	01	3	0	9	5	1	4	26	40	44	41	48		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFGSYQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGAGGGGAACACTGAAGCTTTCTTTGGACAA	CSARDEGNTEAFF	In	VDJ	1	62	9.190958468727023E-5	1.1145506383498898E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	11	0	1	1	0	26	40	-1	41	46		TCRBV20-01,TCRBV20-or09_02												CSARDEGNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*02	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTCTAGGGGGGCTCTTAATGAAAAACTGTTTTTTGGCAGT	CSASSRGALNEKLFF	In	VDJ	1	62	9.190958468727023E-5	1.1145506383498898E-4	45	TCRBV20						TCRBJ01	TCRBJ01-04	01	3	5	1	4	4	5	26	37	47	41	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASSRGALNEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20		TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGGAGAAAGGATAAAGGGACAGGGACGGGTTAACACTGAAGCTTTCTTTGGACAA	CSGERIKGQGRVNTEAFF	In	VDJ	1	62	9.190958468727023E-5	1.1145506383498898E-4	54	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	0	3	2	13	7	26	33	55	46	62		TCRBV20-01,TCRBV20-or09_02												CSGERIKGQGRVNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGCGTTGAGACGATCGAGACCCAGTACTTCGGGCCA	CASSVETIETQYF	In	VDJ	1	62	9.190958468727023E-5	1.1145506383498898E-4	39	unresolved						TCRBJ02	TCRBJ02-05	01	6	2	7	5	6	4	22	33	42	39	46	TCRBV09,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVETIETQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCTCATTCCCATCACTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	62	9.190958468727023E-5		46				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	4	6	0	0	9	18	-1	33	31	42	TCRBV05,TCRBV11	TCRBV05-03,TCRBV11-03												X+X+TCRBJ01-03		TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGTCCCCCGACTCTATGGCTACACCTTCGGTTCG	CSASVPRLYGYTF	In	VDJ	1	63	9.339199734351652E-5	1.1325272615490816E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	3	2	10	4	8	0	26	37	-1	45	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSASVPRLYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATCCTGGGACAGCTAAACACTGAAGCTTTCTTTGGACAA	CSAILGQLNTEAFF	In	VDJ	1	63	9.339199734351652E-5	1.1325272615490816E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	5	2	4	3	26	36	47	40	50		TCRBV20-01,TCRBV20-or09_02												CSAILGQLNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGCTCCCGGACAGGGTCCCACGAGCAGTACTTCGGGCCG	CASSSRTGSHEQYF	In	VDJ	1	63	9.339199734351652E-5	1.1325272615490816E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	3	5	5	4	22	33	46	38	50	TCRBV09,TCRBV12													CASSSRTGSHEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCCTCAGGGCTACGAGCAGTACTTCGGGCCG	CATSDPQGYEQYF	In	VDJ	1	63	9.339199734351652E-5	1.1325272615490816E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	3	3	3	0	24	39	-1	42	47		TCRBV24-01,TCRBV24-or09_02												CATSDPQGYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTACCTCAGGAACACTGAAGCTTTCTTTGGACAA	CASSYLRNTEAFF	In	VDJ	1	63	9.339199734351652E-5	1.1325272615490816E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	5	1	5	0	24	36	-1	41	44		TCRBV24-01,TCRBV24-or09_02												CASSYLRNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCRTGTATSKCTGTGCTAGCAGCTTAGGGGGTGATAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLGGDNTGELFF	In	VDJ	1	63	9.339199734351652E-5	1.1325272615490816E-4	45	unresolved						TCRBJ02	TCRBJ02-02	01	1	6	2	2	0	4	18	-1	38	34	42	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGGDNTGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCCAGCCGGGGAGTAACTATGGCTACACCTTCGGTTCG	CASQPGSNYGYTF	In	VDJ	1	63	9.339199734351652E-5	1.1325272615490816E-4	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	10	8	3	1	6	2	24	31	42	37	44	TCRBV12,TCRBV21					01,02								CASQPGSNYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGCGGAGGGGGAGGGGATCCCAATGAGCAGTTCTTCGGGCCA	CASSGGGGDPNEQFF	In	VDJ	1	63	9.339199734351652E-5	1.1325272615490816E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	9	0	6	4	5	23	36	47	40	52	TCRBV09,TCRBV12													CASSGGGGDPNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGGACAAAACACCGGGGAGCTGTTTTTTGGAGAA	CASSVGQNTGELFF	In	VDJ	1	63	9.339199734351652E-5	1.1325272615490816E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	2	6	2	0	1	23	-1	43	39	44	TCRBV09,TCRBV21													CASSVGQNTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTATGGGAGGGGGGCGAGCAGTACTTCGGGCCG	CASSLWEGGEQYF	In	VDJ	1	64	9.487440999976282E-5	1.1505038847482733E-4	39	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	9	0	6	1	3	26	41	49	42	52		TCRBV12-03,TCRBV12-04												CASSLWEGGEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*02	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTATGGGGTAGCCGACGAAACATTCAGTACTTCGGCGCC	CASSLWGSRRNIQYF	In	VDJ	1	64	9.487440999976282E-5	1.1505038847482733E-4	45	TCRBV12						TCRBJ02	TCRBJ02-04	01	2	6	2	6	1	9	26	41	46	42	55		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLWGSRRNIQYF+TCRBV12-X+TCRBJ02-04	TCRBV12		TCRBJ02-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAGGGCTTTGGGCGGAACTATGGCTACACCTTCGGTTCG	CASSQGFGRNYGYTF	In	VDJ	1	64	9.487440999976282E-5	1.1505038847482733E-4	45	unresolved						TCRBJ01	TCRBJ01-02	01	3	8	0	2	0	9	23	-1	41	37	50	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGFGRNYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGAATCGGGGGACAGGGGATTATGGCTACACCTTCGGTTCG	CASSQNRGTGDYGYTF	In	VDJ	1	64	9.487440999976282E-5	1.1505038847482733E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	2	5	7	2	26	40	57	47	59		TCRBV03-01,TCRBV03-02												CASSQNRGTGDYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTTTGTACGGCTACAATGAGCAGTTCTTCGGGCCA	CASSLYGYNEQFF	In	VDJ	1	64	9.487440999976282E-5	1.1505038847482733E-4	39	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	8	5	3	3	0	22	36	-1	39	42		TCRBV12-03,TCRBV12-04				01,02								CASSLYGYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGACTAGCGGGGAGTCCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	64	9.487440999976282E-5		49				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	4	3	2	0	4	18	-1	44	35	48	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												X+X+TCRBJ02-03		TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCAAGTTCTGGGGGCCACCGGGGAGCTGTTTTTTGGAGAA	CASSQVLGATGELFF	In	VDJ	1	64	9.487440999976282E-5	1.1505038847482733E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	6	0	4	8	0	18	30	-1	38	44	TCRBV07,TCRBV11													CASSQVLGATGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGCCAGGGCCGGGGAGCTGTTTTTTGGAGAA	CASSVARAGELFF	In	VDJ	1	64	9.487440999976282E-5	1.1505038847482733E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	4	3	6	5	0	24	36	-1	41	46	TCRBV09,TCRBV21													CASSVARAGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACYSRRGGACTCAGCYRTGTAYTTYTGTGCCAGCAGTGTCCTGGGGACCGGGGAGCTGTTTTTTGGAGAA	CASSVLGTGELFF	In	VDJ	1	64	9.487440999976282E-5	1.1505038847482733E-4	39	unresolved						TCRBJ02	TCRBJ02-02	01	4	6	2	5	4	0	23	36	-1	40	44	TCRBV02,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVLGTGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCCCGATCCGGGACAGGTTAAGATTGAGGGAGCTTTCTTTGGACAA		Out	VDJ	1	64	9.487440999976282E-5		50	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	4	10	7	13	23	35	50	42	63	TCRBV09,TCRBV21													X+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGCAAGAACGAACACTGAAGCTTTCTTTGGACAA	CASSARTNTEAFF	In	VDJ	1	64	9.487440999976282E-5	1.1505038847482733E-4	39	unresolved						TCRBJ01	TCRBJ01-01	01	3	2	8	1	3	2	23	36	41	39	43	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSARTNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGAGGATGGGGGCGTAAGGGAAAAACTGTTTTTTGGCAGT	CASSLEDGGVREKLFF	In	VDJ	1	65	9.635682265600911E-5	1.1684805079474652E-4	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	6	0	8	5	6	26	42	53	47	59		TCRBV12-03,TCRBV12-04												CASSLEDGGVREKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGACAGGGGGCGGAAGAGACCCAGTACTTCGGGCCA	CASRQGAEETQYF	In	VDJ	1	65	9.635682265600911E-5	1.1684805079474652E-4	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	3	0	3	0	2	26	-1	46	37	48		TCRBV03-01,TCRBV03-02												CASRQGAEETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTCCCAGGGTAATGAACACTGAAGCTTTCTTTGGACAA	CASSPRVMNTEAFF	In	VDJ	1	65	9.635682265600911E-5	1.1684805079474652E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	3	0	3	3	26	37	45	40	48		TCRBV03-01,TCRBV03-02												CASSPRVMNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAATCCGGAGGGGTCCTATGGCTACACCTTCGGTTCG	CASNPEGSYGYTF	In	VDJ	1	65	9.635682265600911E-5	1.1684805079474652E-4	39	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	7	10	0	4	4	3	22	32	42	36	45		TCRBV12-03,TCRBV12-04												CASNPEGSYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD02-01*02	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGAAAACAGGGTGGTCTATGGCTACACCTTCGGTTCG	CASSENRVVYGYTF	In	VDJ	1	65	9.635682265600911E-5	1.1684805079474652E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	3	4	4	4	22	34	44	38	48		TCRBV12-03,TCRBV12-04												CASSENRVVYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGGGACTYGGSCSTRTATKTCTGTGCCAGCAGACGGGACTAGCGGGGGGCACTACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	65	9.635682265600911E-5		50	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	6	0	1	5	2	4	22	33	50	35	54	TCRBV11,TCRBV12													X+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCCTCCCCCCAGAGGAAGCAGTACTTCGGGCCG	CASSSSPQRKQYF	In	VDJ	1	65	9.635682265600911E-5	1.1684805079474652E-4	39	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	11	1	8	11	1	24	36	51	47	52		TCRBV24-01,TCRBV24-or09_02												CASSSSPQRKQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*02	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATTCCAGGGAGGCAATCAGCCCCAGCATTTTGGTGAT	CASSLFQGGNQPQHF	In	VDJ	1	65	9.635682265600911E-5	1.1684805079474652E-4	45	TCRBV24						TCRBJ01	TCRBJ01-05	01	6	4	3	2	6	2	24	36	47	42	49		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLFQGGNQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTAGGGACAGGGGAGGGGAATGAGCAGTTCTTCGGGCCA	CASSLGTGEGNEQFF	In	VDJ	1	65	9.635682265600911E-5	1.1684805079474652E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	1	2	7	0	5	19	-1	44	35	49	TCRBV07,TCRBV11													CASSLGTGEGNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCAAGGGTTCAGGGGGAGCAGTACTTCGGGCCG	CASSLARVQGEQYF	In	VDJ	1	65	9.635682265600911E-5	1.1684805079474652E-4	42				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	2	7	7	0	18	35	-1	42	48	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLARVQGEQYF+X+TCRBJ02-07		TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGGTAACCAACTATGGCTACACCTTCGGTTCG	CASSLAVTNYGYTF	In	VDJ	1	65	9.635682265600911E-5	1.1684805079474652E-4	42							TCRBJ01	TCRBJ01-02	01	0	0	10	2	0	5	18	-1	37	35	42	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAVTNYGYTF+X+TCRBJ01-02			TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCACCCCCACCGGGTCCTACGAGCAGTACTTCGGGCCG	CASSTPTGSYEQYF	In	VDJ	1	65	9.635682265600911E-5	1.1684805079474652E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	8	4	1	7	0	24	37	-1	44	48	TCRBV09,TCRBV21					01,02								CASSTPTGSYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAGTTACAGGGCCGAACTCAACTACACCTTCGGTTCG	CAISYRAELNYTF	In	VDJ	1	66	9.783923531225541E-5	1.1864571311466569E-4	39	unresolved			unresolved			TCRBJ01	TCRBJ01-02	01	5	3	3	10	1	10	24	36	43	37	53	TCRBV06,TCRBV10			TCRBD01,TCRBD02										CAISYRAELNYTF+X+TCRBJ01-02	unresolved	unresolved	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTAGACGGCTATGGCTACACCTTCGGTTCG	CSARVDGYGYTF	In	VDJ	1	66	9.783923531225541E-5	1.1864571311466569E-4	36	TCRBV20						TCRBJ01	TCRBJ01-02	01	1	2	7	4	2	2	26	39	44	41	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARVDGYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAATCCCCGAACACTGAAGCTTTCTTTGGACAA	CASSQSPNTEAFF	In	VJ	1	66	9.783923531225541E-5	1.1864571311466569E-4	39	unresolved						TCRBJ01	TCRBJ01-01	01	2	0	0	1	0	5	23	-1	38	-1	43	TCRBV01,TCRBV04													CASSQSPNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGGGGGTGGCAGGGAGGTATGAACACTGAAGCTTTCTTTGGACAA	CASRGWQGGMNTEAFF	In	VDJ	1	66	9.783923531225541E-5	1.1864571311466569E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	9	1	0	9	2	22	33	48	42	50	TCRBV02,TCRBV12													CASRGWQGGMNTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGATATACAGGAGGAGGATACACTGAAGCTTTCTTTGGACAA	CASRYTGGGYTEAFF	In	VDJ	1	66	9.783923531225541E-5	1.1864571311466569E-4	45	unresolved						TCRBJ01	TCRBJ01-01	01	6	3	4	3	4	8	18	29	38	33	46	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRYTGGGYTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCCTCCTCCTAGCGGGGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLLLAGGNTGELFF	In	VDJ	1	66	9.783923531225541E-5	1.1864571311466569E-4	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	4	1	1	6	0	18	30	-1	36	47	TCRBV07,TCRBV11													CASSLLLAGGNTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGAAACCGGGACGTCAGCTTTCTTTGGACAA	CASSETGTSAFF	In	VDJ	1	66	9.783923531225541E-5	1.1864571311466569E-4	36	unresolved						TCRBJ01	TCRBJ01-01	01	5	0	7	10	7	3	23	34	46	41	49	TCRBV02,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSETGTSAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGTACCCCGGGCAGGGGGAAGTGGCTACACCTTCGGTTCG		Out	VDJ	1	67	9.93216479685017E-5		44	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	1	7	10	3	26	37	54	47	57		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTTGGGGGAGGACTAGGAGGAGGGGAGCTGTTTTTTGGAGAA	CASSFGGGLGGGELFF	In	VDJ	1	67	9.93216479685017E-5	1.2044337543458487E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	1	8	8	7	5	18	32	46	39	51	TCRBV07,TCRBV11					01,02								CASSFGGGLGGGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGTGGGGACTCTCAAGAGACCCAGTACTTCGGGCCA	CASSGDSQETQYF	In	VDJ	1	67	9.93216479685017E-5	1.2044337543458487E-4	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	0	10	2	2	2	24	35	43	37	45	TCRBV02,TCRBV21					01,02								CASSGDSQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGGCGGGGACAGTTACAATGAGCAGTTCTTCGGGCCA	CASSGGDSYNEQFF	In	VDJ	1	67	9.93216479685017E-5	1.2044337543458487E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	5	4	3	1	23	36	46	39	47	TCRBV09,TCRBV21													CASSGGDSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCCCCGACAGGGACCTAGTGAAAAACTGTTTTTTGGCAGT	CASSPRQGPSEKLFF	In	VDJ	1	68	1.0080406062474798E-4	1.2224103775450404E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	2	3	7	5	6	26	37	49	42	55		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSPRQGPSEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTAACAGGGGTGACTGAAGCTTTCTTTGGACAA	CASSLTGVTEAFF	In	VDJ	1	68	1.0080406062474798E-4	1.2224103775450404E-4	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	2	5	2	2	26	39	48	41	50		TCRBV03-01,TCRBV03-02												CASSLTGVTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCTCACAGGGGGCGAACACTGAAGCTTTCTTTGGACAA	CSATSQGANTEAFF	In	VDJ	1	68	1.0080406062474798E-4	1.2224103775450404E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	0	1	4	0	26	36	-1	40	49		TCRBV20-01,TCRBV20-or09_02												CSATSQGANTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTTAGGGCACCCGATACAGATACGCAGTATTTTGGCCCA	CASSFRAPDTDTQYF	In	VDJ	1	68	1.0080406062474798E-4	1.2224103775450404E-4	45	TCRBV24						TCRBJ02	TCRBJ02-03	01	6	5	3	3	3	8	24	36	43	39	51		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFRAPDTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24		TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCCGACAGGGGATTTCAGTGATGAGCAGTTCTTCGGGCCA	CASSPTGDFSDEQFF	In	VDJ	1	68	1.0080406062474798E-4	1.2224103775450404E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	2	2	8	2	9	18	30	40	32	49	TCRBV07,TCRBV11													CASSPTGDFSDEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCCAAGGGCAGATTAATAGCAATCAGCCCCAGCATTTTGGTGAT	CASQGQINSNQPQHF	In	VDJ	1	68	1.0080406062474798E-4	1.2224103775450404E-4	45	unresolved						TCRBJ01	TCRBJ01-05	01	7	5	3	0	2	8	23	32	38	34	46	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASQGQINSNQPQHF+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGTGAGGAGCGGGCATCCGACGAGCAGTTCTTCGGGCCA	CASSEERASDEQFF	In	VDJ	1	69	1.0228647328099429E-4	1.2403870007442322E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	6	4	10	4	8	26	38	48	42	56	TCRBV09,TCRBV12					01,02								CASSEERASDEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAATAGCGGGGGAGTTAAGTGGCACAGATACGCAGTATTTTGGCCCA	CASSLIAGELSGTDTQYF	In	VDJ	1	69	1.0228647328099429E-4	1.2403870007442322E-4	54	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	5	2	1	1	9	26	41	51	42	60		TCRBV12-03,TCRBV12-04												CASSLIAGELSGTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTTTAGATCGGGGAGGCTATGAAAAACTGTTTTTTGGCAGT	CASSLDRGGYEKLFF	In	VDJ	1	69	1.0228647328099429E-4	1.2403870007442322E-4	45	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	1	9	1	6	4	2	26	42	52	46	54		TCRBV12-03,TCRBV12-04												CASSLDRGGYEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD02-01*02	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACGCTAAGGGCTACACCTTCGGTTCG	CASSHAKGYTF	In	VDJ	1	69	1.0228647328099429E-4	1.2403870007442322E-4	33	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	3	4	9	8	2	2	26	40	45	42	47		TCRBV03-01,TCRBV03-02				01,02								CASSHAKGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD02-01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCAGACCTTCCCATTGTGTTAGACGAGCAGTACTTCGGGCCG	CASSPDLPIVLDEQYF	In	VDJ	1	69	1.0228647328099429E-4	1.2403870007442322E-4	48	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	5	8	5	14	0	26	43	-1	57	60		TCRBV03-01,TCRBV03-02				01,02								CASSPDLPIVLDEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGCCCCTGGGCGGGGGAGACCCAGTACTTCGGGCCA	CSPWAGETQYF	In	VDJ	1	69	1.0228647328099429E-4	1.2403870007442322E-4	33	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	9	7	3	5	7	0	26	31	-1	38	44		TCRBV20-01,TCRBV20-or09_02												CSPWAGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTAGGCAGGGGCGAAATCAGCCCCAGCATTTTGGTGAT	CSASRQGRNQPQHF	In	VDJ	1	69	1.0228647328099429E-4	1.2403870007442322E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	2	4	4	3	26	37	47	41	50		TCRBV20-01,TCRBV20-or09_02												CSASRQGRNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TSRGGGACTCAGCTKTGTAYTTCTGTACCAGCAGTGATATGGACTAGGGGTAGACCCAGTACTTCGGGCCA	CTSSDMD*G*TQYF	Stop	VDJ	1	69	1.0228647328099429E-4		42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	1	8	6	5	4	22	34	46	39	50	TCRBV09,TCRBV12					01,02								CTSSDMD*G*TQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTAGGGGAGTTTCGGGGTGAAGCTTTCTTTGGACAA	CASSLGEFRGEAFF	In	VDJ	1	69	1.0228647328099429E-4	1.2403870007442322E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	8	3	7	8	0	18	34	-1	42	47	TCRBV07,TCRBV11					01,02								CASSLGEFRGEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTAGCGCAGAGGATAGATGAGCAGTTCTTCGGGCCA	CASSLAQRIDEQFF	In	VDJ	1	69	1.0228647328099429E-4	1.2403870007442322E-4	42	TCRBV05			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	6	6	8	0	10	19	-1	37	33	47		TCRBV05-06,TCRBV05-07				01,02								CASSLAQRIDEQFF+TCRBV05-X+TCRBJ02-01	TCRBV05	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGCACAGGGAGCTTCCTACGAGCAGTACTTCGGGCCG	CASSAQGASYEQYF	In	VDJ	1	69	1.0228647328099429E-4	1.2403870007442322E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	3	1	2	4	24	36	44	38	48	TCRBV09,TCRBV21													CASSAQGASYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCGCGACGGTCAGCCCCAGCATTTTGGTGAT	CASSRDGQPQHF	In	VDJ	1	70	1.0376888593724057E-4	1.258363623943424E-4	36	TCRBV12						TCRBJ01	TCRBJ01-05	01	5	2	7	6	3	2	26	38	44	41	46		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRDGQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCCCCCCGGGCCAGATACGAGCAGTACTTCGGGCCG	CASSSPRARYEQYF	In	VDJ	1	70	1.0376888593724057E-4	1.258363623943424E-4	42	TCRBV12						TCRBJ02	TCRBJ02-07	01	4	8	0	4	6	4	26	39	49	45	53		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSPRARYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12		TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGGGACAGGGGCATCCCAGCATTTTGGTGAT	CASSLGTGASQHF	In	VDJ	1	70	1.0376888593724057E-4	1.258363623943424E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	1	2	11	0	3	26	-1	51	42	54		TCRBV12-03,TCRBV12-04												CASSLGTGASQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGACCCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQDPNTGELFF	In	VJ	1	70	1.0376888593724057E-4	1.258363623943424E-4	42	unresolved						TCRBJ02	TCRBJ02-02	01	0	0	0	0	0	2	23	-1	40	-1	42	TCRBV01,TCRBV04													CASSQDPNTGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCGCTCCGTGGAGTACTATGGCTACACCTTCGGTTCG	XASSRSVEYYGYTF	In	VDJ	1	70	1.0376888593724057E-4	1.258363623943424E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	4	10	2	3	7	1	23	36	47	43	48	TCRBV01,TCRBV07,TCRBV17													XASSRSVEYYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGACCCGGTGAGGGCCCCGGGCGAGCAGTACTTCGGGCCG	CSASDPVRAPGEQYF	In	VDJ	1	70	1.0376888593724057E-4	1.258363623943424E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	11	0	6	9	7	26	37	51	46	58		TCRBV20-01,TCRBV20-or09_02												CSASDPVRAPGEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCTTCAGACTATGGCTACACCTTCGGTTCG	CSAPSDYGYTF	In	VDJ	1	70	1.0376888593724057E-4	1.258363623943424E-4	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	5	3	4	0	26	35	-1	39	42		TCRBV20-01,TCRBV20-or09_02												CSAPSDYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGGACCACGGGGGGCGGTGAGCAGTTCTTCGGGCCA	CASRTTGGGEQFF	In	VDJ	1	70	1.0376888593724057E-4	1.258363623943424E-4	39	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	8	1	9	5	3	22	33	45	38	48		TCRBV12-03,TCRBV12-04												CASRTTGGGEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAAAACAGGGCCTCGCGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	70	1.0376888593724057E-4		49	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	3	3	1	2	7	24	38	46	40	53		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAAGAGAGAATCAGCCCCAGCATTTTGGTGAT	CASSLRENQPQHF	In	VDJ	1	70	1.0376888593724057E-4	1.258363623943424E-4	39	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	6	11	2	4	4	2	24	36	43	40	45		TCRBV24-01,TCRBV24-or09_02												CASSLRENQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD02-01*02	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTGATGGGCGCGGGCAATCAGCCCCAGCATTTTGGTGAT	CASSLMGAGNQPQHF	In	VDJ	1	70	1.0376888593724057E-4	1.258363623943424E-4	45	unresolved						TCRBJ01	TCRBJ01-05	01	3	8	0	2	3	4	18	32	39	35	43	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLMGAGNQPQHF+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGGATCGGGGGACAGACGTATGGCTACACCTTCGGTTCG	CASRIGGQTYGYTF	In	VDJ	1	70	1.0376888593724057E-4	1.258363623943424E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	5	5	6	3	18	29	42	35	45	TCRBV07,TCRBV11													CASRIGGQTYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGCGACACAGGGCGTGAACACTGAAGCTTTCTTTGGACAA	CASSATQGVNTEAFF	In	VDJ	1	70	1.0376888593724057E-4	1.258363623943424E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	3	0	5	2	24	36	47	41	49	TCRBV09,TCRBV21													CASSATQGVNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTTAAGGGTCGATGAGCAGTTCTTCGGGCCA	CASSLRVDEQFF	In	VDJ	1	71	1.0525129859348688E-4	1.2763402471426157E-4	36	TCRBV12						TCRBJ02	TCRBJ02-01	01	2	5	3	8	0	3	26	-1	45	41	48		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLRVDEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12		TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGAGACAGGGGGACGGTGAAAAACTGTTTTTTGGCAGT	CASRRQGDGEKLFF	In	VDJ	1	71	1.0525129859348688E-4	1.2763402471426157E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	2	1	7	2	4	26	37	48	39	52		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRRQGDGEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTTAATTATGGACTAGCGGGGGGTTCCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	71	1.0525129859348688E-4		55	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	1	1	2	6	3	26	39	59	45	62		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGAACCCCCGCCGGGGCAGTCCTACGAGCAGTACTTCGGGCCG	CASSQEPPPGQSYEQYF	In	VDJ	1	71	1.0525129859348688E-4	1.2763402471426157E-4	51	unresolved						TCRBJ02	TCRBJ02-07	01	0	7	0	1	9	2	23	40	54	49	56	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEPPPGQSYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAAGGACTAGCGGGGGGGATACGCAGTATTTTGGCCCA	CASSQERTSGGDTQYF	In	VDJ	1	71	1.0525129859348688E-4	1.2763402471426157E-4	48	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	1	1	6	2	0	26	43	-1	45	59		TCRBV03-01,TCRBV03-02												CASSQERTSGGDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAGGTGGCTACACCTTCGGTTCG	CASSQEGGYTF	In	VDJ	1	71	1.0525129859348688E-4	1.2763402471426157E-4	33	TCRBV03						TCRBJ01	TCRBJ01-02	01	0	5	4	7	0	0	26	-1	-1	43	46		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEGGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCCCTGACAGCCACCGGGGAGCTGTTTTTTGGAGAA	CSAPLTATGELFF	In	VDJ	1	71	1.0525129859348688E-4	1.2763402471426157E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	2	5	4	6	1	26	34	45	40	46		TCRBV20-01,TCRBV20-or09_02												CSAPLTATGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGTGGGACAGGGCAACTATGGCTACACCTTCGGTTCG	CASSQVGQGNYGYTF	In	VDJ	1	71	1.0525129859348688E-4	1.2763402471426157E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	0	3	2	1	1	23	39	49	40	50	TCRBV01,TCRBV04													CASSQVGQGNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCTCCCCGGGACAGGGAAAACGAACACCGGGGAGCTGTTTTTTGGAGAA	CATSDLPGTGKTNTGELFF	In	VDJ	1	71	1.0525129859348688E-4	1.2763402471426157E-4	57	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	0	3	0	7	4	24	38	54	45	58		TCRBV24-01,TCRBV24-or09_02												CATSDLPGTGKTNTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGACAGGACATGAACACTGAAGCTTTCTTTGGACAA	CASRQDMNTEAFF	In	VDJ	1	71	1.0525129859348688E-4	1.2763402471426157E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	6	0	3	0	23	34	-1	37	42	TCRBV09,TCRBV12													CASRQDMNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTTAGGGGGACAGGTGTCCAACTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	72	1.0673371124973316E-4		52	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	0	4	0	1	7	26	42	51	43	58		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCTCCCGGACAGCGCTGAAGCTTTCTTTGGACAA	CASSLPDSAEAFF	In	VDJ	1	72	1.0673371124973316E-4	1.2943168703418074E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	5	6	5	2	26	38	49	43	51		TCRBV12-03,TCRBV12-04												CASSLPDSAEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGACCGGGACAGGGGACTGAAGCTTTCTTTGGACAA	CASRPGQGTEAFF	In	VDJ	1	72	1.0673371124973316E-4	1.2943168703418074E-4	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	2	5	3	0	26	37	-1	40	50		TCRBV03-01,TCRBV03-02												CASRPGQGTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCCCCAGTTGAGCGGGGGACACTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	72	1.0673371124973316E-4		50	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	6	2	3	10	3	26	39	57	49	60		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGGACTCSGCCSTGTATCTCTGTGCTAGCAGCTCCGGGACAGGGACTGAAGCTTTCTTTGGACAA	CASSSGTGTEAFF	In	VDJ	1	72	1.0673371124973316E-4	1.2943168703418074E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	3	5	2	0	20	33	-1	35	44	TCRBV05,TCRBV07													CASSSGTGTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGRAGACWCRGCMCTGTATCTCTGCGCCAGCAGCCAAGACAGGGCGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSQDRASNQPQHF	In	VDJ	1	72	1.0673371124973316E-4	1.2943168703418074E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	4	3	1	0	2	23	-1	45	40	47	TCRBV04,TCRBV23													CASSQDRASNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGGCCCGGGGGCGGCGGTGGCTACACCTTCGGTTCG	CASRPGGGGGYTF	In	VDJ	1	72	1.0673371124973316E-4	1.2943168703418074E-4	39	unresolved						TCRBJ01	TCRBJ01-02	01	6	6	0	7	4	5	23	34	44	38	49	TCRBV24,TCRBV27			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRPGGGGGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGGACGGGACAAATGAACACTGAAGCTTTCTTTGGACAA	CASRTGQMNTEAFF	In	VDJ	1	72	1.0673371124973316E-4	1.2943168703418074E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	6	0	3	2	23	34	43	37	45	TCRBV06,TCRBV10													CASRTGQMNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAAGAGCAGGGGTTAAGGCCCAGCATTTTGGTGAT	CASSERAGVKAQHF	In	VDJ	1	72	1.0673371124973316E-4	1.2943168703418074E-4	42	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	4	2	11	4	6	23	38	48	42	54		TCRBV06-01,TCRBV06-08												CASSERAGVKAQHF+TCRBV06-X+TCRBJ01-05	TCRBV06	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAAAATGAGGACGAGCAGTACTTCGGGCCG	CAISENEDEQYF	In	VDJ	1	72	1.0673371124973316E-4	1.2943168703418074E-4	36				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	11	1	5	3	0	23	38	-1	41	45	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-08,TCRBV10-03												CAISENEDEQYF+X+TCRBJ02-07		TCRBD02-01*02	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAACGGGACGGAGGAAAACTGTTTTTTGGCAGT	CAISERDGGKLFF	In	VDJ	1	72	1.0673371124973316E-4	1.2943168703418074E-4	39							TCRBJ01	TCRBJ01-04	01	2	0	7	10	1	5	23	38	44	39	49	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-08,TCRBV10-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISERDGGKLFF+X+TCRBJ01-04			TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAGTGAAGGAGGGGACGAAAATCAGCCCCAGCATTTTGGTGAT	CAISEGGDENQPQHF	In	VDJ	1	72	1.0673371124973316E-4	1.2943168703418074E-4	45	unresolved			unresolved			TCRBJ01	TCRBJ01-05	01	1	0	7	4	3	3	23	39	47	42	50	TCRBV06,TCRBV10			TCRBD01,TCRBD02										CAISEGGDENQPQHF+X+TCRBJ01-05	unresolved	unresolved	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTGACTAGCGGGGGGGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	72	1.0673371124973316E-4		46	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	4	2	1	2	0	0	18	-1	-1	31	44	TCRBV07,TCRBV11													X+X+TCRBJ01-05	unresolved	TCRBD02-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGCTGTGGGGGGACGAGCAGTACTTCGGGCCG	CASSLALWGDEQYF	In	VDJ	1	72	1.0673371124973316E-4	1.2943168703418074E-4	42				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	9	1	5	5	0	18	35	-1	40	46	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLALWGDEQYF+X+TCRBJ02-07		TCRBD02-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GCCACGTTTGGTGGTCAGGAGCACAGCACGGTATTTCTGTGCCAGCAGCACCTGACAGGCGCTCCCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	72	1.0673371124973316E-4		44	TCRBV21			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	4	4	3	6	37	50	59	53	65		TCRBV21-or09_02,TCRBV21-01												X+TCRBV21-X+TCRBJ01-02	TCRBV21	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCACCGAGGGCATTGGTAATCAGCCCCAGCATTTTGGTGAT	CASTEGIGNQPQHF	In	VDJ	1	73	1.0821612390597947E-4	1.3122934935409992E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	12	11	0	4	7	7	26	31	43	38	50	TCRBV12,TCRBV21													CASTEGIGNQPQHF+X+TCRBJ01-05	unresolved	TCRBD02-01*02	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCCCCGCCTGGAAACACCATATATTTTGGAGAG	CASSPPPGNTIYF	In	VDJ	1	73	1.0821612390597947E-4	1.3122934935409992E-4	39	TCRBV12						TCRBJ01	TCRBJ01-03	01	5	10	0	2	5	0	26	38	-1	43	45		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPPPGNTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12		TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCGACTAGCGGGGGGGCCCTTGAGCAGTTCTTCGGGCCA	CASSPTSGGALEQFF	In	VDJ	1	73	1.0821612390597947E-4	1.3122934935409992E-4	45	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	2	0	9	1	4	26	39	54	40	58		TCRBV03-01,TCRBV03-02												CASSPTSGGALEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCACCGCCCGCTAGCGGGGGGTGAATTACAGTACTTCGGGCCG	CSAHRPLAGGELQYF	In	VDJ	1	73	1.0821612390597947E-4	1.3122934935409992E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	4	1	10	10	7	26	34	55	44	62		TCRBV20-01,TCRBV20-or09_02												CSAHRPLAGGELQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGCGGACTAGCGGCTACGAGCAGTACTTCGGGCCG	CSARTSGYEQYF	In	VDJ	1	73	1.0821612390597947E-4	1.3122934935409992E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	1	5	3	2	0	26	34	-1	36	46		TCRBV20-01,TCRBV20-or09_02				01,02								CSARTSGYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGGACAGGGGTCCCTATAGCAATCAGCCCCAGCATTTTGGTGAT	CSAREDRGPYSNQPQHF	In	VDJ	1	73	1.0821612390597947E-4	1.3122934935409992E-4	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	1	2	0	0	6	26	-1	49	40	55		TCRBV20-01,TCRBV20-or09_02												CSAREDRGPYSNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAAGGGGGGCACTAATGAAAAACTGTTTTTTGGCAGT	CSARDKGGTNEKLFF	In	VDJ	1	73	1.0821612390597947E-4	1.3122934935409992E-4	45	TCRBV20						TCRBJ01	TCRBJ01-04	01	0	5	1	2	2	2	26	40	48	42	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDKGGTNEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20		TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTCCCCGCAGGGGGCACAGAGACCCAGTACTTCGGGCCA	CSARVPAGGTETQYF	In	VDJ	1	73	1.0821612390597947E-4	1.3122934935409992E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	4	0	4	6	2	26	39	53	45	55		TCRBV20-01,TCRBV20-or09_02												CSARVPAGGTETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGGACATCGTACAGGGAAGGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	73	1.0821612390597947E-4		43	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	7	3	3	8	8	3	24	35	49	43	52		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATTAACCGGGGACACTGAAGCTTTCTTTGGACAA	CASSLLTGDTEAFF	In	VDJ	1	73	1.0821612390597947E-4	1.3122934935409992E-4	42	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	6	8	3	3	8	0	24	36	-1	44	49		TCRBV24-01,TCRBV24-or09_02												CASSLLTGDTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD02-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCCCCGGGCCCGGGGGCTTTCTTTGGACAA	CASSPPGPGAFF	In	VDJ	1	74	1.0969853656222575E-4	1.3302701167401912E-4	36	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	8	3	11	10	0	26	38	-1	48	53		TCRBV12-03,TCRBV12-04												CASSPPGPGAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCATAACTAGCGGGGGCGTTAATGAGCAGTTCTTCGGGCCA	CASSITSGGVNEQFF	In	VDJ	1	74	1.0969853656222575E-4	1.3302701167401912E-4	45	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	3	2	7	3	4	26	38	52	41	56		TCRBV03-01,TCRBV03-02												CASSITSGGVNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCTCCGGACTCTAGCACAGATACGCAGTATTTTGGCCCA	CASSQAPDSSTDTQYF	In	VDJ	1	74	1.0969853656222575E-4	1.3302701167401912E-4	48	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	1	10	0	4	2	26	42	51	46	53		TCRBV03-01,TCRBV03-02				01,02								CASSQAPDSSTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTCCCCCGGGGGGGGCGGGGAGACCCAGTACTTCGGGCCA	CASSSPGGGGETQYF	In	VDJ	1	74	1.0969853656222575E-4	1.3302701167401912E-4	45	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	8	0	5	5	5	26	38	51	43	56		TCRBV03-01,TCRBV03-02												CASSSPGGGGETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGGACTTGCGTAGGCCACTAAAGAGCAGCCCCAGCATTTTGGTGAT	CSAGLA*ATKEQPQHF	Stop	VDJ	1	74	1.0969853656222575E-4		48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	6	1	10	7	1	19	26	34	40	35	59		TCRBV20-01,TCRBV20-or09_02				01,02								CSAGLA*ATKEQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGAAGGTTTGCGGGGGCCGACAGATACGCAGTATTTTGGCCCA	CSASEGLRGPTDTQYF	In	VDJ	1	74	1.0969853656222575E-4	1.3302701167401912E-4	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	7	2	3	9	3	26	37	53	46	56		TCRBV20-01,TCRBV20-or09_02												CSASEGLRGPTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATAACCGACAGGAACACTGAAGCTTTCTTTGGACAA	CSAITDRNTEAFF	In	VDJ	1	74	1.0969853656222575E-4	1.3302701167401912E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	5	1	5	0	26	36	-1	41	46		TCRBV20-01,TCRBV20-or09_02												CSAITDRNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTAACTTGTCCGGGGGCTATGGCTACACCTTCGGTTCG	CASSNLSGGYGYTF	In	VDJ	1	74	1.0969853656222575E-4	1.3302701167401912E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	5	8	2	4	8	0	22	34	-1	42	48	TCRBV09,TCRBV12													CASSNLSGGYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCGGGGACCGCAGCCAGATACGCAGTATTTTGGCCCA	CASSRGPQPDTQYF	In	VDJ	1	74	1.0969853656222575E-4	1.3302701167401912E-4	42	TCRBV24						TCRBJ02	TCRBJ02-03	01	6	0	7	4	2	6	24	36	43	38	49		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRGPQPDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24		TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
SGACTCGGCYSTSTATCTCTGTGCCAGCAGCTTGACGGGACAGGGGTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLTGQGSGANVLTF	In	VDJ	1	74	1.0969853656222575E-4	1.3302701167401912E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	2	0	2	1	3	0	19	33	-1	36	46	TCRBV05,TCRBV07													CASSLTGQGSGANVLTF+X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCTGACTAGCGGGGACAATGAGCAGTTCTTCGGGCCA	CASSLTSGDNEQFF	In	VDJ	1	74	1.0969853656222575E-4	1.3302701167401912E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	2	3	5	2	0	18	30	-1	32	43	TCRBV07,TCRBV11													CASSLTSGDNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCTTAAACAAGGGGTCCTTCAATGAGCAGTTCTTCGGGCCA	CASSLNKGSFNEQFF	In	VDJ	1	74	1.0969853656222575E-4	1.3302701167401912E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	5	2	6	4	5	18	33	42	37	47	TCRBV07,TCRBV11													CASSLNKGSFNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAAATCACGGACCAGACACAGATACGCAGTATTTTGGCCCA	CASSLNHGPDTDTQYF	In	VDJ	1	74	1.0969853656222575E-4	1.3302701167401912E-4	48	unresolved						TCRBJ02	TCRBJ02-03	01	2	1	7	2	6	4	18	33	43	39	47	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLNHGPDTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTGGGACGCTATAGCACAGATACGCAGTATTTTGGCCCA	CASSLGRYSTDTQYF	In	VDJ	1	74	1.0969853656222575E-4	1.3302701167401912E-4	45	unresolved						TCRBJ02	TCRBJ02-03	01	3	0	7	0	0	5	18	-1	37	32	42	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGRYSTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCTCCCCGGAGAACTATGGCTACACCTTCGGTTCG	CASSPENYGYTF	In	VDJ	1	74	1.0969853656222575E-4	1.3302701167401912E-4	36	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	7	10	2	2	5	0	23	32	-1	37	41	TCRBV09,TCRBV21													CASSPENYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACGAGGAGATGGCTACACCTTCGGTTCG	CSARRGDGYTF	In	VDJ	1	75	1.1118094921847204E-4	1.348246739939383E-4	33	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	2	10	2	6	3	0	26	38	-1	41	45		TCRBV20-01,TCRBV20-or09_02												CSARRGDGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*02	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTAAAGCTCTACCGGGACCCCAGCATTTTGGTGAT	CSASKALPGPQHF	In	VDJ	1	75	1.1118094921847204E-4	1.348246739939383E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	3	8	3	10	11	0	26	37	-1	48	53		TCRBV20-01,TCRBV20-or09_02												CSASKALPGPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01*02	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTTTCGGGCTAGCACAGATACGCAGTATTTTGGCCCA	CSAFRASTDTQYF	In	VDJ	1	75	1.1118094921847204E-4	1.348246739939383E-4	39	TCRBV20						TCRBJ02	TCRBJ02-03	01	5	8	0	0	4	1	26	35	43	39	44		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAFRASTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCTCTCGACCGTGAACACTGAAGCTTTCTTTGGACAA	CASSLSTVNTEAFF	In	VDJ	1	75	1.1118094921847204E-4	1.348246739939383E-4	42	unresolved						TCRBJ01	TCRBJ01-01	01	4	2	7	0	4	2	23	36	43	40	45	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSTVNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCCGTGGGACCAAAAAGATAATAACTTTCTTTGGACAA	CATRGTKKIITFF	In	VDJ	1	75	1.1118094921847204E-4	1.348246739939383E-4	39	TCRBV24						TCRBJ01	TCRBJ01-01	01	5	1	7	12	0	14	24	-1	41	37	55		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATRGTKKIITFF+TCRBV24-X+TCRBJ01-01	TCRBV24		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCGATAGGACAGGGCTATTATAATTCACCCCTCCACTTTGGGAAC	CASSLSIGQGYYNSPLHF	In	VDJ	1	75	1.1118094921847204E-4	1.348246739939383E-4	54				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	1	3	4	9	4	24	36	53	45	57	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01												CASSLSIGQGYYNSPLHF+X+TCRBJ01-06		TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCGGCTGGATATGGCTACACCTTCGGTTCG	CASSLSAGYGYTF	In	VDJ	1	75	1.1118094921847204E-4	1.348246739939383E-4	39							TCRBJ01	TCRBJ01-02	01	6	1	8	5	9	0	24	36	-1	45	48	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSAGYGYTF+X+TCRBJ01-02			TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTCAACCAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSSTSSYNEQFF	In	VDJ	1	75	1.1118094921847204E-4	1.348246739939383E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	4	5	0	4	0	18	31	-1	35	38	TCRBV07,TCRBV11													CASSSTSSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCCCCTTCGGGAGCGGGGACCACAGATACGCAGTATTTTGGCCCA	CASSLAPSGAGTTDTQYF	In	VDJ	1	75	1.1118094921847204E-4	1.348246739939383E-4	54				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	6	3	2	9	2	18	35	51	44	53	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLAPSGAGTTDTQYF+X+TCRBJ02-03		TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTKGGKGACTCWGCTGTGTATYTCTGTGCCAGCAGCTTTTTGGTTAATTCACCCCTCCACTTTGGGAAC	CASSFLVNSPLHF	In	VDJ	1	75	1.1118094921847204E-4	1.348246739939383E-4	39	unresolved						TCRBJ01	TCRBJ01-06	01	3	0	10	6	3	1	22	36	41	39	42	TCRBV03,TCRBV07			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFLVNSPLHF+X+TCRBJ01-06	unresolved		TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGGGCTCTCCAATCAGCCCCAGCATTTTGGTGAT	CASSVGLSNQPQHF	In	VDJ	1	75	1.1118094921847204E-4	1.348246739939383E-4	42	unresolved			unresolved			TCRBJ01	TCRBJ01-05	01	0	9	0	3	0	4	23	-1	42	39	46	TCRBV09,TCRBV21			TCRBD01,TCRBD02										CASSVGLSNQPQHF+X+TCRBJ01-05	unresolved	unresolved	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCCCACAGACACTTTCCTACGAGCAGTACTTCGGGCCG	CASSPQTLSYEQYF	In	VDJ	1	76	1.1266336187471834E-4	1.3662233631385747E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	6	1	6	3	26	37	47	43	50	TCRBV09,TCRBV12													CASSPQTLSYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGTAGCTAACGGAGGAGGGGAGACCCAGTACTTCGGGCCA	CASSVANGGGETQYF	In	VDJ	1	76	1.1266336187471834E-4	1.3662233631385747E-4	45	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	10	0	5	13	0	26	37	-1	50	56		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSVANGGGETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01*02	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCAGGGAGCAGGGTCATGAACACTGAAGCTTTCTTTGGACAA	CASSSGSRVMNTEAFF	In	VDJ	1	76	1.1266336187471834E-4	1.3662233631385747E-4	48	TCRBV12						TCRBJ01	TCRBJ01-01	01	4	4	3	0	0	10	26	-1	44	39	54		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSGSRVMNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAAGGGGGCTCGCAACAGCCCCAGCATTTTGGTGAT	CSAREGGSQQPQHF	In	VDJ	1	76	1.1266336187471834E-4	1.3662233631385747E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	5	0	7	0	6	26	-1	47	40	53		TCRBV20-01,TCRBV20-or09_02												CSAREGGSQQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATCGGGAGGTACCACTGAAGCTTTCTTTGGACAA	CSARSGGTTEAFF	In	VDJ	1	76	1.1266336187471834E-4	1.3662233631385747E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	8	1	4	1	3	26	38	46	39	49		TCRBV20-01,TCRBV20-or09_02												CSARSGGTTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*02	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCGCGGGACAGGGAAGATTTCTACTGAAGCTTTCTTTGGACAA	CASSRGTGKISTEAFF	In	VDJ	1	76	1.1266336187471834E-4	1.3662233631385747E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	3	5	3	9	24	36	48	39	57		TCRBV24-01,TCRBV24-or09_02												CASSRGTGKISTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCTTTACCGACAGGGGGCCTGGAAGGGGCTTTCTTTGGACAA		Out	VDJ	1	76	1.1266336187471834E-4		46				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	2	0	11	4	9	18	32	46	36	55	TCRBV05,TCRBV11	TCRBV05-03,TCRBV11-03												X+X+TCRBJ01-01		TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAGATGGGTCGGGGACCGGGGAGCTGTTTTTTGGAGAA	CASSLDGSGTGELFF	In	VDJ	1	76	1.1266336187471834E-4	1.3662233631385747E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	8	3	5	5	0	18	35	-1	40	45	TCRBV07,TCRBV11													CASSLDGSGTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGACCCTCCGGGGGGCTCGGTCAGCCCCAGCATTTTGGTGAT	CASRPSGGLGQPQHF	In	VDJ	1	77	1.1414577453096463E-4	1.3841999863377664E-4	45	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	6	8	1	6	6	5	26	37	50	43	55		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRPSGGLGQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD02-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCATTCCTAGGGGGTATTGGGATACGCAGTATTTTGGCCCA	CASIPRGYWDTQYF	In	VDJ	1	77	1.1414577453096463E-4	1.3841999863377664E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	5	1	6	5	6	22	32	43	37	49	TCRBV02,TCRBV12													CASIPRGYWDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCACACCCGGGACAGGGGGACGAGCAGTACTTCGGGCCG		Out	VDJ	1	77	1.1414577453096463E-4		40	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	0	1	5	5	0	24	34	-1	39	50		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTGATTGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSLIATNEKLFF	In	VDJ	1	77	1.1414577453096463E-4	1.3841999863377664E-4	42	unresolved						TCRBJ01	TCRBJ01-04	01	3	2	8	0	0	3	18	-1	34	32	37	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLIATNEKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCGGCCTAGGAGCGAACAATGAGCAGTTCTTCGGGCCA	CAGLGANNEQFF	In	VDJ	1	77	1.1414577453096463E-4	1.3841999863377664E-4	36	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	11	4	8	5	3	6	24	30	37	33	43	TCRBV09,TCRBV21					01,02								CAGLGANNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGGGCAGCGGAGCCCTACAATGAGCAATTCTTCGGGCCA	CASRAAEPYNEQFF	In	VDJ	1	77	1.1414577453096463E-4	1.3841999863377664E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	6	5	16	3	17	23	34	42	37	59	TCRBV09,TCRBV21					01,02								CASRAAEPYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCCGGCGGACGGTCTGGGGAACTGTTTTTTGGCAGT	CASSSGGRSGELFF	In	VDJ	1	78	1.1562818718721093E-4	1.4021766095369582E-4	42	TCRBV12						TCRBJ01	TCRBJ01-04	01	4	1	7	12	5	9	26	39	48	44	57		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSGGRSGELFF+TCRBV12-X+TCRBJ01-04	TCRBV12		TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCCGGCTAGCGGGGGAGGGGGTGAGCAGTTCTTCGGGCCA	CASSQDPASGGGGEQFF	In	VDJ	1	78	1.1562818718721093E-4	1.4021766095369582E-4	51	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	4	2	9	5	6	26	43	58	48	64		TCRBV03-01,TCRBV03-02												CASSQDPASGGGGEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCCGGGGCGGAACATACACAGATACGCAGTATTTTGGCCCA	CSAPRGGTYTDTQYF	In	VDJ	1	78	1.1562818718721093E-4	1.4021766095369582E-4	45	TCRBV20						TCRBJ02	TCRBJ02-03	01	5	7	0	2	4	8	26	35	44	39	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAPRGGTYTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCGCCGGACAGGGAACAATCAGCCCCAGCATTTTGGTGAT	CASSRRTGNNQPQHF	In	VDJ	1	78	1.1562818718721093E-4	1.4021766095369582E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	1	3	3	3	2	23	36	47	39	49	TCRBV01,TCRBV04													CASSRRTGNNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTGGGAGGGTTCCGCCCTACGAGCAGTACTTCGGGCCG	CASSGRVPPYEQYF	In	VDJ	1	78	1.1562818718721093E-4	1.4021766095369582E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	9	0	2	0	6	22	-1	41	34	47	TCRBV09,TCRBV12													CASSGRVPPYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTACTAGCGGGGGGTCTCAACAATGAGCAGTTCTTCGGGCCA	CASSLLAGGLNNEQFF	In	VDJ	1	78	1.1562818718721093E-4	1.4021766095369582E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	4	1	5	0	5	23	-1	49	38	54	TCRBV24,TCRBV27													CASSLLAGGLNNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTAGCCCGGGCACTATACACCGGGGAGCTGTTTTTTGGAGAA	CASSLARALYTGELFF	In	VDJ	1	78	1.1562818718721093E-4	1.4021766095369582E-4	48	unresolved						TCRBJ02	TCRBJ02-02	01	0	8	0	3	2	5	18	35	41	37	46	TCRBV05,TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLARALYTGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTTGGGACAGCTATGGCTACACCTTCGGTTCG	CASSWDSYGYTF	In	VDJ	1	78	1.1562818718721093E-4	1.4021766095369582E-4	36	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	5	4	1	0	23	35	-1	36	43	TCRBV02,TCRBV09													CASSWDSYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGTCGAACCGGGACAGGGGGCTCCTACGAGCAGTACTTCGGGCCG	CASRTGTGGSYEQYF	In	VDJ	1	78	1.1562818718721093E-4	1.4021766095369582E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	0	1	0	7	0	23	31	-1	38	49	TCRBV02,TCRBV09													CASRTGTGGSYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAAGAATATTGGGGCCGGCAGGGACGGAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	78	1.1562818718721093E-4		58	TCRBV03						TCRBJ01	TCRBJ01-06	01	2	0	7	7	18	2	23	38	61	56	63		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-06	TCRBV03		TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCGTAGGCCTCTCCACCGAGCAGTACTTCGGGCCG	CASSVGLSTEQYF	In	VDJ	1	79	1.1711059984345722E-4	1.42015323273615E-4	39	unresolved						TCRBJ02	TCRBJ02-07	01	6	5	4	6	3	9	26	37	43	40	52	TCRBV09,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVGLSTEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTTGGCGAGGTCACCGGGCCCCAGCATTTTGGTGAT	CSVGEVTGPQHF	In	VDJ	1	79	1.1711059984345722E-4	1.42015323273615E-4	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	7	11	1	9	5	7	26	33	42	38	49		TCRBV20-01,TCRBV20-or09_02												CSVGEVTGPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01*02	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGACAAGGGACCTACAATGAGCAGTTCTTCGGGCCA	CASRQGTYNEQFF	In	VDJ	1	79	1.1711059984345722E-4	1.42015323273615E-4	39	TCRBV12						TCRBJ02	TCRBJ02-01	01	6	0	8	2	4	0	22	33	-1	37	41		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRQGTYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12		TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGAGCAGGGGGCGCGAACTGAAGCTTTCTTTGGACAA	CASSQEQGARTEAFF	In	VDJ	1	79	1.1711059984345722E-4	1.42015323273615E-4	45				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	0	5	1	4	18	35	44	36	48	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQEQGARTEAFF+X+TCRBJ01-01		TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTCGGACCGTCAAATCCATAACTAATGAAAAACTGTTTTTTGGCAGT	CASSRTVKSITNEKLFF	In	VDJ	1	79	1.1711059984345722E-4	1.42015323273615E-4	51	unresolved						TCRBJ01	TCRBJ01-04	01	5	1	7	1	1	12	23	35	40	36	52	TCRBV02,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRTVKSITNEKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCAACCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	80	1.1859301249970352E-4		37	TCRBV12						TCRBJ02	TCRBJ02-03	01	3	3	7	2	2	0	26	40	-1	42	44		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-X+TCRBJ02-03	TCRBV12		TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGTGGGACGGGGAGCAAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	80	1.1859301249970352E-4		47	TCRBV12						TCRBJ01	TCRBJ01-05	01	3	0	7	4	2	8	26	40	47	42	55		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-X+TCRBJ01-05	TCRBV12		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ARCYYRGKGACTCWGCTGTGTATTTYTGTGCCAGCAGCGGCCTCGGGGAGCTGTTTTTTGGAGAA	CASSGLGELFF	In	VDJ	1	80	1.1859301249970352E-4	1.4381298559353417E-4	33	unresolved			unresolved			TCRBJ02	TCRBJ02-02	01	5	9	0	7	0	2	26	-1	41	38	43	TCRBV03,TCRBV12			TCRBD01,TCRBD02										CASSGLGELFF+X+TCRBJ02-02	unresolved	unresolved	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAATCCCGACAGTTATCGACACAGATACGCAGTATTTTGGCCCA	CSARIPTVIDTDTQYF	In	VDJ	1	80	1.1859301249970352E-4	1.4381298559353417E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	2	5	2	5	7	26	38	48	43	55		TCRBV20-01,TCRBV20-or09_02												CSARIPTVIDTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGATCTGGAGGGGCCTTCCCAAGAGACCCAGTACTTCGGGCCA	CSARDLEGPSQETQYF	In	VDJ	1	80	1.1859301249970352E-4	1.4381298559353417E-4	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	10	0	1	6	6	26	37	49	43	55		TCRBV20-01,TCRBV20-or09_02												CSARDLEGPSQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAACGTTATACTACAGGGGGGAAGGGGCTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	80	1.1859301249970352E-4		56	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	3	1	0	10	8	22	32	50	42	58	TCRBV12,TCRBV21													X+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCCCAGAAGGGGGCAGGTAATGGCTACACCTTCGGTTCG	CASSPQKGAGNGYTF	In	VDJ	1	80	1.1859301249970352E-4	1.4381298559353417E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	5	0	6	7	5	24	36	50	43	55		TCRBV24-01,TCRBV24-or09_02												CASSPQKGAGNGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTGAGGCAGATACGCAGTATTTTGGCCCA	CASSEADTQYF	In	VDJ	1	81	1.2007542515594981E-4	1.4561064791345334E-4	33	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	11	1	4	0	0	26	-1	-1	38	42		TCRBV12-03,TCRBV12-04												CASSEADTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*02	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTGGCTAGCGTATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	81	1.2007542515594981E-4		35	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	4	6	8	2	1	26	38	46	40	47		TCRBV12-03,TCRBV12-04				01,02								X+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATTCCTACGAGCAGTACTTCGGGCCG	CASSQDSYEQYF	In	VJ	1	81	1.2007542515594981E-4	1.4561064791345334E-4	36	TCRBV03						TCRBJ02	TCRBJ02-07	01	0	0	0	1	0	1	26	-1	43	-1	44		TCRBV03-01,TCRBV03-02												CASSQDSYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAATGGGACAGGGGGCATAACACTGAAGCTTTCTTTGGACAA	CASSQWDRGHNTEAFF	In	VDJ	1	81	1.2007542515594981E-4	1.4561064791345334E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	0	2	1	2	26	41	54	42	56		TCRBV03-01,TCRBV03-02												CASSQWDRGHNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCATCGGCAGCTAACTATGGCTACACCTTCGGTTCG	CSASAANYGYTF	In	VDJ	1	81	1.2007542515594981E-4	1.4561064791345334E-4	36	TCRBV20						TCRBJ01	TCRBJ01-02	01	6	4	5	0	5	0	26	34	-1	39	42		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASAANYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAGGGTCAGGATTCACCCCTCCACTTTGGGAAC	CSAKGQDSPLHF	In	VDJ	1	81	1.2007542515594981E-4	1.4561064791345334E-4	36	TCRBV20						TCRBJ01	TCRBJ01-06	01	4	4	4	8	5	0	26	36	-1	41	45		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAKGQDSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20		TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCTCCTTGGGACAGGAGGGGAGACCCAGTACTTCGGGCCA	CASSLLGTGGETQYF	In	VDJ	1	81	1.2007542515594981E-4	1.4561064791345334E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	0	4	5	6	4	24	36	50	42	54		TCRBV24-01,TCRBV24-or09_02												CASSLLGTGGETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCCCACACTTCTTTTATCTCAGCCCCAGCATTTTGGTGAT	CASSPTLLLSQPQHF	In	VDJ	1	81	1.2007542515594981E-4	1.4561064791345334E-4	45	unresolved						TCRBJ01	TCRBJ01-05	01	5	3	6	6	3	11	18	30	36	33	47	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPTLLLSQPQHF+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGACGGGGGTATAATGAAAAACTGTTTTTTGGCAGT	CASRRGYNEKLFF	In	VDJ	1	82	1.215578378121961E-4	1.4740831023337252E-4	39	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	6	8	2	4	1	2	26	37	44	38	46		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRRGYNEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD02-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTATTGCCACACTCTGGAAACACCATATATTTTGGAGAG	CASSLLPHSGNTIYF	In	VDJ	1	82	1.215578378121961E-4	1.4740831023337252E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	3	6	0	5	0	26	41	-1	46	49		TCRBV12-03,TCRBV12-04												CASSLLPHSGNTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATAAACTAGCGGGGGCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	82	1.215578378121961E-4		50	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	3	2	1	3	0	26	43	-1	46	57		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGACGTTCACTAGCGGGGATCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	82	1.215578378121961E-4		50	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	3	3	0	8	2	26	37	55	45	57		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAAGCCTAGCGGGGCTTTTTCCTACAATGAGCAGTTCTTCGGGCCA	CASKPSGAFSYNEQFF	In	VDJ	1	82	1.215578378121961E-4	1.4740831023337252E-4	48	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	11	4	3	1	6	5	24	31	46	37	51		TCRBV24-01,TCRBV24-or09_02												CASKPSGAFSYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTACACAGGGGAGGACTGAAGCTTTCTTTGGACAA	CASSTQGRTEAFF	In	VDJ	1	82	1.215578378121961E-4	1.4740831023337252E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	2	5	2	3	24	36	45	38	48		TCRBV24-01,TCRBV24-or09_02												CASSTQGRTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCGGGATTGCCCAAATGACGACCCAGTACTTCGGGCCA		Out	VDJ	1	83	1.230402504684424E-4		44	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	8	3	7	1	13	26	38	44	39	57		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01*02	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGACCGACAGGGGCTAATTCACCCCTCCACTTTGGGAAC	CSARGPTGANSPLHF	In	VDJ	1	83	1.230402504684424E-4	1.492059725532917E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	1	2	2	6	4	1	26	39	51	43	52		TCRBV20-01,TCRBV20-or09_02												CSARGPTGANSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGGGTCGGGACAGGGTATCGACTATGGCTACACCTTCGGTTCG	CSGSGQGIDYGYTF	In	VDJ	1	83	1.230402504684424E-4	1.492059725532917E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	0	3	3	4	5	26	33	46	37	51		TCRBV20-01,TCRBV20-or09_02												CSGSGQGIDYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCGAACAAGAGGGGTTGGTGTACTATGGCTACACCTTCGGTTCG	CASEQEGLVYYGYTF	In	VDJ	1	83	1.230402504684424E-4	1.492059725532917E-4	45	unresolved						TCRBJ01	TCRBJ01-02	01	8	5	2	3	7	7	22	31	43	38	50	TCRBV02,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASEQEGLVYYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCTCCAAACACTGAAGCTTTCTTTGGACAA	CASSLSPNTEAFF	In	VDJ	1	83	1.230402504684424E-4	1.492059725532917E-4	39							TCRBJ01	TCRBJ01-01	01	6	4	6	2	7	0	24	36	-1	43	45	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSPNTEAFF+X+TCRBJ01-01			TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGGRGACWCRGCWSTGTATCTCTGYGCCAGCAGCAACCTGACAGCCTATGGCTACACCTTCGGTTCG	CASSNLTAYGYTF	In	VDJ	1	83	1.230402504684424E-4	1.492059725532917E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	5	4	6	1	20	31	42	37	43	TCRBV07,TCRBV23													CASSNLTAYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGGGACAGCCGGAAACACCATATATTTTGGAGAG	CASSLGTAGNTIYF	In	VDJ	1	84	1.245226631246887E-4	1.5100363487321086E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	1	5	4	0	2	26	-1	48	42	50		TCRBV12-03,TCRBV12-04												CASSLGTAGNTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCATGAGACAGCGTTCGGCTACACCTTCGGTTCG	CASSHETAFGYTF	In	VDJ	1	84	1.245226631246887E-4	1.5100363487321086E-4	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	5	8	3	5	26	40	48	43	53		TCRBV03-01,TCRBV03-02												CASSHETAFGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCTCTAGCGGGGTCATACGAGCAGTACTTCGGGCCG	CSARPLAGSYEQYF	In	VDJ	1	84	1.245226631246887E-4	1.5100363487321086E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	2	4	3	4	3	3	26	38	50	41	53		TCRBV20-01,TCRBV20-or09_02												CSARPLAGSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAAGCAGGGGTGGGCTACACCTTCGGTTCG	CSAREAGVGYTF	In	VDJ	1	84	1.245226631246887E-4	1.5100363487321086E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	2	8	2	2	26	40	48	42	50		TCRBV20-01,TCRBV20-or09_02												CSAREAGVGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGGACAGGGGGGACGGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSGQGGRSNQPQHF	In	VDJ	1	84	1.245226631246887E-4	1.5100363487321086E-4	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	1	1	1	0	5	22	-1	44	34	49		TCRBV12-03,TCRBV12-04												CASSGQGGRSNQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCCCGATAGAGTCGGAGTGACAGGGAAAAGAATACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	84	1.245226631246887E-4		55	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	9	2	3	5	16	8	24	33	56	49	64		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCACCGAGCGAGGACGCATAATGGCTACACCTTCGGTTCG		Out	VDJ	1	84	1.245226631246887E-4		38	unresolved						TCRBJ01	TCRBJ01-02	01	10	1	7	6	8	5	23	30	42	38	47	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAAGTATGGCGGGGAGCTCCTACGAGCAGTACTTCGGGCCG	CASSESMAGSSYEQYF	In	VDJ	1	84	1.245226631246887E-4	1.5100363487321086E-4	48	TCRBV06			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	2	7	3	0	6	2	23	38	50	44	52		TCRBV06-01,TCRBV06-08												CASSESMAGSSYEQYF+TCRBV06-X+TCRBJ02-07	TCRBV06	TCRBD02-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGGGGAAGTTAGGGGAAATCAGCCCCAGCATTTTGGTGAT	CASSGEVRGNQPQHF	In	VDJ	1	84	1.245226631246887E-4	1.5100363487321086E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	5	2	4	9	1	23	35	49	44	50	TCRBV06,TCRBV10													CASSGEVRGNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTACCAGCGGGGGGTAGGGAGACCCAGTACTTCGGGCCA	CASSLPAGGRETQYF	In	VDJ	1	84	1.245226631246887E-4	1.5100363487321086E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	6	1	5	2	4	18	33	44	35	48	TCRBV07,TCRBV11													CASSLPAGGRETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTCCCTGCGAGGGTCCCAGGGAAAACTGTTTTTTGGCAGT		Out	VDJ	1	84	1.245226631246887E-4		46	unresolved						TCRBJ01	TCRBJ01-04	01	2	4	3	10	14	0	19	33	-1	47	52	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGTAGGGAATGAGCAGTTCTTCGGGCCA	CASSVGNEQFF	In	VDJ	1	85	1.26005075780935E-4	1.5280129719313007E-4	33	TCRBV12						TCRBJ02	TCRBJ02-01	01	6	5	3	7	3	0	26	37	-1	40	44		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVGNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12		TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAATTATTACATCGGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	85	1.26005075780935E-4		46	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	3	6	2	5	3	26	41	49	46	52		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGCGATCCATCCATTTGCAAAGAAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	85	1.26005075780935E-4		52	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	5	7	6	4	0	19	26	-1	41	38	60		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-04	TCRBV03	TCRBD02-01	TCRBJ02-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTAGCAGCACTGGAAACACCATATATTTTGGAGAG	CASSSSTGNTIYF	In	VDJ	1	85	1.26005075780935E-4	1.5280129719313007E-4	39	TCRBV12						TCRBJ01	TCRBJ01-03	01	5	4	5	2	2	2	22	34	39	36	41		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSSTGNTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12		TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTACTAGCGGGGGGCAATGAGCAGTTCTTCGGGCCA	CASSLLAGGNEQFF	In	VDJ	1	85	1.26005075780935E-4	1.5280129719313007E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	4	1	6	0	0	18	-1	-1	33	44	TCRBV07,TCRBV11													CASSLLAGGNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAGCTTAGGCGGAATGGACAGGGAGCTGTTTTTTGGAGAA	CASSLGGMDRELFF	In	VDJ	1	85	1.26005075780935E-4	1.5280129719313007E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	1	6	9	11	0	24	36	-1	47	52	TCRBV12,TCRBV21													CASSLGGMDRELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGTACTAGCGGGGCAGATGAGCAGTTCTTCGGGCCA	CASSTSGADEQFF	In	VDJ	1	85	1.26005075780935E-4	1.5280129719313007E-4	39	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	3	3	8	1	3	24	35	46	36	49	TCRBV12,TCRBV21													CASSTSGADEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTACGGGACAGGAGAGACCCAGTACTTCGGGCCA	CASSYGTGETQYF	In	VDJ	1	86	1.274874884371813E-4	1.5459895951304924E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	0	4	4	4	0	26	37	-1	41	49		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSYGTGETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD01-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTAGAGGAGTATAATTCACCCCTCCACTTTGGGAAC	CASSQVEEYNSPLHF	In	VDJ	1	86	1.274874884371813E-4	1.5459895951304924E-4	45	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	1	10	2	4	4	0	26	42	-1	46	50		TCRBV03-01,TCRBV03-02												CASSQVEEYNSPLHF+TCRBV03-X+TCRBJ01-06	TCRBV03	TCRBD02-01*02	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCAGCGGGTTAGCGGGGCGCCTAGCACAGATACGCAGTATTTTGGCCCA	CSAQRVSGAPSTDTQYF	In	VDJ	1	86	1.274874884371813E-4	1.5459895951304924E-4	51	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	5	3	0	9	5	26	34	51	43	56		TCRBV20-01,TCRBV20-or09_02												CSAQRVSGAPSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACCAGGGGTATGAAAAACTGTTTTTTGGCAGT	CSARDQGYEKLFF	In	VDJ	1	86	1.274874884371813E-4	1.5459895951304924E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	4	2	6	1	1	26	40	47	41	48		TCRBV20-01,TCRBV20-or09_02												CSARDQGYEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTTCAGACAGGGAGGTCACTGAAGCTTTCTTTGGACAA	CASSSDREVTEAFF	In	VDJ	1	86	1.274874884371813E-4	1.5459895951304924E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	3	4	2	4	22	35	44	37	48		TCRBV12-03,TCRBV12-04												CASSSDREVTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGTCAAGGACAGGGGTACTATGGCTACACCTTCGGTTCG	CASSQGQGYYGYTF	In	VDJ	1	86	1.274874884371813E-4	1.5459895951304924E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	2	3	4	1	18	29	42	33	43	TCRBV07,TCRBV11													CASSQGQGYYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGCGGGGGACTATGGGAGACCCAGTACTTCGGGCCA	CASSGGLWETQYF	In	VDJ	1	86	1.274874884371813E-4	1.5459895951304924E-4	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	0	9	5	3	3	23	34	44	37	47	TCRBV02,TCRBV12					01,02								CASSGGLWETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCATACCGTACAGGGTTGGCAAAACATTCAGTACTTCGGCGCC	CASSHTVQGWQNIQYF	In	VDJ	1	87	1.2896990109342757E-4	1.5639662183296842E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	3	3	3	5	6	5	26	40	52	46	57		TCRBV03-01,TCRBV03-02												CASSHTVQGWQNIQYF+TCRBV03-X+TCRBJ02-04	TCRBV03	TCRBD01-01*01	TCRBJ02-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTCTCGGACGACCCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	87	1.2896990109342757E-4		43	TCRBV03						TCRBJ02	TCRBJ02-02	01	5	1	7	4	4	4	26	38	46	42	50		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-02	TCRBV03		TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCTTCCCTCCGGGAACTATGGCTACACCTTCGGTTCG	CSALPSGNYGYTF	In	VDJ	1	87	1.2896990109342757E-4	1.5639662183296842E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	6	8	4	2	9	0	26	34	-1	43	47		TCRBV20-01,TCRBV20-or09_02				01,02								CSALPSGNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCGGGGGCAGCAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	87	1.2896990109342757E-4		41	TCRBV20						TCRBJ01	TCRBJ01-01	01	2	6	0	2	2	3	26	38	46	40	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCGCGCAGGGGGCATGAACACTGAAGCTTTCTTTGGACAA	CSASRAGGMNTEAFF	In	VDJ	1	87	1.2896990109342757E-4	1.5639662183296842E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	0	0	5	1	26	37	50	42	51		TCRBV20-01,TCRBV20-or09_02												CSASRAGGMNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTACTCCCAGGGGTCACTGAAGCTTTCTTTGGACAA	CASSLLPGVTEAFF	In	VDJ	1	87	1.2896990109342757E-4	1.5639662183296842E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	2	4	7	1	24	36	49	43	50		TCRBV24-01,TCRBV24-or09_02												CASSLLPGVTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAATAATTAACAGTGCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	87	1.2896990109342757E-4		43	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	3	5	4	6	2	23	38	48	44	50		TCRBV06-01,TCRBV06-08												X+TCRBV06-X+TCRBJ01-02	TCRBV06	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCCTCTATCTCTGTGCTAGCAGCTTCCAGGGGGGCCAAGAGACCCAGTACTTCGGGCCA	CASSFQGGQETQYF	In	VDJ	1	87	1.2896990109342757E-4	1.5639662183296842E-4	42	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	4	1	1	1	1	19	33	41	34	42		TCRBV05-06,TCRBV05-07												CASSFQGGQETQYF+TCRBV05-X+TCRBJ02-05	TCRBV05	TCRBD01-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGTGAAGAGGGCGGGGCAGGGCGGCAGTATTTTGGCCCA	CASSEEGGAGRQYF	In	VDJ	1	87	1.2896990109342757E-4	1.5639662183296842E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	7	3	11	8	7	24	35	49	43	56	TCRBV02,TCRBV21													CASSEEGGAGRQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCTCCTAGCGGGGGGCGGGGATACGCAGTATTTTGGCCCA	CASSLLAGGGDTQYF	In	VDJ	1	88	1.3045231374967387E-4	1.581942841528876E-4	45	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	4	1	6	4	4	26	37	52	41	56		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSLLAGGGDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTAACCAACCGGGACAGGGGGATCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	88	1.3045231374967387E-4		56	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	0	1	1	8	1	25	37	56	45	57		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-06	TCRBV12	TCRBD01-01*01	TCRBJ02-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACGTGGTGGCAGGGGGACAGATACGCAGTATTTTGGCCCA	CSARRGGRGTDTQYF	In	VDJ	1	88	1.3045231374967387E-4	1.581942841528876E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	4	1	3	8	0	26	38	-1	46	53		TCRBV20-01,TCRBV20-or09_02												CSARRGGRGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACATCCGACAGGTGAGCTCCTACGAGCAGTACTTCGGGCCG	CSARDIRQVSSYEQYF	In	VDJ	1	88	1.3045231374967387E-4	1.581942841528876E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	2	4	0	5	4	26	40	51	45	55		TCRBV20-01,TCRBV20-or09_02												CSARDIRQVSSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCAAGAGATCCCGGCAGATACGCAGTATTTTGGCCCA	CSAQEIPADTQYF	In	VDJ	1	88	1.3045231374967387E-4	1.581942841528876E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	8	5	4	10	0	26	35	-1	45	48		TCRBV20-01,TCRBV20-or09_02				01,02								CSAQEIPADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAGGCAGGGTCCTATGGCTACACCTTCGGTTCG	CATSEAGSYGYTF	In	VDJ	1	88	1.3045231374967387E-4	1.581942841528876E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	4	3	4	2	2	24	38	45	40	47		TCRBV24-01,TCRBV24-or09_02												CATSEAGSYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GAGACWCGGCMSTGTATCTCTGYGCCAGCAGCTTATCGACAACCTACGAGCAGTACTTCGGGCCG	CASSLSTTYEQYF	In	VDJ	1	88	1.3045231374967387E-4	1.581942841528876E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	6	2	6	1	20	31	41	37	42	TCRBV07,TCRBV23													CASSLSTTYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTCACCGGGAGAGGGATTCACCCCTCCACTTTGGGAAC	CASSHRERDSPLHF	In	VDJ	1	88	1.3045231374967387E-4	1.581942841528876E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	5	8	2	8	4	4	23	34	44	38	48	TCRBV09,TCRBV12													CASSHRERDSPLHF+X+TCRBJ01-06	unresolved	TCRBD02-01*02	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGCCGACAGGAGTAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	89	1.3193472640592017E-4		41	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	4	2	3	3	26	37	46	40	49		TCRBV12-03,TCRBV12-04,TCRBV12-05												X+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAATGGTAGGGGGGGGAGGGACCCAGTACTTCGGGCCA	CASSQMVGGGGTQYF	In	VDJ	1	89	1.3193472640592017E-4	1.5999194647280677E-4	45	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	9	0	7	6	4	26	41	54	47	58		TCRBV03-01,TCRBV03-02												CASSQMVGGGGTQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGGGGACAGATGAACACTGAAGCTTTCTTTGGACAA	CASSRGQMNTEAFF	In	VDJ	1	89	1.3193472640592017E-4	1.5999194647280677E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	5	0	1	1	26	39	47	40	48		TCRBV03-01,TCRBV03-02												CASSRGQMNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGGACAGGGGGCGCAGGAGTTTATGGCTACACCTTCGGTTCG	CSARGTGGAGVYGYTF	In	VDJ	1	89	1.3193472640592017E-4	1.5999194647280677E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	0	5	1	9	26	37	50	38	59		TCRBV20-01,TCRBV20-or09_02												CSARGTGGAGVYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTGGGAAAAATCGCTATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	89	1.3193472640592017E-4		46	TCRBV20						TCRBJ01	TCRBJ01-06	01	3	0	8	3	2	7	26	37	43	39	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-06	TCRBV20		TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGGCTTACAGGGGGCTGCGTACAATGAGCAGTTCTTCGGGCCA	CSGLQGAAYNEQFF	In	VDJ	1	89	1.3193472640592017E-4	1.5999194647280677E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	3	0	4	4	4	26	33	46	37	50		TCRBV20-01,TCRBV20-or09_02												CSGLQGAAYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGCCAGGGTACTATGGCTACACCTTCGGTTCG	CASSLAPGYYGYTF	In	VDJ	1	89	1.3193472640592017E-4	1.5999194647280677E-4	42				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	3	3	2	1	18	35	42	37	43	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLAPGYYGYTF+X+TCRBJ01-02		TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGCCGAGGGGCCAGTCCGAGCACAGATACGCAGTATTTTGGCCCA	CASSRGASPSTDTQYF	In	VDJ	1	90	1.3341713906216645E-4	1.6178960879272594E-4	48	unresolved						TCRBJ02	TCRBJ02-03	01	6	5	2	0	3	8	26	37	45	40	53	TCRBV12,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRGASPSTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCAGGGGGACGGGGAGCTGTTTTTTGGAGAA	CASSQGDGELFF	In	VDJ	1	90	1.3341713906216645E-4	1.6178960879272594E-4	36	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	4	1	7	0	1	26	-1	45	38	46		TCRBV12-03,TCRBV12-04												CASSQGDGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCTCATTATCTAGCGGAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	90	1.3341713906216645E-4		46	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	4	5	3	8	0	26	40	-1	48	55		TCRBV12-03,TCRBV12-04				01,02								X+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGACGGGGGGTCCTACAATGAGCAGTTCTTCGGGCCA	CASSQDGGSYNEQFF	In	VDJ	1	90	1.3341713906216645E-4	1.6178960879272594E-4	45	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	8	1	1	0	0	26	-1	-1	43	50		TCRBV03-01,TCRBV03-02												CASSQDGGSYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGAGGACAGGGATAGCTCACCCCTCCACTTTGGGAAC	CSAREDRDSSPLHF	In	VDJ	1	90	1.3341713906216645E-4	1.6178960879272594E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	1	3	10	3	5	26	37	48	40	53		TCRBV20-01,TCRBV20-or09_02												CSAREDRDSSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCGGACAGGCCCCCTTAGGGACTGAAGCTTTCTTTGGACAA	CASSGQAPLGTEAFF	In	VDJ	1	90	1.3341713906216645E-4	1.6178960879272594E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	4	5	0	11	18	-1	37	30	48	TCRBV07,TCRBV11													CASSGQAPLGTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGAAACAATGAGCAGTTCTTCGGGCCA	CSARRNNEQFF	In	VDJ	1	91	1.3489955171841275E-4	1.6358727111264511E-4	33	TCRBV20						TCRBJ02	TCRBJ02-01	01	2	2	8	5	1	1	26	38	41	39	42		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARRNNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGGAAACACTGAAGCTTTCTTTGGACAA	CSASGNTEAFF	In	VDJ	1	91	1.3489955171841275E-4	1.6358727111264511E-4	33	TCRBV20						TCRBJ01	TCRBJ01-01	01	3	1	8	2	1	0	26	37	-1	38	41		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASGNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTTTCAGGGGACTGAAGCTTTCTTTGGACAA	CSASFQGTEAFF	In	VDJ	1	91	1.3489955171841275E-4	1.6358727111264511E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	2	5	4	0	26	37	-1	41	47		TCRBV20-01,TCRBV20-or09_02												CSASFQGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATGGATCCGGGACGTGGATGGGGCTACACCTTCGGTTCG	CSAMDPGRGWGYTF	In	VDJ	1	91	1.3489955171841275E-4	1.6358727111264511E-4	42	TCRBV20						TCRBJ01	TCRBJ01-02	01	4	0	7	8	7	8	26	36	48	43	56		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAMDPGRGWGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGGGCGGGGGGACCAAGAGACCCAGTACTTCGGGCCA	CASSQGRGDQETQYF	In	VDJ	1	91	1.3489955171841275E-4	1.6358727111264511E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	7	1	0	1	0	23	39	-1	40	48	TCRBV01,TCRBV04													CASSQGRGDQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCGGTGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CATGGNTGELFF	In	VJ	1	91	1.3489955171841275E-4	1.6358727111264511E-4	36	TCRBV24						TCRBJ02	TCRBJ02-02	01	5	0	0	1	0	1	24	-1	37	-1	38		TCRBV24-01,TCRBV24-or09_02												CATGGNTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24		TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGGGTCCGGCGGGGAGCTGTTTTTTGGAGAA	CASSVGSGGELFF	In	VDJ	1	91	1.3489955171841275E-4	1.6358727111264511E-4	39	unresolved			unresolved			TCRBJ02	TCRBJ02-02	01	0	8	5	7	4	0	23	39	-1	43	46	TCRBV09,TCRBV21			TCRBD01,TCRBD02										CASSVGSGGELFF+X+TCRBJ02-02	unresolved	unresolved	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGGACTAGGGCGAGAGACCCAGTACTTCGGGCCA	CSARDGLGRETQYF	In	VDJ	1	92	1.3638196437465905E-4	1.653849334325643E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	1	8	4	1	4	26	40	48	41	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDGLGRETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCCGCACGCGGGGACTATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	92	1.3638196437465905E-4		43	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	9	7	3	3	5	1	24	33	44	38	45		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-06	TCRBV24	TCRBD02-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTCAGGGGGACGAACACTGAAGCTTTCTTTGGACAA	CASSFRGTNTEAFF	In	VDJ	1	92	1.3638196437465905E-4	1.653849334325643E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	1	1	2	2	24	36	45	38	47		TCRBV24-01,TCRBV24-or09_02												CASSFRGTNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAACGGGAACTGGTTACGAGCAGTACTTCGGGCCG	CASSETGTGYEQYF	In	VDJ	1	92	1.3638196437465905E-4	1.653849334325643E-4	42	TCRBV06			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	8	3	4	1	6	23	38	44	39	50		TCRBV06-01,TCRBV06-08												CASSETGTGYEQYF+TCRBV06-X+TCRBJ02-07	TCRBV06	TCRBD02-01*02	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCTAGCGGGGGACACAACACCGGGGAGCTGTTTTTTGGAGAA	CASSSSGGHNTGELFF	In	VDJ	1	93	1.3786437703090535E-4	1.6718259575248346E-4	48	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	4	4	2	2	0	4	26	-1	49	39	53		TCRBV12-03,TCRBV12-04												CASSSSGGHNTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD02-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGCAGCAAAATGAAAAACTGTTTTTTGGCAGT	CASSLQQNEKLFF	In	VDJ	1	93	1.3786437703090535E-4	1.6718259575248346E-4	39	TCRBV12						TCRBJ01	TCRBJ01-04	01	3	4	5	5	1	3	26	40	44	41	47		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLQQNEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12		TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGACCCCTGACAGTGTCGAAACACCATATATTTTGGAGAG	CASSQDP*QCRNTIYF	Stop	VDJ	1	93	1.3786437703090535E-4		48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	2	5	5	5	4	26	43	53	48	57		TCRBV03-01,TCRBV03-02												CASSQDP*QCRNTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCGGGCCAGGGATCGGGCTTTCTTTGGACAA	CASSQDRARDRAFF	In	VDJ	1	93	1.3786437703090535E-4	1.6718259575248346E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	3	11	6	5	26	43	54	49	59		TCRBV03-01,TCRBV03-02												CASSQDRARDRAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGCGGGAGTACGAGCAGTACTTCGGGCCG	CASSQREYEQYF	In	VDJ	1	93	1.3786437703090535E-4	1.6718259575248346E-4	36	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	7	2	4	0	0	26	-1	-1	40	47		TCRBV03-01,TCRBV03-02												CASSQREYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*02	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTGCCCCGATCGACAGATAAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	93	1.3786437703090535E-4		47	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	2	5	5	8	3	24	37	50	45	53		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGCCCGGACAGGGTTAGGCTACACCTTCGGTTCG	CSARDARTGLGYTF	In	VDJ	1	94	1.3934678968715162E-4	1.6898025807240264E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	1	3	8	5	3	26	40	53	45	56		TCRBV20-01,TCRBV20-or09_02												CSARDARTGLGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGTCGTTGAAGGGGGCGCCGGATATGGCTACACCTTCGGTTCG	CSARVVEGGAGYGYTF	In	VDJ	1	94	1.3934678968715162E-4	1.6898025807240264E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	5	0	5	9	6	26	37	53	46	59		TCRBV20-01,TCRBV20-or09_02												CSARVVEGGAGYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTGGACAGGGATTGGGTCCTACAATGAGCAGTTCTTCGGGCCA	CSAWTGIGSYNEQFF	In	VDJ	1	94	1.3934678968715162E-4	1.6898025807240264E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	1	3	1	1	6	26	35	44	36	50		TCRBV20-01,TCRBV20-or09_02												CSAWTGIGSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTCTCGATTACAGTGATCAGCCCCAGCATTTTGGTGAT	CASSLDYSDQPQHF	In	VDJ	1	94	1.3934678968715162E-4	1.6898025807240264E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	3	5	5	7	2	22	34	45	41	47		TCRBV12-03,TCRBV12-04												CASSLDYSDQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTATGGGGTACACCGGGGAGCTGTTTTTTGGAGAA	CATSMGYTGELFF	In	VDJ	1	94	1.3934678968715162E-4	1.6898025807240264E-4	39	TCRBV24						TCRBJ02	TCRBJ02-02	01	6	6	2	3	2	1	24	36	42	38	43		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSMGYTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24		TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAGTCAGGGAAGTAAACACTGAAGCTTTCTTTGGACAA	CASSLVREVNTEAFF	In	VDJ	1	94	1.3934678968715162E-4	1.6898025807240264E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	3	2	5	5	24	36	46	41	51		TCRBV24-01,TCRBV24-or09_02												CASSLVREVNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGTTTGACGCCCTCACGGCCCCAGCATTTTGGTGAT	CASSLTPSRPQHF	In	VDJ	1	94	1.3934678968715162E-4	1.6898025807240264E-4	39	unresolved						TCRBJ01	TCRBJ01-05	01	4	2	7	9	1	9	23	36	40	37	49	TCRBV06,TCRBV24			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLTPSRPQHF+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCTAAACCTCGCGGGGGGGCAAGAGCAGTACTTCGGGCCG		Out	VDJ	1	94	1.3934678968715162E-4		44				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	7	0	7	7	3	18	31	47	38	50	TCRBV05,TCRBV11	TCRBV05-03,TCRBV11-03												X+X+TCRBJ02-07		TCRBD02-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCTTCTAGACAGGGGGCGGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	94	1.3934678968715162E-4		46				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	2	0	3	3	2	18	32	45	35	47	TCRBV05,TCRBV11	TCRBV05-03,TCRBV11-03												X+X+TCRBJ01-01		TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCAGGCAGAACTTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLAGRTSGANVLTF	In	VDJ	1	94	1.3934678968715162E-4	1.6898025807240264E-4	51							TCRBJ02	TCRBJ02-06	01	0	4	5	1	3	4	18	35	41	38	45	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAGRTSGANVLTF+X+TCRBJ02-06			TCRBJ02-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTACTACCGGGAATTCTACGAGCAGTACTTCGGGCCG	CASSYYREFYEQYF	In	VDJ	1	95	1.4082920234339793E-4	1.7077792039232181E-4	42	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	8	3	3	5	3	26	39	49	44	52		TCRBV12-03,TCRBV12-04												CASSYYREFYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*02	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCTAGCGGCGGGGCCCGTGAGCAGTACTTCGGGCCG	CASSPSGGAREQYF	In	VDJ	1	95	1.4082920234339793E-4	1.7077792039232181E-4	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	4	5	7	0	10	26	-1	46	39	56		TCRBV03-01,TCRBV03-02				01,02								CASSPSGGAREQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTAGGGGGAGGAAGGGGAACAGATACGCAGTATTTTGGCCCA	CASSLGGGRGTDTQYF	In	VDJ	1	95	1.4082920234339793E-4	1.7077792039232181E-4	48	TCRBV03						TCRBJ02	TCRBJ02-03	01	4	5	1	3	1	10	26	39	46	40	56		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGGGRGTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAAACAGGGGGCAGACCTACGAGCAGTACTTCGGGCCG	CSANRGQTYEQYF	In	VDJ	1	95	1.4082920234339793E-4	1.7077792039232181E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	3	0	2	2	3	26	34	45	36	48		TCRBV20-01,TCRBV20-or09_02												CSANRGQTYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAACATTCGGACTACCCACCGGGGAGCTGTTTTTTGGAGAA	CASSQTFGLPTGELFF	In	VDJ	1	95	1.4082920234339793E-4	1.7077792039232181E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	1	9	4	6	2	23	38	50	44	52	TCRBV01,TCRBV04					01,02								CASSQTFGLPTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGTCCTGCAGGGGGCTGATCAGCCCCAGCATTTTGGTGAT	CASSQVLQGADQPQHF	In	VDJ	1	95	1.4082920234339793E-4	1.7077792039232181E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	4	0	5	5	2	23	39	52	44	54	TCRBV01,TCRBV04													CASSQVLQGADQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTCGGGATACGAGCAGTACTTCGGGCCG	CATSDSGYEQYF	In	VDJ	1	95	1.4082920234339793E-4	1.7077792039232181E-4	36	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	8	3	4	0	0	24	-1	-1	40	45		TCRBV24-01,TCRBV24-or09_02												CATSDSGYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*02	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCACCCTGGGCAGGGGGGTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	95	1.4082920234339793E-4		43	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	4	1	4	7	1	23	33	47	40	48	TCRBV09,TCRBV21													X+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGTGAAGTAGGCTAGCGGGGAGTTTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	95	1.4082920234339793E-4		55	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	4	3	0	9	5	23	34	52	43	57	TCRBV09,TCRBV21													X+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCSRGGGACTCAGCTGTGTATYTYTGTGCCAGCAGCTTAAAAGGGAAGGGGAAGCTTTCTTTGGACAA		Out	VDJ	1	96	1.4231161499964423E-4		38	unresolved						TCRBJ01	TCRBJ01-01	01	2	0	8	8	3	4	26	41	48	44	52	TCRBV07,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATTCAGGGAGAGGAAACACCATATATTTTGGAGAG	CASSQDSGRGNTIYF	In	VDJ	1	96	1.4231161499964423E-4	1.72575582712241E-4	45	TCRBV03						TCRBJ01	TCRBJ01-03	01	0	4	3	4	2	3	26	43	50	45	53		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDSGRGNTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03		TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTTCCGGGACCCAGGACGGGAACACTGAAGCTTTCTTTGGACAA	CASSSGTQDGNTEAFF	In	VDJ	1	96	1.4231161499964423E-4	1.72575582712241E-4	48	TCRBV03						TCRBJ01	TCRBJ01-01	01	6	0	7	1	4	9	26	37	46	41	55		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSGTQDGNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGAAGAGACCCAGTACTTCGGGCCA	CSARDEETQYF	In	VJ	1	96	1.4231161499964423E-4	1.72575582712241E-4	33	TCRBV20						TCRBJ02	TCRBJ02-05	01	0	0	0	3	0	2	26	-1	40	-1	42		TCRBV20-01,TCRBV20-or09_02												CSARDEETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGRAGACWCRGCMCTGTATCTCTGCGCCAGCAGCCAACTGACAGCAACTGAAGCTTTCTTTGGACAA	CASSQLTATEAFF	In	VDJ	1	96	1.4231161499964423E-4	1.72575582712241E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	2	5	5	2	2	23	38	45	40	47	TCRBV04,TCRBV23													CASSQLTATEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGCCGAGGGACGACCCTTGGTATGGAGACCCAGTACTTCGGGCCA	CASSRGTTLGMETQYF	In	VDJ	1	96	1.4231161499964423E-4	1.72575582712241E-4	48	TCRBV12						TCRBJ02	TCRBJ02-05	01	6	0	7	5	4	13	22	33	42	37	55		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRGTTLGMETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12		TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAACCGGCTGGGATAGCTAGCGGGGGAAATGAGCAGTTCTTCGGGCCA	CASSEPAGIASGGNEQFF	In	VDJ	1	96	1.4231161499964423E-4	1.72575582712241E-4	54	TCRBV06			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	4	2	7	13	1	23	38	61	51	62		TCRBV06-01,TCRBV06-08												CASSEPAGIASGGNEQFF+TCRBV06-X+TCRBJ02-01	TCRBV06	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCGGACGAACAATGAGCAGTTCTTCGGGCCA	CASSRTNNEQFF	In	VDJ	1	97	1.437940276558905E-4	1.743732450321602E-4	36	TCRBV12						TCRBJ02	TCRBJ02-01	01	5	1	7	5	1	2	26	38	43	39	45		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRTNNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12		TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTGACACAAGGGCCAATTCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	97	1.437940276558905E-4		47	TCRBV12						TCRBJ02	TCRBJ02-03	01	5	2	6	2	0	12	26	-1	42	38	54		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-X+TCRBJ02-03	TCRBV12		TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTACGGGGTACGAGCAGTACTTCGGGCCG	CASSFTGYEQYF	In	VDJ	1	97	1.437940276558905E-4	1.743732450321602E-4	36	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	8	3	4	2	0	26	40	-1	42	47		TCRBV12-03,TCRBV12-04												CASSFTGYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCCATCTCCCAGGAGACACTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	97	1.437940276558905E-4		50	unresolved						TCRBJ01	TCRBJ01-01	01	4	2	6	0	12	1	23	36	52	48	53	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCCCCGACTAGCGGAGGGCTACGAGCAGTACTTCGGGCCG	XASSPRLAEGYEQYF	In	VDJ	1	97	1.437940276558905E-4	1.743732450321602E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	2	5	3	3	4	23	36	48	39	52	TCRBV01,TCRBV07,TCRBV17					01,02								XASSPRLAEGYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAGGTCCCGGGATTGGGCACAGATACGCAGTATTTTGGCCCA	CASSQEVPGLGTDTQYF	In	VDJ	1	97	1.437940276558905E-4	1.743732450321602E-4	51	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	8	3	1	5	4	26	43	53	48	57		TCRBV03-01,TCRBV03-02												CASSQEVPGLGTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*02	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGAACAGGGCGGTACTATGGCTACACCTTCGGTTCG	CSARGTGRYYGYTF	In	VDJ	1	97	1.437940276558905E-4	1.743732450321602E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	3	3	3	2	4	26	39	47	41	51		TCRBV20-01,TCRBV20-or09_02												CSARGTGRYYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCCCTTCCGGGGACAGGGCTTTTCCACTAACTATGGCTACACCTTCGGTTCG	CASSPFRGQGFSTNYGYTF	In	VDJ	1	97	1.437940276558905E-4	1.743732450321602E-4	57	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	3	0	7	8	23	36	52	43	60	TCRBV01,TCRBV04													CASSPFRGQGFSTNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGTGAGGAACGCACAGATACGCAGTATTTTGGCCCA	CASSEERTDTQYF	In	VDJ	1	98	1.452764403121368E-4	1.7617090735207936E-4	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	11	1	1	0	3	26	-1	42	38	45	TCRBV09,TCRBV12													CASSEERTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAAGACAGGGGGCATGACTATGGCTACACCTTCGGTTCG	CSAREDRGHDYGYTF	In	VDJ	1	98	1.452764403121368E-4	1.7617090735207936E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	2	0	3	1	3	26	40	51	41	54		TCRBV20-01,TCRBV20-or09_02												CSAREDRGHDYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTTCGGGACAGGGTTTCACCCCTCCACTTTGGGAAC	CSARVRDRVSPLHF	In	VDJ	1	98	1.452764403121368E-4	1.7617090735207936E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	1	0	3	9	3	1	26	39	51	42	52		TCRBV20-01,TCRBV20-or09_02												CSARVRDRVSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGACATTAGCACAGATACGCAGTATTTTGGCCCA	CSARDISTDTQYF	In	VDJ	1	98	1.452764403121368E-4	1.7617090735207936E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	1	6	0	0	2	26	-1	42	37	44		TCRBV20-01,TCRBV20-or09_02												CSARDISTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGCCCCGGACTTCTACAATGAGCAGTTCTTCGGGCCA	CATSAPDFYNEQFF	In	VDJ	1	98	1.452764403121368E-4	1.7617090735207936E-4	42	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	1	10	3	4	1	24	37	46	41	47		TCRBV24-01,TCRBV24-or09_02				01,02								CATSAPDFYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCGTGGGACGGGGTTGGCCCCAGCATTTTGGTGAT	CASSVGRGWPQHF	In	VDJ	1	98	1.452764403121368E-4	1.7617090735207936E-4	39	TCRBV24						TCRBJ01	TCRBJ01-05	01	7	0	7	9	3	7	24	35	43	38	50		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVGRGWPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCTACCCCCTGAACCCCGGGACACCCTTCCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	98	1.452764403121368E-4		58	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	6	2	18	6	23	31	55	49	61		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGCAAGTCGCAGATAAGGGCTACACCTTCGGTTCG	CASSLAQVADKGYTF	In	VDJ	1	98	1.452764403121368E-4	1.7617090735207936E-4	45				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	5	8	8	5	18	35	46	43	51	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLAQVADKGYTF+X+TCRBJ01-02		TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTGGATGACAGGGACCCTGAACACTGAAGCTTTCTTTGGACAA	CASSWMTGTLNTEAFF	In	VDJ	1	98	1.452764403121368E-4	1.7617090735207936E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	3	0	4	4	19	32	43	36	47	TCRBV05,TCRBV11													CASSWMTGTLNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGACCGGGGCCCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	98	1.452764403121368E-4		41	unresolved						TCRBJ01	TCRBJ01-01	01	5	7	0	4	7	1	24	36	48	43	49	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGGACAGGGGCTTCTGAGGTACCGGCTACACCTTCGGTTCG	CASSQGDRGF*GTGYTF	Stop	VDJ	1	99	1.467588529683831E-4		51	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	0	2	8	0	13	26	-1	52	42	65		TCRBV03-01,TCRBV03-02												CASSQGDRGF*GTGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTGAATTAGCGGGGGGCCCATACGAGCAGTACTTCGGGCCG	CASSELAGGPYEQYF	In	VDJ	1	99	1.467588529683831E-4	1.7796856967199854E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	5	1	4	4	4	22	34	48	38	52	TCRBV09,TCRBV12													CASSELAGGPYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAACTAGCGGGGGCTTCCTACGAGCAGTACTTCGGGCCG	CASSELAGASYEQYF	In	VDJ	1	99	1.467588529683831E-4	1.7796856967199854E-4	45	TCRBV06			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	2	4	2	1	0	2	23	-1	48	38	50		TCRBV06-01,TCRBV06-08												CASSELAGASYEQYF+TCRBV06-X+TCRBJ02-07	TCRBV06	TCRBD02-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCACCCTGACCAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASTLTSSYNEQFF	In	VDJ	1	99	1.467588529683831E-4	1.7796856967199854E-4	42	unresolved						TCRBJ02	TCRBJ02-01	01	7	2	7	0	4	3	18	28	35	32	38	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTLTSSYNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGGTTAGCTATAGGACCCAGTACTTCGGGCCA	CASSLAVSYRTQYF	In	VDJ	1	99	1.467588529683831E-4	1.7796856967199854E-4	42				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	5	7	7	3	5	18	35	42	38	47	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03				01,02								CASSLAVSYRTQYF+X+TCRBJ02-05		TCRBD02-01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCATGGCGCGGGGACAAGAGACCCAGTACTTCGGGCCA	CASMARGQETQYF	In	VDJ	1	100	1.482412656246294E-4	1.7976623199191771E-4	39	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	7	7	3	2	4	1	26	36	46	40	47		TCRBV03-01,TCRBV03-02												CASMARGQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGAAAGCTTCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	100	1.482412656246294E-4		37	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	6	7	0	5	2	26	34	42	39	44		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGAGGAGTTAATTCACCCCTCCACTTTGGGAAC	CSARGVNSPLHF	In	VDJ	1	100	1.482412656246294E-4	1.7976623199191771E-4	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	6	10	2	6	4	1	26	34	42	38	43		TCRBV20-01,TCRBV20-or09_02												CSARGVNSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD02-01*02	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGATATAGCGGGGCGGAGGGAGACCCAGTACTTCGGGCCA	CSARDIAGRRETQYF	In	VDJ	1	100	1.482412656246294E-4	1.7976623199191771E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	5	3	5	5	6	26	37	50	42	56		TCRBV20-01,TCRBV20-or09_02												CSARDIAGRRETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCGCTTAAATTCACCCCTCCACTTTGGGAAC	CASSRLNSPLHF	In	VDJ	1	100	1.482412656246294E-4	1.7976623199191771E-4	36	unresolved						TCRBJ01	TCRBJ01-06	01	4	10	0	7	0	3	23	-1	38	36	41	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRLNSPLHF+X+TCRBJ01-06	unresolved		TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAAGGGAGAGGAACACTGAAGCTTTCTTTGGACAA	CASSLRERNTEAFF	In	VDJ	1	100	1.482412656246294E-4	1.7976623199191771E-4	42	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	9	2	1	4	2	24	36	45	40	47		TCRBV24-01,TCRBV24-or09_02												CASSLRERNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD02-01*02	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCTCGGACAGGGAACACTGAAGCTTTCTTTGGACAA	CASSLSRTGNTEAFF	In	VDJ	1	100	1.482412656246294E-4	1.7976623199191771E-4	45				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	4	1	7	0	24	36	-1	43	50	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01												CASSLSRTGNTEAFF+X+TCRBJ01-01		TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATGGGCGGCCCACTCTAAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	100	1.482412656246294E-4		53	TCRBV24						TCRBJ01	TCRBJ01-04	01	6	8	0	1	4	11	24	36	44	40	55		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ01-04	TCRBV24		TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTGCTTGAGGGACAGGCAATTCCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	100	1.482412656246294E-4		56	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	0	4	0	8	6	24	36	52	44	58		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-03	TCRBV24	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAACAGGAGGGGGCCGGCACTGAAGCTTTCTTTGGACAA	CASSEQEGAGTEAFF	In	VDJ	1	100	1.482412656246294E-4	1.7976623199191771E-4	45	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	5	0	4	4	3	23	38	49	42	52		TCRBV06-01,TCRBV06-08												CASSEQEGAGTEAFF+TCRBV06-X+TCRBJ01-01	TCRBV06	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAACAGCTACAGGCCGGCGCCTAGCATAACCTACAATGAGCAGTTCTTCGGGCCA	CANSYRPAPSITYNEQFF	In	VDJ	1	100	1.482412656246294E-4	1.7976623199191771E-4	54	unresolved						TCRBJ02	TCRBJ02-01	01	5	3	4	2	1	16	24	36	42	37	58	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CANSYRPAPSITYNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGAGATAGGGGTAGGGGCCCAGCCCCAGCATTTTGGTGAT	CASSQEIGVGAQPQHF	In	VDJ	1	101	1.4972367828087568E-4	1.815638943118369E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	5	2	7	3	8	23	40	48	43	56	TCRBV01,TCRBV04													CASSQEIGVGAQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAGGGGGACAGGGAGGGCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	101	1.4972367828087568E-4		49	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	3	2	2	4	26	43	54	45	58		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACGGACAGGGGTTGGCCAAAAACATTCAGTACTTCGGCGCC	CASSHGQGLAKNIQYF	In	VDJ	1	101	1.4972367828087568E-4	1.815638943118369E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	3	1	2	1	1	3	26	40	50	41	53		TCRBV03-01,TCRBV03-02												CASSHGQGLAKNIQYF+TCRBV03-X+TCRBJ02-04	TCRBV03	TCRBD01-01*01	TCRBJ02-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGACAGGGACGGGATGGCTACACCTTCGGTTCG	CSARGQGRDGYTF	In	VDJ	1	101	1.4972367828087568E-4	1.815638943118369E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	2	3	6	0	5	26	-1	46	39	51		TCRBV20-01,TCRBV20-or09_02												CSARGQGRDGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGACGCGATAGGTAACTATGGCTACACCTTCGGTTCG	CASSQDAIGNYGYTF	In	VDJ	1	101	1.4972367828087568E-4	1.815638943118369E-4	45	unresolved						TCRBJ01	TCRBJ01-02	01	0	5	4	1	6	0	23	40	-1	46	49	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDAIGNYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTGCCCGACAGGGAATGAATTCACCCCTCCACTTTGGGAAC	CASSARQGMNSPLHF	In	VDJ	1	101	1.4972367828087568E-4	1.815638943118369E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	2	3	7	4	4	22	34	45	38	49		TCRBV12-03,TCRBV12-04												CASSARQGMNSPLHF+TCRBV12-X+TCRBJ01-06	TCRBV12	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGTGAACCGGGACTAGCGGGGGGTGAGACCCAGTACTTCGGGCCA	CASEPGLAGGETQYF	In	VDJ	1	101	1.4972367828087568E-4	1.815638943118369E-4	45	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	9	0	1	5	6	1	22	30	51	36	52		TCRBV12-03,TCRBV12-04												CASEPGLAGGETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGAAGGGAGCTGGAACACTGAAGCTTTCTTTGGACAA	CASSQEGSWNTEAFF	In	VDJ	1	101	1.4972367828087568E-4	1.815638943118369E-4	45				TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	9	2	1	1	3	18	35	41	36	44	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQEGSWNTEAFF+X+TCRBJ01-01		TCRBD02-01*02	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCCCGGGGGACTGAACACTGAAGCTTTCTTTGGACAA	CASSPGGLNTEAFF	In	VDJ	1	102	1.5120609093712198E-4	1.8336155663175606E-4	42	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	6	8	2	0	3	2	26	37	46	40	48		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSPGGLNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATGGGACGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	102	1.5120609093712198E-4		43	TCRBV03						TCRBJ01	TCRBJ01-01	01	0	0	7	1	1	1	26	43	49	44	50		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCGGGACTAGCGGGGAGTAGGGAGACCCAGTACTTCGGGCCA	CASSSGLAGSRETQYF	In	VDJ	1	103	1.5268850359336829E-4	1.8515921895167524E-4	48	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	0	3	5	1	6	26	39	53	40	59		TCRBV12-03,TCRBV12-04												CASSSGLAGSRETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGGTCGGACGCGGGGGGGCCTGGTGTTGAGCAGTTCTTCGGGCCA	CSARRSDAGGPGVEQFF	In	VDJ	1	103	1.5268850359336829E-4	1.8515921895167524E-4	51	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	7	0	9	9	8	26	38	56	47	64		TCRBV20-01,TCRBV20-or09_02												CSARRSDAGGPGVEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCGGAACAGGGGGCGTTGAAAAACTGTTTTTTGGCAGT	CSAPGTGGVEKLFF	In	VDJ	1	103	1.5268850359336829E-4	1.8515921895167524E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	3	0	7	6	2	26	35	50	41	52		TCRBV20-01,TCRBV20-or09_02												CSAPGTGGVEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGTTCGGCTTTGGAAAACACTGAAGCTTTCTTTGGACAA	CASSALENTEAFF	In	VDJ	1	103	1.5268850359336829E-4	1.8515921895167524E-4	39	unresolved						TCRBJ01	TCRBJ01-01	01	9	1	8	2	9	1	22	30	42	39	43	TCRBV09,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSALENTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAGGGGTAACCTATAATTCACCCCTCCACTTTGGGAAC	CASSLGVTYNSPLHF	In	VDJ	1	103	1.5268850359336829E-4	1.8515921895167524E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	5	2	2	2	3	24	36	43	38	46		TCRBV24-01,TCRBV24-or09_02												CASSLGVTYNSPLHF+TCRBV24-X+TCRBJ01-06	TCRBV24	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCACAAGGACAGGGGCTAACTATGGCTACACCTTCGGTTCG	CASTRTGANYGYTF	In	VDJ	1	103	1.5268850359336829E-4	1.8515921895167524E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	1	2	0	3	0	18	28	-1	31	40	TCRBV07,TCRBV11													CASTRTGANYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGCTTTACTAGCGGGGGCCCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSFTSGGPNTGELFF	In	VDJ	1	104	1.5417091624961456E-4	1.869568812715944E-4	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	6	3	2	0	4	2	26	37	52	41	54	TCRBV12,TCRBV21													CASSFTSGGPNTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCTAGGGGGGGACTTCTACAATGAGCAGTTCTTCGGGCCA	CASSLGGDFYNEQFF	In	VDJ	1	104	1.5417091624961456E-4	1.869568812715944E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	9	0	3	2	4	23	36	45	38	49	TCRBV01,TCRBV04													CASSLGGDFYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ACGTTTGGTGCATCCTGAAGACAGCAGCTTCTMATCTGCAGTGCTAGAGATCTAGACAGGGGGAACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	104	1.5417091624961456E-4		44	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	19	2	1	5	22	1	37	32	63	54	64		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCAGGACAGGGGAGCGTAGCTTTCTTTGGACAA	CASSPGQGSVAFF	In	VDJ	1	104	1.5417091624961456E-4	1.869568812715944E-4	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	2	10	2	5	26	39	50	41	55		TCRBV03-01,TCRBV03-02												CASSPGQGSVAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACGCCGGGACAGACTTTAAGGAACACCGGGGAGCTGTTTTTTGGAGAA	CSATPGQTLRNTGELFF	In	VDJ	1	104	1.5417091624961456E-4	1.869568812715944E-4	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	0	5	1	4	8	26	36	47	40	55		TCRBV20-01,TCRBV20-or09_02												CSATPGQTLRNTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGGGGGGGCACAGATACGCAGTATTTTGGCCCA	CSARRGGTDTQYF	In	VDJ	1	104	1.5417091624961456E-4	1.869568812715944E-4	39	TCRBV20						TCRBJ02	TCRBJ02-03	01	2	5	1	1	0	1	26	-1	44	38	45		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARRGGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTCTCAGGGAATCTGAATACTGAAGCTTTCTTTGGACAA	CSVSGNLNTEAFF	In	VDJ	1	104	1.5417091624961456E-4	1.869568812715944E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	4	3	5	3	9	26	33	41	36	50		TCRBV20-01,TCRBV20-or09_02												CSVSGNLNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGAACAGAATACAGATACGCAGTATTTTGGCCCA	CASSQEQNTDTQYF	In	VDJ	1	104	1.5417091624961456E-4	1.869568812715944E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	3	5	3	0	3	23	-1	44	40	47	TCRBV01,TCRBV04													CASSQEQNTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGACCCAACACCGGGGAGCTGTTTTTTGGAGAA	CASRPNTGELFF	In	VDJ	1	104	1.5417091624961456E-4	1.869568812715944E-4	36	unresolved						TCRBJ02	TCRBJ02-02	01	6	3	7	2	0	2	23	-1	36	34	38	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRPNTGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTAAACAGGGAGACAATCAGCCCCAGCATTTTGGTGAT	CASSKQGDNQPQHF	In	VDJ	1	105	1.5565332890586086E-4	1.887545435915136E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	3	3	3	2	3	26	38	46	40	49		TCRBV12-03,TCRBV12-04												CASSKQGDNQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCAAGACGGGGGGGCAGGAATGAGCAGTTCTTCGGGCCA	CASSPRRGGRNEQFF	In	VDJ	1	105	1.5565332890586086E-4	1.887545435915136E-4	45	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	8	0	7	5	4	26	39	52	44	56		TCRBV03-01,TCRBV03-02												CASSPRRGGRNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGGGGGGGACAGGGCCCAATCAGCCCCAGCATTTTGGTGAT	CSAREGGTGPNQPQHF	In	VDJ	1	105	1.5565332890586086E-4	1.887545435915136E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	0	3	3	4	2	26	40	53	44	55		TCRBV20-01,TCRBV20-or09_02												CSAREGGTGPNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCCGCCGGGACAACCCCCTACGAGCAGTACTTCGGGCCG	CASSSAGTTPYEQYF	In	VDJ	1	105	1.5565332890586086E-4	1.887545435915136E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	6	2	6	4	24	36	48	42	52		TCRBV24-01,TCRBV24-or09_02												CASSSAGTTPYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAATTAGTGCGGACAGGATCCTCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	105	1.5565332890586086E-4		53	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	1	4	3	7	5	23	38	52	45	57		TCRBV06-01,TCRBV06-08												X+TCRBV06-X+TCRBJ01-05	TCRBV06	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGGTAGGGGTCGGCAATCAGCCCCAGCATTTTGGTGAT	CASSLAVGVGNQPQHF	In	VDJ	1	105	1.5565332890586086E-4	1.887545435915136E-4	48				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	5	2	2	3	3	18	35	43	38	46	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLAVGVGNQPQHF+X+TCRBJ01-05		TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGTGTCCACTCCTTCGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSVHSFANTGELFF	In	VDJ	1	105	1.5565332890586086E-4	1.887545435915136E-4	48	unresolved			unresolved			TCRBJ02	TCRBJ02-02	01	6	3	10	0	5	6	18	29	37	34	43	TCRBV07,TCRBV11			TCRBD01,TCRBD02										CASSVHSFANTGELFF+X+TCRBJ02-02	unresolved	unresolved	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAGTGACCCGACCTTGAATAATTCACCCCTCCACTTTGGGAAC	CASSDPTLNNSPLHF	In	VDJ	1	105	1.5565332890586086E-4	1.887545435915136E-4	45	unresolved						TCRBJ01	TCRBJ01-06	01	6	2	7	5	1	10	24	35	39	36	49	TCRBV12,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDPTLNNSPLHF+X+TCRBJ01-06	unresolved		TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAACCCCCGATTCACCCCTCCACTTTGGGAAC	CSARTPDSPLHF	In	VDJ	1	106	1.5713574156210716E-4	1.9055220591143276E-4	36	TCRBV20						TCRBJ01	TCRBJ01-06	01	2	3	7	8	0	5	26	-1	40	38	45		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARTPDSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20		TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGCTCAAGACAGGGCACACTATGGCTACACCTTCGGTTCG	CASSQAQDRAHYGYTF	In	VDJ	1	106	1.5713574156210716E-4	1.9055220591143276E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	2	3	3	5	3	23	39	51	44	54	TCRBV01,TCRBV04													CASSQAQDRAHYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAGTGGGACTAGCGGACTTTACAATGAGCAGTTCTTCGGGCCA	CAISGTSGLYNEQFF	In	VDJ	1	106	1.5713574156210716E-4	1.9055220591143276E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	5	4	0	4	23	-1	46	35	50	TCRBV06,TCRBV10					01,02								CAISGTSGLYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGGGGAGACTTCCTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLGETSYSNQPQHF	In	VDJ	1	107	1.5861815421835347E-4	1.9234986823135194E-4	51	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	1	9	2	0	0	8	26	-1	47	42	55		TCRBV12-03,TCRBV12-04												CASSLGETSYSNQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD02-01*02	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAAGGGGGACAGGGAACGAGCAGTACTTCGGGCCG	CASSQRGTGNEQYF	In	VDJ	1	107	1.5861815421835347E-4	1.9234986823135194E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	0	3	5	3	1	26	41	53	44	54		TCRBV03-01,TCRBV03-02												CASSQRGTGNEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTCCGTGAACTAGCGTACAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	107	1.5861815421835347E-4		47	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	3	6	2	7	2	26	39	53	46	55		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCGTCCCTTGGACAGAAAATTCACCCCTCCACTTTGGGAAC	CASVPWTENSPLHF	In	VDJ	1	107	1.5861815421835347E-4	1.9234986823135194E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	8	1	5	7	7	2	22	31	44	38	46	TCRBV09,TCRBV12													CASVPWTENSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAACGGGGGATTGGTGAAGCTTTCTTTGGACAA	CASSERGIGEAFF	In	VDJ	1	107	1.5861815421835347E-4	1.9234986823135194E-4	39	TCRBV06			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	2	8	2	7	0	5	23	-1	44	38	49		TCRBV06-01,TCRBV06-08												CASSERGIGEAFF+TCRBV06-X+TCRBJ01-01	TCRBV06	TCRBD02-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAGCGCGAGGAGGCGGATATGAAAAACTGTTTTTTGGCAGT	CASSLARGGGYEKLFF	In	VDJ	1	107	1.5861815421835347E-4	1.9234986823135194E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	0	10	1	6	4	5	18	35	44	39	49	TCRBV07,TCRBV11													CASSLARGGGYEKLFF+X+TCRBJ01-04	unresolved	TCRBD02-01*02	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGGAGGTCACCGGGGAGCTGTTTTTTGGAGAA	CASSLAEVTGELFF	In	VDJ	1	107	1.5861815421835347E-4	1.9234986823135194E-4	42				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	0	10	1	4	0	1	18	-1	40	35	41	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLAEVTGELFF+X+TCRBJ02-02		TCRBD02-01*02	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTGGGGGGGCAGGAACTATGGCTACACCTTCGGTTCG	CSARDWGGRNYGYTF	In	VDJ	1	108	1.6010056687459974E-4	1.9414753055127114E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	0	9	0	2	2	4	26	40	49	42	53		TCRBV20-01,TCRBV20-or09_02												CSARDWGGRNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGCGGCAGCCTTTTCAATCAGCCCCAGCATTTTGGTGAT	CSARGGSLFNQPQHF	In	VDJ	1	108	1.6010056687459974E-4	1.9414753055127114E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	1	7	5	3	0	9	26	-1	43	39	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSARGGSLFNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAACGGAGACCACGTCAGGATCTATGGCTACACCTTCGGTTCG	CASNGDHVRIYGYTF	In	VDJ	1	108	1.6010056687459974E-4	1.9414753055127114E-4	45	unresolved						TCRBJ01	TCRBJ01-02	01	7	4	4	4	13	2	18	28	45	41	47	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASNGDHVRIYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCACTAGCGGTCCAAGAGACCCAGTACTTCGGGCCA	CASSLALAVQETQYF	In	VDJ	1	108	1.6010056687459974E-4	1.9414753055127114E-4	45				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	3	5	1	0	1	18	-1	43	35	44	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03				01,02								CASSLALAVQETQYF+X+TCRBJ02-05		TCRBD02-01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCAAGAGAAAATGGTTACCGGGGAGCTGTTTTTTGGAGAA	XASSQEKMVTGELFF	In	VDJ	1	108	1.6010056687459974E-4	1.9414753055127114E-4	45	unresolved						TCRBJ02	TCRBJ02-02	01	0	0	10	5	6	2	22	39	47	45	49	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									XASSQEKMVTGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCCCGAATGGCGGGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSPEWRGGTDTQYF	In	VDJ	1	108	1.6010056687459974E-4	1.9414753055127114E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	7	1	1	8	0	19	31	-1	39	47	TCRBV05,TCRBV11													CASSPEWRGGTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCGGTCGGGGAAGGGGGTCAAGAGACCCAGTACTTCGGGCCA	CASSPVGEGGQETQYF	In	VDJ	1	109	1.6158297953084604E-4	1.9594519287119031E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	5	1	2	10	1	26	39	55	49	56		TCRBV03-01,TCRBV03-02												CASSPVGEGGQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGGGGCGGAGAGAACACTGAAGCTTTCTTTGGACAA	CASSRGGENTEAFF	In	VDJ	1	109	1.6158297953084604E-4	1.9594519287119031E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	7	0	1	0	5	26	-1	44	39	49		TCRBV03-01,TCRBV03-02												CASSRGGENTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATGCGGGGCGGCGTGAGCACAGATACGCAGTATTTTGGCCCA	CSAMRGGVSTDTQYF	In	VDJ	1	109	1.6158297953084604E-4	1.9594519287119031E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	7	3	0	1	7	26	36	43	37	50		TCRBV20-01,TCRBV20-or09_02												CSAMRGGVSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCTCCGGTAGGACAGGGGTACGAGCAGTACTTCGGGCCG	CSASPVGQGYEQYF	In	VDJ	1	109	1.6158297953084604E-4	1.9594519287119031E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	2	4	9	0	26	35	-1	44	53		TCRBV20-01,TCRBV20-or09_02												CSASPVGQGYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTTTCGACAGGGTACGTGGGGCGAGCTTTCTTTGGACAA	CSVSTGYVGRAFF	In	VDJ	1	109	1.6158297953084604E-4	1.9594519287119031E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	2	3	10	4	11	26	33	44	37	55		TCRBV20-01,TCRBV20-or09_02												CSVSTGYVGRAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCGGAACCTACACCTCACCCCTCCACTTTGGGAAC	CASGTYTSPLHF	In	VDJ	1	109	1.6158297953084604E-4	1.9594519287119031E-4	36	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	11	7	5	10	0	10	24	-1	35	31	45		TCRBV24-01,TCRBV24-or09_02				01,02								CASGTYTSPLHF+TCRBV24-X+TCRBJ01-06	TCRBV24	TCRBD02-01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGCGACAGGTGATAATTCACCCCTCCACTTTGGGAAC	CASSATGDNSPLHF	In	VDJ	1	110	1.6306539218709234E-4	1.977428551911095E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	2	4	5	3	2	26	37	46	40	48		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSATGDNSPLHF+TCRBV12-X+TCRBJ01-06	TCRBV12	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGTCGGTAGCGGGGGGGCCTACGAGCAGTACTTCGGGCCG	CASSQVGSGGAYEQYF	In	VDJ	1	110	1.6306539218709234E-4	1.977428551911095E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	1	5	0	2	4	0	23	39	-1	43	54	TCRBV01,TCRBV04													CASSQVGSGGAYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTCCTCAGGATACACTGAAGCTTTCTTTGGACAA	CATSDSSGYTEAFF	In	VDJ	1	110	1.6306539218709234E-4	1.977428551911095E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	4	3	3	2	24	40	47	43	49		TCRBV24-01,TCRBV24-or09_02												CATSDSSGYTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCTCGGACAGAGAGTAACTATGGCTACACCTTCGGTTCG	CASSPRTESNYGYTF	In	VDJ	1	110	1.6306539218709234E-4	1.977428551911095E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	5	1	4	4	24	36	46	40	50		TCRBV24-01,TCRBV24-or09_02												CASSPRTESNYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGAAGCGGGTAGGGAAGGGGACTATGGCTACACCTTCGGTTCG	CASSQEAGREGDYGYTF	In	VDJ	1	110	1.6306539218709234E-4	1.977428551911095E-4	51				TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	0	6	4	3	0	11	18	-1	41	35	52	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03				01,02								CASSQEAGREGDYGYTF+X+TCRBJ01-02		TCRBD02-01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGACCCGGGGCAAAACTATGGCTACACCTTCGGTTCG	CASSQDPGQNYGYTF	In	VDJ	1	110	1.6306539218709234E-4	1.977428551911095E-4	45							TCRBJ01	TCRBJ01-02	01	0	7	0	2	3	2	18	35	43	38	45	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDPGQNYGYTF+X+TCRBJ01-02			TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCGCCGGACTAGCGGGGGGGCAAATGAGCAGTTCTTCGGGCCA	CASSRRTSGGANEQFF	In	VDJ	1	110	1.6306539218709234E-4	1.977428551911095E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	1	0	7	4	2	18	30	49	34	51	TCRBV07,TCRBV11													CASSRRTSGGANEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGTGAAAATCCCCCGACAGAGGCAAGGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	110	1.6306539218709234E-4		53	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	5	3	12	8	24	35	52	47	60	TCRBV02,TCRBV21													X+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGAACGGGGCCCGGGGACTGAAGCTTTCTTTGGACAA	CASSERGPGTEAFF	In	VDJ	1	110	1.6306539218709234E-4	1.977428551911095E-4	42	unresolved						TCRBJ01	TCRBJ01-01	01	5	7	0	5	5	6	23	34	44	39	50	TCRBV02,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSERGPGTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCACACCCGGGCACACTGAAGCTTTCTTTGGACAA	CSATPGHTEAFF	In	VDJ	1	111	1.6454780484333862E-4	1.9954051751102866E-4	36	TCRBV20						TCRBJ01	TCRBJ01-01	01	6	8	0	3	7	0	26	34	-1	41	45		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSATPGHTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTTACCAGGGAGGGAGGTCAAATCAGCCCCAGCATTTTGGTGAT	CASSYQGGRSNQPQHF	In	VDJ	1	111	1.6454780484333862E-4	1.9954051751102866E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	4	9	0	4	4	6	22	35	46	39	52	TCRBV02,TCRBV12													CASSYQGGRSNQPQHF+X+TCRBJ01-05	unresolved	TCRBD02-01*02	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCCCCAGCGGGGGGACTTGGGGCGAGCAGTACTTCGGGCCG	CASSPSGGTWGEQYF	In	VDJ	1	111	1.6454780484333862E-4	1.9954051751102866E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	6	1	6	3	8	18	30	42	33	50	TCRBV07,TCRBV11													CASSPSGGTWGEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCCCCGCCCCGGGAACGAACACTGAAGCTTTCTTTGGACAA	CASSPAPGTNTEAFF	In	VDJ	1	111	1.6454780484333862E-4	1.9954051751102866E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	8	3	1	7	2	18	30	42	37	44	TCRBV07,TCRBV11													CASSPAPGTNTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTTTGGACAGGGAACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSFGQGTNTGELFF	In	VDJ	1	111	1.6454780484333862E-4	1.9954051751102866E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	1	3	0	1	2	18	32	41	33	43	TCRBV07,TCRBV11													CASSFGQGTNTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTTTATGGGTTAGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CASSLWVSSYNSPLHF	In	VDJ	1	112	1.6603021749958492E-4	2.0133817983094784E-4	48	TCRBV12						TCRBJ01	TCRBJ01-06	01	2	0	9	0	1	4	26	41	45	42	49		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLWVSSYNSPLHF+TCRBV12-X+TCRBJ01-06	TCRBV12		TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATCTCCACTAACACCTATGGCTACACCTTCGGTTCG	CSAISTNTYGYTF	In	VDJ	1	112	1.6603021749958492E-4	2.0133817983094784E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	4	3	9	4	5	4	26	36	45	41	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSAISTNTYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCCGGGACAGGGGTGTCTCACCCCTCCACTTTGGGAAC	CASRDRGVSPLHF	In	VDJ	1	112	1.6603021749958492E-4	2.0133817983094784E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	8	0	2	10	1	4	22	31	42	32	46	TCRBV09,TCRBV12													CASRDRGVSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAACGAACGGGGGGAAACGGGGATGCCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	112	1.6603021749958492E-4		46	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	11	8	1	7	5	12	24	31	43	36	55		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD02-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGGGGAAGGGACATCGGGGAGACCCAGTACTTCGGGCCA	CASRGRDIGETQYF	In	VDJ	1	112	1.6603021749958492E-4	2.0133817983094784E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	0	6	5	5	5	24	35	46	40	51	TCRBV09,TCRBV21													CASRGRDIGETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCGTAGAAGGGGAAGATACGCAGTATTTTGGCCCA	CASSVEGEDTQYF	In	VDJ	1	112	1.6603021749958492E-4	2.0133817983094784E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	5	2	5	1	1	23	39	45	40	46	TCRBV09,TCRBV12													CASSVEGEDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTCGGGGGGGACCATAATTCACCCCTCCACTTTGGGAAC	CASSVGGDHNSPLHF	In	VDJ	1	112	1.6603021749958492E-4	2.0133817983094784E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	2	8	0	5	0	3	23	-1	45	37	48	TCRBV09,TCRBV21													CASSVGGDHNSPLHF+X+TCRBJ01-06	unresolved	TCRBD02-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLNTGELFF	In	VJ	1	113	1.6751263015583122E-4	2.03135842150867E-4	36	TCRBV12						TCRBJ02	TCRBJ02-02	01	2	0	0	2	0	0	26	-1	-1	-1	41		TCRBV12-03,TCRBV12-04												CASSLNTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12		TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGGGGACTACAATGAGCAGTTCTTCGGGCCA	CASSQGDYNEQFF	In	VDJ	1	113	1.6751263015583122E-4	2.03135842150867E-4	39	TCRBV03						TCRBJ02	TCRBJ02-01	01	3	6	1	3	0	1	26	-1	45	40	46		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGDYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTTTACAGGGAGGTCTGAAGCTTTCTTTGGACAA	CASSFTGRSEAFF	In	VDJ	1	113	1.6751263015583122E-4	2.03135842150867E-4	39	TCRBV03						TCRBJ01	TCRBJ01-01	01	5	3	3	6	3	4	26	38	47	41	51		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFTGRSEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGTTGGACTAGCGGGGTCCGGGGAGCTGTTTTTTGGAGAA	CSAVGLAGSGELFF	In	VDJ	1	113	1.6751263015583122E-4	2.03135842150867E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	6	1	3	6	4	1	26	34	50	38	51		TCRBV20-01,TCRBV20-or09_02												CSAVGLAGSGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCTCGAGGACAGGGGGCTACAATGAGCAGTTCTTCGGGCCA	CSASRTGGYNEQFF	In	VDJ	1	113	1.6751263015583122E-4	2.03135842150867E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	1	1	3	5	0	26	34	-1	39	49		TCRBV20-01,TCRBV20-or09_02												CSASRTGGYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGGGAGGACGGGGCTACACCTTCGGTTCG	CSAREGGRGYTF	In	VDJ	1	113	1.6751263015583122E-4	2.03135842150867E-4	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	0	9	1	8	0	4	26	-1	46	40	50		TCRBV20-01,TCRBV20-or09_02												CSAREGGRGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*02	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATGGACAGGCCCCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	113	1.6751263015583122E-4		40	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	1	4	3	1	3	26	36	44	37	47		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCACCCTCCCGGGGGGTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	113	1.6751263015583122E-4		43	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	11	8	1	0	9	0	24	31	-1	40	47		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD02-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGTCCCGGGACAGGGACAGGAAACACCATATATTTTGGAGAG	CASSPGTGTGNTIYF	In	VDJ	1	114	1.6899504281207752E-4	2.049335044707862E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	0	3	4	3	3	26	38	50	41	53	TCRBV09,TCRBV12													CASSPGTGTGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAAGGCGAAGTTCTGATACGCAGTATTTTGGCCCA	CASSLRRSSDTQYF	In	VDJ	1	114	1.6899504281207752E-4	2.049335044707862E-4	42	TCRBV12						TCRBJ02	TCRBJ02-03	01	2	5	4	6	0	9	26	-1	44	41	53		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLRRSSDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12		TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCAGGGGTGGGGGAACACTGAAGCTTTCTTTGGACAA	CSASQGWGNTEAFF	In	VDJ	1	114	1.6899504281207752E-4	2.049335044707862E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	2	1	1	5	26	37	44	38	49		TCRBV20-01,TCRBV20-or09_02												CSASQGWGNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTTTCGACAGTCAACACCGGGGAGCTGTTTTTTGGAGAA	CSVSTVNTGELFF	In	VDJ	1	114	1.6899504281207752E-4	2.049335044707862E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	2	5	2	4	2	26	33	42	37	44		TCRBV20-01,TCRBV20-or09_02												CSVSTVNTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAATTGGGAAGGGACCGGGGAGCTGTTTTTTGGAGAA	CASNWEGTGELFF	In	VDJ	1	114	1.6899504281207752E-4	2.049335044707862E-4	39	TCRBV24						TCRBJ02	TCRBJ02-02	01	11	0	8	5	6	4	24	31	41	37	45		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASNWEGTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24		TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCCCGAAGGGCAGAGACGCTCTGGAAACACCATATATTTTGGAGAG	CASSPEGQRRSGNTIYF	In	VDJ	1	114	1.6899504281207752E-4	2.049335044707862E-4	51	unresolved						TCRBJ01	TCRBJ01-03	01	4	5	3	0	5	8	19	31	40	36	48	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPEGQRRSGNTIYF+X+TCRBJ01-03	unresolved		TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGGGGACTCRGCYGTGTATCTCTGTGCCAGCAGCTTAGAAAGCACAGATACGCAGTATTTTGGCCCA	CASSLESTDTQYF	In	VJ	1	114	1.6899504281207752E-4	2.049335044707862E-4	39	unresolved						TCRBJ02	TCRBJ02-03	01	1	0	0	0	0	2	22	-1	38	-1	40	TCRBV07,TCRBV11													CASSLESTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCACCCGGACAGTCCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	115	1.704774554683238E-4		40	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	5	4	4	2	26	38	48	42	50		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGACAGGCTAGCGGGGAGATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	115	1.704774554683238E-4		35	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	9	4	3	8	5	2	26	31	45	36	47		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAACTCACCGGGACAGGGTCCCCGAAGCTTTCTTTGGACAA	CSARTHRDRVPEAFF	In	VDJ	1	115	1.704774554683238E-4	2.0673116679070536E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	3	8	7	5	26	38	54	45	59		TCRBV20-01,TCRBV20-or09_02												CSARTHRDRVPEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCRTGTATSKCTGTGCTAGCAGCTTGTCCGGACAGCCCACAGATACGCAGTATTTTGGCCCA	CASSLSGQPTDTQYF	In	VDJ	1	115	1.704774554683238E-4	2.0673116679070536E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	1	5	2	4	2	18	32	42	36	44	TCRBV07,TCRBV11													CASSLSGQPTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGTGGGGGACAGGGGAATTTCGAGCAGTACTTCGGGCCG	CASSGGQGNFEQYF	In	VDJ	1	116	1.719598681245701E-4	2.0852882911062454E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	2	6	2	5	26	38	50	40	55	TCRBV12,TCRBV21													CASSGGQGNFEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGACGACCAGGGGTTTGCAGATACGCAGTATTTTGGCCCA	CASSQDDQGFADTQYF	In	VDJ	1	116	1.719598681245701E-4	2.0852882911062454E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	4	2	4	4	4	26	43	53	47	57		TCRBV03-01,TCRBV03-02												CASSQDDQGFADTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACCCGGGCTCACAAAGGGCCTACAATGAGCAGTTCTTCGGGCCA	CASSHPGSQRAYNEQFF	In	VDJ	1	116	1.719598681245701E-4	2.0852882911062454E-4	51	TCRBV03						TCRBJ02	TCRBJ02-01	01	3	5	3	2	13	0	26	40	-1	53	57		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHPGSQRAYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGGCGGTAGGAAAGGTGGCTACACCTTCGGTTCG	CSAGGRKGGYTF	In	VDJ	1	116	1.719598681245701E-4	2.0852882911062454E-4	36	TCRBV20						TCRBJ01	TCRBJ01-02	01	6	8	0	7	0	11	26	-1	38	34	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAGGRKGGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAATGGTTTCCGGGACAGGAGCTCCTACGAGCAGTACTTCGGGCCG	CSANGFRDRSSYEQYF	In	VDJ	1	116	1.719598681245701E-4	2.0852882911062454E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	4	0	9	2	26	36	53	45	55		TCRBV20-01,TCRBV20-or09_02												CSANGFRDRSSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTGGGCGGGTACCCAAGAGACCCAGTACTTCGGGCCA	CASSWAGTQETQYF	In	VDJ	1	116	1.719598681245701E-4	2.0852882911062454E-4	42	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	7	4	1	3	3	24	36	44	39	47		TCRBV24-01,TCRBV24-or09_02				01,02								CASSWAGTQETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGTCGGACAGGGGGGAACGAGCAGTACTTCGGGCCG	CASRTGGNEQYF	In	VDJ	1	116	1.719598681245701E-4	2.0852882911062454E-4	36	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	11	1	1	5	3	2	24	31	44	34	46		TCRBV24-01,TCRBV24-or09_02												CASRTGGNEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATGGAGAGGGTCATCAGCCCCAGCATTTTGGTGAT	CASSQDGEGHQPQHF	In	VDJ	1	116	1.719598681245701E-4	2.0852882911062454E-4	45				TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	0	11	0	5	4	2	18	35	44	39	46	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQDGEGHQPQHF+X+TCRBJ01-05		TCRBD02-01*02	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCCGCCCCGTGGCAGTGGAGAAACCCAGTACTTCGGGCCA	CASSPPRGSGETQYF	In	VDJ	1	116	1.719598681245701E-4	2.0852882911062454E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	10	2	8	15	2	18	30	49	45	51	TCRBV07,TCRBV11													CASSPPRGSGETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCCCGATGGAGGGTTCCCATGAGCAGTTCTTCGGGCCA	CASSPMEGSHEQFF	In	VDJ	1	116	1.719598681245701E-4	2.0852882911062454E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	10	0	8	5	5	23	35	46	40	51	TCRBV09,TCRBV21													CASSPMEGSHEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCGGGACAGAGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CASSQAGQSSYNSPLHF	In	VDJ	1	117	1.734422807808164E-4	2.103264914305437E-4	51	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	1	0	5	0	1	2	26	42	50	43	52		TCRBV03-01,TCRBV03-02												CASSQAGQSSYNSPLHF+TCRBV03-X+TCRBJ01-06	TCRBV03	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATTCATCCACCTCGGCTACAATGAGCAGTTCTTCGGGCCA	CSARFIHLGYNEQFF	In	VDJ	1	117	1.734422807808164E-4	2.103264914305437E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	8	5	3	11	0	26	38	-1	49	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSARFIHLGYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGGGGTCGACGGGGAAACCCAGTACTTCGGGCCA	CSASGVDGETQYF	In	VDJ	1	117	1.734422807808164E-4	2.103264914305437E-4	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	8	3	8	0	11	26	-1	42	37	53		TCRBV20-01,TCRBV20-or09_02												CSASGVDGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGACATTAGAGTGGCGGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	117	1.734422807808164E-4		44	unresolved			unresolved			TCRBJ02	TCRBJ02-05	01	5	2	6	4	0	12	23	-1	39	35	51	TCRBV06,TCRBV10			TCRBD01,TCRBD02										X+X+TCRBJ02-05	unresolved	unresolved	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCAAAGGGGGACAGGGGACCACTGAAGCTTTCTTTGGACAA	CASSKGGQGTTEAFF	In	VDJ	1	117	1.734422807808164E-4	2.103264914305437E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	2	4	5	2	18	30	45	35	47	TCRBV07,TCRBV11													CASSKGGQGTTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATCGGTCGGGGGACTATGGCTACACCTTCGGTTCG	CASSQDRSGDYGYTF	In	VDJ	1	117	1.734422807808164E-4	2.103264914305437E-4	45				TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	0	8	2	3	5	0	18	35	-1	40	46	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQDRSGDYGYTF+X+TCRBJ01-02		TCRBD02-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAATAGAAGACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLIEDSGANVLTF	In	VDJ	1	117	1.734422807808164E-4	2.103264914305437E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	2	5	8	0	1	4	18	33	37	34	41	TCRBV07,TCRBV11					01,02								CASSLIEDSGANVLTF+X+TCRBJ02-06	unresolved	TCRBD02-01	TCRBJ02-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGGAGGACAGGGTGGGGGAAAAACTGTTTTTTGGCAGT	CASSLAEDRVGEKLFF	In	VDJ	1	117	1.734422807808164E-4	2.103264914305437E-4	48				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	1	3	8	3	5	18	35	46	38	51	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLAEDRVGEKLFF+X+TCRBJ01-04		TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGCGTACACCGTTAGACAGGGGGAGACACTGAAGCTTTCTTTGGACAA	CASSVHR*TGGDTEAFF	Stop	VDJ	1	117	1.734422807808164E-4		51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	1	3	11	2	24	36	56	47	58	TCRBV12,TCRBV21													CASSVHR*TGGDTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGTGCGGTAGGGGTTGGCTACACCTTCGGTTCG	CASSAVGVGYTF	In	VDJ	1	117	1.734422807808164E-4	2.103264914305437E-4	36	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	5	2	7	4	1	23	36	45	40	46	TCRBV02,TCRBV21													CASSAVGVGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGAACTCAACAGGGACTATGGCTACACCTTCGGTTCG	CASSELNRDYGYTF	In	VDJ	1	117	1.734422807808164E-4	2.103264914305437E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	3	3	8	0	23	34	-1	42	48	TCRBV02,TCRBV09													CASSELNRDYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGTAGGACTTTGAGACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	118	1.7492469343706268E-4		46	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	1	1	10	5	2	5	23	39	46	41	51	TCRBV01,TCRBV04					01,02								X+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCAGGGGACAGTTGAACACTGAAGCTTTCTTTGGACAA	CASSRGQLNTEAFF	In	VDJ	1	118	1.7492469343706268E-4	2.1212415375046289E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	0	5	0	3	1	24	35	45	38	46		TCRBV24-01,TCRBV24-or09_02												CASSRGQLNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCGTTCAGACAGGGGCGGATGAAAAACTGTTTTTTGGCAGT	CASSVQTGADEKLFF	In	VDJ	1	118	1.7492469343706268E-4	2.1212415375046289E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	2	2	6	5	3	18	30	43	35	46	TCRBV05,TCRBV11													CASSVQTGADEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAGAGGCAGGAGATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLEAGDSNQPQHF	In	VDJ	1	118	1.7492469343706268E-4	2.1212415375046289E-4	48	unresolved						TCRBJ01	TCRBJ01-05	01	0	4	4	0	2	3	18	35	41	37	44	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLEAGDSNQPQHF+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGTTTAAAGGCAGGGAACTATGGCTACACCTTCGGTTCG	CASSLKAGNYGYTF	In	VDJ	1	118	1.7492469343706268E-4	2.1212415375046289E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	4	3	2	8	0	24	35	-1	43	48	TCRBV12,TCRBV21													CASSLKAGNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGTAGAGGGTCGGAACACTGAAGCTTTCTTTGGACAA	CASSVEGRNTEAFF	In	VDJ	1	118	1.7492469343706268E-4	2.1212415375046289E-4	42	unresolved			unresolved			TCRBJ01	TCRBJ01-01	01	4	11	0	1	2	3	23	36	43	38	46	TCRBV02,TCRBV09			TCRBD01,TCRBD02										CASSVEGRNTEAFF+X+TCRBJ01-01	unresolved	unresolved	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCGACGAAGGGGGATTAGGTGAAAAACTGTTTTTTGGCAGT	CASDEGGLGEKLFF	In	VDJ	1	119	1.7640710609330898E-4	2.139218160703821E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	8	5	1	7	5	6	26	35	46	40	52		TCRBV03-01,TCRBV03-02												CASDEGGLGEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCTGGGAAGGGTGATGGCTACACCTTCGGTTCG	CSARDPGKGDGYTF	In	VDJ	1	119	1.7640710609330898E-4	2.139218160703821E-4	42	TCRBV20						TCRBJ01	TCRBJ01-02	01	0	0	8	6	4	6	26	40	48	44	54		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDPGKGDGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTTCTAGCGGGGGAGACCAATGAGCAGTTCTTCGGGCCA	CSARDLLAGETNEQFF	In	VDJ	1	119	1.7640710609330898E-4	2.139218160703821E-4	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	4	2	6	4	4	26	40	54	44	58		TCRBV20-01,TCRBV20-or09_02												CSARDLLAGETNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCGACTAGCGGGGGGTACAATGAGCAGTTCTTCGGGCCA	CSAPTSGGYNEQFF	In	VDJ	1	119	1.7640710609330898E-4	2.139218160703821E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	2	1	4	2	0	26	35	-1	37	50		TCRBV20-01,TCRBV20-or09_02												CSAPTSGGYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATGGCTTTAACTATGGCTACACCTTCGGTTCG	CASSQDGFNYGYTF	In	VDJ	1	119	1.7640710609330898E-4	2.139218160703821E-4	42				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	9	0	1	1	2	18	35	39	36	41	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQDGFNYGYTF+X+TCRBJ01-02		TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGACAGGACAAACTACAATGAGCAGTTCTTCGGGCCA	CASSQDRTNYNEQFF	In	VDJ	1	120	1.7788951874955528E-4	2.1571947839030126E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	1	6	3	2	2	23	40	47	42	49	TCRBV01,TCRBV04													CASSQDRTNYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGGACGGCTGTCTTGTCTGAGCAGTTCTTCGGGCCA	CSARRTAVLSEQFF	In	VDJ	1	120	1.7788951874955528E-4	2.1571947839030126E-4	42	TCRBV20						TCRBJ02	TCRBJ02-01	01	2	1	7	9	1	12	26	38	43	39	55		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARRTAVLSEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATTGTCAGGGGGACTTAATTCACCCCTCCACTTTGGGAAC	CASSLLSGGLNSPLHF	In	VDJ	1	120	1.7788951874955528E-4	2.1571947839030126E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	4	1	6	7	3	24	36	50	43	53		TCRBV24-01,TCRBV24-or09_02												CASSLLSGGLNSPLHF+TCRBV24-X+TCRBJ01-06	TCRBV24	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGTCCCGACAGGGTGGGATTCACAGATACGCAGTATTTTGGCCCA	CASSPDRVGFTDTQYF	In	VDJ	1	120	1.7788951874955528E-4	2.1571947839030126E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	2	3	2	4	7	24	35	46	39	53	TCRBV12,TCRBV21													CASSPDRVGFTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTCCCCGACGCAGGGTATCCTACAATGAGCAGTTCTTCGGGCCA	CASSPRRRVSYNEQFF	In	VDJ	1	120	1.7788951874955528E-4	2.1571947839030126E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	4	3	1	8	2	23	35	48	43	50	TCRBV02,TCRBV09													CASSPRRRVSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCGGAATCAGCCCCAGCATTTTGGTGAT	CASSQDRNQPQHF	In	VDJ	1	121	1.7937193140580158E-4	2.1751714071022044E-4	39	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	0	8	5	4	1	0	26	43	-1	44	47		TCRBV03-01,TCRBV03-02				01,02								CASSQDRNQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD02-01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACGACGGGACTAGCGGAAACAATGAGCAGTTCTTCGGGCCA	CSARDDGTSGNNEQFF	In	VDJ	1	121	1.7937193140580158E-4	2.1751714071022044E-4	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	0	5	5	4	2	26	40	55	44	57		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDDGTSGNNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTTGGCTGTAGCGGGGGTTGTGGGGAATGAGCAGTTCTTCGGGCCA	CASSLAVAGVVGNEQFF	In	VDJ	1	121	1.7937193140580158E-4	2.1751714071022044E-4	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	5	2	7	5	8	18	32	46	37	54	TCRBV07,TCRBV11													CASSLAVAGVVGNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAAGGGAGGCCTATAATTCACCCCTCCACTTTGGGAAC	CASSVREAYNSPLHF	In	VDJ	1	121	1.7937193140580158E-4	2.1751714071022044E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	1	9	1	2	1	0	23	38	-1	39	45	TCRBV09,TCRBV21													CASSVREAYNSPLHF+X+TCRBJ01-06	unresolved	TCRBD02-01*02	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAACCTGCTTTTGGGGTCGGGGGAGAGACCCAGTACTTCGGGCCA	CASSQPAFGVGGETQYF	In	VDJ	1	122	1.8085434406204785E-4	2.193148030301396E-4	51	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	8	2	4	14	0	26	41	-1	55	61		TCRBV03-01,TCRBV03-02												CASSQPAFGVGGETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCGGTACCGGGACATTGTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	122	1.8085434406204785E-4		47	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	6	4	7	3	26	39	52	46	55		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGCGGTACATCATTTCTTTCTCTGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	122	1.8085434406204785E-4		49	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	7	5	5	0	18	26	-1	42	38	60		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAGGGGGCCGGACCACCGGCCCTGAAGCTTTCTTTGGACAA	CSAGGRTTGPEAFF	In	VDJ	1	122	1.8085434406204785E-4	2.193148030301396E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	5	0	6	0	13	26	-1	41	34	54		TCRBV20-01,TCRBV20-or09_02												CSAGGRTTGPEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACGTTGAACACTGAAGCTTTCTTTGGACAA	CSATLNTEAFF	In	VDJ	1	122	1.8085434406204785E-4	2.193148030301396E-4	33	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	8	6	0	0	1	26	-1	38	36	39		TCRBV20-01,TCRBV20-or09_02				01,02								CSATLNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTACCCGGACTGAACACTGAAGCTTTCTTTGGACAA	CATSDLPGLNTEAFF	In	VDJ	1	122	1.8085434406204785E-4	2.193148030301396E-4	45	TCRBV24						TCRBJ01	TCRBJ01-01	01	1	1	7	0	4	0	24	41	-1	45	49		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDLPGLNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGATGGGACTCTGGAAACACCATATATTTTGGAGAG	CASRWDSGNTIYF	In	VDJ	1	122	1.8085434406204785E-4	2.193148030301396E-4	39	unresolved						TCRBJ01	TCRBJ01-03	01	6	0	8	0	2	0	23	34	-1	36	40	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRWDSGNTIYF+X+TCRBJ01-03	unresolved		TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGGGGGGGTTGAACACTGAAGCTTTCTTTGGACAA	CASSLGGLNTEAFF	In	VDJ	1	123	1.8233675671829416E-4	2.211124653500588E-4	42	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	9	0	0	0	1	26	-1	47	40	48		TCRBV12-03,TCRBV12-04												CASSLGGLNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGGGGGAGGAACACTGAAGCTTTCTTTGGACAA	CSAGGRNTEAFF	In	VDJ	1	123	1.8233675671829416E-4	2.211124653500588E-4	36	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	9	1	1	0	2	26	-1	41	35	43		TCRBV20-01,TCRBV20-or09_02												CSAGGRNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATTTTCCTCACTAGGGGACAGGGGGAATACGCAGTATTTTGGCCCA	CASSLFSSLGDRGNTQYF	In	VDJ	1	123	1.8233675671829416E-4	2.211124653500588E-4	54	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	0	1	7	16	1	24	36	63	52	64		TCRBV24-01,TCRBV24-or09_02												CASSLFSSLGDRGNTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATTACGGGGGAGCCGGGGAGCTGTTTTTTGGAGAA	CASSQDYGGAGELFF	In	VDJ	1	123	1.8233675671829416E-4	2.211124653500588E-4	45				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	8	2	6	3	2	18	35	44	38	46	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQDYGGAGELFF+X+TCRBJ02-02		TCRBD02-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCAGGAACACGCAGGGTTTAACTATGGCTACACCTTCGGTTCG	XASSQEHAGFNYGYTF	In	VDJ	1	123	1.8233675671829416E-4	2.211124653500588E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	3	1	8	2	22	36	49	44	51	TCRBV04,TCRBV07,TCRBV17													XASSQEHAGFNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACCGCCGGGATGAAAAACTGTTTTTTGGCAGT	CSARDRRDEKLFF	In	VDJ	1	124	1.8381916937454046E-4	2.2291012766997796E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	0	8	4	6	4	0	26	40	-1	44	48		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDRRDEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD02-01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGTTTCGGGGGGCATGAACACTGAAGCTTTCTTTGGACAA	CSARDVSGGMNTEAFF	In	VDJ	1	124	1.8381916937454046E-4	2.2291012766997796E-4	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	0	8	1	0	5	2	26	40	52	45	54		TCRBV20-01,TCRBV20-or09_02												CSARDVSGGMNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCCGCACAAGGGCGCGAGGAGCATTTTGGTGAT	CASSSAQGREEHF	In	VDJ	1	124	1.8381916937454046E-4	2.2291012766997796E-4	39	TCRBV24						TCRBJ01	TCRBJ01-05	01	6	5	3	14	8	7	24	36	48	44	55		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSAQGREEHF+TCRBV24-X+TCRBJ01-05	TCRBV24		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGCGGTGCGACAGGGACCTAATGAAAAACTGTTTTTTGGCAGT	CASSLAVRQGPNEKLFF	In	VDJ	1	125	1.8530158203078673E-4	2.2470778998989714E-4	51	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	2	3	3	5	2	26	43	55	48	57		TCRBV12-03,TCRBV12-04												CASSLAVRQGPNEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTTCCCTTAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSFSLSSYNEQFF	In	VDJ	1	125	1.8530158203078673E-4	2.2470778998989714E-4	45	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	5	8	0	6	0	26	40	-1	46	49		TCRBV12-03,TCRBV12-04				01,02								CASSFSLSSYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ACGTTTGGTGCATCCTGAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTAGACAGGGGGAACAATGAGCAGTTCTTCGGGCCA	CSARDLDRGNNEQFF	In	VDJ	1	125	1.8530158203078673E-4	2.2470778998989714E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	2	1	5	4	1	36	50	63	54	64		TCRBV20-01,TCRBV20-or09_02												CSARDLDRGNNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCGAGCGGGGGGGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	125	1.8530158203078673E-4		52	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	6	0	0	3	0	26	43	-1	46	56		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAAGAGGTCGGGCTCGCTTTCTTTGGACAA	CSAKEVGLAFF	In	VDJ	1	125	1.8530158203078673E-4	2.2470778998989714E-4	33	TCRBV20						TCRBJ01	TCRBJ01-01	01	0	8	0	11	4	2	26	40	48	44	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAKEVGLAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAGCGCCTAGCGGGGGGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	126	1.8678399468703303E-4		52	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	4	1	1	4	0	26	43	-1	47	58		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCAAGGCTGGGGACGGACTGAAGCTTTCTTTGGACAA	XASSQGWGRTEAFF	In	VDJ	1	126	1.8678399468703303E-4	2.265054523098163E-4	42	unresolved						TCRBJ01	TCRBJ01-01	01	1	0	7	5	4	2	22	38	47	42	49	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									XASSQGWGRTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATAAATGGGGGCCCCAGCATTTTGGTGAT	CASSQDKWGPQHF	In	VDJ	1	127	1.8826640734327934E-4	2.2830311462973549E-4	39	TCRBV03						TCRBJ01	TCRBJ01-05	01	0	6	2	9	5	0	26	43	-1	48	52		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDKWGPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGGGGACAGAGCGAAAAACTGTTTTTTGGCAGT	CASRGQSEKLFF	In	VDJ	1	127	1.8826640734327934E-4	2.2830311462973549E-4	36	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	0	5	8	0	3	26	-1	44	37	47		TCRBV03-01,TCRBV03-02												CASRGQSEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGAGGGAGTTGGAAACACCATATATTTTGGAGAG	CASSQEGVGNTIYF	In	VDJ	1	127	1.8826640734327934E-4	2.2830311462973549E-4	42				TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	0	9	2	3	0	1	18	-1	40	35	41	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQEGVGNTIYF+X+TCRBJ01-03		TCRBD02-01*02	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGTAGCGGGGTATTACAAGAGACCCAGTACTTCGGGCCA	CASSSGVLQETQYF	In	VDJ	1	127	1.8826640734327934E-4	2.2830311462973549E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	5	3	2	0	5	18	-1	37	29	42	TCRBV07,TCRBV11													CASSSGVLQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTATTAGGGACAGGGGCCTACGAGCAGTACTTCGGGCCG	CASSLLGTGAYEQYF	In	VDJ	1	128	1.8974881999952564E-4	2.3010077694965466E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	0	2	2	3	0	26	41	-1	44	54		TCRBV12-03,TCRBV12-04												CASSLLGTGAYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
MAGAAGACTCAGCYSYGTATCTCTGCACCAGCAGCCAAGCGGGACTAGGGCAGACCCAGTACTTCGGGCCA	CTSSQAGLGQTQYF	In	VDJ	1	128	1.8974881999952564E-4	2.3010077694965466E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	0	8	6	1	3	23	39	48	40	51	TCRBV01,TCRBV04					01,02								CTSSQAGLGQTQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGAGGATCCAGGGGGACCCACGAGCAGTACTTCGGGCCG	CSARGGSRGTHEQYF	In	VDJ	1	128	1.8974881999952564E-4	2.3010077694965466E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	4	1	5	7	4	26	39	53	46	57		TCRBV20-01,TCRBV20-or09_02												CSARGGSRGTHEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTCCAATTGGAGAGCATAGAGACTCAGTACTTCGGGCCA	CSVQLESIETQYF	In	VDJ	1	128	1.8974881999952564E-4	2.3010077694965466E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	7	2	10	11	19	0	26	33	-1	52	56		TCRBV20-01,TCRBV20-or09_02				01,02								CSVQLESIETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAAGAGGCAGCAAATAGCGGGGGGGAGGTTAGAGACCCAGTACTTCGGGCCA	CASKRQQIAGGRLETQYF	In	VDJ	1	128	1.8974881999952564E-4	2.3010077694965466E-4	54	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	7	5	0	4	12	5	23	33	56	45	61	TCRBV06,TCRBV10													CASKRQQIAGGRLETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATGAGGCGGTGGGGGAGCAGTACTTCGGGCCG	CASSQDEAVGEQYF	In	VDJ	1	128	1.8974881999952564E-4	2.3010077694965466E-4	42							TCRBJ02	TCRBJ02-07	01	0	6	2	7	9	0	18	35	-1	44	48	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDEAVGEQYF+X+TCRBJ02-07			TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTAAATCCGGCGGGTCAGAAAGAGACCCAGTACTTCGGGCCA	CASSLNPAGQKETQYF	In	VDJ	1	128	1.8974881999952564E-4	2.3010077694965466E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	7	4	3	6	5	18	33	44	39	49	TCRBV05,TCRBV11					01,02								CASSLNPAGQKETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCTCATCGACTAGCGGGGGCCAAGAGACCCAGTACTTCGGGCCA	CASSSSTSGGQETQYF	In	VDJ	1	128	1.8974881999952564E-4	2.3010077694965466E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	2	2	1	5	0	24	36	-1	41	53	TCRBV09,TCRBV21													CASSSSTSGGQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCACTTATTTTGAACACTGAAGCTTTCTTTGGACAA	CSAPLILNTEAFF	In	VDJ	1	129	1.912312326557719E-4	2.3189843926957383E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	3	10	0	3	5	26	34	40	37	45		TCRBV20-01,TCRBV20-or09_02				01,02								CSAPLILNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCGCCCAGGATATAATTCACCCCTCCACTTTGGGAAC	CSARPGYNSPLHF	In	VDJ	1	129	1.912312326557719E-4	2.3189843926957383E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	4	4	4	4	1	26	35	43	39	44		TCRBV20-01,TCRBV20-or09_02												CSARPGYNSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATTTGGGGGGGCTAGCACAGATACGCAGTATTTTGGCCCA	CSARFGGASTDTQYF	In	VDJ	1	130	1.9271364531201821E-4	2.3369610158949304E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	9	0	0	3	2	26	38	48	41	50		TCRBV20-01,TCRBV20-or09_02												CSARFGGASTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAAACTGGGTTCAGCCCCAGCATTTTGGTGAT	CASSENWVQPQHF	In	VDJ	1	130	1.9271364531201821E-4	2.3369610158949304E-4	39	TCRBV06						TCRBJ01	TCRBJ01-05	01	2	0	9	6	4	1	23	38	45	42	46		TCRBV06-01,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSENWVQPQHF+TCRBV06-X+TCRBJ01-05	TCRBV06		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCGGAGAATGGGGGGGATTAAAGAGGGAGCTGTTTTTTGGAGAA	CASGEWGGLKRELFF	In	VDJ	1	130	1.9271364531201821E-4	2.3369610158949304E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	8	9	0	9	7	8	23	32	46	39	54	TCRBV06,TCRBV10													CASGEWGGLKRELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCAAAGGAGGGGACAGGGTATTGGTTGATGAAAAACTGTTTTTTGGCAGT	CASSKGGDRVLVDEKLFF	In	VDJ	1	130	1.9271364531201821E-4	2.3369610158949304E-4	54	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	0	3	6	7	9	18	30	46	37	55	TCRBV07,TCRBV11													CASSKGGDRVLVDEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCGGACTAGATTCCTACAATGAGCAGTTCTTCGGGCCA	CASSGLDSYNEQFF	In	VDJ	1	130	1.9271364531201821E-4	2.3369610158949304E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	1	8	1	0	2	18	-1	37	30	39	TCRBV07,TCRBV11					01,02								CASSGLDSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGTGAATTGGGCAGGGCCGGAGATACGCAGTATTTTGGCCCA	CASSELGRAGDTQYF	In	VDJ	1	130	1.9271364531201821E-4	2.3369610158949304E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	4	3	5	9	4	23	34	48	43	52	TCRBV09,TCRBV21													CASSELGRAGDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCTGGGACTAGCGGGGGGGTGAGGGAGACCCAGTACTTCGGGCCA	CASSSGTSGGVRETQYF	In	VDJ	1	131	1.9419605796826452E-4	2.354937639094122E-4	51	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	0	0	5	2	5	26	39	57	41	62		TCRBV12-03,TCRBV12-04												CASSSGTSGGVRETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACGGCTCTACAGGCTGGCTCTCTGGAAACACCATATATTTTGGAGAG	CASSHGSTGWLSGNTIYF	In	VDJ	1	131	1.9419605796826452E-4	2.354937639094122E-4	54	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	3	4	0	7	6	26	40	52	47	58		TCRBV03-01,TCRBV03-02												CASSHGSTGWLSGNTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGAAGGGGGAGGCCTTTATAGCAATCAGCCCCAGCATTTTGGTGAT	CSAEGGGLYSNQPQHF	In	VDJ	1	131	1.9419605796826452E-4	2.354937639094122E-4	48	TCRBV20						TCRBJ01	TCRBJ01-05	01	6	5	1	0	3	9	26	34	43	37	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAEGGGLYSNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCAGGGAGTTGGTACGAGCAGTACTTCGGGCCG	CASSPGSWYEQYF	In	VDJ	1	131	1.9419605796826452E-4	2.354937639094122E-4	39	TCRBV24						TCRBJ02	TCRBJ02-07	01	6	4	3	4	1	6	24	36	42	37	48		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGSWYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTGTCTGGACAGGATCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSVWTGSGANVLTF	In	VDJ	1	131	1.9419605796826452E-4	2.354937639094122E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	1	4	1	3	1	24	37	47	40	48	TCRBV24,TCRBV27													CASSVWTGSGANVLTF+X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGCGCCGGACAGTTTGGCTACCAAGAGACCCAGTACTTCGGGCCA	CASSAGQFGYQETQYF	In	VDJ	1	131	1.9419605796826452E-4	2.354937639094122E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	1	5	0	2	7	23	36	44	38	51	TCRBV02,TCRBV09													CASSAGQFGYQETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGAACCAGCTCTGGAAACACCATATATTTTGGAGAG	CASRTSSGNTIYF	In	VDJ	1	132	1.9567847062451082E-4	2.3729142622933139E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	4	5	0	3	0	26	37	-1	40	43		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRTSSGNTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGACCCCGGACTAGCGGGGGGGAGGGGACCCAGTACTTCGGGCCA	CASRPRTSGGEGTQYF	In	VDJ	1	132	1.9567847062451082E-4	2.3729142622933139E-4	48	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	1	0	7	5	4	26	37	57	42	61		TCRBV03-01,TCRBV03-02												CASRPRTSGGEGTQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCCGAGACAGGGGACGACACTGAAGCTTTCTTTGGACAA	CASSSETGDDTEAFF	In	VDJ	1	133	1.971608832807571E-4	2.3908908854925056E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	2	3	4	3	26	39	51	43	54		TCRBV12-03,TCRBV12-04												CASSSETGDDTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTACTGGGTAACACTGAAGCTTTCTTTGGACAA	CASSLLGNTEAFF	In	VDJ	1	133	1.971608832807571E-4	2.3908908854925056E-4	39	TCRBV12						TCRBJ01	TCRBJ01-01	01	2	0	9	2	2	1	26	41	46	43	47		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLLGNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGGGTTTCGAATACAGGGGGCTGGCGAGCAGTACTTCGGGCCG	CASSQGFRIQGAGEQYF	In	VDJ	1	133	1.971608832807571E-4	2.3908908854925056E-4	51	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	3	0	6	12	3	26	40	61	52	64		TCRBV03-01,TCRBV03-02												CASSQGFRIQGAGEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTGGCGGGGCCGAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	133	1.971608832807571E-4		41	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	7	3	3	2	3	26	39	47	41	50		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCGGGGGCGAAACAATGAGCAGTTCTTCGGGCCA	CSASRGRNNEQFF	In	VDJ	1	133	1.971608832807571E-4	2.3908908854925056E-4	39	TCRBV20						TCRBJ02	TCRBJ02-01	01	3	6	0	5	2	3	26	37	45	39	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASRGRNNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCGGACAGGGAGTCCCGATACGCAGTATTTTGGCCCA	CSASRTGSPDTQYF	In	VDJ	1	133	1.971608832807571E-4	2.3908908854925056E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	1	3	6	2	6	26	37	47	39	53		TCRBV20-01,TCRBV20-or09_02												CSASRTGSPDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCGAAGGAGGGACAGGGTCCAACGGGGAGCTGTTTTTTGGAGAA	CASSEGGTGSNGELFF	In	VDJ	1	133	1.971608832807571E-4	2.3908908854925056E-4	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	0	3	7	7	5	22	33	49	40	54		TCRBV12-03,TCRBV12-04												CASSEGGTGSNGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCCGGACAGGGTGATACTGAAGCTTTCTTTGGACAA	CASSPGQGDTEAFF	In	VDJ	1	133	1.971608832807571E-4	2.3908908854925056E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	3	5	3	4	24	36	47	39	51		TCRBV24-01,TCRBV24-or09_02												CASSPGQGDTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAATCGGCGGCAGGGCACTATGGCTACACCTTCGGTTCG	CASSESAAGHYGYTF	In	VDJ	1	133	1.971608832807571E-4	2.3908908854925056E-4	45	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	3	3	7	1	23	38	50	45	51		TCRBV06-01,TCRBV06-08												CASSESAAGHYGYTF+TCRBV06-X+TCRBJ01-02	TCRBV06	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATTTTTCAGGTAGTGGCTCACCCCTCCACTTTGGGAAC	CASSQDFSGSGSPLHF	In	VDJ	1	133	1.971608832807571E-4	2.3908908854925056E-4	48				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	4	4	10	5	7	18	35	44	40	51	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQDFSGSGSPLHF+X+TCRBJ01-06		TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCATCCGCCGGCAGGGAAAACACTGAAGCTTTCTTTGGACAA	CASAGRENTEAFF	In	VDJ	1	134	1.986432959370034E-4	2.4088675086916974E-4	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	12	4	3	2	9	2	26	31	45	40	47		TCRBV03-01,TCRBV03-02												CASAGRENTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTCAAGCCTAGGCCCAGATACGCAGTATTTTGGCCCA	CASSSSLGPDTQYF	In	VDJ	1	134	1.986432959370034E-4	2.4088675086916974E-4	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	4	8	4	6	3	26	38	48	44	51		TCRBV03-01,TCRBV03-02				01,02								CASSSSLGPDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACGGACGACACTGAAGCTTTCTTTGGACAA	CSATDDTEAFF	In	VDJ	1	134	1.986432959370034E-4	2.4088675086916974E-4	33	TCRBV20						TCRBJ01	TCRBJ01-01	01	4	1	7	3	1	1	26	36	41	37	42		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSATDDTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCTCGGACAGGGAGGCACTGAAGCTTTCTTTGGACAA	CSALGQGGTEAFF	In	VDJ	1	134	1.986432959370034E-4	2.4088675086916974E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	3	4	3	3	26	35	46	38	49		TCRBV20-01,TCRBV20-or09_02												CSALGQGGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCCCCGTCCCCCCGGCGTAGGGTAAGTCAACCCCAGCATTTTGGTGAT		Out	VDJ	1	134	1.986432959370034E-4		46	TCRBV24						TCRBJ01	TCRBJ01-05	01	12	5	3	10	16	8	24	30	50	46	58		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ01-05	TCRBV24		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCCGAGGAGGCAGGACAGTGAACACCGGGGAGCTGTTTTTTGGAGAA	CASRGGRTVNTGELFF	In	VDJ	1	134	1.986432959370034E-4	2.4088675086916974E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	8	1	5	1	10	1	18	27	43	37	44	TCRBV05,TCRBV11													CASRGGRTVNTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAAGGGTCGGGGTTCTGCTGGCTACACCTTCGGTTCG		Out	VDJ	1	135	2.001257085932497E-4		44	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	2	8	3	7	5	6	26	41	51	46	57		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD02-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCGGCCAGGGACCTCACGGGCTTTCTTTGGACAA	CASSQDRPGTSRAFF	In	VDJ	1	135	2.001257085932497E-4	2.426844131890889E-4	45	TCRBV03						TCRBJ01	TCRBJ01-01	01	0	0	7	11	7	7	26	43	55	50	62		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDRPGTSRAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCACCACGGGGGGGGCAGATACGCAGTATTTTGGCCCA	CASSPTTGGADTQYF	In	VDJ	1	136	2.0160812124949597E-4	2.444820755090081E-4	45	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	8	0	4	6	1	26	39	53	45	54		TCRBV03-01,TCRBV03-02												CASSPTTGGADTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCACGGGGAAGAGACCCAGTACTTCGGGCCA	CSASHGEETQYF	In	VDJ	1	136	2.0160812124949597E-4	2.444820755090081E-4	36	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	8	3	3	3	0	26	37	-1	40	45		TCRBV20-01,TCRBV20-or09_02												CSASHGEETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGACCTAGCGGGGACATACAATGAGCAGTTCTTCGGGCCA	CAISDLAGTYNEQFF	In	VDJ	1	136	2.0160812124949597E-4	2.444820755090081E-4	45				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	4	3	4	3	3	23	35	47	38	50	TCRBV06,TCRBV10	TCRBV06-08,TCRBV10-03												CAISDLAGTYNEQFF+X+TCRBJ02-01		TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGGGGTGGTTATAGGGACACCACCGGGGAGCTGTTTTTTGGAGAA	CARGGYRDTTGELFF	In	VDJ	1	136	2.0160812124949597E-4	2.444820755090081E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	10	0	6	4	12	1	24	31	49	43	50	TCRBV09,TCRBV21													CARGGYRDTTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAAGCGGGGGAGTCCAAGAGACCCAGTACTTCGGGCCA	CASSQESGGVQETQYF	In	VDJ	1	137	2.0309053390574227E-4	2.4627973782892726E-4	48	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	6	2	1	1	3	26	43	52	44	55		TCRBV03-01,TCRBV03-02												CASSQESGGVQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGACGGGAGGCGGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASRREAATNEKLFF	In	VDJ	1	137	2.0309053390574227E-4	2.4627973782892726E-4	45	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	7	8	1	0	1	3	24	35	43	36	46		TCRBV24-01,TCRBV24-or09_02												CASRREAATNEKLFF+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD02-01*02	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTACAACCGACTTAGCTCTGGAAACACCATATATTTTGGAGAG	CASSYNRLSSGNTIYF	In	VDJ	1	137	2.0309053390574227E-4	2.4627973782892726E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	4	2	10	0	6	3	18	31	41	37	44	TCRBV05,TCRBV11					01,02								CASSYNRLSSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD02-01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCCTTCACAGGGGCCAGGGGAAAAACTGTTTTTTGGCAGT	CASSPSQGPGEKLFF	In	VDJ	1	138	2.0457294656198857E-4	2.4807740014884643E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	3	2	8	6	6	26	37	50	43	56		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSPSQGPGEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCGGCAGACGAACACTGAAGCTTTCTTTGGACAA	CSASRQTNTEAFF	In	VDJ	1	138	2.0457294656198857E-4	2.4807740014884643E-4	39	TCRBV20						TCRBJ01	TCRBJ01-01	01	3	2	7	1	6	0	26	37	-1	43	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASRQTNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCGACACCGAACACTGAAGCTTTCTTTGGACAA	CSAPTPNTEAFF	In	VDJ	1	138	2.0457294656198857E-4	2.4807740014884643E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	6	1	2	2	26	35	41	37	43		TCRBV20-01,TCRBV20-or09_02												CSAPTPNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGTGCCAGGTTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	138	2.0457294656198857E-4		43	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	4	4	1	3	1	23	39	46	42	47	TCRBV01,TCRBV04													X+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGGRGACWYGGCWSTGTATCTCTGYGCCAGCACCCCGGACAGGAACACTGAAGCTTTCTTTGGACAA	CASTPDRNTEAFF	In	VDJ	1	138	2.0457294656198857E-4	2.4807740014884643E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	1	5	1	4	0	20	30	-1	34	40	TCRBV07,TCRBV23													CASTPDRNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCTAGGGCAGGGGAGGGACACCATATATTTTGGAGAG		Out	VDJ	1	138	2.0457294656198857E-4		41	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	4	9	0	8	8	0	23	35	-1	43	50	TCRBV09,TCRBV21													X+X+TCRBJ01-03	unresolved	TCRBD02-01*02	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAATACGGGAACTATAATTCACCCCTCCACTTTGGGAAC	CASSQEYGNYNSPLHF	In	VDJ	1	139	2.0605535921823487E-4	2.498750624687656E-4	48	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	0	8	3	3	3	1	26	43	51	46	52		TCRBV03-01,TCRBV03-02												CASSQEYGNYNSPLHF+TCRBV03-X+TCRBJ01-06	TCRBV03	TCRBD02-01*02	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGGGGGGTCGATAATTCACCCCTCCACTTTGGGAAC	CASRGVDNSPLHF	In	VDJ	1	139	2.0605535921823487E-4	2.498750624687656E-4	39	TCRBV03						TCRBJ01	TCRBJ01-06	01	6	6	1	5	0	3	26	-1	42	37	45		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRGVDNSPLHF+TCRBV03-X+TCRBJ01-06	TCRBV03		TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAAGGACAGGGGGAGAAAATTCACCCCTCCACTTTGGGAAC	CASSQRTGGENSPLHF	In	VDJ	1	139	2.0605535921823487E-4	2.498750624687656E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	2	1	1	7	1	4	23	38	49	39	53	TCRBV01,TCRBV04													CASSQRTGGENSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCCCGGGCCCCAAGCTGGCTACACCTTCGGTTCG	CASSPGPQAGYTF	In	VDJ	1	139	2.0605535921823487E-4	2.498750624687656E-4	39	TCRBV24						TCRBJ01	TCRBJ01-02	01	7	8	0	7	4	7	24	35	43	39	50		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGPQAGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGGGATCCCCAGGGAAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASRDPQGSSYNEQFF	In	VDJ	1	139	2.0605535921823487E-4	2.498750624687656E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	4	3	0	7	3	23	34	46	41	49	TCRBV02,TCRBV09													CASRDPQGSSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCATTGTGGGGGGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	140	2.0753777187448115E-4		41	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	9	1	3	4	0	26	40	-1	44	50		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAGGGGGCTAGCAGAATACAATGAGCAGTTCTTCGGGCCA	CSARGLAEYNEQFF	In	VDJ	1	140	2.0753777187448115E-4	2.516727247886848E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	4	0	4	0	8	26	-1	42	34	50		TCRBV20-01,TCRBV20-or09_02												CSARGLAEYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCGAGGTTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CSARDRGSGANVLTF	In	VDJ	1	140	2.0753777187448115E-4	2.516727247886848E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	0	11	1	1	2	1	26	40	46	42	47		TCRBV20-01,TCRBV20-or09_02												CSARDRGSGANVLTF+TCRBV20-X+TCRBJ02-06	TCRBV20	TCRBD02-01*02	TCRBJ02-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGAACCTAACACTGAAGCTTTCTTTGGACAA	CSASEPNTEAFF	In	VDJ	1	140	2.0753777187448115E-4	2.516727247886848E-4	36	TCRBV20						TCRBJ01	TCRBJ01-01	01	3	2	8	2	1	4	26	37	40	38	44		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASEPNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTTGCGGGCCCTCGCGGGGAGTATACAATGAGCAGTTCTTCGGGCCA	CSCGPSRGVYNEQFF	In	VDJ	1	140	2.0753777187448115E-4	2.516727247886848E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	8	7	3	4	11	4	26	32	49	43	53		TCRBV20-01,TCRBV20-or09_02												CSCGPSRGVYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGGACAGGGGGACGAAGCTCCTACGAGCAGTACTTCGGGCCG	CARTGGRSSYEQYF	In	VDJ	1	140	2.0753777187448115E-4	2.516727247886848E-4	42				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	9	2	1	0	0	6	18	-1	35	26	41	TCRBV11,TCRBV12	TCRBV11-03,TCRBV12-02												CARTGGRSSYEQYF+X+TCRBJ02-07		TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCACACCCCCTGACGGGGGGGGACTACGAGCAGTACTTCGGGCCG	CASSSHPLTGGDYEQYF	In	VDJ	1	141	2.0902018453072745E-4	2.5347038710860396E-4	51	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	8	0	3	12	2	26	39	59	51	61		TCRBV12-03,TCRBV12-04												CASSSHPLTGGDYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATTCCCGGGACTTTCTCACGATACGCAGTATTTTGGCCCA		Out	VDJ	1	141	2.0902018453072745E-4		50	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	0	10	6	5	7	26	43	54	48	61		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGATGGACTAGCGTCATGATGAATGAGCAGTTCTTCGGGCCA	CSARGWTSVMMNEQFF	In	VDJ	1	141	2.0902018453072745E-4	2.5347038710860396E-4	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	1	6	7	3	8	26	39	51	42	59		TCRBV20-01,TCRBV20-or09_02				01,02								CSARGWTSVMMNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATCAAATGGGGGGGGCCCACAATGAGCAGTTCTTCGGGCCA	CASSQDQMGGAHNEQFF	In	VDJ	1	141	2.0902018453072745E-4	2.5347038710860396E-4	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	9	0	5	6	4	23	40	53	46	57	TCRBV01,TCRBV04													CASSQDQMGGAHNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCTTCGGGCTCGAACGGGATGAAAAACTGTTTTTTGGCAGT	CASSFGLERDEKLFF	In	VDJ	1	141	2.0902018453072745E-4	2.5347038710860396E-4	45	unresolved						TCRBJ01	TCRBJ01-04	01	5	8	0	6	3	9	24	36	43	39	52	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFGLERDEKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGAATGGATATCCTCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSEWISSNTGELFF	In	VDJ	1	141	2.0902018453072745E-4	2.5347038710860396E-4	48	unresolved						TCRBJ02	TCRBJ02-02	01	5	1	8	0	5	6	23	34	42	39	48	TCRBV02,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEWISSNTGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ACGTTTGGTGCATCCTGAAGACAGCAGCTTTACATCTGCAGTGCTAGAGATCTAGACAGGGGGAACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	142	2.1050259718697375E-4		44	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	21	2	1	5	24	1	37	30	63	54	64		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAACAACGTCTAGCGGATACACAGATACGCAGTATTTTGGCCCA	CASSQTTSSGYTDTQYF	In	VDJ	1	142	2.1050259718697375E-4	2.5526804942852313E-4	51	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	4	5	2	7	3	26	41	55	48	58		TCRBV03-01,TCRBV03-02				01,02								CASSQTTSSGYTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGAGACAGGGAACACTGAAGCTTTCTTTGGACAA	CSAETGNTEAFF	In	VDJ	1	142	2.1050259718697375E-4	2.5526804942852313E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	4	1	3	0	26	34	-1	37	43		TCRBV20-01,TCRBV20-or09_02												CSAETGNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCCTTGGACAGGGTACAGGAGAGACCCAGTACTTCGGGCCA	CASSLGQGTGETQYF	In	VDJ	1	142	2.1050259718697375E-4	2.5526804942852313E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	1	3	4	3	6	23	35	46	38	52	TCRBV09,TCRBV21													CASSLGQGTGETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGCCCCTTCAGGGGGCTACACCTTCGGTTCG	CASSLAPSGGYTF	In	VDJ	1	143	2.1198500984322003E-4	2.570657117484423E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	3	8	5	0	26	43	-1	48	53		TCRBV12-03,TCRBV12-04												CASSLAPSGGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCTATGACAACGGGACTGGCTGAAGCTTTCTTTGGACAA	CASSPMTTGLAEAFF	In	VDJ	1	143	2.1198500984322003E-4	2.570657117484423E-4	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	0	10	6	10	2	26	39	55	49	57		TCRBV03-01,TCRBV03-02				01,02								CASSPMTTGLAEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCAAGAATCAATGATGGCGGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSQESMMAATNEKLFF	In	VDJ	1	143	2.1198500984322003E-4	2.570657117484423E-4	54	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	0	7	5	0	10	0	18	35	-1	45	49	TCRBV04,TCRBV07,TCRBV11					01,02								CASSQESMMAATNEKLFF+X+TCRBJ01-04	unresolved	TCRBD02-01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCGGGACTAGCGCGGGAGACCCAGTACTTCGGGCCA	CASSSGLARETQYF	In	VDJ	1	144	2.1346742249946633E-4	2.588633740683615E-4	42	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	0	6	5	1	3	26	39	50	40	53		TCRBV12-03,TCRBV12-04				01,02								CASSSGLARETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGTTTATCGGGGACAGGCGATGAGCAGTTCTTCGGGCCA	CASSLSGTGDEQFF	In	VDJ	1	144	2.1346742249946633E-4	2.588633740683615E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	4	8	6	2	24	36	50	42	52	TCRBV06,TCRBV24,TCRBV27													CASSLSGTGDEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTCGGGACGAACTGAAGCTTTCTTTGGACAA	CSARDSGRTEAFF	In	VDJ	1	145	2.1494983515571263E-4	2.6066103638828066E-4	39	TCRBV20						TCRBJ01	TCRBJ01-01	01	0	0	7	5	3	2	26	40	48	43	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDSGRTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAACAGGGGTACCAAGAGACCCAGTACTTCGGGCCA	CASSQQGYQETQYF	In	VDJ	1	145	2.1494983515571263E-4	2.6066103638828066E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	4	2	0	0	1	23	-1	44	38	45	TCRBV01,TCRBV04													CASSQQGYQETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGGCCTGGGGGCGTTGCCTACGAGCAGTACTTCGGGCCG	CASRPGGVAYEQYF	In	VDJ	1	145	2.1494983515571263E-4	2.6066103638828066E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	6	0	2	4	4	24	35	45	39	49	TCRBV02,TCRBV21													CASRPGGVAYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCAACCCCACCGGGACAGCGACTGGAAACACCATATATTTTGGAGAG	CASSNPTGTATGNTIYF	In	VDJ	1	146	2.1643224781195893E-4	2.6245869870819983E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	0	5	2	9	3	23	35	51	44	54	TCRBV01,TCRBV04													CASSNPTGTATGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTTACAGGCGAACACTGAAGCTTTCTTTGGACAA	CSASLQANTEAFF	In	VDJ	1	146	2.1643224781195893E-4	2.6245869870819983E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	4	1	3	1	26	37	45	40	46		TCRBV20-01,TCRBV20-or09_02												CSASLQANTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCGACTCGAAGGGTTGAGCACAGATACGCAGTATTTTGGCCCA	CSARLEGLSTDTQYF	In	VDJ	1	146	2.1643224781195893E-4	2.6245869870819983E-4	45	TCRBV20						TCRBJ02	TCRBJ02-03	01	5	5	3	0	8	3	26	35	47	43	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARLEGLSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGGTCTAGAGCTCCATGGCTACACCTTCGGTTCG	CASSVGLELHGYTF	In	VDJ	1	146	2.1643224781195893E-4	2.6245869870819983E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	0	4	8	6	2	6	23	39	45	41	51	TCRBV09,TCRBV21					01,02								CASSVGLELHGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACGGGACAGGAGACGAAAAACTGTTTTTTGGCAGT	CASSHGTGDEKLFF	In	VDJ	1	148	2.193970731244515E-4	2.6605402334803824E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	0	4	8	1	4	26	40	49	41	53		TCRBV03-01,TCRBV03-02												CASSHGTGDEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTCGGACTAGCGGGGGGGAGGAGTGCCTATGAGCAGTTCTTCGGGCCA	CASSLGLAGGRSAYEQFF	In	VDJ	1	148	2.193970731244515E-4	2.6605402334803824E-4	54	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	1	0	8	2	10	26	39	56	41	66		TCRBV03-01,TCRBV03-02												CASSLGLAGGRSAYEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGTTTATCGGTCGGACAGGCTAAGCAGTTCTTCGGGCCA	CASSLSVGQAKQFF	In	VDJ	1	148	2.193970731244515E-4	2.6605402334803824E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	1	4	11	8	3	23	36	51	44	54	TCRBV06,TCRBV24,TCRBV27													CASSLSVGQAKQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCTTCGGGTCTGGGCACTGAAGCTTTCTTTGGACAA	CASSPSGLGTEAFF	In	VDJ	1	149	2.208794857806978E-4	2.678516856679574E-4	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	8	4	4	3	6	26	39	46	42	52		TCRBV03-01,TCRBV03-02				01,02								CASSPSGLGTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGGGCACACTACCCGAACACCGGGGAGCTGTTTTTTGGAGAA	CRAHYPNTGELFF	In	VDJ	1	149	2.208794857806978E-4	2.678516856679574E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	9	3	9	0	5	2	26	31	40	36	42		TCRBV20-01,TCRBV20-or09_02				01,02								CRAHYPNTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGTGGGGCGCCCACTGAAGCTTTCTTTGGACAA	CSARGGAPTEAFF	In	VDJ	1	149	2.208794857806978E-4	2.678516856679574E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	7	0	4	4	3	26	37	46	41	49		TCRBV20-01,TCRBV20-or09_02												CSARGGAPTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTCGGGGACAGGGTGGAGACCCAGTACTTCGGGCCA	CATSDFGDRVETQYF	In	VDJ	1	149	2.208794857806978E-4	2.678516856679574E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	0	3	5	2	2	24	41	52	43	54		TCRBV24-01,TCRBV24-or09_02												CATSDFGDRVETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCCCAGGGACAGACAACTAATGAAAAACTGTTTTTTGGCAGT	CASSSQGQTTNEKLFF	In	VDJ	1	149	2.208794857806978E-4	2.678516856679574E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	0	5	0	5	1	24	36	48	41	49		TCRBV24-01,TCRBV24-or09_02												CASSSQGQTTNEKLFF+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTAGCGGGGGGGCCAGATACGCAGTATTTTGGCCCA	CASSLAGGPDTQYF	In	VDJ	1	149	2.208794857806978E-4	2.678516856679574E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	9	0	4	0	1	18	-1	42	35	43	TCRBV07,TCRBV11													CASSLAGGPDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGTAGACTGGATGGATAACACAGATACGCAGTATTTTGGCCCA	CSAVDWMDNTDTQYF	In	VDJ	1	150	2.2236189843694408E-4	2.696493479878766E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	2	10	2	4	10	26	34	42	38	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSAVDWMDNTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGGTACAAGGCCAGGGGTCGCAGATACGCAGTATTTTGGCCCA	CSGTRPGVADTQYF	In	VDJ	1	150	2.2236189843694408E-4	2.696493479878766E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	4	2	4	9	3	26	33	48	42	51		TCRBV20-01,TCRBV20-or09_02												CSGTRPGVADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCTGGACTACCAATCCCCCCGGGGAGCTGTTTTTTGGAGAA	CASSWTTNPPGELFF	In	VDJ	1	150	2.2236189843694408E-4	2.696493479878766E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	1	9	6	1	9	24	36	43	37	52	TCRBV09,TCRBV21					01,02								CASSWTTNPPGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTACGCCACAGCAACACTGAAGCTTTCTTTGGACAA	CASSLRHSNTEAFF	In	VDJ	1	151	2.2384431109319039E-4	2.7144701030779576E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	5	2	4	1	26	41	49	45	50		TCRBV12-03,TCRBV12-04												CASSLRHSNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGAGGGGGGCTACTCACCCCTCCACTTTGGGAAC	CASSLEGGYSPLHF	In	VDJ	1	151	2.2384431109319039E-4	2.7144701030779576E-4	42	TCRBV12						TCRBJ01	TCRBJ01-06	01	1	5	1	10	0	5	26	-1	48	42	53		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLEGGYSPLHF+TCRBV12-X+TCRBJ01-06	TCRBV12		TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATTATCCGAATAATTCACCCCTCCACTTTGGGAAC	CASSQDYPNNSPLHF	In	VDJ	1	151	2.2384431109319039E-4	2.7144701030779576E-4	45	TCRBV03						TCRBJ01	TCRBJ01-06	01	0	2	8	5	6	0	26	43	-1	49	51		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDYPNNSPLHF+TCRBV03-X+TCRBJ01-06	TCRBV03		TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCAAGGTAGCGGCACAGATACGCAGTATTTTGGCCCA	CSARDQGSGTDTQYF	In	VDJ	1	151	2.2384431109319039E-4	2.7144701030779576E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	5	6	1	6	0	26	40	-1	46	51		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDQGSGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTACAGGACAGGATCCACGAGCAGTACTTCGGGCCG		Out	VDJ	1	151	2.2384431109319039E-4		41	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	4	5	4	4	24	36	47	40	51		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAACTAGCGGGGGGGCAAGATACGCAGTATTTTGGCCCA	CASSELAGGQDTQYF	In	VDJ	1	151	2.2384431109319039E-4	2.7144701030779576E-4	45	TCRBV06			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	4	0	5	0	2	23	-1	50	38	52		TCRBV06-01,TCRBV06-08												CASSELAGGQDTQYF+TCRBV06-X+TCRBJ02-03	TCRBV06	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGAGGCGGACTCTGGAAACACCATATATTTTGGAGAG	CASSVEADSGNTIYF	In	VDJ	1	151	2.2384431109319039E-4	2.7144701030779576E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	5	7	5	0	6	1	24	36	46	42	47	TCRBV09,TCRBV21					01,02								CASSVEADSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD02-01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGGGACCCGACAGGGTGCAGATACGCAGTATTTTGGCCCA	CSAGTRQGADTQYF	In	VDJ	1	152	2.253267237494367E-4	2.7324467262771493E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	2	3	4	8	2	26	34	49	42	51		TCRBV20-01,TCRBV20-or09_02												CSAGTRQGADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCCGTATTGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSRIATNEKLFF	In	VDJ	1	152	2.253267237494367E-4	2.7324467262771493E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	4	5	9	0	2	3	19	31	35	33	38	TCRBV07,TCRBV11					01,02								CASSRIATNEKLFF+X+TCRBJ01-04	unresolved	TCRBD02-01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGTGGCAGTTAATCTGTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLVAVNLYSNQPQHF	In	VDJ	1	153	2.26809136405683E-4	2.750423349476341E-4	54	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	4	5	0	3	10	26	42	48	45	58		TCRBV12-03,TCRBV12-04												CASSLVAVNLYSNQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ACGTTTGGTGCATCCTGAAGACAGCAGTTCTACATCTGCAGTGCTAGAGATCTAGACAGGGGGAACAATGAGCAGTTCTTCGGGCCA	CSARDLDRGNNEQFF	In	VDJ	1	153	2.26809136405683E-4	2.750423349476341E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	2	1	5	4	1	36	50	63	54	64		TCRBV20-01,TCRBV20-or09_02												CSARDLDRGNNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGTAAAGGGGGCAGATACGCAGTATTTTGGCCCA	CSARDVKGADTQYF	In	VDJ	1	154	2.2829154906192926E-4	2.768399972675533E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	5	1	4	5	0	26	40	-1	45	51		TCRBV20-01,TCRBV20-or09_02												CSARDVKGADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTGTCGGGGGGAGGACTGAAGCTTTCTTTGGACAA	CASSVGGRTEAFF	In	VDJ	1	155	2.2977396171817557E-4	2.7863765958747246E-4	39	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	8	1	5	2	3	22	34	43	36	46		TCRBV12-03,TCRBV12-04												CASSVGGRTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATTCAGGGTACACCGGGGAGCTGTTTTTTGGAGAA	CASSQDSGYTGELFF	In	VDJ	1	155	2.2977396171817557E-4	2.7863765958747246E-4	45				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	4	3	3	2	1	18	35	42	37	43	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQDSGYTGELFF+X+TCRBJ02-02		TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGTGCGGGTCCAAACCCTCCTTCGGGCCG		Out	VDJ	1	156	2.3125637437442187E-4		37	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	7	4	15	1	11	23	39	45	40	56	TCRBV01,TCRBV04					01,02								X+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTAGGCGGCGGGGGCCGTGAAGCTTTCTTTGGACAA	CASSLGGGGREAFF	In	VDJ	1	157	2.3273878703066814E-4	2.822329842273108E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	1	7	2	7	3	3	18	34	44	37	47	TCRBV07,TCRBV11													CASSLGGGGREAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTCGGTAGCGGGGGGAACTACGAGCAGTACTTCGGGCCG	CASSQVGSGGNYEQYF	In	VDJ	1	158	2.3422119968691444E-4	2.8403064654723E-4	48	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	1	5	1	3	4	2	26	42	56	46	58		TCRBV03-01,TCRBV03-02												CASSQVGSGGNYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCTAGCCTAGCGGGAGCGAGAGAGACCCAGTACTTCGGGCCA	CASSPSLAGARETQYF	In	VDJ	1	158	2.3422119968691444E-4	2.8403064654723E-4	48	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	4	2	4	5	4	26	39	54	44	58		TCRBV03-01,TCRBV03-02												CASSPSLAGARETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*02	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGAGGGGAGCTATGGCTACACCTTCGGTTCG	CSAREGSYGYTF	In	VDJ	1	158	2.3422119968691444E-4	2.8403064654723E-4	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	3	10	0	4	0	3	26	-1	43	37	46		TCRBV20-01,TCRBV20-or09_02												CSAREGSYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*02	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGACCTCCGGGGACAGCTAGATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	158	2.3422119968691444E-4		47	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	9	0	5	0	7	5	23	31	45	38	50	TCRBV06,TCRBV10													X+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCTCACCCGGGACAGAGCATGAAAAACTGTTTTTTGGCAGT	CSASPGTEHEKLFF	In	VDJ	1	159	2.3570361234316075E-4	2.8582830886714916E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	0	5	6	7	3	26	34	48	41	51		TCRBV20-01,TCRBV20-or09_02												CSASPGTEHEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGGGGGCGGGGCCAATGAGCAGTTCTTCGGGCCA	CASSQGGGANEQFF	In	VDJ	1	159	2.3570361234316075E-4	2.8582830886714916E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	7	3	6	3	1	23	39	48	42	49	TCRBV01,TCRBV04													CASSQGGGANEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTAGAGGGCTTGGGTGAGCAGTTCTTCGGGCCA	CASSLEGLGEQFF	In	VDJ	1	159	2.3570361234316075E-4	2.8582830886714916E-4	39							TCRBJ02	TCRBJ02-01	01	1	5	3	9	0	6	18	-1	38	34	44	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLEGLGEQFF+X+TCRBJ02-01			TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGCGGGGCGCGCTGAAGCTTTCTTTGGACAA	CASSLAGRAEAFF	In	VDJ	1	160	2.3718602499940705E-4	2.8762597118706833E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	7	0	6	0	3	26	-1	48	43	51		TCRBV12-03,TCRBV12-04												CASSLAGRAEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGGAAGGGCAGCCGTCAGGGGCTACACCTTCGGTTCG	CASSLGRAAVRGYTF	In	VDJ	1	160	2.3718602499940705E-4	2.8762597118706833E-4	45	TCRBV12						TCRBJ01	TCRBJ01-02	01	1	4	4	8	13	0	26	42	-1	55	59		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGRAAVRGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATTGGGCAGCGTATGAAAAACTGTTTTTTGGCAGT	CASSQDWAAYEKLFF	In	VDJ	1	160	2.3718602499940705E-4	2.8762597118706833E-4	45	unresolved						TCRBJ01	TCRBJ01-04	01	0	8	0	6	2	5	23	40	46	42	51	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDWAAYEKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGGTCGATGAAGCTTTCTTTGGACAA	CASSQGVDEAFF	In	VDJ	1	162	2.4015085031189962E-4	2.912212958269067E-4	36	TCRBV03						TCRBJ01	TCRBJ01-01	01	1	0	9	7	0	4	26	-1	45	42	49		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGVDEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAGGGACAGGGGTTACGAGCAGTACTTCGGGCCG	CSARDRDRGYEQYF	In	VDJ	1	162	2.4015085031189962E-4	2.912212958269067E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	2	4	2	1	26	40	52	42	53		TCRBV20-01,TCRBV20-or09_02												CSARDRDRGYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATCGGGTCGCGGTGGCTACACCTTCGGTTCG	CSARSGRGGYTF	In	VDJ	1	162	2.4015085031189962E-4	2.912212958269067E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	2	7	5	7	7	0	26	38	-1	45	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSARSGRGGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAACCAGGACAGGGGGGAACTGAAGCTTTCTTTGGACAA	CASSEPGQGGTEAFF	In	VDJ	1	162	2.4015085031189962E-4	2.912212958269067E-4	45	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	1	1	5	3	2	23	38	51	41	53		TCRBV06-01,TCRBV06-08												CASSEPGQGGTEAFF+TCRBV06-X+TCRBJ01-01	TCRBV06	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGCCGCCTCGCGCAAGCTAATGAAAAACTGTTTTTTGGCAGT	CASSRLAQANEKLFF	In	VDJ	1	163	2.4163326296814592E-4	2.9301895814682586E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	6	7	6	3	7	4	23	34	44	41	48	TCRBV02,TCRBV21					01,02								CASSRLAQANEKLFF+X+TCRBJ01-04	unresolved	TCRBD02-01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGTGCCGAGGCAGGGAATGAGCCCCAGCATTTTGGTGAT	CASSAEAGNEPQHF	In	VDJ	1	163	2.4163326296814592E-4	2.9301895814682586E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	4	3	8	6	4	23	36	47	42	51	TCRBV02,TCRBV21													CASSAEAGNEPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCACCGGGACAGGGACCAGATACGCAGTATTTTGGCCCA	CASSPPGQGPDTQYF	In	VDJ	1	164	2.431156756243922E-4	2.9481662046674503E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	0	3	4	4	2	26	39	52	43	54		TCRBV03-01,TCRBV03-02												CASSPPGQGPDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGTGGGACAGGAAGACAGATACGCAGTATTTTGGCCCA	CSAREWDRKTDTQYF	In	VDJ	1	164	2.431156756243922E-4	2.9481662046674503E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	0	4	3	2	3	26	40	50	42	53		TCRBV20-01,TCRBV20-or09_02												CSAREWDRKTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTTTCGGGGGAGCAAGAGACCCAGTACTTCGGGCCA	CSARVSGEQETQYF	In	VDJ	1	164	2.431156756243922E-4	2.9481662046674503E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	8	2	2	3	2	26	39	48	42	50		TCRBV20-01,TCRBV20-or09_02												CSARVSGEQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTTCTCTGGGGTCCCGGGAGGCTTTCTTTGGACAA	CASSFSLGSREAFF	In	VDJ	1	165	2.445980882806385E-4	2.966142827866642E-4	42	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	8	2	11	13	0	26	40	-1	53	59		TCRBV12-03,TCRBV12-04												CASSFSLGSREAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01*02	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGGACAGGGGGCGCTTTACGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	166	2.460805009368848E-4		46	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	2	0	3	0	8	24	-1	45	35	53		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTTGAAGGATGGACAGAATTCACCCCTCCACTTTGGGAAC	CSARDLKDGQNSPLHF	In	VDJ	1	167	2.475629135931311E-4	3.0020960742650255E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	1	5	7	10	0	26	40	-1	50	56		TCRBV20-01,TCRBV20-or09_02												CSARDLKDGQNSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGGACAGGGACACTGAAGCTTTCTTTGGACAA	CSARGDRDTEAFF	In	VDJ	1	167	2.475629135931311E-4	3.0020960742650255E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	0	3	3	0	0	26	-1	-1	39	48		TCRBV20-01,TCRBV20-or09_02												CSARGDRDTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGAGACAGGGGGGGATGGCTACACCTTCGGTTCG	CSAETGGDGYTF	In	VDJ	1	168	2.490453262493774E-4	3.0200726974642173E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	1	6	3	2	26	34	46	37	48		TCRBV20-01,TCRBV20-or09_02												CSAETGGDGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTTACGCAGGGCGGGAATCAGCCCCAGCATTTTGGTGAT	CSARVTQGGNQPQHF	In	VDJ	1	168	2.490453262493774E-4	3.0200726974642173E-4	45	TCRBV20						TCRBJ01	TCRBJ01-05	01	1	4	3	4	5	4	26	39	49	44	53		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARVTQGGNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGAAAAGCCCCTTGGGCTAGATACGCAGTATTTTGGCCCA	CSAEKPLGLDTQYF	In	VDJ	1	168	2.490453262493774E-4	3.0200726974642173E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	8	0	5	12	1	26	35	51	47	52		TCRBV20-01,TCRBV20-or09_02												CSAEKPLGLDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTACCCGGACAGGGCCTCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	168	2.490453262493774E-4		44	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	1	3	6	4	3	24	36	48	40	51		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTCACGTGGGACTAGAATACTACGAGCAGTACTTCGGGCCG	CASSHVGLEYYEQYF	In	VDJ	1	169	2.5052773890562365E-4	3.038049320663409E-4	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	0	8	3	6	4	26	37	51	43	55		TCRBV03-01,TCRBV03-02				01,02								CASSHVGLEYYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTAAAAGGGGGGTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLKGGYSNQPQHF	In	VDJ	1	169	2.5052773890562365E-4	3.038049320663409E-4	48	unresolved						TCRBJ01	TCRBJ01-05	01	6	5	1	0	5	3	24	36	47	41	50	TCRBV24,TCRBV27			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLKGGYSNQPQHF+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTAACGACGGGGAAAAACTGTTTTTTGGCAGT	CASSNDGEKLFF	In	VDJ	1	170	2.5201015156187E-4	3.0560259438626013E-4	36	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	5	8	4	8	5	0	26	38	-1	43	47		TCRBV12-03,TCRBV12-04				01,02								CASSNDGEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD02-01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGTTTCAGAGATAACACCGGGGAGCTGTTTTTTGGAGAA	CASFRDNTGELFF	In	VDJ	1	170	2.5201015156187E-4	3.0560259438626013E-4	39	unresolved						TCRBJ02	TCRBJ02-02	01	10	4	5	2	4	4	24	31	38	35	42	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASFRDNTGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACCCTACAGGGAGCCCGGACTATGGCTACACCTTCGGTTCG	CASSHPTGSPDYGYTF	In	VDJ	1	171	2.5349256421811626E-4	3.074002567061793E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	3	3	3	4	7	26	40	50	44	57		TCRBV03-01,TCRBV03-02												CASSHPTGSPDYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAACGGGACTAGCGGGCTACAATGAGCAGTTCTTCGGGCCA	CSARTGLAGYNEQFF	In	VDJ	1	171	2.5349256421811626E-4	3.074002567061793E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	0	4	3	2	0	26	38	-1	40	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSARTGLAGYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAACCAAGTAGGGGGGGCCAGGGAGCTGTTTTTTGGAGAA	CASNQVGGARELFF	In	VDJ	1	172	2.549749768743626E-4	3.091979190260985E-4	42	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	1	9	0	9	2	3	26	42	51	44	54		TCRBV03-01,TCRBV03-02												CASNQVGGARELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGCCAAAACCGGGGGACATCGAACACTGAAGCTTTCTTTGGACAA	CASSQNRGTSNTEAFF	In	VDJ	1	173	2.5645738953060886E-4	3.1099558134601766E-4	48	unresolved						TCRBJ01	TCRBJ01-01	01	6	0	6	1	10	2	26	37	53	47	55	TCRBV12,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQNRGTSNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCTTAGCTTACAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPLAYNTGELFF	In	VDJ	1	173	2.5645738953060886E-4	3.1099558134601766E-4	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	5	7	2	3	4	26	39	46	42	50		TCRBV03-01,TCRBV03-02				01,02								CASSPLAYNTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGGCGCGGGGAGGAAAAACTGTTTTTTGGCAGT	CASSRRGEEKLFF	In	VDJ	1	173	2.5645738953060886E-4	3.1099558134601766E-4	39	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	4	7	3	8	3	2	26	39	48	42	50		TCRBV03-01,TCRBV03-02												CASSRRGEEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD02-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGGGACGGGTTGAACACCGGGGAGCTGTTTTTTGGAGAA	CSARRDGLNTGELFF	In	VDJ	1	173	2.5645738953060886E-4	3.1099558134601766E-4	45	TCRBV20						TCRBJ02	TCRBJ02-02	01	2	0	7	1	1	5	26	38	44	39	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARRDGLNTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20		TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAACCCCCTTCCGGGACTATTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	173	2.5645738953060886E-4		49	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	0	9	1	10	1	18	28	45	38	46	TCRBV05,TCRBV11					01,02								X+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTGGGGGCTTACTCTGGAAACACCATATATTTTGGAGAG	CASSLGAYSGNTIYF	In	VDJ	1	173	2.5645738953060886E-4	3.1099558134601766E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	6	0	0	0	3	18	-1	38	32	41	TCRBV05,TCRBV11													CASSLGAYSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGACAGGTTCTACGAGCAGTACTTCGGGCCG	CASSQDRFYEQYF	In	VDJ	1	174	2.5793980218685513E-4	3.1279324366593683E-4	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	4	3	0	2	26	-1	47	43	49		TCRBV03-01,TCRBV03-02												CASSQDRFYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGTCGGGGCCTCCTACGAGCAGTACTTCGGGCCG	CSASVGASYEQYF	In	VDJ	1	174	2.5793980218685513E-4	3.1279324366593683E-4	39	TCRBV20						TCRBJ02	TCRBJ02-07	01	3	7	0	0	4	0	26	37	-1	41	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASVGASYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGAGGACAGGGATCAGCAATCAGCCCCAGCATTTTGGTGAT	CSARTGISNQPQHF	In	VDJ	1	175	2.5942221484310146E-4	3.14590905985856E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	1	3	1	2	3	26	34	44	36	47		TCRBV20-01,TCRBV20-or09_02												CSARTGISNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATACGGCAGGGGGCATCTACGAGCAGTACTTCGGGCCG	CASSQDTAGGIYEQYF	In	VDJ	1	175	2.5942221484310146E-4	3.14590905985856E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	0	3	5	2	23	40	53	45	55	TCRBV01,TCRBV04													CASSQDTAGGIYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCRTGTATSKCTGTGCTAGCAGCTTAGGTCAGGACAGCTCCTACGAGCAGTACTTCGGGCCG	CASSLGQDSSYEQYF	In	VDJ	1	176	2.6090462749934774E-4	3.163885683057752E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	1	5	0	4	0	18	34	-1	38	44	TCRBV07,TCRBV11													CASSLGQDSSYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGAGAGGGGGGCCCTTAATGAAAAACTGTTTTTTGGCAGT	CSASERGALNEKLFF	In	VDJ	1	177	2.62387040155594E-4	3.1818623062569436E-4	45	TCRBV20						TCRBJ01	TCRBJ01-04	01	3	5	1	4	4	5	26	37	47	41	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASERGALNEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20		TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAGCCCCCCACCGGGGGCGGCCCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	178	2.6386945281184034E-4		52	unresolved						TCRBJ01	TCRBJ01-03	01	6	6	0	0	9	4	22	33	48	42	52	TCRBV12,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-03	unresolved		TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCGAGGGACAGGAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	178	2.6386945281184034E-4		44				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	0	4	1	2	0	18	30	-1	32	40	TCRBV05,TCRBV11	TCRBV05-03,TCRBV11-03												X+X+TCRBJ01-04		TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGCACTTTGAAGCTTTCTTTGGACAA	CASSQGHFEAFF	In	VDJ	1	179	2.653518654680866E-4	3.217815552655327E-4	36	TCRBV03						TCRBJ01	TCRBJ01-01	01	1	9	0	7	0	4	26	-1	45	42	49		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGHFEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGACAGGGTCCGCCTATGAAAAACTGTTTTTTGGCAGT	CSARTGSAYEKLFF	In	VDJ	1	179	2.653518654680866E-4	3.217815552655327E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	2	3	6	0	7	26	-1	44	37	51		TCRBV20-01,TCRBV20-or09_02												CSARTGSAYEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCTTTTGAAGCTGAACCGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	179	2.653518654680866E-4		50	unresolved						TCRBJ01	TCRBJ01-02	01	5	2	7	4	19	0	23	35	-1	54	57	TCRBV04,TCRBV07			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCSRGGGACTCAGCTGTGTATYTYTGTGCCAGCAGCTCCGGACAGGGGGCAAGTCGAGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	179	2.653518654680866E-4		50	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	1	0	3	2	8	22	35	48	37	56	TCRBV07,TCRBV12													X+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTCTCGGCACAGTAACTAAACACCATATATTTTGGAGAG		Out	VDJ	1	180	2.668342781243329E-4		37	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	8	3	5	6	6	5	26	32	42	38	47		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCAAGATCCGGGGGGTTTGTACATTCAGTACTTCGGCGCC	CSAQDPGGLYIQYF	In	VDJ	1	180	2.668342781243329E-4	3.235792175854519E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	6	8	1	8	8	5	26	34	49	42	54		TCRBV20-01,TCRBV20-or09_02												CSAQDPGGLYIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD02-01*01	TCRBJ02-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGGTCGGGACAGGGCTCGGGCACTGAAGCTTTCTTTGGACAA	CSARRSGQGSGTEAFF	In	VDJ	1	180	2.668342781243329E-4	3.235792175854519E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	3	4	5	6	26	38	52	43	58		TCRBV20-01,TCRBV20-or09_02												CSARRSGQGSGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGGCGGTACTCTGGAAACACCATATATTTTGGAGAG	CSARGRYSGNTIYF	In	VDJ	1	180	2.668342781243329E-4	3.235792175854519E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	7	0	0	0	4	26	-1	42	37	46		TCRBV20-01,TCRBV20-or09_02												CSARGRYSGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCGATCCCTGGGGGGAGTAAGCTCCGAAGCTTTCTTTGGACAA	CSASRSLGGVSSEAFF	In	VDJ	1	180	2.668342781243329E-4	3.235792175854519E-4	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	9	1	8	9	10	26	37	52	46	62		TCRBV20-01,TCRBV20-or09_02												CSASRSLGGVSSEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTATAAGTTGGAAACACCATATATTTTGGAGAG	CASSL*VGNTIYF	Stop	VDJ	1	180	2.668342781243329E-4		39	unresolved						TCRBJ01	TCRBJ01-03	01	6	5	5	3	5	1	24	36	43	41	44	TCRBV24,TCRBV27			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSL*VGNTIYF+X+TCRBJ01-03	unresolved		TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCCCGGGGATTCACCCCTCCACTTTGGGAAC	CASSQDPGDSPLHF	In	VDJ	1	182	2.697991034368255E-4	3.2717454222529023E-4	42	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	0	8	3	8	3	0	26	43	-1	46	51		TCRBV03-01,TCRBV03-02												CASSQDPGDSPLHF+TCRBV03-X+TCRBJ01-06	TCRBV03	TCRBD02-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGGCAGGGTCCTCTGGAAACACCATATATTTTGGAGAG	CASSQGAGSSGNTIYF	In	VDJ	1	182	2.697991034368255E-4	3.2717454222529023E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	4	3	0	3	2	26	42	50	45	52		TCRBV03-01,TCRBV03-02												CASSQGAGSSGNTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTGAGGCAGGGTCAAATTCACCCCTCCACTTTGGGAAC	CASSFEAGSNSPLHF	In	VDJ	1	183	2.712815160930718E-4	3.289722045452094E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	4	3	7	5	3	26	40	50	45	53		TCRBV12-03,TCRBV12-04												CASSFEAGSNSPLHF+TCRBV12-X+TCRBJ01-06	TCRBV12	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGCAGGGACGGAGTACGAGCAGTACTTCGGGCCG	CASSQAGTEYEQYF	In	VDJ	1	184	2.727639287493181E-4	3.307698668651286E-4	42	unresolved						TCRBJ02	TCRBJ02-07	01	1	0	7	4	2	4	23	39	46	41	50	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQAGTEYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCCCCAGGGGATGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	184	2.727639287493181E-4		46	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	4	2	1	4	2	24	36	46	40	48		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCCTTAGCGGGGGGTCTTCAGGATACGCAGTATTTTGGCCCA	CASSPLAGGLQDTQYF	In	VDJ	1	184	2.727639287493181E-4	3.307698668651286E-4	48	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	5	1	6	4	7	24	36	50	40	57		TCRBV24-01,TCRBV24-or09_02												CASSPLAGGLQDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCACATTTGGGACAGGGGCCGAAAAACTGTTTTTTGGCAGT	CASTFGTGAEKLFF	In	VDJ	1	185	2.7424634140556437E-4	3.3256752918504775E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	7	0	2	8	5	2	26	36	51	41	53		TCRBV03-01,TCRBV03-02												CASTFGTGAEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGTCTCCTGGGACAGGGGGACGGGGAGCTGTTTTTTGGAGAA	CASLLGQGDGELFF	In	VDJ	1	185	2.7424634140556437E-4	3.3256752918504775E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	9	0	1	7	6	1	23	31	48	37	49	TCRBV02,TCRBV09													CASLLGQGDGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGCATTGAGGACAGATCCTATCAGCCCCAGCATTTTGGTGAT	CASSIEDRSYQPQHF	In	VDJ	1	186	2.757287540618107E-4	3.3436519150496693E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	1	5	5	6	5	23	34	46	40	51	TCRBV02,TCRBV12													CASSIEDRSYQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAAAGGGGGCGGCCTACAATGAGCAGTTCTTCGGGCCA	CASSQKGAAYNEQFF	In	VDJ	1	187	2.77211166718057E-4	3.361628538248861E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	5	0	2	1	2	26	41	49	42	51		TCRBV03-01,TCRBV03-02												CASSQKGAAYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGCCTTTAGGACAAAGGCTACACCTTCGGTTCG		Out	VDJ	1	187	2.77211166718057E-4		41	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	1	6	8	6	2	23	39	50	45	52	TCRBV01,TCRBV04													X+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCGAACGACAGCACAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	187	2.77211166718057E-4		46				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	2	5	0	4	2	18	30	39	34	41	TCRBV05,TCRBV11	TCRBV05-03,TCRBV11-03												X+X+TCRBJ01-04		TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGAAGATGGGGACAGGGAAGCCTCCAAGAGACCCAGTACTTCGGGCCA	CASSRRWGQGSLQETQYF	In	VDJ	1	188	2.7869357937430325E-4	3.379605161448053E-4	54	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	0	3	1	7	6	26	39	55	46	61		TCRBV03-01,TCRBV03-02												CASSRRWGQGSLQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAGTGGACTAGCGGGACTACTAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	189	2.801759920305496E-4		55	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	4	1	3	0	2	5	24	38	52	40	57		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-04	TCRBV24	TCRBD02-01*02	TCRBJ02-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGTTTATCTGGGCATTACAATGAGCAGTTCTTCGGGCCA	CASSLSGHYNEQFF	In	VDJ	1	190	2.8165840468679585E-4	3.4155584078464363E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	8	0	4	3	2	26	41	48	44	50	TCRBV12,TCRBV21													CASSLSGHYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCCCGGTTTTACGCAGTATTTTGGCCCA	CASSPGFTQYF	In	VDJ	1	191	2.8314081734304213E-4	3.433535031045628E-4	33	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	8	5	8	3	3	26	37	43	40	46		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASSPGFTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCGGACGGGGGTGGATACGAGCAGTACTTCGGGCCG	CASSQADGGGYEQYF	In	VDJ	1	191	2.8314081734304213E-4	3.433535031045628E-4	45	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	1	8	2	4	4	4	26	42	52	46	56		TCRBV03-01,TCRBV03-02												CASSQADGGGYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAAGGGGGTCGAACACTGAAGCTTTCTTTGGACAA	CASSLRGSNTEAFF	In	VDJ	1	191	2.8314081734304213E-4	3.433535031045628E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	5	1	1	3	2	24	36	45	39	47		TCRBV24-01,TCRBV24-or09_02												CASSLRGSNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGAGGGGAGTCGGAAACACCATATATTTTGGAGAG	CASSQRGVGNTIYF	In	VDJ	1	192	2.8462322999928846E-4	3.45151165424482E-4	42	TCRBV03						TCRBJ01	TCRBJ01-03	01	3	5	2	4	1	4	26	40	46	41	50		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQRGVGNTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03		TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCCTATAGCGGGGGGACAAGAGACCCAGTACTTCGGGCCA	CASSQDPIAGGQETQYF	In	VDJ	1	195	2.8907046796802733E-4	3.5054415238423956E-4	51	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	5	1	2	5	1	26	43	58	48	59		TCRBV03-01,TCRBV03-02												CASSQDPIAGGQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGCCCGACCCCCGGGACGAAGCTTTCTTTGGACAA	CSAPDPRDEAFF	In	VDJ	1	195	2.8907046796802733E-4	3.5054415238423956E-4	36	TCRBV20						TCRBJ01	TCRBJ01-01	01	6	0	7	8	11	0	26	34	-1	45	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAPDPRDEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGATAGTGGGGGGGCCCAGGAGACCCAGTACTTCGGGCCA	CASSQDSGGAQETQYF	In	VDJ	1	196	2.905528806242736E-4	3.5234181470415873E-4	48	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	9	0	5	7	5	26	40	54	47	59		TCRBV03-01,TCRBV03-02												CASSQDSGGAQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGAAGGGAGGCTACACCTTCGGTTCG	CSAREKGGYTF	In	VDJ	1	196	2.905528806242736E-4	3.5234181470415873E-4	33	TCRBV20						TCRBJ01	TCRBJ01-02	01	0	0	8	8	3	0	26	40	-1	43	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAREKGGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTCTAAAGGAGGGACGCAGCCCCAGCATTTTGGTGAT	CASSSKGGTQPQHF	In	VDJ	1	196	2.905528806242736E-4	3.5234181470415873E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	4	10	0	7	5	3	18	31	42	36	45	TCRBV07,TCRBV11													CASSSKGGTQPQHF+X+TCRBJ01-05	unresolved	TCRBD02-01*02	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
MAGAAGACTCAGCYSYGTATCTCTGCGTCAGCAGCCAAGGGACTAGCGAGGATACGCAGTATTTTGGCCCA	CVSSQGTSEDTQYF	In	VDJ	1	197	2.9203529328051994E-4	3.541394770240779E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	1	6	6	0	2	23	-1	48	39	50	TCRBV01,TCRBV04					01,02								CVSSQGTSEDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTTTCCTCAGTAGGGGGCGCACAGATACGCAGTATTTTGGCCCA	CSFLSRGRTDTQYF	In	VDJ	1	198	2.935177059367662E-4	3.559371393439971E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	8	5	0	1	9	0	26	32	-1	41	48		TCRBV20-01,TCRBV20-or09_02												CSFLSRGRTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCAAACAGGGGCAGCTACGAGCAGTACTTCGGGCCG	CSAPNRGSYEQYF	In	VDJ	1	199	2.950001185930125E-4	3.5773480166391625E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	3	2	3	5	3	26	34	46	39	49		TCRBV20-01,TCRBV20-or09_02												CSAPNRGSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCCCCCGCGAGGGGAGTTCCACAGATACGCAGTATTTTGGCCCA	CASSPREGSSTDTQYF	In	VDJ	1	202	2.9944735656175136E-4	3.631277886236738E-4	48	unresolved						TCRBJ02	TCRBJ02-03	01	4	5	2	2	7	5	23	35	47	42	52	TCRBV09,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPREGSSTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCCGGGGAGAGACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	203	3.009297692179977E-4		40	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	7	8	3	3	2	4	24	35	42	37	46		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCATTTCCTTCCTACAGGGATACCTATGGCTACACCTTCGGTTCG	CASSPFPSYRDTYGYTF	In	VDJ	1	204	3.0241218187424397E-4	3.6672311326351213E-4	51	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	3	3	4	12	4	26	39	57	51	61		TCRBV03-01,TCRBV03-02												CASSPFPSYRDTYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTGACAGGGGGCTTTGAAAAACTGTTTTTTGGCAGT	CASSLTGGFEKLFF	In	VDJ	1	205	3.0389459453049024E-4	3.685207755834313E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	2	0	7	2	2	24	36	48	38	50		TCRBV24-01,TCRBV24-or09_02												CASSLTGGFEKLFF+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGACAGGGGAGTAACTATGGCTACACCTTCGGTTCG	CARQGSNYGYTF	In	VDJ	1	206	3.0537700718673657E-4	3.703184379033505E-4	36	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	9	3	2	1	0	2	23	-1	38	31	40	TCRBV01,TCRBV04													CARQGSNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAGCAGGGCCGAACACTGAAGCTTTCTTTGGACAA	CASSLAGPNTEAFF	In	VDJ	1	206	3.0537700718673657E-4	3.703184379033505E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	3	1	4	2	24	36	45	40	47		TCRBV24-01,TCRBV24-or09_02												CASSLAGPNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGGAGTCACCCCTCCACTTTGGGAAC	CASSQGESPLHF	In	VDJ	1	207	3.0685941984298285E-4	3.7211610022326965E-4	36	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	1	9	2	10	0	0	26	-1	-1	42	47		TCRBV03-01,TCRBV03-02												CASSQGESPLHF+TCRBV03-X+TCRBJ01-06	TCRBV03	TCRBD02-01*02	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCGAACCGTTGCCTTATCTTGAGCAGTACTTCGGGCCG	CASSPEPLPYLEQYF	In	VDJ	1	207	3.0685941984298285E-4	3.7211610022326965E-4	45	TCRBV03						TCRBJ02	TCRBJ02-07	01	4	2	8	7	2	16	26	39	43	41	59		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPEPLPYLEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTAGGGGGGGATCGAACACTGAAGCTTTCTTTGGACAA	CASSRGGSNTEAFF	In	VDJ	1	211	3.1278907046796805E-4	3.7930674950294635E-4	42	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	9	0	1	1	3	26	38	46	39	49		TCRBV12-03,TCRBV12-04												CASSRGGSNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGCCTAAAACAGGRGGTCTAAGAATCACCCCTCCACTTTGGGAAC		Out	VDJ	1	211	3.1278907046796805E-4		50	unresolved			unresolved			TCRBJ01	TCRBJ01-06	01	5	3	4	10	7	11	24	36	48	43	59	TCRBV09,TCRBV21			TCRBD01,TCRBD02										X+X+TCRBJ01-06	unresolved	unresolved	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATTGGGGGACTACGAACACCCAAGAGACCCAGTACTTCGGGCCA	CASSQDWGTTNTQETQYF	In	VDJ	1	212	3.142714831242143E-4	3.811044118228655E-4	54				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	0	9	1	4	7	18	35	46	39	53	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03				01,02								CASSQDWGTTNTQETQYF+X+TCRBJ02-05		TCRBD02-01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGGGGGCCGCCACAGATACGCAGTATTTTGGCCCA	CSAREGAATDTQYF	In	VDJ	1	214	3.1723630843670693E-4	3.846997364627039E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	6	0	2	0	3	26	-1	46	40	49		TCRBV20-01,TCRBV20-or09_02												CSAREGAATDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGTGAAAGTGGACTAGCGGGGGGGCGCCCGGGGACCCAGTACTTCGGGCCA	CASSESGLAGGRPGTQYF	In	VDJ	1	214	3.1723630843670693E-4	3.846997364627039E-4	54	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	1	0	7	7	8	24	35	57	42	65	TCRBV12,TCRBV21													CASSESGLAGGRPGTQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGGGGGACATCGGAATTCACCCCTCCACTTTGGGAAC	CSASGGHRNSPLHF	In	VDJ	1	215	3.187187210929532E-4	3.864973987826231E-4	42	TCRBV20						TCRBJ01	TCRBJ01-06	01	3	0	6	7	3	4	26	37	46	40	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASGGHRNSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20		TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCAGACTAGCGGGGTACAATGAGCAGTTCTTCGGGCCA	CASSPRLAGYNEQFF	In	VDJ	1	216	3.202011337491995E-4	3.882950611025423E-4	45	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	2	3	4	3	0	26	39	-1	42	53		TCRBV03-01,TCRBV03-02												CASSPRLAGYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGCTCTAGCGGTTCCACAGATACGCAGTATTTTGGCCCA	CSARGSSGSTDTQYF	In	VDJ	1	216	3.202011337491995E-4	3.882950611025423E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	4	5	2	3	3	26	39	49	42	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSARGSSGSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGGACCGGGACAGTTAACACCGGGGAGCTGTTTTTTGGAGAA	CASRTGTVNTGELFF	In	VDJ	1	216	3.202011337491995E-4	3.882950611025423E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	0	5	2	4	2	24	35	46	39	48		TCRBV24-01,TCRBV24-or09_02												CASRTGTVNTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGTGACAGGGGTTCGAGCTACACCTTCGGTTCG	CASSQGDRGSSYTF	In	VDJ	1	219	3.2464837171793836E-4	3.936880480622998E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	2	2	9	2	5	26	42	52	44	57		TCRBV03-01,TCRBV03-02												CASSQGDRGSSYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATATAGGTGAAGAGACCCAGTACTTCGGGCCA	CASSQDIGEETQYF	In	VDJ	1	221	3.2761319703043096E-4	3.9728337270213815E-4	42	TCRBV03						TCRBJ02	TCRBJ02-05	01	0	5	4	3	3	2	26	43	49	46	51		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDIGEETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03		TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCTTCAGCGGGGCCGCCTACGAGCAGTACTTCGGGCCG	CASSFSGAAYEQYF	In	VDJ	1	224	3.3206043499916984E-4	4.026763596618957E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	6	3	2	1	3	18	32	40	33	43	TCRBV07,TCRBV11													CASSFSGAAYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTTAGGGCCCGGGAGCGGAGATATAGCAATCAGCCCCAGCATTTTGGTGAT	CSVRARERRYSNQPQHF	In	VDJ	1	225	3.3354284765541617E-4	4.0447402198181485E-4	51	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	3	8	2	0	4	8	26	37	47	41	55		TCRBV20-01,TCRBV20-or09_02												CSVRARERRYSNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01*02	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAATGCCGCCGGGACAGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASNAAGTGNTGELFF	In	VDJ	1	226	3.3502526031166244E-4	4.06271684301734E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	12	0	4	1	13	0	26	31	-1	44	52	TCRBV12,TCRBV21													CASNAAGTGNTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGTCGGAAAGAAAAAAGTAGGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	226	3.3502526031166244E-4		53	TCRBV03						TCRBJ02	TCRBJ02-07	01	1	1	8	3	4	14	26	42	49	46	63		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGCTACGAGAAGCACAGATACGCAGTATTTTGGCCCA	CSARDATRSTDTQYF	In	VDJ	1	227	3.365076729679087E-4	4.080693466216532E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	4	9	0	2	5	26	40	45	42	50		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDATRSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGCATTAGCACAGATACGCAGTATTTTGGCCCA	CASSISTDTQYF	In	VJ	1	229	3.394724982804013E-4	4.1166467126149155E-4	36	unresolved			unresolved			TCRBJ02	TCRBJ02-03	01	4	0	0	0	0	3	23	-1	35	-1	38	TCRBV02,TCRBV09			TCRBD01										CASSISTDTQYF+X+TCRBJ02-03	unresolved	unresolved	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCCGGGGACTGCAAACACAGATACGCAGTATTTTGGCCCA	CATSDPGTANTDTQYF	In	VDJ	1	231	3.424373235928939E-4	4.152599959013299E-4	48	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	0	10	2	4	5	24	38	48	42	53		TCRBV24-01,TCRBV24-or09_02				01,02								CATSDPGTANTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAGACCATCCCGGGACCCCCGGAGGAGACCCAGTACTTCGGGCCA	CASSQTIPGPPEETQYF	In	VDJ	1	232	3.439197362491402E-4	4.170576582212491E-4	51	unresolved						TCRBJ02	TCRBJ02-05	01	3	0	7	5	9	8	23	37	51	46	59	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQTIPGPPEETQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCACTCAATCTGGGCAGCAACCTGAGCAGTTCTTCGGGCCA	XASTQSGQQPEQFF	In	VDJ	1	232	3.439197362491402E-4	4.170576582212491E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	11	8	0	9	15	7	22	25	44	40	51	TCRBV01,TCRBV17													XASTQSGQQPEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCCTTCAGGGACAGGGTACACCGGGGAGCTGTTTTTTGGAGAA	XASSPSGTGYTGELFF	In	VDJ	1	232	3.439197362491402E-4	4.170576582212491E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	3	3	6	1	22	34	49	40	50	TCRBV04,TCRBV07,TCRBV17													XASSPSGTGYTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTACATCGATCGGAAAAACTGTTTTTTGGCAGT	CASSLHRSEKLFF	In	VDJ	1	235	3.483669742178791E-4	4.224506451810066E-4	39	TCRBV12						TCRBJ01	TCRBJ01-04	01	2	2	8	8	4	3	26	41	47	45	50		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLHRSEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12		TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAGTAATAGCAATCAGCCCCAGCATTTTGGTGAT	CSARDSNSNQPQHF	In	VDJ	1	235	3.483669742178791E-4	4.224506451810066E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	0	5	8	0	0	3	26	-1	43	40	46		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDSNSNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGCCAGAGGGGTCCATCACTGAAGCTTTCTTTGGACAA	CASRPEGSITEAFF	In	VDJ	1	236	3.4984938687412535E-4	4.2424830750092577E-4	42	TCRBV12						TCRBJ01	TCRBJ01-01	01	6	5	2	4	5	5	26	37	47	42	52		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRPEGSITEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCGAGGTGGACAAAACCTTCAAGAGACCCAGTACTTCGGGCCA	CASSRGGQNLQETQYF	In	VDJ	1	236	3.4984938687412535E-4	4.2424830750092577E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	1	6	2	5	7	23	36	46	41	53	TCRBV01,TCRBV04													CASSRGGQNLQETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACGCCGGGAGGGGGAATTCCGTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	236	3.4984938687412535E-4		50	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	4	8	0	6	3	9	24	38	49	41	58		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD02-01*02	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAATTGGGCGGGACAGGGGGCTACGAGCAGTACTTCGGGCCG	CASSELGGTGGYEQYF	In	VDJ	1	236	3.4984938687412535E-4	4.2424830750092577E-4	48	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	0	1	3	6	0	23	38	-1	44	55		TCRBV06-01,TCRBV06-08												CASSELGGTGGYEQYF+TCRBV06-X+TCRBJ02-07	TCRBV06	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAGGAGGACTAGCGGGGGATACACAGATACGCAGTATTTTGGCCCA	CASRRTSGGYTDTQYF	In	VDJ	1	236	3.4984938687412535E-4	4.2424830750092577E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	1	2	2	2	3	24	35	50	37	53	TCRBV12,TCRBV21													CASRRTSGGYTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCTACAGGGGGCTACTATGGCTACACCTTCGGTTCG	CASSSTGGYYGYTF	In	VDJ	1	238	3.5281421218661795E-4	4.278436321407642E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	3	0	3	3	1	24	36	48	39	49		TCRBV24-01,TCRBV24-or09_02												CASSSTGGYYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCKGCYGTGTATYTCTGTGCCAGCAGCTTAAGCGGGACACATGAAGCTTTCTTTGGACAA	CASSLSGTHEAFF	In	VDJ	1	240	3.5577903749911056E-4	4.314389567806025E-4	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	6	3	7	3	4	26	38	48	41	52	TCRBV03,TCRBV07													CASSLSGTHEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACTTCAACAGGGTTTTGGAAAACACCATATATTTTGGAGAG	CSARDFNRVLENTIYF	In	VDJ	1	240	3.5577903749911056E-4	4.314389567806025E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	3	3	6	5	7	26	40	51	45	58		TCRBV20-01,TCRBV20-or09_02												CSARDFNRVLENTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TTTCTGTGCCAGCAGCCAAAATGGTGCGTGGGGACAGGGGCTATACGACCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	241	3.5726145015535683E-4		64	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	0	2	2	11	9	4	19	40	30	49		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTGGCAGGCGGATCCTACAATGAGCAGTTCTTCGGGCCA	CASSLAGGSYNEQFF	In	VDJ	1	242	3.5874386281160316E-4	4.350342814204409E-4	45	unresolved						TCRBJ02	TCRBJ02-01	01	3	4	4	1	2	4	18	32	38	34	42	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAGGSYNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGTGGGGAAGAACACTGAAGCTTTCTTTGGACAA	CASSQVGKNTEAFF	In	VDJ	1	244	3.617086881240957E-4	4.386296060602792E-4	42	TCRBV03						TCRBJ01	TCRBJ01-01	01	3	0	8	1	4	1	26	40	48	44	49		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQVGKNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTGACAGGGGAGGACTATRGCTACACCTTCGGTTCG	CSARVTGEDYXYTF	In	VDJ	1	244	3.617086881240957E-4	4.386296060602792E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	2	2	9	1	9	26	39	48	40	57		TCRBV20-01,TCRBV20-or09_02												CSARVTGEDYXYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGCGACCCTGGCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	245	3.6319110078034204E-4		37	unresolved						TCRBJ02	TCRBJ02-03	01	6	2	7	4	1	5	23	34	38	35	43	TCRBV02,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAATATCGAAGAGCCCAGGGCTGCTTTCTTTGGACAA	CASNIEEPRAAFF	In	VDJ	1	248	3.676383387490809E-4	4.458202553399559E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	4	3	11	13	2	22	32	50	45	52		TCRBV12-03,TCRBV12-04												CASNIEEPRAAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCCCAGGAGATGAACACTGAAGCTTTCTTTGGACAA	CASSPQEMNTEAFF	In	VDJ	1	249	3.691207514053272E-4	4.476179176598751E-4	42	TCRBV24						TCRBJ01	TCRBJ01-01	01	6	4	4	0	3	3	24	36	43	39	46		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPQEMNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGTGAAGCGGGGGGCCCCACAGATACGCAGTATTTTGGCCCA	CASSEAGGPTDTQYF	In	VDJ	1	249	3.691207514053272E-4	4.476179176598751E-4	45	unresolved			unresolved			TCRBJ02	TCRBJ02-03	01	6	6	1	2	3	3	24	35	47	38	50	TCRBV02,TCRBV21			TCRBD01,TCRBD02										CASSEAGGPTDTQYF+X+TCRBJ02-03	unresolved	unresolved	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGGGAGGGACGAACACTGAAGCTTTCTTTGGACAA	CASSLGGTNTEAFF	In	VDJ	1	250	3.7060316406157347E-4	4.4941557997979427E-4	42	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	9	0	1	0	2	26	-1	47	40	49		TCRBV12-03,TCRBV12-04												CASSLGGTNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01*02	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCAGACAGGTTTCTACGAGCAGTACTTCGGGCCG	CSAQTGFYEQYF	In	VDJ	1	250	3.7060316406157347E-4	4.4941557997979427E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	4	3	3	3	26	34	43	37	46		TCRBV20-01,TCRBV20-or09_02												CSAQTGFYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAGGACGGGTTGAGCACTGAAGCTTTCTTTGGACAA	CASSQEDGLSTEAFF	In	VDJ	1	253	3.750504020303124E-4	4.548085669395518E-4	45	TCRBV03						TCRBJ01	TCRBJ01-01	01	0	1	7	4	0	8	26	-1	47	43	55		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEDGLSTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGAAGGGACGGCAGCAATGAAAAACTGTTTTTTGGCAGT	CASRRDGSNEKLFF	In	VDJ	1	253	3.750504020303124E-4	4.548085669395518E-4	42	unresolved						TCRBJ01	TCRBJ01-04	01	6	0	7	5	2	6	23	34	41	36	47	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRRDGSNEKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCAGGGCAGGGGTTACGAGCAGTACTTCGGGCCG	CSAQGRGYEQYF	In	VDJ	1	257	3.8098005265529755E-4	4.619992162192285E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	4	2	4	5	1	26	35	46	40	47		TCRBV20-01,TCRBV20-or09_02												CSAQGRGYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCAAACCGGGACAGAGAAAGGCTACACCTTCGGTTCG	CSAQTGTEKGYTF	In	VDJ	1	258	3.824624653115438E-4	4.6379687853914767E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	5	8	6	5	26	35	48	41	53		TCRBV20-01,TCRBV20-or09_02												CSAQTGTEKGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTCATGACTACGAACACCGGGGAGCTGTTTTTTGGAGAA	CSVMTTNTGELFF	In	VDJ	1	258	3.824624653115438E-4	4.6379687853914767E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	7	2	9	0	4	0	26	33	-1	37	42		TCRBV20-01,TCRBV20-or09_02				01,02								CSVMTTNTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCTAAGTTCGGGGTACAGCACCGGGGAGCTGTTTTTTGGAGAA	CSALSSGYSTGELFF	In	VDJ	1	259	3.8394487796779015E-4	4.6559454085906684E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	6	8	3	4	8	5	26	34	47	42	52		TCRBV20-01,TCRBV20-or09_02												CSALSSGYSTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGGTAGTCAGGGAAATTCACCCCTCCACTTTGGGAAC	CASSVGSQGNSPLHF	In	VDJ	1	259	3.8394487796779015E-4	4.6559454085906684E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	4	3	7	5	1	23	39	49	44	50	TCRBV09,TCRBV21													CASSVGSQGNSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATATGGATTCGAACACTGAAGCTTTCTTTGGACAA	CSARDMDSNTEAFF	In	VDJ	1	261	3.869097032802827E-4	4.6918986549890525E-4	42	TCRBV20						TCRBJ01	TCRBJ01-01	01	0	1	8	1	3	3	26	40	46	43	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDMDSNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTTCGGACAGGGCAAATCAGCCCCAGCATTTTGGTGAT	CASSFSDRANQPQHF	In	VDJ	1	262	3.8839211593652903E-4	4.709875278188244E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	1	3	4	3	2	26	40	51	43	53		TCRBV12-03,TCRBV12-04												CASSFSDRANQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGATCTCAAGACCGGGACAGGGGGCTTCGAGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	262	3.8839211593652903E-4		58	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	0	0	1	11	5	23	34	57	45	62		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTATGGACAGGGGCCGAGCAGTACTTCGGGCCG		Out	VDJ	2	267	3.958041792177605E-4		40	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	1	2	6	3	1	26	40	52	43	53		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGGGCTCCATCGACAGGGGGGAACACTGAAGCTTTCTTTGGACAA	CASRAPSTGGNTEAFF	In	VDJ	2	278	4.1211071843646975E-4	4.997501249375312E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	1	1	9	0	26	37	-1	46	55		TCRBV03-01,TCRBV03-02												CASRAPSTGGNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGAAGCGGGACGCCGAAACACCATATATTTTGGAGAG	CASSEAGRRNTIYF	In	VDJ	2	286	4.2397001968644005E-4	5.141314234968846E-4	42	unresolved			unresolved			TCRBJ01	TCRBJ01-03	01	0	0	7	5	0	3	23	-1	45	40	48	TCRBV02,TCRBV12			TCRBD01,TCRBD02										CASSEAGRRNTIYF+X+TCRBJ01-03	unresolved	unresolved	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGGGAGGCGGCGGTAGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	290	4.2989967031142526E-4		46	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	10	1	4	0	7	24	-1	47	42	54		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01*02	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGGGACCCGGGAGAAAAACTGTTTTTTGGCAGT	CASRDPGEKLFF	In	VDJ	2	290	4.2989967031142526E-4	5.213220727765613E-4	36	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	6	8	3	8	5	0	23	34	-1	39	44	TCRBV02,TCRBV09													CASRDPGEKLFF+X+TCRBJ01-04	unresolved	TCRBD02-01*02	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGTCGACGGGACTTGGAACCGCAATGAGCAGTTCTTCGGGCCA	CATSVDGTWNRNEQFF	In	VDJ	2	293	4.3434690828016414E-4	5.267150597363188E-4	48	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	10	6	5	8	24	37	48	42	56		TCRBV24-01,TCRBV24-or09_02				01,02								CATSVDGTWNRNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGTAATACGTCAGCGAGGTTCACCCCTCCACTTTGGGAAC	CASSQVIRQRGSPLHF	In	VDJ	2	294	4.358293209364104E-4	5.285127220562381E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	1	6	6	9	9	3	23	39	52	48	55	TCRBV01,TCRBV04					01,02								CASSQVIRQRGSPLHF+X+TCRBJ01-06	unresolved	TCRBD02-01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGGACTCSGCCGTGTATCTCTGTGCCAGCAGCTTAGAATCCCTTTCACCCCTCCACTTTGGGAAC	CASSLESLSPLHF	In	VDJ	2	294	4.358293209364104E-4	5.285127220562381E-4	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	1	4	10	9	5	0	18	34	-1	39	41	TCRBV07,TCRBV11					01,02								CASSLESLSPLHF+X+TCRBJ01-06	unresolved	TCRBD02-01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCCGCCCCCCGACAGTTTGGCTACACCTTCGGTTCG		Out	VDJ	2	301	4.462062095301345E-4		37	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	2	5	7	8	2	23	32	45	40	47	TCRBV09,TCRBV21													X+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGCCCCAGACAGTTATGGCTACACCTTCGGTTCG	CASSQAPDSYGYTF	In	VDJ	2	304	4.506534474988734E-4	5.464893452554299E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	2	5	5	5	1	23	39	49	44	50	TCRBV01,TCRBV04													CASSQAPDSYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGAGATCCTCAGGGTGCAATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	2	304	4.506534474988734E-4		49	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	4	3	5	7	4	23	36	48	43	52	TCRBV09,TCRBV21													X+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTACACAGGGGTTTGGCAGATAAATGAAAAACTGTTTTTTGGCAGT	CASSYTGVWQINEKLFF	In	VDJ	2	310	4.5954792343635113E-4	5.572753191749449E-4	51	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	3	2	5	2	11	26	39	48	41	59		TCRBV12-03,TCRBV12-04												CASSYTGVWQINEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGCTACCGGGACAGCTGGAAACACCATATATTTTGGAGAG	CSARATGTAGNTIYF	In	VDJ	2	313	4.6399516140509E-4	5.626683061347024E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	0	5	2	7	0	26	37	-1	44	51		TCRBV20-01,TCRBV20-or09_02												CSARATGTAGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGAATCAGGGAGGGACACTGAAGCTTTCTTTGGACAA	CASSQESGRDTEAFF	In	VDJ	2	313	4.6399516140509E-4	5.626683061347024E-4	45				TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	9	0	3	4	0	18	35	-1	39	46	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQESGRDTEAFF+X+TCRBJ01-01		TCRBD02-01*02	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTACTATAAGGGGGGATACGCAGTATTTTGGCCCA	CASSTIRGDTQYF	In	VDJ	2	315	4.669599867175826E-4	5.662636307745408E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	5	1	6	6	0	26	38	-1	44	50		TCRBV12-03,TCRBV12-04												CASSTIRGDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGGAAAGGGGACTATTCACCCCTCCACTTTGGGAAC	CSARKGDYSPLHF	In	VDJ	2	316	4.684423993738289E-4	5.6806129309446E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	6	0	10	8	8	0	26	34	-1	42	48		TCRBV20-01,TCRBV20-or09_02				01,02								CSARKGDYSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD02-01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGAACTATGGCTACACCTTCGGTTCG	CASSQNYGYTF	In	VJ	2	319	4.7288963734256777E-4	5.734542800542175E-4	33	TCRBV03						TCRBJ01	TCRBJ01-02	01	3	0	0	2	0	1	26	-1	40	-1	41		TCRBV03-01,TCRBV03-02												CASSQNYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGGACAGAACTACAATGAGCAGTTCTTCGGGCCA	CSGQNYNEQFF	In	VDJ	2	322	4.7733687531130664E-4	5.78847267013975E-4	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	2	5	3	0	2	26	-1	38	33	40		TCRBV20-01,TCRBV20-or09_02												CSGQNYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGACGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSQDATNEKLFF	In	VDJ	2	329	4.8771376390503073E-4	5.914309032534092E-4	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	0	8	6	0	0	0	26	-1	-1	43	45		TCRBV03-01,TCRBV03-02				01,02								CASSQDATNEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD02-01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACACCAGCGGGGGGGCAATAGATACGCAGTATTTTGGCCCA	CATSDTSGGAIDTQYF	In	VDJ	2	330	4.89196176561277E-4	5.932285655733284E-4	48	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	6	0	5	4	4	24	38	52	42	56		TCRBV24-01,TCRBV24-or09_02												CATSDTSGGAIDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTAGCTCACGCCGGGACACTGAACACTGAAGCTTTCTTTGGACAA	CASSLAHAGTLNTEAFF	In	VDJ	2	333	4.936434145300159E-4	5.986215525330859E-4	51	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	6	0	11	1	26	39	56	50	57		TCRBV03-01,TCRBV03-02												CASSLAHAGTLNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSQGSNQPQHF	In	VDJ	2	337	4.995730651550011E-4	6.058122018127626E-4	39	TCRBV03						TCRBJ01	TCRBJ01-05	01	1	0	10	1	0	0	26	-1	-1	42	44		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGSNQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCATAGTGGGTGGGAGAACACTGAAGCTTTCTTTGGACAA	CSAHSGWENTEAFF	In	VDJ	2	338	5.010554778112473E-4	6.076098641326818E-4	42	TCRBV20						TCRBJ01	TCRBJ01-01	01	5	0	8	1	10	0	26	35	-1	45	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAHSGWENTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCCGGTCCATAACTATGGCTACACCTTCGGTTCG	CASSPVHNYGYTF	In	VDJ	2	352	5.218092549986955E-4	6.327771366115504E-4	39	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	6	8	5	1	2	4	26	37	42	39	46		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASSPVHNYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD02-01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGAACGGGGGGAGCTGTTTTTTGGAGAA	CASSQERGELFF	In	VDJ	2	352	5.218092549986955E-4	6.327771366115504E-4	36	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	8	5	8	1	0	23	40	-1	41	44	TCRBV01,TCRBV04					01,02								CASSQERGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCACCCCGGGTAGCGGGAGTTACAATGAGCAGTTCTTCGGGCCA	CASTPGSGSYNEQFF	In	VDJ	2	355	5.262564929674344E-4	6.381701235713079E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	5	2	4	7	1	23	33	49	40	50	TCRBV09,TCRBV21													CASTPGSGSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCTTAAGTCGCCATCTCGCCCCCCAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	2	356	5.277389056236807E-4		52	unresolved						TCRBJ01	TCRBJ01-06	01	2	4	6	7	6	11	18	33	41	39	52	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-06	unresolved		TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCCAGGGTAGGCTACGAGCAGTACTTCGGGCCG	CSARDPRVGYEQYF	In	VDJ	2	359	5.321861435924196E-4	6.453607728509846E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	3	3	3	4	26	40	48	43	52		TCRBV20-01,TCRBV20-or09_02												CSARDPRVGYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCGACCGGAGGGGTCTATGGCTACACCTTCGGTTCG	CASSLSTGGVYGYTF	In	VDJ	2	361	5.351509689049121E-4	6.489560974908229E-4	45				TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	6	10	0	4	9	2	24	36	51	45	53	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01												CASSLSTGGVYGYTF+X+TCRBJ01-02		TCRBD02-01*02	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGTGTAGAGGAACTCCAAACTTTCTTTGGACAA	CASSVEELQTFF	In	VDJ	2	361	5.351509689049121E-4	6.489560974908229E-4	36	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	11	1	12	4	9	24	35	43	39	52	TCRBV02,TCRBV21													CASSVEELQTFF+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTCTTGGGGGGCCTAATGAAAAACTGTTTTTTGGCAGT	CASSFLGGPNEKLFF	In	VDJ	2	363	5.381157942174047E-4	6.525514221306613E-4	45	TCRBV12						TCRBJ01	TCRBJ01-04	01	3	6	0	3	5	0	26	40	-1	45	51		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFLGGPNEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12		TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCGAGACATCACCGGGGAGCTGTTTTTTGGAGAA	CASSRDITGELFF	In	VDJ	2	364	5.39598206873651E-4	6.543490844505805E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	2	6	4	3	1	26	38	45	41	46		TCRBV12-03,TCRBV12-04												CASSRDITGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCCGGGACTAGGAGTACAGATACGCAGTATTTTGGCCCA	CSARPGTRSTDTQYF	In	VDJ	2	367	5.440454448423899E-4	6.59742071410338E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	0	8	3	3	4	26	38	49	41	53		TCRBV20-01,TCRBV20-or09_02				01,02								CSARPGTRSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCGGGACAGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSPGTGGTDTQYF	In	VDJ	2	369	5.470102701548825E-4	6.633373960501763E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	0	2	1	2	0	26	39	-1	41	51		TCRBV03-01,TCRBV03-02												CASSPGTGGTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGGACAGGGGGCTTACGAGCAGTACTTCGGGCCG	CASSQGQGAYEQYF	In	VDJ	2	376	5.573871587486065E-4	6.759210322896106E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	0	4	0	1	26	-1	52	40	53		TCRBV03-01,TCRBV03-02												CASSQGQGAYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAGTGAGGTACCGGGGGAAAAACTGTTTTTTGGCAGT	CASSEVPGEKLFF	In	VDJ	2	384	5.692464599985769E-4	6.90302330848964E-4	39	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	5	8	3	8	7	0	22	34	-1	41	46	TCRBV12,TCRBV21													CASSEVPGEKLFF+X+TCRBJ01-04	unresolved	TCRBD02-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTCGCCGGCTAGCGGGGGGCGAGATACGCAGTATTTTGGCCCA	CSARDSPASGGRDTQYF	In	VDJ	2	387	5.736936979673158E-4	6.956953178087216E-4	51	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	4	1	5	8	2	26	40	59	48	61		TCRBV20-01,TCRBV20-or09_02												CSARDSPASGGRDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGAAGACCACACTGCAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	2	392	5.811057612485472E-4		52	TCRBV03						TCRBJ01	TCRBJ01-04	01	1	2	7	0	3	7	26	42	48	45	55		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-04	TCRBV03		TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGTGTTGAGGGGRCGTACACTGAAGCTTTCTTTGGACAA	CASSRVEGXYTEAFF	In	VDJ	2	400	5.929650624985176E-4	7.190649279676709E-4	45	TCRBV03			unresolved			TCRBJ01	TCRBJ01-01	01	4	0	7	3	8	2	26	39	52	47	54		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02										CASSRVEGXYTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	unresolved	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCCCGCCCGGGACAGAGGTACGTCGGGCAGTACTTCGGGCCG		Out	VDJ	2	411	6.092716017172268E-4		46	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	5	9	6	11	24	36	49	42	60	TCRBV09,TCRBV21													X+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTCGGGGGCCCTGAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	2	418	6.196484903109509E-4		46	TCRBV20						TCRBJ01	TCRBJ01-04	01	0	6	0	5	4	4	26	40	50	44	54		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-04	TCRBV20		TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATCGSGGTAGCGGGGGCTACGAGCAGTACTTCGGGCCG	CASSQDRGSGGYEQYF	In	VDJ	2	420	6.226133156234434E-4	7.550181743660544E-4	48				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	5	2	3	6	0	18	35	-1	41	50	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQDRGSGGYEQYF+X+TCRBJ02-07		TCRBD02-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAAGTTTGCGGACAGGGAACCTCTACGAGCAGTACTTCGGGCCG	CASSESLRTGNLYEQYF	In	VDJ	2	423	6.270605535921823E-4	7.604111613258119E-4	51	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	1	3	3	7	5	23	38	53	45	58		TCRBV06-01,TCRBV06-08												CASSESLRTGNLYEQYF+TCRBV06-X+TCRBJ02-07	TCRBV06	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCCTCGGAGTTCTGAACACTGAAGCTTTCTTTGGACAA	CASSLGVLNTEAFF	In	VDJ	2	424	6.285429662484287E-4	7.62208823645731E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	10	2	0	3	3	18	30	37	33	40	TCRBV07,TCRBV11													CASSLGVLNTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGCCGGGAGGGCCTATGGCTACACCTTCGGTTCG	CASSQAGRAYGYTF	In	VDJ	2	436	6.463319181233842E-4	7.837807714847613E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	1	8	0	4	1	1	23	39	48	40	49	TCRBV01,TCRBV04													CASSQAGRAYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCCCAAGGGACGGATTAAATGAAAAACTGTTTTTTGGCAGT	CASSPRDGLNEKLFF	In	VDJ	3	448	6.641208699983397E-4	8.053527193237914E-4	45	unresolved						TCRBJ01	TCRBJ01-04	01	4	0	7	5	4	6	23	35	44	39	50	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPRDGLNEKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAATCCTATGGGGCGCTCCAAGAGACCCAGTACTTCGGGCCA	CASSQSYGALQETQYF	In	VDJ	3	452	6.700505206233249E-4	8.12543368603468E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	7	0	1	6	3	23	38	49	44	52	TCRBV01,TCRBV04													CASSQSYGALQETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGCTTATCCACTTCAAAAGCGGGGGTGGGTTCTTCGGGCCA		Out	VDJ	3	453	6.715329332795712E-4		44	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	6	2	15	14	3	23	35	57	49	60	TCRBV02,TCRBV09,TCRBV13													X+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTGGCGGGGGGTCTCCTACGAGCAGTACTTCGGGCCG	CASSWRGVSYEQYF	In	VDJ	3	464	6.878394724982804E-4	8.341153164424981E-4	42	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	7	1	0	1	1	26	39	48	40	49		TCRBV12-03,TCRBV12-04												CASSWRGVSYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCACGAGAACAGGGGGCTCTGGAAACACCATATATTTTGGAGAG	CATRTGGSGNTIYF	In	VDJ	3	464	6.878394724982804E-4	8.341153164424981E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	10	3	1	0	5	0	23	30	-1	35	43	TCRBV06,TCRBV10													CATRTGGSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTGACAGGCCCGATAAACACTGAAGCTTTCTTTGGACAA	CASSLTGPINTEAFF	In	VDJ	3	470	6.967339484357582E-4	8.449012903620132E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	4	2	2	7	24	36	44	38	51		TCRBV24-01,TCRBV24-or09_02												CASSLTGPINTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTAATGCAGGACAAAAACATTCAGTACTTCGGCGCC	CASSQVMQDKNIQYF	In	VDJ	3	471	6.982163610920045E-4	8.466989526819324E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	1	4	4	3	5	1	26	42	51	47	52		TCRBV03-01,TCRBV03-02												CASSQVMQDKNIQYF+TCRBV03-X+TCRBJ02-04	TCRBV03	TCRBD01-01*01	TCRBJ02-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCACGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSHGSYNEQFF	In	VDJ	3	490	7.263822015606841E-4	8.808545367603968E-4	39	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	8	5	0	2	0	26	38	-1	40	43		TCRBV12-03,TCRBV12-04				01,02								CASSHGSYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGGGACAGGGGATATTTGAACACTGAAGCTTTCTTTGGACAA	CASRDRGYLNTEAFF	In	VDJ	3	499	7.397239154669007E-4	8.970334976396694E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	2	0	0	5	23	-1	43	34	48	TCRBV02,TCRBV12													CASRDRGYLNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAAGAGGGATGGGCTGGGGAGCTGTTTTTTGGAGAA	CSAKEGWAGELFF	In	VDJ	3	504	7.471359787481321E-4	9.060218092392652E-4	39	TCRBV20						TCRBJ02	TCRBJ02-02	01	0	0	8	8	0	6	26	-1	44	40	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAKEGWAGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20		TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCCCCACCGGTGGCAGGAACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	3	527	7.812314698417969E-4		49	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	4	4	2	11	2	23	36	51	47	53	TCRBV01,TCRBV04													X+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTTTGGCGGGCCTTCCTACGAGCAGTACTTCGGGCCG	CASSFGGPSYEQYF	In	VDJ	3	543	8.049500723417377E-4	9.761306397161132E-4	42	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	7	4	1	5	3	26	37	47	42	50		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASSFGGPSYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCGGGGTTGAACACTGAAGCTTTCTTTGGACAA	CSARDPGLNTEAFF	In	VDJ	3	547	8.108797229667228E-4	9.833212889957899E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	0	8	3	0	2	1	26	40	47	42	48		TCRBV20-01,TCRBV20-or09_02												CSARDPGLNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAACAGGGGCACACTGAAGCTTTCTTTGGACAA	CASSEQGHTEAFF	In	VDJ	3	552	8.182917862479543E-4	9.923096005953857E-4	39	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	2	3	0	1	23	-1	44	38	45		TCRBV06-01,TCRBV06-08												CASSEQGHTEAFF+TCRBV06-X+TCRBJ01-01	TCRBV06	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCACAAGATGGGACAGAGAATTCACCCCTCCACTTTGGGAAC	CSAQDGTENSPLHF	In	VDJ	3	554	8.212566115604468E-4	9.95904925235224E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	0	5	7	7	2	26	34	48	41	50		TCRBV20-01,TCRBV20-or09_02												CSAQDGTENSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGCAGGGGTCAATCAAGATACGCAGTATTTTGGCCCA	CASSVAGVNQDTQYF	In	VDJ	3	554	8.212566115604468E-4	9.95904925235224E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	4	2	5	0	7	23	-1	45	39	52	TCRBV09,TCRBV21													CASSVAGVNQDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGCCGGGAGTTATAATTCACCCCTCCACTTTGGGAAC	CSARAGSYNSPLHF	In	VDJ	3	555	8.227390242166932E-4	9.977025875551433E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	3	8	2	4	3	1	26	37	46	40	47		TCRBV20-01,TCRBV20-or09_02												CSARAGSYNSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD02-01*02	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCKGCYGTGTATKTCTGTGCCAGCAGCTTACTAGCGGGGGGTGGCAATGAGCAGTTCTTCGGGCCA	CASSLLAGGGNEQFF	In	VDJ	3	574	8.509048646853728E-4	0.0010318581716336076	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	4	1	6	0	3	18	-1	44	33	47	TCRBV03,TCRBV11													CASSLLAGGGNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTCTATCTGGACGGGAGGGAGCTTTCTTTGGACAA	CASSLSGREGAFF	In	VDJ	3	579	8.583169279666042E-4	0.0010408464832332035	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	8	0	10	9	0	22	34	-1	43	51	TCRBV02,TCRBV12													CASSLSGREGAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTCGGGACAGGATGGTAGGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	3	587	8.701762292165746E-4		46	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	4	5	2	9	26	38	48	40	57		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGTTTAGGTAGCTACACAGATACGCAGTATTTTGGCCCA	CASSLGSYTDTQYF	In	VDJ	3	587	8.701762292165746E-4	0.0010552277817925569	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	5	7	2	6	2	23	34	44	40	46	TCRBV09,TCRBV21					01,02								CASSLGSYTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCTGACTAGCGGGGGGCGTGGAGATACGCAGTATTTTGGCCCA	CSASLTSGGRGDTQYF	In	VDJ	3	596	8.835179431227912E-4	0.0010714067426718296	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	2	1	5	3	5	26	37	53	40	58		TCRBV20-01,TCRBV20-or09_02												CSASLTSGGRGDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGAGCGGTTTGAACACTGAAGCTTTCTTTGGACAA	CSARSGLNTEAFF	In	VDJ	4	621	9.205782595289486E-4	0.001116348300669809	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	6	5	0	1	2	26	37	43	38	45		TCRBV20-01,TCRBV20-or09_02				01,02								CSARSGLNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTGTTCTAGCGGGGGGTGGCCCCCATGAGCAGTTCTTCGGGCCA	CASSVLAGGGPHEQFF	In	VDJ	4	635	9.413320367163967E-4	0.0011415155731486775	48	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	4	1	8	2	8	24	37	50	39	58		TCRBV24-01,TCRBV24-or09_02												CASSVLAGGGPHEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGGACAGGGGGGCTTCTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	4	648	9.606034012475985E-4		46	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	1	0	0	4	23	-1	45	36	49	TCRBV02,TCRBV12													X+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGCGTAGGGAGGGGCTCTGGAAACACCATATATTTTGGAGAG	CASSRVGRGSGNTIYF	In	VDJ	4	651	9.650506392163374E-4	0.0011702781702673842	48	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	4	9	0	0	5	1	26	39	51	44	52		TCRBV03-01,TCRBV03-02												CASSRVGRGSGNTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03	TCRBD02-01*02	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGATGGAATCTTACAAGAGACCCAGTACTTCGGGCCA	CASSDGILQETQYF	In	VDJ	4	696	0.0010317592087474205	0.0012511729746637473	42	unresolved						TCRBJ02	TCRBJ02-05	01	3	1	8	2	2	6	23	36	41	38	47	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDGILQETQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGGAAGGCAACTACAATGAGCAGTTCTTCGGGCCA	CASSLEGNYNEQFF	In	VDJ	4	703	0.0010421360973411446	0.0012637566109031816	42	TCRBV12						TCRBJ02	TCRBJ02-01	01	3	1	8	3	0	6	26	-1	43	40	49		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLEGNYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12		TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAGATTTGGGACTAGCGGGGGGTTATGTTTTTGCCCAGTACTTCGGGCCA	CASSQEDLGLAGGYVFAQYF	In	VDJ	4	737	0.0010925381276535187	0.0013248771297804335	60	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	0	1	9	6	11	15	32	53	38	64		TCRBV03-01,TCRBV03-02												CASSQEDLGLAGGYVFAQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCACCAGGGACAGGGGGCGCGGAAACACCATATATTTTGGAGAG	CASTRDRGRGNTIYF	In	VDJ	4	742	0.0010999501909347501	0.0013338654413800294	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	7	0	0	4	3	2	23	33	48	36	50	TCRBV02,TCRBV12													CASTRDRGRGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGGGTTTTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	4	766	0.0011355280946846612		37	unresolved						TCRBJ01	TCRBJ01-05	01	0	0	10	6	0	3	23	-1	41	39	44	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGGGGTGGGAACAGGGCTCTAACTATGGCTACACCTTCGGTTCG	CASSLGWEQGSNYGYTF	In	VDJ	4	767	0.0011370105073409075	0.0013788069993780087	51	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	3	3	0	9	2	26	40	55	49	57		TCRBV12-03,TCRBV12-04												CASSLGWEQGSNYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTCGTCGCGGGGATCACCGGGGAGCTGTTTTTTGGAGAA	CASSLVAGITGELFF	In	VDJ	4	789	0.0011696235857783259	0.0014183555704162308	45	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	4	7	3	4	5	2	26	39	50	44	52		TCRBV03-01,TCRBV03-02												CASSLVAGITGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTACAGGGGCGAAATTCACCCCTCCACTTTGGGAAC	CASSLQGRNSPLHF	In	VDJ	5	898	0.001331206565309172	0.001614300763287421	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	2	4	2	7	0	3	18	-1	39	33	42	TCRBV07,TCRBV11													CASSLQGRNSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGAGGTCGTGGAGGAGACACAAATTGGGTAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	5	932	0.0013816085956215459		56	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	6	10	1	6	7	14	25	36	48	43	62		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-06	TCRBV03	TCRBD02-01*02	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGACAGGCAAAGCAATCAGCCCCAGCATTTTGGTGAT	CASSQDRQSNQPQHF	In	VDJ	6	1046	0.0015506036384336235	0.0018803547866354593	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	1	4	1	0	3	26	-1	47	40	50		TCRBV03-01,TCRBV03-02												CASSQDRQSNQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGTGGACGGCAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CATSVDGSSYNEQFF	In	VDJ	6	1118	0.0016573373496833568	0.00200978647366964	45	TCRBV24						TCRBJ02	TCRBJ02-01	01	5	1	7	0	1	5	24	37	42	38	47		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSVDGSSYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24		TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTGGGGACCGCTAAACTATGGCTACACCTTCGGTTCG	CSARDWGPLNYGYTF	In	VDJ	6	1144	0.0016958800787457602	0.0020565256939875385	45	TCRBV20						TCRBJ01	TCRBJ01-02	01	0	0	7	2	3	5	26	40	48	43	53		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDWGPLNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGGGACAGGACCCGTAGACTATGGCTACACCTTCGGTTCG	CASSQGTGPVDYGYTF	In	VDJ	7	1186	0.0017581414103081047	0.0021320275114241442	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	4	3	1	8	26	40	49	41	57		TCRBV03-01,TCRBV03-02												CASSQGTGPVDYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCGTCGGGACAGGTGAATGATGGCTACACCTTCGGTTCG	CASSLSSGQVNDGYTF	In	VDJ	7	1219	0.0018070610279642323	0.0021913503679814768	48				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	4	6	8	6	24	36	52	44	58	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01												CASSLSSGQVNDGYTF+X+TCRBJ01-02		TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGAAGGGGGGGATTTTAATTCACCCCTCCACTTTGGGAAC	CASSQEGGDFNSPLHF	In	VDJ	7	1271	0.0018841464860890396	0.0022848288086172743	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	0	9	0	6	1	4	23	40	48	41	52	TCRBV01,TCRBV04													CASSQEGGDFNSPLHF+X+TCRBJ01-06	unresolved	TCRBD02-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCACCGAGGGACAGTAGGGAAACACCATATATTTTGGAGAG	CASTEGQ*GNTIYF	Stop	VDJ	7	1282	0.0019004530253077488		42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	0	5	4	4	3	23	33	44	37	47	TCRBV09,TCRBV21													CASTEGQ*GNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCGCTGGACCCTCCTACGAGCAGTACTTCGGGCCG	CASSFAGPSYEQYF	In	VDJ	8	1333	0.00197605607077631	0.002396283872452263	42	TCRBV12						TCRBJ02	TCRBJ02-07	01	3	1	7	0	4	1	26	40	48	44	49		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFAGPSYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12		TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCCCATGACAGGGAGGAGGTCTACACCTTCGGTTCG	CASSSHDREEVYTF	In	VDJ	8	1345	0.0019938450226512656	0.0024178558202912932	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	3	10	6	7	24	36	49	42	56		TCRBV24-01,TCRBV24-or09_02												CASSSHDREEVYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGGGGCGGGGGTAGAGACCCAGTACTTCGGGCCA	CASSVGAGVETQYF	In	VDJ	8	1488	0.0022058300324944856	0.0026749215320397354	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	7	2	4	2	1	23	39	48	41	49	TCRBV09,TCRBV21													CASSVGAGVETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTAGACTAGCGGGGGAGGGTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	10	1705	0.0025275135788999314		49	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	2	2	4	2	4	26	39	53	41	57		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGTCTCAGGGATCGGTTCACCCCTCCACTTTGGGAAC	CASSQVSGIGSPLHF	In	VDJ	10	1777	0.0026342472901496644	0.0031944459424963776	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	1	4	3	9	3	5	23	39	47	42	52	TCRBV01,TCRBV04													CASSQVSGIGSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCCGGGGCGGGGAGAGGGACTGAAGCTTTCTTTGGACAA	CSARDPGAGRGTEAFF	In	VDJ	11	2023	0.0029989208035862526	0.0036366708731964954	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	0	7	3	5	7	6	26	40	53	47	59		TCRBV20-01,TCRBV20-or09_02												CSARDPGAGRGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGAGGGACAGACCTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	13	2259	0.003348770190460378		41	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	7	0	5	3	1	2	24	35	43	36	45		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGTGGGTTTTAATGAAAAACTGTTTTTTGGCAGT	CASSVGFNEKLFF	In	VDJ	16	2873	0.004258971561395602	0.005164683845127796	39	unresolved						TCRBJ01	TCRBJ01-04	01	4	0	9	4	1	3	23	36	40	37	43	TCRBV02,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVGFNEKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGTCAGGGGGCCTACGAGCAGTACTTCGGGCCG	CASSQGQGAYEQYF	In	VDJ	27	4712	0.006985128436232537	0.008470584851459163	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	4	1	2	2	0	26	42	-1	44	51		TCRBV03-01,TCRBV03-02												CASSQGQGAYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCAAGGGACATGCAACTAATGAAAAACTGTTTTTTGGCAGT	CSASKGHATNEKLFF	In	VDJ	28	4949	0.007336460235762909	0.008896630821280007	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	0	6	0	3	2	26	37	46	40	48		TCRBV20-01,TCRBV20-or09_02												CSASKGHATNEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGCGCCCGGGGGGAGCGCCGCCTACAATGAGCAGTTCTTCGGGCCA	CASSLAPGGSAAYNEQFF	In	VDJ	81	14310	0.021213325110884466	0.025724547798043423	54	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	8	1	2	3	7	26	43	53	46	60		TCRBV12-03,TCRBV12-04												CASSLAPGGSAAYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTAGACAGGGGGAACAATGAGCAGTTCTTCGGGCCA	CSARDLDRGNNEQFF	In	VDJ	133	23494	0.03482780294585043	0.042234278544181145	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	2	1	5	4	1	26	40	53	44	54		TCRBV20-01,TCRBV20-or09_02												CSARDLDRGNNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCTTGGGACTAGCGGGGGGCCAGTGGATTTACGAGCAGTACTTCGGGCCG	CARSLGLAGGQWIYEQYF	In	VDJ	1	142	2.1050259718697375E-4	2.5526804942852313E-4	54	TCRBV05	TCRBV05-03		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	2	1	4	0	10	18	-1	47	34	57			01,02											CARSLGLAGGQWIYEQYF+TCRBV05-03+TCRBJ02-07	TCRBV05-03	TCRBD02-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTAGCACCCTGGTCAGAAGCTTTCTTTGGACAA	CASSLAPWSEAFF	In	VDJ	1	50	7.41206328123147E-5	8.988311599595886E-5	39	TCRBV07	TCRBV07-02	01				TCRBJ01	TCRBJ01-01	01	0	0	10	8	5	3	18	35	42	40	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAPWSEAFF+TCRBV07-02+TCRBJ01-01	TCRBV07-02*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTAAAGGCAGACGAAAAACTGTTTTTTGGCAGT	CASSLKADEKLFF	In	VDJ	1	52	7.708545812480728E-5	9.34784406357972E-5	39	TCRBV07	TCRBV07-02	01				TCRBJ01	TCRBJ01-04	01	2	2	7	8	6	0	18	33	-1	39	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLKADEKLFF+TCRBV07-02+TCRBJ01-04	TCRBV07-02*01		TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTAGGGATGAACACTGAAGCTTTCTTTGGACAA	CASSLGMNTEAFF	In	VDJ	1	87	1.2896990109342757E-4	1.5639662183296842E-4	39	TCRBV07	TCRBV07-02	01				TCRBJ01	TCRBJ01-01	01	1	1	8	0	0	0	18	-1	-1	34	37				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGMNTEAFF+TCRBV07-02+TCRBJ01-01	TCRBV07-02*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATCTCTGTGCCAGCCACAGTTCCGTCGAGTATGGCTACACCTTCGGTTCG	CASHSSVEYGYTF	In	VDJ	1	101	1.4972367828087568E-4	1.815638943118369E-4	39	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	8	3	5	5	1	10	18	27	32	28	42														CASHSSVEYGYTF+TCRBV07-02+TCRBJ01-02	TCRBV07-02*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTCGTGGTGGGGAAACACCATATATTTTGGAGAG	CASSSWWGNTIYF	In	VDJ	1	119	1.7640710609330898E-4	2.139218160703821E-4	39	TCRBV07	TCRBV07-02	01				TCRBJ01	TCRBJ01-03	01	4	0	10	4	3	3	18	31	36	34	39				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSWWGNTIYF+TCRBV07-02+TCRBJ01-03	TCRBV07-02*01		TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCACCGGGCCAAATTCACCCCTCCACTTTGGGAAC	CASSTGPNSPLHF	In	VDJ	1	148	2.193970731244515E-4	2.6605402334803824E-4	39	TCRBV07	TCRBV07-02	01				TCRBJ01	TCRBJ01-06	01	5	8	0	7	3	2	18	30	37	33	39				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSTGPNSPLHF+TCRBV07-02+TCRBJ01-06	TCRBV07-02*01		TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGGGGGGACAGCTCCTACGAGCAGTACTTCGGGCCG	CASRGDSSYEQYF	In	VDJ	1	205	3.0389459453049024E-4	3.685207755834313E-4	39	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	5	0	2	0	18	29	-1	31	38														CASRGDSSYEQYF+TCRBV07-02+TCRBJ02-07	TCRBV07-02*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGTGGGAGGGGGCTCCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	44	6.522615687483693E-5		46	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-05	01	5	5	0	3	6	2	18	30	43	36	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCCCCCGTTCTAGCGGGGGGGCCTACGAGCAGTACTTCGGGCCG	CASSSPRSSGGAYEQYF	In	VDJ	1	44	6.522615687483693E-5	7.90971420764438E-5	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	4	0	2	9	0	18	31	-1	40	52														CASSSPRSSGGAYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCACAGAACGAGCTAACTATGGCTACACCTTCGGTTCG	CASSFTERANYGYTF	In	VDJ	1	44	6.522615687483693E-5	7.90971420764438E-5	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	3	5	0	1	6	18	32	37	33	43														CASSFTERANYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGAAATAGGGTATGGGGTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	44	6.522615687483693E-5		47	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-05	01	3	5	3	6	6	7	18	32	42	38	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCTTAAAAAGGACAGGTTCTAATGAAAAACTGTTTTTTGGCAGT	CARSLKRTGSNEKLFF	In	VDJ	1	45	6.670856953108322E-5	8.089480439636297E-5	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	1	4	3	4	2	18	33	44	37	46														CARSLKRTGSNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACCATTAGGATTTGACGGAGCGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	46	6.819098218732952E-5		50	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	7	10	2	2	15	1	18	28	47	43	48														X+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCATGGGCCCACCCCCCTACGAGCAGTACTTCGGGCCG	CASSMGPPPYEQYF	In	VDJ	1	46	6.819098218732952E-5	8.269246671628214E-5	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	8	0	2	2	7	18	30	36	32	43														CASSMGPPPYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGCCAGGGGGCAACTGAAGCTTTCTTTGGACAA	CASSLGQGATEAFF	In	VDJ	1	46	6.819098218732952E-5	8.269246671628214E-5	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	4	0	5	2	1	18	34	44	36	45														CASSLGQGATEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGCAGGGGGCTATGGAGAGACCCAGTACTTCGGGCCA	CASSLAGGYGETQYF	In	VDJ	1	46	6.819098218732952E-5	8.269246671628214E-5	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	4	0	4	2	5	18	32	42	34	47														CASSLAGGYGETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCATTCCGAGGGAAGGGTTGGAGCAGCTTTCTTTGGACAA	CASSHSEGRVGAAFF	In	VDJ	1	47	6.967339484357581E-5	8.449012903620132E-5	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	11	0	10	6	12	18	30	41	36	53														CASSHSEGRVGAAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCTGGACAGGGGGGATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	48	7.115580749982211E-5		41	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	1	1	8	4	1	18	30	44	34	45														X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTAGTTGCGACTAATGAAAAACTGTTTTTTGGCAGT	CASSLVATNEKLFF	In	VDJ	1	48	7.115580749982211E-5	8.62877913561205E-5	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	1	7	6	2	2	0	18	34	-1	36	39						01,02								CASSLVATNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD02-01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTACGGGACGAGGAATTCACCCCTCCACTTTGGGAAC	CASSYGTRNSPLHF	In	VDJ	1	48	7.115580749982211E-5	8.62877913561205E-5	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-06	01	4	0	7	7	2	4	18	31	38	33	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYGTRNSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01		TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCGGTCCTACGAGCAGTCATAACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	48	7.115580749982211E-5		52	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	4	4	5	2	13	6	18	31	47	44	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGACTAGTGTTGGGACAGATACGCAGTATTTTGGCCCA	CASSLGTSVGTDTQYF	In	VDJ	1	48	7.115580749982211E-5	8.62877913561205E-5	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	1	8	3	0	7	18	-1	41	34	48						01,02								CASSLGTSVGTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTGACTAGCCGGTACAATGAGCAGTTCTTCGGGCCA	CASSLVTSRYNEQFF	In	VDJ	1	48	7.115580749982211E-5	8.62877913561205E-5	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	2	7	4	1	3	18	34	42	35	45						01,02								CASSLVTSRYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTGGTGGGAGCGGGCACAGATACGCAGTATTTTGGCCCA	CASSLVVGAGTDTQYF	In	VDJ	1	48	7.115580749982211E-5	8.62877913561205E-5	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	6	5	1	7	0	18	34	-1	41	46						01,02								CASSLVVGAGTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGGCCGGGACTTCCGAACACTGAAGCTTTCTTTGGACAA	CASRPGLPNTEAFF	In	VDJ	1	48	7.115580749982211E-5	8.62877913561205E-5	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	0	10	1	3	3	18	29	38	32	41						01,02								CASRPGLPNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGCAGGGCTGAACACTGAAGCTTTCTTTGGACAA	CASSQAGLNTEAFF	In	VDJ	1	49	7.26382201560684E-5	8.808545367603968E-5	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	3	0	4	1	18	30	39	34	40														CASSQAGLNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTCGGACACTCCTATAATTCACCCCTCCACTTTGGGAAC	CASSLGHSYNSPLHF	In	VDJ	1	49	7.26382201560684E-5	8.808545367603968E-5	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	1	6	0	3	0	18	30	-1	33	38														CASSLGHSYNSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGATGAGTCGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLDESSSYNEQFF	In	VDJ	1	49	7.26382201560684E-5	8.808545367603968E-5	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	11	2	0	1	5	18	35	39	36	44														CASSLDESSSYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATTAGCGGGGGGCCTTAATGAGCAGTTCTTCGGGCCA	CASSLLAGGLNEQFF	In	VDJ	1	49	7.26382201560684E-5	8.808545367603968E-5	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	5	1	7	1	4	18	33	44	34	48														CASSLLAGGLNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGGGCAGGGGAACAGCCCCAGCATTTTGGTGAT	CASSLGAGEQPQHF	In	VDJ	1	49	7.26382201560684E-5	8.808545367603968E-5	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	2	7	5	2	18	32	43	37	45														CASSLGAGEQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTCGGACTAGCGGGGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	50	7.41206328123147E-5		44	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	1	3	3	4	0	18	30	-1	34	46														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGTAAATAGCGGGGGAGTCCTGCGGGAGACCCAGTACTTCGGGCCA	CASSVNSGGVLRETQYF	In	VDJ	1	50	7.41206328123147E-5	8.988311599595886E-5	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	5	2	5	5	10	18	30	44	35	54														CASSVNSGGVLRETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCAGGACTCACTCCGGGACAGAGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	50	7.41206328123147E-5		53	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	5	1	13	1	18	31	51	44	52														X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCTCCTTACTAGCGGGGAAGCAAGAGACCCAGTACTTCGGGCCA	CASSSSLLAGKQETQYF	In	VDJ	1	50	7.41206328123147E-5	8.988311599595886E-5	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	3	3	2	7	3	18	31	48	38	51														CASSSSLLAGKQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATCGTACAGGGTCTCTGAAGCTTTCTTTGGACAA	CASSLSYRVSEAFF	In	VDJ	1	50	7.41206328123147E-5	8.988311599595886E-5	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	3	6	4	3	18	33	43	37	46														CASSLSYRVSEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGGGACACGGTGAAGAGACCCAGTACTTCGGGCCA	CASSPGHGEETQYF	In	VDJ	1	51	7.560304546856099E-5	9.168077831587803E-5	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	6	3	2	5	18	30	38	32	43														CASSPGHGEETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTGGACAGACCCTGGAAACACCATATATTTTGGAGAG	CASSWTDPGNTIYF	In	VDJ	1	51	7.560304546856099E-5	9.168077831587803E-5	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	1	5	2	0	3	18	-1	37	31	40														CASSWTDPGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTGGGGCGGGGACAGTGGTTATGGCTACACCTTCGGTTCG	CASSWGGDSGYGYTF	In	VDJ	1	51	7.560304546856099E-5	9.168077831587803E-5	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	5	5	6	4	18	31	44	37	48														CASSWGGDSGYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGACTCTCTCTAGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSLGLSLGSTDTQYF	In	VDJ	1	51	7.560304546856099E-5	9.168077831587803E-5	51	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	1	5	3	0	10	0	18	34	-1	44	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGLSLGSTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAGGGGGGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSLRGGSTDTQYF	In	VDJ	1	52	7.708545812480728E-5	9.34784406357972E-5	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	9	0	0	1	1	18	33	41	34	42														CASSLRGGSTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTCGGGGCGGTGATGAACACTGAAGCTTTCTTTGGACAA	CASSLVGAVMNTEAFF	In	VDJ	1	52	7.708545812480728E-5	9.34784406357972E-5	48	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	1	7	0	0	2	5	18	34	41	36	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVGAVMNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGACAGGGAAAGGAAAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	52	7.708545812480728E-5		47	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	1	3	2	0	7	18	-1	40	32	47														X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCATCAGACAGGGGCGCCAACTATGGCTACACCTTCGGTTCG	CASSPSDRGANYGYTF	In	VDJ	1	53	7.856787078105358E-5	9.527610295571638E-5	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	2	2	6	4	18	30	44	36	48														CASSPSDRGANYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGACTAGGTGGGGACACTGAAGCTTTCTTTGGACAA	CASSRLGGDTEAFF	In	VDJ	1	53	7.856787078105358E-5	9.527610295571638E-5	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	2	8	3	1	6	18	30	37	31	43						01,02								CASSRLGGDTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGGGACTGGAGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CASSRDWSSYNSPLHF	In	VDJ	1	53	7.856787078105358E-5	9.527610295571638E-5	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	5	0	10	0	1	4	18	30	37	31	41						01,02								CASSRDWSSYNSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD02-01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGCCGACAGGTGGAAATGAGCAGTTCTTCGGGCCA	CASSSPTGGNEQFF	In	VDJ	1	53	7.856787078105358E-5	9.527610295571638E-5	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	2	4	7	4	4	18	31	41	35	45														CASSSPTGGNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAACCCCAGGCAGGGCCACCGGGGAGCTGTTTTTTGGAGAA	CASSLTPGRATGELFF	In	VDJ	1	53	7.856787078105358E-5	9.527610295571638E-5	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	4	3	4	8	1	18	33	46	41	47														CASSLTPGRATGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTTTCTTAGACTAACGTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSLVS*TNVAKNIQYF	Stop	VDJ	1	53	7.856787078105358E-5		54	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	1	2	9	0	7	4	18	34	46	41	50						01,02								CASSLVS*TNVAKNIQYF+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01	TCRBD02-01	TCRBJ02-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCGGGGGACGTACGAACACTGAAGCTTTCTTTGGACAA	CASSFGGRTNTEAFF	In	VDJ	1	53	7.856787078105358E-5	9.527610295571638E-5	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	8	2	1	0	6	18	-1	38	32	44														CASSFGGRTNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCCGGGGGACCGTGGGAACTAATGAAAAACTGTTTTTTGGCAGT	CASSPRGTVGTNEKLFF	In	VDJ	1	54	8.005028343729987E-5	9.707376527563557E-5	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	5	8	2	1	3	8	18	30	39	33	47														CASSPRGTVGTNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGGGGACAGCATACGATGAACACTGAAGCTTTCTTTGGACAA	CASSRGQHTMNTEAFF	In	VDJ	1	54	8.005028343729987E-5	9.707376527563557E-5	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	5	0	2	7	18	30	39	32	46														CASSRGQHTMNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTGCTAGCGGGGGGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSC*RGGSYNEQFF	Stop	VDJ	1	54	8.005028343729987E-5		48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	4	0	0	1	0	18	31	-1	32	44														CASSC*RGGSYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTGTATAGGGAGGGATCCCTCAATGAGCAGTTCTTCGGGCCA	CASSLVYREGSLNEQFF	In	VDJ	1	54	8.005028343729987E-5	9.707376527563557E-5	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	9	0	6	6	6	18	34	47	40	53														CASSLVYREGSLNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGTCGGGGGGCACAATGGCTACACCTTCGGTTCG	CASSLVGGHNGYTF	In	VDJ	1	54	8.005028343729987E-5	9.707376527563557E-5	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	3	8	1	6	3	4	18	32	42	35	46														CASSLVGGHNGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTGGGGACAGGGCAGCGGCACAGATACGCAGTATTTTGGCCCA	CASSWGQGSGTDTQYF	In	VDJ	1	55	8.153269609354617E-5	9.887142759555474E-5	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	0	3	1	1	5	18	31	41	32	46														CASSWGQGSGTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGAATGGCTGGAAACACCATATATTTTGGAGAG	CASSLGMAGNTIYF	In	VDJ	1	55	8.153269609354617E-5	9.887142759555474E-5	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-03	01	3	0	8	2	0	4	18	-1	36	32	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGMAGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01		TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCATCCCTGGGAATATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	55	8.153269609354617E-5		44	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-05	01	7	0	8	0	5	3	18	28	37	33	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGGAGGGTTGAACAATCAGCCCCAGCATTTTGGTGAT	CASSGGLNNQPQHF	In	VDJ	1	56	8.301510874979246E-5	1.0066908991547392E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	5	10	0	3	0	5	18	-1	36	30	41														CASSGGLNNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGTTCGGGACATTTCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSVRDISNTGELFF	In	VDJ	1	56	8.301510874979246E-5	1.0066908991547392E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	6	0	4	3	18	30	40	34	43														CASSVRDISNTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAACCCGCGGGGGGGTCTAGATACGCAGTATTTTGGCCCA	CASSLNPRGGLDTQYF	In	VDJ	1	56	8.301510874979246E-5	1.0066908991547392E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	7	0	5	5	3	18	33	47	38	50														CASSLNPRGGLDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCATCCTTGGCGGCACGAACACTGAAGCTTTCTTTGGACAA	CASSILGGTNTEAFF	In	VDJ	1	57	8.449752140603876E-5	1.024667522353931E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	7	5	1	7	3	18	30	41	37	44						01,02								CASSILGGTNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGGAGGGGGCCTAACACTGAAGCTTTCTTTGGACAA	CASSRRGPNTEAFF	In	VDJ	1	57	8.449752140603876E-5	1.024667522353931E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	5	0	2	3	2	18	30	40	33	42														CASSRRGPNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTCCCCGGACTGAATTCACCCCTCCACTTTGGGAAC	CASSLPGLNSPLHF	In	VDJ	1	57	8.449752140603876E-5	1.024667522353931E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	5	1	10	7	6	1	18	30	41	36	42						01,02								CASSLPGLNSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD02-01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAATACCTTCCAGGGATCCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	57	8.449752140603876E-5		47	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	3	4	8	3	18	33	46	41	49														X+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACAGGGGGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLQGANTGELFF	In	VDJ	1	57	8.449752140603876E-5	1.024667522353931E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	4	1	0	0	0	18	-1	-1	33	40														CASSLQGANTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCGGGATGTCTAGCGGCACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	57	8.449752140603876E-5		50	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	4	5	3	8	1	18	32	47	40	48						01,02								X+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGGGACCCCGAGAACACCATATATTTTGGAGAG	CASSLGDPENTIYF	In	VDJ	1	57	8.449752140603876E-5	1.024667522353931E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-03	01	3	0	7	7	2	6	18	32	39	34	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGDPENTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01		TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGTACAGGGGGCCTATGGCTACACCTTCGGTTCG	CASSLVQGAYGYTF	In	VDJ	1	57	8.449752140603876E-5	1.024667522353931E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	3	0	4	3	0	18	32	-1	35	44														CASSLVQGAYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACTAGCGGCATAGTCACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	58	8.597993406228505E-5		52	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	7	4	5	5	0	15	18	-1	35	28	50						01,02								X+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD02-01	TCRBJ02-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGGACAGGAAAACAATTCACCCCTCCACTTTGGGAAC	CASSGQENNSPLHF	In	VDJ	1	58	8.597993406228505E-5	1.0426441455531227E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	1	4	7	0	5	18	-1	37	30	42														CASSGQENNSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAGTCCTGGCTAGCGGGGGGCCGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	58	8.597993406228505E-5		59	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	4	1	0	8	3	18	33	52	41	55														X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCTCCGGGACAACTATCTATGGCTACACCTTCGGTTCG	CASSSSGTTIYGYTF	In	VDJ	1	59	8.746234671853134E-5	1.0606207687523144E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	6	4	5	5	18	31	42	36	47														CASSSSGTTIYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAACTAGCGGGGGGGACAGATACGCAGTATTTTGGCCCA	CASSLELAGGTDTQYF	In	VDJ	1	59	8.746234671853134E-5	1.0606207687523144E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	3	0	3	0	0	18	-1	-1	35	48														CASSLELAGGTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGACCCGCAGGCGAGGAGGGGCTACACCTTCGGTTCG	CASSLDPQARRGYTF	In	VDJ	1	59	8.746234671853134E-5	1.0606207687523144E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	0	10	1	8	11	0	18	35	-1	46	51														CASSLDPQARRGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGCCCCACCGACAGGGGTCCTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	59	8.746234671853134E-5		52	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	2	0	8	2	18	32	48	40	50														X+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGGGGTACAGGGTCTTTGGGCACTGAAGCTTTCTTTGGACAA	CASSLGGTGSLGTEAFF	In	VDJ	1	59	8.746234671853134E-5	1.0606207687523144E-4	51	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	3	3	3	4	7	8	18	32	45	39	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGGTGSLGTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACCTCGTACAGGGGGTAAAGGGAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	60	8.894475937477764E-5		46	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	3	1	7	6	7	18	28	42	34	49														X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCACAACCCTCGCGGGCCTACAATGAGCAGTTCTTCGGGCCA	CASSSQPSRAYNEQFF	In	VDJ	1	60	8.894475937477764E-5	1.0785973919515063E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	7	4	2	10	0	18	31	-1	41	46						01,02								CASSSQPSRAYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCCCCGGCAACACAGATACGCAGTATTTTGGCCCA	CASSSPGNTDTQYF	In	VDJ	1	60	8.894475937477764E-5	1.0785973919515063E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	4	9	0	2	5	2	18	31	39	36	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSPGNTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTGGACTGGGCTATGTCACCGGGGAGCTGTTTTTTGGAGAA	CASSPGLGYVTGELFF	In	VDJ	1	61	9.042717203102393E-5	1.096574015150698E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	1	10	4	3	9	18	30	38	33	47						01,02								CASSPGLGYVTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGTGGACAGGGGGCTTACGAGCAGTACTTCGGGCCG	CASSRGQGAYEQYF	In	VDJ	1	61	9.042717203102393E-5	1.096574015150698E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	0	4	3	1	18	30	44	33	45														CASSRGQGAYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGACTAAATCCGGGACAGGGGTTTTACGAGCAGTACTTCGGGCCG	CASRLNPGQGFYEQYF	In	VDJ	1	62	9.190958468727023E-5	1.1145506383498898E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	2	4	9	3	18	29	48	38	51														CASRLNPGQGFYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCATATGACAGGGTGGCGATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	62	9.190958468727023E-5		46	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	2	3	5	5	5	18	30	42	35	47														X+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGAAACCAAGGGGCCACCGGGGAGCTGTTTTTTGGAGAA	CASSLGNQGATGELFF	In	VDJ	1	62	9.190958468727023E-5	1.1145506383498898E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	5	2	4	7	1	18	34	46	41	47														CASSLGNQGATGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTGATTTAGCGGGGGTTTACTACGAGCAGTACTTCGGGCCG	CASSFDLAGVYYEQYF	In	VDJ	1	62	9.190958468727023E-5	1.1145506383498898E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	5	2	3	5	4	18	32	46	37	50														CASSFDLAGVYYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGGGTAACACGGGGGGCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	62	9.190958468727023E-5		41	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	6	8	1	4	7	0	18	29	-1	36	43														X+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCGGGACAGCCTTGGGCGGCTACACCTTCGGTTCG	CASSSGTALGGYTF	In	VDJ	1	63	9.339199734351652E-5	1.1325272615490816E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	5	8	2	8	18	31	40	33	48														CASSSGTALGGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGGGACCCGGGACAGGGAACCGGGGAGCTGTTTTTTGGAGAA	CASRDPGQGTGELFF	In	VDJ	1	63	9.339199734351652E-5	1.1325272615490816E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	0	3	5	6	1	18	29	44	35	45														CASRDPGQGTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCACGCACTAGCGCCCGGTGCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	64	9.487440999976282E-5		50	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	3	6	4	5	7	18	30	42	35	49						01,02								X+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCACGACAGGACAAAACTATGGCTACACCTTCGGTTCG	CASSSTTGQNYGYTF	In	VDJ	1	64	9.487440999976282E-5	1.1505038847482733E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	4	2	4	4	18	31	41	35	45														CASSSTTGQNYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGACGACCAGCGGGATACGCAGTATTTTGGCCCA	CASSLDDQRDTQYF	In	VDJ	1	64	9.487440999976282E-5	1.1505038847482733E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	6	5	6	5	0	18	35	-1	40	45						01,02								CASSLDDQRDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATATCAGGGCCCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	64	9.487440999976282E-5		44	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	4	3	3	3	2	18	33	41	36	43														X+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCCAGCCGGGGGGCAGGCAATGAGCAGTTCTTCGGGCCA	CASSASRGAGNEQFF	In	VDJ	1	65	9.635682265600911E-5	1.1684805079474652E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	8	1	6	6	4	18	30	43	36	47														CASSASRGAGNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCGGGGGCACTCATAACTATGGCTACACCTTCGGTTCG	CASSSGGTHNYGYTF	In	VDJ	1	66	9.783923531225541E-5	1.1864571311466569E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-02	01	4	6	0	1	2	5	18	31	39	33	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSGGTHNYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGAGTCAGGGGACTATGGCTACACCTTCGGTTCG	CASSLESGDYGYTF	In	VDJ	1	66	9.783923531225541E-5	1.1864571311466569E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	2	3	5	0	18	32	-1	37	43														CASSLESGDYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGTTTCGGGTACCAAGAGACCCAGTACTTCGGGCCA	CASSLGFGYQETQYF	In	VDJ	1	66	9.783923531225541E-5	1.1864571311466569E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	8	4	0	6	1	18	32	42	38	43						01,02								CASSLGFGYQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCTTCCAGGGGAAATTCACCCCTCCACTTTGGGAAC	CASSSSRGNSPLHF	In	VDJ	1	67	9.93216479685017E-5	1.2044337543458487E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	4	2	7	4	1	18	31	41	35	42														CASSSSRGNSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACCCCCCCAGACACTCAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	68	1.0080406062474798E-4		43	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	2	6	2	8	3	18	28	40	36	43														X+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTATACAATGGGGCTAGCGGGGGCCGAAATCCAAGAGACCCAGTACTTCGGGCCA	CASSYTMGLAGAEIQETQYF	In	VDJ	1	68	1.0080406062474798E-4	1.2224103775450404E-4	60	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	4	2	1	11	7	18	31	52	42	59														CASSYTMGLAGAEIQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCGGGACAGGCTCCTACGAGCAGTACTTCGGGCCG	CASSSGTGSYEQYF	In	VDJ	1	68	1.0080406062474798E-4	1.2224103775450404E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	4	0	2	0	18	31	-1	33	41														CASSSGTGSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGAAGCGACAGGGGAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	68	1.0080406062474798E-4		46	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	2	2	6	0	18	32	-1	38	46														X+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTAGACAGGGGGGTGATGGCTACACCTTCGGTTCG	CASSFRQGGDGYTF	In	VDJ	1	68	1.0080406062474798E-4	1.2224103775450404E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	1	6	2	3	18	32	43	34	46														CASSFRQGGDGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCTAGCAGCCTGGGGTTTTACAAGGTAGCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	68	1.0080406062474798E-4		47	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	5	6	2	4	2	13	18	30	36	32	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAATCCACAGGGTTACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	69	1.0228647328099429E-4		46	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	3	3	3	6	2	18	30	42	36	44														X+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGATGTCGGGGTAGGTGAGCAGTTCTTCGGGCCA	CASSLDVGVGEQFF	In	VDJ	1	69	1.0228647328099429E-4	1.2403870007442322E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	8	3	9	3	4	18	35	43	38	47														CASSLDVGVGEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGCCGGGGGGTACAATGAGCAGTTCTTCGGGCCA	CASSLAGGYNEQFF	In	VDJ	1	69	1.0228647328099429E-4	1.2403870007442322E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	8	1	4	3	0	18	32	-1	35	42														CASSLAGGYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTGGGACAGCAAAAACTGAAGCTTTCTTTGGACAA	CASSFGTAKTEAFF	In	VDJ	1	69	1.0228647328099429E-4	1.2403870007442322E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	5	5	1	5	18	32	40	33	45														CASSFGTAKTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAGGCAGGGACTGGAAACACCATATATTTTGGAGAG	CASSQAGTGNTIYF	In	VDJ	1	70	1.0376888593724057E-4	1.258363623943424E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	4	3	2	4	1	18	30	39	34	40														CASSQAGTGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGCTCCGGGACACCGTGCCGGGAGCCCAGCATTTTGGTGAT	CASSLLRDTVPGAQHF	In	VDJ	1	70	1.0376888593724057E-4	1.258363623943424E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-05	01	3	0	6	11	5	12	18	32	43	37	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLLRDTVPGAQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCGGGACAGAGTATGAAAAACTGTTTTTTGGCAGT	CASSSGTEYEKLFF	In	VDJ	1	71	1.0525129859348688E-4	1.2763402471426157E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	0	5	6	2	3	18	31	40	33	43														CASSSGTEYEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGACATCAGGCACAGATACGCAGTATTTTGGCCCA	CASSLGTSGTDTQYF	In	VDJ	1	71	1.0525129859348688E-4	1.2763402471426157E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	1	6	1	0	4	18	-1	39	34	43														CASSLGTSGTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATCACTACACAGGGGTTTGAACACTGAAGCTTTCTTTGGACAA	CASSLSLHRGLNTEAFF	In	VDJ	1	71	1.0525129859348688E-4	1.2763402471426157E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	2	0	7	2	18	33	47	40	49														CASSLSLHRGLNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGTTGGCGGTCTCGCATGAGCAGTTCTTCGGGCCA	CASSLLAVSHEQFF	In	VDJ	1	71	1.0525129859348688E-4	1.2763402471426157E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	7	5	8	4	6	18	32	40	36	46						01,02								CASSLLAVSHEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCGACAGTTTAGAGGCCACTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	72	1.0673371124973316E-4		47	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	2	5	3	2	11	18	31	38	33	49														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGGGGAGCGGAAATGGCTACACCTTCGGTTCG	CASSLGGSGNGYTF	In	VDJ	1	72	1.0673371124973316E-4	1.2943168703418074E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-02	01	1	6	1	6	0	7	18	-1	39	34	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGGSGNGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTGTGACAGGGTTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	72	1.0673371124973316E-4		46	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	2	3	1	3	1	18	32	42	35	43														X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCCGAGGAGCGTTCGATCAAGAGACCCAGTACTTCGGGCCA	CASRGAFDQETQYF	In	VDJ	1	72	1.0673371124973316E-4	1.2943168703418074E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	8	6	6	2	5	6	18	27	36	32	42						01,02								CASRGAFDQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCACGCGGGGGCCCCCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	73	1.0821612390597947E-4		44	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	7	2	2	2	4	18	30	39	32	43														X+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAACAGGGCCGGGGACTGAAGCTTTCTTTGGACAA	CASSLTGPGTEAFF	In	VDJ	1	73	1.0821612390597947E-4	1.3122934935409992E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	3	5	0	6	18	-1	39	33	45														CASSLTGPGTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGAACAGGGCCGAAAAACTGTTTTTTGGCAGT	CASSLGNRAEKLFF	In	VDJ	1	73	1.0821612390597947E-4	1.3122934935409992E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	3	3	8	3	2	18	34	43	37	45														CASSLGNRAEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTACTTGGACAGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	73	1.0821612390597947E-4		46	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	1	5	0	5	0	18	34	-1	39	45														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTAGCCCCCCGACAGGCTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	74	1.0969853656222575E-4		50	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	4	0	11	1	18	30	47	41	48														X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTGGGGGGGACGGGAGCTAGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	74	1.0969853656222575E-4		50	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	9	0	0	0	11	18	-1	38	31	49														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGGGCCGCTATAATTCACCCCTCCACTTTGGGAAC	CASSLGGRYNSPLHF	In	VDJ	1	75	1.1118094921847204E-4	1.348246739939383E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	1	7	0	3	0	2	18	-1	39	34	41														CASSLGGRYNSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCCTCGACAGAGACTATGGCTACACCTTCGGTTCG	CASSSLDRDYGYTF	In	VDJ	1	76	1.1266336187471834E-4	1.3662233631385747E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	5	3	5	2	18	31	41	36	43														CASSSLDRDYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAGGGACAGGGGGCTTTTAGCTACACCTTCGGTTCG		Out	VDJ	1	76	1.1266336187471834E-4		44	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	0	0	9	1	5	18	33	46	34	51														X+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTCCATGGGGACTAGCGGGGGACAATGAGCAGTTCTTCGGGCCA	CASSPWGLAGDNEQFF	In	VDJ	1	76	1.1266336187471834E-4	1.3662233631385747E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	0	2	5	6	0	18	29	-1	35	49														CASSPWGLAGDNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGTTGGCAGGGGAACTGAAGCTTTCTTTGGACAA	CASSLVGRGTEAFF	In	VDJ	1	77	1.1414577453096463E-4	1.3841999863377664E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	2	5	6	1	18	32	44	38	45														CASSLVGRGTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCAAGGACTCTTACCTACGAGCAGTACTTCGGGCCG	CASSPRTLTYEQYF	In	VDJ	1	78	1.1562818718721093E-4	1.4021766095369582E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	1	10	2	4	4	18	30	39	34	43						01,02								CASSPRTLTYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCACCGGGGGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPPGGSYNEQFF	In	VDJ	1	78	1.1562818718721093E-4	1.4021766095369582E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	8	1	0	4	0	18	30	-1	34	41														CASSPPGGSYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCAGGGGGCGCGGGGTCTACAATGAGCAGTTCTTCGGGCCA	CASSPRGRGVYNEQFF	In	VDJ	1	78	1.1562818718721093E-4	1.4021766095369582E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	4	0	3	2	7	18	30	40	32	47														CASSPRGRGVYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCCAAGCAGGGGGCCAAGGACCCCTCCACTTTGGGAAC	CASSPQAGGQGPLHF	In	VDJ	1	78	1.1562818718721093E-4	1.4021766095369582E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	4	0	12	7	5	18	30	45	37	50														CASSPQAGGQGPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGACAGGACACTCACCCCTCCACTTTGGGAAC	CASSLGTGHSPLHF	In	VDJ	1	79	1.1711059984345722E-4	1.42015323273615E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	1	1	4	10	0	4	18	-1	41	34	45														CASSLGTGHSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGGGGGACGGCAGATACGCAGTATTTTGGCCCA	CASSLGGTADTQYF	In	VDJ	1	79	1.1711059984345722E-4	1.42015323273615E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	9	0	4	0	4	18	-1	39	32	43														CASSLGGTADTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGTCGCGGAGGCCTTAACACTGAAGCTTTCTTTGGACAA	CASSLGRGGLNTEAFF	In	VDJ	1	79	1.1711059984345722E-4	1.42015323273615E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	10	1	2	7	4	18	32	44	39	48														CASSLGRGGLNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTGGGGATCTGAACACTGAAGCTTTCTTTGGACAA	CASSFGDLNTEAFF	In	VDJ	1	79	1.1711059984345722E-4	1.42015323273615E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	3	0	8	0	2	2	18	32	38	34	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFGDLNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGACAGGGGCCGTGGGTGAGCAGTACTTCGGGCCG	CASSSTGAVGEQYF	In	VDJ	1	80	1.1859301249970352E-4	1.4381298559353417E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	2	2	7	1	8	18	31	40	32	48														CASSSTGAVGEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGACAGGGATAACTCCAACTACGAGCAGTACTTCGGGCCG	CASSLDRDNSNYEQYF	In	VDJ	1	80	1.1859301249970352E-4	1.4381298559353417E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	1	3	3	0	10	18	-1	40	32	50														CASSLDRDNSNYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGACTAGCGGGGGGGTCAGAGACCCAGTACTTCGGGCCA	CASSLGLAGGSETQYF	In	VDJ	1	80	1.1859301249970352E-4	1.4381298559353417E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	0	0	4	0	2	18	-1	48	32	50														CASSLGLAGGSETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCATTCAACAGGGGGCTTATGAAAAACTGTTTTTTGGCAGT	CASSIQQGAYEKLFF	In	VDJ	1	81	1.2007542515594981E-4	1.4561064791345334E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	3	0	6	5	2	18	30	44	35	46														CASSIQQGAYEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGTTGGGGTGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSQVGVDTGELFF	In	VDJ	1	81	1.2007542515594981E-4	1.4561064791345334E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-02	01	5	6	2	3	6	3	18	30	40	36	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQVGVDTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01		TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCCTCCTGCCTCGGGCAGACAATCAGCCCCAGCATTTTGGTGAT	CASSPLLPRADNQPQHF	In	VDJ	1	82	1.215578378121961E-4	1.4740831023337252E-4	51	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-05	01	5	8	0	3	13	3	18	30	47	43	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPLLPRADNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTGCATTAGGTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	82	1.215578378121961E-4		47	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-06	01	4	5	4	0	5	1	18	31	39	36	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01		TCRBJ02-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAGGGATCTAGGGACGCGGAAACTGTTTTTTGGCAGT	CASSRDLGTRKLFF	In	VDJ	1	83	1.230402504684424E-4	1.492059725532917E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-04	01	5	0	7	11	9	4	18	30	44	39	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRDLGTRKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01		TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAAGTCAATGGGATTGGCCAACGTCCTGACTTTCGGGGCC	CASSLKSMGLANVLTF	In	VDJ	1	83	1.230402504684424E-4	1.492059725532917E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-06	01	2	0	8	6	8	2	18	33	45	41	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLKSMGLANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01		TCRBJ02-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGACAGGGGGACATCGGGGAGCTGTTTTTTGGAGAA	CASSLGQGDIGELFF	In	VDJ	1	83	1.230402504684424E-4	1.492059725532917E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	2	1	7	0	4	18	-1	43	34	47														CASSLGQGDIGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATCTGAGGGGCGCTCCTACAATGAACAGTTCTTCGGGCCA	CASSLSEGRSYNEQFF	In	VDJ	1	83	1.230402504684424E-4	1.492059725532917E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	2	5	2	13	4	15	18	33	42	37	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSEGRSYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGCAGGAGAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	83	1.230402504684424E-4		41	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-06	01	3	4	4	7	3	2	18	32	39	35	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01		TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGTATAGCCGATCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	83	1.230402504684424E-4		47	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	3	5	7	0	3	4	18	32	39	35	43						01,02								X+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD02-01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGAGGGTAGACAGGGGGTGGCACTGAAGCTTTCTTTGGACAA	CASSRG*TGGGTEAFF	Stop	VDJ	1	84	1.245226631246887E-4		48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	1	4	8	3	18	30	47	38	50														CASSRG*TGGGTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGGAACACTTCCAGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	84	1.245226631246887E-4		44	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	5	1	8	1	1	9	18	30	34	31	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCCAGGGACAGGGATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	84	1.245226631246887E-4		46	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	3	0	4	1	18	30	43	34	44														X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGGGGACGGGCGGACCGGGGAGCTGTTTTTTGGAGAA	CASSGDGRTGELFF	In	VDJ	1	84	1.245226631246887E-4	1.5100363487321086E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-02	01	5	0	7	5	1	6	18	30	36	31	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGDGRTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01		TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGACTAGCGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSLGTSGGTDTQYF	In	VDJ	1	84	1.245226631246887E-4	1.5100363487321086E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	1	3	1	0	0	18	-1	-1	34	46														CASSLGTSGGTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCATAACCGGGACTGAGGGCAATGAGCAGTTCTTCGGGCCA	CASITGTEGNEQFF	In	VDJ	1	84	1.245226631246887E-4	1.5100363487321086E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	0	10	6	5	5	18	28	39	33	44						01,02								CASITGTEGNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCACGATGGGCAGCAATCAGCCCCAGCATTTTGGTGAT	CASSTMGSNQPQHF	In	VDJ	1	85	1.26005075780935E-4	1.5280129719313007E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	8	0	1	5	0	18	30	-1	35	39														CASSTMGSNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCAAGAGGGACAGGGGACAACTATGGCTACACCTTCGGTTCG	CASSSRGTGDNYGYTF	In	VDJ	1	85	1.26005075780935E-4	1.5280129719313007E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	2	2	5	2	18	31	46	36	48														CASSSRGTGDNYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGTCCGGTCATGAACACTGAAGCTTTCTTTGGACAA	CASSLGPVMNTEAFF	In	VDJ	1	85	1.26005075780935E-4	1.5280129719313007E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	8	5	0	3	3	18	34	40	37	43						01,02								CASSLGPVMNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGGTTTACAGGGGGCAAGAACACTGAAGCTTTCTTTGGACAA	CASRFTGGKNTEAFF	In	VDJ	1	85	1.26005075780935E-4	1.5280129719313007E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	0	1	4	2	18	29	42	33	44														CASRFTGGKNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCTAACGCTGCAATAGTCACAAAGCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	85	1.26005075780935E-4		52	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-06	01	8	3	6	5	16	4	18	27	46	43	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01		TCRBJ02-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCATAGATCATGGGGGGACTAGTAATATCCATGAGCAGTTCTTCGGGCCA	CASSIDHGGTSNIHEQFF	In	VDJ	1	86	1.274874884371813E-4	1.5459895951304924E-4	54	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	0	8	8	7	8	18	35	50	42	58						01,02								CASSIDHGGTSNIHEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCAATCCGGTCGGAGGAAACACCATATATTTTGGAGAG	CASSPNPVGGNTIYF	In	VDJ	1	86	1.274874884371813E-4	1.5459895951304924E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-03	01	5	1	8	4	12	0	18	30	-1	42	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPNPVGGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01		TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCAAAGGGACTAGCTGCAGATACGCAGTATTTTGGCCCA	CASSSKGLAADTQYF	In	VDJ	1	86	1.274874884371813E-4	1.5459895951304924E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	0	7	4	4	2	18	31	44	35	46						01,02								CASSSKGLAADTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGGGACAGAAGTCCTATGGCTACACCTTCGGTTCG	CASSSGQKSYGYTF	In	VDJ	1	86	1.274874884371813E-4	1.5459895951304924E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	5	4	1	5	18	31	39	32	44														CASSSGQKSYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGGACCGGACTCTCTGGAAACACCATATATTTTGGAGAG	CASSLGTGLSGNTIYF	In	VDJ	1	86	1.274874884371813E-4	1.5459895951304924E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-03	01	3	0	7	0	1	6	18	32	38	33	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGTGLSGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01		TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGGCTACCGGGACAGGGACAAGAGACCCAGTACTTCGGGCCA	CASRLPGQGQETQYF	In	VDJ	1	86	1.274874884371813E-4	1.5459895951304924E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	0	3	2	6	1	18	29	44	35	45														CASRLPGQGQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACTATGACTAGCGGGGTCACAGATACGCAGTATTTTGGCCCA	CASTMTSGVTDTQYF	In	VDJ	1	87	1.2896990109342757E-4	1.5639662183296842E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	7	2	3	2	4	1	18	28	43	32	44														CASTMTSGVTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTCTACCGGGACAGGGAGTACCATGGCTACACCTTCGGTTCG		Out	VDJ	1	87	1.2896990109342757E-4		46	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	3	6	6	6	18	29	44	35	50														X+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAGGACAGGATCTACAATGAGCAGTTCTTCGGGCCA	CASSQDRIYNEQFF	In	VDJ	1	88	1.3045231374967387E-4	1.581942841528876E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	1	4	3	2	2	18	30	39	32	41														CASSQDRIYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCGGGACTAGCGGGGGGGCGTACAATGAGCAGTTCTTCGGGCCA	CASSSGTSGGAYNEQFF	In	VDJ	1	88	1.3045231374967387E-4	1.581942841528876E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	0	0	4	2	2	18	31	49	33	51														CASSSGTSGGAYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGGGAAGTTCAGGGAGGTAAGGCCGAGCAGTACTTCGGGCCG	CASREVQGGKAEQYF	In	VDJ	1	89	1.3193472640592017E-4	1.5999194647280677E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	9	1	6	9	6	18	29	44	38	50														CASREVQGGKAEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTGTCGGACTAGCGGGGGCGGAAGATACGCAGTATTTTGGCCCA	CASSVGLAGAEDTQYF	In	VDJ	1	89	1.3193472640592017E-4	1.5999194647280677E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	1	2	5	4	4	18	29	46	33	50														CASSVGLAGAEDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCAGACCCGGGACGGCCTGGGAGACCCAGTACTTCGGGCCA	CASSPRPGTAWETQYF	In	VDJ	1	90	1.3341713906216645E-4	1.6178960879272594E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	5	0	7	5	9	7	18	30	44	39	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPRPGTAWETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCGGACTAGCGGGGGACTTAGAGACCCAGTACTTCGGGCCA	CASSPGLAGDLETQYF	In	VDJ	1	90	1.3341713906216645E-4	1.6178960879272594E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	1	2	4	3	4	18	30	46	33	50														CASSPGLAGDLETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTACAGGGTCTCGAACACTGAAGCTTTCTTTGGACAA	CASSYRVSNTEAFF	In	VDJ	1	90	1.3341713906216645E-4	1.6178960879272594E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	3	1	0	4	18	-1	37	31	41														CASSYRVSNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGGACAGGGCTTTCACAGCCCCAGCATTTTGGTGAT	CASSRTGLSQPQHF	In	VDJ	1	91	1.3489955171841275E-4	1.6358727111264511E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	1	3	7	1	6	18	30	39	31	45														CASSRTGLSQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGCGGGATAGCTCCTACGAGCAGTACTTCGGGCCG	CASSLRDSSYEQYF	In	VDJ	1	91	1.3489955171841275E-4	1.6358727111264511E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	7	3	0	0	3	18	-1	38	32	41														CASSLRDSSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCCTCCCCCCCGGGACAAGGGACTTTCTTTGGACAA	CASSASPPGQGTFF	In	VDJ	1	92	1.3638196437465905E-4	1.653849334325643E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	6	12	11	5	18	30	47	41	52														CASSASPPGQGTFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGGGGACAGGGGGGAATGAAAAACTGTTTTTTGGCAGT	CASSPGTGGNEKLFF	In	VDJ	1	93	1.3786437703090535E-4	1.6718259575248346E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	0	1	5	3	1	18	30	44	33	45														CASSPGTGGNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCCGGGGGGAAACAGGGTTGTCCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	93	1.3786437703090535E-4		44	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	8	8	1	7	0	13	18	-1	34	27	47														X+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGGGGACAGGAATCAGCGTCCTGACTTTCGGGGCC	CASSPGTGISVLTF	In	VDJ	1	94	1.3934678968715162E-4	1.6898025807240264E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	0	4	12	3	6	18	30	41	33	47														CASSPGTGISVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGGATTGGAGGGGCACTGAAGCTTTCTTTGGACAA	CASSSDWRGTEAFF	In	VDJ	1	96	1.4231161499964423E-4	1.72575582712241E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	10	0	4	6	1	18	31	43	37	44														CASSSDWRGTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCAGGGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSFRATNEKLFF	In	VDJ	1	96	1.4231161499964423E-4	1.72575582712241E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	4	3	0	0	0	18	-1	-1	32	37														CASSFRATNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTGGGGACAGGGGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLVGTGANTGELFF	In	VDJ	1	97	1.437940276558905E-4	1.743732450321602E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	0	2	0	2	0	18	34	-1	36	46														CASSLVGTGANTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCACCCTGGGGCACAGGGGAAATTCACCCCTCCACTTTGGGAAC	CASSTLGHRGNSPLHF	In	VDJ	1	98	1.452764403121368E-4	1.7617090735207936E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	3	2	7	10	1	18	30	47	40	48														CASSTLGHRGNSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCCTCGACAGGGGAGGAACTGAAGCTTTCTTTGGACAA	CASSPLDRGGTEAFF	In	VDJ	1	98	1.452764403121368E-4	1.7617090735207936E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	2	5	6	4	18	30	44	36	48														CASSPLDRGGTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTAAGATCAAGCGGGGGCATCCTACGAGCAGTACTTCGGGCCG	CASS*DQAGASYEQYF	Stop	VDJ	1	98	1.452764403121368E-4		48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	6	2	1	3	2	18	35	46	38	48														CASS*DQAGASYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGCTGGACACTGAACACTGAAGCTTTCTTTGGACAA	CASSLGWTLNTEAFF	In	VDJ	1	98	1.452764403121368E-4	1.7617090735207936E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	1	6	0	3	1	18	34	42	37	43														CASSLGWTLNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGACAGGGGATGAATACTGAAGCTTTCTTTGGACAA	CASSLGQGMNTEAFF	In	VDJ	1	98	1.452764403121368E-4	1.7617090735207936E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	2	5	0	6	18	-1	42	32	48														CASSLGQGMNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATTAAGCTCTGGGAGTATGTATGGCTACACCTTCGGTTCG	CASSLLSSGSMYGYTF	In	VDJ	1	99	1.467588529683831E-4	1.7796856967199854E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	2	9	2	5	9	4	18	33	47	42	51														CASSLLSSGSMYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGCCGAAATGAGCACAGATACGCAGTATTTTGGCCCA	CASSLAEMSTDTQYF	In	VDJ	1	99	1.467588529683831E-4	1.7796856967199854E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	9	0	0	0	7	18	-1	35	32	42														CASSLAEMSTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCAGTGAAGGGACAGGATCAACTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	100	1.482412656246294E-4		53	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	4	0	8	5	18	30	46	38	51														X+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGGGACAGCCTAGCACAGATACGCAGTATTTTGGCCCA	CASSPGQPSTDTQYF	In	VDJ	1	100	1.482412656246294E-4	1.7976623199191771E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	5	0	2	3	18	30	39	32	42														CASSPGQPSTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTCCCAAACGGGACAGAGAGTAGGACCTATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	100	1.482412656246294E-4		58	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	0	5	2	8	9	18	29	44	37	53														X+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGCCGGGCCAGGTGGCGAAAAACTGTTTTTTGGCAGT	CASSLAGPGGEKLFF	In	VDJ	1	101	1.4972367828087568E-4	1.815638943118369E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-04	01	3	4	4	8	8	4	18	32	44	40	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAGPGGEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01		TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCCCCGATGGAGACCTAGGGGAGCAGTTCTTCGGGCCA	CASSSPDGDLGEQFF	In	VDJ	1	102	1.5120609093712198E-4	1.8336155663175606E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	4	5	3	10	16	0	18	31	-1	47	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSPDGDLGEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCCCGACAGGGTACTATGGCTACACCTTCGGTTCG	CASSFPTGYYGYTF	In	VDJ	1	102	1.5120609093712198E-4	1.8336155663175606E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	3	3	3	1	18	32	42	35	43														CASSFPTGYYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCTCCTTAACCCGGGACAGGGGGCCTTGCTAAGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	102	1.5120609093712198E-4		58	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	0	0	1	10	8	18	27	49	37	57														X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCCGGCGGGCAGGGGGCTCCTACGAGCAGTACTTCGGGCCG	CASSPRRAGGSYEQYF	In	VDJ	1	103	1.5268850359336829E-4	1.8515921895167524E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	4	1	0	10	0	18	30	-1	40	47														CASSPRRAGGSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGGGGACAGGGGCACGCGACGAGCAGTACTTCGGGCCG	CASSPGTGARDEQYF	In	VDJ	1	103	1.5268850359336829E-4	1.8515921895167524E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	2	5	3	6	18	30	43	33	49														CASSPGTGARDEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAATTAGGGGACAGGGCCAAYAAATTCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	103	1.5268850359336829E-4		58	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	0	3	3	5	10	18	33	47	38	57														X+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACACGGACAGCAAGAGACCCAGTACTTCGGGCCA	CASSLHGQQETQYF	In	VDJ	1	103	1.5268850359336829E-4	1.8515921895167524E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	1	5	2	3	0	18	33	-1	36	42														CASSLHGQQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGCCTTCCGGGGGACGAGCAGTACTTCGGGCCG		Out	VDJ	1	104	1.5417091624961456E-4		41	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	8	2	5	7	0	18	32	-1	39	45														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAGGCGGGGGGGCCTTACAATGAGCAGTTCTTCGGGCCA	CASSQAGGPYNEQFF	In	VDJ	1	105	1.5565332890586086E-4	1.887545435915136E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	7	0	4	3	3	18	30	42	33	45														CASSQAGGPYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGCGGGACTTCTAGGGGTGAAAAACTGTTTTTTGGCAGT	CASSRGTSRGEKLFF	In	VDJ	1	105	1.5565332890586086E-4	1.887545435915136E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	5	0	10	7	3	8	18	30	39	33	47						01,02								CASSRGTSRGEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD02-01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCATCTCGACAGGGCTCCCTACGAGCAGTACTTCGGGCCG	CASSHLDRAPYEQYF	In	VDJ	1	106	1.5713574156210716E-4	1.9055220591143276E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	3	2	6	3	18	30	43	36	46														CASSHLDRAPYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGGGACAGGGAGCTCTGGAAACACCATATATTTTGGAGAG	CASSGTGSSGNTIYF	In	VDJ	1	106	1.5713574156210716E-4	1.9055220591143276E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	0	3	0	0	2	18	-1	39	30	41														CASSGTGSSGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGATGGGGGGAACTAATGAAAAACTGTTTTTTGGCAGT	CASSPMGGTNEKLFF	In	VDJ	1	107	1.5861815421835347E-4	1.9234986823135194E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	5	9	1	1	5	0	18	30	-1	35	41														CASSPMGGTNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTCGGGCGGGGTAACACTGAAGCTTTCTTTGGACAA	CASSLVGRGNTEAFF	In	VDJ	1	107	1.5861815421835347E-4	1.9234986823135194E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	1	7	3	2	4	1	18	34	44	38	45														CASSLVGRGNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAACACAGGGGAGGGGGTGAAAAACTGTTTTTTGGCAGT	CASSQHRGGGEKLFF	In	VDJ	1	109	1.6158297953084604E-4	1.9594519287119031E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-04	01	5	3	2	7	4	6	18	30	41	34	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQHRGGGEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01		TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCGGACGGTAGATACTTGAATTCACCCCTCCACTTTGGGAAC	CASSADGRYLNSPLHF	In	VDJ	1	109	1.6158297953084604E-4	1.9594519287119031E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-06	01	5	1	7	7	2	12	18	30	36	32	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSADGRYLNSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01		TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCTGGGGGGCACCACACTGAAGCTTTCTTTGGACAA	CASSSGGHHTEAFF	In	VDJ	1	109	1.6158297953084604E-4	1.9594519287119031E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	4	6	0	3	3	3	18	31	40	34	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSGGHHTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGGAGCCGATACAGGGGCGGGATGAAAAACTGTTTTTTGGCAGT	CASSPEPIQGRDEKLFF	In	VDJ	1	110	1.6306539218709234E-4	1.977428551911095E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	3	2	6	11	4	18	30	48	41	52														CASSPEPIQGRDEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTACGGGAACAGGGACGCCTATGGCTACACCTTCGGTTCG	CASSYGNRDAYGYTF	In	VDJ	1	110	1.6306539218709234E-4	1.977428551911095E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	3	3	4	6	4	18	31	43	37	47														CASSYGNRDAYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGCCTAGGGACACCACAGGCCCGGGGAGCTGTTTTTTGGAGAA	CASSLA*GHHRPGELFF	Stop	VDJ	1	112	1.6603021749958492E-4		51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	0	6	6	6	8	18	32	44	38	52														CASSLA*GHHRPGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTTTGACAGGACGCACCGGGGAGCTGTTTTTTGGAGAA	CASSLTGRTGELFF	In	VDJ	1	112	1.6603021749958492E-4	2.0133817983094784E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	2	4	4	3	3	18	29	38	32	41														CASSLTGRTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAATCTACAGGGAATCAGCCCCAGCATTTTGGTGAT	CASSQSTGNQPQHF	In	VDJ	1	113	1.6751263015583122E-4	2.03135842150867E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	3	3	4	6	0	18	30	-1	36	42														CASSQSTGNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGGAGCGGACAGGCCCGAAAATGAGCAGTACTTCGGGCCG	CASSGADRPENEQYF	In	VDJ	1	113	1.6751263015583122E-4	2.03135842150867E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	4	7	5	9	18	30	42	35	51														CASSGADRPENEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGGGACAGGGGGAAGTAACGAGCAGTACTTCGGGCCG		Out	VDJ	1	113	1.6751263015583122E-4		44	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	1	5	1	5	18	31	43	32	48														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCGGGACAGGGAACACTGAAGCTTTCTTTGGACAA	CASSSGTGNTEAFF	In	VDJ	1	114	1.6899504281207752E-4	2.049335044707862E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	4	1	2	0	18	31	-1	33	41														CASSSGTGNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCATCTCACAGGGAGAGAAGGGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	115	1.704774554683238E-4		52	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	3	3	1	5	8	18	30	41	35	49														X+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAATCCAAACAGGGATCCCCTTAATCCCCTCCACTTTGGGAAC	CASSNPNRDPLNPLHF	In	VDJ	1	116	1.719598681245701E-4	2.0852882911062454E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	3	3	13	7	11	18	30	43	37	54														CASSNPNRDPLNPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGCCCTATTCCGGGACAGGAAAAAGCTATGGCTACACCTTCGGTTCG	CASSLPYSGTGKSYGYTF	In	VDJ	1	116	1.719598681245701E-4	2.0852882911062454E-4	54	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	4	4	10	6	18	32	50	42	56														CASSLPYSGTGKSYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGATCTTGGCACGGCCAGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	118	1.7492469343706268E-4		46	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-02	01	0	9	0	8	4	7	18	35	42	39	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01		TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATCCCGAGGGGTGTCCTACGAGCAGTACTTCGGGCCG	CASSLSRGVSYEQYF	In	VDJ	1	118	1.7492469343706268E-4	2.1212415375046289E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	2	5	2	1	5	2	18	33	43	38	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSRGVSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTGCGTTCGGACAGGGTAAAAATGAGCAGTTCTTCGGGCCA	CASSPAFGQGKNEQFF	In	VDJ	1	122	1.8085434406204785E-4	2.193148030301396E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	1	3	7	9	4	18	30	47	39	51														CASSPAFGQGKNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAGACAGGGTGGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	123	1.8233675671829416E-4		47	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	0	2	3	1	0	2	18	-1	42	35	44														X+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCTCCTACACGTACGCGAGCACTGAAGCTTTCTTTGGACAA	CASSYTYASTEAFF	In	VDJ	1	123	1.8233675671829416E-4	2.211124653500588E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	8	3	6	4	4	10	18	27	34	31	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYTYASTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCGGACGCCGATGTGAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	124	1.8381916937454046E-4		49	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-05	01	5	1	7	1	3	9	18	30	37	33	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAGGGACAGGGGGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	124	1.8381916937454046E-4		47	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	1	0	0	0	18	-1	-1	35	46														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGATGCCGTCACCAATGAGCAGTTCTTCGGGCCA	CASSLDAVTNEQFF	In	VDJ	1	124	1.8381916937454046E-4	2.2291012766997796E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	0	3	7	6	7	0	18	35	-1	42	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDAVTNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCGGGTCACACGGGAAAGAGACCCAGTACTTCGGGCCA	CASSPGSHGKETQYF	In	VDJ	1	125	1.8530158203078673E-4	2.2470778998989714E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	8	3	3	11	0	18	30	-1	41	46														CASSPGSHGKETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCGGGACAGTATTTGAAAAACTGTTTTTTGGCAGT	CASSSGTVFEKLFF	In	VDJ	1	125	1.8530158203078673E-4	2.2470778998989714E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	0	5	7	2	4	18	31	40	33	44														CASSSGTVFEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAGCCGGGACAGGGGTATAACTAATGAAAAACTGTTTTTTGGCAGT	CASSSRDRGITNEKLFF	In	VDJ	1	128	1.8974881999952564E-4	2.3010077694965466E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	0	2	1	4	3	18	30	44	34	47														CASSSRDRGITNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTCTAGACTCCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	128	1.8974881999952564E-4		47	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	2	10	0	4	1	18	34	42	38	43						01,02								X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGACCGACCCCGGGACCCTCAGAAAAACTGTTTTTTGGCAGT	CASRPTPGPSEKLFF	In	VDJ	1	129	1.912312326557719E-4	2.3189843926957383E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-04	01	6	0	7	8	9	5	18	29	43	38	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRPTPGPSEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01		TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACGGGGGCGCGGGTTGGACGAGCAGTACTTCGGGCCG	CASSLRGRGLDEQYF	In	VDJ	1	130	1.9271364531201821E-4	2.3369610158949304E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	2	6	0	5	1	9	18	33	40	34	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLRGRGLDEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGCCACTAGCGGGGGGCAATGAGCAGTTCTTCGGGCCA	CASSLPLAGGNEQFF	In	VDJ	1	132	1.9567847062451082E-4	2.3729142622933139E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	3	1	6	3	0	18	32	-1	35	47														CASSLPLAGGNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCCCGTCGACAGATAACCACGAGCAGTACTTCGGGCCG	CASSSPSTDNHEQYF	In	VDJ	1	134	1.986432959370034E-4	2.4088675086916974E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	2	5	5	7	6	18	31	43	38	49														CASSSPSTDNHEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAGGGACTAGTATTCACAGATACGCAGTATTTTGGCCCA	CASSQGLVFTDTQYF	In	VDJ	1	135	2.001257085932497E-4	2.426844131890889E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	0	8	2	2	4	18	30	40	32	44						01,02								CASSQGLVFTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTRCCAGCAGCCCTGGGACAGGGCGAAGGGGCTACACCTTCGGTTCG	CXSSPGTGRRGYTF	In	VDJ	1	136	2.0160812124949597E-4	2.444820755090081E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	3	8	3	6	18	30	42	33	48														CXSSPGTGRRGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGAAGGGAACCCCTCGGGACTGAAGCTTTCTTTGGACAA	CASRREPLGTEAFF	In	VDJ	1	137	2.0309053390574227E-4	2.4627973782892726E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	6	0	8	5	2	10	18	29	35	31	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRREPLGTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTAATCTAGACGACTCTAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	137	2.0309053390574227E-4		46	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	4	2	10	4	9	2	18	31	44	40	46						01,02								X+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD02-01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTACAGAGACAGGTCCTTATTTCATGAACACTGAAGCTTTCTTTGGACAA	CASSTETGPYFMNTEAFF	In	VDJ	1	137	2.0309053390574227E-4	2.4627973782892726E-4	54	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	4	0	6	11	18	29	41	35	52														CASSTETGPYFMNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCAGGGACAGCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	138	2.0457294656198857E-4		44	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	0	5	0	3	0	18	30	-1	33	40														X+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTGGGACAGTGGCCACTGAAGCTTTCTTTGGACAA	CASSPGTVATEAFF	In	VDJ	1	138	2.0457294656198857E-4	2.4807740014884643E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	5	4	3	4	18	30	40	33	44														CASSPGTVATEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGAAGCACTAATGAAAAACTGTTTTTTGGCAGT	CASSLGSTNEKLFF	In	VDJ	1	140	2.0753777187448115E-4	2.516727247886848E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-04	01	3	0	8	2	0	3	18	-1	36	32	39				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGSTNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01		TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTCCCGGACAGGGGTACTACAATGAGCAGTTCTTCGGGCCA	CASSPGQGYYNEQFF	In	VDJ	1	141	2.0902018453072745E-4	2.5347038710860396E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	1	2	3	4	2	18	29	42	33	44														CASSPGQGYYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCTCCGGGACAGGGGGTGATTACTACGAGCAGTACTTCGGGCCG	CASSFSGTGGDYYEQYF	In	VDJ	1	142	2.1050259718697375E-4	2.5526804942852313E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	1	3	4	6	18	32	47	36	53														CASSFSGTGGDYYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTCAGGGGTCGAGCGGGGAGCTGTTTTTTGGAGAA	CASSFQGSSGELFF	In	VDJ	1	142	2.1050259718697375E-4	2.5526804942852313E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	4	2	7	1	5	18	32	39	33	44														CASSFQGSSGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGGCAGGGGGCGTGGATACGCAGTATTTTGGCCCA	CASSLGAGGVDTQYF	In	VDJ	1	146	2.1643224781195893E-4	2.6245869870819983E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	4	0	6	3	3	18	34	45	37	48														CASSLGAGGVDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCATAGCCTTCGACAGGGACGATGGCTACACCTTCGGTTCG	CASIAFDRDDGYTF	In	VDJ	1	147	2.179146604682052E-4	2.6425636102811906E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	2	3	6	8	3	18	28	43	36	46														CASIAFDRDDGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGAACAGGCTCTGGAAACACCATATATTTTGGAGAG	CASSLGTGSGNTIYF	In	VDJ	1	148	2.193970731244515E-4	2.6605402334803824E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	3	4	0	4	0	18	32	-1	36	41														CASSLGTGSGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGTCGGCGATGCCCGGGGAGCTGTTTTTTGGAGAA	CASSLSAMPGELFF	In	VDJ	1	151	2.2384431109319039E-4	2.7144701030779576E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-02	01	3	9	0	6	3	5	18	32	38	35	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSAMPGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01		TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCGATTGGGCGGGGGGCTACCACAATGAGCAGTTCTTCGGGCCA	CASSFDWAGGYHNEQFF	In	VDJ	1	152	2.253267237494367E-4	2.7324467262771493E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	7	1	5	7	5	18	32	47	39	52														CASSFDWAGGYHNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAGGCCGGACTAGCTCGTGAGCAGTTCTTCGGGCCA	CASSQAGLAREQFF	In	VDJ	1	156	2.3125637437442187E-4	2.8043532190739163E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	1	7	9	6	3	18	30	44	36	47						01,02								CASSQAGLAREQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCATTGACCGGGACACGGGGTGAAAAACTGTTTTTTGGCAGT	CASSPLTGTRGEKLFF	In	VDJ	1	156	2.3125637437442187E-4	2.8043532190739163E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	0	6	7	9	5	18	30	45	39	50														CASSPLTGTRGEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCGGGACAGCTAACACTGAAGCTTTCTTTGGACAA	CASSFGTANTEAFF	In	VDJ	1	158	2.3422119968691444E-4	2.8403064654723E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	5	2	1	2	18	32	40	33	42														CASSFGTANTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTAGCGGGGGGCGGTAATGAGCAGTTCTTCGGGCCA	CASSLVAGGGNEQFF	In	VDJ	1	162	2.4015085031189962E-4	2.912212958269067E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	5	1	7	0	4	18	-1	44	34	48														CASSLVAGGGNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTCCGGGACACGGAATCAGCGAGCAGTACTTCGGGCCG	CASSPPGHGISEQYF	In	VDJ	1	163	2.4163326296814592E-4	2.9301895814682586E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	6	6	5	9	18	30	41	35	50														CASSPPGHGISEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGGCGGTTGGCACTGAAGCTTTCTTTGGACAA	CASSLGAVGTEAFF	In	VDJ	1	163	2.4163326296814592E-4	2.9301895814682586E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	1	8	0	4	0	6	18	-1	38	34	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGAVGTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCCGACTAGCGGGGGACCTAACTGGGAGCAGTACTTCGGGCCG		Out	VDJ	1	164	2.431156756243922E-4		44	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	8	2	2	7	1	10	18	27	40	28	50														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAGACCGGATAGCTCTGGAAACACCATATATTTTGGAGAG	CASSRPDSSGNTIYF	In	VDJ	1	165	2.445980882806385E-4	2.966142827866642E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-03	01	5	1	8	0	5	3	18	30	38	35	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRPDSSGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01		TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAGGGGTGGAGGACTAGCGGTGGGGGAGACCCAGTACTTCGGGCCA	CASSRGGGLAVGETQYF	In	VDJ	1	165	2.445980882806385E-4	2.966142827866642E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	1	5	5	9	5	18	30	49	39	54						01,02								CASSRGGGLAVGETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGATCTTCAGGGAAGGACGCAGTATTTTGGCCCA	CASSLDLQGRTQYF	In	VDJ	1	169	2.5052773890562365E-4	3.038049320663409E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	4	3	9	4	4	18	35	44	39	48														CASSLDLQGRTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTGGGGACCTCTGGAAACACCATATATTTTGGAGAG	CASSLVGTSGNTIYF	In	VDJ	1	171	2.5349256421811626E-4	3.074002567061793E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-03	01	1	0	7	0	2	0	18	34	-1	36	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVGTSGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01		TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGACCTCCGCTTCGGACGGCTACACCTTCGGTTCG	CASSLGTSASDGYTF	In	VDJ	1	192	2.8462322999928846E-4	3.45151165424482E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-02	01	1	1	7	8	0	13	18	-1	38	34	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGTSASDGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTCATACAGGGTAGATGAATTCACCCCTCCACTTTGGGAAC	CASSPHTG*MNSPLHF	Stop	VDJ	1	194	2.87588055311781E-4		48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	3	3	7	6	6	18	30	42	36	48														CASSPHTG*MNSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATTAGCGGGGGGAGGAAATGAGCAGTTCTTCGGGCCA	CASSLLAGGGNEQFF	In	VDJ	1	194	2.87588055311781E-4	3.487464900643204E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	5	1	7	1	4	18	33	44	34	48														CASSLLAGGGNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAAGATGGGACAGGGGGCTGGTTCACCCCTCCACTTTGGGAAC	CASKMGQGAGSPLHF	In	VDJ	1	195	2.8907046796802733E-4	3.5054415238423956E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	7	0	0	9	4	3	18	28	44	32	47														CASKMGQGAGSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTCACAGGGGGGGAAAAGAGACCCAGTACTTCGGGCCA	CASSHRGGKETQYF	In	VDJ	1	195	2.8907046796802733E-4	3.5054415238423956E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	3	1	3	2	4	18	29	39	31	43														CASSHRGGKETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCACAGACAGGGGAGCTAACTATGGCTACACCTTCGGTTCG	CASSPTDRGANYGYTF	In	VDJ	1	202	2.9944735656175136E-4	3.631277886236738E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	2	0	6	2	18	30	44	36	46														CASSPTDRGANYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGGGACAGGGGTACACCGGGGAGCTGTTTTTTGGAGAA	CASSPGQGYTGELFF	In	VDJ	1	203	3.009297692179977E-4	3.6492545094359295E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	2	3	2	1	18	30	42	32	43														CASSPGQGYTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGCGGGGAAGAAACTACGAGCAGTACTTCGGGCCG	CASSLRGRNYEQYF	In	VDJ	1	203	3.009297692179977E-4	3.6492545094359295E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	7	3	3	0	6	18	-1	38	32	44														CASSLRGRNYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGGGATTGGGGGACAGATACGCAGTATTTTGGCCCA	CASSRDWGTDTQYF	In	VDJ	1	204	3.0241218187424397E-4	3.6672311326351213E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	5	6	1	3	7	0	18	30	-1	37	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRDWGTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGGGTTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLGVGANVLTF	In	VDJ	1	204	3.0241218187424397E-4	3.6672311326351213E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-06	01	3	6	1	3	0	1	18	-1	37	32	38				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGVGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01		TCRBJ02-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAACCGGGACCAAGGCGCTAATGAAAAACTGTTTTTTGGCAGT	CASSNRDQGANEKLFF	In	VDJ	1	205	3.0389459453049024E-4	3.685207755834313E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-04	01	5	0	7	3	4	7	18	30	39	34	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSNRDQGANEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01		TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGATCAGGGTTCGGGAATCAGCCCCAGCATTTTGGTGAT	CASRSGFGNQPQHF	In	VDJ	1	215	3.187187210929532E-4	3.864973987826231E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	4	3	4	2	6	18	29	36	31	42														CASRSGFGNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCTAGCAGCTTAGGCCCGGAGGGGGAAAAGACCCAGTACTTCGGGCCA	CASSLGPEGEKTQYF	In	VDJ	1	215	3.187187210929532E-4	3.864973987826231E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	1	5	1	6	6	3	18	34	46	40	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGPEGEKTQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTACAGGGACTTCTAATGAAAAACTGTTTTTTGGCAGT	CASSFTGTSNEKLFF	In	VDJ	1	221	3.2761319703043096E-4	3.9728337270213815E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-04	01	3	3	3	3	1	4	18	32	39	33	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFTGTSNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01		TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCATCAGCCCATACAGGGGTCCGGGCTATGGCTACACCTTCGGTTCG	CASSISPYRGPGYGYTF	In	VDJ	1	223	3.3057802234292356E-4	4.008786973419765E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	2	4	10	6	18	30	47	40	53														CASSISPYRGPGYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTAGGCCGATACAATCAGCCCCAGCATTTTGGTGAT	CASSLVGRYNQPQHF	In	VDJ	1	227	3.365076729679087E-4	4.080693466216532E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-05	01	1	5	4	3	1	6	18	34	38	35	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVGRYNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGAGGACTGAGCACAGATACGCAGTATTTTGGCCCA	CASSLGGLSTDTQYF	In	VDJ	1	229	3.394724982804013E-4	4.1166467126149155E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	1	10	0	2	1	18	34	41	36	42						01,02								CASSLGGLSTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTCTGGGGAGCTACAATGAGCAGTTCTTCGGGCCA	CASSPLGSYNEQFF	In	VDJ	1	232	3.439197362491402E-4	4.170576582212491E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	9	2	3	6	0	18	30	-1	36	41														CASSPLGSYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCGGGGTTGACAGGGGGCCTTACAATGAGCAGTTCTTCGGGCCA	CASGVDRGPYNEQFF	In	VDJ	1	235	3.483669742178791E-4	4.224506451810066E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	8	2	0	4	6	2	18	27	43	33	45														CASGVDRGPYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGCGAAACAGGGCCGGACACTGAAGCTTTCTTTGGACAA	CASSLGETGPDTEAFF	In	VDJ	1	236	3.4984938687412535E-4	4.2424830750092577E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	3	3	3	5	4	18	34	45	39	49														CASSLGETGPDTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTGGCGGGGGCTTAGATACGCAGTATTTTGGCCCA	CASSFGGGLDTQYF	In	VDJ	1	241	3.5726145015535683E-4	4.332366191005217E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	7	2	5	2	3	18	32	41	34	44														CASSFGGGLDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCAGGGACAGGGGGGGGAAAAGAGACCCAGTACTTCGGGCCA	CASSPGTGGGKETQYF	In	VDJ	1	248	3.676383387490809E-4	4.458202553399559E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	1	3	3	5	18	30	44	33	49														CASSPGTGGGKETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTAGACAGGGTCAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	250	3.7060316406157347E-4		43	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	2	3	7	2	2	18	32	41	34	43														X+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGGGACAGGGGGCTGAATGAGCAGTTCTTCGGGCCA	CASSRDRGLNEQFF	In	VDJ	1	252	3.7356798937406607E-4	4.530109046196326E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	0	7	1	2	18	30	43	31	45														CASSRDRGLNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGGGTAGGCTATAATTCACCCCTCCACTTTGGGAAC	CASSLGVGYNSPLHF	In	VDJ	1	253	3.750504020303124E-4	4.548085669395518E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-06	01	3	6	1	3	0	4	18	-1	37	32	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGVGYNSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01		TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCTAGCAGCTCCAAGAGCGTTAACCTTTATACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	256	3.794976399990513E-4		50	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	6	6	4	5	10	18	31	40	36	50						01,02								X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCTTAGGCGTCTCTGGAAACACCATATATTTTGGAGAG	CARSLGVSGNTIYF	In	VDJ	1	258	3.824624653115438E-4	4.6379687853914767E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	1	7	6	0	0	1	18	-1	37	34	38						01,02								CARSLGVSGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD02-01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCAGGGGCCCGAATCATGAACACTGAAGCTTTCTTTGGACAA	CASSSGARIMNTEAFF	In	VDJ	1	259	3.8394487796779015E-4	4.6559454085906684E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	2	0	0	9	18	-1	37	31	46														CASSSGARIMNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTTCCGGGACAGCTTATGAAAAACTGTTTTTTGGCAGT	CASSSGTAYEKLFF	In	VDJ	1	262	3.8839211593652903E-4	4.709875278188244E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	0	5	6	4	3	18	29	40	33	43														CASSSGTAYEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGACTGTTATCAGACACCGGGGAGCTGTTTTTTGGAGAA	CASRLLSDTGELFF	In	VDJ	2	277	4.106283057802234E-4	4.97952462617612E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-02	01	6	4	5	3	8	0	18	29	-1	37	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRLLSDTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01		TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGAGGCGAAGGGGAAGAGAAGGAAACACCATATATTTTGGAGAG	CASSLRRRGREGNTIYF	In	VDJ	2	281	4.1655795640520863E-4	5.051431118972887E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	5	2	4	7	7	18	32	44	39	51														CASSLRRRGREGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTCATGACTAGCGGGGCGGGGGGTACGCAGTATTTTGGCCCA	CASSLMTSGAGGTQYF	In	VDJ	2	282	4.180403690614549E-4	5.069407742172079E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	2	3	8	5	7	18	30	46	35	53														CASSLMTSGAGGTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGAAGGGCCCCTCGGAAGGGAGCAGTTCTTCGGGCCA	CASSEGPLGREQFF	In	VDJ	2	295	4.3731173359265674E-4	5.303103843761573E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	5	5	3	10	2	12	18	30	36	32	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEGPLGREQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGAACAGGGTAGGTCACCCCTCCACTTTGGGAAC	CASSLEQGRSPLHF	In	VDJ	2	296	4.38794146248903E-4	5.321080466960765E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	3	3	10	3	4	18	32	41	35	45														CASSLEQGRSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGGCGGGGGGGGACAGATACGCAGTATTTTGGCCCA	CASSRRGGTDTQYF	In	VDJ	2	314	4.654775740613363E-4	5.644659684546216E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	7	0	3	2	1	18	30	41	32	42														CASSRRGGTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGAGAAACAGGGGGGACTAAGAGTGAGCAGTTCTTCGGGCCA		Out	VDJ	2	327	4.847489385925381E-4		47	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	3	1	9	5	9	18	30	43	35	52														X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGACCGGGGATCCACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	334	4.951258271862622E-4		46	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	8	3	5	4	4	18	34	43	38	47														X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTCACGGGTGTAGGGACCAAAAACATTCAGTACTTCGGCGCC	CASSLVTGVGTKNIQYF	In	VDJ	2	365	5.410806195298973E-4	6.561467467704996E-4	51	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-04	01	1	0	8	2	11	0	18	34	-1	45	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVTGVGTKNIQYF+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01		TCRBJ02-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAGGGACTCCTAAACTATGGCTACACCTTCGGTTCG	CASSQGLLNYGYTF	In	VDJ	2	368	5.455278574986362E-4	6.615397337302572E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	0	10	2	2	4	18	30	38	32	42						01,02								CASSQGLLNYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCATTTTAGACTAGTCGCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	368	5.455278574986362E-4		41	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	4	8	2	0	3	18	-1	39	35	42						01,02								X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGTTGTGGGGGGGCCTGGGAATGAGCAGTTCTTCGGGCCA	CASSLVVGGPGNEQFF	In	VDJ	2	399	5.914826498422713E-4	7.172672656477517E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	9	0	7	6	6	18	32	45	38	51														CASSLVVGGPGNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAAACGGGGGCGAACTGAAGCTTTCTTTGGACAA	CASSLKRGRTEAFF	In	VDJ	2	418	6.196484903109509E-4	7.51422849726216E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	2	6	0	5	4	2	18	33	43	37	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLKRGRTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGCCCGCTTGGAAACACCATATATTTTGGAGAG	CASSLGPLGNTIYF	In	VDJ	2	418	6.196484903109509E-4	7.51422849726216E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-03	01	1	10	0	3	0	5	18	-1	36	34	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGPLGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01		TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGACGGCTCTGGAAACACCATATATTTTGGAGAG	CASSLDGSGNTIYF	In	VDJ	3	471	6.982163610920045E-4	8.466989526819324E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-03	01	3	1	7	0	0	2	18	-1	36	32	38				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDGSGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01		TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAGCAGCAACGGCTACGAGCAGTACTTCGGGCCG	CASSLSSNGYEQYF	In	VDJ	3	505	7.486183914043785E-4	9.078194715591844E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	2	4	5	3	2	6	18	33	38	35	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSSNGYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAACCCTTCGTATCGACAGGGACTGGAAACACCATATATTTTGGAGAG	CASSLEPFVSTGTGNTIYF	In	VDJ	3	512	7.589952799981026E-4	9.204031077986186E-4	57	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	2	3	2	12	1	18	35	54	47	55														CASSLEPFVSTGTGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCACCGACAGGGCGGTGAAAAACTGTTTTTTGGCAGT	CASSHRQGGEKLFF	In	VDJ	3	522	7.738194065605654E-4	9.383797309978105E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	2	3	7	4	3	18	30	41	34	44														CASSHRQGGEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGGACAGGGATCACTGAAGCTTTCTTTGGACAA	CASSLGTGITEAFF	In	VDJ	3	529	7.841962951542895E-4	9.509633672372447E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	3	4	1	2	18	32	42	33	44														CASSLGTGITEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGAGTCCTGGGCACAGATACGCAGTATTTTGGCCCA	CASSLGVLGTDTQYF	In	VDJ	3	547	8.108797229667228E-4	9.833212889957899E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	9	2	1	0	6	18	-1	37	32	43														CASSLGVLGTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTCCGGGATGAGGGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	3	592	8.77588292497806E-4		44	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	8	3	3	2	6	18	32	39	34	45														X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCACTAGACAGGGGGAGGTTGGCTACACCTTCGGTTCG	CASSTRQGEVGYTF	In	VDJ	3	596	8.835179431227912E-4	0.0010714067426718296	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	1	7	4	4	18	30	43	34	47														CASSTRQGEVGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCATGACTAGCGGAAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	4	628	9.309551481226726E-4		46	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	2	5	2	3	1	18	30	42	33	43						01,02								X+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGCGACCCCAAAGGGACACTGAAGCTTTCTTTGGACAA	CASSLRPQRDTEAFF	In	VDJ	4	645	9.561561632788596E-4	0.0011594921963478692	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	3	5	3	3	10	0	18	32	-1	42	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLRPQRDTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTACAGTGGGCAAATGAAAAACTGTTTTTTGGCAGT	CASSLQWANEKLFF	In	VDJ	4	711	0.001053995398591115	0.001278137909462535	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	3	5	5	2	6	18	30	36	32	42														CASSLQWANEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCATCGAACGGGGGGAACACAGATACGCAGTATTTTGGCCCA	CASSPSNGGNTDTQYF	In	VDJ	6	990	0.001467588529683831	0.0017796856967199853	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	8	1	2	8	2	18	30	45	38	47														CASSPSNGGNTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGCTAGAGGGTTGGCAGCCCCAGCATTTTGGTGAT		Out	VDJ	8	1440	0.002134674224994663		44	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	1	11	0	7	4	4	18	34	43	38	47														X+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAGTCTGTCAGAAACTATGGTGGGCTACACCTTCGGTTCG	CASSLSLSETMVGYTF	In	VDJ	8	1441	0.0021361566376509097	0.002590431403003534	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	2	3	9	8	12	5	18	33	49	45	54						01,02								CASSLSLSETMVGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATCCCTCGGGGGACCCTGGGACTATGGCTACACCTTCGGTTCG	CASSLSLGGPWDYGYTF	In	VDJ	9	1598	0.002368895424681578	0.002872664387230845	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	2	8	2	3	5	8	18	33	44	38	52														CASSLSLGGPWDYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTTCCGGGAAGGGGGCCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	10	1681	0.0024919356751500203		49	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	5	0	2	8	0	18	32	-1	40	47														X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTTTCCATTTCGTCTCCCTACGAGCAGTACTTCGGGCCG	CASSLSISSPYEQYF	In	VDJ	10	1749	0.002592739735774768	0.0031441113975386407	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	5	4	6	2	5	9	18	30	37	35	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSISSPYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCACTTTCGGGTTTTTACTTCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	10	1769	0.0026223879888996942		52	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	5	8	4	0	5	9	18	30	39	35	48						01,02								X+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD02-01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCCTGGCGGGAACTAATGAAAAACTGTTTTTTGGCAGT	CASSPLAGTNEKLFF	In	VDJ	10	1769	0.0026223879888996942	0.003180064643937024	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	5	7	4	1	6	0	18	30	-1	36	41						01,02								CASSPLAGTNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD02-01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTTGGGGGACAATGAACACTGAAGCTTTCTTTGGACAA	CASSPWGTMNTEAFF	In	VDJ	15	2643	0.003918016650458955	0.004751221511546385	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	6	0	6	1	18	30	42	36	43														CASSPWGTMNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCGGGCAGGGGGCAGGGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	21	3675	0.0054478665117051305		47	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	0	3	4	4	18	32	44	36	48														X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGTAGGGACAGGGCATGGCTACACCTTCGGTTCG	CASSLVGTGHGYTF	In	VDJ	54	9584	0.014207442897464482	0.017228795674105395	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	3	6	4	1	18	32	45	36	46														CASSLVGTGHGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAGCAGCTTGGGACAGTAAACACTGAAGCTTTCTTTGGACAA	CASSQQLGTVNTEAFF	In	VDJ	259	45878	0.06801012784326747	0.08247315191325201	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	5	2	9	2	18	30	46	39	48														CASSQQLGTVNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGCCCTACAGCGGAACACTGAAGCTTTCTTTGGACAA	CASALQRNTEAFF	In	VDJ	1	50	7.41206328123147E-5	8.988311599595886E-5	39	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-01	01	7	3	5	1	4	2	26	36	44	40	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASALQRNTEAFF+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCAGGGACTCAGCTGTGTATTTTTGTGCCAGCACCCTGGTGATGCTGAAAAGCGGGGGGTCTGGGCGATACGCAGTATTTTGGCCCA		Out	VDJ	1	50	7.41206328123147E-5		58	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	12	6	1	6	22	7	23	28	59	50	66														X+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAACGACGGGACCAACTATGGCTACACCTTCGGTTCG	CASNDGTNYGYTF	In	VDJ	1	54	8.005028343729987E-5	9.707376527563557E-5	39	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-02	01	12	0	7	2	10	1	26	31	46	41	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASNDGTNYGYTF+TCRBV12-05+TCRBJ01-02	TCRBV12-05*01		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGCGCGGGAAAGGCGGCACGGCCTTCGTAATCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	63	9.339199734351652E-5		58	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	7	3	3	1	22	23	33	40	34	62														X+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD02-01*02	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGACCCGTACTGAAGCTTTCTTTGGACAA	CASGLTRTEAFF	In	VDJ	1	65	9.635682265600911E-5	1.1684805079474652E-4	36	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-01	01	2	3	7	5	0	4	26	-1	43	41	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGLTRTEAFF+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCATCGAGGCGAATAGCGGGGGCATTGGGGATACGCAGTATTTTGGCCCA	CASIEANSGGIGDTQYF	In	VDJ	1	72	1.0673371124973316E-4	1.2943168703418074E-4	51	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	12	5	2	6	15	7	26	31	55	46	62														CASIEANSGGIGDTQYF+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGTGCGGCCTCCAAAGGTGGCTACACCTTCGGTTCG	CASAASKGGYTF	In	VDJ	1	72	1.0673371124973316E-4	1.2943168703418074E-4	36	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-02	01	7	5	4	7	10	0	26	36	-1	46	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASAASKGGYTF+TCRBV12-05+TCRBJ01-02	TCRBV12-05*01		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGCACCGGAGGGGCAGTACCTGGAAACACCATATATTTTGGAGAG	CASTGGAVPGNTIYF	In	VDJ	1	74	1.0969853656222575E-4	1.3302701167401912E-4	45	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	9	10	0	2	4	7	26	34	44	38	51														CASTGGAVPGNTIYF+TCRBV12-05+TCRBJ01-03	TCRBV12-05*01	TCRBD02-01*02	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCTGCAGGACAGGGTGGACTGAAGCTTTCTTTGGACAA	CASCRTGWTEAFF	In	VDJ	1	83	1.230402504684424E-4	1.492059725532917E-4	39	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	12	1	3	5	8	3	26	31	47	39	50														CASCRTGWTEAFF+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAACACCCGGACAGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASNTRTGSYNEQFF	In	VDJ	1	85	1.26005075780935E-4	1.5280129719313007E-4	45	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	12	1	4	0	11	0	26	31	-1	42	49														CASNTRTGSYNEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTCCTTCAACGGGACCTTACAATCAACCCCAGCATTTTGGTGAT	CASGPSTGPYNQPQHF	In	VDJ	1	85	1.26005075780935E-4	1.5280129719313007E-4	48	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-05	01	5	0	7	10	8	11	26	38	51	46	62				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGPSTGPYNQPQHF+TCRBV12-05+TCRBJ01-05	TCRBV12-05*01		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTCCAAGCCAGGGGACTGGGTGAACTAATGAAAAACTGTTTTTTGGCAGT	CASGPSQGTG*TNEKLFF	Stop	VDJ	1	87	1.2896990109342757E-4		54	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-04	01	5	4	2	1	6	8	26	38	50	44	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGPSQGTG*TNEKLFF+TCRBV12-05+TCRBJ01-04	TCRBV12-05*01		TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGCTCTGGGACAGGGGAGCACTGAAGCTTTCTTTGGACAA	CASALGQGSTEAFF	In	VDJ	1	91	1.3489955171841275E-4	1.6358727111264511E-4	42	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	0	2	4	4	2	26	36	50	40	52														CASALGQGSTEAFF+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGTTCAGGGAGGCCCATATGGACCCAGTACTTCGGGCCA		Out	VDJ	1	94	1.3934678968715162E-4		47	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	9	1	7	3	8	26	43	52	46	60														X+TCRBV12-05+TCRBJ02-05	TCRBV12-05*01	TCRBD02-01*02	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGACAACAGGGGGAGAGCAGCCCCAGCATTTTGGTGAT	CASGLTTGGEQPQHF	In	VDJ	1	96	1.4231161499964423E-4	1.72575582712241E-4	45	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	3	1	7	3	4	26	41	52	44	56														CASGLTTGGEQPQHF+TCRBV12-05+TCRBJ01-05	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGTCGGGGGGCCGCCTCAAGAGACCCAGTACTTCGGGCCA	CASGLVGGPPQETQYF	In	VDJ	1	96	1.4231161499964423E-4	1.72575582712241E-4	48	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	8	1	2	0	6	26	-1	50	43	56														CASGLVGGPPQETQYF+TCRBV12-05+TCRBJ02-05	TCRBV12-05*01	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGCCCTGGACACAGGGTCTAACTATAACTACACCTTCGGTTCG	CASALDTGSNYNYTF	In	VDJ	1	98	1.452764403121368E-4	1.7617090735207936E-4	45	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	3	3	10	8	11	26	36	50	44	61														CASALDTGSNYNYTF+TCRBV12-05+TCRBJ01-02	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGTACGAGGGAACGGTCAGCCCCAGCATTTTGGTGAT	CASGLVRGNGQPQHF	In	VDJ	1	103	1.5268850359336829E-4	1.8515921895167524E-4	45	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	0	11	0	6	2	5	26	43	50	45	55														CASGLVRGNGQPQHF+TCRBV12-05+TCRBJ01-05	TCRBV12-05*01	TCRBD02-01*02	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGCCCTCAGGCGCAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	110	1.6306539218709234E-4		44	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	4	4	0	4	2	26	37	45	41	47														X+TCRBV12-05+TCRBJ01-04	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGCCTCGGGGGGGTCCCTACAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	112	1.6603021749958492E-4		55	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	2	8	0	0	3	6	26	41	52	44	58														X+TCRBV12-05+TCRBJ01-04	TCRBV12-05*01	TCRBD02-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAAAGGAGACAGCCCCAACAATGAGCAGTTCTTCGGGCCA	CASKGDSPNNEQFF	In	VDJ	1	113	1.6751263015583122E-4	2.03135842150867E-4	42	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	12	2	5	5	10	5	26	31	46	41	51														CASKGDSPNNEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAACATCACCAACGGATCACTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	113	1.6751263015583122E-4		43	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-07	01	12	1	8	3	16	3	26	31	50	47	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01		TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGAAACGGGACAAGAAAAATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	113	1.6751263015583122E-4		47	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	0	6	0	4	7	26	36	46	40	53														X+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ACGTTTGGTGGAACCCAGGACTCAGCTGTGTATTTTTGTGCTAGTGCCCTGGACACAGGGTCTAACTATGGCTACACCTTCGGTTCG	CASALDTGSNYGYTF	In	VDJ	1	116	1.719598681245701E-4	2.0852882911062454E-4	45	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	3	3	0	8	1	36	46	60	54	61														CASALDTGSNYGYTF+TCRBV12-05+TCRBJ01-02	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTTTCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASGFSNTGELFF	In	VJ	1	127	1.8826640734327934E-4	2.2830311462973549E-4	39	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-02	01	3	0	0	0	0	2	26	-1	40	-1	42														CASGFSNTGELFF+TCRBV12-05+TCRBJ02-02	TCRBV12-05*01		TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCACTCAGGGATCCGGGGAGCTGTTTTTTGGAGAA	CASTQGSGELFF	In	VDJ	1	131	1.9419605796826452E-4	2.354937639094122E-4	36	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	12	4	3	6	7	2	26	31	43	38	45														CASTQGSGELFF+TCRBV12-05+TCRBJ02-02	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTACCGGGACAGGCCCACGAGCAGTACTTCGGGCCG		Out	VDJ	1	131	1.9419605796826452E-4		40	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	4	5	3	3	26	38	49	41	52														X+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGTCATGGGAGTCGATAAGCAATCAGCCCCAGCATTTTGGTGAT	CASGLSWESISNQPQHF	In	VDJ	1	133	1.971608832807571E-4	2.3908908854925056E-4	51	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	2	9	2	1	4	6	26	41	50	45	56														CASGLSWESISNQPQHF+TCRBV12-05+TCRBJ01-05	TCRBV12-05*01	TCRBD02-01*02	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCTACCGAGGGGGCGAGGAAAAACTGTTTTTTGGCAGT	CASYRGGEEKLFF	In	VDJ	1	143	2.1198500984322003E-4	2.570657117484423E-4	39	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	12	5	0	8	9	3	26	31	47	40	50														CASYRGGEEKLFF+TCRBV12-05+TCRBJ01-04	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCACCGGGACTAGCGGAGGAGGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	172	2.549749768743626E-4		49	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	12	0	5	1	7	5	26	31	49	38	54						01,02								X+TCRBV12-05+TCRBJ02-04	TCRBV12-05*01	TCRBD02-01	TCRBJ02-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGCTCTCATACCGGGGAGCTGTTTTTTGGAGAA	CASSHTGELFF	In	VDJ	1	173	2.5645738953060886E-4	3.1099558134601766E-4	33	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-02	01	9	4	6	5	4	1	26	34	40	38	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHTGELFF+TCRBV12-05+TCRBJ02-02	TCRBV12-05*01		TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTCCCGGGACTAGCCAGAAGCCTACGAGCAGTACTTCGGGCCG	CASGSRD*PEAYEQYF	Stop	VDJ	1	175	2.5942221484310146E-4		48	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	0	7	2	3	6	26	39	51	42	57						01,02								CASGSRD*PEAYEQYF+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01	TCRBD02-01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGGACGGACAGGGGATGCTTTCTTTGGACAA	CASGLGRTGDAFF	In	VDJ	1	178	2.6386945281184034E-4	3.1998389294561353E-4	39	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	1	2	11	3	2	26	42	54	45	56														CASGLGRTGDAFF+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGTCGGGGGACAGGGGGCCGCACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	178	2.6386945281184034E-4		52	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	0	0	3	3	3	26	43	58	46	61														X+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTCCCCGACAGGGGGCCTACGAGCAGTACTTCGGGCCG	CASGPRQGAYEQYF	In	VDJ	1	181	2.683166907805792E-4	3.2537687990537105E-4	42	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	1	2	4	0	26	38	-1	42	51														CASGPRQGAYEQYF+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGGACTAGGATCCCGGGGGGGAGCAGTTCTTCGGGCCA		Out	VDJ	1	182	2.697991034368255E-4		46	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	8	1	10	11	0	26	42	-1	53	60														X+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ACGTTTGGTGGAACCCAGGGACTCAGCTGTGTATTTTGTGCTAGTGCCCTGGACACAGGGTCTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	190	2.8165840468679585E-4		44	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	17	3	3	0	17	1	37	37	60	54	61														X+TCRBV12-05+TCRBJ01-02	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGCCCGCCTAGCGGGGGTTTCCCCCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	196	2.905528806242736E-4		56	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	4	2	2	5	7	25	40	55	45	62														X+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGGCGGACGGAAGGTTACAATGAGCAGTTCTTCGGGCCA	CASGRTEGYNEQFF	In	VDJ	1	198	2.935177059367662E-4	3.559371393439971E-4	42	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-01	01	6	1	7	4	2	7	26	37	43	39	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGRTEGYNEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01		TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGTATAAGATACAGGGAGAAGTGGACACCCCTCCACTTTGGGAAC		Out	VDJ	1	218	3.231659590616921E-4		53	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	3	3	11	7	9	26	43	56	50	65														X+TCRBV12-05+TCRBJ01-06	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTGAACAGGGCCCGGGGGAGCAGTACTTCGGGCCG	CASGEQGPGEQYF	In	VDJ	1	225	3.3354284765541617E-4	4.0447402198181485E-4	39	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	3	7	2	7	26	38	46	40	53														CASGEQGPGEQYF+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
ACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGTAAAAGTGACAGGGGGCGAAAGGGAAACACCATATATTTTGGAGAG		Out	VDJ	2	287	4.254524323426864E-4		56	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	2	0	4	6	5	25	42	58	48	63														X+TCRBV12-05+TCRBJ01-03	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGTACTTACAGGGCCCGGAGGAAGCTTTCTTTGGACAA		Out	VDJ	2	339	5.025378904674936E-4		46	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	3	3	8	4	7	26	43	53	47	60														X+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAAAGATGGGACCCCGCGTCGGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	390	5.781409359360547E-4		44	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-05	01	12	0	7	5	10	9	26	31	46	41	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-05+TCRBJ02-05	TCRBV12-05*01		TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGCCCATATCCGTCCGGCGTGGGGGACACCATATATTTTGGAGAG		Out	VDJ	3	566	8.390455634354024E-4		52	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-03	01	2	6	1	8	18	0	26	41	-1	59	64				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-05+TCRBJ01-03	TCRBV12-05*01		TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGCCCTGGACACAGGGTCTAACTATGGCTACACCTTCGGTTCG	CASALDTGSNYGYTF	In	VDJ	177	31252	0.04632836033300918	0.05618054282211412	45	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	3	3	0	8	1	26	36	50	44	51														CASALDTGSNYGYTF+TCRBV12-05+TCRBJ01-02	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAGATTAGCGGGGAAGACACAGATACGCAGTATTTTGGCCCA	CASSQISGEDTDTQYF	In	VDJ	1	45	6.670856953108322E-5	8.089480439636297E-5	48	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	5	3	2	3	4	20	34	45	37	49														CASSQISGEDTDTQYF+TCRBV23-01+TCRBJ02-03	TCRBV23-01*01	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCGGGACCTAGGGACTGAAGCTTTCTTTGGACAA	CASSRDLGTEAFF	In	VDJ	1	48	7.115580749982211E-5	8.62877913561205E-5	39	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-01	01	6	0	7	5	2	6	20	31	38	33	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRDLGTEAFF+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCCTGAAGGACGGGAAAAAGAGACCCAGTACTTCGGGCCA	CASSPEGREKETQYF	In	VDJ	1	62	9.190958468727023E-5	1.1145506383498898E-4	45	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	8	3	3	10	2	20	31	46	41	48														CASSPEGREKETQYF+TCRBV23-01+TCRBJ02-05	TCRBV23-01*01	TCRBD02-01*02	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAAGGGGACGGGTGTCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	63	9.339199734351652E-5		43	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-02	01	2	0	7	4	1	6	20	35	41	36	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV23-01+TCRBJ01-02	TCRBV23-01*01		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCACTTAGCGGGGGGGCTGGCAGATACGCAGTATTTTGGCCCA	CASSHLAGGLADTQYF	In	VDJ	1	72	1.0673371124973316E-4	1.2943168703418074E-4	48	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	5	0	4	5	4	20	31	47	36	51														CASSHLAGGLADTQYF+TCRBV23-01+TCRBJ02-03	TCRBV23-01*01	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATGAGGACAGGGGGCATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	77	1.1414577453096463E-4		46	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	1	0	5	2	0	20	36	-1	38	49														X+TCRBV23-01+TCRBJ01-05	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTTGGACTCTGGAAACACCATATATTTTGGAGAG	CASSLDSGNTIYF	In	VDJ	1	80	1.1859301249970352E-4	1.4381298559353417E-4	39	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-03	01	6	1	8	0	3	0	20	31	-1	34	37				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDSGNTIYF+TCRBV23-01+TCRBJ01-03	TCRBV23-01*01		TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCCGGGACAAGGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	86	1.274874884371813E-4		43	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	0	6	4	1	3	20	37	44	38	47														X+TCRBV23-01+TCRBJ02-05	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCACCAGGGGGGATTCTACTACGAGCAGTACTTCGGGCCG	CASSHQGGFYYEQYF	In	VDJ	1	94	1.3934678968715162E-4	1.6898025807240264E-4	45	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	4	1	3	4	7	20	31	42	35	49														CASSHQGGFYYEQYF+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GAGACACGGCACTGTATCTCTGCGCCAGCCTACTTCGGGGGGACCCAGACACCGGGGAGCTGTTTTTTGGAGAA	CASLLRGDPDTGELFF	In	VDJ	1	95	1.4082920234339793E-4	1.7077792039232181E-4	48	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	8	8	1	3	6	6	20	29	42	35	48														CASLLRGDPDTGELFF+TCRBV23-01+TCRBJ02-02	TCRBV23-01*01	TCRBD02-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCAACAGAAAACACTGAAGCTTTCTTTGGACAA	CASSQSTENTEAFF	In	VDJ	1	99	1.467588529683831E-4	1.7796856967199854E-4	42	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	3	5	2	1	2	20	37	42	38	44														CASSQSTENTEAFF+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCATCTCCTGGACAGGGGGATGGGGCTACACCTTCGGTTCG		Out	VDJ	1	104	1.5417091624961456E-4		46	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	1	8	6	4	20	34	50	40	54														X+TCRBV23-01+TCRBJ01-02	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGAAGGGGCGGGGGCACTGAAGCTTTCTTTGGACAA	CASRRGGGTEAFF	In	VDJ	1	116	1.719598681245701E-4	2.0852882911062454E-4	39	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	6	7	2	4	5	0	20	31	-1	36	43														CASRRGGGTEAFF+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD02-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GAGACACGGCACTGTATCTCTGCGCCACCGAGGGGAGCTCTGGAAACACCATATATTTTGGAGAG	CATEGSSGNTIYF	In	VDJ	1	153	2.26809136405683E-4	2.750423349476341E-4	39	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-03	01	10	5	2	0	3	2	20	27	35	30	37				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATEGSSGNTIYF+TCRBV23-01+TCRBJ01-03	TCRBV23-01*01		TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GAGACACGGCACTGTATCTCTGCGCCAGTGGGACTTCAGCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	160	2.3718602499940705E-4		41	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	9	0	10	0	1	4	20	28	35	29	39						01,02								X+TCRBV23-01+TCRBJ01-03	TCRBV23-01*01	TCRBD02-01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GAGACACGGCACTGTATCTCTGCGCCAGTTCCTGCGGGAGGGCGAACAYTGAAGCTTTCTTTGGACAA	CASSCGRANXEAFF	In	VDJ	1	169	2.5052773890562365E-4	3.038049320663409E-4	42	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	9	7	0	1	5	1	20	28	42	33	43														CASSCGRANXEAFF+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD02-01*02	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCGGAGGTAGGCTGTGGGACTGAAGCTTTCTTTGGACAA	CASSQSEVGCGTEAFF	In	VDJ	1	180	2.668342781243329E-4	3.235792175854519E-4	48	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	10	1	5	0	11	20	-1	42	37	53														CASSQSEVGCGTEAFF+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD02-01*02	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAAAGGACACTCAGACACTGAAGCTTTCTTTGGACAA	CASKGHSDTEAFF	In	VDJ	1	227	3.365076729679087E-4	4.080693466216532E-4	39	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	1	6	3	2	5	20	30	37	32	42														CASKGHSDTEAFF+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCGTAGAGGGATCCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSQS*RDPTNEKLFF	Stop	VDJ	1	228	3.3799008562415505E-4		51	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	0	11	0	0	3	3	20	37	45	40	48														CASSQS*RDPTNEKLFF+TCRBV23-01+TCRBJ01-04	TCRBV23-01*01	TCRBD02-01*02	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCCACGAGAGCCAACTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	2	428	6.344726168734139E-4		47	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	4	6	7	0	6	3	20	33	42	39	45						01,02								X+TCRBV23-01+TCRBJ01-03	TCRBV23-01*01	TCRBD02-01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAAAAGTCAGGGGGACAGCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	6	1113	0.0016499252864021251		43	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	0	5	2	9	0	20	30	-1	39	46														X+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCGAACTGACGGGACCTGGTTTGTGGCCCAGCATTTTGGTGAT	CASSRTDGTWFVAQHF	In	VDJ	1	44	6.522615687483693E-5	7.90971420764438E-5	48	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	6	0	7	11	10	11	23	34	49	44	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRTDGTWFVAQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGAACAGGGATACGCAGATACGCAGTATTTTGGCCCA	CASREQGYADTQYF	In	VDJ	1	44	6.522615687483693E-5	7.90971420764438E-5	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	3	3	4	3	5	23	34	43	37	48														CASREQGYADTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCAGACAGGGCCCTAGGCACAGATACGCAGTATTTTGGCCCA	CASSPDRALGTDTQYF	In	VDJ	1	44	6.522615687483693E-5	7.90971420764438E-5	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	2	3	1	3	6	23	35	45	38	51														CASSPDRALGTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCTCAGGTTCTTACAGATACGCAGTATTTTGGCCCA	CASSSQVLTDTQYF	In	VDJ	1	46	6.819098218732952E-5	8.269246671628214E-5	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	4	4	3	2	5	23	36	42	38	47														CASSSQVLTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATCAACAGGGAGATGAACACTGAAGCTTTCTTTGGACAA	CASINREMNTEAFF	In	VDJ	1	46	6.819098218732952E-5	8.269246671628214E-5	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	3	3	0	3	3	23	33	42	36	45														CASINREMNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGAACAGGGATATAATTCACCCCTCCACTTTGGGAAC	CASSEQGYNSPLHF	In	VDJ	1	47	6.967339484357581E-5	8.449012903620132E-5	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	3	3	4	3	1	23	34	43	37	44														CASSEQGYNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGACAGGGGGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CASSYSTGGSYNSPLHF	In	VDJ	1	47	6.967339484357581E-5	8.449012903620132E-5	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	2	1	0	0	0	23	-1	-1	40	49														CASSYSTGGSYNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCTCCGGGGGTCAGGGACTGAAGCTTTCTTTGGACAA	CASLRGSGTEAFF	In	VDJ	1	47	6.967339484357581E-5	8.449012903620132E-5	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	8	8	2	5	3	6	23	32	41	35	47														CASLRGSGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGGGGCAGGGAGATTTAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	48	7.115580749982211E-5		46	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	6	0	6	0	9	23	-1	41	35	50														X+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATCTACCGGGACCGACAGTATATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSYLPGPTVYSNQPQHF	In	VDJ	1	48	7.115580749982211E-5	8.62877913561205E-5	57	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	3	0	7	0	6	10	23	37	48	43	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYLPGPTVYSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATGGCGGGAACACTGAAGCTTTCTTTGGACAA	CASSYGGNTEAFF	In	VDJ	1	48	7.115580749982211E-5	8.62877913561205E-5	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	7	5	1	2	0	23	37	-1	39	43						01,02								CASSYGGNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATCCCGGTAGGGGGCGATGGCTACACCTTCGGTTCG	CASIPVGGDGYTF	In	VDJ	1	48	7.115580749982211E-5	8.62877913561205E-5	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	5	0	6	7	1	23	33	47	40	48														CASIPVGGDGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCTTCCCCCCCTCCGACACTGAAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	49	7.26382201560684E-5		50	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	2	6	4	14	4	23	33	51	47	55														X+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACACGGGTATGACAGATACGCAGTATTTTGGCCCA	CASSYTGMTDTQYF	In	VDJ	1	49	7.26382201560684E-5	8.808545367603968E-5	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	8	4	3	1	4	23	38	43	39	47						01,02								CASSYTGMTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGATGGGGGGGACTGAAGCTTTCTTTGGACAA	CASSYSMGGTEAFF	In	VDJ	1	49	7.26382201560684E-5	8.808545367603968E-5	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	0	9	0	5	3	0	23	40	-1	43	50														CASSYSMGGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACTTACACAGGGGGCAGGTGGCTACACCTTCGGTTCG	CASRLTQGAGGYTF	In	VDJ	1	50	7.41206328123147E-5	8.988311599595886E-5	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	3	0	7	6	3	23	34	49	40	52														CASRLTQGAGGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTGGGACAGGGGCCAGCCCCAGCATTTTGGTGAT	CASSWDRGQPQHF	In	VDJ	1	50	7.41206328123147E-5	8.988311599595886E-5	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	0	2	7	0	1	23	-1	46	36	47														CASSWDRGQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTATCCGGGCCTGGAGACATTCAGTACTTCGGCGCC	CASSLSGPGDIQYF	In	VDJ	1	50	7.41206328123147E-5	8.988311599595886E-5	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-04	01	4	8	0	8	5	6	23	36	45	41	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSGPGDIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01		TCRBJ02-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTATATGCAGGGTTGAACACTGAAGCTTTCTTTGGACAA	CASSLYAGLNTEAFF	In	VDJ	1	51	7.560304546856099E-5	9.168077831587803E-5	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	3	0	6	1	23	36	47	42	48														CASSLYAGLNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCTTCTATAACCAGGGGGCGAATACTGAAGCTTTCTTTGGACAA	CASFYNQGANTEAFF	In	VDJ	1	51	7.560304546856099E-5	9.168077831587803E-5	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	4	0	5	9	4	23	32	49	41	53														CASFYNQGANTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGTTTTGACAGGGGCTTATCTGGAAACACCATATATTTTGGAGAG	CASFDRGLSGNTIYF	In	VDJ	1	51	7.560304546856099E-5	9.168077831587803E-5	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	9	2	2	1	4	4	23	31	43	35	47														CASFDRGLSGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAGAGACAGGGGGCGACCGTGGCTACACCTTCGGTTCG	CASRETGGDRGYTF	In	VDJ	1	52	7.708545812480728E-5	9.34784406357972E-5	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	0	7	3	5	23	34	47	37	52														CASRETGGDRGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCTTCAAGACGGCGCCCGGGATGGCTACACCTTCGGTTCG	CASSLQDGARDGYTF	In	VDJ	1	53	7.856787078105358E-5	9.527610295571638E-5	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	8	4	6	15	0	23	35	-1	50	54						01,02								CASSLQDGARDGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCGAAGCGGACAGGGTGGACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	54	8.005028343729987E-5		50	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	1	3	3	5	3	23	40	53	45	56														X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAACAGTTACCCCGACAGCTTCTATGGCTACACCTTCGGTTCG	CANSYPDSFYGYTF	In	VDJ	1	55	8.153269609354617E-5	9.887142759555474E-5	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	2	5	4	3	3	23	38	46	41	49														CANSYPDSFYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAAAGCGCCGCCTACTATGGCTACACCTTCGGTTCG	CASKSAAYYGYTF	In	VDJ	1	55	8.153269609354617E-5	9.887142759555474E-5	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	7	6	6	3	2	6	23	33	39	35	45						01,02								CASKSAAYYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTGGGGGCCGGTGAAGCTTTCTTTGGACAA	CASSVGAGEAFF	In	VDJ	1	55	8.153269609354617E-5	9.887142759555474E-5	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	6	0	7	2	3	23	35	43	37	46														CASSVGAGEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGCCGGACAGGGAATGGCTACACCTTCGGTTCG	CAISRTGNGYTF	In	VDJ	1	55	8.153269609354617E-5	9.887142759555474E-5	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	3	6	2	1	23	34	44	36	45														CAISRTGNGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGACTACAACTACTACGAGCAGTACTTCGGGCCG	CAISDYNYYEQYF	In	VDJ	1	55	8.153269609354617E-5	9.887142759555474E-5	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	3	9	3	3	0	23	39	-1	42	46						01,02								CAISDYNYYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCAGGGGGCCGGGGCCCCGGGCCTCTACGAGCAGTACTTCGGGCCG	CASSQGAGAPGLYEQYF	In	VDJ	1	56	8.301510874979246E-5	1.0066908991547392E-4	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	4	0	3	1	15	23	34	43	35	58														CASSQGAGAPGLYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCTCCTTATCCGGCGACAGGGGAGCTCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	56	8.301510874979246E-5		56	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	2	2	3	13	4	23	38	59	51	63														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGATAACAGGCAATCAGCCCCAGCATTTTGGTGAT	CASSYSITGNQPQHF	In	VDJ	1	56	8.301510874979246E-5	1.0066908991547392E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	3	5	2	4	0	23	40	-1	44	48														CASSYSITGNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGAGGACTATGGCTACACCTTCGGTTCG	CASSYEDYGYTF	In	VDJ	1	57	8.449752140603876E-5	1.024667522353931E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	2	11	1	3	0	0	23	-1	-1	38	42														CASSYEDYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATCGTTGTAGGACTAGCTAGGTATAGGAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	57	8.449752140603876E-5		55	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	1	7	7	8	10	23	37	53	45	63						01,02								X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGGTAGGGCGGGGAACACTGAAGCTTTCTTTGGACAA	CASGRAGNTEAFF	In	VDJ	1	57	8.449752140603876E-5	1.024667522353931E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	8	7	4	1	6	0	23	32	-1	38	43						01,02								CASGRAGNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCCCTTCCGGGACTAGATTCTACTACGAGCAGTACTTCGGGCCG	CASTPSGTRFYYEQYF	In	VDJ	1	58	8.597993406228505E-5	1.0426441455531227E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	0	8	3	8	6	23	33	49	41	55						01,02								CASTPSGTRFYYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGACAACTCTGGAAACACCATATATTTTGGAGAG	CASSYSDNSGNTIYF	In	VDJ	1	58	8.597993406228505E-5	1.0426441455531227E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	1	6	0	0	1	23	-1	45	40	46														CASSYSDNSGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAACAAAATGGGGGGACAGGGTATAACTGGAAACACCATATATTTTGGAGAG	CASNKMGGQGITGNTIYF	In	VDJ	1	59	8.746234671853134E-5	1.0606207687523144E-4	54	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	7	0	3	2	10	5	23	33	52	43	57														CASNKMGGQGITGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACGCCGGGTGGGGGACACTGAAGCTTTCTTTGGACAA	CASRRRVGDTEAFF	In	VDJ	1	59	8.746234671853134E-5	1.0606207687523144E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	6	6	1	3	9	0	23	34	-1	43	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRRRVGDTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACCTGTTGGGAGAAGCTTTCTTTGGACAA	CASSDLLGEAFF	In	VDJ	1	61	9.042717203102393E-5	1.096574015150698E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	5	0	8	8	8	0	23	35	-1	43	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDLLGEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGAGACAGGGAAACACCATATATTTTGGAGAG	CASSERQGNTIYF	In	VDJ	1	61	9.042717203102393E-5	1.096574015150698E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	2	5	4	4	0	23	35	-1	39	44														CASSERQGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGCGGGACAGGGACACGGCTACACCTTCGGTTCG	CASSYAGQGHGYTF	In	VDJ	1	61	9.042717203102393E-5	1.096574015150698E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	0	3	8	2	4	23	38	49	40	53														CASSYAGQGHGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
TCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCTTTCCCCAGCCGGTCCTAACCTTATACACACAGATACGCAGTATTTTGGCCCA	CASSLSPAGPNLIHTDTQYF	In	VDJ	1	61	9.042717203102393E-5	1.096574015150698E-4	60	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	6	3	6	2	27	0	21	32	-1	59	62				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSPAGPNLIHTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCAGAGGTGGCAGGGGGAACTGAAGCTTTCTTTGGACAA	CASSPEVAGGTEAFF	In	VDJ	1	62	9.190958468727023E-5	1.1145506383498898E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	1	5	10	1	23	35	52	45	53														CASSPEVAGGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGAGTATCAGGCGGCGCAGTACTTCGGGCCG	CASSYEYQAAQYF	In	VDJ	1	62	9.190958468727023E-5	1.1145506383498898E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	2	4	4	9	6	4	23	38	48	44	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYEYQAAQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTCCTCTCTCGGGGCTACGAGCAGTACTTCGGGCCG	CASSFLSRGYEQYF	In	VDJ	1	62	9.190958468727023E-5	1.1145506383498898E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	8	3	3	8	0	23	36	-1	44	49														CASSFLSRGYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACGCACAGGGGAAGGGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	63	9.339199734351652E-5		46	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	3	2	2	4	4	23	34	45	38	49														X+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAGGGGACAGGGACGGCTATGGCTACACCTTCGGTTCG	CASRGDRDGYGYTF	In	VDJ	1	64	9.487440999976282E-5	1.1505038847482733E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	3	4	2	4	23	34	45	36	49														CASRGDRDGYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACACCAGACAGGGTGGGTCACCCCTCCACTTTGGGAAC	CASSYTRQGGSPLHF	In	VDJ	1	64	9.487440999976282E-5	1.1505038847482733E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	2	2	3	10	4	4	23	38	49	42	53														CASSYTRQGGSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCTAGCACTGAACAGGGGATATACAATGAGCAGTTCTTCGGGCCA	CASTEQGIYNEQFF	In	VDJ	1	64	9.487440999976282E-5	1.1505038847482733E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	3	2	4	4	3	23	33	44	37	47														CASTEQGIYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAAACAGGGGGACGAGCCCAGAACTCAGCAATCAGCCCCAGCATTTTGGTGAT	CASRNRGTSPELSNQPQHF	In	VDJ	1	65	9.635682265600911E-5	1.1684805079474652E-4	57	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	3	1	1	2	15	23	34	44	36	59														CASRNRGTSPELSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAGATAGCGGGGGATACAATGAGCAGTTCTTCGGGCCA	CASRDSGGYNEQFF	In	VDJ	1	65	9.635682265600911E-5	1.1684805079474652E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	5	2	4	3	1	23	34	46	37	47														CASRDSGGYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGAGGACGCGGAGGGAGACCCAGTACTTCGGGCCA	CASSYSRTRRETQYF	In	VDJ	1	65	9.635682265600911E-5	1.1684805079474652E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	10	1	5	8	0	23	40	-1	48	53														CASSYSRTRRETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCTCCGGGACAGAAAAAATGAACACTGAAGCTTTCTTTGGACAA	CASSSGTEKMNTEAFF	In	VDJ	1	66	9.783923531225541E-5	1.1864571311466569E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	5	0	4	6	23	34	45	38	51														CASSSGTEKMNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGGCGAGGAACACTGAAGCTTTCTTTGGACAA	CASSEARNTEAFF	In	VDJ	1	67	9.93216479685017E-5	1.2044337543458487E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	11	1	1	0	4	23	-1	39	35	43														CASSEARNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGCCTAGGGGGATATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSGLGGYSNQPQHF	In	VDJ	1	69	1.0228647328099429E-4	1.2403870007442322E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	5	1	0	5	3	23	35	46	40	49														CASSGLGGYSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGGGACGTAAGGGAGACCCAGTACTTCGGGCCA	CASSGDVRETQYF	In	VDJ	1	69	1.0228647328099429E-4	1.2403870007442322E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	5	0	7	5	1	6	23	35	41	36	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGDVRETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCGGGGGATACGAGCAGTACTTCGGGCCG	CASSYSGGYEQYF	In	VDJ	1	69	1.0228647328099429E-4	1.2403870007442322E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	8	2	4	0	1	23	-1	46	40	47														CASSYSGGYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGACAGGGGGCACTGAAGCTTTCTTTGGACAA	CASSYSTGGTEAFF	In	VDJ	1	69	1.0228647328099429E-4	1.2403870007442322E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	2	1	4	0	0	23	-1	-1	40	49														CASSYSTGGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCGCCCGGGACAGGGTCACCGGGGAGCTGTTTTTTGGAGAA	CAIARDRVTGELFF	In	VDJ	1	69	1.0228647328099429E-4	1.2403870007442322E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	10	0	3	4	6	1	23	30	45	36	46														CAIARDRVTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCTGGTGATCCAAGGGGAGCAGTACTTCGGGCCG	CASSLVIQGEQYF	In	VDJ	1	70	1.0376888593724057E-4	1.258363623943424E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	6	5	3	7	12	0	23	34	-1	46	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVIQGEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCTCTCCGAGGTAAACGGGCACTTCGGGCCA	CASSYLSEVNGHF	In	VDJ	1	70	1.0376888593724057E-4	1.258363623943424E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	2	8	0	15	15	0	23	38	-1	53	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYLSEVNGHF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATAGGGACAGGGGCAGGAAACACCATATATTTTGGAGAG	CASIGTGAGNTIYF	In	VDJ	1	70	1.0376888593724057E-4	1.258363623943424E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	7	0	2	4	2	2	23	33	45	35	47														CASIGTGAGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCTAGGACAGGGGCCTGGCTACACCTTCGGTTCG	CASSLGQGPGYTF	In	VDJ	1	71	1.0525129859348688E-4	1.2763402471426157E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	2	7	4	2	23	34	47	38	49														CASSLGQGPGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCTAGGGGGAACACTGAAGCTTTCTTTGGACAA	CASSARGNTEAFF	In	VDJ	1	71	1.0525129859348688E-4	1.2763402471426157E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	5	2	1	3	0	23	35	-1	38	43														CASSARGNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGCCAATCGGTCGGGGGCCTTTACAATGAGCAGTTCTTCGGGCCA	CASSGQSVGGLYNEQFF	In	VDJ	1	71	1.0525129859348688E-4	1.2763402471426157E-4	51	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	5	6	0	4	12	3	23	35	53	47	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGQSVGGLYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTAAACCGGGACATAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	71	1.0525129859348688E-4		43	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	0	6	4	4	0	23	37	-1	41	47														X+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACAGGGGGTACAGGGGAATATAATTCACCCCTCCACTTTGGGAAC	CASTGGTGEYNSPLHF	In	VDJ	1	72	1.0673371124973316E-4	1.2943168703418074E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	7	3	2	4	8	2	23	33	48	41	50														CASTGGTGEYNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTAAAGTGGCGGGGGTCTACCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	72	1.0673371124973316E-4		49	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	7	2	0	5	3	23	37	49	42	52														X+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCTATCTACAGGGGAATTCACCCCTCCACTTTGGGAAC	CASSYLQGNSPLHF	In	VDJ	1	73	1.0821612390597947E-4	1.3122934935409992E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	3	2	7	6	0	23	34	-1	40	47														CASSYLQGNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCGGGACGGAGGAAACCGGGGAGCTGTTTTTTGGAGAA	CASSPGTEETGELFF	In	VDJ	1	73	1.0821612390597947E-4	1.3122934935409992E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	5	0	7	5	3	7	23	35	43	38	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGTEETGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCGCAGGGAGGGACTGAAGCTTTCTTTGGACAA	CASSAQGGTEAFF	In	VDJ	1	73	1.0821612390597947E-4	1.3122934935409992E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	9	0	5	5	0	23	35	-1	40	47														CASSAQGGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTGGACAGAGAAAAACTGTTTTTTGGCAGT	CASSLDREKLFF	In	VDJ	1	73	1.0821612390597947E-4	1.3122934935409992E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	1	5	8	1	1	23	36	43	37	44														CASSLDREKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGGACTAGCGGGGGCCCTCTACGAGAGCAGTACTTCGGGCCG	CASSGTSGGPLREQYF	In	VDJ	1	74	1.0969853656222575E-4	1.3302701167401912E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	0	2	7	0	10	23	-1	49	35	59														CASSGTSGGPLREQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCGGAGGAGATGTACGGCTACACCTTCGGTTCG	CASSSEEMYGYTF	In	VDJ	1	74	1.0969853656222575E-4	1.3302701167401912E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	4	10	1	8	1	8	23	36	42	37	50														CASSSEEMYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCGGACGTTCGGATACATCTGGAAACACCATATATTTTGGAGAG	CAGRSDTSGNTIYF	In	VDJ	1	74	1.0969853656222575E-4	1.3302701167401912E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-03	01	11	1	7	1	0	11	23	-1	33	29	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAGRSDTSGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01		TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGCCGGGACAGGGAATTGAACACTGAAGCTTTCTTTGGACAA	CAISRDRELNTEAFF	In	VDJ	1	75	1.1118094921847204E-4	1.348246739939383E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	3	0	2	3	23	34	45	36	48														CAISRDRELNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAACGGGCCCGGGGAGACCCAGTACTTCGGGCCA	CASNGPGETQYF	In	VDJ	1	76	1.1266336187471834E-4	1.3662233631385747E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	7	8	0	5	2	5	23	33	39	35	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASNGPGETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGTTTACGGGAGAAAGATACGCAGTATTTTGGCCCA	CASSGLREKDTQYF	In	VDJ	1	76	1.1266336187471834E-4	1.3662233631385747E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	8	2	5	6	2	23	35	47	41	49														CASSGLREKDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCGTAGCGGGGGGGCCGACACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	76	1.1266336187471834E-4		50	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	5	0	5	2	5	23	38	51	40	56														X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCAGCCGTGGGAACACTGAAGCTTTCTTTGGACAA	CASSSRGNTEAFF	In	VDJ	1	77	1.1414577453096463E-4	1.3841999863377664E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	6	4	5	1	0	6	23	-1	37	34	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSRGNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGATTTAGGGGGCGGGCCCCAGCATTTTGGTGAT	CASSDLGGGPQHF	In	VDJ	1	77	1.1414577453096463E-4	1.3841999863377664E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	5	0	9	5	2	23	35	47	40	49														CASSDLGGGPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGCAAATACAGGGGGCGCTGACACTGAAGCTTTCTTTGGACAA	CAISANTGGADTEAFF	In	VDJ	1	77	1.1414577453096463E-4	1.3841999863377664E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	0	3	6	4	23	35	50	41	54														CAISANTGGADTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCTTCGGCAATCAGCCCCAGCATTTTGGTGAT	CASSFGNQPQHF	In	VDJ	1	78	1.1562818718721093E-4	1.4021766095369582E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	6	4	10	2	0	3	23	-1	36	34	39						01,02								CASSFGNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCCCCCAGGGCCACAGATACGCAGTATTTTGGCCCA	CASSDSPRATDTQYF	In	VDJ	1	79	1.1711059984345722E-4	1.42015323273615E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	4	3	2	3	1	23	40	48	43	49														CASSDSPRATDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTAACTTTTCCGGGACAGGAAGCTTTCTTTGGACAA		Out	VDJ	1	80	1.1859301249970352E-4		41	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	5	8	8	0	23	37	-1	45	52														X+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCGAAGGGTAGCGGGGGCCACCCAATACGGAGTATTTTGGCCCA		Out	VDJ	1	80	1.1859301249970352E-4		52	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	5	2	13	7	13	23	38	54	45	67														X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCTCCCTTTCACACACAGATACGCAGTATTTTGGCCCA	CATSLSHTDTQYF	In	VDJ	1	81	1.2007542515594981E-4	1.4561064791345334E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	10	3	6	2	10	0	23	30	-1	40	43														CATSLSHTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTTGGGGCCCGCGGCTACGAGCAGTACTTCGGGCCG	CASSVGARGYEQYF	In	VDJ	1	81	1.2007542515594981E-4	1.4561064791345334E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	7	0	3	3	6	23	35	43	38	49														CASSVGARGYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCTCCGACAGGGGACCAGCCCCAGCATTTTGGTGAT	CASSYSPTGDQPQHF	In	VDJ	1	83	1.230402504684424E-4	1.492059725532917E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	2	2	7	3	2	23	40	51	43	53														CASSYSPTGDQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGACTAGCGGGGGGGCCAGATACGCAGTATTTTGGCCCA	CASSGLAGGPDTQYF	In	VDJ	1	84	1.245226631246887E-4	1.5100363487321086E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	1	0	4	0	1	23	-1	50	35	51														CASSGLAGGPDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCACTCCGGGGGTGGGTCGAGCTTTCTTTGGACAA	CASSTPGVGRAFF	In	VDJ	1	85	1.26005075780935E-4	1.5280129719313007E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	6	8	2	10	5	7	23	34	45	39	52														CASSTPGVGRAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCAATCGGGACAGGGAAGAACGAGCAGTACTTCGGGCCG	CASSYSIGTGKNEQYF	In	VDJ	1	85	1.26005075780935E-4	1.5280129719313007E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	3	5	4	4	23	40	53	44	57														CASSYSIGTGKNEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGAGGCACAGTAACTATGGCTACACCTTCGGTTCG	CASSERHSNYGYTF	In	VDJ	1	86	1.274874884371813E-4	1.5459895951304924E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	5	3	5	1	7	0	23	35	-1	42	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSERHSNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCAGCCAGGGCTACGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSSARATDTGELFF	In	VDJ	1	86	1.274874884371813E-4	1.5459895951304924E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	4	3	3	4	6	23	36	45	40	51														CASSSARATDTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGGGGGACTTAGCACAGATACGCAGTATTTTGGCCCA	CAISGGLSTDTQYF	In	VDJ	1	86	1.274874884371813E-4	1.5459895951304924E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	0	10	0	2	1	23	35	43	37	44						01,02								CAISGGLSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCACCCTAGCGGGCAGCACAGATACGCAGTATTTTGGCCCA	CASTTLAGSTDTQYF	In	VDJ	1	87	1.2896990109342757E-4	1.5639662183296842E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	7	4	4	0	5	1	23	33	46	38	47						01,02								CASTTLAGSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCTGGGACCCCTCCTACGAGCAGTACTTCGGGCCG	CASTWDPSYEQYF	In	VDJ	1	87	1.2896990109342757E-4	1.5639662183296842E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	7	0	7	0	3	2	23	33	41	36	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTWDPSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGACGACAGGGGTGAACACTGAAGCTTTCTTTGGACAA	CASRTTGVNTEAFF	In	VDJ	1	87	1.2896990109342757E-4	1.5639662183296842E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	2	0	3	0	23	34	-1	37	45														CASRTTGVNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCGGGACAGGGTTCACTGAAGCTTTCTTTGGACAA	CASSYSGTGFTEAFF	In	VDJ	1	87	1.2896990109342757E-4	1.5639662183296842E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	0	3	4	1	2	23	40	50	41	52														CASSYSGTGFTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCTCAGAATACAGGGGCTCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	87	1.2896990109342757E-4		49	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	3	2	0	8	2	23	36	51	44	53														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAACCGACCGGACTAGTCAAGAGACCCAGTACTTCGGGCCA	CASRTDRTSQETQYF	In	VDJ	1	88	1.3045231374967387E-4	1.581942841528876E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	1	8	2	8	1	23	34	49	42	50						01,02								CASRTDRTSQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCATCCTTCCTTTCTAACACAGATACGCAGTATTTTGGCCCA	CASSASFLSNTDTQYF	In	VDJ	1	88	1.3045231374967387E-4	1.581942841528876E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	4	9	2	13	1	23	35	51	48	52						01,02								CASSASFLSNTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTACCAGCAGTTATACGACAGGGGATACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	89	1.3193472640592017E-4		44	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	2	3	3	2	23	37	48	40	50														X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACCCGGGACAGGGGGCGCGATGGGTGGCTACACCTTCGGTTCG	CASRPGTGGAMGGYTF	In	VDJ	1	89	1.3193472640592017E-4	1.5999194647280677E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	0	7	4	8	23	34	50	38	58														CASRPGTGGAMGGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCAGGACAGGGGACGCGGGCGACGAGCAGTACTTCGGGCCG	CASSRTGDAGDEQYF	In	VDJ	1	89	1.3193472640592017E-4	1.5999194647280677E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	2	5	2	9	23	34	45	36	54														CASSRTGDAGDEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAACGACAGGGAGACCCAGTACTTCGGGCCA	CASSNDRETQYF	In	VDJ	1	89	1.3193472640592017E-4	1.5999194647280677E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	2	4	5	3	0	23	35	-1	38	44														CASSNDRETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGCCTCCTTAGGGAATAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	89	1.3193472640592017E-4		43	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	6	0	8	2	8	2	23	34	46	42	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGAGTATTCAGGTACATCACCCCTCCACTTTGGGAAC	CASREYSGTSPLHF	In	VDJ	1	90	1.3341713906216645E-4	1.6178960879272594E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-06	01	6	4	4	10	8	4	23	34	46	42	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASREYSGTSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01		TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCCTCCAACAGGGACGGAATTCACCCCTCCACTTTGGGAAC	CALQQGRNSPLHF	In	VDJ	1	91	1.3489955171841275E-4	1.6358727111264511E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	11	3	3	7	5	4	23	29	40	34	44														CALQQGRNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGGGGTAGAGGGCTATGGCTACACCTTCGGTTCG	CASSYSGVEGYGYTF	In	VDJ	1	92	1.3638196437465905E-4	1.653849334325643E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	0	6	1	4	0	7	23	-1	45	40	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSGVEGYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCCCGACTAGCGGAACTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	92	1.3638196437465905E-4		44	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	2	5	3	4	2	23	36	49	40	51						01,02								X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGATACGACAGGGACGGCTACACCTTCGGTTCG	CASRYDRDGYTF	In	VDJ	1	93	1.3786437703090535E-4	1.6718259575248346E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	2	3	8	0	2	23	-1	45	38	47														CASRYDRDGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGGACAGTACCTTAGCAATCAGCCCCAGCATTTTGGTGAT	CASRGQYLSNQPQHF	In	VDJ	1	93	1.3786437703090535E-4	1.6718259575248346E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	0	5	0	0	5	23	-1	41	34	46														CASRGQYLSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCACACGGATGGAGGATTCACCCCTCCACTTTGGGAAC	CATTRMEDSPLHF	In	VDJ	1	94	1.3934678968715162E-4	1.6898025807240264E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	10	10	1	8	10	0	23	30	-1	40	45														CATTRMEDSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACAATGACAGGGGGCACTGAAGCTTTCTTTGGACAA	CASTMTGGTEAFF	In	VDJ	1	94	1.3934678968715162E-4	1.6898025807240264E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	2	1	4	4	0	23	33	-1	37	46														CASTMTGGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCAACAGGAAACACTGAAGCTTTCTTTGGACAA	CASSATGNTEAFF	In	VDJ	1	94	1.3934678968715162E-4	1.6898025807240264E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	4	2	3	1	23	35	43	38	44														CASSATGNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCGGGGTGGGGGCGAAGCTTTCTTTGGACAA	CASSYRGGGEAFF	In	VDJ	1	94	1.3934678968715162E-4	1.6898025807240264E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	6	0	8	6	0	23	38	-1	44	50														CASSYRGGGEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGCAGGGGAACCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	94	1.3934678968715162E-4		43	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	2	2	2	3	23	38	46	40	49														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGGCAGGGGCCAAGAGACCCAGTACTTCGGGCCA	CASSYSGRGQETQYF	In	VDJ	1	94	1.3934678968715162E-4	1.6898025807240264E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	4	2	1	3	0	23	40	-1	43	49														CASSYSGRGQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTTAGGGGAGGTGAAGCTTTCTTTGGACAA	CASSFRGGEAFF	In	VDJ	1	95	1.4082920234339793E-4	1.7077792039232181E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	9	1	7	4	0	23	36	-1	40	46														CASSFRGGEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATCGGGGCTAATAGCAATCAGCCCCAGCATTTTGGTGAT	CASIGANSNQPQHF	In	VDJ	1	95	1.4082920234339793E-4	1.7077792039232181E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	7	7	0	0	2	3	23	33	40	35	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASIGANSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACAGGACAGGGGTGGTACAATGAGCAGTTCTTCGGGCCA	CATGQGWYNEQFF	In	VDJ	1	96	1.4231161499964423E-4	1.72575582712241E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	10	1	2	4	2	3	23	30	41	32	44														CATGQGWYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCTCGGACACGGGAGGAGAGACCCAGTACTTCGGGCCA	CASSSDTGGETQYF	In	VDJ	1	96	1.4231161499964423E-4	1.72575582712241E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	8	1	4	8	0	23	34	-1	42	49														CASSSDTGGETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCGTGGGACAGCCGTAATGAAAAACTGTTTTTTGGCAGT	CASSPWDSRNEKLFF	In	VDJ	1	96	1.4231161499964423E-4	1.72575582712241E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	0	5	4	4	3	23	35	46	39	49														CASSPWDSRNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTAGGGTTGACAGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLGLTGANVLTF	In	VDJ	1	96	1.4231161499964423E-4	1.72575582712241E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-06	01	4	2	6	4	7	0	23	36	-1	43	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGLTGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01		TCRBJ02-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAACCGCATTAACTATGGCTACACCTTCGGTTCG	CASSYNRINYGYTF	In	VDJ	1	97	1.437940276558905E-4	1.743732450321602E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	2	3	7	1	1	5	23	38	41	39	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYNRINYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCACTCGGGGACAGGGTTCGGGCAGCCCCAGCATTTTGGTGAT	CASSYHSGTGFGQPQHF	In	VDJ	1	97	1.437940276558905E-4	1.743732450321602E-4	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	0	3	7	6	6	23	38	53	44	59														CASSYHSGTGFGQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCAGGCGTAGGACTCACAGATACGCAGTATTTTGGCCCA	CASSYSGVGLTDTQYF	In	VDJ	1	97	1.437940276558905E-4	1.743732450321602E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	1	10	2	7	0	23	40	-1	47	52						01,02								CASSYSGVGLTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGCCCGGGACAGGGGAACACTGAAGCTTTCTTTGGACAA	CAISPGQGNTEAFF	In	VDJ	1	97	1.437940276558905E-4	1.743732450321602E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	3	1	3	0	23	34	-1	37	46														CAISPGQGNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTGACAGGGGTAGAACAGCCCCAGCATTTTGGTGAT	CASSVTGVEQPQHF	In	VDJ	1	98	1.452764403121368E-4	1.7617090735207936E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	2	2	7	2	5	23	35	45	37	50														CASSVTGVEQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCGGACAGAGTTTTCCTACGAGCAGTACTTCGGGCCG	CASRTEFSYEQYF	In	VDJ	1	98	1.452764403121368E-4	1.7617090735207936E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	1	5	1	1	5	23	32	39	33	44														CASRTEFSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAAGGGACAGCCTAATGAAAAACTGTTTTTTGGCAGT	CAIKGQPNEKLFF	In	VDJ	1	98	1.452764403121368E-4	1.7617090735207936E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	10	0	5	3	4	1	23	30	41	34	42														CAIKGQPNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTCGAAGCGGGGGTCAACAATGAGCAGTTCTTCGGGCCA	CASSFEAGVNNEQFF	In	VDJ	1	99	1.467588529683831E-4	1.7796856967199854E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	6	2	5	4	3	23	36	48	40	51														CASSFEAGVNNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCATTAGCGGGGGCTCTGGAGACCCAGTACTTCGGGCCA	CASSALAGALETQYF	In	VDJ	1	100	1.482412656246294E-4	1.7976623199191771E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	5	2	5	4	5	23	35	48	39	53														CASSALAGALETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCGGGGGTAAAGGCTACACCTTCGGTTCG	CASSPGGKGYTF	In	VDJ	1	102	1.5120609093712198E-4	1.8336155663175606E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	5	8	2	8	2	4	23	35	43	37	47														CASSPGGKGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAGGCGGAACACTGAAGCTTTCTTTGGACAA	CASSYRRNTEAFF	In	VDJ	1	102	1.5120609093712198E-4	1.8336155663175606E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	2	5	4	1	0	2	23	-1	41	38	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYRRNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCTTTGTCCGGGGAGCTGTTTTTTGGAGAA	CASSSLSGELFF	In	VDJ	1	102	1.5120609093712198E-4	1.8336155663175606E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	4	10	6	0	4	23	-1	38	36	42						01,02								CASSSLSGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCCCTGGGTGGAGAGAGGACAGATACGCAGTATTTTGGCCCA	CASSPLGGERTDTQYF	In	VDJ	1	103	1.5268850359336829E-4	1.8515921895167524E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	10	2	3	10	5	23	34	48	44	53														CASSPLGGERTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCATCGACAAGACCAGGAGACCCAGTACTTCGGGCCA	CASSHRQDQETQYF	In	VDJ	1	103	1.5268850359336829E-4	1.8515921895167524E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	2	6	5	4	7	23	35	43	39	50														CASSHRQDQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCCCCTAGGGGGGGGGCCCGTAACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	103	1.5268850359336829E-4		53	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	4	9	0	5	7	8	23	36	50	43	58														X+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCGCCGACAGGGTCGTCCTACGAGCAGTACTTCGGGCCG	CASSAPTGSSYEQYF	In	VDJ	1	104	1.5417091624961456E-4	1.869568812715944E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	3	1	5	3	23	35	47	40	50														CASSAPTGSSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAAATCAGGGGGCGTTAGTTGGCTACACCTTCGGTTCG		Out	VDJ	1	105	1.5565332890586086E-4		37	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	10	4	0	7	3	6	23	30	41	33	47														X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAGAGGTCCGATCAATCAGCCCCAGCATTTTGGTGAT	CASSRGPINQPQHF	In	VDJ	1	105	1.5565332890586086E-4	1.887545435915136E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	5	11	1	3	1	6	23	35	40	36	46														CASSRGPINQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACGCTTCCCCTTGACAGGGGGGAACACTGAAGCTTTCTTTGGACAA	CASRRFPLTGGNTEAFF	In	VDJ	1	106	1.5713574156210716E-4	1.9055220591143276E-4	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	1	1	12	0	23	34	-1	46	55														CASRRFPLTGGNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGGGACAGGGTATTCACCCCTCCACTTTGGGAAC	CASGTGYSPLHF	In	VDJ	1	106	1.5713574156210716E-4	1.9055220591143276E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	8	0	3	8	0	1	23	-1	41	32	42														CASGTGYSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTTATTCCGGGACAGCCCTCCCGGGGACTGAAGCTTTCTTTGGACAA	CAISYSGTALPGTEAFF	In	VDJ	1	108	1.6010056687459974E-4	1.9414753055127114E-4	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	5	5	4	11	23	37	48	41	59														CAISYSGTALPGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAACTCCTAGCGAGCCCTGAAGCTTTCTTTGGACAA		Out	VDJ	1	109	1.6158297953084604E-4		38	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	7	4	6	6	4	4	23	33	43	37	47						01,02								X+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATCGCGAAGATCAGGGGATGGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	109	1.6158297953084604E-4		53	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	2	2	10	3	23	37	53	47	56														X+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCCCTGCGGGGGCCTACAATGAGCAGTTCTTCGGGCCA	CASTPAGAYNEQFF	In	VDJ	1	110	1.6306539218709234E-4	1.977428551911095E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	7	7	2	2	5	0	23	33	-1	38	45														CASTPAGAYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGCCCACAGGAGGAGGCTACACCTTCGGTTCG	CASSYSPTGGGYTF	In	VDJ	1	110	1.6306539218709234E-4	1.977428551911095E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	0	3	4	8	4	4	23	40	49	44	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSPTGGGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACGCCGGGACAGGGGAGTTTGAACACAGATACGCAGTATTTTGGCCCA	CASTPGQGSLNTDTQYF	In	VDJ	1	111	1.6454780484333862E-4	1.9954051751102866E-4	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	0	2	2	4	8	23	33	47	37	55														CASTPGQGSLNTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGCCGGGACAGCGTTCTATGGCTACACCTTCGGTTCG	CASRAGTAFYGYTF	In	VDJ	1	111	1.6454780484333862E-4	1.9954051751102866E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	5	4	4	4	23	34	45	38	49														CASRAGTAFYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGACAATGAAAAACTGTTTTTTGGCAGT	CASSYDNEKLFF	In	VDJ	1	112	1.6603021749958492E-4	2.0133817983094784E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-04	01	2	2	7	5	0	0	23	-1	-1	38	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYDNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01		TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGGACTCCCGGGACAGGAGAATCCTCCTACGAGCAGTACTTCGGGCCG	CAIRTPGTGESSYEQYF	In	VDJ	1	112	1.6603021749958492E-4	2.0133817983094784E-4	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	4	0	7	6	23	34	49	41	55														CAIRTPGTGESSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCTCGAGACCCGGACCACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	113	1.6751263015583122E-4		41	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	8	1	7	4	9	3	23	32	45	41	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGCAGGGATCCCCTACGAGCAGTACTTCGGGCCG	CASSYAGIPYEQYF	In	VDJ	1	114	1.6899504281207752E-4	2.049335044707862E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	3	2	1	4	23	38	44	39	48														CASSYAGIPYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAGACGGGGCAGGGGGCACTGAAGCTTTCTTTGGACAA	CASRDGAGGTEAFF	In	VDJ	1	115	1.704774554683238E-4	2.0673116679070536E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	1	4	8	0	23	34	-1	42	49														CASRDGAGGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCCCTGGGGGGGCCGGATCTGAAGCTTTCTTTGGACAA	CASTPGGAGSEAFF	In	VDJ	1	116	1.719598681245701E-4	2.0852882911062454E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	7	9	0	6	5	6	23	33	45	38	51														CASTPGGAGSEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCGGGACAGGGGACGAGCAGTACTTCGGGCCG	CASSPGTGDEQYF	In	VDJ	1	116	1.719598681245701E-4	2.0852882911062454E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	2	5	3	0	23	35	-1	38	48														CASSPGTGDEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACCCGCTAGACAGGGGGATGGCTACACCTTCGGTTCG	CASRPARQGDGYTF	In	VDJ	1	117	1.734422807808164E-4	2.103264914305437E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	1	6	8	0	23	34	-1	42	51														CASRPARQGDGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGATTCCGGGACAGGGTCCTACGAGCAGTACTTCGGGCCG	CASSDSGTGSYEQYF	In	VDJ	1	117	1.734422807808164E-4	2.103264914305437E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	3	1	6	0	23	35	-1	41	50														CASSDSGTGSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTGCGGGGGAGAGGAGGCTATGGCTACACCTTCGGTTCG	CASSLRGRGGYGYTF	In	VDJ	1	117	1.734422807808164E-4	2.103264914305437E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	4	7	2	4	1	8	23	36	44	37	52														CASSLRGRGGYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGGTCAGTCCCCCTACGAGCAGTACTTCGGGCCG	CASSYSGQSPYEQYF	In	VDJ	1	119	1.7640710609330898E-4	2.139218160703821E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	0	0	9	2	0	8	23	-1	43	40	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSGQSPYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTCGGACGGGAGAGACTGAAGCTTTCTTTGGACAA	CAISRTGETEAFF	In	VDJ	1	119	1.7640710609330898E-4	2.139218160703821E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	8	2	5	4	2	23	35	45	39	47														CAISRTGETEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAAACGGGACGCTGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	120	1.7788951874955528E-4		38	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	10	0	7	3	6	4	23	30	41	36	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAGGGGACAGGGGAGGAAAAACTGTTTTTTGGCAGT	CASKGTGEEKLFF	In	VDJ	1	121	1.7937193140580158E-4	2.1751714071022044E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	7	0	2	8	2	2	23	33	45	35	47														CASKGTGEEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGCAGGGAAGTTCACCCCTCCACTTTGGGAAC	CASRQGSSPLHF	In	VDJ	1	121	1.7937193140580158E-4	2.1751714071022044E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	4	3	9	1	3	23	34	40	35	43														CASRQGSSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGACGGGCGCTGGGTCTGGAAACACCATATATTTTGGAGAG	CASSETGAGSGNTIYF	In	VDJ	1	121	1.7937193140580158E-4	2.1751714071022044E-4	48	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-03	01	5	8	0	1	5	6	23	35	44	40	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSETGAGSGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01		TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGATCGGACTTTCTACGAGCAGTACTTCGGGCCG	CASSDRTFYEQYF	In	VDJ	1	121	1.7937193140580158E-4	2.1751714071022044E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	1	10	3	4	2	23	35	44	39	46						01,02								CASSDRTFYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGGGCCGCGAGCAGTACTTCGGGCCG	CASSYGGREQYF	In	VDJ	1	121	1.7937193140580158E-4	2.1751714071022044E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	6	0	6	0	2	23	-1	44	38	46														CASSYGGREQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCAACTTCACCGACAGAGACAACCCACAGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	123	1.8233675671829416E-4		58	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	5	1	11	12	23	34	50	45	62														X+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCAGTAAACACCCCCTACGAGCAGTACTTCGGGCCG	CASSYSVNTPYEQYF	In	VDJ	1	123	1.8233675671829416E-4	2.211124653500588E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	3	6	2	5	3	23	40	48	45	51														CASSYSVNTPYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCAACAAGGACAGTCCAGATACGCAGTATTTTGGCCCA	CASSNKDSPDTQYF	In	VDJ	1	125	1.8530158203078673E-4	2.2470778998989714E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	1	5	4	6	2	23	34	46	40	48														CASSNKDSPDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCACCGGGACTAGCGGGGGGGCCTGGCAGGTACGAGCAGTACTTCGGGCCG	CASSSPGLAGGPGRYEQYF	In	VDJ	1	125	1.8530158203078673E-4	2.2470778998989714E-4	57	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	0	0	4	4	9	23	36	56	40	65														CASSSPGLAGGPGRYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCGGACTAGCGGGGCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	126	1.8678399468703303E-4		47	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	1	3	2	0	1	23	-1	52	40	53														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCTTCCCCCGGGGAGGTACTGAAGCTTTCTTTGGACAA	CASSPFPRGGTEAFF	In	VDJ	1	127	1.8826640734327934E-4	2.2830311462973549E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	9	1	5	11	1	23	35	52	46	53														CASSPFPRGGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCCCCGACATTAACTCGATCGACGGACAGCGCAAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	127	1.8826640734327934E-4		58	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	10	1	5	2	23	4	23	30	59	53	63														X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCTCTAGCGGGGATTTACAATGAGCAGTTCTTCGGGCCA	CASSPLAGIYNEQFF	In	VDJ	1	128	1.8974881999952564E-4	2.3010077694965466E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	4	3	4	3	3	23	35	47	38	50														CASSPLAGIYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCTATCCACTCCCTATAATTCACCCCTCCACTTTGGGAAC	CASSLSTPYNSPLHF	In	VDJ	1	128	1.8974881999952564E-4	2.3010077694965466E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	5	3	10	2	6	1	23	35	44	41	45						01,02								CASSLSTPYNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD02-01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAGTACGGGACAGGGAGGGTACGAGCAGTACTTCGGGCCG	CASSYSTGQGGYEQYF	In	VDJ	1	128	1.8974881999952564E-4	2.3010077694965466E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	0	3	4	5	4	23	38	52	43	56														CASSYSTGQGGYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAACAGGGGGCTCTGGAAACACCATATATTTTGGAGAG	CASRTGGSGNTIYF	In	VDJ	1	129	1.912312326557719E-4	2.3189843926957383E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	3	1	0	1	0	23	34	-1	35	43														CASRTGGSGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGGGACAGGGGTAAAGGAAAAACTGTTTTTTGGCAGT	CASRGTGVKEKLFF	In	VDJ	1	131	1.9419605796826452E-4	2.354937639094122E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	0	2	8	1	5	23	34	45	35	50														CASRGTGVKEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGATTAGTTGAAGCCAAAAACATTCAGTACTTCGGCGCC	CASRLVEAKNIQYF	In	VDJ	1	132	1.9567847062451082E-4	2.3729142622933139E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	6	5	8	0	2	4	23	34	39	36	43						01,02								CASRLVEAKNIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD02-01	TCRBJ02-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAACAGAGGCGATCCTAACTATGGCTACACCTTCGGTTCG	CAINRGDPNYGYTF	In	VDJ	1	132	1.9567847062451082E-4	2.3729142622933139E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	10	3	5	0	3	8	23	30	37	33	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAINRGDPNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCGGGTCTAAGCCTTCGGGAGAGACCCAGTACTTCGGGCCA	CAGSKPSGETQYF	In	VDJ	1	132	1.9567847062451082E-4	2.3729142622933139E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	11	8	4	4	13	0	23	29	-1	42	46						01,02								CAGSKPSGETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAACAGTGACAGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CANSDSSGANVLTF	In	VDJ	1	133	1.971608832807571E-4	2.3908908854925056E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	2	5	0	0	0	23	-1	-1	35	40														CANSDSSGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCTACCTAGCGGGGGTGTACCAAGAGACCCAGTACTTCGGGCCA	CASSYLAGVYQETQYF	In	VDJ	1	133	1.971608832807571E-4	2.3908908854925056E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	4	2	0	0	3	23	-1	48	38	51														CASSYLAGVYQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCTGCGGGGGTAATGAAAAACTGTTTTTTGGCAGT	CATCGGNEKLFF	In	VDJ	1	134	1.986432959370034E-4	2.4088675086916974E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	10	7	2	4	3	0	23	30	-1	33	40														CATCGGNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATAGGAGTTTCGGTTCACCCCTCCACTTTGGGAAC	CASSYRSFGSPLHF	In	VDJ	1	135	2.001257085932497E-4	2.426844131890889E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	3	10	2	9	2	6	23	37	43	39	49														CASSYRSFGSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGATGGATACAAGAGGGCAGATACGCAGTATTTTGGCCCA	CASSDGYKRADTQYF	In	VDJ	1	136	2.0160812124949597E-4	2.444820755090081E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	11	0	4	11	0	23	35	-1	46	51														CASSDGYKRADTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCCTGTACACAGATACGCAGTATTTTGGCCCA	CASSSLYTDTQYF	In	VDJ	1	139	2.0605535921823487E-4	2.498750624687656E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	4	10	2	2	3	23	36	40	38	43						01,02								CASSSLYTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAGAGGGGTGGAACACTGAAGCTTTCTTTGGACAA	CASREGWNTEAFF	In	VDJ	1	140	2.0753777187448115E-4	2.516727247886848E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	6	5	2	1	2	2	23	34	41	36	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASREGWNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGATTCGGGTAGGAAAGCTTTCTTTGGACAA	CASSDSGRKAFF	In	VDJ	1	140	2.0753777187448115E-4	2.516727247886848E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	8	4	9	4	5	23	35	43	39	48						01,02								CASSDSGRKAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGGGTGGGAGGGCGGACCGGGGAGCTGTTTTTTGGAGAA	CASSGVGGRTGELFF	In	VDJ	1	140	2.0753777187448115E-4	2.516727247886848E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	9	0	5	5	3	23	35	47	40	50														CASSGVGGRTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCGGCTCCGCTGGAAACTATGGCTACACCTTCGGTTCG	CAGSAGNYGYTF	In	VDJ	1	142	2.1050259718697375E-4	2.5526804942852313E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	11	1	8	2	9	0	23	29	-1	38	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAGSAGNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCATCCAGGGGGCGTTGGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSYSSRGRWSNQPQHF	In	VDJ	1	143	2.1198500984322003E-4	2.570657117484423E-4	54	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	4	0	1	3	5	23	40	51	43	56														CASSYSSRGRWSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATGCCCCTCGGGCAGCCTAACACTGAAGCTTTCTTTGGACAA	CASMPLGQPNTEAFF	In	VDJ	1	144	2.1346742249946633E-4	2.588633740683615E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	7	8	0	2	8	5	23	33	45	41	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASMPLGQPNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCCACTAGCGGGGGGGCCGGGGAGCTGTTTTTTGGAGAA	CASSPTSGGAGELFF	In	VDJ	1	145	2.1494983515571263E-4	2.6066103638828066E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	6	3	0	6	4	0	23	34	-1	38	51														CASSPTSGGAGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCGGCAGGGAGCGGGGAGCTGTTTTTTGGAGAA	CASSYPAGSGELFF	In	VDJ	1	145	2.1494983515571263E-4	2.6066103638828066E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	2	4	3	7	4	2	23	38	47	42	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYPAGSGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGGGGGGCCTGTCGGGAAAACTGTTTTTTGGCAGT	CASSYGGGLSGKLFF	In	VDJ	1	145	2.1494983515571263E-4	2.6066103638828066E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	2	9	0	10	0	10	23	-1	45	38	55														CASSYGGGLSGKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACATTAGCGGGAGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSDISGRNTGELFF	In	VDJ	1	146	2.1643224781195893E-4	2.6245869870819983E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	5	2	1	5	0	23	35	-1	40	49														CASSDISGRNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTAGGTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLGSNQPQHF	In	VDJ	1	146	2.1643224781195893E-4	2.6245869870819983E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	4	5	4	0	1	0	23	36	-1	37	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCTCCCGGGACAGGTACACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	147	2.179146604682052E-4		41	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	10	0	4	5	6	3	23	30	44	36	47														X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACCGACAGGGGGTGAACACTGAAGCTTTCTTTGGACAA	CASSDRQGVNTEAFF	In	VDJ	1	148	2.193970731244515E-4	2.6605402334803824E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	1	0	4	0	23	35	-1	39	48														CASSDRQGVNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCAGACATGGAGGAAGCTTTCTTTGGACAA	CASSYPDMEEAFF	In	VDJ	1	149	2.208794857806978E-4	2.678516856679574E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	2	2	6	8	3	5	23	38	45	41	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYPDMEEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCCAGACATCTGTGTACTTGTGTGCCAGCAGTGATACAACCTCCAGGGCGTTAGGTCGGGAGGAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	150	2.2236189843694408E-4		61	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	5	8	1	4	24	0	20	32	-1	56	63														X+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGAGGGGCACCTACGAGCAGTACTTCGGGCCG	CASSYSRGTYEQYF	In	VDJ	1	150	2.2236189843694408E-4	2.696493479878766E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	0	5	2	2	1	2	23	40	46	41	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSRGTYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACGGGGTGGGTAATCAGCCCCAGCATTTTGGTGAT	CASSDGVGNQPQHF	In	VDJ	1	151	2.2384431109319039E-4	2.7144701030779576E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	5	8	3	4	2	5	23	35	42	37	47														CASSDGVGNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGCGAGGACAGATAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	151	2.2384431109319039E-4		44	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	5	2	6	2	23	35	47	41	49														X+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCTTAGCGGGGGGCTACGAGCAGTACTTCGGGCCG	CASSLAGGYEQYF	In	VDJ	1	153	2.26809136405683E-4	2.750423349476341E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	5	1	3	2	0	23	34	-1	36	46														CASSLAGGYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGTGGCTAGCGGGGAGTACAGATACGCAGTATTTTGGCCCA	CASSEWLAGSTDTQYF	In	VDJ	1	153	2.26809136405683E-4	2.750423349476341E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	4	3	3	6	3	23	35	50	41	53														CASSEWLAGSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTGGGTCAGGGGGACCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	155	2.2977396171817557E-4		46	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	4	1	2	4	2	23	39	50	43	52														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCAGGGCCCTATAATTCACCCCTCCACTTTGGGAAC	CASSAGPYNSPLHF	In	VDJ	1	156	2.3125637437442187E-4	2.8043532190739163E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	4	3	2	1	1	23	35	41	36	42														CASSAGPYNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCGGGGGGAGAATAATTCACCCCTCCACTTTGGGAAC	CASSRGENNSPLHF	In	VDJ	1	157	2.3273878703066814E-4	2.822329842273108E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	6	8	1	5	1	3	23	34	42	35	45														CASSRGENNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGCCAATACAGGGAGTAGGGTGGCTACACCTTCGGTTCG	CAISQYRE*GGYTF	Stop	VDJ	1	157	2.3273878703066814E-4		42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	3	3	7	5	7	23	34	45	39	52														CAISQYRE*GGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTACCCGGGACGGACCCTACGAGCAGTACTTCGGGCCG	CASSTRDGPYEQYF	In	VDJ	1	158	2.3422119968691444E-4	2.8403064654723E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	5	0	7	2	4	4	23	35	44	39	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSTRDGPYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCCTCGGAGAATTCACCCCTCCACTTTGGGAAC	CASSASENSPLHF	In	VDJ	1	158	2.3422119968691444E-4	2.8403064654723E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	5	10	2	7	5	0	23	35	-1	40	44														CASSASENSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCTGGTTCTGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSYPGSATNEKLFF	In	VDJ	1	160	2.3718602499940705E-4	2.8762597118706833E-4	48	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-04	01	2	0	10	0	3	5	23	38	43	41	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYPGSATNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01		TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCTTCAGGGGCGGCACACTGAAGCTTTCTTTGGACAA	CASSLQGRHTEAFF	In	VDJ	1	161	2.3866843765565332E-4	2.894236335069875E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	2	3	4	4	23	34	44	38	48														CASSLQGRHTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGCGGGACAGGGACCCTTTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSYGGTGTLYSNQPQHF	In	VDJ	1	162	2.4015085031189962E-4	2.912212958269067E-4	57	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	0	3	0	3	8	23	38	50	41	58														CASSYGGTGTLYSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCGGGACGAATTTTCAGCCCCAGCATTTTGGTGAT	CASSSGTNFQPQHF	In	VDJ	1	162	2.4015085031189962E-4	2.912212958269067E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	4	0	7	6	2	6	23	36	43	38	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSGTNFQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAAACTCTACTAACCTACGAGCAGTACTTCGGGCCG	CASKTLLTYEQYF	In	VDJ	1	164	2.431156756243922E-4	2.9481662046674503E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	3	9	2	7	1	23	33	44	40	45						01,02								CASKTLLTYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCGGCCGGGACAGGACGTCAGATACGCAGTATTTTGGCCCA	CAGRDRTSDTQYF	In	VDJ	1	164	2.431156756243922E-4	2.9481662046674503E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	11	0	4	4	4	4	23	29	41	33	45														CAGRDRTSDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCCTCTCTGGAAACACCATATATTTTGGAGAG	CASTLSGNTIYF	In	VDJ	1	165	2.445980882806385E-4	2.966142827866642E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	7	4	10	0	2	0	23	33	-1	35	37						01,02								CASTLSGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD02-01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCATGGGGCACGGCTACGAGCAGTACTTCGGGCCG	CASSMGHGYEQYF	In	VDJ	1	165	2.445980882806385E-4	2.966142827866642E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	7	0	3	3	4	23	34	42	37	46														CASSMGHGYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGACAGGGACACTGAAGCTTTCTTTGGACAA	CASRDRDTEAFF	In	VDJ	1	166	2.460805009368848E-4	2.984119451065834E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	3	3	0	0	23	-1	-1	34	42														CASRDRDTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCAACCGGGGGGGCATGGAGACCCAGTACTTCGGGCCA	CASSPNRGGMETQYF	In	VDJ	1	166	2.460805009368848E-4	2.984119451065834E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	8	0	5	6	4	23	35	49	41	53														CASSPNRGGMETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCCACAGTTCGATAGAGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	166	2.460805009368848E-4		43	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	5	8	0	3	2	23	36	42	39	44						01,02								X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAAGAGACAGGAGTGAACACTGAAGCTTTCTTTGGACAA	CASKETGVNTEAFF	In	VDJ	1	168	2.490453262493774E-4	3.0200726974642173E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	2	4	0	4	2	23	33	43	37	45														CASKETGVNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGTCCTCTTTCAACACTGAAGCTTTCTTTGGACAA	CASSYGSSFNTEAFF	In	VDJ	1	168	2.490453262493774E-4	3.0200726974642173E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	2	0	9	2	0	9	23	-1	41	38	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYGSSFNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATGAAGGAACCGGGGRGTGCCTACAATGAGCAGTTCTTCGGGCCA	CASMKEPGXAYNEQFF	In	VDJ	1	170	2.5201015156187E-4	3.0560259438626013E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	7	8	1	2	9	2	23	33	49	42	51						unresolved								CASMKEPGXAYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCAGGGGATCGGGGGAAAAACTGTTTTTTGGCAGT	CASSYSRGSGEKLFF	In	VDJ	1	171	2.5349256421811626E-4	3.074002567061793E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	4	2	8	0	7	23	-1	46	40	53														CASSYSRGSGEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGGGGAGGGAGACCCAGTACTTCGGGCCA	CASSYGGRETQYF	In	VDJ	1	172	2.549749768743626E-4	3.091979190260985E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	9	1	5	0	3	23	-1	44	38	47						01,02								CASSYGGRETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTGGGGGGACTATGGCTACACCTTCGGTTCG	CASSWGDYGYTF	In	VDJ	1	172	2.549749768743626E-4	3.091979190260985E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	4	9	1	3	0	0	23	-1	-1	36	42														CASSWGDYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATAAAGGGGGATTTGGCTGAAGCTTTCTTTGGACAA	CAIKGDLAEAFF	In	VDJ	1	172	2.549749768743626E-4	3.091979190260985E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	10	5	1	6	3	6	23	30	39	33	45														CAIKGDLAEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTATCTAGCCAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	173	2.5645738953060886E-4		41	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	4	7	0	2	1	23	35	42	37	43						01,02								X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACGGGGGGGCCAGCACAGATACGCAGTATTTTGGCCCA	CASSDGGASTDTQYF	In	VDJ	1	174	2.5793980218685513E-4	3.1279324366593683E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	8	0	0	2	2	23	35	45	37	47														CASSDGGASTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTAGGGACAGGGAAGAGAAAAACTGTTTTTTGGCAGT	CASSD*GQGREKLFF	Stop	VDJ	1	174	2.5793980218685513E-4		45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	0	3	8	1	4	23	39	49	40	53														CASSD*GQGREKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTATCGCTAGCGAAACAGATACGCAGTATTTTGGCCCA	CASSIASETDTQYF	In	VDJ	1	175	2.5942221484310146E-4	3.14590905985856E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	4	6	3	4	2	23	35	45	39	47						01,02								CASSIASETDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATCAAAAAACACCACAACACTGAAGCTTTCTTTGGACAA	CASIKKHHNTEAFF	In	VDJ	1	176	2.6090462749934774E-4	3.163885683057752E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	3	6	2	7	4	23	33	43	40	47														CASIKKHHNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTACCAGCAGTGCCGGGACAGGTTGGACCGGGGAGCTGTTTTTTGGAGAA	CTSSAGTGWTGELFF	In	VDJ	1	177	2.62387040155594E-4	3.1818623062569436E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	4	5	3	4	23	35	46	38	50														CTSSAGTGWTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGCAAGGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CASSEQGSYNSPLHF	In	VDJ	1	177	2.62387040155594E-4	3.1818623062569436E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-06	01	5	5	4	0	5	0	23	35	-1	40	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEQGSYNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01		TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGAAGGGACGGGGGAGACTCAGTACTTCGGGCCA	CASSYEGTGETQYF	In	VDJ	1	180	2.668342781243329E-4	3.235792175854519E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	8	2	11	7	5	23	38	51	45	56														CASSYEGTGETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGAGCCGGGACAGAGATAGCAATCAGCCCCAGCATTTTGGTGAT	CASRSRDRDSNQPQHF	In	VDJ	1	184	2.727639287493181E-4	3.307698668651286E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	0	5	0	5	3	23	34	46	39	49														CASRSRDRDSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGCTGTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASRLYSNQPQHF	In	VDJ	1	185	2.7424634140556437E-4	3.3256752918504775E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	6	10	0	0	0	4	23	-1	36	34	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRLYSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGGGACAGGGAGTGAAAAACTGTTTTTTGGCAGT	CASGTGSEKLFF	In	VDJ	1	185	2.7424634140556437E-4	3.3256752918504775E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	8	0	3	7	0	2	23	-1	41	32	43														CASGTGSEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGACAGGGACCTTTGAAGCTTTCTTTGGACAA	CASSYGTGTFEAFF	In	VDJ	1	187	2.77211166718057E-4	3.361628538248861E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	3	7	0	5	23	-1	47	38	52														CASSYGTGTFEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCTGGGTTACTGAACACTGAAGCTTTCTTTGGACAA	CASSYSGLLNTEAFF	In	VDJ	1	187	2.77211166718057E-4	3.361628538248861E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	0	0	9	0	1	4	23	40	44	41	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSGLLNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCTCGACTAGCGGGGGGATATTTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSPRLAGGYLAKNIQYF	In	VDJ	1	188	2.7869357937430325E-4	3.379605161448053E-4	57	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	5	2	1	0	4	6	23	35	52	39	58														CASSPRLAGGYLAKNIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAGGGGACAGGGAACCTACGAGCAGTACTTCGGGCCG	CASSYRGQGTYEQYF	In	VDJ	1	188	2.7869357937430325E-4	3.379605161448053E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	0	3	2	2	2	23	38	49	40	51														CASSYRGQGTYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGACCGCCGAAGTCTACGAGCAGTACTTCGGGCCG	CASSETAEVYEQYF	In	VDJ	1	189	2.801759920305496E-4	3.3975817846472445E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	5	2	7	3	2	9	23	35	40	37	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSETAEVYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAGTATTGGGGCAGGGAAGGGTACAATGAGCAATTCTTCGGGCCA	CASKYWGREGYNEQFF	In	VDJ	1	192	2.8462322999928846E-4	3.45151165424482E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	4	3	16	10	17	23	33	48	43	65														CASKYWGREGYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCTGGTCCGAACATTCAGTACTTCGGCGCC	CASSPGPNIQYF	In	VDJ	1	192	2.8462322999928846E-4	3.45151165424482E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-04	01	6	0	10	7	4	4	23	34	40	38	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGPNIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01		TCRBJ02-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCCCTAGCGGGGTACACCGGGGAGCTGTTTTTTGGAGAA	CASSPLAGYTGELFF	In	VDJ	1	198	2.935177059367662E-4	3.559371393439971E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	6	4	3	3	4	1	23	34	47	38	48														CASSPLAGYTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTTGGCCAGGAACACTGAAGCTTTCTTTGGACAA	CASSYLARNTEAFF	In	VDJ	1	199	2.950001185930125E-4	3.5773480166391625E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	4	5	1	4	0	23	39	-1	43	46														CASSYLARNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACTACTCCAGGGGGCCCGAGAGACCCAGTACTTCGGGCCA	CASRLLQGARETQYF	In	VDJ	1	200	2.964825312492588E-4	3.5953246398383543E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	4	0	4	7	3	23	34	49	41	52														CASRLLQGARETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCGGGACAGACAAAACATTCAGTACTTCGGCGCC	CASSRDRQNIQYF	In	VDJ	1	201	2.979649439055051E-4	3.613301263037546E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	6	0	5	5	2	2	23	34	43	36	45														CASSRDRQNIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAACCTCGAGGGGTCATAGGCAGTACTTCGGGCCG		Out	VDJ	1	202	2.9944735656175136E-4		37	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	7	5	2	9	6	6	23	33	44	39	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCGCCCCGGGGTGGGTTCCTACGAGCAGTACTTCGGGCCG	CASRPGVGSYEQYF	In	VDJ	1	203	3.009297692179977E-4	3.6492545094359295E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	8	8	3	1	5	5	23	32	42	37	47														CASRPGVGSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAGGACAGCCAACAATGAGCAGTTCTTCGGGCCA	CASSRTANNEQFF	In	VDJ	1	205	3.0389459453049024E-4	3.685207755834313E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	1	5	5	1	3	23	35	42	36	45														CASSRTANNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCCGGACAGGGTCCAACGAGCAGTACTTCGGGCCG	CASSSRTGSNEQYF	In	VDJ	1	205	3.0389459453049024E-4	3.685207755834313E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	1	3	5	3	4	23	36	47	39	51														CASSSRTGSNEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGTTGGGCTATGAGCAGTTCTTCGGGCCA	CASSELGYEQFF	In	VDJ	1	206	3.0537700718673657E-4	3.703184379033505E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	8	0	8	5	1	23	35	44	40	45														CASSELGYEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAGAGGGACAGGGGAACTATGGCTACACCTTCGGTTCG	CASREGQGNYGYTF	In	VDJ	1	207	3.0685941984298285E-4	3.7211610022326965E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	2	2	3	0	23	34	-1	37	47														CASREGQGNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGCAAGGGACGCCGGCCTGGGATGGCTACACCTTCGGTTCG	CASSEQGTPAWDGYTF	In	VDJ	1	210	3.113066578117217E-4	3.775090871830272E-4	48	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	5	0	7	6	6	11	23	35	46	41	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEQGTPAWDGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCGACAGGGGAGCGTACACCGGGGAGCTGTTTTTTGGAGAA	CASSSDRGAYTGELFF	In	VDJ	1	218	3.231659590616921E-4	3.9189038574238063E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	2	2	3	2	5	23	36	46	38	51														CASSSDRGAYTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAGGAAGGGATTACAATGAGCAGTTCTTCGGGCCA	CASRGRDYNEQFF	In	VDJ	1	219	3.2464837171793836E-4	3.936880480622998E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	6	0	8	4	5	1	23	34	43	39	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRGRDYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAACGGACAGTATAACCTACGAGCAGTACTTCGGGCCG	CASRTDSITYEQYF	In	VDJ	1	223	3.3057802234292356E-4	4.008786973419765E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	5	2	3	5	23	34	43	37	48														CASRTDSITYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTAATCTAGGGACAGCAGTCCACTTTAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	227	3.365076729679087E-4		55	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	0	5	6	5	10	23	37	49	42	59														X+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGACAGGGTTGAAAAACTGTTTTTTGGCAGT	CASSDRVEKLFF	In	VDJ	1	229	3.394724982804013E-4	4.1166467126149155E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	2	3	7	1	1	23	34	42	35	43														CASSDRVEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAATTAGGATATCAGGGGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	240	3.5577903749911056E-4		46	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	4	3	8	11	0	23	38	-1	49	54														X+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGCGGGACGACAGGGTGAAAAACTGTTTTTTGGCAGT	CASSYAGRQGEKLFF	In	VDJ	1	243	3.6022627546784943E-4	4.3683194374036005E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	2	3	7	7	0	23	38	-1	45	52														CASSYAGRQGEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCGACTTGAGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	243	3.6022627546784943E-4		40	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	8	2	10	0	1	4	23	32	37	33	41						01,02								X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGTGGTAGTCACAGATACGCAGTATTTTGGCCCA	CAISVVVTDTQYF	In	VDJ	1	245	3.6319110078034204E-4	4.404272683801984E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	5	8	2	4	1	23	35	42	39	43						01,02								CAISVVVTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGCCAGGAGAGACCCAGTACTTCGGGCCA	CASSYGPGETQYF	In	VDJ	1	248	3.676383387490809E-4	4.458202553399559E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	4	4	4	4	0	23	38	-1	42	46														CASSYGPGETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGAAGCACAGCACAGATACGCAGTATTTTGGCCCA	CASRKHSTDTQYF	In	VDJ	1	253	3.750504020303124E-4	4.548085669395518E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	6	7	0	2	2	23	34	39	36	41						01,02								CASRKHSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGCGGGACACCTCACAGATACGCAGTATTTTGGCCCA	CASAGHLTDTQYF	In	VDJ	1	255	3.7801522734280495E-4	4.5840389157939015E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	8	0	6	2	2	3	23	32	40	34	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASAGHLTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAGCACAAATCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	259	3.8394487796779015E-4		40	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	5	3	6	2	3	3	23	35	41	38	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGCGGACCTCTACGAGCAGTACTTCGGGCCG	CAISADLYEQYF	In	VDJ	2	272	4.0321624249899194E-4	4.889641510180162E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	5	1	7	3	2	2	23	35	41	37	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISADLYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCCGTCGGACCAGATACGCAGTATTTTGGCCCA	CASSDSVGPDTQYF	In	VDJ	2	280	4.150755437489623E-4	5.033454495773696E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	0	1	7	4	4	0	23	40	-1	44	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDSVGPDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAGGGGGCTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	2	280	4.150755437489623E-4		38	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	5	0	6	0	0	23	-1	-1	38	45														X+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGAACACCGGGCCCCAGCATTTTGGTGAT	CASSYSNTGPQHF	In	VDJ	2	293	4.3434690828016414E-4	5.267150597363188E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	0	3	6	9	2	4	23	40	45	42	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSNTGPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGAAATCTCCAGGGTGACTAATGAAAAACTGTTTTTTGGCAGT	CASSEISRVTNEKLFF	In	VDJ	2	294	4.358293209364104E-4	5.285127220562381E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	4	3	2	9	2	23	34	48	43	50														CASSEISRVTNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTTGGGGACTCCTACCAAAAACATTCAGTACTTCGGCGCC	CASSDLGTPTKNIQYF	In	VDJ	2	319	4.7288963734256777E-4	5.734542800542175E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	1	0	10	2	2	4	23	39	47	41	51						01,02								CASSDLGTPTKNIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD02-01	TCRBJ02-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTGGACAGGGAAGTTAGATACGCAGTATTTTGGCCCA	CASSWTGKLDTQYF	In	VDJ	2	323	4.7881928796755297E-4	5.806449293338942E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	1	3	5	0	5	23	-1	44	36	49														CASSWTGKLDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACCGCGCGGGGGGGCGTGAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	324	4.8030170062379925E-4		47	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	7	0	5	6	4	23	35	50	41	54														X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTGAAAGGAGATGACGTTGGGCTGTTTTTTGGAGAA		Out	VDJ	2	336	4.980906524987548E-4		41	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	10	2	13	4	10	23	36	44	40	54														X+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGTTATCCTACAGGTTATAATGAAAAACTGTTTTTTGGCAGT	CASSRYPTGYNEKLFF	In	VDJ	2	347	5.14397191717464E-4	6.237888250119545E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	3	4	4	9	3	23	35	49	44	52														CASSRYPTGYNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGAAGCGCCGGGGAGACCCAGTACTTCGGGCCA	CASSYGSAGETQYF	In	VDJ	2	355	5.262564929674344E-4	6.381701235713079E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	6	6	5	3	5	23	38	45	41	50						01,02								CASSYGSAGETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCGTGGGACAGGGGTCCCCCTATGGCTACACCTTCGGTTCG	CAVGQGSPYGYTF	In	VDJ	2	358	5.307037309361732E-4	6.435631105310654E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	11	0	2	4	2	5	23	29	41	31	46														CAVGQGSPYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATTACGGGGGCCCTTCGAACACTGAAGCTTTCTTTGGACAA	CASSYYGGPSNTEAFF	In	VDJ	2	379	5.618343967173454E-4	6.813140192493681E-4	48	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	3	6	0	1	4	5	23	37	47	41	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYYGGPSNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCCACGGGGACACCGGAGACCCAGTACTTCGGGCCA	CASSATGTPETQYF	In	VDJ	2	383	5.677640473423306E-4	6.885046685290448E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	6	5	6	3	23	35	47	41	50														CASSATGTPETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGACATCCGGGACAGGGTCCACTGAAGCTTTCTTTGGACAA	CASRTSGTGSTEAFF	In	VDJ	2	434	6.433670928108916E-4	7.801854468449229E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	3	4	7	2	23	34	50	41	52														CASRTSGTGSTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGATCATCCGGGGTCTGAAGCTTTCTTTGGACAA	CASSDHPGSEAFF	In	VDJ	2	440	6.522615687483694E-4	7.90971420764438E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	8	3	6	7	1	23	35	47	42	48														CASSDHPGSEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTTCCTAGGGACTGAAGCTTTCTTTGGACAA	CASSDFLGTEAFF	In	VDJ	2	441	6.537439814046156E-4	7.927690830843571E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	1	5	3	5	4	0	23	39	-1	43	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDFLGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCTGACAGGGAACTATGGCTACACCTTCGGTTCG	CASLTGNYGYTF	In	VDJ	3	481	7.130404876544674E-4	8.646755758811242E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	8	2	3	2	2	0	23	32	-1	34	41														CASLTGNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTATTTTTACTAGAAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSIFTRSSYNEQFF	In	VDJ	3	523	7.753018192168117E-4	9.401773933177297E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	3	8	0	6	3	23	35	46	41	49						01,02								CASSIFTRSSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCTTGGGAGGGGGACACTGAAGCTTTCTTTGGACAA	CASSPWEGDTEAFF	In	VDJ	3	531	7.871611204667821E-4	9.545586918770831E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	9	0	3	4	2	23	35	46	39	48														CASSPWEGDTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCAACAAGTCAATCCGCCCTACGAGCAGTACTTCGGGCCG	CASSQQVNPPYEQYF	In	VDJ	3	543	8.049500723417377E-4	9.761306397161132E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	3	6	2	3	11	23	34	40	37	51														CASSQQVNPPYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTACCTTCGGGCGACAGGGGTCTGATCAGCCCCAGCATTTTGGTGAT	CASSTFGRQGSDQPQHF	In	VDJ	3	588	8.716586418728208E-4	0.0010570254441124762	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	2	2	5	10	4	23	35	53	45	57														CASSTFGRQGSDQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAGGGGACAAGAAGCTTTCTTTGGACAA	CASSYRGQEAFF	In	VDJ	3	589	8.731410545290672E-4	0.0010588231064323954	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	6	8	2	1	23	38	46	40	47														CASSYRGQEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGGAGAGAACTCTGGAAACACCATATATTTTGGAGAG	CASRGENSGNTIYF	In	VDJ	4	627	9.294727354664263E-4	0.001127134274589324	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	6	9	2	0	0	4	23	-1	39	34	43														CASRGENSGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCGGGACAACTATGGCTACACCTTCGGTTCG	CASSYRDNYGYTF	In	VDJ	4	691	0.0010243471454661891	0.0012421846630641515	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	2	0	7	2	1	0	23	38	-1	39	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYRDNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGTCTCTAGCGGACAAGAGACCCAGTACTTCGGGCCA	CAISVSSGQETQYF	In	VDJ	4	751	0.0011132919048409667	0.001350044402259302	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	4	5	2	4	1	23	35	46	39	47						01,02								CAISVSSGQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCGATCCGGGGTAGTTGAAGCTTTCTTTGGACAA	CASSYRSGVVEAFF	In	VDJ	4	781	0.0011577642845283557	0.0014039742718568774	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	2	8	3	7	5	4	23	38	48	43	52														CASSYRSGVVEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTGGACGGGGGAGACTACAATGAGCAGTTCTTCGGGCCA	CASSLDGGDYNEQFF	In	VDJ	5	881	0.001306005550152985	0.001583740503848795	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	8	2	3	4	3	23	36	46	40	49														CASSLDGGDYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGATCCACAGGGAGGAGGCTACACCTTCGGTTCG	CASSDPQGGGYTF	In	VDJ	6	1001	0.0014838950689025402	0.0017994599822390963	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	5	3	3	8	5	4	23	35	46	40	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDPQGGGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGATCCTTACGACAGGGTATCGGGAAACACCATATATTTTGGAGAG	CASRDPYDRVSGNTIYF	In	VDJ	10	1778	0.0026357297028059105	0.003196243604816297	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	2	3	4	10	5	23	34	51	44	56														CASRDPYDRVSGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGCCAATGGGAGGCTCTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	26	4551	0.006746459998576884		50	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	9	1	0	7	4	23	35	48	42	52														X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGGGACACTTACTCTGGAAACACCATATATTTTGGAGAG	CASSRDTYSGNTIYF	In	VDJ	29	5056	0.007495078389981262	0.00908898068951136	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	0	6	0	1	4	23	35	42	36	46														CASSRDTYSGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGACGACTACAGGGGTCACGAGCAGTACTTCGGGCCG	CASDDYRGHEQYF	In	VDJ	32	5578	0.008268897796541828	0.01002736042050917	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	3	2	5	7	2	23	32	46	39	48														CASDDYRGHEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCGGGACCGGGACTAGCAAGGCCGGGGAGCTGTTTTTTGGAGAA	CAIGTGTSKAGELFF	In	VDJ	39	6979	0.010345757927942886	0.012545885330715937	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	10	0	7	6	8	4	23	30	47	38	51						01,02								CAIGTGTSKAGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGACAGATAGGAATCAGCCCCAGCATTTTGGTGAT	CASSPTDRNQPQHF	In	VDJ	1	46	6.819098218732952E-5	8.269246671628214E-5	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	2	5	4	0	5	24	-1	43	38	48													Vb 18	CASSPTDRNQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGTCGGACGGACTTAATTCACCCCTCCACTTTGGGAAC	CASSSDGLNSPLHF	In	VDJ	1	48	7.115580749982211E-5	8.62877913561205E-5	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	6	1	10	6	7	0	24	35	-1	42	47						01,02							Vb 18	CASSSDGLNSPLHF+TCRBV18-01+TCRBJ01-06	TCRBV18-01*01	TCRBD02-01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGGGGTTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPGGSYNEQFF	In	VDJ	1	50	7.41206328123147E-5	8.988311599595886E-5	42	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-01	01	2	6	1	1	0	1	24	-1	44	39	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPGGSYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01		TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCATCCTGGGCCGGGAAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	50	7.41206328123147E-5		46	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	2	8	3	5	8	0	24	39	-1	47	52													Vb 18	X+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGTGGAGGTCCAGGGGCATCTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	52	7.708545812480728E-5		52	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	2	0	9	3	24	38	53	47	56													Vb 18	X+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCACTGGTATGGGTGGCGACACTGAAGCTTTCTTTGGACAA	CASTGMGGDTEAFF	In	VDJ	1	55	8.153269609354617E-5	9.887142759555474E-5	42	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	8	0	9	3	8	5	24	33	44	41	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASTGMGGDTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAGAGTTTCAGGGGGGGCCTAACACTGAAGCTTTCTTTGGACAA	CASSEFQGGPNTEAFF	In	VDJ	1	55	8.153269609354617E-5	9.887142759555474E-5	48	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	5	4	1	2	6	5	24	36	49	42	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSEFQGGPNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCCGGGACAGGGCAGCTCCTACGAGCAGTACTTCGGGCCG	CASSPGQGSSYEQYF	In	VDJ	1	57	8.449752140603876E-5	1.024667522353931E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	3	0	3	3	24	35	47	38	50													Vb 18	CASSPGQGSSYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCGGGGACAGGGGCTCGGAAACACCATATATTTTGGAGAG	CASSRGQGLGNTIYF	In	VDJ	1	58	8.597993406228505E-5	1.0426441455531227E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	0	2	4	3	3	24	35	48	38	51													Vb 18	CASSRGQGLGNTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
GAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGTTCAAGCGGGGGCCGATCTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	58	8.597993406228505E-5		58	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	6	2	0	5	7	23	40	53	45	60													Vb 18	X+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACTCCCAAGCAGGGAGTCTAACTATGGCTACACCTTCGGTTCG	CASSPLPSRESNYGYTF	In	VDJ	1	60	8.894475937477764E-5	1.0785973919515063E-4	51	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-02	01	1	4	3	0	7	3	24	40	52	47	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPLPSRESNYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACAGGGATACGAGCAGTACTTCGGGCCG	CASSPQGYEQYF	In	VDJ	1	61	9.042717203102393E-5	1.096574015150698E-4	36	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-07	01	1	0	8	4	1	0	24	40	-1	41	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPQGYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01		TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCTCCAAGGACGACGGGAAGCTTTCTTTGGACAA		Out	VDJ	1	61	9.042717203102393E-5		41	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	3	1	7	8	6	5	24	38	48	44	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	X+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGGCCTGGAAACACCATATATTTTGGAGAG	CASSPGPGNTIYF	In	VDJ	1	63	9.339199734351652E-5	1.1325272615490816E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	8	0	2	0	0	24	-1	-1	39	43													Vb 18	CASSPGPGNTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGGGGCGCGGGGGGCCAACGTCCTGACTTTCGGGGCC	CASSPGARGANVLTF	In	VDJ	1	65	9.635682265600911E-5	1.1684805079474652E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	3	6	0	4	0	4	24	-1	44	38	48													Vb 18	CASSPGARGANVLTF+TCRBV18-01+TCRBJ02-06	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAATCACGTGACAGTTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	70	1.0376888593724057E-4		46	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	2	5	1	7	1	24	39	51	46	52													Vb 18	X+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCAGGGTAACTATGGCTACACCTTCGGTTCG	CASSPQGNYGYTF	In	VDJ	1	72	1.0673371124973316E-4	1.2943168703418074E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	3	1	1	0	24	38	-1	39	44													Vb 18	CASSPQGNYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCGGAGCACGGGGCTTCGCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	73	1.0821612390597947E-4		47	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	3	7	0	4	8	4	24	38	51	46	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	X+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGGACAGGGAGATCCTACGAGCAGTACTTCGGGCCG	CASSPGTGRSYEQYF	In	VDJ	1	75	1.1118094921847204E-4	1.348246739939383E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	0	3	1	0	3	24	-1	48	39	51													Vb 18	CASSPGTGRSYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCGGGGAGACTCCAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPRGDSNTGELFF	In	VDJ	1	77	1.1414577453096463E-4	1.3841999863377664E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	8	3	2	1	7	24	38	44	39	51						01,02							Vb 18	CASSPRGDSNTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD02-01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAAGGGGGACTAATGAAAAACTGTTTTTTGGCAGT	CASSRGTNEKLFF	In	VDJ	1	78	1.1562818718721093E-4	1.4021766095369582E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	5	1	2	0	0	24	-1	-1	36	42													Vb 18	CASSRGTNEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTCGTAGGGTGGGGGACACTGAAGCTTTCTTTGGACAA	CASSPRRVGDTEAFF	In	VDJ	1	78	1.1562818718721093E-4	1.4021766095369582E-4	45	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	3	6	1	3	9	0	24	38	-1	47	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPRRVGDTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAAGACAGGGGATCACTGAAGCTTTCTTTGGACAA	CASSRQGITEAFF	In	VDJ	1	80	1.1859301249970352E-4	1.4381298559353417E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	2	4	1	2	24	36	45	37	47													Vb 18	CASSRQGITEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACTGGGGGGGAACACTGAAGCTTTCTTTGGACAA	CASSPLGGNTEAFF	In	VDJ	1	83	1.230402504684424E-4	1.492059725532917E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	1	9	1	1	1	0	24	40	-1	41	47													Vb 18	CASSPLGGNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACGGACAGGGGGTATAGGAAACACCATATATTTTGGAGAG	CASSPRTGGIGNTIYF	In	VDJ	1	88	1.3045231374967387E-4	1.581942841528876E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	1	1	4	0	4	24	-1	50	40	54													Vb 18	CASSPRTGGIGNTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACGGCAGACTATGGCCTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	88	1.3045231374967387E-4		43	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	4	2	9	6	4	5	24	37	46	41	51						01,02							Vb 18	X+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD02-01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAGGGACAGACTATGGCTACACCTTCGGTTCG	CASSGTDYGYTF	In	VDJ	1	89	1.3193472640592017E-4	1.5999194647280677E-4	36	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	5	3	0	0	24	-1	-1	36	43													Vb 18	CASSGTDYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGCCATAGATCAGCCCCAGCATTTTGGTGAT	CASSPAIDQPQHF	In	VDJ	1	92	1.3638196437465905E-4	1.653849334325643E-4	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	2	5	8	5	4	0	24	39	-1	43	46						01,02							Vb 18	CASSPAIDQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD02-01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAACGGGACATACCGGACTGTTTTTTGGCAGT	CASSPTGHTGLFF	In	VDJ	1	94	1.3934678968715162E-4	1.6898025807240264E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	0	6	13	2	6	24	39	47	41	53													Vb 18	CASSPTGHTGLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAACGCCAGGGGGCTTAAACACTGAAGCTTTCTTTGGACAA	CASSPTPGGLNTEAFF	In	VDJ	1	95	1.4082920234339793E-4	1.7077792039232181E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	0	2	4	3	24	39	51	43	54													Vb 18	CASSPTPGGLNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGAGACAGGGCCCTATGGCTACACCTTCGGTTCG	CASSPETGPYGYTF	In	VDJ	1	95	1.4082920234339793E-4	1.7077792039232181E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	2	3	4	2	2	24	39	48	41	50													Vb 18	CASSPETGPYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCCGTGAGGGGAATCAGCCCCAGCATTTTGGTGAT	CASREGNQPQHF	In	VDJ	1	97	1.437940276558905E-4	1.743732450321602E-4	36	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-05	01	8	5	2	8	4	4	24	33	42	37	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASREGNQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCCGTGAGGGGAATTAGCCCCAGCATTTTGGTGAT	CASREGN*PQHF	Stop	VDJ	1	97	1.437940276558905E-4		36	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-05	01	8	5	2	8	4	4	24	33	42	37	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASREGN*PQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01		TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACGGTGACAGGGTGACTATGGCTACACCTTCGGTTCG	CASSPR*QGDYGYTF	Stop	VDJ	1	97	1.437940276558905E-4		45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	2	3	3	3	2	24	40	50	43	52													Vb 18	CASSPR*QGDYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACGGGCCCAAGAGACCCAGTACTTCGGGCCA	CASSRAQETQYF	In	VDJ	1	98	1.452764403121368E-4	1.7617090735207936E-4	36	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	8	0	1	0	0	24	-1	-1	37	41													Vb 18	CASSRAQETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGTGGACAGTATAATTCACCCCTCCACTTTGGGAAC	CASSPGGQYNSPLHF	In	VDJ	1	100	1.482412656246294E-4	1.7976623199191771E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	2	1	5	4	3	0	24	39	-1	42	48													Vb 18	CASSPGGQYNSPLHF+TCRBV18-01+TCRBJ01-06	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCTAGCTCACCGGACAGGGGGTCCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	101	1.4972367828087568E-4		41	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	1	1	7	0	2	24	-1	48	38	50													Vb 18	X+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGACAACGGCCTACGAGCAGTACTTCGGGCCG	CASSPTTAYEQYF	In	VDJ	1	104	1.5417091624961456E-4	1.869568812715944E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	2	6	2	0	4	24	-1	42	38	46													Vb 18	CASSPTTAYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGAGGTATGATGAGCAGTTCTTCGGGCCA	CASSPRYDEQFF	In	VDJ	1	104	1.5417091624961456E-4	1.869568812715944E-4	36	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	11	1	8	0	4	24	-1	42	38	46													Vb 18	CASSPRYDEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAGGAGGGACAGGGGATGGCTACACCTTCGGTTCG	CASSGGTGDGYTF	In	VDJ	1	109	1.6158297953084604E-4	1.9594519287119031E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	2	6	3	0	24	36	-1	39	49													Vb 18	CASSGGTGDGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACGGACGGGGCCCCAGGGTGGTGGCTACACCTTCGGTTCG	CASSPRTGPQGGGYTF	In	VDJ	1	112	1.6603021749958492E-4	2.0133817983094784E-4	48	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-02	01	1	4	3	7	11	3	24	40	56	51	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPRTGPQGGGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATTCAGGGCGGGGTACACTGAAGCTTTCTTTGGACAA	CASSFRAGYTEAFF	In	VDJ	1	113	1.6751263015583122E-4	2.03135842150867E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	7	3	3	6	1	24	36	48	42	49													Vb 18	CASSFRAGYTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCGCAACAGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSATGGTDTQYF	In	VDJ	1	118	1.7492469343706268E-4	2.1212415375046289E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	3	2	1	4	0	24	35	-1	39	46													Vb 18	CASSATGGTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACATCCCGGGACCGGGGAGCTGTTTTTTGGAGAA	CASSHPGTGELFF	In	VDJ	1	121	1.7937193140580158E-4	2.1751714071022044E-4	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	8	4	5	4	0	24	37	-1	41	45						01,02							Vb 18	CASSHPGTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD02-01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCGGGACAGGGTTTACCCCTCCACTTTGGGAAC		Out	VDJ	1	122	1.8085434406204785E-4		41	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	0	3	12	2	3	24	38	49	40	52													Vb 18	X+TCRBV18-01+TCRBJ01-06	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGCCACAGGGTACGGCCACCGGGGAGCTGTTTTTTGGAGAA	CASSPQGTATGELFF	In	VDJ	1	123	1.8233675671829416E-4	2.211124653500588E-4	45	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-02	01	1	5	3	4	0	6	24	-1	44	40	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPQGTATGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01		TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCCGGGGCGGGGTGCTCATGAACACTGAAGCTTTCTTTGGACAA	CASRGGVLMNTEAFF	In	VDJ	1	126	1.8678399468703303E-4	2.265054523098163E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	8	7	3	0	4	6	24	33	43	37	49													Vb 18	CASRGGVLMNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAAGTCAAGGGCTTATGGCTACACCTTCGGTTCG		Out	VDJ	1	126	1.8678399468703303E-4		41	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-02	01	2	5	3	5	5	2	24	39	48	44	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	X+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCATCGGGAAGGTTGACTGAAGCTTTCTTTGGACAA	CASSPSGRLTEAFF	In	VDJ	1	126	1.8678399468703303E-4	2.265054523098163E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	8	3	5	1	6	24	39	45	40	51													Vb 18	CASSPSGRLTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGCGAGGGGGGAATTTATATGGCTACACCTTCGGTTCG	CASSPRGGNLYGYTF	In	VDJ	1	126	1.8678399468703303E-4	2.265054523098163E-4	45	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-02	01	3	5	1	5	3	7	24	38	47	41	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPRGGNLYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01		TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCCGGAGGTGGACAGGGGAGATACGCAGTATTTTGGCCCA	CASSPEVDRGDTQYF	In	VDJ	1	126	1.8678399468703303E-4	2.265054523098163E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	1	2	5	9	0	24	35	-1	44	53													Vb 18	CASSPEVDRGDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCCGGCCGGGTCTACTAATGAAAAACTGTTTTTTGGCAGT	CASSPAGSTNEKLFF	In	VDJ	1	126	1.8678399468703303E-4	2.265054523098163E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	6	8	4	2	6	3	24	35	45	41	48						01,02							Vb 18	CASSPAGSTNEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD02-01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATGGGGGACGTTGAGCTCTGGAAACACCATATATTTTGGAGAG	CASSWGTLSSGNTIYF	In	VDJ	1	130	1.9271364531201821E-4	2.3369610158949304E-4	48	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-03	01	5	0	7	0	3	6	24	36	44	39	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSWGTLSSGNTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01		TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGCGAGAGGGGACAGGGAGGGCGGAGCAGTACTTCGGGCCG	CASSREGTGRAEQYF	In	VDJ	1	130	1.9271364531201821E-4	2.3369610158949304E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	3	7	7	6	24	35	51	42	57													Vb 18	CASSREGTGRAEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATCACAGGGATGTGAGGGACCCAGTACTTCGGGCCA		Out	VDJ	1	132	1.9567847062451082E-4		41	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-05	01	1	0	8	7	1	7	24	40	45	41	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	X+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01		TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCTTTCGTACCAAGAGACCCAATACTTCGGGCCA	CASSLSYQETQYF	In	VDJ	1	134	1.986432959370034E-4	2.4088675086916974E-4	39	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-05	01	6	2	7	14	15	4	24	35	53	50	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSLSYQETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01		TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGCGGGACAGGGCTCTCTATGGCTACACCTTCGGTTCG	CASSRDRALYGYTF	In	VDJ	1	145	2.1494983515571263E-4	2.6066103638828066E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	3	4	2	4	24	35	46	37	50													Vb 18	CASSRDRALYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGGACGGGAGGGGTGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	153	2.26809136405683E-4		46	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	8	0	3	4	3	24	38	50	42	53													Vb 18	X+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCCCTGGGTTAGGGAGAACACTGAAGCTTTCTTTGGACAA	CASSPWVRENTEAFF	In	VDJ	1	161	2.3866843765565332E-4	2.894236335069875E-4	45	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	6	0	8	1	11	0	24	35	-1	46	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPWVRENTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGTCAGCTCACTATCAGGGGCTAAGGAAGGCTACACCTTCGGTTCG	CVSSLSGAKEGYTF	In	VDJ	1	169	2.5052773890562365E-4	3.038049320663409E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	4	2	8	3	8	24	37	46	40	54													Vb 18	CVSSLSGAKEGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGTGGGACAGGGAGGAAACACTGAAGCTTTCTTTGGACAA	CASSPVGQGGNTEAFF	In	VDJ	1	171	2.5349256421811626E-4	3.074002567061793E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	3	2	2	4	24	39	50	41	54													Vb 18	CASSPVGQGGNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGTCAGAACTAGCGAGCCCCCAGTACTTCGGGCCA	CASSPSELASPQYF	In	VDJ	1	171	2.5349256421811626E-4	3.074002567061793E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	3	6	9	6	4	24	38	51	44	55						01,02							Vb 18	CASSPSELASPQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD02-01	TCRBJ02-05*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACTAGGGTCTGACACTGAAGCTTTCTTTGGACAA	CASSPLGSDTEAFF	In	VDJ	1	173	2.5645738953060886E-4	3.1099558134601766E-4	42	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	1	5	3	3	1	4	24	40	45	41	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPLGSDTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCGGCAGGGGGCCCACGAGCAGTACTTCGGGCCG	CASSPRQGAHEQYF	In	VDJ	1	173	2.5645738953060886E-4	3.1099558134601766E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	0	5	4	2	24	38	50	42	52													Vb 18	CASSPRQGAHEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGGGAGAACACTGAAGCTTTCTTTGGACAA	CASSPGENTEAFF	In	VDJ	1	175	2.5942221484310146E-4	3.14590905985856E-4	39	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	2	0	8	1	1	0	24	39	-1	40	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPGENTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAAGAAGAGCGAACACTGAAGCTTTCTTTGGACAA	CASSPRRANTEAFF	In	VDJ	1	185	2.7424634140556437E-4	3.3256752918504775E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	2	6	7	1	5	0	24	39	-1	44	47						01,02							Vb 18	CASSPRRANTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAGAAGAATACACTGAAGCTTTCTTTGGACAA	CASSEEYTEAFF	In	VDJ	1	190	2.8165840468679585E-4	3.4155584078464363E-4	36	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	5	2	8	3	0	5	24	-1	38	36	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSEEYTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCTCCCTCAGACAGGTAGCACAGATACGCAGTATTTTGGCCCA	CASSPLPQTGSTDTQYF	In	VDJ	1	191	2.8314081734304213E-4	3.433535031045628E-4	51	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	2	4	0	9	1	24	38	53	47	54													Vb 18	CASSPLPQTGSTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCTGGGATGGGGGATACGCAGTATTTTGGCCCA	CASSGMGDTQYF	In	VDJ	1	191	2.8314081734304213E-4	3.433535031045628E-4	36	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-03	01	6	0	8	6	1	5	24	35	40	36	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSGMGDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01		TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACTCGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPLANTGELFF	In	VDJ	1	198	2.935177059367662E-4	3.559371393439971E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	1	8	6	0	1	0	24	40	-1	41	43						01,02							Vb 18	CASSPLANTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD02-01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGGGACAAAGCTCTGGAAACACCATATATTTTGGAGAG	CASSGQSSGNTIYF	In	VDJ	1	202	2.9944735656175136E-4	3.631277886236738E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	0	6	0	0	3	24	-1	41	35	44													Vb 18	CASSGQSSGNTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAACTAGTCGACAGGGGGACTATGGCTACACCTTCGGTTCG	CASSTSRQGDYGYTF	In	VDJ	1	205	3.0389459453049024E-4	3.685207755834313E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	1	3	7	0	24	36	-1	43	52													Vb 18	CASSTSRQGDYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGGGACAACCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPPGQPNTGELFF	In	VDJ	1	212	3.142714831242143E-4	3.811044118228655E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	0	6	0	0	2	24	-1	47	41	49													Vb 18	CASSPPGQPNTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-02*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGGAGGGGATGGGATACGCAGTATTTTGGCCCA	CASSPGRGWDTQYF	In	VDJ	1	213	3.157538957804606E-4	3.829020741427847E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	9	0	6	0	5	24	-1	46	39	51													Vb 18	CASSPGRGWDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTCCTATTGAGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	218	3.231659590616921E-4		46	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	4	9	0	2	5	24	38	43	40	48						01,02							Vb 18	X+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACAGAACAGGGACTACGAGCAGTACTTCGGGCCG	CASSQNRDYEQYF	In	VDJ	1	219	3.2464837171793836E-4	3.936880480622998E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	3	3	3	3	1	24	37	46	40	47													Vb 18	CASSQNRDYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACGGGCAGCCCCCCATGTTGGCACTGAAGCTTTCTTTGGACAA	CASSRAAPHVGTEAFF	In	VDJ	1	234	3.468845615616328E-4	4.206529828610874E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	8	0	4	0	15	24	-1	41	37	56													Vb 18	CASSRAAPHVGTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGTGGGGGACAGGGGTACCTGGAAACACCATATATTTTGGAGAG	CASSPPWGTGVPGNTIYF	In	VDJ	1	262	3.8839211593652903E-4	4.709875278188244E-4	54	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	0	2	2	4	3	24	41	55	45	58													Vb 18	CASSPPWGTGVPGNTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATCCAACGGGCAGTCTTACAATGAGCAGTTCTTCGGGCCA	CASSSNGQSYNEQFF	In	VDJ	2	268	3.972865918740068E-4	4.8177350173833947E-4	45	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-01	01	5	8	0	4	6	5	24	36	46	42	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSSNGQSYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01		TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTGGAAACTGGAAACACCATATATTTTGGAGAG	CASSLETGNTIYF	In	VDJ	2	315	4.669599867175826E-4	5.662636307745408E-4	39	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-03	01	4	1	8	2	1	2	24	37	41	38	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSLETGNTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01		TCRBJ01-03*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGTGACTATTTCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPGDYFSYNEQFF	In	VDJ	2	361	5.351509689049121E-4	6.489560974908229E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	2	9	0	3	3	24	39	47	42	50						01,02							Vb 18	CASSPGDYFSYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01	TCRBJ02-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAAGCCGGGACACTAAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	2	367	5.440454448423899E-4		43	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	0	6	7	4	3	24	36	46	40	49													Vb 18	X+TCRBV18-01+TCRBJ01-06	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-06*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCCTGCCGGCGGGACAGGGAACTCCTACGAGCAGTACTTCGGGCCG	CASSPAGGTGNSYEQYF	In	VDJ	2	383	5.677640473423306E-4	6.885046685290448E-4	51	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	3	0	10	2	24	35	54	45	56													Vb 18	CASSPAGGTGNSYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGACAGACAGGGGGAAGAACACTGAAGCTTTCTTTGGACAA	CASSPTDRGKNTEAFF	In	VDJ	2	400	5.929650624985176E-4	7.190649279676709E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	1	1	4	2	24	38	51	42	53													Vb 18	CASSPTDRGKNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCATCTGGAGCGGTGAACACTGAAGCTTTCTTTGGACAA	CASSPSGAVNTEAFF	In	VDJ	2	427	6.329902042171675E-4	7.676018106054886E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	2	6	5	0	5	0	24	39	-1	44	49						01,02							Vb 18	CASSPSGAVNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGCCAATGCCAGTGAACACTGAAGCTTTCTTTGGACAA	CASSPMPVNTEAFF	In	VDJ	3	519	7.693721685918265E-4	9.329867440380529E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	5	0	4	0	24	39	-1	43	46													Vb 18	CASSPMPVNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGACGTCGGGACAAAGCCCCGAGCAGTACTTCGGGCCG	CASSTSGQSPEQYF	In	VDJ	4	757	0.0011221863807784444	0.001360830376178817	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	6	6	6	6	24	35	47	41	53													Vb 18	CASSTSGQSPEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGACAGGGAACACTGAAGCTTTCTTTGGACAA	CASSPTGNTEAFF	In	VDJ	5	972	0.0014409051018713977	0.0017473277749614402	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	4	1	0	0	24	-1	-1	38	44													Vb 18	CASSPTGNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGGGTTGGACACTGAAGCTTTCTTTGGACAA	CASSPGLDTEAFF	In	VDJ	6	1110	0.0016454780484333863	0.0019954051751102865	39	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	3	6	2	3	0	4	24	-1	42	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPGLDTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGACAGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSPTATNEKLFF	In	VDJ	7	1234	0.0018292972178079268	0.0022183153027802646	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	2	5	0	0	0	24	-1	-1	38	43													Vb 18	CASSPTATNEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-04*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCTAGCGGGGGGGCTCTACGAGCAGTACTTCGGGCCG	CASSPLAGGLYEQYF	In	VDJ	9	1593	0.0023614833614003464	0.002863676075631249	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	4	0	3	1	2	24	38	51	39	53													Vb 18	CASSPLAGGLYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-07*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTAGACAGAACTGAAGCTTTCTTTGGACAA	CASSLDRTEAFF	In	VDJ	15	2728	0.00404402172623989	0.0049040228087395155	36	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	5	5	2	1	24	37	44	39	45													Vb 18	CASSLDRTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCTCGATCTTCGACGGCAGCTTTCTTTGGACAA	CASSPPRSSTAAFF	In	VDJ	16	2854	0.004230805720926923	0.005130528261049331	42	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	0	2	7	10	9	3	24	41	53	50	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPPRSSTAAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	1941B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4841	3992	806	42	0	2940	2442	461	37	0	674576	556278	112429	5869	0	0.17944634	9.23438549	0.171093151	9.55033302				141502	0.0291595235	0.0824731514	0.068010129	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:50:32	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8246229892981543	MSKCC- Snyder- P01-02		4126.0	
